data_2mzj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mzj _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.3 ptt85 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 120.722 0.296 . . . . 72.12 110.669 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -126.36 162.91 24.43 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.956 1.702 . . . . 73.13 106.838 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 mp -129.15 149.67 33.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.11 0.964 . . . . 74.14 108.577 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.2 t -109.79 124.69 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.249 1.42 . . . . 75.53 107.922 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -91.2 100.28 13.13 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.605 -1.998 . . . . 72.43 105.605 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.1 t -104.75 132.04 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.935 -1.876 . . . . 72.11 105.935 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.77 179.3 27.6 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 121.352 1.887 . . . . 54.54 113.758 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.72 14.01 0.99 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.291 2.637 . . . . 73.34 111.943 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 mp -55.7 157.65 7.35 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.897 1.679 . . . . 74.35 115.059 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.69 153.0 59.55 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.289 3.326 . . . . 72.25 110.544 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -34.32 75.3 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.216 0.606 . . . . 74.52 111.685 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -90.39 11.12 22.49 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.714 1.375 . . . . 61.24 114.714 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.3 tp -45.44 140.39 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 114.603 1.334 . . . . 74.43 114.603 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.38 147.6 46.92 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.149 1.38 . . . . 60.43 108.744 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -29.18 69.04 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.493 0.717 . . . . 74.31 111.105 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.16 -43.33 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.194 0.998 . . . . 73.11 109.17 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.09 -18.89 61.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.954 1.301 . . . . 73.52 111.744 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.9 mt -86.25 -44.24 12.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 120.573 -1.329 . . . . 75.14 109.524 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -62.17 -45.64 92.53 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.01 0.924 . . . . 73.43 110.955 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -65.35 -27.26 68.45 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 114.171 1.174 . . . . 65.24 114.171 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -74.49 -60.92 2.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.544 1.138 . . . . 75.34 109.587 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -80.94 3.65 22.15 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 114.675 1.361 . . . . 61.14 114.675 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -48.53 -51.68 26.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.795 1.638 . . . . 75.54 110.595 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -60.54 -44.42 96.12 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.774 0.83 . . . . 65.41 111.857 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 p -70.57 -16.41 62.86 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.145 -0.972 . . . . 53.43 112.981 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m 49.78 71.42 1.58 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.792 2.037 . . . . 53.23 116.064 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.29 165.72 23.67 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.944 2.429 . . . . 71.45 110.312 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -99.15 -47.41 5.22 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.812 1.645 . . . . 62.42 108.134 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.62 149.19 40.11 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.212 1.005 . . . . 73.52 109.872 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -146.7 112.31 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.651 1.58 . . . . 74.55 107.08 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -140.27 104.08 4.72 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.653 1.581 . . . . 74.41 110.13 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -89.87 127.78 36.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.132 1.773 . . . . 62.44 110.589 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -118.95 85.58 2.39 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.22 1.808 . . . . 75.41 108.109 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.64 -22.04 43.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.338 0.655 . . . . 74.21 112.544 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -51.5 -28.21 12.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.664 2.386 . . . . 53.03 112.346 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -133.44 8.43 3.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.697 1.999 . . . . 75.23 110.448 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.01 36.24 72.9 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.787 -1.007 . . . . 73.12 111.877 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.5 170.36 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 126.441 1.896 . . . . 73.33 108.575 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.06 170.89 19.35 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.534 -1.284 . . . . 54.42 107.534 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -128.23 135.83 50.22 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.429 -2.063 . . . . 73.34 105.429 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.96 107.82 6.3 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 106.812 -1.551 . . . . 75.35 106.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -88.36 154.3 20.5 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.442 -1.688 . . . . 53.35 106.442 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -139.93 116.2 10.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.763 1.225 . . . . 72.23 107.817 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -70.22 108.93 4.38 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.624 0.726 . . . . 74.21 111.55 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.43 69.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.387 1.075 . . . . 51.11 110.016 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.14 -21.05 65.85 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.649 0.779 . . . . 71.52 111.76 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -37.91 87.07 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.542 -0.91 . . . . 74.52 108.542 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -158.44 102.69 1.75 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 119.385 0.993 . . . . 74.41 111.327 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -52.74 -33.94 50.51 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.814 0.846 . . . . 74.14 112.769 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 12.9 18.8 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.736 1.013 . . . . 72.43 113.736 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.23 -24.91 3.38 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.849 1.214 . . . . 72.24 112.076 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tp -55.56 -33.4 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 118.442 1.121 . . . . 71.32 110.643 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -61.28 2.54 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.513 1.125 . . . . 71.51 109.545 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -60.54 -36.62 78.87 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 118.791 -0.623 . . . . 72.21 111.515 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -59.2 -42.97 92.19 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.713 -0.847 . . . . 74.33 108.713 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.2 mtm -67.76 -45.5 74.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.469 -1.253 . . . . 73.31 108.801 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -52.27 -51.47 58.26 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.103 1.319 . . . . 64.55 110.001 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.3 mt -59.09 -38.62 75.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 125.32 1.448 . . . . 75.34 110.449 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.36 -42.39 62.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.455 0.571 . . . . 72.41 109.623 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 mt -65.53 -30.3 71.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.791 1.636 . . . . 75.52 111.498 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 mt -65.9 -12.95 58.51 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.996 -0.526 . . . . 74.33 110.527 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -86.7 6.15 32.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.003 0.921 . . . . 71.31 110.823 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -73.76 115.36 13.09 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.39 -2.078 . . . . 72.41 105.39 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.04 5.71 70.26 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 125.053 1.311 . . . . 54.31 111.909 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 p -75.53 162.96 27.86 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 119.949 1.875 . . . . 72.25 107.203 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 mt -95.25 139.42 31.6 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 126.919 2.087 . . . . 73.11 108.048 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -145.74 122.85 11.46 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.668 1.987 . . . . 63.21 107.713 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt 42.06 46.95 3.79 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.779 1.232 . . . . 74.33 113.02 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.315 98.5 mt-10 66.0 23.71 11.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.814 2.045 . . . . 75.42 116.406 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -125.26 152.46 44.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.393 -2.077 . . . . 74.14 105.393 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -103.56 135.7 44.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 102.372 -3.195 . . . . 64.24 102.372 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.5 pt -122.63 161.28 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 119.0 0.818 . . . . 75.32 112.929 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -107.17 156.93 18.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.851 1.26 . . . . 72.43 111.244 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -147.49 118.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 125.512 1.525 . . . . 71.34 107.908 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -141.75 174.92 10.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.593 1.157 . . . . 75.44 110.506 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -84.05 151.9 24.7 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.29 1.036 . . . . 71.33 111.045 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 105.951 -1.87 . . . . 71.22 105.951 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 . . . . . 0 CA--C 1.511 -0.521 0 CA-C-O 120.022 -0.037 . . . . 74.32 110.947 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -95.25 163.43 13.27 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.119 1.368 . . . . 75.13 107.49 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -135.16 138.12 49.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 107.392 -1.336 . . . . 74.04 107.392 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.2 t -96.28 146.63 6.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 104.671 -2.344 . . . . 72.42 104.671 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.05 103.62 12.88 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.404 -2.072 . . . . 71.11 105.404 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.6 t -110.78 121.58 63.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.508 -1.664 . . . . 70.1 106.508 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.39 178.35 20.99 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 119.993 1.27 . . . . 74.21 113.043 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.72 21.93 5.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.087 2.155 . . . . 72.54 112.297 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.5 mp -64.15 150.02 93.07 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.325 1.45 . . . . 73.41 112.854 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.12 149.75 76.76 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.908 2.405 . . . . 70.14 110.171 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -59.8 -35.59 75.0 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.112 0.565 . . . . 74.53 110.142 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.83 14.14 10.99 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.5 1.296 . . . . 62.42 114.5 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.46 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 10.1 tp -47.08 142.88 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 124.372 1.069 . . . . 73.21 111.609 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 p -124.37 148.75 47.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.385 1.074 . . . . 75.23 108.33 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -32.77 72.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.683 -0.675 . . . . 73.24 110.074 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.12 -41.47 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-N 118.831 0.741 . . . . 65.23 109.829 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.36 -42.23 79.5 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.543 -0.54 . . . . 73.3 109.543 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 mt -65.96 -40.44 91.31 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.698 0.399 . . . . 75.3 111.605 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -46.63 77.46 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.516 -1.29 . . . . 75.35 107.516 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -61.11 -48.49 81.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 114.083 1.142 . . . . 74.23 114.083 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -28.44 68.61 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.488 0.921 . . . . 73.05 113.488 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -112.52 9.18 19.51 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 112.92 0.711 . . . . 73.35 112.92 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -55.34 -34.32 64.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.683 -1.26 . . . . 74.42 112.349 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.92 -34.6 44.44 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.324 0.511 . . . . 73.34 110.602 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -27.95 62.86 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.12 -0.696 . . . . 74.2 109.12 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.4 m 58.55 66.24 2.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 127.054 2.141 . . . . 52.51 114.792 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -63.53 164.96 19.13 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.731 2.954 . . . . 72.34 111.854 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -91.1 -40.74 11.43 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.115 1.766 . . . . 63.11 109.291 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -137.23 164.39 28.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.35 0.66 . . . . 74.42 111.311 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.8 mt -151.46 126.26 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.502 -1.666 . . . . 75.52 106.502 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.58 104.65 4.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.444 1.497 . . . . 74.42 107.172 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.35 125.42 34.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.389 -1.337 . . . . 74.1 107.389 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -112.97 86.41 2.37 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.165 -1.791 . . . . 65.41 106.165 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.14 -29.77 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.39 0.676 . . . . 71.32 111.01 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.7 -24.27 8.31 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.305 2.242 . . . . 72.32 113.096 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -132.73 -0.09 3.52 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.846 1.258 . . . . 72.31 111.836 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.63 41.76 98.98 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.132 -1.187 . . . . 75.31 110.132 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 pt -137.0 167.48 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.707 1.603 . . . . 75.34 109.149 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.18 166.36 24.91 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.382 1.073 . . . . 74.44 108.498 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -130.77 119.14 21.87 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.201 -2.148 . . . . 74.54 105.201 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.14 108.99 12.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.388 -1.708 . . . . 73.22 106.388 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.51 153.06 24.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.322 1.849 . . . . 74.45 109.533 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -144.58 108.37 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.687 1.195 . . . . 74.44 108.633 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -72.59 115.68 12.15 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.578 0.704 . . . . 73.34 110.227 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.2 -24.26 54.68 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.933 2.093 . . . . 75.14 111.834 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.85 -27.98 50.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.321 -0.371 . . . . 61.25 110.415 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -71.09 -36.97 72.4 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.21 0.604 . . . . 73.41 111.206 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.7 76.18 1.71 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.493 1.117 . . . . 75.51 111.085 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -47.55 66.07 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.512 -1.368 . . . . 72.4 113.684 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.25 5.25 52.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 114.086 1.143 . . . . 74.32 114.086 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.59 -5.76 2.8 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 117.386 -1.785 . . . . 72.43 115.502 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.7 tp -56.29 -42.39 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 121.073 2.436 . . . . 74.33 108.781 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -56.34 23.16 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 107.722 -1.214 . . . . 74.25 107.722 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -50.36 -48.49 55.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.417 1.087 . . . . 75.23 110.739 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -48.65 74.28 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.451 0.7 . . . . 73.12 109.124 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 48.8 mtm -68.84 -32.29 71.87 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 118.662 -0.685 . . . . 73.23 112.207 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.21 -51.53 68.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.134 2.173 . . . . 74.25 110.291 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mt -63.1 -39.6 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.313 1.445 . . . . 73.42 108.189 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.02 -41.63 81.89 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.178 -0.915 . . . . 73.42 109.554 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.2 mt -65.72 -31.24 72.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.33 0.968 . . . . 74.4 111.352 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 mt -66.16 -12.71 57.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.713 -0.661 . . . . 73.44 111.319 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -86.29 6.7 28.51 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 117.974 -1.012 . . . . 75.21 111.321 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -73.04 121.54 20.32 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.354 1.862 . . . . 70.42 108.86 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.96 3.22 58.08 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.828 -0.984 . . . . 73.33 114.377 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.4 p -68.84 151.61 46.37 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 119.35 1.575 . . . . 64.1 108.465 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.8 mt -97.42 110.84 23.32 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.711 -1.589 . . . . 74.4 106.711 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mt -113.59 119.11 36.37 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.843 -1.91 . . . . 75.14 105.843 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 41.9 mttm 45.03 58.31 4.13 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.643 1.577 . . . . 72.53 109.806 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 59.12 14.43 3.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.265 1.826 . . . . 70.41 115.033 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -121.14 122.01 39.08 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 120.479 -1.388 . . . . 52.03 110.545 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.86 123.85 25.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 104.601 -2.37 . . . . 74.31 104.601 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.4 pt -108.67 169.85 3.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 119.276 0.944 . . . . 72.23 112.9 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -112.56 146.03 39.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.691 1.196 . . . . 73.14 108.904 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.5 t -143.59 108.54 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 106.48 -1.674 . . . . 74.31 106.48 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -132.84 171.66 13.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.437 1.495 . . . . 72.54 109.144 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.8 152.6 19.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 120.666 -1.271 . . . . 62.33 113.795 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 p . . . . . 0 CA--C 1.539 0.524 0 C-N-CA 124.604 1.161 . . . . 75.32 108.9 177.485 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.272 0 N-CA-C 108.881 -0.785 . . . . 74.4 108.881 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -138.9 156.79 46.99 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.713 1.605 . . . . 74.45 106.768 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.2 mt -136.18 146.76 28.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.314 -0.857 . . . . 75.44 109.971 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.0 t -106.33 119.24 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 127.949 2.5 . . . . 74.43 106.522 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -88.59 135.13 33.65 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 104.562 -2.384 . . . . 74.24 104.562 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.9 t -138.77 122.51 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.135 -2.172 . . . . 75.22 105.135 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.0 -176.57 14.48 Favored Glycine 0 N--CA 1.467 0.718 0 CA-C-N 121.127 1.785 . . . . 52.32 111.027 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 m 70.51 17.53 6.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.691 1.596 . . . . 71.12 111.554 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 mp -67.29 147.55 98.89 Favored Pre-proline 0 C--O 1.235 0.295 0 O-C-N 120.975 -1.078 . . . . 75.11 109.963 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.82 152.31 77.54 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.511 2.141 . . . . 71.12 110.574 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -62.94 -30.76 71.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.779 -0.823 . . . . 73.12 108.779 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.39 -1.4 33.25 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 127.653 2.381 . . . . 73.15 114.121 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.1 tp -47.75 137.44 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.663 1.185 . . . . 73.42 113.29 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 p -115.43 150.01 37.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.464 1.506 . . . . 74.23 108.173 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.77 69.79 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.021 0.528 . . . . 61.13 110.722 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.51 -37.32 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 109.389 -0.597 . . . . 75.4 109.389 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.23 -43.26 82.43 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.061 -1.088 . . . . 61.24 108.061 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.08 -50.47 71.85 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.93 -0.396 . . . . 75.11 109.93 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -54.34 -50.22 67.92 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.587 1.155 . . . . 74.11 108.573 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -60.0 -41.78 92.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.555 1.142 . . . . 74.22 111.021 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -31.18 71.19 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 114.87 1.433 . . . . 71.21 114.87 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.27 9.72 33.86 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.013 0.525 . . . . 74.34 112.36 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -51.81 -43.73 63.21 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.504 1.522 . . . . 74.24 113.309 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -71.73 -25.83 62.23 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.122 0.569 . . . . 72.24 112.117 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.01 -30.02 20.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.182 0.593 . . . . 72.22 109.976 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 56.59 81.41 0.26 Allowed Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 127.946 2.498 . . . . 73.3 112.508 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -68.95 161.37 46.04 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.252 1.968 . . . . 71.42 110.616 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -91.9 -33.4 14.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.686 1.194 . . . . 74.41 109.535 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -138.39 151.36 47.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.196 0.999 . . . . 65.53 110.691 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.8 mt -143.21 121.75 7.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.972 -0.751 . . . . 71.33 108.972 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.7 128.79 25.44 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.055 -1.832 . . . . 72.14 106.055 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -115.84 116.78 28.61 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.323 1.849 . . . . 74.23 106.965 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -110.8 86.49 2.32 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.799 -1.926 . . . . 72.21 105.799 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.31 -19.08 31.88 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 113.475 0.917 . . . . 73.4 113.475 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.41 -28.19 12.12 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.841 2.056 . . . . 71.13 111.622 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -132.67 3.19 3.81 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.471 1.508 . . . . 74.51 109.506 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.74 54.6 36.56 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 126.871 2.177 . . . . 74.23 110.133 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 pt -137.29 155.51 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.897 1.279 . . . . 73.14 109.634 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.6 155.24 50.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.551 1.541 . . . . 63.33 109.047 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -125.28 118.67 26.49 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.981 -1.859 . . . . 75.43 105.981 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.03 104.81 10.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.379 -1.341 . . . . 63.04 107.379 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -84.46 156.8 21.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.726 0.81 . . . . 73.4 108.938 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -143.01 143.84 32.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.264 -1.754 . . . . 74.55 106.264 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -102.01 110.46 22.43 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.535 -0.913 . . . . 74.23 108.535 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.33 -27.16 64.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.691 1.196 . . . . 74.01 111.141 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.9 -33.34 75.11 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.393 -0.965 . . . . 75.4 108.393 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -61.96 -23.36 66.33 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 116.504 -1.713 . . . . 75.2 113.932 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -166.01 96.95 0.62 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.497 1.499 . . . . 72.54 110.771 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -31.9 38.46 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 117.328 2.344 . . . . 74.5 117.328 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -118.18 -9.85 10.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.603 1.547 . . . . 70.33 113.312 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.99 -17.66 34.33 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.256 -1.302 . . . . 64.32 110.759 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.4 tp -58.63 -38.85 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.954 1.877 . . . . 75.41 107.63 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -55.42 -61.28 2.44 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.182 1.793 . . . . 74.33 107.07 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -51.01 -49.44 60.45 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 121.944 -0.472 . . . . 74.34 111.491 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -54.31 -48.37 71.4 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.174 0.59 . . . . 62.2 110.448 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.7 mtm -65.68 -41.4 92.48 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 119.031 -0.509 . . . . 74.44 110.493 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -47.13 86.52 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.431 1.014 . . . . 73.23 110.266 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 mt -60.0 -39.64 80.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.701 1.2 . . . . 73.23 108.683 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.69 -41.16 72.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.419 -0.586 . . . . 74.34 109.419 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.5 mt -63.88 -34.36 77.76 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.928 0.891 . . . . 73.31 110.988 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.2 mt -63.33 -9.57 12.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.191 0.996 . . . . 75.53 111.729 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -85.87 -2.8 58.61 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.615 1.098 . . . . 72.12 110.186 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -64.21 118.91 9.28 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.092 -1.447 . . . . 74.41 107.092 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.45 ' O ' ' HE2' ' A' ' 73' ' ' LYS . . . 84.85 6.64 85.03 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-O 117.006 -1.997 . . . . 64.11 114.248 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.9 p -78.26 163.18 25.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 121.112 2.456 . . . . 75.34 107.731 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HG ' ' HE3' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -101.4 108.21 19.75 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.06 -1.089 . . . . 72.43 108.06 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -113.98 121.42 43.86 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 126.307 1.843 . . . . 72.54 107.434 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt 47.44 44.64 16.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.552 1.141 . . . . 72.12 113.074 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 69.37 18.19 8.0 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.289 2.236 . . . . 74.21 114.604 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -125.93 124.14 40.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.98 0.912 . . . . 72.21 108.557 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 66' ' ' GLY . 1.3 ttmt -75.02 114.81 13.93 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 101.815 -3.402 . . . . 72.31 101.815 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.3 pt -96.11 169.62 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.265 0.839 . . . . 65.52 113.265 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -121.43 148.09 44.88 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.819 1.647 . . . . 64.33 108.685 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.3 t -142.15 138.97 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.457 1.103 . . . . 72.32 109.053 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -159.99 176.26 12.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.772 2.029 . . . . 75.53 109.232 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.65 151.67 22.77 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.901 -1.125 . . . . 74.04 109.905 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 105.22 -2.141 . . . . 74.12 105.22 177.393 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.424 0.154 . . . . 75.1 110.709 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -91.62 165.23 13.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.393 1.477 . . . . 75.02 107.977 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mt -134.97 148.16 29.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.136 1.374 . . . . 74.52 108.96 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.4 136.69 47.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.764 1.625 . . . . 72.04 107.353 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -106.34 117.08 33.1 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.912 1.285 . . . . 74.15 108.253 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 t -122.02 136.37 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.11 -1.07 . . . . 64.31 108.11 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.2 169.7 26.22 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 119.858 1.208 . . . . 71.32 111.477 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 74' ' ' ILE . 7.2 t 82.9 17.09 0.31 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 128.441 2.696 . . . . 74.32 109.766 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mp -53.62 152.09 9.92 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 124.61 1.164 . . . . 74.34 112.591 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -52.54 148.66 26.33 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.958 2.439 . . . . 75.52 111.106 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -59.9 -31.73 70.08 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.785 -0.572 . . . . 75.24 111.083 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -113.63 33.41 5.18 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.123 1.369 . . . . 54.12 111.747 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.68 143.08 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.97 -1.122 . . . . 64.32 107.97 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.36 147.66 46.0 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.426 -0.953 . . . . 73.34 108.426 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.18 68.73 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 117.961 -1.019 . . . . 54.52 111.179 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -62.96 -35.49 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 119.793 1.179 . . . . 71.12 109.509 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -66.46 -48.19 70.71 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.678 -0.86 . . . . 72.44 108.678 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.4 mt -59.91 -52.15 66.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.638 0.775 . . . . 74.43 109.01 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -57.72 -36.48 72.07 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.438 1.495 . . . . 73.32 109.796 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -75.95 -46.24 30.8 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.234 1.414 . . . . 74.32 112.849 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -35.91 81.91 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.632 0.773 . . . . 73.33 111.978 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -97.84 0.28 46.43 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.282 0.845 . . . . 75.35 113.282 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -50.99 -40.97 59.32 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.859 1.664 . . . . 73.45 112.567 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -66.79 -49.33 66.2 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.238 -0.653 . . . . 64.13 109.238 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 p -66.38 -17.15 64.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.789 1.236 . . . . 73.41 112.852 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.8 t 47.55 77.14 0.48 Allowed Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.658 1.583 . . . . 63.05 113.711 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.54 163.76 33.65 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.44 2.76 . . . . 71.41 110.652 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.6 -41.66 17.6 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.73 1.212 . . . . 72.32 108.426 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.33 162.12 40.7 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.641 1.176 . . . . 71.43 108.079 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.3 mt -135.52 128.5 47.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 126.182 1.793 . . . . 74.12 107.793 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -141.12 104.4 4.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.744 1.218 . . . . 74.12 109.359 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.29 125.28 37.81 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.937 -1.505 . . . . 72.42 106.937 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -118.82 91.53 3.58 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.349 1.059 . . . . 74.5 108.854 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.11 -20.94 64.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.203 1.001 . . . . 74.34 110.551 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.07 -32.34 21.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.949 2.1 . . . . 73.15 110.084 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -131.98 3.6 4.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.951 1.7 . . . . 74.12 111.966 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.29 34.8 90.94 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 119.66 1.118 . . . . 54.23 111.929 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.87 171.3 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.289 1.435 . . . . 73.13 110.249 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.12 163.89 33.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.848 0.859 . . . . 72.12 111.031 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -130.49 135.49 48.01 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.398 1.479 . . . . 72.53 107.866 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -142.28 111.63 6.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.124 -1.435 . . . . 70.22 107.124 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.2 159.48 21.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.149 -1.056 . . . . 75.14 108.149 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -144.43 104.47 4.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.047 1.339 . . . . 70.53 107.426 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.69 110.0 5.96 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.644 1.178 . . . . 71.53 112.228 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.71 72.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.506 0.928 . . . . 73.32 113.506 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -75.11 -24.29 58.05 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.21 0.914 . . . . 75.24 111.954 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -61.38 -30.72 70.72 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.498 -0.751 . . . . 65.15 110.302 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -157.0 84.02 0.94 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.976 -0.75 . . . . 73.04 108.976 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -52.47 -38.51 59.51 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.553 0.575 . . . . 73.02 112.553 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.0 -4.77 57.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 113.983 1.105 . . . . 74.22 113.983 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.1 -14.32 4.62 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.148 -1.362 . . . . 63.15 115.024 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.5 tp -51.72 -43.69 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 120.21 2.005 . . . . 73.12 110.886 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -57.05 -51.3 69.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.9 -1.148 . . . . 75.42 107.9 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -57.06 -48.86 77.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.206 1.002 . . . . 74.54 109.318 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.7 mtt85 -52.07 -51.97 54.24 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.656 0.662 . . . . 74.5 109.872 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 21.4 mtm -62.94 -39.61 95.14 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 119.096 -0.478 . . . . 75.33 110.771 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -49.96 75.42 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.297 1.039 . . . . 73.33 110.24 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.37 -39.36 78.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.597 1.159 . . . . 70.35 108.504 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.49 -40.38 70.26 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.324 0.511 . . . . 74.42 110.353 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.11 -38.82 92.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.338 1.055 . . . . 74.33 110.375 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.98 -2.44 1.23 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.719 1.608 . . . . 75.3 113.853 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -92.32 1.17 57.39 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.939 0.79 . . . . 63.12 110.852 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.62 115.3 4.59 Favored 'General case' 0 C--N 1.338 0.078 0 O-C-N 120.279 -1.513 . . . . 63.44 111.054 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.2 4.6 74.14 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 118.291 -1.283 . . . . 74.51 111.955 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.6 p -68.27 157.95 34.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.216 1.508 . . . . 74.14 109.65 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 mt -102.71 111.4 23.69 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.243 -1.392 . . . . 72.35 107.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -116.25 116.17 27.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.31 -1.367 . . . . 74.2 107.31 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt 49.88 53.44 12.79 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.793 1.237 . . . . 74.41 111.68 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 57.62 30.58 19.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.257 1.823 . . . . 74.21 113.838 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.21 118.02 13.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.313 1.445 . . . . 73.44 108.44 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -76.03 140.39 41.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.116 -1.809 . . . . 73.21 106.116 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 11.8 pt -126.63 170.08 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.438 1.086 . . . . 73.13 112.866 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.44 157.13 37.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.195 1.398 . . . . 73.1 110.699 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.0 t -136.87 148.55 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 125.275 1.43 . . . . 72.35 108.938 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.0 174.59 10.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.979 2.512 . . . . 74.45 109.175 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.22 152.0 20.07 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.433 1.093 . . . . 74.25 109.959 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--N 1.332 -0.193 0 N-CA-C 107.72 -1.215 . . . . 63.42 107.72 178.307 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 107.935 -1.135 . . . . 63.12 107.935 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -95.04 162.86 13.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.721 -1.585 . . . . 55.22 106.721 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 mt -134.23 149.01 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.534 0.683 . . . . 74.44 109.715 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.9 t -121.06 115.06 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 105.949 -1.871 . . . . 74.12 105.949 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -84.61 139.03 32.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.54 -2.393 . . . . 75.32 104.54 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.74 136.57 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.746 -1.946 . . . . 64.04 105.746 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -141.83 -178.4 17.92 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 119.718 1.145 . . . . 70.13 110.596 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.44 13.06 9.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.14 1.776 . . . . 71.13 112.628 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.8 148.61 26.27 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.565 1.546 . . . . 73.41 112.603 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.44 150.71 87.77 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.893 2.395 . . . . 75.02 110.365 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -53.58 -45.75 70.08 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.135 0.974 . . . . 75.21 110.718 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.02 18.53 5.72 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.248 1.573 . . . . 74.2 115.248 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.5 tp -44.98 137.21 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 119.902 1.228 . . . . 74.01 111.968 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 p -115.96 150.52 37.03 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.293 1.437 . . . . 75.21 109.236 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.71 -29.63 70.83 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-O 119.13 -0.462 . . . . 74.33 110.647 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.48 -38.35 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 118.443 0.565 . . . . 74.31 109.581 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.42 -38.14 84.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.088 0.858 . . . . 73.2 109.125 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.77 -54.46 31.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.107 -0.701 . . . . 71.05 109.107 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -54.81 -46.56 74.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.123 0.969 . . . . 74.11 109.097 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -62.77 -41.22 99.15 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 114.378 1.251 . . . . 75.33 114.378 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -46.56 69.84 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.056 -1.028 . . . . 71.22 110.493 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -86.09 3.06 44.21 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.057 1.132 . . . . 72.0 114.057 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -53.43 -40.63 65.32 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.538 -1.351 . . . . 74.42 110.69 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -70.59 -31.38 68.35 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.926 1.69 . . . . 74.24 112.174 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 p -89.49 -11.21 43.61 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 117.913 -1.042 . . . . 71.24 112.459 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m 48.58 70.44 2.08 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 115.445 1.646 . . . . 73.53 115.445 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.94 161.4 46.1 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.961 2.441 . . . . 74.01 111.682 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -91.55 -39.5 11.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.05 1.74 . . . . 71.34 107.649 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -135.35 158.19 44.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.698 1.199 . . . . 75.44 110.748 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.6 mt -145.79 126.3 6.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.341 -1.726 . . . . 62.24 106.341 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -140.27 105.93 5.13 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.985 1.314 . . . . 74.42 109.833 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -92.76 121.16 33.87 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.313 1.045 . . . . 75.04 110.241 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -118.88 81.7 1.74 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.941 -1.133 . . . . 74.22 107.941 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.63 -21.63 60.72 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.217 1.007 . . . . 64.45 111.096 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.74 -20.21 7.93 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.953 1.701 . . . . 64.14 112.346 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -132.37 -4.1 3.4 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.702 1.601 . . . . 75.41 109.447 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.32 41.77 51.69 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.207 -1.557 . . . . 70.5 109.207 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.463 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 40.5 pt -132.86 171.82 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 124.537 1.135 . . . . 75.44 110.678 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.87 165.6 34.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.739 1.615 . . . . 65.31 109.187 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -135.22 142.3 45.99 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.552 1.941 . . . . 65.13 106.219 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -142.9 114.08 7.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.28 -1.378 . . . . 74.41 107.28 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.3 155.98 19.02 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.551 -1.648 . . . . 72.12 106.551 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -145.1 114.02 6.89 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.275 1.83 . . . . 75.41 109.187 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -72.01 112.77 8.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.776 1.028 . . . . 71.35 113.776 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.95 -16.26 61.54 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.427 1.491 . . . . 74.43 112.789 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.62 -22.51 27.94 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.058 0.845 . . . . 75.34 109.57 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -61.62 -43.93 97.94 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 120.952 -1.092 . . . . 64.54 109.697 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -145.44 89.21 1.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.512 0.596 . . . . 72.21 110.755 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -37.57 48.92 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 114.358 1.244 . . . . 75.32 114.358 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.8 p -97.15 -19.85 18.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.221 1.373 . . . . 72.24 112.381 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.49 -16.29 43.56 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 117.65 -1.639 . . . . 52.21 114.911 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.42 -37.3 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.799 2.3 . . . . 71.04 109.366 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -60.84 -60.93 3.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.632 -1.247 . . . . 73.14 107.632 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -50.79 -44.22 58.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 118.614 -0.708 . . . . 74.52 110.628 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -56.42 -49.98 72.98 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.939 -0.763 . . . . 72.14 108.939 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.2 mtm -58.68 -47.71 83.57 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 124.204 1.002 . . . . 73.23 109.447 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -53.76 50.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.997 1.719 . . . . 74.45 111.837 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.6 mt -61.27 -37.01 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.804 1.242 . . . . 75.41 108.937 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.36 -41.44 63.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.434 -0.58 . . . . 71.52 109.434 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.39 -34.95 78.85 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.915 1.286 . . . . 75.12 111.241 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.8 mt -65.81 -9.77 31.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.044 0.938 . . . . 74.4 111.889 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -85.76 -1.68 57.46 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.128 0.876 . . . . 65.41 110.418 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -62.76 111.9 2.3 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.883 1.674 . . . . 74.2 109.673 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.74 7.25 53.68 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.619 1.104 . . . . 64.41 112.945 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.1 p -66.08 146.85 54.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.528 1.664 . . . . 64.44 109.121 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.6 mt -93.08 121.21 34.19 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.547 -2.39 . . . . 62.52 104.547 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.8 120.05 28.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.996 1.318 . . . . 73.23 108.152 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt 48.39 40.48 14.79 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.22 1.408 . . . . 75.13 112.561 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 70.48 29.35 3.47 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 128.519 2.728 . . . . 62.33 113.913 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -136.15 120.71 18.26 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 126.551 1.94 . . . . 74.34 108.772 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -73.61 138.33 44.8 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 105.636 -1.987 . . . . 75.05 105.636 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 pt -119.5 170.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 124.636 1.174 . . . . 74.1 110.695 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -123.66 158.74 30.86 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.247 1.419 . . . . 72.13 111.23 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.96 132.89 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.09 1.756 . . . . 74.35 108.862 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -148.24 160.53 42.86 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.616 1.566 . . . . 73.25 108.565 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.28 148.13 25.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.848 1.259 . . . . 71.31 109.784 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.602 0 C-N-CA 125.991 1.717 . . . . 63.23 107.261 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 . . . . . 0 N--CA 1.466 0.369 0 N-CA-C 109.384 -0.598 . . . . 73.33 109.384 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -119.03 161.38 20.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 105.81 -1.922 . . . . 72.42 105.81 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -134.68 139.41 47.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.178 1.391 . . . . 75.44 110.261 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.75 141.56 27.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 106.971 -1.492 . . . . 74.34 106.971 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -103.79 133.19 49.2 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.31 -2.107 . . . . 72.43 105.31 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.2 t -136.79 130.6 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.731 -1.952 . . . . 72.34 105.731 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.95 179.92 21.74 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 121.348 1.885 . . . . 65.44 115.041 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.82 17.15 2.32 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.162 2.585 . . . . 74.41 111.399 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.76 146.23 99.05 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 125.023 1.329 . . . . 74.12 112.765 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -67.07 167.76 19.13 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.681 2.921 . . . . 75.13 112.119 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -75.0 -34.64 61.97 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.297 -1.001 . . . . 75.3 108.297 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.6 11.62 3.65 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.149 1.38 . . . . 62.22 112.172 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.465 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 8.7 tp -54.77 143.61 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 120.679 -1.263 . . . . 72.43 109.31 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 p -128.11 148.25 50.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.445 1.098 . . . . 71.42 110.074 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.95 -29.63 70.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.209 -0.9 . . . . 74.33 110.652 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.65 -38.21 81.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 119.069 0.85 . . . . 75.2 109.782 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.48 -43.11 67.19 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.022 -0.732 . . . . 75.43 109.022 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.51 -49.64 75.91 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.34 1.056 . . . . 74.31 111.253 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -59.39 -42.14 91.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.629 0.772 . . . . 75.13 109.178 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -68.79 -40.88 79.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.385 1.474 . . . . 74.31 113.535 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -41.28 91.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 118.739 0.699 . . . . 72.24 111.978 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -99.75 4.74 45.56 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.82 1.044 . . . . 70.24 113.82 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -51.19 -47.54 62.18 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.067 1.347 . . . . 72.51 109.896 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.06 -39.9 79.64 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.633 0.773 . . . . 74.32 111.838 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 p -81.87 -10.76 59.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.732 1.213 . . . . 75.2 112.794 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.64 65.95 6.38 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 114.965 1.468 . . . . 74.24 114.965 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -64.91 151.86 84.32 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.751 2.301 . . . . 64.54 108.897 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.68 -48.49 8.24 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.077 -1.083 . . . . 63.3 108.077 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' NE2' ' H ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -124.5 153.88 41.38 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.258 -1.016 . . . . 75.23 108.258 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.473 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 65.3 mt -145.92 119.83 2.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.425 -1.694 . . . . 74.43 106.425 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.43 108.22 10.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.733 -1.58 . . . . 74.34 106.733 178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -93.59 125.93 38.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.746 -1.576 . . . . 73.24 106.746 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -118.24 89.69 3.18 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.426 -2.064 . . . . 75.34 105.426 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.15 -16.41 52.56 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.148 -0.453 . . . . 64.55 111.417 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -50.48 -40.08 50.0 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.246 2.219 . . . . 75.23 111.034 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -126.84 6.56 6.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.853 1.661 . . . . 74.31 110.174 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.12 42.63 99.73 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.313 -1.115 . . . . 74.4 110.313 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.7 162.31 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.856 1.263 . . . . 74.31 109.37 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.75 152.23 40.06 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.126 0.971 . . . . 64.3 109.527 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -120.31 135.25 55.08 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 103.958 -2.608 . . . . 74.13 103.958 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.53 122.99 25.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.158 -1.793 . . . . 72.23 106.158 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -96.6 150.71 20.35 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.188 -1.412 . . . . 71.51 107.188 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -142.13 110.68 6.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.388 -1.338 . . . . 75.12 107.388 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -76.25 118.19 18.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.645 0.778 . . . . 71.23 109.302 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.76 -18.88 50.03 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 128.025 2.53 . . . . 75.54 112.344 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.5 -30.33 52.94 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.479 -1.674 . . . . 73.05 106.479 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -61.73 -37.5 84.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.696 1.198 . . . . 70.33 112.348 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -147.94 97.92 2.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.297 0.953 . . . . 73.51 108.876 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -51.46 -31.52 23.59 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 115.894 -2.003 . . . . 74.21 116.315 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.79 -20.59 8.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 121.021 1.737 . . . . 73.2 111.287 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.42 -30.7 66.54 Favored Glycine 0 C--N 1.338 0.66 0 O-C-N 121.015 -1.053 . . . . 71.33 110.835 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.7 tp -49.76 -41.95 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.388 1.094 . . . . 73.41 112.055 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -68.23 -61.34 1.89 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.222 0.609 . . . . 74.52 110.342 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -56.15 -30.84 62.74 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.93 -0.481 . . . . 75.32 111.331 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.3 mtt85 -68.44 -41.16 80.7 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.01 -1.056 . . . . 74.32 108.741 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.0 mtm -64.55 -44.09 91.9 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 107.163 -1.421 . . . . 73.12 107.163 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -56.5 -48.24 77.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.948 0.899 . . . . 74.43 109.048 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.58 -41.38 87.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.137 0.975 . . . . 73.5 109.848 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.27 84.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.448 -0.575 . . . . 75.2 109.448 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.28 -32.55 74.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.828 0.851 . . . . 73.31 110.245 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.3 mt -65.28 -13.04 57.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 118.795 -0.621 . . . . 72.14 110.951 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -86.49 3.93 41.97 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.932 0.787 . . . . 65.21 110.262 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -69.53 112.71 6.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.083 -1.636 . . . . 74.41 107.842 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.65 -3.93 85.05 Favored Glycine 0 C--O 1.225 -0.447 0 CA-C-O 116.436 -2.313 . . . . 75.4 111.893 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -64.87 137.73 57.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 121.44 2.62 . . . . 74.34 107.138 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.49 126.28 30.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.027 -1.842 . . . . 75.34 106.027 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.7 tp -129.82 122.9 29.65 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 105.364 -2.088 . . . . 75.31 105.364 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 6.0 mtpm? 51.37 44.85 28.69 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.768 1.627 . . . . 74.23 111.359 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 57.83 33.89 23.74 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 127.644 2.378 . . . . 72.01 113.193 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -134.46 128.54 33.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 126.039 1.736 . . . . 73.34 108.137 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -78.52 112.15 15.29 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 103.534 -2.765 . . . . 74.44 103.534 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.8 pt -104.56 169.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 118.137 0.426 . . . . 75.51 110.359 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -121.64 158.7 28.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.286 1.034 . . . . 74.33 111.236 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -146.21 143.63 21.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.846 1.258 . . . . 74.12 108.048 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -162.07 161.13 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.647 1.579 . . . . 72.24 108.863 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.67 152.18 22.78 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.916 1.286 . . . . 74.41 109.109 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.33 -0.261 0 C-N-CA 124.797 1.239 . . . . 72.43 108.603 179.531 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.602 0.239 . . . . 75.52 110.74 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -130.21 158.8 38.75 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 129.786 3.234 . . . . 73.13 105.196 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.4 mt -130.36 149.32 33.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.832 0.825 . . . . 71.22 109.338 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 t -108.9 127.14 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 125.798 1.639 . . . . 74.42 107.421 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -91.45 128.32 37.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.537 -2.394 . . . . 75.05 104.537 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.84 129.55 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.462 -1.681 . . . . 75.34 106.462 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.72 -175.72 14.44 Favored Glycine 0 N--CA 1.468 0.814 0 CA-C-N 120.317 1.417 . . . . 75.4 113.09 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 72.21 14.45 5.56 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.217 2.207 . . . . 74.24 111.543 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.26 149.59 82.3 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 125.232 1.413 . . . . 73.14 112.334 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.98 165.15 31.05 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.282 2.655 . . . . 72.45 110.036 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.19 -31.52 58.51 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.219 1.008 . . . . 75.21 109.494 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -85.35 10.89 11.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.303 1.441 . . . . 75.41 113.467 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.488 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 8.6 tp -57.61 138.97 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.488 1.115 . . . . 73.34 111.69 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 p -128.32 153.4 47.05 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.184 0.994 . . . . 74.3 109.738 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.36 -33.31 65.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.446 1.898 . . . . 71.34 111.366 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.8 p -66.14 -37.7 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 119.126 -0.464 . . . . 72.33 110.113 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.79 -43.39 72.22 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.392 -0.966 . . . . 73.24 108.392 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -60.36 -55.63 31.24 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 125.276 1.43 . . . . 73.33 110.069 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -57.63 -45.06 85.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.037 -0.727 . . . . 74.3 109.037 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -60.34 -44.1 95.83 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 65.11 112.813 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -47.98 74.89 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 119.419 1.009 . . . . 74.41 110.825 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -83.01 1.02 42.09 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 115.362 1.615 . . . . 74.53 115.362 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -51.26 -41.57 60.49 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.223 1.409 . . . . 74.32 113.382 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -32.75 74.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.885 0.874 . . . . 75.32 110.666 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 88.1 p -87.16 -28.76 22.25 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.255 1.206 . . . . 71.23 114.255 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.4 t 62.81 75.21 0.42 Allowed Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.53 1.932 . . . . 72.41 112.358 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -67.33 159.97 49.86 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.934 3.09 . . . . 63.51 110.719 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -85.63 -46.47 10.74 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.871 1.668 . . . . 72.14 108.009 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.56 157.21 44.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.902 -0.59 . . . . 73.42 109.598 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.6 mt -137.93 128.46 36.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 125.028 1.331 . . . . 75.25 108.875 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 103.39 5.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.35 -1.352 . . . . 74.15 107.35 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -88.62 111.73 22.25 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.95 -1.5 . . . . 73.32 106.95 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -105.28 80.22 1.57 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.079 -1.452 . . . . 74.34 107.079 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.66 -27.97 43.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.977 0.911 . . . . 74.31 111.246 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -51.09 -27.9 9.32 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 127.515 2.326 . . . . 70.3 113.904 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -132.65 9.96 4.31 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.888 1.275 . . . . 74.53 111.093 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.14 42.7 99.87 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.795 1.188 . . . . 71.24 110.619 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.54 166.05 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 C-N-CA 124.816 1.246 . . . . 73.24 111.482 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.31 148.77 36.84 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.328 2.251 . . . . 72.1 108.239 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -124.16 129.39 50.74 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.961 -1.866 . . . . 75.34 105.961 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.11 114.13 15.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.209 -1.034 . . . . 71.32 108.209 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -92.66 155.04 17.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.745 -1.946 . . . . 64.22 105.745 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -140.02 137.22 34.46 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.629 -1.619 . . . . 74.34 106.629 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -81.7 110.19 16.81 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.944 1.247 . . . . 73.43 109.444 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.59 -16.99 62.9 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.631 1.172 . . . . 73.3 112.273 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.69 -18.38 29.66 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.997 0.817 . . . . 73.32 110.777 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -60.98 -35.61 77.24 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.157 0.889 . . . . 75.42 110.357 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -150.14 86.71 1.43 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.922 -1.881 . . . . 74.4 105.922 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -49.75 -37.36 29.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.471 1.108 . . . . 75.52 112.226 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 -3.1 39.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.257 1.423 . . . . 72.23 113.578 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.06 -19.75 5.84 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 124.923 1.249 . . . . 74.21 114.788 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 tp -52.83 -36.99 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.42 1.61 . . . . 65.32 111.461 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -56.42 -54.84 40.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.846 1.259 . . . . 71.01 108.398 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -47.03 79.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.34 1.056 . . . . 74.14 109.793 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -54.74 -46.59 74.3 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 118.727 -0.654 . . . . 75.01 109.273 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 2.7 mtm -61.33 -50.88 71.16 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 108.173 -1.047 . . . . 73.54 108.173 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.04 -52.52 8.87 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.796 2.038 . . . . 74.14 111.836 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.0 mt -59.08 -41.9 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.199 1.4 . . . . 71.32 110.091 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.32 -36.82 61.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.159 0.984 . . . . 71.13 111.058 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -66.96 -36.08 81.41 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.642 1.11 . . . . 74.31 109.586 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.68 -12.73 11.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.568 1.147 . . . . 74.35 111.512 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -84.61 5.02 29.59 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.871 0.759 . . . . 64.03 110.278 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -69.07 113.92 6.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.285 -1.746 . . . . 72.23 106.285 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.28 6.23 61.56 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.282 -1.288 . . . . 70.42 113.458 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.5 p -68.07 143.56 55.44 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 120.482 2.141 . . . . 74.51 108.607 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 mt -88.71 107.6 19.03 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 103.174 -2.899 . . . . 74.44 103.174 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.9 tp -113.0 117.5 32.21 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.715 -1.587 . . . . 64.0 106.715 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 14.3 mtpp 47.05 56.1 7.22 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.883 0.873 . . . . 73.41 111.891 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 60.95 23.38 13.5 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.856 1.662 . . . . 72.45 114.789 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -132.41 126.67 33.67 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 124.685 1.194 . . . . 73.31 108.757 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -80.1 114.3 18.9 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 104.067 -2.568 . . . . 75.55 104.067 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.2 pt -94.96 169.24 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 118.436 0.562 . . . . 72.25 109.984 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -122.99 158.59 30.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.01 1.324 . . . . 72.34 110.861 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.0 t -142.52 126.44 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 126.009 1.723 . . . . 74.41 108.797 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -139.03 174.47 10.48 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.475 1.51 . . . . 74.32 108.156 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.46 151.78 18.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.152 -0.967 . . . . 74.51 110.124 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 107.249 -1.389 . . . . 63.22 107.249 178.203 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 108.384 -0.969 . . . . 73.31 108.384 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -128.55 157.71 40.46 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.778 1.631 . . . . 75.34 107.233 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -134.91 146.01 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.361 1.065 . . . . 64.25 110.02 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.8 126.44 57.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.62 -1.993 . . . . 72.15 105.62 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -96.58 105.14 17.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.594 -1.632 . . . . 74.23 106.594 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -113.66 139.35 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 120.027 1.285 . . . . 73.43 108.675 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -149.06 178.31 26.7 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 119.928 1.24 . . . . 62.44 112.663 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 84.99 6.3 0.5 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.405 3.082 . . . . 74.21 111.833 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp -46.24 148.67 1.49 Allowed Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 127.339 2.256 . . . . 73.03 115.392 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.86 175.28 7.55 Favored 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.98 4.453 . . . . 73.14 113.379 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mmt-85 -78.47 -45.44 22.08 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 107.898 -1.149 . . . . 75.45 107.898 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -84.25 22.02 1.3 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.031 1.733 . . . . 73.42 112.889 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.7 tp -61.93 142.25 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.628 -1.249 . . . . 71.45 107.628 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.99 150.01 50.58 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.376 -0.972 . . . . 72.32 108.376 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -32.39 70.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.848 -0.797 . . . . 75.42 108.848 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.01 -49.08 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.138 1.375 . . . . 74.25 109.868 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.46 -34.75 74.84 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.01 -0.676 . . . . 73.42 109.215 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.12 -49.85 72.77 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.943 0.792 . . . . 75.03 109.436 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -59.92 -37.78 80.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.828 -0.606 . . . . 74.45 110.501 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -69.59 -50.82 40.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.394 0.677 . . . . 61.42 110.764 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -24.11 67.7 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 120.971 -1.081 . . . . 74.24 112.213 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -108.54 8.79 27.39 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.88 1.218 . . . . 70.35 111.712 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -61.27 -26.72 67.96 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 120.107 -1.62 . . . . 74.44 114.062 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -30.1 23.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.639 1.109 . . . . 71.43 108.767 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -31.2 58.73 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.407 -0.96 . . . . 71.04 108.407 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m 60.69 72.35 0.73 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 126.674 1.99 . . . . 73.53 113.134 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.14 158.1 58.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.741 2.961 . . . . 71.44 110.465 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -78.96 -45.74 19.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.857 -1.534 . . . . 73.15 106.857 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -156.77 139.71 15.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.477 1.511 . . . . 74.51 108.48 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.14 142.19 22.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.384 -1.71 . . . . 74.54 106.384 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -135.09 103.8 5.69 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.581 -1.637 . . . . 73.33 106.581 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -86.7 121.44 29.22 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.463 -1.31 . . . . 65.45 107.463 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -108.85 82.35 1.59 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.542 -1.651 . . . . 75.03 106.542 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.56 -23.22 62.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.216 0.606 . . . . 72.3 111.347 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.95 -26.93 66.37 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.56 1.544 . . . . 74.12 111.981 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -133.17 6.6 3.89 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.693 1.197 . . . . 73.13 112.591 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.32 47.41 91.03 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 119.063 0.847 . . . . 62.03 111.287 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 2.3 pt -134.73 159.78 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.196 1.398 . . . . 73.25 108.727 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.68 135.06 21.88 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.58 1.152 . . . . 72.41 108.347 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -108.17 139.33 43.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.573 -2.01 . . . . 74.13 105.573 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.32 116.03 15.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 105.406 -2.072 . . . . 65.42 105.406 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -88.05 149.98 23.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.918 0.887 . . . . 72.14 109.711 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -140.98 123.31 15.79 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.188 1.795 . . . . 72.32 107.654 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -90.82 112.4 24.19 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.111 0.964 . . . . 73.34 110.882 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.42 -22.58 62.71 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.107 1.363 . . . . 61.45 111.74 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.93 -37.04 64.71 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.941 -1.133 . . . . 51.32 107.941 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -69.17 -38.25 78.61 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 118.687 -0.673 . . . . 74.5 109.657 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.0 75.86 1.4 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.823 0.738 . . . . 71.32 111.564 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -54.15 -39.61 66.68 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 118.837 -0.601 . . . . 74.44 111.979 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.9 p -104.26 -1.26 27.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.872 1.269 . . . . 75.23 113.449 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.43 -13.88 7.91 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-O 117.958 -1.468 . . . . 63.2 114.813 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.3 tp -51.4 -50.37 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 120.171 1.986 . . . . 74.02 112.218 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -53.33 57.02 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.331 -0.989 . . . . 62.34 108.331 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -50.59 -48.65 57.69 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.133 0.573 . . . . 73.13 111.068 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -57.01 -49.63 75.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.549 1.14 . . . . 73.11 108.719 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 43.2 mtm -64.08 -36.53 84.32 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.405 0.682 . . . . 71.41 111.345 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -55.35 -51.07 67.98 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.704 2.002 . . . . 52.53 111.65 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.47 -26.56 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.568 1.547 . . . . 65.13 109.368 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.89 -39.58 19.67 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.973 0.909 . . . . 75.02 108.927 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.31 -44.67 95.23 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.032 1.733 . . . . 74.42 110.221 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.3 mt -58.41 -6.82 0.74 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.485 1.914 . . . . 74.22 113.938 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -89.4 -3.7 58.32 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.29 0.95 . . . . 72.34 111.331 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -59.23 112.66 1.8 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.797 1.239 . . . . 72.1 108.85 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.452 ' CA ' ' HE2' ' A' ' 73' ' ' LYS . . . 91.28 3.52 69.51 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.934 -1.481 . . . . 72.34 115.009 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 p -70.6 160.77 31.91 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.618 1.709 . . . . 62.33 109.124 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 mt -109.49 108.85 19.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.307 1.443 . . . . 75.14 109.536 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.78 132.83 55.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.858 -2.275 . . . . 74.35 104.858 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.7 mttm 46.09 45.8 12.6 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.282 1.039 . . . . 75.33 111.655 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 64.32 0.12 0.99 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.685 2.794 . . . . 74.15 115.855 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -109.89 140.2 44.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.63 1.104 . . . . 74.3 109.645 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.452 ' HE2' ' CA ' ' A' ' 66' ' ' GLY . 15.8 tttm -78.95 156.16 28.64 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.47 -0.937 . . . . 73.43 108.47 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 pt -129.58 170.08 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.884 1.274 . . . . 73.03 111.003 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.25 147.98 52.03 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.156 1.783 . . . . 63.23 106.457 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.6 t -139.12 136.31 42.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 124.802 1.241 . . . . 73.15 108.333 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -147.18 171.98 14.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.149 1.78 . . . . 62.13 108.049 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.14 152.79 20.45 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.373 1.469 . . . . 64.42 108.831 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 106.886 -1.524 . . . . 72.42 106.886 176.662 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 ptt-85 . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 108.934 -0.765 . . . . 74.11 108.934 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -123.14 160.42 26.5 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 105.179 -2.156 . . . . 75.13 105.179 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -134.68 129.64 52.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.463 1.505 . . . . 75.21 110.873 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.5 t -102.79 128.42 55.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 105.349 -2.093 . . . . 62.42 105.349 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -96.81 141.49 29.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.184 -1.784 . . . . 74.24 106.184 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.45 133.35 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.944 -1.873 . . . . 74.14 105.944 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.84 177.96 20.46 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 120.888 1.676 . . . . 64.42 111.791 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.422 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 0.5 OUTLIER 73.78 16.47 3.78 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.047 2.539 . . . . 54.24 111.116 -178.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.54 147.63 92.07 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.445 1.498 . . . . 64.33 113.648 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -66.67 164.96 27.11 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.301 2.668 . . . . 74.23 111.329 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -76.38 -29.53 57.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 122.976 0.51 . . . . 71.24 110.742 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.09 13.51 11.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.175 0.99 . . . . 73.44 112.984 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.538 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.6 tp -59.02 138.87 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.234 1.014 . . . . 72.32 111.328 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 p -128.3 158.39 38.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.744 1.618 . . . . 74.44 109.909 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.1 -29.58 69.37 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.101 0.56 . . . . 63.51 110.348 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.21 -34.04 67.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.305 0.642 . . . . 75.43 110.228 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -73.66 -47.94 36.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.038 -1.468 . . . . 74.11 107.038 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -56.06 -46.41 78.95 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.302 1.441 . . . . 75.02 110.652 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -61.6 -36.61 81.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.521 -0.752 . . . . 74.53 110.214 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.14 -30.99 60.94 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.757 0.708 . . . . 74.41 110.877 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -68.36 -50.19 54.87 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.182 -0.949 . . . . 71.44 110.015 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -91.74 10.87 26.58 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.222 1.009 . . . . 75.1 112.825 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -35.76 63.82 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 120.681 -1.262 . . . . 75.42 110.793 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -82.6 -9.15 59.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.1 0.96 . . . . 75.13 113.533 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.17 -10.79 14.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.671 1.188 . . . . 75.34 111.586 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 t 47.24 61.78 13.03 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.58 2.352 . . . . 73.21 114.893 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.36 161.0 15.02 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.399 2.733 . . . . 73.15 111.561 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -38.86 10.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.36 1.064 . . . . 74.32 109.404 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -136.01 153.17 51.45 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.191 0.997 . . . . 73.42 108.358 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.3 mt -139.5 125.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 105.388 -2.078 . . . . 73.35 105.388 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.42 104.5 4.6 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.528 -1.286 . . . . 75.53 107.528 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -88.7 119.47 29.21 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 124.689 1.196 . . . . 75.03 108.331 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -108.69 82.45 1.61 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.026 -1.472 . . . . 73.1 107.026 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.97 -26.88 50.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.778 0.831 . . . . 73.24 111.548 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.08 -28.39 10.41 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 128.285 2.634 . . . . 72.05 112.709 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -132.92 9.16 4.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.782 1.233 . . . . 75.14 110.443 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.16 43.85 96.81 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 119.6 1.091 . . . . 51.14 110.932 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.1 pt -134.85 166.2 29.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.102 1.361 . . . . 75.13 111.247 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.49 154.37 43.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.076 1.351 . . . . 74.43 109.489 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.48 123.26 39.74 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.107 1.363 . . . . 75.04 107.387 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.5 114.77 21.71 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.321 -0.992 . . . . 75.2 108.321 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -91.21 151.07 21.09 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.919 -1.141 . . . . 74.23 107.919 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -136.74 134.26 36.93 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.672 1.589 . . . . 74.13 107.304 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.27 112.54 24.35 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.86 1.664 . . . . 74.02 111.319 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.38 -27.41 68.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.086 1.354 . . . . 74.44 111.32 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.52 -32.99 68.79 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.423 -0.322 . . . . 72.1 110.393 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -62.94 -22.82 67.06 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.79 0.723 . . . . 72.44 112.928 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -158.82 99.43 1.55 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.192 -1.41 . . . . 73.52 107.192 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -54.02 50.03 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.512 0.725 . . . . 74.11 112.463 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.84 -19.6 23.23 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.309 1.044 . . . . 72.25 110.976 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.53 -22.3 62.57 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-O 117.228 -1.873 . . . . 73.14 113.589 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.77 -40.8 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 120.532 2.166 . . . . 75.43 110.106 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.53 -58.5 6.94 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.657 -1.238 . . . . 64.55 107.657 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.1 -48.37 76.29 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.812 0.845 . . . . 72.33 111.095 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.18 -41.05 68.1 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.128 -0.693 . . . . 74.32 109.128 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 6.4 mtm -71.88 -44.45 63.73 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.332 1.053 . . . . 75.42 110.681 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -48.88 72.0 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.831 1.652 . . . . 75.54 110.575 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.74 -39.77 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.691 1.597 . . . . 74.32 108.802 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.72 75.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.876 -0.583 . . . . 74.22 109.573 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.43 -31.58 72.75 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.965 0.802 . . . . 73.13 110.493 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.4 mt -68.95 -5.13 19.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.649 -0.657 . . . . 75.34 112.092 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -89.65 -0.64 57.66 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.058 0.845 . . . . 62.34 110.453 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -66.02 113.09 4.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.026 1.73 . . . . 73.31 110.991 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.2 2.99 67.92 Favored Glycine 0 N--CA 1.459 0.233 0 CA-C-O 117.942 -1.477 . . . . 64.14 114.173 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -66.93 133.77 50.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.59 1.695 . . . . 75.53 108.369 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.6 mt -76.21 108.21 8.98 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 105.743 -1.947 . . . . 74.5 105.743 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.6 tp -115.88 119.6 36.5 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.675 -1.602 . . . . 71.52 106.675 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 17.3 mtpp 49.21 50.44 17.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.741 1.616 . . . . 63.4 112.368 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 64.28 24.99 13.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.172 2.189 . . . . 71.31 113.576 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 10' ' ' SER . 15.0 mmmt -131.77 124.44 29.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.62 1.168 . . . . 74.25 110.647 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -79.83 105.77 11.36 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 101.7 -3.444 . . . . 75.42 101.7 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.3 pt -95.63 169.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 124.006 0.922 . . . . 75.34 108.685 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -127.17 158.97 35.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.796 1.238 . . . . 75.23 111.52 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.0 t -137.06 139.22 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 126.526 1.931 . . . . 73.53 107.191 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -149.67 162.74 39.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.674 1.189 . . . . 71.41 108.127 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 147.55 25.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.469 1.108 . . . . 74.12 109.291 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 117.912 -1.042 . . . . 74.51 108.748 178.883 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.295 0 N-CA-C 112.018 0.377 . . . . 73.14 112.018 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -100.16 157.31 16.67 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 128.21 2.604 . . . . 74.41 107.125 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mt -135.41 149.19 28.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 124.696 1.198 . . . . 74.14 108.082 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.1 t -116.65 127.49 74.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 105.768 -1.938 . . . . 73.24 105.768 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -94.75 139.32 31.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.374 -1.713 . . . . 72.43 106.374 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 t -139.26 132.49 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.327 -1.731 . . . . 72.23 106.327 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.62 -178.19 17.55 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 120.095 1.316 . . . . 61.22 111.63 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.03 10.68 4.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.599 2.36 . . . . 73.44 111.344 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mp -54.27 144.94 38.48 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 125.487 1.515 . . . . 72.11 112.695 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -67.65 157.76 60.28 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.352 2.035 . . . . 74.42 110.26 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -65.57 -43.23 90.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.91 -1.145 . . . . 74.25 107.91 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.64 13.34 0.64 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.352 2.261 . . . . 63.45 112.857 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.474 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 10.3 tp -57.56 144.82 9.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 O-C-N 120.878 -1.139 . . . . 74.45 108.984 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.56 147.5 50.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.45 -1.315 . . . . 72.42 107.45 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.88 71.46 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.253 -0.647 . . . . 52.1 109.253 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.14 -44.28 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 124.048 0.939 . . . . 73.12 110.496 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.99 -38.56 76.06 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.494 -0.558 . . . . 74.54 109.494 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.15 -47.09 86.11 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.876 -0.416 . . . . 75.14 109.876 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -60.88 -47.41 86.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.701 -0.852 . . . . 64.43 108.701 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -58.45 -35.89 72.83 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 115.247 1.573 . . . . 72.15 115.247 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -76.17 -51.84 11.32 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.528 -0.733 . . . . 75.3 110.62 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -81.17 7.32 11.44 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.906 1.076 . . . . 75.43 113.906 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -57.0 -27.12 61.31 Favored 'General case' 0 CA--C 1.527 0.094 0 O-C-N 120.586 -1.321 . . . . 72.45 113.602 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -87.27 -16.65 34.57 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.379 0.672 . . . . 74.33 112.038 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.5 -13.98 18.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.132 0.973 . . . . 73.25 111.701 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m 49.15 73.53 0.98 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 125.921 1.688 . . . . 75.34 114.569 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.83 158.32 54.39 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.919 1.746 . . . . 74.43 110.543 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -89.39 -41.57 12.03 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.784 0.834 . . . . 75.42 109.029 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -137.31 153.56 50.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.711 1.204 . . . . 52.54 109.814 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.3 mt -143.77 121.05 5.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.358 1.463 . . . . 74.22 108.215 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 104.24 6.67 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 125.519 1.528 . . . . 73.11 108.096 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.39 116.11 28.08 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.084 1.354 . . . . 74.23 107.931 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 46.5 mtt-85 -109.46 85.5 2.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.96 -1.496 . . . . 74.41 106.96 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.14 -22.5 60.99 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.706 -0.679 . . . . 71.43 111.508 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -51.58 -29.59 17.86 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.709 2.404 . . . . 73.21 112.286 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -132.88 9.78 4.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.202 1.401 . . . . 74.13 110.335 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.93 48.28 86.83 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.506 -1.037 . . . . 74.43 110.506 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.3 pt -136.76 167.39 23.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.368 1.467 . . . . 64.45 110.718 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.18 155.69 38.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.563 1.145 . . . . 53.21 109.569 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -125.68 125.73 43.53 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.038 1.335 . . . . 75.12 108.185 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.57 112.06 18.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.156 -1.053 . . . . 74.34 108.156 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -91.25 156.07 18.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.847 -1.538 . . . . 72.11 106.847 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -144.09 148.65 35.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.2 -1.408 . . . . 74.41 107.2 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -101.58 111.05 23.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.244 0.929 . . . . 75.32 110.897 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.08 -24.25 62.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.556 0.742 . . . . 72.31 111.242 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.35 -28.4 62.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.008 0.822 . . . . 72.04 110.46 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -64.21 -29.09 70.21 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 124.66 1.184 . . . . 74.24 112.251 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -158.45 86.13 0.86 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.12 -1.067 . . . . 75.32 108.12 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -48.35 -36.34 14.28 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.75 1.759 . . . . 72.44 115.75 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.62 -17.21 14.31 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.627 1.103 . . . . 61.31 111.896 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.1 -26.7 43.4 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 118.196 -1.335 . . . . 75.34 111.71 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.31 -39.9 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.217 1.509 . . . . 72.25 110.689 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -60.68 -58.14 9.71 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.099 -1.074 . . . . 65.54 108.099 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -57.32 -40.17 77.36 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.034 -1.041 . . . . 75.32 111.253 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -58.53 -41.06 84.65 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.101 -1.074 . . . . 74.13 108.101 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 9.0 mtm -66.85 -50.15 63.45 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 117.972 -1.014 . . . . 74.33 108.292 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -51.62 -48.87 63.11 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.54 1.136 . . . . 63.51 110.169 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.12 -31.2 49.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.665 1.586 . . . . 73.22 111.148 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.62 -38.48 21.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.931 0.787 . . . . 61.32 109.2 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.4 mt -67.17 -31.06 71.23 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.338 1.055 . . . . 74.42 110.268 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.81 -12.76 38.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.938 0.895 . . . . 75.54 110.559 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -89.79 4.21 50.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.805 1.242 . . . . 72.24 111.436 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -68.16 120.56 14.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.608 -1.997 . . . . 73.24 105.608 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.39 9.01 63.68 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.028 -1.429 . . . . 60.35 113.245 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 p -68.04 144.17 55.22 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 120.065 1.933 . . . . 75.53 109.912 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.8 mt -93.19 107.4 19.21 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 102.187 -3.264 . . . . 75.42 102.187 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.19 113.93 27.01 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 104.64 -2.355 . . . . 75.01 104.64 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER 51.76 49.34 21.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.922 0.889 . . . . 74.42 109.325 -178.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 60.51 32.22 20.44 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 127.442 2.297 . . . . 74.22 114.083 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -130.72 118.04 20.31 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.898 0.879 . . . . 74.24 110.195 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -70.06 100.88 1.7 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.822 1.249 . . . . 73.25 108.136 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.1 pt -92.78 165.87 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.277 -0.889 . . . . 74.5 109.517 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.83 156.39 39.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.541 1.136 . . . . 65.32 111.334 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.21 149.22 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.453 1.501 . . . . 73.34 110.631 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -164.33 173.63 12.02 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.939 1.296 . . . . 73.55 111.138 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.63 147.72 23.11 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.294 1.437 . . . . 73.02 109.733 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.252 0 C-N-CA 123.137 0.575 . . . . 74.21 110.523 -179.57 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.44 0 CA-C-O 121.396 0.617 . . . . 75.42 112.169 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -97.74 152.71 18.85 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 128.577 2.751 . . . . 74.03 109.124 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -135.1 147.06 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.748 1.619 . . . . 75.24 109.404 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.2 t -113.37 131.08 66.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.297 -1.742 . . . . 73.42 106.297 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -91.48 108.98 20.27 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.422 1.889 . . . . 73.35 106.428 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 t -115.83 126.47 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.01 -2.218 . . . . 73.21 105.01 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.26 -179.88 16.88 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 120.214 1.37 . . . . 70.43 112.461 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.84 19.44 5.83 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.03 1.732 . . . . 61.53 111.626 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.1 mp -60.91 147.91 84.53 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.918 0.887 . . . . 71.31 110.681 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.76 156.98 58.61 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.907 3.071 . . . . 72.12 114.526 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.47 -27.74 68.79 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.642 1.177 . . . . 72.02 112.118 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.65 20.54 18.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.597 1.159 . . . . 74.53 112.536 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.494 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 9.7 tp -55.27 143.16 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 O-C-N 121.005 -1.059 . . . . 72.04 110.852 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 p -128.76 154.56 46.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.61 1.164 . . . . 72.23 109.736 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.0 -30.48 70.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.315 1.046 . . . . 74.22 109.085 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.95 -48.68 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.714 1.206 . . . . 73.42 109.424 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.436 ' HG3' ' HE2' ' A' ' 70' ' ' LYS . 4.1 mm-40 -69.59 -29.3 66.81 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.518 0.727 . . . . 74.42 110.54 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -68.97 -51.27 41.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.06 -1.089 . . . . 74.34 108.06 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -58.75 -45.56 89.43 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 107.946 -1.131 . . . . 73.23 107.946 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -56.08 -48.0 76.92 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.517 1.527 . . . . 74.44 113.629 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -56.34 15.66 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 122.292 1.044 . . . . 74.43 111.454 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -79.68 8.55 6.4 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.481 1.512 . . . . 75.34 114.414 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -56.04 -39.78 72.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.94 -1.1 . . . . 75.13 110.412 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.21 -15.51 57.94 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.982 0.734 . . . . 75.02 112.982 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 p -102.16 -1.49 31.29 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.9 -1.125 . . . . 73.23 111.197 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.0 t 37.32 79.78 0.3 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 127.552 2.341 . . . . 71.15 115.066 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.08 156.57 55.65 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.595 1.53 . . . . 64.04 109.616 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.47 -49.2 8.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.799 -1.556 . . . . 74.43 106.799 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -136.71 154.37 50.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.174 0.99 . . . . 73.21 110.007 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -136.09 133.04 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.372 1.869 . . . . 74.33 109.577 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -142.37 107.95 5.08 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 127.189 2.196 . . . . 73.43 109.5 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -96.41 122.43 39.29 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.649 -1.241 . . . . 74.22 107.649 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -110.29 86.01 2.22 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.948 1.699 . . . . 75.32 106.722 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.65 -32.66 63.39 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.966 0.906 . . . . 71.43 112.333 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -56.78 -19.01 14.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.355 1.462 . . . . 54.34 113.232 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -132.16 -1.31 3.65 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.146 1.378 . . . . 71.54 110.569 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.69 38.79 96.48 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.578 1.085 . . . . 72.11 110.934 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -127.8 163.45 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.19 1.396 . . . . 74.11 109.88 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.61 155.32 47.51 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.04 1.336 . . . . 72.21 109.332 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.76 104.36 9.25 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.18 -1.785 . . . . 73.31 106.18 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.22 111.65 24.14 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 105.158 -2.164 . . . . 72.33 105.158 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.62 157.91 17.23 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.62 0.768 . . . . 75.2 109.494 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -146.19 133.41 20.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.6 1.56 . . . . 73.04 107.304 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -101.73 122.63 44.28 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 105.013 -2.217 . . . . 62.14 105.013 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.63 -23.48 62.55 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.611 1.564 . . . . 71.22 111.261 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -83.65 -18.71 37.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.964 0.506 . . . . 65.55 109.912 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -69.0 -19.11 64.13 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.3 -0.857 . . . . 73.41 111.372 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -168.42 85.04 0.18 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.86 1.664 . . . . 72.21 106.621 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -32.73 6.5 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.821 1.648 . . . . 75.12 113.666 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.3 p -107.57 -20.23 13.3 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.187 0.903 . . . . 73.24 112.806 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.38 -18.03 53.78 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-O 117.677 -1.624 . . . . 75.14 114.494 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.1 tp -50.93 -36.7 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 119.645 1.723 . . . . 71.35 109.13 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -61.26 -61.72 2.35 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.982 2.513 . . . . 74.0 110.653 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.87 -35.45 76.63 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.213 -0.929 . . . . 75.41 109.724 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -60.81 -49.22 78.35 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 108.074 -1.084 . . . . 75.12 108.074 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.4 mtt -57.67 -50.54 72.85 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 124.647 1.179 . . . . 73.41 109.888 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -56.99 -44.62 82.92 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.272 1.029 . . . . 74.2 111.773 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.5 mt -69.85 -34.5 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 108.951 -0.759 . . . . 73.31 108.951 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.82 79.76 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.508 -1.293 . . . . 61.13 107.508 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.4 mt -58.65 -32.24 68.9 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.321 1.048 . . . . 74.33 111.3 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 46.4 mt -66.74 -9.02 32.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.283 -0.865 . . . . 75.12 112.258 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -86.16 -2.48 58.4 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.276 1.398 . . . . 72.24 111.49 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 112.23 2.78 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.788 1.235 . . . . 75.3 108.036 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.11 10.27 59.86 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.404 1.002 . . . . 64.4 114.284 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.3 p -75.1 143.23 43.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.573 1.687 . . . . 71.44 109.591 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.14 108.97 19.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 106.861 -1.533 . . . . 75.04 106.861 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mt -110.38 119.72 40.12 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 105.337 -2.097 . . . . 71.33 105.337 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 33.1 mttt 45.95 49.59 11.87 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.011 0.91 . . . . 75.42 110.528 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 63.29 16.45 9.47 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.92 2.088 . . . . 73.42 116.348 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -119.79 126.77 51.82 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.123 1.369 . . . . 72.31 108.185 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -79.18 106.93 11.57 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.354 -0.239 . . . . 73.31 110.354 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.42 169.89 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 123.543 0.737 . . . . 75.04 111.7 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -128.25 158.75 37.3 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.883 2.073 . . . . 64.21 108.878 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.0 t -142.79 127.41 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.676 1.19 . . . . 73.43 108.784 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -144.0 173.29 11.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.779 1.232 . . . . 74.24 109.361 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.85 151.86 21.55 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.221 1.009 . . . . 75.21 110.308 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 106.986 -1.487 . . . . 71.14 106.986 -179.493 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 . . . . . 0 CA--C 1.512 -0.491 0 N-CA-C 108.584 -0.895 . . . . 72.14 108.584 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -130.77 165.53 22.75 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.081 -1.822 . . . . 63.02 106.081 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.3 mt -130.56 146.41 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 109.001 -0.74 . . . . 72.22 109.001 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.3 131.93 63.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.144 -1.428 . . . . 74.43 107.144 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -89.93 115.41 27.22 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 105.421 -2.066 . . . . 74.25 105.421 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -124.46 128.67 73.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.425 -2.065 . . . . 71.45 105.425 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.3 -179.93 18.45 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 119.233 0.924 . . . . 71.54 111.62 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.83 18.61 5.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.281 1.832 . . . . 73.31 111.097 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.59 153.21 62.99 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 124.663 1.185 . . . . 71.43 113.042 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.33 167.88 13.85 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.127 2.551 . . . . 71.44 111.64 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -75.34 -41.66 56.17 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 121.716 -0.615 . . . . 73.03 109.938 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.56 19.77 4.37 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.591 0.96 . . . . 64.31 113.591 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.507 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.7 tp -53.47 140.73 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 121.289 -0.882 . . . . 74.31 109.547 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -127.81 150.58 49.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.643 1.177 . . . . 75.43 109.106 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.4 -28.46 69.8 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.579 -0.7 . . . . 72.54 111.069 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -43.1 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.793 -0.818 . . . . 75.21 108.793 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -63.96 -45.27 89.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.682 0.793 . . . . 73.22 109.21 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.89 -48.81 80.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.065 -0.493 . . . . 75.34 110.113 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -61.28 -36.63 80.58 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 118.894 0.77 . . . . 62.24 109.784 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.52 -40.02 77.2 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.813 0.733 . . . . 73.41 111.843 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.81 -37.99 70.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.109 0.868 . . . . 65.34 111.316 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -94.61 6.2 49.55 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.459 -0.776 . . . . 74.24 112.264 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -54.84 -39.34 68.47 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.958 1.303 . . . . 74.3 112.531 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -71.17 -35.85 71.79 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.379 -0.825 . . . . 64.23 110.639 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -74.69 -24.14 58.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.636 0.774 . . . . 72.32 112.859 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.9 m 63.74 69.54 0.77 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 116.284 1.957 . . . . 73.51 116.284 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.51 159.6 52.97 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.813 2.342 . . . . 74.22 109.896 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.28 -53.99 5.11 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.91 -1.885 . . . . 74.31 105.91 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -143.92 161.53 38.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.424 1.49 . . . . 73.51 109.406 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.12 140.5 42.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 126.039 1.736 . . . . 72.11 107.151 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -133.16 103.93 6.25 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 107.352 -1.351 . . . . 74.33 107.352 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -87.71 112.57 22.52 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.882 0.873 . . . . 72.11 109.157 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -101.24 87.43 3.23 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.557 -1.646 . . . . 73.33 106.557 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.6 -28.8 61.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.634 1.174 . . . . 74.44 112.687 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -52.61 -38.89 61.01 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.967 2.107 . . . . 71.21 114.064 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -118.88 -6.45 10.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 118.219 -0.896 . . . . 74.41 111.956 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.67 48.25 29.67 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.728 -1.749 . . . . 64.34 108.728 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pt -137.24 156.13 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 126.233 1.813 . . . . 75.23 108.034 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.4 126.97 12.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.964 -0.754 . . . . 64.13 108.964 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -90.11 135.99 33.32 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.49 -1.3 . . . . 74.45 107.49 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.91 123.99 39.82 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.171 -1.788 . . . . 74.4 106.171 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -95.26 143.44 26.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.312 1.445 . . . . 73.42 108.214 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -135.77 106.85 6.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.052 -1.462 . . . . 73.4 107.052 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.68 116.55 8.51 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.979 0.911 . . . . 71.12 110.538 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.01 -31.23 61.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.608 1.963 . . . . 64.2 112.164 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.02 -22.34 63.11 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.098 0.559 . . . . 65.54 109.845 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -60.7 -35.92 77.52 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 108.964 -0.754 . . . . 75.5 108.964 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -162.22 96.29 0.97 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.042 -0.725 . . . . 62.0 109.042 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -55.55 -29.83 59.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 117.81 -1.09 . . . . 74.35 113.068 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.253 29.9 p -110.74 7.5 22.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.947 0.794 . . . . 74.51 112.738 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.41 -20.71 4.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.484 1.516 . . . . 70.4 112.27 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.3 tp -54.55 -39.93 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 125.048 1.339 . . . . 64.32 111.853 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -58.05 9.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.227 -0.657 . . . . 64.43 109.227 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -57.54 -32.61 67.26 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.52 -0.738 . . . . 75.04 111.551 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -64.42 -51.18 64.49 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.179 -1.415 . . . . 73.04 107.179 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.6 mtm -66.27 -30.59 71.05 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.753 0.821 . . . . 74.53 112.429 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.02 -39.73 90.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.691 1.132 . . . . 75.41 108.884 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.6 mt -66.03 -39.16 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.784 -1.191 . . . . 74.23 107.784 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.38 95.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.368 -0.975 . . . . 74.04 108.368 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.1 mt -63.13 -31.08 72.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.304 0.502 . . . . 73.24 111.264 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.56 -6.95 8.58 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.725 1.009 . . . . 74.42 113.725 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -93.45 -0.56 56.39 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.732 0.697 . . . . 75.11 111.029 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.65 112.78 2.14 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.718 1.607 . . . . 73.32 109.833 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.69 5.55 61.35 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.481 -1.177 . . . . 61.22 113.657 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.3 p -66.79 147.69 52.92 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.988 1.894 . . . . 71.31 109.486 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.41 107.92 19.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.498 -2.038 . . . . 75.41 105.498 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 mt -107.19 126.07 51.92 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 105.331 -2.1 . . . . 74.32 105.331 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 18.6 mttt 42.1 49.84 4.3 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.486 1.039 . . . . 74.45 111.345 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 64.04 21.85 12.73 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.356 2.263 . . . . 74.23 115.235 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -124.87 126.37 45.45 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.313 -1.492 . . . . 62.35 110.986 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 tptt -74.75 109.46 8.24 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.567 -1.642 . . . . 65.44 106.567 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.9 pp -92.8 170.02 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.009 0.924 . . . . 73.23 111.103 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.57 158.13 38.3 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.881 1.272 . . . . 74.22 109.674 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.4 t -141.52 132.38 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.476 -1.675 . . . . 72.32 106.476 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -146.76 163.02 37.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.827 1.251 . . . . 72.41 109.021 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.52 152.17 28.81 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.265 1.026 . . . . 74.13 109.638 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 C-N-CA 124.065 0.946 . . . . 74.32 109.331 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.1 ptt85 . . . . . 0 CA--C 1.512 -0.492 0 CA-C-O 120.562 0.22 . . . . 74.4 110.932 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -113.55 163.15 15.3 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 104.775 -2.305 . . . . 73.34 104.775 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mt -132.24 149.26 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.618 -1.252 . . . . 62.15 107.618 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.8 t -120.01 124.03 71.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.365 -1.717 . . . . 73.12 106.365 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -88.3 136.29 33.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.837 -1.912 . . . . 74.52 105.837 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.0 t -136.7 129.14 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.244 -2.132 . . . . 73.13 105.244 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.74 -177.97 15.63 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 120.18 1.354 . . . . 74.25 113.374 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.93 14.37 5.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.495 2.318 . . . . 63.22 110.11 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mp -58.39 142.03 82.37 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.746 1.219 . . . . 70.15 111.802 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.28 156.98 60.19 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.11 2.54 . . . . 74.34 111.071 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -68.3 -35.01 77.19 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.498 -0.751 . . . . 74.34 109.172 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.34 8.98 5.17 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.712 1.605 . . . . 75.4 113.392 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 tp -51.13 145.71 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.952 1.301 . . . . 72.24 112.678 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.59 150.41 50.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.511 1.124 . . . . 74.53 110.221 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.0 72.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.64 1.176 . . . . 74.12 109.969 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 t -61.41 -41.26 89.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.647 0.779 . . . . 74.44 110.874 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -70.89 -39.03 73.05 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.97 -0.752 . . . . 74.14 108.97 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.33 -51.5 65.72 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.232 1.013 . . . . 75.03 110.674 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -42.78 99.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.063 0.945 . . . . 64.13 109.267 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -64.5 -52.28 58.63 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.334 1.054 . . . . 53.11 113.023 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -48.97 78.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.911 0.778 . . . . 75.44 111.749 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -85.81 1.84 48.07 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 113.857 1.058 . . . . 73.04 113.857 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -47.12 70.24 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 120.083 1.31 . . . . 73.43 111.477 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -60.68 -34.11 73.84 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.133 0.424 . . . . 65.25 111.696 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 p -83.86 -10.48 57.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.883 0.873 . . . . 64.01 111.597 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 m 42.78 68.78 2.61 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 127.057 2.143 . . . . 75.32 113.953 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -64.07 158.39 48.13 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.866 2.377 . . . . 75.51 109.527 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.94 -36.81 13.9 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.032 0.933 . . . . 74.13 108.862 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -127.67 155.74 43.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.901 0.881 . . . . 74.15 111.087 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 75.4 mt -144.74 115.5 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.797 -1.557 . . . . 74.15 106.797 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 104.64 5.57 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.475 1.51 . . . . 75.14 108.407 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.04 119.94 30.82 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.705 1.202 . . . . 73.05 108.285 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 -109.65 84.19 1.88 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.469 -1.678 . . . . 75.02 106.469 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.29 -29.27 65.71 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.343 -0.836 . . . . 63.43 111.369 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -54.31 -26.99 32.57 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.834 1.05 . . . . 71.53 113.834 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.3 mmtt -127.38 9.04 6.59 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.886 0.875 . . . . 65.45 111.262 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.98 48.22 80.99 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.982 -1.247 . . . . 73.45 109.982 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.38 171.29 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 C-N-CA 124.821 1.248 . . . . 74.12 109.675 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.17 168.77 20.82 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.813 1.245 . . . . 70.51 108.46 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -134.82 137.08 43.0 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 104.974 -2.232 . . . . 74.51 104.974 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -137.19 116.29 12.49 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 105.984 -1.858 . . . . 74.13 105.984 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.05 151.33 19.59 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.691 -1.596 . . . . 53.41 106.691 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -141.43 111.83 6.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.069 -1.826 . . . . 74.44 106.069 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.38 122.17 28.56 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.831 0.852 . . . . 65.23 111.183 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.27 93.91 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.496 1.118 . . . . 63.03 111.95 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.25 -28.9 70.03 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.961 -0.755 . . . . 74.3 108.961 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.71 -23.77 66.35 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 117.448 -1.263 . . . . 74.42 112.113 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -163.81 90.4 0.61 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.715 1.606 . . . . 62.3 107.837 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 -56.39 -16.39 5.63 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.513 1.525 . . . . 74.41 115.086 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 m -122.7 -19.44 6.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 120.038 1.29 . . . . 63.54 112.413 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.51 -14.62 43.51 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 117.245 -1.864 . . . . 55.32 114.883 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -50.17 -44.51 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 120.491 2.146 . . . . 74.24 111.572 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -62.39 -58.16 8.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.961 0.904 . . . . 73.54 110.472 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -59.2 -31.2 68.81 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.516 -1.365 . . . . 74.31 111.054 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -62.53 -41.11 98.65 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.519 -1.289 . . . . 70.44 107.519 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 12.1 mtm -65.8 -42.83 90.23 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.158 -1.053 . . . . 72.12 108.158 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -54.13 -49.78 68.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.524 1.056 . . . . 54.03 110.375 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -61.28 -44.85 99.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.299 1.44 . . . . 65.35 109.481 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.83 -42.0 95.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.374 0.534 . . . . 71.45 109.983 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.19 -29.9 69.7 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.132 0.973 . . . . 73.54 111.428 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.19 -13.31 57.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.772 -0.632 . . . . 75.12 109.895 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -85.49 2.17 45.8 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.979 0.809 . . . . 75.2 111.079 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -67.11 112.07 4.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.137 -1.602 . . . . 72.44 108.519 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.47 10.47 53.61 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.646 1.117 . . . . 73.51 113.563 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.9 p -68.77 141.01 55.33 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.773 1.786 . . . . 74.13 110.214 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.5 mt -87.41 110.68 20.44 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 101.938 -3.356 . . . . 75.35 101.938 176.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -115.41 121.49 42.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.587 1.555 . . . . 72.02 108.422 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? 50.17 44.57 26.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.011 0.924 . . . . 74.54 112.761 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 67.67 24.27 8.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.106 2.162 . . . . 74.44 112.315 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -140.19 126.61 20.12 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.638 1.575 . . . . 70.0 110.302 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -75.17 143.54 43.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.475 -1.676 . . . . 75.51 106.475 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.6 pt -128.47 162.64 34.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.002 0.921 . . . . 74.42 109.492 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -120.43 159.02 25.97 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 125.368 1.467 . . . . 75.32 111.694 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.6 t -136.0 148.06 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 107.896 -1.15 . . . . 73.03 107.896 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -161.71 161.56 29.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.868 1.667 . . . . 74.3 108.771 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.5 152.22 23.35 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.626 1.17 . . . . 71.54 113.214 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 125.302 1.441 . . . . 63.22 108.34 179.32 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 106.35 -1.722 . . . . 72.54 106.35 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -127.92 162.9 25.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.508 -1.293 . . . . 75.54 107.508 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.412 ' HB ' HG22 ' A' ' 79' ' ' THR . 5.0 mt -135.17 144.09 35.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.874 -1.898 . . . . 74.21 105.874 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.3 t -118.99 128.82 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 126.391 1.876 . . . . 73.53 106.127 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -101.21 139.14 37.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.25 -2.129 . . . . 75.12 105.25 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.56 127.76 31.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 104.014 -2.587 . . . . 74.34 104.014 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.38 179.54 17.14 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 120.078 1.308 . . . . 55.44 112.634 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.17 17.77 3.97 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.194 2.198 . . . . 64.44 110.302 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 mp -55.03 148.63 27.87 Favored Pre-proline 0 C--O 1.239 0.524 0 C-N-CA 124.929 1.292 . . . . 74.02 111.95 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.28 153.61 75.69 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.956 3.104 . . . . 75.32 112.239 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -65.38 -34.03 77.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 118.508 -0.758 . . . . 75.01 109.492 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -92.65 21.06 5.76 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.641 1.176 . . . . 75.31 112.646 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.52 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 10.3 tp -52.36 138.92 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 121.256 -0.903 . . . . 61.03 109.951 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 p -125.38 150.77 46.91 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.48 -0.933 . . . . 74.32 108.48 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.01 -26.24 68.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 118.299 -0.858 . . . . 74.04 110.133 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.6 p -65.09 -41.17 91.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 119.697 1.135 . . . . 72.5 108.682 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.502 ' HG3' ' HE2' ' A' ' 70' ' ' LYS . 15.8 mm-40 -68.11 -45.27 74.14 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.346 -0.983 . . . . 73.24 108.346 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.1 mt -59.71 -47.65 84.79 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.494 0.588 . . . . 74.11 111.086 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -61.0 -38.01 84.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.56 0.744 . . . . 72.14 109.987 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -74.44 -54.35 7.76 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.364 1.066 . . . . 71.13 113.796 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -34.6 70.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.681 0.993 . . . . 64.43 113.681 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -97.4 3.71 50.88 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.806 0.842 . . . . 70.11 112.58 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -60.72 -28.96 69.06 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.845 -1.159 . . . . 70.0 109.918 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -73.67 -17.57 61.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.093 0.957 . . . . 74.45 111.058 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 p -113.84 -5.84 13.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.439 1.895 . . . . 53.13 113.581 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.8 t 41.68 77.33 0.44 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 126.503 1.921 . . . . 75.05 114.973 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.57 165.99 30.08 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 121.931 1.754 . . . . 72.42 109.988 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -91.2 -32.89 15.61 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 120.742 -1.224 . . . . 72.24 109.501 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -143.54 153.26 42.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.169 1.388 . . . . 72.31 108.187 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.4 mt -133.73 105.12 6.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.788 -1.56 . . . . 71.44 106.788 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.1 ttt-85 -122.62 103.94 9.01 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.875 -0.787 . . . . 75.41 108.875 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -83.15 127.38 33.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.107 -1.812 . . . . 74.33 106.107 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 85.54 2.37 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.582 -2.007 . . . . 75.21 105.582 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.53 -27.55 49.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.918 0.887 . . . . 72.33 113.003 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -52.05 -30.09 24.12 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.68 1.992 . . . . 71.01 114.314 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -132.23 11.96 4.61 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.043 1.337 . . . . 72.2 111.418 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.77 52.45 50.68 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.345 -1.502 . . . . 62.24 109.345 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.84 168.07 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.613 1.165 . . . . 65.11 110.594 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.99 154.29 41.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.649 1.179 . . . . 62.21 108.014 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -124.45 123.32 39.88 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.118 -1.808 . . . . 72.21 106.118 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mp -117.77 113.81 22.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.861 -1.533 . . . . 75.2 106.861 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -85.18 152.81 23.08 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.335 -1.357 . . . . 75.25 107.335 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -141.1 136.86 32.37 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.446 1.098 . . . . 74.24 108.709 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -97.98 108.51 21.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.394 1.478 . . . . 75.23 112.616 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.4 -22.6 51.34 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.483 0.713 . . . . 64.22 112.543 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.93 -37.09 35.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 112.096 0.406 . . . . 75.22 112.096 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -68.87 -55.47 10.99 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.186 1.394 . . . . 73.41 111.036 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.57 71.91 0.81 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 122.011 0.91 . . . . 60.41 110.281 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -48.85 -38.49 22.55 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.685 1.194 . . . . 71.33 112.718 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.8 p -104.99 8.0 34.29 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.761 1.022 . . . . 74.44 113.761 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.94 -23.14 2.54 Favored Glycine 0 C--O 1.221 -0.676 0 CA-C-O 118.038 -1.423 . . . . 73.13 113.604 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.1 tp -49.36 -49.57 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 120.244 2.022 . . . . 74.43 113.127 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -64.07 -55.46 22.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.841 -0.8 . . . . 75.45 108.841 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -49.49 -53.2 24.5 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.171 0.896 . . . . 74.51 109.417 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -51.91 -54.86 24.51 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.14 1.776 . . . . 74.31 110.337 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 44.0 mtm -66.32 -28.32 68.59 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 118.908 0.776 . . . . 72.34 111.218 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -65.06 -47.51 77.05 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 120.074 -1.641 . . . . 73.31 109.798 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.5 mt -65.29 -31.65 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.284 1.833 . . . . 73.31 108.063 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.23 -41.13 58.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.674 -0.862 . . . . 75.23 108.674 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -60.61 -37.06 80.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.479 0.712 . . . . 73.23 110.311 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.6 mt -64.42 -6.08 6.52 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.236 1.414 . . . . 72.22 113.616 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -92.39 6.23 47.71 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.491 1.041 . . . . 73.53 111.234 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -72.25 114.89 10.86 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.727 1.211 . . . . 74.34 108.546 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.48 5.09 61.98 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-O 118.005 -1.442 . . . . 63.54 114.445 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.9 p -72.01 154.01 41.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.997 1.899 . . . . 74.52 109.422 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 mt -100.49 107.54 19.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.588 -1.634 . . . . 71.42 106.588 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.67 121.92 44.86 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.622 -2.362 . . . . 74.22 104.622 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 18.8 mttm 48.1 47.33 19.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.822 0.849 . . . . 75.0 110.971 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 58.0 26.97 14.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.846 1.658 . . . . 73.31 114.186 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -126.47 122.31 34.88 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.728 -1.212 . . . . 74.32 107.728 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -81.62 102.55 10.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.298 -1.371 . . . . 73.33 107.298 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.6 pt -85.54 169.64 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 124.282 1.033 . . . . 73.21 110.898 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.62 155.27 45.23 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 125.888 1.675 . . . . 75.24 109.467 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.62 148.91 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.339 1.055 . . . . 73.13 108.479 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.8 172.14 13.34 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.571 1.949 . . . . 64.42 109.368 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.55 153.42 18.18 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.067 1.747 . . . . 63.13 107.366 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.412 HG22 ' HB ' ' A' ' 5' ' ' ILE . 9.2 t . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 108.947 -0.76 . . . . 64.54 108.947 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 109.889 -0.412 . . . . 72.41 109.889 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -133.19 165.62 24.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.105 1.362 . . . . 74.41 108.583 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mt -134.45 148.64 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.024 -0.732 . . . . 74.24 109.024 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.33 126.64 74.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 105.942 -1.873 . . . . 75.25 105.942 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -91.04 137.73 32.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.522 1.529 . . . . 65.42 107.688 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 t -138.73 126.09 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.729 -1.582 . . . . 74.42 106.729 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' H ' ' ND2' ' A' ' 75' ' ' ASN . . . -136.9 176.76 20.23 Favored Glycine 0 N--CA 1.468 0.774 0 CA-C-N 120.347 1.431 . . . . 44.31 111.628 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.25 19.02 0.77 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.48 2.312 . . . . 75.11 109.585 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.76 143.25 98.08 Favored Pre-proline 0 C--O 1.235 0.315 0 O-C-N 120.9 -1.125 . . . . 72.33 112.884 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.3 160.74 43.78 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.62 2.88 . . . . 75.53 111.604 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -44.06 93.46 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.784 -0.821 . . . . 75.23 108.784 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.72 9.46 1.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.522 1.929 . . . . 74.45 114.095 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.48 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.5 tp -58.62 139.45 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 O-C-N 120.725 -1.234 . . . . 74.34 109.822 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 150.52 50.11 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.818 0.847 . . . . 75.41 109.75 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.84 -30.73 70.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.076 0.95 . . . . 75.42 110.404 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.67 -43.27 96.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.549 1.14 . . . . 70.3 109.487 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.08 -42.12 85.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.96 -1.126 . . . . 64.41 107.96 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.67 -53.47 55.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.988 1.315 . . . . 74.23 110.454 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -46.9 83.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.688 -1.226 . . . . 72.44 107.688 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -62.58 -42.85 99.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.918 1.081 . . . . 74.53 113.918 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.99 -47.68 67.86 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 120.993 -1.067 . . . . 74.32 110.66 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.33 6.05 28.04 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.25 1.204 . . . . 74.42 114.25 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -51.48 -41.13 60.7 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 125.067 1.347 . . . . 75.31 113.715 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.402 HD21 HD13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -72.57 -21.93 61.07 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.404 0.547 . . . . 72.41 112.247 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.66 -17.89 22.76 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.218 1.407 . . . . 72.51 110.843 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 m 49.17 74.15 0.87 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.094 1.758 . . . . 74.01 114.412 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.87 153.15 79.34 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.116 1.877 . . . . 74.35 109.111 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -91.62 -39.8 11.67 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.996 -1.112 . . . . 74.11 107.996 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -123.46 146.35 48.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.548 1.139 . . . . 73.41 108.867 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.3 mt -141.38 107.02 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.982 -1.118 . . . . 74.23 107.982 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.43 104.74 8.07 Favored 'General case' 0 N--CA 1.46 0.055 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.53 118.66 30.78 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.776 2.03 . . . . 74.02 108.191 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.68 87.84 2.73 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.631 1.572 . . . . 75.22 108.432 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.32 -16.89 63.04 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.696 -0.628 . . . . 73.23 109.88 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -51.62 -26.74 9.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.937 2.495 . . . . 74.1 110.797 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -133.23 -1.6 3.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.798 2.439 . . . . 71.25 111.128 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.83 50.75 45.36 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.263 1.411 . . . . 64.32 110.134 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.3 pt -140.8 167.94 17.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 125.988 1.715 . . . . 70.44 110.827 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.83 149.81 33.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.247 1.819 . . . . 74.0 109.227 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.35 132.98 55.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.691 -1.596 . . . . 71.22 106.691 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.17 110.12 12.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.183 -1.784 . . . . 62.02 106.183 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -96.86 148.49 22.88 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.755 -1.202 . . . . 74.33 107.755 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -143.5 120.97 11.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.401 1.08 . . . . 75.02 109.358 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.38 121.13 22.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.479 0.712 . . . . 70.21 110.541 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.1 -38.76 63.75 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.943 1.697 . . . . 74.22 112.209 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.38 -29.62 70.89 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.594 -0.521 . . . . 75.11 109.594 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -61.7 -19.27 62.19 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.393 1.077 . . . . 74.34 112.489 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.03 90.33 0.44 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.105 1.321 . . . . 75.12 109.619 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -48.85 -38.71 23.15 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 116.125 1.898 . . . . 75.11 116.125 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -114.59 -0.95 13.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 123.337 0.398 . . . . 74.2 111.371 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.04 -28.68 8.05 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.474 1.035 . . . . 71.41 111.438 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.2 tp -54.13 -37.76 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.906 1.353 . . . . 75.44 110.648 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -56.75 18.04 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.148 -0.686 . . . . 74.14 109.148 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -42.78 66.82 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.715 1.206 . . . . 71.35 110.325 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -57.35 -46.73 83.02 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.001 -1.111 . . . . 71.33 108.001 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.3 mtm -66.88 -44.58 80.52 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 117.938 -1.029 . . . . 75.44 110.769 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -52.42 -49.85 63.69 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.315 1.416 . . . . 54.11 110.217 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.402 HD13 HD21 ' A' ' 26' ' ' ASN . 64.4 mt -65.92 -43.51 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.722 1.209 . . . . 74.1 109.16 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.14 96.76 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.783 0.719 . . . . 73.34 109.968 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.39 -26.35 68.42 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.007 1.323 . . . . 74.41 111.571 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.56 -8.2 54.97 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.458 -0.776 . . . . 72.43 109.946 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -88.84 9.02 26.21 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.178 -0.915 . . . . 75.32 111.803 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -76.86 118.03 19.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.694 1.588 . . . . 72.42 106.735 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.62 3.02 64.81 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.508 -1.162 . . . . 72.11 115.094 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.1 p -67.97 144.89 54.99 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 120.018 1.909 . . . . 73.4 107.766 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.8 mt -92.87 107.66 19.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 103.936 -2.616 . . . . 74.41 103.936 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.07 115.39 30.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 102.931 -2.988 . . . . 74.23 102.931 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER 48.41 56.96 6.73 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.533 1.159 . . . . 63.52 110.384 -177.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 60.47 13.09 3.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.359 2.264 . . . . 75.34 114.999 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -118.35 120.0 36.31 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.259 1.023 . . . . 74.01 111.469 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -71.63 115.7 11.12 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.872 -1.529 . . . . 72.32 106.872 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.335 16.4 pt -101.39 170.69 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.358 0.526 . . . . 54.43 110.201 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -120.89 151.83 39.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.482 1.113 . . . . 72.04 109.704 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.3 t -137.62 135.19 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.579 1.152 . . . . 72.01 108.45 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.35 152.97 32.73 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.427 1.091 . . . . 73.23 110.574 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 143.62 38.49 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.252 1.021 . . . . 72.25 111.005 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 124.917 1.287 . . . . 63.21 110.218 179.551 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 . . . . . 0 CA--C 1.513 -0.464 0 N-CA-C 110.152 -0.314 . . . . 72.32 110.152 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -115.77 165.04 13.5 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 128.042 2.537 . . . . 75.33 104.391 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.5 mt -134.89 135.75 52.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.534 -0.757 . . . . 73.31 109.091 -177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.9 t -96.98 145.34 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 104.992 -2.225 . . . . 75.32 104.992 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -113.62 131.73 56.02 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 104.904 -2.258 . . . . 75.11 104.904 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.88 126.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.091 -1.818 . . . . 64.03 106.091 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.22 177.63 18.36 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.052 0.842 . . . . 73.43 112.419 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.0 17.18 2.22 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.58 2.752 . . . . 64.12 110.671 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -58.31 144.32 77.82 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 124.91 1.284 . . . . 74.22 111.688 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.19 160.76 43.4 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.362 2.708 . . . . 71.43 112.406 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -67.06 -37.5 84.13 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.422 -0.955 . . . . 75.35 108.422 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.8 13.59 1.64 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.72 1.007 . . . . 72.11 113.72 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.589 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 6.4 tp -63.98 134.78 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 120.451 -1.405 . . . . 70.34 110.452 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . 0.254 1.3 p -128.63 150.05 50.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.456 1.902 . . . . 71.5 107.124 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.37 64.49 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.382 -0.824 . . . . 74.53 112.638 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 p -64.18 -36.54 77.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.462 -0.94 . . . . 75.23 108.462 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -70.35 -43.44 70.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.979 0.912 . . . . 73.24 108.595 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.99 -47.44 84.8 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.232 -0.655 . . . . 75.41 109.232 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -60.03 -38.55 83.03 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.863 0.865 . . . . 74.13 108.797 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -68.85 -41.9 77.85 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.814 1.188 . . . . 72.23 111.076 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -69.99 -35.86 74.72 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.565 -0.709 . . . . 73.35 112.561 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -100.87 6.44 43.72 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.668 0.787 . . . . 74.0 112.405 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -54.27 -43.85 71.37 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.054 1.342 . . . . 73.42 110.747 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -60.79 -32.03 71.38 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.369 1.068 . . . . 73.31 112.123 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 p -94.24 -22.45 18.4 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.686 1.194 . . . . 72.42 111.378 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t 54.4 79.95 0.32 Allowed Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 129.537 3.135 . . . . 65.33 112.396 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.89 166.24 18.92 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.677 2.918 . . . . 73.51 111.484 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -96.65 -38.55 9.89 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.116 0.966 . . . . 74.43 109.429 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -131.82 151.52 51.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.056 1.342 . . . . 65.22 108.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -139.8 105.29 2.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 106.473 -1.676 . . . . 73.23 106.473 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 104.29 9.26 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.46 -1.311 . . . . 74.23 107.46 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -87.01 125.24 33.97 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.63 1.172 . . . . 74.32 108.575 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.17 79.4 1.27 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.16 1.784 . . . . 73.3 107.078 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.01 54.77 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.104 0.962 . . . . 73.44 111.746 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.73 -34.98 29.14 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 126.688 1.995 . . . . 63.32 111.918 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -131.48 14.95 4.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.585 1.154 . . . . 74.52 111.298 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.5 50.23 66.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 124.265 0.936 . . . . 63.41 111.095 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 pt -138.21 170.95 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.235 1.414 . . . . 75.23 109.492 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.74 164.94 34.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.579 1.152 . . . . 61.25 109.094 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -128.69 127.69 42.62 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 105.505 -2.035 . . . . 60.15 105.505 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mp -130.07 106.45 8.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.743 -1.577 . . . . 74.02 106.743 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -96.16 150.14 20.85 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.581 -1.266 . . . . 75.34 107.581 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -136.27 135.28 38.85 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.496 -1.298 . . . . 72.43 107.496 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -79.46 109.61 14.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.323 0.965 . . . . 72.32 110.986 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.17 -24.78 60.6 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.609 1.564 . . . . 73.34 113.668 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.13 -25.93 58.8 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.713 -0.847 . . . . 74.43 108.713 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -60.64 -27.79 68.06 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.913 0.885 . . . . 72.35 111.051 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -161.35 88.48 0.73 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.842 0.746 . . . . 71.43 111.007 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -59.64 -25.41 64.66 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.162 -0.961 . . . . 71.14 112.831 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.0 p -96.95 -12.24 23.62 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.136 0.88 . . . . 72.31 113.181 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.99 -12.24 7.15 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-O 117.753 -1.582 . . . . 60.3 115.5 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 tp -58.0 -37.27 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 120.727 2.263 . . . . 74.33 110.773 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -58.69 -58.55 8.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.672 -1.233 . . . . 71.14 107.672 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -43.19 68.45 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.874 0.761 . . . . 74.25 111.777 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -57.3 -43.8 83.55 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.836 -0.801 . . . . 74.23 108.836 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.2 mtm -64.35 -43.27 95.1 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.985 -0.746 . . . . 75.42 108.985 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.44 -47.58 72.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.142 1.777 . . . . 62.24 111.495 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.11 -37.09 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.263 1.425 . . . . 71.32 107.959 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.06 -37.83 66.67 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.332 0.969 . . . . 75.43 109.44 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.59 -28.58 67.89 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.625 0.77 . . . . 70.14 110.914 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.58 -8.53 27.6 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.405 0.682 . . . . 74.41 110.978 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -86.42 3.82 42.15 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.874 0.761 . . . . 64.32 111.203 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -66.97 131.1 45.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 119.688 -1.882 . . . . 75.54 107.845 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.09 8.68 58.88 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 117.976 -1.458 . . . . 74.44 114.579 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 p -70.39 146.82 50.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.883 2.342 . . . . 73.15 108.059 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.0 mt -89.9 108.0 19.45 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.743 -2.317 . . . . 73.0 104.743 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.9 tp -110.04 121.81 46.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.912 -1.885 . . . . 74.21 105.912 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 13.9 mtpp 53.92 38.42 28.73 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.813 0.845 . . . . 74.23 111.296 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 62.61 33.21 15.93 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.225 1.41 . . . . 73.52 112.462 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -140.79 117.87 11.22 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.925 1.69 . . . . 75.22 107.949 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -73.95 148.37 42.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.835 -1.543 . . . . 75.24 106.835 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.0 pt -133.66 169.2 22.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 124.876 1.27 . . . . 73.41 111.236 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -120.86 152.34 38.54 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.077 1.351 . . . . 74.3 111.11 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -135.05 136.5 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.528 1.131 . . . . 75.12 108.507 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -150.84 162.8 40.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.614 1.966 . . . . 73.44 108.521 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.73 152.22 18.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.019 1.328 . . . . 72.52 111.589 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.9 p . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 125.208 1.403 . . . . 75.33 108.671 178.687 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.7 ptt85 . . . . . 0 CA--C 1.527 0.092 0 N-CA-C 109.539 -0.541 . . . . 74.11 109.539 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -133.39 165.56 24.55 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.606 2.362 . . . . 75.52 105.877 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.53 136.85 57.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.734 0.778 . . . . 72.51 109.819 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -103.21 118.87 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 104.558 -2.386 . . . . 63.43 104.558 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -90.62 133.15 35.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.222 -1.77 . . . . 75.33 106.222 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 t -138.85 130.93 37.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 118.144 -0.931 . . . . 50.11 108.509 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.81 -179.82 18.57 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 120.022 1.283 . . . . 73.44 112.019 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.48 25.65 2.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.13 2.172 . . . . 71.03 111.598 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.26 149.08 98.19 Favored Pre-proline 0 C--O 1.237 0.398 0 O-C-N 120.877 -1.14 . . . . 74.55 112.474 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.63 168.62 16.17 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.571 3.514 . . . . 75.54 111.612 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -70.31 -46.34 64.43 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.476 -0.935 . . . . 74.12 108.476 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.61 5.03 2.04 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.778 1.631 . . . . 74.1 114.163 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 tp -57.01 130.43 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 121.08 -1.012 . . . . 74.2 109.064 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.69 154.95 45.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.406 1.483 . . . . 71.22 107.788 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.17 -30.28 66.27 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 118.985 -0.531 . . . . 74.3 109.902 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -58.55 -43.96 88.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 118.465 0.575 . . . . 73.43 109.942 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -65.47 -43.73 89.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.169 0.988 . . . . 74.21 109.68 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.8 mt -67.43 -44.69 78.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.911 0.884 . . . . 73.31 111.297 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -56.8 -48.38 78.07 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 107.174 -1.417 . . . . 63.13 107.174 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.93 -40.87 95.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.539 1.136 . . . . 75.44 113.327 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.55 -22.24 57.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 114.377 1.251 . . . . 74.13 114.377 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -108.31 2.86 22.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.821 0.737 . . . . 75.21 111.895 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -52.18 -33.3 40.03 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.464 2.306 . . . . 73.03 113.731 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -82.25 -38.24 24.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.833 0.742 . . . . 64.35 110.046 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -22.6 64.67 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.634 1.173 . . . . 72.33 110.217 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m 53.78 67.27 3.71 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.543 1.137 . . . . 70.24 113.446 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.71 173.38 8.08 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.768 2.979 . . . . 54.42 109.638 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.7 -43.54 4.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.8 -1.185 . . . . 63.13 107.8 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -122.19 154.18 37.81 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.608 1.563 . . . . 74.31 109.648 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -146.7 122.9 3.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.899 -1.889 . . . . 75.34 105.899 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.34 102.95 4.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.441 1.497 . . . . 75.34 109.452 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -80.22 126.65 31.39 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.148 -1.797 . . . . 74.31 106.148 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -118.53 87.44 2.73 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.262 1.425 . . . . 74.42 111.146 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.34 -21.2 61.78 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.996 0.918 . . . . 63.43 111.87 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -54.61 -32.55 58.96 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.267 1.427 . . . . 72.25 111.576 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.3 mmtm -132.85 2.43 3.69 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 114.341 1.237 . . . . 74.01 114.341 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.47 40.38 54.55 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 120.39 1.45 . . . . 74.51 110.106 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 pt -129.53 170.12 19.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.616 1.966 . . . . 75.25 110.625 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.85 120.46 4.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.61 1.964 . . . . 73.15 108.859 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -99.14 150.95 21.52 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 118.615 0.643 . . . . 74.3 109.808 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.9 131.07 24.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.164 -1.051 . . . . 74.31 108.164 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -102.04 149.88 23.8 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 104.648 -2.353 . . . . 62.05 104.648 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -135.81 109.34 7.95 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.119 0.968 . . . . 71.41 108.5 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -68.39 110.01 3.92 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.816 1.246 . . . . 73.33 110.718 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.09 -15.23 57.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.569 2.347 . . . . 73.22 112.943 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.56 -39.3 32.12 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.393 -1.706 . . . . 74.24 106.393 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -61.73 -46.07 91.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.401 -0.963 . . . . 72.32 108.401 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.34 73.84 0.87 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.026 0.93 . . . . 62.01 109.556 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -48.21 -34.19 9.75 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.092 1.145 . . . . 63.43 114.092 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 p -121.81 -19.12 6.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 124.05 0.844 . . . . 75.01 111.686 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.08 -16.73 76.05 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.125 -0.984 . . . . 63.54 112.006 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 tp -50.75 -40.22 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.99 1.316 . . . . 70.13 110.914 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -57.51 -61.56 2.41 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.126 1.37 . . . . 64.11 108.439 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -50.98 -50.94 57.33 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.577 1.151 . . . . 73.41 110.095 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -52.85 -52.01 58.81 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.293 0.637 . . . . 70.31 110.776 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 36.4 mtm -66.79 -35.56 80.37 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 123.103 0.561 . . . . 74.4 111.358 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -46.98 87.7 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.863 1.265 . . . . 71.53 109.454 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.7 mt -62.87 -36.35 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.581 -0.896 . . . . 71.42 108.581 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.4 -43.06 70.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.94 -0.763 . . . . 72.12 108.94 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 mt -63.9 -33.15 75.05 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.663 0.785 . . . . 72.41 111.031 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.78 -13.14 41.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.298 0.851 . . . . 74.55 113.298 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -86.53 3.4 44.35 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.896 0.771 . . . . 74.23 111.547 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -59.74 113.98 2.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.931 -1.106 . . . . 72.53 109.414 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.06 12.34 55.25 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 118.371 -1.238 . . . . 74.44 115.385 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.4 p -69.62 149.08 48.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.174 1.987 . . . . 72.21 109.62 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.9 mt -96.43 107.18 19.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.062 -1.829 . . . . 64.32 106.062 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.423 ' CD2' ' HZ2' ' A' ' 70' ' ' LYS . 3.1 mt -109.92 122.66 48.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.189 -2.152 . . . . 73.21 105.189 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.423 ' HZ2' ' CD2' ' A' ' 69' ' ' LEU . 4.5 mtmm 46.43 40.3 7.79 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.328 1.051 . . . . 72.32 110.954 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 67.74 20.38 9.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.627 2.371 . . . . 74.24 114.248 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -120.22 125.96 49.44 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.092 1.357 . . . . 70.4 108.354 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -82.57 112.99 19.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.838 -0.801 . . . . 73.4 108.838 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.0 pp -87.46 171.13 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 124.429 1.092 . . . . 74.34 110.906 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.95 151.27 51.83 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.228 1.411 . . . . 61.11 109.106 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.3 t -134.1 144.24 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.231 1.413 . . . . 63.44 108.31 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -153.54 160.76 42.58 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.467 1.907 . . . . 75.11 108.864 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.34 151.84 22.33 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 120.99 -1.068 . . . . 71.15 108.699 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 108.708 -0.849 . . . . 72.24 108.708 178.861 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.424 HH11 ' CD ' ' A' ' 44' ' ' GLU . 8.9 ttm180 . . . . . 0 CA--C 1.506 -0.748 0 N-CA-C 106.714 -1.587 . . . . 75.25 106.714 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -99.85 164.91 11.82 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.107 0.963 . . . . 72.33 108.546 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.3 mt -134.87 149.01 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.933 1.293 . . . . 74.41 110.965 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.2 t -118.51 134.3 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.802 2.041 . . . . 75.43 105.851 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -100.62 142.21 32.4 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 126.15 1.78 . . . . 74.43 108.826 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.41 133.53 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.21 -1.774 . . . . 74.11 106.21 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -132.57 -179.7 16.5 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 120.385 1.448 . . . . 55.5 111.123 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.88 14.48 9.84 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.526 1.931 . . . . 71.41 112.621 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.35 148.05 9.37 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 124.737 1.215 . . . . 73.45 112.958 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.78 154.34 50.27 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.649 2.899 . . . . 74.22 110.341 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -70.36 -37.56 74.62 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.881 -0.512 . . . . 75.2 109.917 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.59 25.3 3.11 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.336 1.054 . . . . 61.33 111.855 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.414 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 8.4 tp -53.84 139.92 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.832 1.253 . . . . 75.11 110.537 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -124.78 148.04 48.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.611 1.164 . . . . 73.44 108.423 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.29 -29.84 70.12 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 118.852 -0.594 . . . . 64.44 111.097 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.66 -37.01 76.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 118.764 0.711 . . . . 74.3 109.708 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -69.17 -44.67 71.76 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.727 -0.842 . . . . 74.42 108.727 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 mt -60.49 -54.71 42.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.342 0.657 . . . . 75.22 110.786 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -59.87 -41.42 91.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.373 -0.602 . . . . 74.12 109.373 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -67.94 -40.53 83.29 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.855 0.687 . . . . 64.21 112.855 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -22.68 65.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 120.047 1.294 . . . . 73.33 113.071 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -112.29 6.07 18.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.056 0.942 . . . . 75.52 111.513 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -41.7 63.04 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.25 1.42 . . . . 74.54 112.264 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -58.17 -54.32 48.31 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.972 -0.751 . . . . 75.44 108.972 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.09 -22.06 66.39 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.653 1.181 . . . . 64.42 112.627 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 t 50.41 78.26 0.41 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.195 2.198 . . . . 74.54 112.418 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.55 168.14 20.66 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.256 2.637 . . . . 72.02 110.577 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -94.68 -31.8 13.65 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.488 1.115 . . . . 72.32 109.961 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.04 161.0 41.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.859 0.863 . . . . 65.13 109.807 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.68 107.13 2.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 104.295 -2.483 . . . . 73.25 104.295 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.5 ttp180 -117.98 103.96 10.43 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.577 -1.268 . . . . 75.53 107.577 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.57 124.78 36.85 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.49 1.516 . . . . 75.41 110.51 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.56 80.12 1.49 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.602 1.961 . . . . 74.23 108.024 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.83 -17.37 56.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.107 0.963 . . . . 73.41 111.216 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.429 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 1.4 m-20 -51.4 -32.8 27.63 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.647 1.979 . . . . 65.14 109.884 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.433 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 5.3 mmpt? -126.73 -9.69 6.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.378 1.871 . . . . 74.22 111.351 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.42 36.77 33.2 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.661 -1.376 . . . . 75.13 109.661 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.416 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 36.0 pt -124.47 168.42 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.173 1.389 . . . . 73.4 108.417 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.67 166.3 33.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.569 1.148 . . . . 72.34 109.442 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -135.77 140.82 44.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.562 1.545 . . . . 74.2 108.083 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mp -134.49 123.62 24.25 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.016 -1.475 . . . . 74.13 107.016 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.424 ' CD ' HH11 ' A' ' 3' ' ' ARG . 4.5 mt-10 -98.64 156.73 16.67 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.614 -0.513 . . . . 73.34 109.614 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -146.65 119.63 8.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.201 -1.407 . . . . 74.5 107.201 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -83.72 119.14 24.43 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.765 -0.458 . . . . 73.12 109.765 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.35 61.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.991 1.716 . . . . 54.12 111.219 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -70.4 -23.77 62.82 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.86 -1.163 . . . . 73.45 107.86 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -62.18 -32.37 72.99 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-O 118.362 -0.828 . . . . 71.15 110.368 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -168.02 101.52 0.46 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.461 1.504 . . . . 72.32 108.078 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -52.76 -22.62 5.49 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 116.301 1.963 . . . . 74.43 116.301 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p -121.43 -19.36 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 120.115 1.325 . . . . 71.33 110.872 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.9 -30.62 51.33 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-O 118.592 -1.116 . . . . 64.54 110.705 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.1 tp -52.58 -37.65 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.24 1.416 . . . . 74.14 110.061 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.01 -58.05 9.52 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.618 1.167 . . . . 74.44 107.934 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -54.79 -41.29 70.39 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.258 0.623 . . . . 72.42 110.242 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.6 mtt85 -57.95 -50.23 74.09 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-O 118.421 -0.8 . . . . 74.14 110.233 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 10.8 mtm -59.85 -45.49 92.27 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.195 0.452 . . . . 74.03 110.451 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.4 -54.57 45.13 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 122.86 0.464 . . . . 72.24 110.666 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.8 mt -58.1 -36.94 59.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 125.194 1.398 . . . . 73.35 109.596 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.11 -43.97 73.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.733 -0.469 . . . . 65.14 109.733 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.68 -35.66 81.75 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.347 0.659 . . . . 74.4 110.337 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.8 mt -62.47 -2.57 1.1 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.949 1.7 . . . . 72.3 113.646 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -94.45 3.73 54.77 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.675 1.19 . . . . 71.21 110.314 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -65.85 135.08 54.34 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.153 1.781 . . . . 74.21 109.686 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.01 15.53 67.36 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.706 1.622 . . . . 74.25 113.312 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -78.59 155.99 29.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.883 1.342 . . . . 61.42 108.139 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.32 108.0 20.15 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.356 -0.979 . . . . 73.5 108.356 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -112.32 115.59 29.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.631 -1.618 . . . . 74.02 106.631 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 3.8 mtpp 50.2 53.45 12.84 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.027 0.918 . . . . 75.21 111.081 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 55.43 20.44 3.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.303 2.241 . . . . 74.53 114.523 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -122.8 122.77 39.49 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 126.079 1.751 . . . . 63.44 107.837 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -83.14 104.86 13.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.036 -1.098 . . . . 73.42 108.036 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 pt -87.92 169.3 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.234 -0.894 . . . . 63.45 111.289 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -123.87 154.18 40.03 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.435 1.494 . . . . 74.35 110.222 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.2 142.15 42.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.936 -1.505 . . . . 73.13 106.936 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.67 174.78 14.05 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.472 1.909 . . . . 74.3 110.517 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -90.42 149.2 22.35 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.797 1.239 . . . . 75.11 112.422 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--N 1.329 -0.317 0 N-CA-C 106.505 -1.665 . . . . 73.24 106.505 177.004 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? . . . . . 0 C--O 1.237 0.415 0 CA-C-O 121.101 0.477 . . . . 73.34 111.889 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -99.05 159.33 15.04 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 127.738 2.415 . . . . 73.15 110.055 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.17 149.22 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.604 1.162 . . . . 72.14 110.953 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.8 t -116.07 128.8 73.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.752 -1.573 . . . . 73.3 106.752 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -88.05 131.62 34.59 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.661 1.584 . . . . 73.2 106.886 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 t -138.58 128.69 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.31 -1.737 . . . . 75.53 106.31 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.08 -175.15 13.85 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 119.212 0.914 . . . . 75.41 111.871 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.49 14.66 8.35 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.97 1.708 . . . . 74.11 111.157 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.85 150.81 75.76 Favored Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 125.283 1.433 . . . . 74.52 111.551 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.74 157.63 60.9 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.035 2.49 . . . . 64.24 109.975 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -69.3 -36.15 76.73 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.265 -0.897 . . . . 64.12 111.015 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -88.26 15.06 8.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.884 0.874 . . . . 73.3 112.955 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.1 tp -50.46 140.92 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.779 1.231 . . . . 74.31 111.617 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 p -128.47 147.5 50.67 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.122 -0.695 . . . . 70.02 109.122 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.68 -27.21 66.2 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 118.481 -0.771 . . . . 75.0 112.064 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.78 -36.54 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.02 -0.733 . . . . 64.0 109.02 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -73.41 -42.53 61.96 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 123.82 0.848 . . . . 72.5 108.857 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.9 mt -62.09 -49.41 76.05 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.484 -0.561 . . . . 70.25 109.484 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -58.46 -46.58 86.3 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.901 -1.148 . . . . 71.24 107.901 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -57.44 -46.13 83.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 114.003 1.112 . . . . 75.1 114.003 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -65.95 -56.45 11.63 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.08 1.309 . . . . 64.33 110.405 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -73.25 4.27 4.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.424 1.268 . . . . 73.21 114.424 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -53.89 -31.23 49.2 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 125.364 1.466 . . . . 74.33 113.353 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -8.27 56.61 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.298 1.039 . . . . 71.52 112.48 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 p -112.08 -9.62 13.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.333 1.853 . . . . 70.21 110.858 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.4 m 39.5 78.2 0.38 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.912 2.085 . . . . 73.34 115.762 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.37 164.14 29.51 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.991 2.461 . . . . 71.13 109.962 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -90.01 -41.15 11.88 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.018 0.927 . . . . 71.11 108.999 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -144.32 155.88 44.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.316 0.646 . . . . 74.52 109.688 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.35 123.96 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 127.044 2.138 . . . . 65.4 108.939 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.09 104.69 6.03 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.384 2.273 . . . . 75.45 107.233 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.13 121.79 32.51 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.831 -1.174 . . . . 72.42 107.831 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -116.96 75.07 0.94 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.901 -1.518 . . . . 74.42 106.901 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -26.68 27.03 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.186 1.394 . . . . 64.41 112.248 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -51.68 -25.79 7.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.289 2.236 . . . . 75.41 113.315 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -133.07 10.39 4.19 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.907 1.683 . . . . 74.41 110.269 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.85 44.04 96.24 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.043 1.306 . . . . 73.22 110.012 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.5 pt -132.77 169.77 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 C-N-CA 125.067 1.347 . . . . 72.42 111.011 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.06 166.0 29.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.245 1.818 . . . . 62.02 108.829 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.1 116.8 14.96 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.608 -1.627 . . . . 74.23 106.608 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -113.92 115.52 27.81 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.77 -1.567 . . . . 75.41 106.77 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -88.48 152.83 21.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.11 -1.441 . . . . 71.43 107.11 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -145.58 133.27 21.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.342 1.457 . . . . 74.0 107.173 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -101.89 108.33 19.77 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.066 1.346 . . . . 62.12 112.234 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.57 -23.26 65.39 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.083 1.353 . . . . 63.21 112.21 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -75.39 -25.48 57.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.014 -0.736 . . . . 64.31 109.014 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -66.59 -34.51 78.04 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.928 0.891 . . . . 75.23 110.402 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -156.72 91.26 1.21 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.921 0.782 . . . . 74.15 111.269 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -48.65 -34.26 11.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.402 1.881 . . . . 75.12 115.787 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.94 -16.49 14.29 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 113.344 0.868 . . . . 75.45 113.344 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.31 -19.07 29.09 Favored Glycine 0 C--O 1.225 -0.461 0 CA-C-O 117.707 -1.607 . . . . 74.11 112.927 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 tp -56.04 -35.57 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 120.187 1.993 . . . . 74.42 108.758 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -62.52 -60.81 3.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.363 1.865 . . . . 73.14 108.263 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.0 mmt-85 -54.44 -39.01 66.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.144 0.977 . . . . 71.42 110.344 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -62.94 -47.62 82.43 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.207 -1.034 . . . . 74.45 108.207 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.8 mtm -63.27 -41.82 99.06 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 123.839 0.856 . . . . 75.3 110.226 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -56.81 -50.53 72.08 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.601 1.16 . . . . 72.54 109.051 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.36 -30.86 50.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.273 1.429 . . . . 75.42 110.88 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 -44.23 52.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.477 -0.935 . . . . 74.42 108.477 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mt -63.59 -29.01 70.32 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.376 1.071 . . . . 75.21 112.206 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.79 -2.82 22.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 118.755 -0.64 . . . . 72.11 112.018 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -84.79 -5.95 59.34 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.425 1.011 . . . . 72.54 109.987 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -66.19 112.53 3.98 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.724 1.147 . . . . 71.42 108.671 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.23 -8.19 38.07 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.626 1.108 . . . . 73.42 113.049 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.1 p -65.72 148.98 50.88 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 119.234 1.517 . . . . 75.44 108.678 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.2 mt -98.51 108.07 20.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.58 -2.378 . . . . 71.02 104.58 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.0 tp -102.55 111.11 23.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.291 -1.744 . . . . 75.34 106.291 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt 48.89 51.34 16.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.451 1.1 . . . . 73.42 111.163 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.274 9.6 mt-10 57.97 38.7 26.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 128.031 2.532 . . . . 74.34 114.159 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -137.58 118.15 13.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 126.285 1.834 . . . . 74.03 106.59 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -78.46 105.23 9.58 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.772 -1.195 . . . . 75.24 107.772 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.6 pt -79.52 172.4 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 125.149 1.379 . . . . 75.43 113.262 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.42 149.94 44.41 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.528 1.931 . . . . 73.22 106.61 177.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.8 t -139.91 120.98 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 106.308 -1.738 . . . . 73.1 106.308 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.01 175.69 9.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.834 1.254 . . . . 72.53 110.608 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.53 152.22 30.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.442 1.497 . . . . 74.44 113.396 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.505 0 N-CA-C 107.24 -1.393 . . . . 75.12 107.24 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.501 0 N-CA-C 107.987 -1.116 . . . . 75.23 107.987 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -103.18 160.71 14.41 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.214 1.805 . . . . 74.32 108.558 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mp -134.37 149.83 30.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.924 1.69 . . . . 72.04 107.63 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.9 t -119.18 124.21 72.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 105.238 -2.134 . . . . 72.44 105.238 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -82.53 131.8 35.21 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.543 -2.021 . . . . 72.44 105.543 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.2 t -136.36 122.53 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.546 -2.02 . . . . 73.44 105.546 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.81 180.0 17.21 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 120.066 1.303 . . . . 73.54 113.485 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.48 19.62 5.11 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.987 2.115 . . . . 64.4 111.331 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.63 148.13 91.52 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.152 0.981 . . . . 55.14 110.951 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.56 150.91 80.17 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.677 2.918 . . . . 71.02 110.553 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -30.15 71.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.618 -0.706 . . . . 74.45 111.3 178.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.98 11.97 18.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.37 1.248 . . . . 74.24 114.37 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.438 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 7.8 tp -54.46 147.93 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.922 1.289 . . . . 74.33 110.42 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -128.21 157.0 42.05 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.428 0.691 . . . . 62.41 110.822 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.12 -32.19 73.66 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.977 -0.452 . . . . 62.3 109.802 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 p -63.39 -44.51 98.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.457 -0.572 . . . . 73.31 109.457 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.58 ' CD ' ' HZ2' ' A' ' 70' ' ' LYS . 69.8 mt-10 -71.05 -36.08 72.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.196 -0.43 . . . . 72.21 110.061 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.0 mt -63.4 -46.28 87.13 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.421 -0.955 . . . . 74.34 108.421 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -58.33 -49.99 75.22 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.883 -1.155 . . . . 75.11 107.883 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -55.45 -44.16 76.13 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.529 0.937 . . . . 75.12 113.529 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -30.25 70.31 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 114.342 1.238 . . . . 73.0 114.342 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.07 6.23 19.11 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.61 0.764 . . . . 74.22 112.662 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -54.44 -43.32 71.5 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.412 1.485 . . . . 64.21 110.637 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -61.21 -35.3 76.83 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.561 0.744 . . . . 64.2 111.618 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.92 -17.36 38.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.735 1.614 . . . . 73.02 111.417 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.43 72.95 0.98 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 126.728 2.011 . . . . 74.34 116.239 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.39 161.71 43.68 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.037 2.492 . . . . 75.44 110.187 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.09 -46.56 8.4 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.031 1.732 . . . . 63.13 108.939 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -131.72 156.32 46.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.25 -0.886 . . . . 73.32 112.383 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.9 mt -146.77 123.9 3.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.416 -1.328 . . . . 75.42 107.416 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.72 104.91 5.44 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 128.28 2.632 . . . . 72.53 106.794 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.12 112.25 24.14 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.33 1.052 . . . . 75.03 110.25 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -97.79 82.78 3.08 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.092 -1.818 . . . . 75.43 106.092 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.04 -29.71 58.03 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.669 0.787 . . . . 74.42 111.563 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.18 -32.3 22.98 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.483 2.313 . . . . 74.15 112.6 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -122.15 -5.13 8.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.372 1.469 . . . . 74.25 110.2 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.09 47.43 85.36 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 125.674 1.607 . . . . 61.22 109.488 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.2 pt -135.57 162.4 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.152 1.381 . . . . 74.23 108.869 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.96 166.22 24.59 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.926 1.29 . . . . 74.31 108.369 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -133.47 104.7 6.53 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.627 -1.62 . . . . 73.4 106.627 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.27 113.16 26.58 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.429 -1.323 . . . . 74.54 107.429 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.32 153.6 19.81 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.33 1.452 . . . . 75.15 108.703 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -147.75 136.24 21.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.895 1.278 . . . . 70.4 108.224 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -101.48 111.51 23.76 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.958 1.303 . . . . 75.1 111.919 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.64 -21.47 55.43 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.073 2.149 . . . . 63.53 110.396 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.64 -30.41 71.35 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.989 -1.486 . . . . 41.5 106.989 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -62.06 -33.59 74.68 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 117.994 -1.003 . . . . 73.25 110.765 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -157.24 108.41 2.33 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 114.642 1.349 . . . . 53.51 114.642 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -68.05 -19.31 64.87 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 117.182 -1.389 . . . . 74.15 112.999 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.359 43.5 p -122.53 14.73 10.29 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.795 1.634 . . . . 74.35 114.535 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -131.03 -19.89 1.21 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.346 1.45 . . . . 60.55 115.167 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.8 -30.41 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 120.484 2.142 . . . . 72.14 109.514 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -64.14 -55.97 18.08 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 126.142 1.777 . . . . 73.31 110.086 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -58.55 -27.36 64.5 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.428 1.491 . . . . 71.54 110.719 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -76.33 -45.83 30.41 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.239 -1.023 . . . . 71.33 108.239 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 8.2 mtm -57.57 -41.67 81.54 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.959 0.904 . . . . 73.1 108.904 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -55.17 -49.08 72.77 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.322 1.449 . . . . 74.14 110.391 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.7 mt -64.66 -41.55 92.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 124.271 1.028 . . . . 73.32 109.439 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.36 93.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.69 -0.856 . . . . 64.43 108.69 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.3 mt -63.83 -32.52 74.06 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.188 0.995 . . . . 73.23 110.51 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.32 -10.78 26.36 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.175 -0.917 . . . . 75.0 110.808 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -85.91 -0.78 56.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.031 1.287 . . . . 70.31 110.755 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.2 112.38 3.01 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.682 -1.261 . . . . 73.32 107.767 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.56 1.75 57.68 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 117.421 -1.766 . . . . 70.55 113.261 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.256 51.3 p -66.02 142.83 57.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.988 2.394 . . . . 74.23 110.33 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.48 116.65 29.03 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.593 1.157 . . . . 74.4 108.172 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 mt -122.53 120.4 33.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 105.949 -1.871 . . . . 71.22 105.949 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.58 ' HZ2' ' CD ' ' A' ' 19' ' ' GLU . 10.7 mtmm 44.3 47.53 7.88 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.749 1.62 . . . . 75.43 110.076 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 59.39 33.71 22.49 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.225 1.81 . . . . 73.23 114.712 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -130.18 117.56 20.09 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 104.742 -2.318 . . . . 75.52 104.742 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -78.58 107.96 11.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.97 -1.122 . . . . 74.14 107.97 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -78.99 170.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 124.501 1.12 . . . . 62.21 111.06 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.26 155.62 47.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.001 1.72 . . . . 74.41 109.344 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.6 t -139.23 133.11 39.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 O-C-N 124.003 0.815 . . . . 64.41 110.224 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -143.9 175.43 10.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.013 1.325 . . . . 64.52 108.621 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.89 150.58 21.16 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.828 0.851 . . . . 73.34 109.168 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.99 -1.115 . . . . 73.42 107.99 178.651 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.738 0 N-CA-C 110.306 -1.118 . . . . 54.05 110.306 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.72 40.76 0.11 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.029 1.731 . . . . 71.45 112.624 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.3 ptt85 -153.55 157.34 39.6 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 120.285 -1.509 . . . . 72.12 110.669 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -126.36 162.91 24.43 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.956 1.702 . . . . 73.13 106.838 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 mp -129.15 149.67 33.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.11 0.964 . . . . 74.14 108.577 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.2 t -109.79 124.69 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.249 1.42 . . . . 75.53 107.922 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -91.2 100.28 13.13 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.605 -1.998 . . . . 72.43 105.605 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.1 t -104.75 132.04 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.935 -1.876 . . . . 72.11 105.935 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.77 179.3 27.6 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 121.352 1.887 . . . . 54.54 113.758 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.72 14.01 0.99 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.291 2.637 . . . . 73.34 111.943 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 mp -55.7 157.65 7.35 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.897 1.679 . . . . 74.35 115.059 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.69 153.0 59.55 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.289 3.326 . . . . 72.25 110.544 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -34.32 75.3 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.216 0.606 . . . . 74.52 111.685 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -90.39 11.12 22.49 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.714 1.375 . . . . 61.24 114.714 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.3 tp -45.44 140.39 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 114.603 1.334 . . . . 74.43 114.603 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.38 147.6 46.92 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.149 1.38 . . . . 60.43 108.744 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -29.18 69.04 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.493 0.717 . . . . 74.31 111.105 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.16 -43.33 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.194 0.998 . . . . 73.11 109.17 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.09 -18.89 61.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.954 1.301 . . . . 73.52 111.744 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.9 mt -86.25 -44.24 12.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 120.573 -1.329 . . . . 75.14 109.524 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -62.17 -45.64 92.53 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.01 0.924 . . . . 73.43 110.955 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -65.35 -27.26 68.45 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 114.171 1.174 . . . . 65.24 114.171 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -74.49 -60.92 2.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.544 1.138 . . . . 75.34 109.587 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -80.94 3.65 22.15 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 114.675 1.361 . . . . 61.14 114.675 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -48.53 -51.68 26.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.795 1.638 . . . . 75.54 110.595 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -60.54 -44.42 96.12 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.774 0.83 . . . . 65.41 111.857 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 p -70.57 -16.41 62.86 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.145 -0.972 . . . . 53.43 112.981 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m 49.78 71.42 1.58 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.792 2.037 . . . . 53.23 116.064 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.29 165.72 23.67 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.944 2.429 . . . . 71.45 110.312 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -99.15 -47.41 5.22 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.812 1.645 . . . . 62.42 108.134 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.62 149.19 40.11 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.212 1.005 . . . . 73.52 109.872 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -146.7 112.31 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.651 1.58 . . . . 74.55 107.08 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -140.27 104.08 4.72 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.653 1.581 . . . . 74.41 110.13 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -89.87 127.78 36.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.132 1.773 . . . . 62.44 110.589 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -118.95 85.58 2.39 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.22 1.808 . . . . 75.41 108.109 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.64 -22.04 43.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.338 0.655 . . . . 74.21 112.544 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -51.5 -28.21 12.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.664 2.386 . . . . 53.03 112.346 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -133.44 8.43 3.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.697 1.999 . . . . 75.23 110.448 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.01 36.24 72.9 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.787 -1.007 . . . . 73.12 111.877 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.5 170.36 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 126.441 1.896 . . . . 73.33 108.575 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.06 170.89 19.35 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.534 -1.284 . . . . 54.42 107.534 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -128.23 135.83 50.22 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.429 -2.063 . . . . 73.34 105.429 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.96 107.82 6.3 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 106.812 -1.551 . . . . 75.35 106.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -88.36 154.3 20.5 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.442 -1.688 . . . . 53.35 106.442 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -139.93 116.2 10.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.763 1.225 . . . . 72.23 107.817 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -70.22 108.93 4.38 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.624 0.726 . . . . 74.21 111.55 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.43 69.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.387 1.075 . . . . 51.11 110.016 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.14 -21.05 65.85 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.649 0.779 . . . . 71.52 111.76 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -37.91 87.07 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.542 -0.91 . . . . 74.52 108.542 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -158.44 102.69 1.75 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 119.385 0.993 . . . . 74.41 111.327 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -52.74 -33.94 50.51 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.814 0.846 . . . . 74.14 112.769 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 12.9 18.8 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.736 1.013 . . . . 72.43 113.736 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.23 -24.91 3.38 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.849 1.214 . . . . 72.24 112.076 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tp -55.56 -33.4 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 118.442 1.121 . . . . 71.32 110.643 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -61.28 2.54 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.513 1.125 . . . . 71.51 109.545 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -60.54 -36.62 78.87 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 118.791 -0.623 . . . . 72.21 111.515 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -59.2 -42.97 92.19 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.713 -0.847 . . . . 74.33 108.713 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.2 mtm -67.76 -45.5 74.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.469 -1.253 . . . . 73.31 108.801 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -52.27 -51.47 58.26 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.103 1.319 . . . . 64.55 110.001 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.3 mt -59.09 -38.62 75.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 125.32 1.448 . . . . 75.34 110.449 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.36 -42.39 62.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.455 0.571 . . . . 72.41 109.623 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 mt -65.53 -30.3 71.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.791 1.636 . . . . 75.52 111.498 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 mt -65.9 -12.95 58.51 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.996 -0.526 . . . . 74.33 110.527 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -86.7 6.15 32.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.003 0.921 . . . . 71.31 110.823 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -73.76 115.36 13.09 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.39 -2.078 . . . . 72.41 105.39 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.04 5.71 70.26 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 125.053 1.311 . . . . 54.31 111.909 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 p -75.53 162.96 27.86 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 119.949 1.875 . . . . 72.25 107.203 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 mt -95.25 139.42 31.6 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 126.919 2.087 . . . . 73.11 108.048 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -145.74 122.85 11.46 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.668 1.987 . . . . 63.21 107.713 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt 42.06 46.95 3.79 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.779 1.232 . . . . 74.33 113.02 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.315 98.5 mt-10 66.0 23.71 11.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.814 2.045 . . . . 75.42 116.406 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -125.26 152.46 44.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.393 -2.077 . . . . 74.14 105.393 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -103.56 135.7 44.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 102.372 -3.195 . . . . 64.24 102.372 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.5 pt -122.63 161.28 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 119.0 0.818 . . . . 75.32 112.929 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -107.17 156.93 18.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.851 1.26 . . . . 72.43 111.244 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -147.49 118.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 125.512 1.525 . . . . 71.34 107.908 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -141.75 174.92 10.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.593 1.157 . . . . 75.44 110.506 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -84.05 151.9 24.7 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.29 1.036 . . . . 71.33 111.045 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t -154.53 117.23 4.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.951 -1.87 . . . . 71.22 105.951 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 p 160.6 -65.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 129.242 3.017 . . . . 71.21 105.691 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.18 70.57 1.05 Allowed Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 108.492 -1.843 . . . . 75.32 108.492 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.427 0 N-CA-C 106.314 -2.714 . . . . 75.35 106.314 -178.28 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.939 0 N-CA-C 109.906 -1.278 . . . . 75.24 109.906 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -76.47 5.86 6.63 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 114.561 1.319 . . . . 74.14 114.561 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -144.76 117.95 8.94 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.282 1.856 . . . . 74.32 110.947 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -95.25 163.43 13.27 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.119 1.368 . . . . 75.13 107.49 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -135.16 138.12 49.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 107.392 -1.336 . . . . 74.04 107.392 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.2 t -96.28 146.63 6.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 104.671 -2.344 . . . . 72.42 104.671 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.05 103.62 12.88 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.404 -2.072 . . . . 71.11 105.404 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.6 t -110.78 121.58 63.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.508 -1.664 . . . . 70.1 106.508 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.39 178.35 20.99 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 119.993 1.27 . . . . 74.21 113.043 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.72 21.93 5.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.087 2.155 . . . . 72.54 112.297 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.5 mp -64.15 150.02 93.07 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.325 1.45 . . . . 73.41 112.854 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.12 149.75 76.76 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.908 2.405 . . . . 70.14 110.171 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -59.8 -35.59 75.0 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.112 0.565 . . . . 74.53 110.142 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.83 14.14 10.99 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.5 1.296 . . . . 62.42 114.5 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.46 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 10.1 tp -47.08 142.88 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 124.372 1.069 . . . . 73.21 111.609 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 p -124.37 148.75 47.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.385 1.074 . . . . 75.23 108.33 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -32.77 72.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.683 -0.675 . . . . 73.24 110.074 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.12 -41.47 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-N 118.831 0.741 . . . . 65.23 109.829 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.36 -42.23 79.5 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.543 -0.54 . . . . 73.3 109.543 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 mt -65.96 -40.44 91.31 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.698 0.399 . . . . 75.3 111.605 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -46.63 77.46 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.516 -1.29 . . . . 75.35 107.516 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -61.11 -48.49 81.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 114.083 1.142 . . . . 74.23 114.083 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -28.44 68.61 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.488 0.921 . . . . 73.05 113.488 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -112.52 9.18 19.51 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 112.92 0.711 . . . . 73.35 112.92 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -55.34 -34.32 64.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.683 -1.26 . . . . 74.42 112.349 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.92 -34.6 44.44 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.324 0.511 . . . . 73.34 110.602 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -27.95 62.86 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.12 -0.696 . . . . 74.2 109.12 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.4 m 58.55 66.24 2.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 127.054 2.141 . . . . 52.51 114.792 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -63.53 164.96 19.13 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.731 2.954 . . . . 72.34 111.854 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -91.1 -40.74 11.43 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.115 1.766 . . . . 63.11 109.291 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -137.23 164.39 28.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.35 0.66 . . . . 74.42 111.311 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.8 mt -151.46 126.26 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.502 -1.666 . . . . 75.52 106.502 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.58 104.65 4.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.444 1.497 . . . . 74.42 107.172 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.35 125.42 34.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.389 -1.337 . . . . 74.1 107.389 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -112.97 86.41 2.37 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.165 -1.791 . . . . 65.41 106.165 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.14 -29.77 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.39 0.676 . . . . 71.32 111.01 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.7 -24.27 8.31 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.305 2.242 . . . . 72.32 113.096 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -132.73 -0.09 3.52 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.846 1.258 . . . . 72.31 111.836 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.63 41.76 98.98 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.132 -1.187 . . . . 75.31 110.132 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 pt -137.0 167.48 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.707 1.603 . . . . 75.34 109.149 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.18 166.36 24.91 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.382 1.073 . . . . 74.44 108.498 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -130.77 119.14 21.87 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.201 -2.148 . . . . 74.54 105.201 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.14 108.99 12.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.388 -1.708 . . . . 73.22 106.388 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.51 153.06 24.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.322 1.849 . . . . 74.45 109.533 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -144.58 108.37 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.687 1.195 . . . . 74.44 108.633 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -72.59 115.68 12.15 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.578 0.704 . . . . 73.34 110.227 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.2 -24.26 54.68 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.933 2.093 . . . . 75.14 111.834 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.85 -27.98 50.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.321 -0.371 . . . . 61.25 110.415 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -71.09 -36.97 72.4 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.21 0.604 . . . . 73.41 111.206 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.7 76.18 1.71 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.493 1.117 . . . . 75.51 111.085 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -47.55 66.07 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.512 -1.368 . . . . 72.4 113.684 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.25 5.25 52.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 114.086 1.143 . . . . 74.32 114.086 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.59 -5.76 2.8 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 117.386 -1.785 . . . . 72.43 115.502 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.7 tp -56.29 -42.39 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 121.073 2.436 . . . . 74.33 108.781 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -56.34 23.16 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 107.722 -1.214 . . . . 74.25 107.722 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -50.36 -48.49 55.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.417 1.087 . . . . 75.23 110.739 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -48.65 74.28 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.451 0.7 . . . . 73.12 109.124 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 48.8 mtm -68.84 -32.29 71.87 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 118.662 -0.685 . . . . 73.23 112.207 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.21 -51.53 68.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.134 2.173 . . . . 74.25 110.291 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mt -63.1 -39.6 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.313 1.445 . . . . 73.42 108.189 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.02 -41.63 81.89 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.178 -0.915 . . . . 73.42 109.554 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.2 mt -65.72 -31.24 72.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.33 0.968 . . . . 74.4 111.352 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 mt -66.16 -12.71 57.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.713 -0.661 . . . . 73.44 111.319 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -86.29 6.7 28.51 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 117.974 -1.012 . . . . 75.21 111.321 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -73.04 121.54 20.32 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.354 1.862 . . . . 70.42 108.86 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.96 3.22 58.08 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.828 -0.984 . . . . 73.33 114.377 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.4 p -68.84 151.61 46.37 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 119.35 1.575 . . . . 64.1 108.465 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.8 mt -97.42 110.84 23.32 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.711 -1.589 . . . . 74.4 106.711 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mt -113.59 119.11 36.37 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.843 -1.91 . . . . 75.14 105.843 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 41.9 mttm 45.03 58.31 4.13 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.643 1.577 . . . . 72.53 109.806 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 59.12 14.43 3.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.265 1.826 . . . . 70.41 115.033 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -121.14 122.01 39.08 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 120.479 -1.388 . . . . 52.03 110.545 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.86 123.85 25.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 104.601 -2.37 . . . . 74.31 104.601 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.4 pt -108.67 169.85 3.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 119.276 0.944 . . . . 72.23 112.9 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -112.56 146.03 39.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.691 1.196 . . . . 73.14 108.904 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.5 t -143.59 108.54 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 106.48 -1.674 . . . . 74.31 106.48 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -132.84 171.66 13.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.437 1.495 . . . . 72.54 109.144 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.8 152.6 19.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 120.666 -1.271 . . . . 62.33 113.795 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 p -141.52 155.93 45.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.604 1.161 . . . . 75.32 108.9 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t 57.52 86.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.817 2.447 . . . . 70.13 114.06 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.85 -9.63 2.06 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.048 -0.862 . . . . 75.15 114.291 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 117.604 -1.665 . . . . 65.3 109.364 179.768 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.563 0 N-CA-C 111.234 -0.746 . . . . 64.51 111.234 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -108.28 8.11 27.62 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.243 1.201 . . . . 72.22 114.243 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 137.87 52.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.734 1.152 . . . . 74.4 108.881 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -138.9 156.79 46.99 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.713 1.605 . . . . 74.45 106.768 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.2 mt -136.18 146.76 28.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.314 -0.857 . . . . 75.44 109.971 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.0 t -106.33 119.24 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 127.949 2.5 . . . . 74.43 106.522 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -88.59 135.13 33.65 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 104.562 -2.384 . . . . 74.24 104.562 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.9 t -138.77 122.51 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.135 -2.172 . . . . 75.22 105.135 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -130.0 -176.57 14.48 Favored Glycine 0 N--CA 1.467 0.718 0 CA-C-N 121.127 1.785 . . . . 52.32 111.027 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 m 70.51 17.53 6.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.691 1.596 . . . . 71.12 111.554 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.1 mp -67.29 147.55 98.89 Favored Pre-proline 0 C--O 1.235 0.295 0 O-C-N 120.975 -1.078 . . . . 75.11 109.963 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.82 152.31 77.54 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.511 2.141 . . . . 71.12 110.574 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -62.94 -30.76 71.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.779 -0.823 . . . . 73.12 108.779 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.39 -1.4 33.25 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 127.653 2.381 . . . . 73.15 114.121 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.1 tp -47.75 137.44 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.663 1.185 . . . . 73.42 113.29 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 p -115.43 150.01 37.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.464 1.506 . . . . 74.23 108.173 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.77 69.79 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.021 0.528 . . . . 61.13 110.722 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.51 -37.32 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 109.389 -0.597 . . . . 75.4 109.389 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.23 -43.26 82.43 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.061 -1.088 . . . . 61.24 108.061 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.08 -50.47 71.85 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.93 -0.396 . . . . 75.11 109.93 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -54.34 -50.22 67.92 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.587 1.155 . . . . 74.11 108.573 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -60.0 -41.78 92.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.555 1.142 . . . . 74.22 111.021 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -31.18 71.19 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 114.87 1.433 . . . . 71.21 114.87 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.27 9.72 33.86 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.013 0.525 . . . . 74.34 112.36 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -51.81 -43.73 63.21 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.504 1.522 . . . . 74.24 113.309 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -71.73 -25.83 62.23 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.122 0.569 . . . . 72.24 112.117 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.01 -30.02 20.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.182 0.593 . . . . 72.22 109.976 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 56.59 81.41 0.26 Allowed Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 127.946 2.498 . . . . 73.3 112.508 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -68.95 161.37 46.04 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.252 1.968 . . . . 71.42 110.616 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -91.9 -33.4 14.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.686 1.194 . . . . 74.41 109.535 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -138.39 151.36 47.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.196 0.999 . . . . 65.53 110.691 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.8 mt -143.21 121.75 7.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.972 -0.751 . . . . 71.33 108.972 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.7 128.79 25.44 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.055 -1.832 . . . . 72.14 106.055 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -115.84 116.78 28.61 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.323 1.849 . . . . 74.23 106.965 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -110.8 86.49 2.32 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.799 -1.926 . . . . 72.21 105.799 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.31 -19.08 31.88 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 113.475 0.917 . . . . 73.4 113.475 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.41 -28.19 12.12 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.841 2.056 . . . . 71.13 111.622 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -132.67 3.19 3.81 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.471 1.508 . . . . 74.51 109.506 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.74 54.6 36.56 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 126.871 2.177 . . . . 74.23 110.133 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 pt -137.29 155.51 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.897 1.279 . . . . 73.14 109.634 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.6 155.24 50.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.551 1.541 . . . . 63.33 109.047 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -125.28 118.67 26.49 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.981 -1.859 . . . . 75.43 105.981 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.03 104.81 10.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.379 -1.341 . . . . 63.04 107.379 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -84.46 156.8 21.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.726 0.81 . . . . 73.4 108.938 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -143.01 143.84 32.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.264 -1.754 . . . . 74.55 106.264 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -102.01 110.46 22.43 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.535 -0.913 . . . . 74.23 108.535 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.33 -27.16 64.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.691 1.196 . . . . 74.01 111.141 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.9 -33.34 75.11 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.393 -0.965 . . . . 75.4 108.393 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -61.96 -23.36 66.33 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 116.504 -1.713 . . . . 75.2 113.932 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -166.01 96.95 0.62 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.497 1.499 . . . . 72.54 110.771 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -31.9 38.46 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 117.328 2.344 . . . . 74.5 117.328 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -118.18 -9.85 10.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.603 1.547 . . . . 70.33 113.312 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.99 -17.66 34.33 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.256 -1.302 . . . . 64.32 110.759 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.4 tp -58.63 -38.85 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.954 1.877 . . . . 75.41 107.63 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -55.42 -61.28 2.44 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.182 1.793 . . . . 74.33 107.07 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -51.01 -49.44 60.45 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 121.944 -0.472 . . . . 74.34 111.491 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -54.31 -48.37 71.4 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.174 0.59 . . . . 62.2 110.448 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.7 mtm -65.68 -41.4 92.48 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 119.031 -0.509 . . . . 74.44 110.493 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -47.13 86.52 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.431 1.014 . . . . 73.23 110.266 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 mt -60.0 -39.64 80.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.701 1.2 . . . . 73.23 108.683 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.69 -41.16 72.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.419 -0.586 . . . . 74.34 109.419 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.5 mt -63.88 -34.36 77.76 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.928 0.891 . . . . 73.31 110.988 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.2 mt -63.33 -9.57 12.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.191 0.996 . . . . 75.53 111.729 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -85.87 -2.8 58.61 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.615 1.098 . . . . 72.12 110.186 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -64.21 118.91 9.28 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.092 -1.447 . . . . 74.41 107.092 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.45 ' O ' ' HE2' ' A' ' 73' ' ' LYS . . . 84.85 6.64 85.03 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-O 117.006 -1.997 . . . . 64.11 114.248 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.9 p -78.26 163.18 25.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 121.112 2.456 . . . . 75.34 107.731 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.403 ' HG ' ' HE3' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -101.4 108.21 19.75 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.06 -1.089 . . . . 72.43 108.06 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -113.98 121.42 43.86 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 126.307 1.843 . . . . 72.54 107.434 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt 47.44 44.64 16.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.552 1.141 . . . . 72.12 113.074 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 69.37 18.19 8.0 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.289 2.236 . . . . 74.21 114.604 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -125.93 124.14 40.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.98 0.912 . . . . 72.21 108.557 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 66' ' ' GLY . 1.3 ttmt -75.02 114.81 13.93 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 101.815 -3.402 . . . . 72.31 101.815 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.3 pt -96.11 169.62 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.265 0.839 . . . . 65.52 113.265 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -121.43 148.09 44.88 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.819 1.647 . . . . 64.33 108.685 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.3 t -142.15 138.97 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.457 1.103 . . . . 72.32 109.053 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -159.99 176.26 12.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.772 2.029 . . . . 75.53 109.232 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.65 151.67 22.77 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.901 -1.125 . . . . 74.04 109.905 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.9 t -140.84 81.3 1.79 Allowed 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 105.22 -2.141 . . . . 74.12 105.22 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 p -174.54 164.38 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.655 -2.35 . . . . 73.32 104.655 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.21 156.54 27.8 Favored Glycine 0 N--CA 1.45 -0.43 0 O-C-N 121.008 -1.057 . . . . 62.23 111.32 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.215 0 C-N-CA 125.518 1.532 . . . . 72.0 110.201 179.819 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.729 0 N-CA-C 111.11 -0.796 . . . . 71.3 111.11 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -71.75 -4.96 30.63 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.644 1.178 . . . . 73.42 113.206 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.28 128.89 35.16 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.474 -0.766 . . . . 75.1 110.709 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -91.62 165.23 13.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.393 1.477 . . . . 75.02 107.977 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mt -134.97 148.16 29.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.136 1.374 . . . . 74.52 108.96 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.4 136.69 47.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.764 1.625 . . . . 72.04 107.353 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -106.34 117.08 33.1 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.912 1.285 . . . . 74.15 108.253 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 t -122.02 136.37 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.11 -1.07 . . . . 64.31 108.11 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.2 169.7 26.22 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 119.858 1.208 . . . . 71.32 111.477 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 74' ' ' ILE . 7.2 t 82.9 17.09 0.31 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 128.441 2.696 . . . . 74.32 109.766 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mp -53.62 152.09 9.92 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 124.61 1.164 . . . . 74.34 112.591 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -52.54 148.66 26.33 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.958 2.439 . . . . 75.52 111.106 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -59.9 -31.73 70.08 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.785 -0.572 . . . . 75.24 111.083 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -113.63 33.41 5.18 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.123 1.369 . . . . 54.12 111.747 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.68 143.08 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.97 -1.122 . . . . 64.32 107.97 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.36 147.66 46.0 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.426 -0.953 . . . . 73.34 108.426 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.18 68.73 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 117.961 -1.019 . . . . 54.52 111.179 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -62.96 -35.49 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 119.793 1.179 . . . . 71.12 109.509 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -66.46 -48.19 70.71 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.678 -0.86 . . . . 72.44 108.678 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.4 mt -59.91 -52.15 66.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.638 0.775 . . . . 74.43 109.01 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -57.72 -36.48 72.07 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.438 1.495 . . . . 73.32 109.796 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -75.95 -46.24 30.8 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.234 1.414 . . . . 74.32 112.849 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -35.91 81.91 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.632 0.773 . . . . 73.33 111.978 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -97.84 0.28 46.43 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.282 0.845 . . . . 75.35 113.282 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -50.99 -40.97 59.32 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.859 1.664 . . . . 73.45 112.567 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -66.79 -49.33 66.2 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.238 -0.653 . . . . 64.13 109.238 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 p -66.38 -17.15 64.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.789 1.236 . . . . 73.41 112.852 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.8 t 47.55 77.14 0.48 Allowed Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.658 1.583 . . . . 63.05 113.711 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.54 163.76 33.65 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.44 2.76 . . . . 71.41 110.652 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.6 -41.66 17.6 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.73 1.212 . . . . 72.32 108.426 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.33 162.12 40.7 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.641 1.176 . . . . 71.43 108.079 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.3 mt -135.52 128.5 47.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 126.182 1.793 . . . . 74.12 107.793 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -141.12 104.4 4.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.744 1.218 . . . . 74.12 109.359 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.29 125.28 37.81 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.937 -1.505 . . . . 72.42 106.937 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -118.82 91.53 3.58 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.349 1.059 . . . . 74.5 108.854 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.11 -20.94 64.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.203 1.001 . . . . 74.34 110.551 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.07 -32.34 21.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.949 2.1 . . . . 73.15 110.084 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -131.98 3.6 4.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.951 1.7 . . . . 74.12 111.966 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.29 34.8 90.94 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 119.66 1.118 . . . . 54.23 111.929 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.7 pp -124.87 171.3 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.289 1.435 . . . . 73.13 110.249 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.12 163.89 33.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.848 0.859 . . . . 72.12 111.031 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -130.49 135.49 48.01 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.398 1.479 . . . . 72.53 107.866 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -142.28 111.63 6.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.124 -1.435 . . . . 70.22 107.124 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.2 159.48 21.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.149 -1.056 . . . . 75.14 108.149 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -144.43 104.47 4.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.047 1.339 . . . . 70.53 107.426 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.69 110.0 5.96 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.644 1.178 . . . . 71.53 112.228 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.71 72.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.506 0.928 . . . . 73.32 113.506 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -75.11 -24.29 58.05 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.21 0.914 . . . . 75.24 111.954 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -61.38 -30.72 70.72 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.498 -0.751 . . . . 65.15 110.302 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -157.0 84.02 0.94 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.976 -0.75 . . . . 73.04 108.976 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -52.47 -38.51 59.51 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.553 0.575 . . . . 73.02 112.553 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.0 -4.77 57.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 113.983 1.105 . . . . 74.22 113.983 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.1 -14.32 4.62 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.148 -1.362 . . . . 63.15 115.024 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.5 tp -51.72 -43.69 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 120.21 2.005 . . . . 73.12 110.886 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -57.05 -51.3 69.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.9 -1.148 . . . . 75.42 107.9 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -57.06 -48.86 77.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.206 1.002 . . . . 74.54 109.318 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.7 mtt85 -52.07 -51.97 54.24 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.656 0.662 . . . . 74.5 109.872 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 21.4 mtm -62.94 -39.61 95.14 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 119.096 -0.478 . . . . 75.33 110.771 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -49.96 75.42 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.297 1.039 . . . . 73.33 110.24 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.37 -39.36 78.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.597 1.159 . . . . 70.35 108.504 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.49 -40.38 70.26 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.324 0.511 . . . . 74.42 110.353 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.11 -38.82 92.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.338 1.055 . . . . 74.33 110.375 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.98 -2.44 1.23 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.719 1.608 . . . . 75.3 113.853 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -92.32 1.17 57.39 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.939 0.79 . . . . 63.12 110.852 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.62 115.3 4.59 Favored 'General case' 0 C--N 1.338 0.078 0 O-C-N 120.279 -1.513 . . . . 63.44 111.054 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.2 4.6 74.14 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 118.291 -1.283 . . . . 74.51 111.955 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.6 p -68.27 157.95 34.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.216 1.508 . . . . 74.14 109.65 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 mt -102.71 111.4 23.69 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.243 -1.392 . . . . 72.35 107.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -116.25 116.17 27.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.31 -1.367 . . . . 74.2 107.31 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt 49.88 53.44 12.79 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.793 1.237 . . . . 74.41 111.68 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 57.62 30.58 19.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.257 1.823 . . . . 74.21 113.838 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.21 118.02 13.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.313 1.445 . . . . 73.44 108.44 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -76.03 140.39 41.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.116 -1.809 . . . . 73.21 106.116 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.465 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 11.8 pt -126.63 170.08 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.438 1.086 . . . . 73.13 112.866 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.44 157.13 37.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.195 1.398 . . . . 73.1 110.699 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.0 t -136.87 148.55 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 125.275 1.43 . . . . 72.35 108.938 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.0 174.59 10.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.979 2.512 . . . . 74.45 109.175 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.22 152.0 20.07 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.433 1.093 . . . . 74.25 109.959 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 t -140.13 82.44 1.86 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.72 -1.215 . . . . 63.42 107.72 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.0 p -166.82 -39.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 123.499 0.72 . . . . 74.54 109.446 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.74 -52.64 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 CA-C-O 118.87 -0.961 . . . . 73.24 111.448 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 N-CA-C 106.513 -2.635 . . . . 50.41 106.513 -179.596 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.349 0 N-CA-C 111.371 -0.691 . . . . 75.33 111.371 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -151.54 45.31 0.79 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.731 1.613 . . . . 73.22 108.567 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 -134.73 131.83 38.09 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.935 -1.135 . . . . 63.12 107.935 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -95.04 162.86 13.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.721 -1.585 . . . . 55.22 106.721 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 mt -134.23 149.01 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.534 0.683 . . . . 74.44 109.715 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.9 t -121.06 115.06 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 105.949 -1.871 . . . . 74.12 105.949 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -84.61 139.03 32.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.54 -2.393 . . . . 75.32 104.54 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.74 136.57 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.746 -1.946 . . . . 64.04 105.746 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -141.83 -178.4 17.92 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 119.718 1.145 . . . . 70.13 110.596 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.44 13.06 9.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.14 1.776 . . . . 71.13 112.628 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.8 148.61 26.27 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.565 1.546 . . . . 73.41 112.603 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.44 150.71 87.77 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.893 2.395 . . . . 75.02 110.365 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -53.58 -45.75 70.08 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.135 0.974 . . . . 75.21 110.718 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.02 18.53 5.72 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.248 1.573 . . . . 74.2 115.248 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.5 tp -44.98 137.21 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 119.902 1.228 . . . . 74.01 111.968 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 p -115.96 150.52 37.03 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.293 1.437 . . . . 75.21 109.236 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.71 -29.63 70.83 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-O 119.13 -0.462 . . . . 74.33 110.647 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.48 -38.35 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 118.443 0.565 . . . . 74.31 109.581 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.42 -38.14 84.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.088 0.858 . . . . 73.2 109.125 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.77 -54.46 31.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.107 -0.701 . . . . 71.05 109.107 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -54.81 -46.56 74.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.123 0.969 . . . . 74.11 109.097 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -62.77 -41.22 99.15 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 114.378 1.251 . . . . 75.33 114.378 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -46.56 69.84 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.056 -1.028 . . . . 71.22 110.493 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -86.09 3.06 44.21 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.057 1.132 . . . . 72.0 114.057 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -53.43 -40.63 65.32 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.538 -1.351 . . . . 74.42 110.69 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -70.59 -31.38 68.35 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.926 1.69 . . . . 74.24 112.174 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 p -89.49 -11.21 43.61 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 117.913 -1.042 . . . . 71.24 112.459 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m 48.58 70.44 2.08 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 115.445 1.646 . . . . 73.53 115.445 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.94 161.4 46.1 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.961 2.441 . . . . 74.01 111.682 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -91.55 -39.5 11.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.05 1.74 . . . . 71.34 107.649 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -135.35 158.19 44.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.698 1.199 . . . . 75.44 110.748 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.6 mt -145.79 126.3 6.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.341 -1.726 . . . . 62.24 106.341 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -140.27 105.93 5.13 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.985 1.314 . . . . 74.42 109.833 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -92.76 121.16 33.87 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.313 1.045 . . . . 75.04 110.241 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -118.88 81.7 1.74 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.941 -1.133 . . . . 74.22 107.941 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.63 -21.63 60.72 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.217 1.007 . . . . 64.45 111.096 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.74 -20.21 7.93 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.953 1.701 . . . . 64.14 112.346 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -132.37 -4.1 3.4 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.702 1.601 . . . . 75.41 109.447 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.32 41.77 51.69 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.207 -1.557 . . . . 70.5 109.207 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.463 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 40.5 pt -132.86 171.82 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 124.537 1.135 . . . . 75.44 110.678 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.87 165.6 34.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.739 1.615 . . . . 65.31 109.187 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -135.22 142.3 45.99 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.552 1.941 . . . . 65.13 106.219 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -142.9 114.08 7.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.28 -1.378 . . . . 74.41 107.28 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.3 155.98 19.02 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.551 -1.648 . . . . 72.12 106.551 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -145.1 114.02 6.89 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.275 1.83 . . . . 75.41 109.187 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -72.01 112.77 8.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.776 1.028 . . . . 71.35 113.776 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.95 -16.26 61.54 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.427 1.491 . . . . 74.43 112.789 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.62 -22.51 27.94 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.058 0.845 . . . . 75.34 109.57 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -61.62 -43.93 97.94 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 120.952 -1.092 . . . . 64.54 109.697 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -145.44 89.21 1.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.512 0.596 . . . . 72.21 110.755 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -37.57 48.92 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 114.358 1.244 . . . . 75.32 114.358 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.8 p -97.15 -19.85 18.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.221 1.373 . . . . 72.24 112.381 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.49 -16.29 43.56 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 117.65 -1.639 . . . . 52.21 114.911 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.42 -37.3 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.799 2.3 . . . . 71.04 109.366 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -60.84 -60.93 3.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.632 -1.247 . . . . 73.14 107.632 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -50.79 -44.22 58.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 118.614 -0.708 . . . . 74.52 110.628 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -56.42 -49.98 72.98 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.939 -0.763 . . . . 72.14 108.939 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.2 mtm -58.68 -47.71 83.57 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 124.204 1.002 . . . . 73.23 109.447 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -53.76 50.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.997 1.719 . . . . 74.45 111.837 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.6 mt -61.27 -37.01 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.804 1.242 . . . . 75.41 108.937 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.36 -41.44 63.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.434 -0.58 . . . . 71.52 109.434 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.39 -34.95 78.85 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.915 1.286 . . . . 75.12 111.241 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.8 mt -65.81 -9.77 31.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.044 0.938 . . . . 74.4 111.889 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -85.76 -1.68 57.46 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.128 0.876 . . . . 65.41 110.418 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -62.76 111.9 2.3 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.883 1.674 . . . . 74.2 109.673 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.74 7.25 53.68 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.619 1.104 . . . . 64.41 112.945 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.1 p -66.08 146.85 54.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.528 1.664 . . . . 64.44 109.121 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.6 mt -93.08 121.21 34.19 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.547 -2.39 . . . . 62.52 104.547 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.8 120.05 28.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.996 1.318 . . . . 73.23 108.152 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt 48.39 40.48 14.79 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.22 1.408 . . . . 75.13 112.561 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 70.48 29.35 3.47 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 128.519 2.728 . . . . 62.33 113.913 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -136.15 120.71 18.26 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 126.551 1.94 . . . . 74.34 108.772 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -73.61 138.33 44.8 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 105.636 -1.987 . . . . 75.05 105.636 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 pt -119.5 170.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 124.636 1.174 . . . . 74.1 110.695 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -123.66 158.74 30.86 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.247 1.419 . . . . 72.13 111.23 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.96 132.89 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.09 1.756 . . . . 74.35 108.862 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -148.24 160.53 42.86 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.616 1.566 . . . . 73.25 108.565 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.28 148.13 25.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.848 1.259 . . . . 71.31 109.784 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.77 155.86 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.991 1.717 . . . . 63.23 107.261 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.2 t 38.94 77.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.798 1.639 . . . . 72.31 110.745 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.71 88.42 0.07 OUTLIER Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 118.562 -1.78 . . . . 71.1 108.798 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 N-CA-C 104.31 -3.516 . . . . 75.11 104.31 -179.608 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.346 0 N-CA-C 109.966 -1.254 . . . . 73.01 109.966 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -107.85 24.2 13.3 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.851 1.26 . . . . 64.21 112.722 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -125.13 155.89 39.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.759 1.618 . . . . 73.33 109.384 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -119.03 161.38 20.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 105.81 -1.922 . . . . 72.42 105.81 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -134.68 139.41 47.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.178 1.391 . . . . 75.44 110.261 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.75 141.56 27.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 106.971 -1.492 . . . . 74.34 106.971 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -103.79 133.19 49.2 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.31 -2.107 . . . . 72.43 105.31 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.2 t -136.79 130.6 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.731 -1.952 . . . . 72.34 105.731 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.95 179.92 21.74 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 121.348 1.885 . . . . 65.44 115.041 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.82 17.15 2.32 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.162 2.585 . . . . 74.41 111.399 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.76 146.23 99.05 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 125.023 1.329 . . . . 74.12 112.765 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -67.07 167.76 19.13 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.681 2.921 . . . . 75.13 112.119 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -75.0 -34.64 61.97 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.297 -1.001 . . . . 75.3 108.297 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.6 11.62 3.65 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.149 1.38 . . . . 62.22 112.172 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.465 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 8.7 tp -54.77 143.61 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 120.679 -1.263 . . . . 72.43 109.31 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 p -128.11 148.25 50.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.445 1.098 . . . . 71.42 110.074 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.95 -29.63 70.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.209 -0.9 . . . . 74.33 110.652 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.65 -38.21 81.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 119.069 0.85 . . . . 75.2 109.782 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -71.48 -43.11 67.19 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.022 -0.732 . . . . 75.43 109.022 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.51 -49.64 75.91 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.34 1.056 . . . . 74.31 111.253 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -59.39 -42.14 91.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.629 0.772 . . . . 75.13 109.178 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -68.79 -40.88 79.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.385 1.474 . . . . 74.31 113.535 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -41.28 91.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 118.739 0.699 . . . . 72.24 111.978 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -99.75 4.74 45.56 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.82 1.044 . . . . 70.24 113.82 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -51.19 -47.54 62.18 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.067 1.347 . . . . 72.51 109.896 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.06 -39.9 79.64 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.633 0.773 . . . . 74.32 111.838 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 p -81.87 -10.76 59.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.732 1.213 . . . . 75.2 112.794 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.64 65.95 6.38 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 114.965 1.468 . . . . 74.24 114.965 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -64.91 151.86 84.32 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.751 2.301 . . . . 64.54 108.897 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.68 -48.49 8.24 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.077 -1.083 . . . . 63.3 108.077 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' NE2' ' H ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -124.5 153.88 41.38 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.258 -1.016 . . . . 75.23 108.258 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.473 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 65.3 mt -145.92 119.83 2.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.425 -1.694 . . . . 74.43 106.425 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.43 108.22 10.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.733 -1.58 . . . . 74.34 106.733 178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -93.59 125.93 38.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.746 -1.576 . . . . 73.24 106.746 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -118.24 89.69 3.18 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.426 -2.064 . . . . 75.34 105.426 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.15 -16.41 52.56 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.148 -0.453 . . . . 64.55 111.417 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -50.48 -40.08 50.0 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.246 2.219 . . . . 75.23 111.034 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -126.84 6.56 6.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.853 1.661 . . . . 74.31 110.174 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.12 42.63 99.73 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.313 -1.115 . . . . 74.4 110.313 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.7 162.31 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.856 1.263 . . . . 74.31 109.37 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.75 152.23 40.06 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.126 0.971 . . . . 64.3 109.527 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -120.31 135.25 55.08 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 103.958 -2.608 . . . . 74.13 103.958 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.53 122.99 25.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.158 -1.793 . . . . 72.23 106.158 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -96.6 150.71 20.35 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.188 -1.412 . . . . 71.51 107.188 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -142.13 110.68 6.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.388 -1.338 . . . . 75.12 107.388 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -76.25 118.19 18.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.645 0.778 . . . . 71.23 109.302 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.76 -18.88 50.03 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 128.025 2.53 . . . . 75.54 112.344 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.5 -30.33 52.94 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.479 -1.674 . . . . 73.05 106.479 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -61.73 -37.5 84.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.696 1.198 . . . . 70.33 112.348 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -147.94 97.92 2.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.297 0.953 . . . . 73.51 108.876 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -51.46 -31.52 23.59 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 115.894 -2.003 . . . . 74.21 116.315 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.79 -20.59 8.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 121.021 1.737 . . . . 73.2 111.287 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.42 -30.7 66.54 Favored Glycine 0 C--N 1.338 0.66 0 O-C-N 121.015 -1.053 . . . . 71.33 110.835 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.7 tp -49.76 -41.95 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.388 1.094 . . . . 73.41 112.055 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -68.23 -61.34 1.89 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.222 0.609 . . . . 74.52 110.342 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -56.15 -30.84 62.74 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.93 -0.481 . . . . 75.32 111.331 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.3 mtt85 -68.44 -41.16 80.7 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.01 -1.056 . . . . 74.32 108.741 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.0 mtm -64.55 -44.09 91.9 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 107.163 -1.421 . . . . 73.12 107.163 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -56.5 -48.24 77.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.948 0.899 . . . . 74.43 109.048 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.58 -41.38 87.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.137 0.975 . . . . 73.5 109.848 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.27 84.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.448 -0.575 . . . . 75.2 109.448 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.28 -32.55 74.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.828 0.851 . . . . 73.31 110.245 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.3 mt -65.28 -13.04 57.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 118.795 -0.621 . . . . 72.14 110.951 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -86.49 3.93 41.97 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.932 0.787 . . . . 65.21 110.262 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -69.53 112.71 6.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.083 -1.636 . . . . 74.41 107.842 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.65 -3.93 85.05 Favored Glycine 0 C--O 1.225 -0.447 0 CA-C-O 116.436 -2.313 . . . . 75.4 111.893 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -64.87 137.73 57.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 121.44 2.62 . . . . 74.34 107.138 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.49 126.28 30.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.027 -1.842 . . . . 75.34 106.027 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.7 tp -129.82 122.9 29.65 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 105.364 -2.088 . . . . 75.31 105.364 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 6.0 mtpm? 51.37 44.85 28.69 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.768 1.627 . . . . 74.23 111.359 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 57.83 33.89 23.74 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 127.644 2.378 . . . . 72.01 113.193 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -134.46 128.54 33.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 126.039 1.736 . . . . 73.34 108.137 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -78.52 112.15 15.29 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 103.534 -2.765 . . . . 74.44 103.534 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.8 pt -104.56 169.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 118.137 0.426 . . . . 75.51 110.359 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -121.64 158.7 28.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.286 1.034 . . . . 74.33 111.236 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -146.21 143.63 21.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.846 1.258 . . . . 74.12 108.048 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -162.07 161.13 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.647 1.579 . . . . 72.24 108.863 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.67 152.18 22.78 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.916 1.286 . . . . 74.41 109.109 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 p -150.14 144.15 25.51 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.797 1.239 . . . . 72.43 108.603 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.8 t 59.49 79.13 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.254 1.422 . . . . 75.53 112.272 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.32 24.94 0.07 OUTLIER Glycine 0 CA--C 1.523 0.592 0 O-C-N 120.805 -1.184 . . . . 54.45 112.61 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 N-CA-C 108.106 -1.998 . . . . 64.34 108.106 179.921 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.842 0 N-CA-C 111.173 -0.771 . . . . 53.24 111.173 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.04 51.9 0.84 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.55 1.175 . . . . 74.31 111.548 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -155.8 159.06 39.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 120.967 -1.083 . . . . 75.52 110.74 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -130.21 158.8 38.75 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 129.786 3.234 . . . . 73.13 105.196 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.4 mt -130.36 149.32 33.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.832 0.825 . . . . 71.22 109.338 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 t -108.9 127.14 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 125.798 1.639 . . . . 74.42 107.421 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -91.45 128.32 37.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.537 -2.394 . . . . 75.05 104.537 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.84 129.55 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.462 -1.681 . . . . 75.34 106.462 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.72 -175.72 14.44 Favored Glycine 0 N--CA 1.468 0.814 0 CA-C-N 120.317 1.417 . . . . 75.4 113.09 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 72.21 14.45 5.56 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.217 2.207 . . . . 74.24 111.543 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.26 149.59 82.3 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 125.232 1.413 . . . . 73.14 112.334 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.98 165.15 31.05 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.282 2.655 . . . . 72.45 110.036 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.19 -31.52 58.51 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.219 1.008 . . . . 75.21 109.494 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -85.35 10.89 11.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.303 1.441 . . . . 75.41 113.467 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.488 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 8.6 tp -57.61 138.97 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.488 1.115 . . . . 73.34 111.69 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 p -128.32 153.4 47.05 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.184 0.994 . . . . 74.3 109.738 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.36 -33.31 65.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.446 1.898 . . . . 71.34 111.366 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.8 p -66.14 -37.7 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 119.126 -0.464 . . . . 72.33 110.113 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.79 -43.39 72.22 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.392 -0.966 . . . . 73.24 108.392 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -60.36 -55.63 31.24 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 125.276 1.43 . . . . 73.33 110.069 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -57.63 -45.06 85.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.037 -0.727 . . . . 74.3 109.037 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -60.34 -44.1 95.83 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 65.11 112.813 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -47.98 74.89 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 119.419 1.009 . . . . 74.41 110.825 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -83.01 1.02 42.09 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 115.362 1.615 . . . . 74.53 115.362 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -51.26 -41.57 60.49 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.223 1.409 . . . . 74.32 113.382 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -32.75 74.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.885 0.874 . . . . 75.32 110.666 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 88.1 p -87.16 -28.76 22.25 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.255 1.206 . . . . 71.23 114.255 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.4 t 62.81 75.21 0.42 Allowed Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.53 1.932 . . . . 72.41 112.358 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -67.33 159.97 49.86 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.934 3.09 . . . . 63.51 110.719 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -85.63 -46.47 10.74 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.871 1.668 . . . . 72.14 108.009 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.56 157.21 44.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.902 -0.59 . . . . 73.42 109.598 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.6 mt -137.93 128.46 36.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 125.028 1.331 . . . . 75.25 108.875 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 103.39 5.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.35 -1.352 . . . . 74.15 107.35 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -88.62 111.73 22.25 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.95 -1.5 . . . . 73.32 106.95 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -105.28 80.22 1.57 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.079 -1.452 . . . . 74.34 107.079 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.66 -27.97 43.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.977 0.911 . . . . 74.31 111.246 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -51.09 -27.9 9.32 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 127.515 2.326 . . . . 70.3 113.904 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -132.65 9.96 4.31 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.888 1.275 . . . . 74.53 111.093 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.14 42.7 99.87 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.795 1.188 . . . . 71.24 110.619 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.54 166.05 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 C-N-CA 124.816 1.246 . . . . 73.24 111.482 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.31 148.77 36.84 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.328 2.251 . . . . 72.1 108.239 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -124.16 129.39 50.74 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.961 -1.866 . . . . 75.34 105.961 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.11 114.13 15.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.209 -1.034 . . . . 71.32 108.209 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -92.66 155.04 17.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.745 -1.946 . . . . 64.22 105.745 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -140.02 137.22 34.46 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.629 -1.619 . . . . 74.34 106.629 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -81.7 110.19 16.81 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.944 1.247 . . . . 73.43 109.444 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.59 -16.99 62.9 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.631 1.172 . . . . 73.3 112.273 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.69 -18.38 29.66 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.997 0.817 . . . . 73.32 110.777 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -60.98 -35.61 77.24 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.157 0.889 . . . . 75.42 110.357 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -150.14 86.71 1.43 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.922 -1.881 . . . . 74.4 105.922 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -49.75 -37.36 29.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.471 1.108 . . . . 75.52 112.226 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 -3.1 39.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.257 1.423 . . . . 72.23 113.578 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.06 -19.75 5.84 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 124.923 1.249 . . . . 74.21 114.788 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 tp -52.83 -36.99 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.42 1.61 . . . . 65.32 111.461 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -56.42 -54.84 40.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.846 1.259 . . . . 71.01 108.398 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -47.03 79.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.34 1.056 . . . . 74.14 109.793 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -54.74 -46.59 74.3 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 118.727 -0.654 . . . . 75.01 109.273 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 2.7 mtm -61.33 -50.88 71.16 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 108.173 -1.047 . . . . 73.54 108.173 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.04 -52.52 8.87 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.796 2.038 . . . . 74.14 111.836 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.0 mt -59.08 -41.9 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.199 1.4 . . . . 71.32 110.091 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.32 -36.82 61.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.159 0.984 . . . . 71.13 111.058 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -66.96 -36.08 81.41 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.642 1.11 . . . . 74.31 109.586 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.68 -12.73 11.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.568 1.147 . . . . 74.35 111.512 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -84.61 5.02 29.59 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.871 0.759 . . . . 64.03 110.278 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -69.07 113.92 6.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.285 -1.746 . . . . 72.23 106.285 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.28 6.23 61.56 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.282 -1.288 . . . . 70.42 113.458 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.5 p -68.07 143.56 55.44 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 120.482 2.141 . . . . 74.51 108.607 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 15.2 mt -88.71 107.6 19.03 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 103.174 -2.899 . . . . 74.44 103.174 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.9 tp -113.0 117.5 32.21 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.715 -1.587 . . . . 64.0 106.715 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 14.3 mtpp 47.05 56.1 7.22 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.883 0.873 . . . . 73.41 111.891 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 60.95 23.38 13.5 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.856 1.662 . . . . 72.45 114.789 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -132.41 126.67 33.67 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 124.685 1.194 . . . . 73.31 108.757 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -80.1 114.3 18.9 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 104.067 -2.568 . . . . 75.55 104.067 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.2 pt -94.96 169.24 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 118.436 0.562 . . . . 72.25 109.984 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -122.99 158.59 30.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.01 1.324 . . . . 72.34 110.861 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.0 t -142.52 126.44 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 126.009 1.723 . . . . 74.41 108.797 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -139.03 174.47 10.48 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.475 1.51 . . . . 74.32 108.156 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.46 151.78 18.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.152 -0.967 . . . . 74.51 110.124 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 t -152.64 132.17 13.01 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.249 -1.389 . . . . 63.22 107.249 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.0 t 68.15 113.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.681 1.592 . . . . 75.02 112.715 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.79 6.47 40.4 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.564 1.078 . . . . 70.32 113.746 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 N-CA-C 104.397 -3.481 . . . . 51.45 104.397 179.196 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 N-CA-C 110.998 -0.841 . . . . 73.33 110.998 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -76.35 16.68 0.44 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.556 1.317 . . . . 74.15 114.556 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -138.28 138.43 38.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 121.116 1.78 . . . . 73.31 108.384 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -128.55 157.71 40.46 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.778 1.631 . . . . 75.34 107.233 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -134.91 146.01 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.361 1.065 . . . . 64.25 110.02 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.8 126.44 57.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.62 -1.993 . . . . 72.15 105.62 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -96.58 105.14 17.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.594 -1.632 . . . . 74.23 106.594 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -113.66 139.35 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 120.027 1.285 . . . . 73.43 108.675 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -149.06 178.31 26.7 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 119.928 1.24 . . . . 62.44 112.663 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 84.99 6.3 0.5 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.405 3.082 . . . . 74.21 111.833 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp -46.24 148.67 1.49 Allowed Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 127.339 2.256 . . . . 73.03 115.392 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.86 175.28 7.55 Favored 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.98 4.453 . . . . 73.14 113.379 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mmt-85 -78.47 -45.44 22.08 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 107.898 -1.149 . . . . 75.45 107.898 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -84.25 22.02 1.3 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.031 1.733 . . . . 73.42 112.889 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.7 tp -61.93 142.25 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.628 -1.249 . . . . 71.45 107.628 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.99 150.01 50.58 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.376 -0.972 . . . . 72.32 108.376 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -32.39 70.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.848 -0.797 . . . . 75.42 108.848 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.01 -49.08 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.138 1.375 . . . . 74.25 109.868 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.46 -34.75 74.84 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.01 -0.676 . . . . 73.42 109.215 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.12 -49.85 72.77 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.943 0.792 . . . . 75.03 109.436 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -59.92 -37.78 80.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.828 -0.606 . . . . 74.45 110.501 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -69.59 -50.82 40.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.394 0.677 . . . . 61.42 110.764 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -24.11 67.7 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 120.971 -1.081 . . . . 74.24 112.213 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -108.54 8.79 27.39 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.88 1.218 . . . . 70.35 111.712 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -61.27 -26.72 67.96 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 120.107 -1.62 . . . . 74.44 114.062 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -30.1 23.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.639 1.109 . . . . 71.43 108.767 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -31.2 58.73 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.407 -0.96 . . . . 71.04 108.407 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m 60.69 72.35 0.73 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 126.674 1.99 . . . . 73.53 113.134 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.14 158.1 58.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.741 2.961 . . . . 71.44 110.465 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -78.96 -45.74 19.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.857 -1.534 . . . . 73.15 106.857 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -156.77 139.71 15.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.477 1.511 . . . . 74.51 108.48 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.14 142.19 22.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.384 -1.71 . . . . 74.54 106.384 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -135.09 103.8 5.69 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.581 -1.637 . . . . 73.33 106.581 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -86.7 121.44 29.22 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.463 -1.31 . . . . 65.45 107.463 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -108.85 82.35 1.59 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.542 -1.651 . . . . 75.03 106.542 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.56 -23.22 62.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.216 0.606 . . . . 72.3 111.347 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.95 -26.93 66.37 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.56 1.544 . . . . 74.12 111.981 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -133.17 6.6 3.89 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.693 1.197 . . . . 73.13 112.591 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.32 47.41 91.03 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 119.063 0.847 . . . . 62.03 111.287 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.402 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 2.3 pt -134.73 159.78 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.196 1.398 . . . . 73.25 108.727 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.68 135.06 21.88 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.58 1.152 . . . . 72.41 108.347 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -108.17 139.33 43.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.573 -2.01 . . . . 74.13 105.573 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.32 116.03 15.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 105.406 -2.072 . . . . 65.42 105.406 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -88.05 149.98 23.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.918 0.887 . . . . 72.14 109.711 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -140.98 123.31 15.79 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.188 1.795 . . . . 72.32 107.654 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -90.82 112.4 24.19 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.111 0.964 . . . . 73.34 110.882 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.42 -22.58 62.71 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.107 1.363 . . . . 61.45 111.74 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.93 -37.04 64.71 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.941 -1.133 . . . . 51.32 107.941 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -69.17 -38.25 78.61 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 118.687 -0.673 . . . . 74.5 109.657 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.0 75.86 1.4 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.823 0.738 . . . . 71.32 111.564 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -54.15 -39.61 66.68 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 118.837 -0.601 . . . . 74.44 111.979 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.9 p -104.26 -1.26 27.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.872 1.269 . . . . 75.23 113.449 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.43 -13.88 7.91 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-O 117.958 -1.468 . . . . 63.2 114.813 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.3 tp -51.4 -50.37 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 120.171 1.986 . . . . 74.02 112.218 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -53.33 57.02 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.331 -0.989 . . . . 62.34 108.331 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -50.59 -48.65 57.69 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.133 0.573 . . . . 73.13 111.068 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -57.01 -49.63 75.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.549 1.14 . . . . 73.11 108.719 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 43.2 mtm -64.08 -36.53 84.32 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.405 0.682 . . . . 71.41 111.345 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -55.35 -51.07 67.98 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.704 2.002 . . . . 52.53 111.65 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.47 -26.56 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.568 1.547 . . . . 65.13 109.368 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.89 -39.58 19.67 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.973 0.909 . . . . 75.02 108.927 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.31 -44.67 95.23 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.032 1.733 . . . . 74.42 110.221 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.3 mt -58.41 -6.82 0.74 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.485 1.914 . . . . 74.22 113.938 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -89.4 -3.7 58.32 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.29 0.95 . . . . 72.34 111.331 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -59.23 112.66 1.8 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.797 1.239 . . . . 72.1 108.85 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.452 ' CA ' ' HE2' ' A' ' 73' ' ' LYS . . . 91.28 3.52 69.51 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.934 -1.481 . . . . 72.34 115.009 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 p -70.6 160.77 31.91 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.618 1.709 . . . . 62.33 109.124 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 mt -109.49 108.85 19.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.307 1.443 . . . . 75.14 109.536 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.78 132.83 55.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.858 -2.275 . . . . 74.35 104.858 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.7 mttm 46.09 45.8 12.6 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.282 1.039 . . . . 75.33 111.655 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 64.32 0.12 0.99 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.685 2.794 . . . . 74.15 115.855 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -109.89 140.2 44.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.63 1.104 . . . . 74.3 109.645 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.452 ' HE2' ' CA ' ' A' ' 66' ' ' GLY . 15.8 tttm -78.95 156.16 28.64 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.47 -0.937 . . . . 73.43 108.47 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 pt -129.58 170.08 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.884 1.274 . . . . 73.03 111.003 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.25 147.98 52.03 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.156 1.783 . . . . 63.23 106.457 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.6 t -139.12 136.31 42.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 124.802 1.241 . . . . 73.15 108.333 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -147.18 171.98 14.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.149 1.78 . . . . 62.13 108.049 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.14 152.79 20.45 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.373 1.469 . . . . 64.42 108.831 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 t -156.05 147.69 22.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.886 -1.524 . . . . 72.42 106.886 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.5 t 48.93 90.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.558 1.543 . . . . 63.15 113.664 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.65 -13.69 13.22 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-O 118.762 -1.021 . . . . 73.24 112.802 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 N-CA-C 104.863 -3.295 . . . . 65.43 104.863 178.334 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.952 0 N-CA-C 110.709 -0.956 . . . . 73.33 110.709 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.86 46.41 2.62 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.873 1.269 . . . . 73.54 108.987 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 ptt-85 -139.23 156.78 46.84 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.934 -0.765 . . . . 74.11 108.934 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -123.14 160.42 26.5 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 105.179 -2.156 . . . . 75.13 105.179 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -134.68 129.64 52.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.463 1.505 . . . . 75.21 110.873 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.5 t -102.79 128.42 55.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 105.349 -2.093 . . . . 62.42 105.349 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -96.81 141.49 29.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.184 -1.784 . . . . 74.24 106.184 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -138.45 133.35 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.944 -1.873 . . . . 74.14 105.944 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.84 177.96 20.46 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 120.888 1.676 . . . . 64.42 111.791 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.422 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 0.5 OUTLIER 73.78 16.47 3.78 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.047 2.539 . . . . 54.24 111.116 -178.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.5 mp -62.54 147.63 92.07 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.445 1.498 . . . . 64.33 113.648 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -66.67 164.96 27.11 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.301 2.668 . . . . 74.23 111.329 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -76.38 -29.53 57.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 122.976 0.51 . . . . 71.24 110.742 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.09 13.51 11.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.175 0.99 . . . . 73.44 112.984 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.538 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.6 tp -59.02 138.87 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.234 1.014 . . . . 72.32 111.328 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 p -128.3 158.39 38.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.744 1.618 . . . . 74.44 109.909 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.1 -29.58 69.37 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.101 0.56 . . . . 63.51 110.348 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.21 -34.04 67.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.305 0.642 . . . . 75.43 110.228 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -73.66 -47.94 36.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.038 -1.468 . . . . 74.11 107.038 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -56.06 -46.41 78.95 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.302 1.441 . . . . 75.02 110.652 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -61.6 -36.61 81.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.521 -0.752 . . . . 74.53 110.214 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.14 -30.99 60.94 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.757 0.708 . . . . 74.41 110.877 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -68.36 -50.19 54.87 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.182 -0.949 . . . . 71.44 110.015 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -91.74 10.87 26.58 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.222 1.009 . . . . 75.1 112.825 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -35.76 63.82 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 120.681 -1.262 . . . . 75.42 110.793 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -82.6 -9.15 59.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.1 0.96 . . . . 75.13 113.533 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.17 -10.79 14.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.671 1.188 . . . . 75.34 111.586 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 t 47.24 61.78 13.03 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.58 2.352 . . . . 73.21 114.893 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.36 161.0 15.02 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.399 2.733 . . . . 73.15 111.561 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -38.86 10.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.36 1.064 . . . . 74.32 109.404 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -136.01 153.17 51.45 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.191 0.997 . . . . 73.42 108.358 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.3 mt -139.5 125.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 105.388 -2.078 . . . . 73.35 105.388 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.42 104.5 4.6 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.528 -1.286 . . . . 75.53 107.528 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -88.7 119.47 29.21 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 124.689 1.196 . . . . 75.03 108.331 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -108.69 82.45 1.61 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.026 -1.472 . . . . 73.1 107.026 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.97 -26.88 50.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.778 0.831 . . . . 73.24 111.548 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.08 -28.39 10.41 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 128.285 2.634 . . . . 72.05 112.709 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -132.92 9.16 4.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.782 1.233 . . . . 75.14 110.443 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.16 43.85 96.81 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 119.6 1.091 . . . . 51.14 110.932 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.1 pt -134.85 166.2 29.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.102 1.361 . . . . 75.13 111.247 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.49 154.37 43.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.076 1.351 . . . . 74.43 109.489 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.48 123.26 39.74 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.107 1.363 . . . . 75.04 107.387 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.5 114.77 21.71 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.321 -0.992 . . . . 75.2 108.321 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -91.21 151.07 21.09 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.919 -1.141 . . . . 74.23 107.919 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -136.74 134.26 36.93 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.672 1.589 . . . . 74.13 107.304 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.27 112.54 24.35 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.86 1.664 . . . . 74.02 111.319 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.38 -27.41 68.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.086 1.354 . . . . 74.44 111.32 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.52 -32.99 68.79 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.423 -0.322 . . . . 72.1 110.393 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -62.94 -22.82 67.06 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.79 0.723 . . . . 72.44 112.928 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -158.82 99.43 1.55 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.192 -1.41 . . . . 73.52 107.192 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -54.02 50.03 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.512 0.725 . . . . 74.11 112.463 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.84 -19.6 23.23 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.309 1.044 . . . . 72.25 110.976 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.53 -22.3 62.57 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-O 117.228 -1.873 . . . . 73.14 113.589 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.77 -40.8 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 120.532 2.166 . . . . 75.43 110.106 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.53 -58.5 6.94 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.657 -1.238 . . . . 64.55 107.657 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.1 -48.37 76.29 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.812 0.845 . . . . 72.33 111.095 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.18 -41.05 68.1 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.128 -0.693 . . . . 74.32 109.128 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 6.4 mtm -71.88 -44.45 63.73 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.332 1.053 . . . . 75.42 110.681 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -48.88 72.0 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.831 1.652 . . . . 75.54 110.575 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.74 -39.77 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.691 1.597 . . . . 74.32 108.802 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.72 75.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.876 -0.583 . . . . 74.22 109.573 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.43 -31.58 72.75 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.965 0.802 . . . . 73.13 110.493 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.4 mt -68.95 -5.13 19.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.649 -0.657 . . . . 75.34 112.092 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -89.65 -0.64 57.66 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.058 0.845 . . . . 62.34 110.453 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -66.02 113.09 4.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.026 1.73 . . . . 73.31 110.991 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.2 2.99 67.92 Favored Glycine 0 N--CA 1.459 0.233 0 CA-C-O 117.942 -1.477 . . . . 64.14 114.173 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -66.93 133.77 50.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.59 1.695 . . . . 75.53 108.369 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.6 mt -76.21 108.21 8.98 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 105.743 -1.947 . . . . 74.5 105.743 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.6 tp -115.88 119.6 36.5 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.675 -1.602 . . . . 71.52 106.675 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 17.3 mtpp 49.21 50.44 17.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.741 1.616 . . . . 63.4 112.368 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 64.28 24.99 13.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.172 2.189 . . . . 71.31 113.576 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 10' ' ' SER . 15.0 mmmt -131.77 124.44 29.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.62 1.168 . . . . 74.25 110.647 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 tptm -79.83 105.77 11.36 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 101.7 -3.444 . . . . 75.42 101.7 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.3 pt -95.63 169.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 124.006 0.922 . . . . 75.34 108.685 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -127.17 158.97 35.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.796 1.238 . . . . 75.23 111.52 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.0 t -137.06 139.22 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 126.526 1.931 . . . . 73.53 107.191 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -149.67 162.74 39.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.674 1.189 . . . . 71.41 108.127 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 147.55 25.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.469 1.108 . . . . 74.12 109.291 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 p -148.46 130.36 15.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 117.912 -1.042 . . . . 74.51 108.748 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.8 t 70.53 160.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 126.124 1.77 . . . . 72.12 110.786 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.28 62.54 0.01 OUTLIER Glycine 0 C--O 1.237 0.282 0 N-CA-C 107.557 -2.217 . . . . 75.33 107.557 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 N-CA-C 105.359 -3.096 . . . . 73.15 105.359 -179.224 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 109.002 -1.639 . . . . 61.31 109.002 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -67.06 1.26 2.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.18 1.49 . . . . 73.22 114.978 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.63 107.82 7.7 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.578 1.081 . . . . 73.14 112.018 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -100.16 157.31 16.67 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 128.21 2.604 . . . . 74.41 107.125 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mt -135.41 149.19 28.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 124.696 1.198 . . . . 74.14 108.082 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.1 t -116.65 127.49 74.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 105.768 -1.938 . . . . 73.24 105.768 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -94.75 139.32 31.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.374 -1.713 . . . . 72.43 106.374 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 t -139.26 132.49 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.327 -1.731 . . . . 72.23 106.327 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.62 -178.19 17.55 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 120.095 1.316 . . . . 61.22 111.63 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.03 10.68 4.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.599 2.36 . . . . 73.44 111.344 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mp -54.27 144.94 38.48 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 125.487 1.515 . . . . 72.11 112.695 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -67.65 157.76 60.28 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.352 2.035 . . . . 74.42 110.26 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -65.57 -43.23 90.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.91 -1.145 . . . . 74.25 107.91 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.64 13.34 0.64 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.352 2.261 . . . . 63.45 112.857 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.474 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 10.3 tp -57.56 144.82 9.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 O-C-N 120.878 -1.139 . . . . 74.45 108.984 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.56 147.5 50.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.45 -1.315 . . . . 72.42 107.45 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.88 71.46 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.253 -0.647 . . . . 52.1 109.253 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.14 -44.28 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 124.048 0.939 . . . . 73.12 110.496 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.99 -38.56 76.06 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.494 -0.558 . . . . 74.54 109.494 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.15 -47.09 86.11 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.876 -0.416 . . . . 75.14 109.876 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -60.88 -47.41 86.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.701 -0.852 . . . . 64.43 108.701 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -58.45 -35.89 72.83 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 115.247 1.573 . . . . 72.15 115.247 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -76.17 -51.84 11.32 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.528 -0.733 . . . . 75.3 110.62 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -81.17 7.32 11.44 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.906 1.076 . . . . 75.43 113.906 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -57.0 -27.12 61.31 Favored 'General case' 0 CA--C 1.527 0.094 0 O-C-N 120.586 -1.321 . . . . 72.45 113.602 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -87.27 -16.65 34.57 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.379 0.672 . . . . 74.33 112.038 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.5 -13.98 18.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.132 0.973 . . . . 73.25 111.701 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m 49.15 73.53 0.98 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 125.921 1.688 . . . . 75.34 114.569 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.83 158.32 54.39 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.919 1.746 . . . . 74.43 110.543 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -89.39 -41.57 12.03 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.784 0.834 . . . . 75.42 109.029 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -137.31 153.56 50.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.711 1.204 . . . . 52.54 109.814 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.3 mt -143.77 121.05 5.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.358 1.463 . . . . 74.22 108.215 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 104.24 6.67 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 125.519 1.528 . . . . 73.11 108.096 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.39 116.11 28.08 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.084 1.354 . . . . 74.23 107.931 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 46.5 mtt-85 -109.46 85.5 2.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.96 -1.496 . . . . 74.41 106.96 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.14 -22.5 60.99 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.706 -0.679 . . . . 71.43 111.508 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -51.58 -29.59 17.86 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.709 2.404 . . . . 73.21 112.286 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -132.88 9.78 4.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.202 1.401 . . . . 74.13 110.335 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.93 48.28 86.83 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.506 -1.037 . . . . 74.43 110.506 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.3 pt -136.76 167.39 23.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.368 1.467 . . . . 64.45 110.718 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.18 155.69 38.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.563 1.145 . . . . 53.21 109.569 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -125.68 125.73 43.53 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.038 1.335 . . . . 75.12 108.185 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.57 112.06 18.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.156 -1.053 . . . . 74.34 108.156 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -91.25 156.07 18.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.847 -1.538 . . . . 72.11 106.847 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -144.09 148.65 35.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.2 -1.408 . . . . 74.41 107.2 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -101.58 111.05 23.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.244 0.929 . . . . 75.32 110.897 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.08 -24.25 62.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.556 0.742 . . . . 72.31 111.242 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.35 -28.4 62.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.008 0.822 . . . . 72.04 110.46 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -64.21 -29.09 70.21 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 124.66 1.184 . . . . 74.24 112.251 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -158.45 86.13 0.86 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.12 -1.067 . . . . 75.32 108.12 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -48.35 -36.34 14.28 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.75 1.759 . . . . 72.44 115.75 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.62 -17.21 14.31 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.627 1.103 . . . . 61.31 111.896 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.1 -26.7 43.4 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 118.196 -1.335 . . . . 75.34 111.71 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.31 -39.9 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.217 1.509 . . . . 72.25 110.689 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -60.68 -58.14 9.71 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.099 -1.074 . . . . 65.54 108.099 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -57.32 -40.17 77.36 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.034 -1.041 . . . . 75.32 111.253 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -58.53 -41.06 84.65 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.101 -1.074 . . . . 74.13 108.101 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 9.0 mtm -66.85 -50.15 63.45 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 117.972 -1.014 . . . . 74.33 108.292 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -51.62 -48.87 63.11 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.54 1.136 . . . . 63.51 110.169 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.12 -31.2 49.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.665 1.586 . . . . 73.22 111.148 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.62 -38.48 21.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.931 0.787 . . . . 61.32 109.2 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.4 mt -67.17 -31.06 71.23 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.338 1.055 . . . . 74.42 110.268 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.81 -12.76 38.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.938 0.895 . . . . 75.54 110.559 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -89.79 4.21 50.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.805 1.242 . . . . 72.24 111.436 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -68.16 120.56 14.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.608 -1.997 . . . . 73.24 105.608 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.39 9.01 63.68 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.028 -1.429 . . . . 60.35 113.245 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 p -68.04 144.17 55.22 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 120.065 1.933 . . . . 75.53 109.912 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.8 mt -93.19 107.4 19.21 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 102.187 -3.264 . . . . 75.42 102.187 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.19 113.93 27.01 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 104.64 -2.355 . . . . 75.01 104.64 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER 51.76 49.34 21.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.922 0.889 . . . . 74.42 109.325 -178.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 60.51 32.22 20.44 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 127.442 2.297 . . . . 74.22 114.083 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -130.72 118.04 20.31 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.898 0.879 . . . . 74.24 110.195 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -70.06 100.88 1.7 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.822 1.249 . . . . 73.25 108.136 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.1 pt -92.78 165.87 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.277 -0.889 . . . . 74.5 109.517 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.83 156.39 39.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.541 1.136 . . . . 65.32 111.334 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.21 149.22 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.453 1.501 . . . . 73.34 110.631 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -164.33 173.63 12.02 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.939 1.296 . . . . 73.55 111.138 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.63 147.72 23.11 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.294 1.437 . . . . 73.02 109.733 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t -147.77 82.83 1.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.137 0.575 . . . . 74.21 110.523 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -157.34 164.55 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.844 -1.539 . . . . 64.41 106.844 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.73 101.28 0.21 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-N 119.424 1.011 . . . . 65.43 112.384 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.816 0 N-CA-C 110.147 -1.181 . . . . 70.13 110.147 178.792 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 N-CA-C 109.987 -1.245 . . . . 64.53 109.987 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -70.12 -9.02 54.19 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.153 1.538 . . . . 74.34 115.153 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.43 104.54 10.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 75.42 112.169 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -97.74 152.71 18.85 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 128.577 2.751 . . . . 74.03 109.124 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -135.1 147.06 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.748 1.619 . . . . 75.24 109.404 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.2 t -113.37 131.08 66.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.297 -1.742 . . . . 73.42 106.297 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -91.48 108.98 20.27 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.422 1.889 . . . . 73.35 106.428 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.6 t -115.83 126.47 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.01 -2.218 . . . . 73.21 105.01 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.26 -179.88 16.88 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 120.214 1.37 . . . . 70.43 112.461 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.84 19.44 5.83 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.03 1.732 . . . . 61.53 111.626 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.1 mp -60.91 147.91 84.53 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.918 0.887 . . . . 71.31 110.681 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.76 156.98 58.61 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.907 3.071 . . . . 72.12 114.526 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.47 -27.74 68.79 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.642 1.177 . . . . 72.02 112.118 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.65 20.54 18.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.597 1.159 . . . . 74.53 112.536 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.494 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 9.7 tp -55.27 143.16 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 O-C-N 121.005 -1.059 . . . . 72.04 110.852 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 p -128.76 154.56 46.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.61 1.164 . . . . 72.23 109.736 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.0 -30.48 70.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.315 1.046 . . . . 74.22 109.085 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.95 -48.68 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.714 1.206 . . . . 73.42 109.424 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.436 ' HG3' ' HE2' ' A' ' 70' ' ' LYS . 4.1 mm-40 -69.59 -29.3 66.81 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.518 0.727 . . . . 74.42 110.54 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -68.97 -51.27 41.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.06 -1.089 . . . . 74.34 108.06 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -58.75 -45.56 89.43 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 107.946 -1.131 . . . . 73.23 107.946 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -56.08 -48.0 76.92 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.517 1.527 . . . . 74.44 113.629 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -56.34 15.66 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 122.292 1.044 . . . . 74.43 111.454 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -79.68 8.55 6.4 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.481 1.512 . . . . 75.34 114.414 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -56.04 -39.78 72.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.94 -1.1 . . . . 75.13 110.412 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.21 -15.51 57.94 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.982 0.734 . . . . 75.02 112.982 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 p -102.16 -1.49 31.29 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.9 -1.125 . . . . 73.23 111.197 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.0 t 37.32 79.78 0.3 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 127.552 2.341 . . . . 71.15 115.066 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.08 156.57 55.65 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.595 1.53 . . . . 64.04 109.616 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.47 -49.2 8.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.799 -1.556 . . . . 74.43 106.799 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -136.71 154.37 50.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.174 0.99 . . . . 73.21 110.007 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -136.09 133.04 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.372 1.869 . . . . 74.33 109.577 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -142.37 107.95 5.08 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 127.189 2.196 . . . . 73.43 109.5 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -96.41 122.43 39.29 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.649 -1.241 . . . . 74.22 107.649 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -110.29 86.01 2.22 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.948 1.699 . . . . 75.32 106.722 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.65 -32.66 63.39 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.966 0.906 . . . . 71.43 112.333 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -56.78 -19.01 14.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.355 1.462 . . . . 54.34 113.232 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -132.16 -1.31 3.65 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.146 1.378 . . . . 71.54 110.569 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.69 38.79 96.48 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.578 1.085 . . . . 72.11 110.934 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -127.8 163.45 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.19 1.396 . . . . 74.11 109.88 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.61 155.32 47.51 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.04 1.336 . . . . 72.21 109.332 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.76 104.36 9.25 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.18 -1.785 . . . . 73.31 106.18 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.22 111.65 24.14 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 105.158 -2.164 . . . . 72.33 105.158 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.62 157.91 17.23 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.62 0.768 . . . . 75.2 109.494 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -146.19 133.41 20.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.6 1.56 . . . . 73.04 107.304 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -101.73 122.63 44.28 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 105.013 -2.217 . . . . 62.14 105.013 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.63 -23.48 62.55 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.611 1.564 . . . . 71.22 111.261 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -83.65 -18.71 37.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.964 0.506 . . . . 65.55 109.912 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -69.0 -19.11 64.13 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.3 -0.857 . . . . 73.41 111.372 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -168.42 85.04 0.18 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.86 1.664 . . . . 72.21 106.621 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -32.73 6.5 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.821 1.648 . . . . 75.12 113.666 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.3 p -107.57 -20.23 13.3 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.187 0.903 . . . . 73.24 112.806 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.38 -18.03 53.78 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-O 117.677 -1.624 . . . . 75.14 114.494 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.1 tp -50.93 -36.7 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 119.645 1.723 . . . . 71.35 109.13 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -61.26 -61.72 2.35 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.982 2.513 . . . . 74.0 110.653 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.87 -35.45 76.63 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.213 -0.929 . . . . 75.41 109.724 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -60.81 -49.22 78.35 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 108.074 -1.084 . . . . 75.12 108.074 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.4 mtt -57.67 -50.54 72.85 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 124.647 1.179 . . . . 73.41 109.888 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -56.99 -44.62 82.92 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.272 1.029 . . . . 74.2 111.773 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.5 mt -69.85 -34.5 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 108.951 -0.759 . . . . 73.31 108.951 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.82 79.76 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.508 -1.293 . . . . 61.13 107.508 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.4 mt -58.65 -32.24 68.9 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.321 1.048 . . . . 74.33 111.3 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 46.4 mt -66.74 -9.02 32.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.283 -0.865 . . . . 75.12 112.258 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -86.16 -2.48 58.4 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.276 1.398 . . . . 72.24 111.49 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 112.23 2.78 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.788 1.235 . . . . 75.3 108.036 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.11 10.27 59.86 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.404 1.002 . . . . 64.4 114.284 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.3 p -75.1 143.23 43.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.573 1.687 . . . . 71.44 109.591 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.14 108.97 19.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 106.861 -1.533 . . . . 75.04 106.861 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mt -110.38 119.72 40.12 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 105.337 -2.097 . . . . 71.33 105.337 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 33.1 mttt 45.95 49.59 11.87 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.011 0.91 . . . . 75.42 110.528 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 63.29 16.45 9.47 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.92 2.088 . . . . 73.42 116.348 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -119.79 126.77 51.82 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.123 1.369 . . . . 72.31 108.185 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -79.18 106.93 11.57 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.354 -0.239 . . . . 73.31 110.354 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.42 169.89 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 123.543 0.737 . . . . 75.04 111.7 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -128.25 158.75 37.3 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.883 2.073 . . . . 64.21 108.878 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.0 t -142.79 127.41 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.676 1.19 . . . . 73.43 108.784 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -144.0 173.29 11.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.779 1.232 . . . . 74.24 109.361 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.85 151.86 21.55 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.221 1.009 . . . . 75.21 110.308 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -153.54 82.42 1.17 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 106.986 -1.487 . . . . 71.14 106.986 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.5 p -167.98 171.05 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.273 -1.38 . . . . 71.51 107.273 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.27 -111.17 0.38 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 109.425 -1.47 . . . . 75.14 109.425 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 N-CA-C 108.209 -1.956 . . . . 75.24 108.209 -179.856 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.673 0 N-CA-C 111.82 -0.512 . . . . 75.14 111.82 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -130.82 48.87 2.37 Favored 'General case' 0 N--CA 1.46 0.054 0 C-N-CA 125.19 1.396 . . . . 75.34 113.193 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -151.55 167.58 27.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 120.828 -1.17 . . . . 72.14 108.584 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -130.77 165.53 22.75 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.081 -1.822 . . . . 63.02 106.081 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.3 mt -130.56 146.41 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 109.001 -0.74 . . . . 72.22 109.001 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.3 131.93 63.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.144 -1.428 . . . . 74.43 107.144 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -89.93 115.41 27.22 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 105.421 -2.066 . . . . 74.25 105.421 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -124.46 128.67 73.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.425 -2.065 . . . . 71.45 105.425 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.3 -179.93 18.45 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 119.233 0.924 . . . . 71.54 111.62 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.83 18.61 5.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.281 1.832 . . . . 73.31 111.097 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.59 153.21 62.99 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 124.663 1.185 . . . . 71.43 113.042 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.33 167.88 13.85 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.127 2.551 . . . . 71.44 111.64 178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -75.34 -41.66 56.17 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 121.716 -0.615 . . . . 73.03 109.938 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.56 19.77 4.37 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.591 0.96 . . . . 64.31 113.591 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.507 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.7 tp -53.47 140.73 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 121.289 -0.882 . . . . 74.31 109.547 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -127.81 150.58 49.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.643 1.177 . . . . 75.43 109.106 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.4 -28.46 69.8 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.579 -0.7 . . . . 72.54 111.069 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -43.1 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.793 -0.818 . . . . 75.21 108.793 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -63.96 -45.27 89.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.682 0.793 . . . . 73.22 109.21 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.89 -48.81 80.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.065 -0.493 . . . . 75.34 110.113 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -61.28 -36.63 80.58 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 118.894 0.77 . . . . 62.24 109.784 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.52 -40.02 77.2 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.813 0.733 . . . . 73.41 111.843 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.81 -37.99 70.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.109 0.868 . . . . 65.34 111.316 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -94.61 6.2 49.55 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.459 -0.776 . . . . 74.24 112.264 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -54.84 -39.34 68.47 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.958 1.303 . . . . 74.3 112.531 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -71.17 -35.85 71.79 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.379 -0.825 . . . . 64.23 110.639 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -74.69 -24.14 58.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.636 0.774 . . . . 72.32 112.859 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.9 m 63.74 69.54 0.77 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 116.284 1.957 . . . . 73.51 116.284 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.51 159.6 52.97 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.813 2.342 . . . . 74.22 109.896 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.28 -53.99 5.11 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.91 -1.885 . . . . 74.31 105.91 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -143.92 161.53 38.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.424 1.49 . . . . 73.51 109.406 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.12 140.5 42.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 126.039 1.736 . . . . 72.11 107.151 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -133.16 103.93 6.25 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 107.352 -1.351 . . . . 74.33 107.352 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -87.71 112.57 22.52 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.882 0.873 . . . . 72.11 109.157 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -101.24 87.43 3.23 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.557 -1.646 . . . . 73.33 106.557 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.6 -28.8 61.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.634 1.174 . . . . 74.44 112.687 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -52.61 -38.89 61.01 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.967 2.107 . . . . 71.21 114.064 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -118.88 -6.45 10.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 118.219 -0.896 . . . . 74.41 111.956 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.67 48.25 29.67 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.728 -1.749 . . . . 64.34 108.728 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pt -137.24 156.13 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 126.233 1.813 . . . . 75.23 108.034 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.4 126.97 12.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.964 -0.754 . . . . 64.13 108.964 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -90.11 135.99 33.32 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.49 -1.3 . . . . 74.45 107.49 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.91 123.99 39.82 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.171 -1.788 . . . . 74.4 106.171 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -95.26 143.44 26.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.312 1.445 . . . . 73.42 108.214 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -135.77 106.85 6.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.052 -1.462 . . . . 73.4 107.052 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.68 116.55 8.51 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.979 0.911 . . . . 71.12 110.538 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.01 -31.23 61.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.608 1.963 . . . . 64.2 112.164 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.02 -22.34 63.11 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.098 0.559 . . . . 65.54 109.845 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -60.7 -35.92 77.52 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 108.964 -0.754 . . . . 75.5 108.964 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -162.22 96.29 0.97 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.042 -0.725 . . . . 62.0 109.042 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -55.55 -29.83 59.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 117.81 -1.09 . . . . 74.35 113.068 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.253 29.9 p -110.74 7.5 22.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.947 0.794 . . . . 74.51 112.738 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.41 -20.71 4.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.484 1.516 . . . . 70.4 112.27 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.3 tp -54.55 -39.93 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 125.048 1.339 . . . . 64.32 111.853 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -58.05 9.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.227 -0.657 . . . . 64.43 109.227 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -57.54 -32.61 67.26 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.52 -0.738 . . . . 75.04 111.551 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -64.42 -51.18 64.49 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.179 -1.415 . . . . 73.04 107.179 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.6 mtm -66.27 -30.59 71.05 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.753 0.821 . . . . 74.53 112.429 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.02 -39.73 90.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.691 1.132 . . . . 75.41 108.884 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.6 mt -66.03 -39.16 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.784 -1.191 . . . . 74.23 107.784 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.38 95.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.368 -0.975 . . . . 74.04 108.368 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.1 mt -63.13 -31.08 72.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.304 0.502 . . . . 73.24 111.264 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.56 -6.95 8.58 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.725 1.009 . . . . 74.42 113.725 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -93.45 -0.56 56.39 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.732 0.697 . . . . 75.11 111.029 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.65 112.78 2.14 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.718 1.607 . . . . 73.32 109.833 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.69 5.55 61.35 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.481 -1.177 . . . . 61.22 113.657 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.3 p -66.79 147.69 52.92 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.988 1.894 . . . . 71.31 109.486 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.41 107.92 19.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.498 -2.038 . . . . 75.41 105.498 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 mt -107.19 126.07 51.92 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 105.331 -2.1 . . . . 74.32 105.331 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 18.6 mttt 42.1 49.84 4.3 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.486 1.039 . . . . 74.45 111.345 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 64.04 21.85 12.73 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.356 2.263 . . . . 74.23 115.235 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -124.87 126.37 45.45 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.313 -1.492 . . . . 62.35 110.986 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 tptt -74.75 109.46 8.24 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.567 -1.642 . . . . 65.44 106.567 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.9 pp -92.8 170.02 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.009 0.924 . . . . 73.23 111.103 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.57 158.13 38.3 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.881 1.272 . . . . 74.22 109.674 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.4 t -141.52 132.38 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.476 -1.675 . . . . 72.32 106.476 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -146.76 163.02 37.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.827 1.251 . . . . 72.41 109.021 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.52 152.17 28.81 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.265 1.026 . . . . 74.13 109.638 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.57 143.85 29.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.065 0.946 . . . . 74.32 109.331 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.4 t 68.7 -49.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.3 2.24 . . . . 75.54 113.562 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.98 13.42 60.52 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.001 1.762 . . . . 72.23 113.558 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.829 0 N-CA-C 108.592 -1.803 . . . . 73.33 108.592 178.883 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 112.068 -0.413 . . . . 71.25 112.068 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -141.74 37.5 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.78 -1.563 . . . . 74.03 106.78 178.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.1 ptt85 -113.77 148.94 35.63 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.066 -1.021 . . . . 74.4 110.932 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -113.55 163.15 15.3 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 104.775 -2.305 . . . . 73.34 104.775 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mt -132.24 149.26 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.618 -1.252 . . . . 62.15 107.618 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.8 t -120.01 124.03 71.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.365 -1.717 . . . . 73.12 106.365 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -88.3 136.29 33.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.837 -1.912 . . . . 74.52 105.837 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.0 t -136.7 129.14 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.244 -2.132 . . . . 73.13 105.244 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.74 -177.97 15.63 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 120.18 1.354 . . . . 74.25 113.374 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.93 14.37 5.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.495 2.318 . . . . 63.22 110.11 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mp -58.39 142.03 82.37 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.746 1.219 . . . . 70.15 111.802 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.28 156.98 60.19 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.11 2.54 . . . . 74.34 111.071 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -68.3 -35.01 77.19 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.498 -0.751 . . . . 74.34 109.172 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.34 8.98 5.17 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.712 1.605 . . . . 75.4 113.392 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 tp -51.13 145.71 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.952 1.301 . . . . 72.24 112.678 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.59 150.41 50.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.511 1.124 . . . . 74.53 110.221 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.0 72.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.64 1.176 . . . . 74.12 109.969 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 t -61.41 -41.26 89.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.647 0.779 . . . . 74.44 110.874 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -70.89 -39.03 73.05 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.97 -0.752 . . . . 74.14 108.97 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.33 -51.5 65.72 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.232 1.013 . . . . 75.03 110.674 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -42.78 99.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.063 0.945 . . . . 64.13 109.267 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -64.5 -52.28 58.63 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.334 1.054 . . . . 53.11 113.023 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -48.97 78.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.911 0.778 . . . . 75.44 111.749 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -85.81 1.84 48.07 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 113.857 1.058 . . . . 73.04 113.857 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -47.12 70.24 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 120.083 1.31 . . . . 73.43 111.477 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -60.68 -34.11 73.84 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.133 0.424 . . . . 65.25 111.696 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 p -83.86 -10.48 57.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.883 0.873 . . . . 64.01 111.597 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 m 42.78 68.78 2.61 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 127.057 2.143 . . . . 75.32 113.953 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -64.07 158.39 48.13 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.866 2.377 . . . . 75.51 109.527 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.94 -36.81 13.9 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.032 0.933 . . . . 74.13 108.862 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -127.67 155.74 43.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.901 0.881 . . . . 74.15 111.087 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 75.4 mt -144.74 115.5 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.797 -1.557 . . . . 74.15 106.797 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 104.64 5.57 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.475 1.51 . . . . 75.14 108.407 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.04 119.94 30.82 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.705 1.202 . . . . 73.05 108.285 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 -109.65 84.19 1.88 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.469 -1.678 . . . . 75.02 106.469 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.29 -29.27 65.71 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.343 -0.836 . . . . 63.43 111.369 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -54.31 -26.99 32.57 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.834 1.05 . . . . 71.53 113.834 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.3 mmtt -127.38 9.04 6.59 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.886 0.875 . . . . 65.45 111.262 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.98 48.22 80.99 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.982 -1.247 . . . . 73.45 109.982 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.38 171.29 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 C-N-CA 124.821 1.248 . . . . 74.12 109.675 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.17 168.77 20.82 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.813 1.245 . . . . 70.51 108.46 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -134.82 137.08 43.0 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 104.974 -2.232 . . . . 74.51 104.974 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -137.19 116.29 12.49 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 105.984 -1.858 . . . . 74.13 105.984 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.05 151.33 19.59 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.691 -1.596 . . . . 53.41 106.691 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -141.43 111.83 6.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.069 -1.826 . . . . 74.44 106.069 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.38 122.17 28.56 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.831 0.852 . . . . 65.23 111.183 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.27 93.91 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.496 1.118 . . . . 63.03 111.95 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.486 ' H ' ' ND2' ' A' ' 2' ' ' ASN . 5.0 t70 -62.25 -28.9 70.03 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.961 -0.755 . . . . 74.3 108.961 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.71 -23.77 66.35 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 117.448 -1.263 . . . . 74.42 112.113 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -163.81 90.4 0.61 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.715 1.606 . . . . 62.3 107.837 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 -56.39 -16.39 5.63 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.513 1.525 . . . . 74.41 115.086 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 m -122.7 -19.44 6.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 120.038 1.29 . . . . 63.54 112.413 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.51 -14.62 43.51 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 117.245 -1.864 . . . . 55.32 114.883 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -50.17 -44.51 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 120.491 2.146 . . . . 74.24 111.572 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -62.39 -58.16 8.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.961 0.904 . . . . 73.54 110.472 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -59.2 -31.2 68.81 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.516 -1.365 . . . . 74.31 111.054 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -62.53 -41.11 98.65 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.519 -1.289 . . . . 70.44 107.519 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 12.1 mtm -65.8 -42.83 90.23 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.158 -1.053 . . . . 72.12 108.158 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -54.13 -49.78 68.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.524 1.056 . . . . 54.03 110.375 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -61.28 -44.85 99.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.299 1.44 . . . . 65.35 109.481 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.83 -42.0 95.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.374 0.534 . . . . 71.45 109.983 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.19 -29.9 69.7 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.132 0.973 . . . . 73.54 111.428 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.19 -13.31 57.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.772 -0.632 . . . . 75.12 109.895 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -85.49 2.17 45.8 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.979 0.809 . . . . 75.2 111.079 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -67.11 112.07 4.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.137 -1.602 . . . . 72.44 108.519 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.47 10.47 53.61 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.646 1.117 . . . . 73.51 113.563 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.9 p -68.77 141.01 55.33 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.773 1.786 . . . . 74.13 110.214 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.5 mt -87.41 110.68 20.44 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 101.938 -3.356 . . . . 75.35 101.938 176.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -115.41 121.49 42.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.587 1.555 . . . . 72.02 108.422 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? 50.17 44.57 26.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.011 0.924 . . . . 74.54 112.761 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 67.67 24.27 8.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.106 2.162 . . . . 74.44 112.315 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -140.19 126.61 20.12 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.638 1.575 . . . . 70.0 110.302 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -75.17 143.54 43.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.475 -1.676 . . . . 75.51 106.475 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.6 pt -128.47 162.64 34.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.002 0.921 . . . . 74.42 109.492 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -120.43 159.02 25.97 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 125.368 1.467 . . . . 75.32 111.694 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.6 t -136.0 148.06 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 107.896 -1.15 . . . . 73.03 107.896 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -161.71 161.56 29.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.868 1.667 . . . . 74.3 108.771 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.5 152.22 23.35 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.626 1.17 . . . . 71.54 113.214 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -148.57 129.42 14.28 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.302 1.441 . . . . 63.22 108.34 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.1 t 64.54 95.24 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 126.454 1.902 . . . . 74.14 111.686 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.25 70.78 0.11 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 108.363 -1.895 . . . . 64.45 108.363 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.458 0 N-CA-C 109.037 -1.625 . . . . 73.12 109.037 179.323 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.896 0 CA-C-O 121.741 0.634 . . . . 75.34 111.638 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.86 22.54 7.42 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.501 1.92 . . . . 71.52 108.701 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.34 144.84 49.89 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 106.35 -1.722 . . . . 72.54 106.35 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -127.92 162.9 25.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.508 -1.293 . . . . 75.54 107.508 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.412 ' HB ' HG22 ' A' ' 79' ' ' THR . 5.0 mt -135.17 144.09 35.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.874 -1.898 . . . . 74.21 105.874 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.3 t -118.99 128.82 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 126.391 1.876 . . . . 73.53 106.127 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -101.21 139.14 37.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.25 -2.129 . . . . 75.12 105.25 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.56 127.76 31.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 104.014 -2.587 . . . . 74.34 104.014 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -132.38 179.54 17.14 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 120.078 1.308 . . . . 55.44 112.634 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.17 17.77 3.97 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.194 2.198 . . . . 64.44 110.302 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 mp -55.03 148.63 27.87 Favored Pre-proline 0 C--O 1.239 0.524 0 C-N-CA 124.929 1.292 . . . . 74.02 111.95 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.28 153.61 75.69 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.956 3.104 . . . . 75.32 112.239 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -65.38 -34.03 77.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 118.508 -0.758 . . . . 75.01 109.492 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -92.65 21.06 5.76 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.641 1.176 . . . . 75.31 112.646 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.52 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 10.3 tp -52.36 138.92 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 121.256 -0.903 . . . . 61.03 109.951 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 p -125.38 150.77 46.91 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.48 -0.933 . . . . 74.32 108.48 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.01 -26.24 68.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 118.299 -0.858 . . . . 74.04 110.133 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.6 p -65.09 -41.17 91.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 119.697 1.135 . . . . 72.5 108.682 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.502 ' HG3' ' HE2' ' A' ' 70' ' ' LYS . 15.8 mm-40 -68.11 -45.27 74.14 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.346 -0.983 . . . . 73.24 108.346 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.1 mt -59.71 -47.65 84.79 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.494 0.588 . . . . 74.11 111.086 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -61.0 -38.01 84.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.56 0.744 . . . . 72.14 109.987 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -74.44 -54.35 7.76 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.364 1.066 . . . . 71.13 113.796 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -34.6 70.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.681 0.993 . . . . 64.43 113.681 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -97.4 3.71 50.88 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.806 0.842 . . . . 70.11 112.58 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -60.72 -28.96 69.06 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.845 -1.159 . . . . 70.0 109.918 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -73.67 -17.57 61.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.093 0.957 . . . . 74.45 111.058 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 p -113.84 -5.84 13.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.439 1.895 . . . . 53.13 113.581 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.8 t 41.68 77.33 0.44 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 126.503 1.921 . . . . 75.05 114.973 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.57 165.99 30.08 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 121.931 1.754 . . . . 72.42 109.988 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -91.2 -32.89 15.61 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 120.742 -1.224 . . . . 72.24 109.501 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -143.54 153.26 42.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.169 1.388 . . . . 72.31 108.187 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.4 mt -133.73 105.12 6.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.788 -1.56 . . . . 71.44 106.788 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.1 ttt-85 -122.62 103.94 9.01 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.875 -0.787 . . . . 75.41 108.875 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -83.15 127.38 33.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.107 -1.812 . . . . 74.33 106.107 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 85.54 2.37 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.582 -2.007 . . . . 75.21 105.582 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.53 -27.55 49.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.918 0.887 . . . . 72.33 113.003 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -52.05 -30.09 24.12 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.68 1.992 . . . . 71.01 114.314 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -132.23 11.96 4.61 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.043 1.337 . . . . 72.2 111.418 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.77 52.45 50.68 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.345 -1.502 . . . . 62.24 109.345 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.84 168.07 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.613 1.165 . . . . 65.11 110.594 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.99 154.29 41.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.649 1.179 . . . . 62.21 108.014 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -124.45 123.32 39.88 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.118 -1.808 . . . . 72.21 106.118 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mp -117.77 113.81 22.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.861 -1.533 . . . . 75.2 106.861 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -85.18 152.81 23.08 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.335 -1.357 . . . . 75.25 107.335 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -141.1 136.86 32.37 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.446 1.098 . . . . 74.24 108.709 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -97.98 108.51 21.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.394 1.478 . . . . 75.23 112.616 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.4 -22.6 51.34 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.483 0.713 . . . . 64.22 112.543 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.93 -37.09 35.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 112.096 0.406 . . . . 75.22 112.096 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -68.87 -55.47 10.99 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.186 1.394 . . . . 73.41 111.036 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.57 71.91 0.81 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 122.011 0.91 . . . . 60.41 110.281 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -48.85 -38.49 22.55 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.685 1.194 . . . . 71.33 112.718 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.8 p -104.99 8.0 34.29 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.761 1.022 . . . . 74.44 113.761 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.94 -23.14 2.54 Favored Glycine 0 C--O 1.221 -0.676 0 CA-C-O 118.038 -1.423 . . . . 73.13 113.604 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.1 tp -49.36 -49.57 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 120.244 2.022 . . . . 74.43 113.127 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -64.07 -55.46 22.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.841 -0.8 . . . . 75.45 108.841 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -49.49 -53.2 24.5 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.171 0.896 . . . . 74.51 109.417 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -51.91 -54.86 24.51 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.14 1.776 . . . . 74.31 110.337 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 44.0 mtm -66.32 -28.32 68.59 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 118.908 0.776 . . . . 72.34 111.218 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -65.06 -47.51 77.05 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 120.074 -1.641 . . . . 73.31 109.798 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.5 mt -65.29 -31.65 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.284 1.833 . . . . 73.31 108.063 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.23 -41.13 58.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.674 -0.862 . . . . 75.23 108.674 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -60.61 -37.06 80.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.479 0.712 . . . . 73.23 110.311 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.6 mt -64.42 -6.08 6.52 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.236 1.414 . . . . 72.22 113.616 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -92.39 6.23 47.71 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.491 1.041 . . . . 73.53 111.234 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -72.25 114.89 10.86 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.727 1.211 . . . . 74.34 108.546 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.48 5.09 61.98 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-O 118.005 -1.442 . . . . 63.54 114.445 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.9 p -72.01 154.01 41.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.997 1.899 . . . . 74.52 109.422 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 mt -100.49 107.54 19.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.588 -1.634 . . . . 71.42 106.588 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.67 121.92 44.86 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.622 -2.362 . . . . 74.22 104.622 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 18.8 mttm 48.1 47.33 19.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.822 0.849 . . . . 75.0 110.971 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 58.0 26.97 14.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.846 1.658 . . . . 73.31 114.186 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -126.47 122.31 34.88 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.728 -1.212 . . . . 74.32 107.728 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -81.62 102.55 10.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.298 -1.371 . . . . 73.33 107.298 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.6 pt -85.54 169.64 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 124.282 1.033 . . . . 73.21 110.898 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.62 155.27 45.23 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 125.888 1.675 . . . . 75.24 109.467 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.62 148.91 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.339 1.055 . . . . 73.13 108.479 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.8 172.14 13.34 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.571 1.949 . . . . 64.42 109.368 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.55 153.42 18.18 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.067 1.747 . . . . 63.13 107.366 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.412 HG22 ' HB ' ' A' ' 5' ' ' ILE . 9.2 t -143.27 82.33 1.74 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.947 -0.76 . . . . 64.54 108.947 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 p -167.89 -44.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.444 0.698 . . . . 73.12 111.854 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.46 18.03 0.07 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 114.463 0.545 . . . . 73.55 114.463 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.194 0 C-N-CA 129.209 3.29 . . . . 75.44 106.076 -179.702 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.63 0 N-CA-C 110.29 -1.124 . . . . 73.43 110.29 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.12 52.18 0.8 Allowed 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 124.274 1.03 . . . . 70.13 110.186 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.92 163.75 37.95 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.012 -1.055 . . . . 72.41 109.889 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -133.19 165.62 24.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.105 1.362 . . . . 74.41 108.583 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mt -134.45 148.64 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.024 -0.732 . . . . 74.24 109.024 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.33 126.64 74.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 105.942 -1.873 . . . . 75.25 105.942 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -91.04 137.73 32.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.522 1.529 . . . . 65.42 107.688 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.9 t -138.73 126.09 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.729 -1.582 . . . . 74.42 106.729 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' H ' ' ND2' ' A' ' 75' ' ' ASN . . . -136.9 176.76 20.23 Favored Glycine 0 N--CA 1.468 0.774 0 CA-C-N 120.347 1.431 . . . . 44.31 111.628 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.25 19.02 0.77 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.48 2.312 . . . . 75.11 109.585 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.76 143.25 98.08 Favored Pre-proline 0 C--O 1.235 0.315 0 O-C-N 120.9 -1.125 . . . . 72.33 112.884 -178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.3 160.74 43.78 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.62 2.88 . . . . 75.53 111.604 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -44.06 93.46 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.784 -0.821 . . . . 75.23 108.784 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.72 9.46 1.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.522 1.929 . . . . 74.45 114.095 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.48 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.5 tp -58.62 139.45 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 O-C-N 120.725 -1.234 . . . . 74.34 109.822 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 150.52 50.11 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.818 0.847 . . . . 75.41 109.75 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.84 -30.73 70.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.076 0.95 . . . . 75.42 110.404 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.67 -43.27 96.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.549 1.14 . . . . 70.3 109.487 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.08 -42.12 85.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.96 -1.126 . . . . 64.41 107.96 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.67 -53.47 55.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.988 1.315 . . . . 74.23 110.454 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -46.9 83.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.688 -1.226 . . . . 72.44 107.688 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -62.58 -42.85 99.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.918 1.081 . . . . 74.53 113.918 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.99 -47.68 67.86 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 120.993 -1.067 . . . . 74.32 110.66 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.33 6.05 28.04 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.25 1.204 . . . . 74.42 114.25 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -51.48 -41.13 60.7 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 125.067 1.347 . . . . 75.31 113.715 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.402 HD21 HD13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -72.57 -21.93 61.07 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.404 0.547 . . . . 72.41 112.247 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.66 -17.89 22.76 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.218 1.407 . . . . 72.51 110.843 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 m 49.17 74.15 0.87 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.094 1.758 . . . . 74.01 114.412 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -65.87 153.15 79.34 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.116 1.877 . . . . 74.35 109.111 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -91.62 -39.8 11.67 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.996 -1.112 . . . . 74.11 107.996 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -123.46 146.35 48.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.548 1.139 . . . . 73.41 108.867 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 57.3 mt -141.38 107.02 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.982 -1.118 . . . . 74.23 107.982 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.43 104.74 8.07 Favored 'General case' 0 N--CA 1.46 0.055 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.53 118.66 30.78 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.776 2.03 . . . . 74.02 108.191 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.68 87.84 2.73 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.631 1.572 . . . . 75.22 108.432 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.32 -16.89 63.04 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.696 -0.628 . . . . 73.23 109.88 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -51.62 -26.74 9.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.937 2.495 . . . . 74.1 110.797 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -133.23 -1.6 3.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.798 2.439 . . . . 71.25 111.128 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.83 50.75 45.36 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.263 1.411 . . . . 64.32 110.134 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.3 pt -140.8 167.94 17.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 125.988 1.715 . . . . 70.44 110.827 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.83 149.81 33.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.247 1.819 . . . . 74.0 109.227 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.35 132.98 55.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.691 -1.596 . . . . 71.22 106.691 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.17 110.12 12.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.183 -1.784 . . . . 62.02 106.183 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -96.86 148.49 22.88 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.755 -1.202 . . . . 74.33 107.755 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -143.5 120.97 11.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.401 1.08 . . . . 75.02 109.358 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.38 121.13 22.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.479 0.712 . . . . 70.21 110.541 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.1 -38.76 63.75 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.943 1.697 . . . . 74.22 112.209 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.38 -29.62 70.89 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.594 -0.521 . . . . 75.11 109.594 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -61.7 -19.27 62.19 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.393 1.077 . . . . 74.34 112.489 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.03 90.33 0.44 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.105 1.321 . . . . 75.12 109.619 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -48.85 -38.71 23.15 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 116.125 1.898 . . . . 75.11 116.125 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -114.59 -0.95 13.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 123.337 0.398 . . . . 74.2 111.371 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.04 -28.68 8.05 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.474 1.035 . . . . 71.41 111.438 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.2 tp -54.13 -37.76 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.906 1.353 . . . . 75.44 110.648 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -56.75 18.04 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.148 -0.686 . . . . 74.14 109.148 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -42.78 66.82 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.715 1.206 . . . . 71.35 110.325 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -57.35 -46.73 83.02 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.001 -1.111 . . . . 71.33 108.001 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.3 mtm -66.88 -44.58 80.52 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 117.938 -1.029 . . . . 75.44 110.769 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -52.42 -49.85 63.69 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.315 1.416 . . . . 54.11 110.217 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.402 HD13 HD21 ' A' ' 26' ' ' ASN . 64.4 mt -65.92 -43.51 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.722 1.209 . . . . 74.1 109.16 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.14 96.76 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.783 0.719 . . . . 73.34 109.968 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.39 -26.35 68.42 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.007 1.323 . . . . 74.41 111.571 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.56 -8.2 54.97 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.458 -0.776 . . . . 72.43 109.946 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -88.84 9.02 26.21 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.178 -0.915 . . . . 75.32 111.803 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -76.86 118.03 19.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.694 1.588 . . . . 72.42 106.735 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.62 3.02 64.81 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.508 -1.162 . . . . 72.11 115.094 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.1 p -67.97 144.89 54.99 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 120.018 1.909 . . . . 73.4 107.766 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.8 mt -92.87 107.66 19.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 103.936 -2.616 . . . . 74.41 103.936 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.07 115.39 30.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 102.931 -2.988 . . . . 74.23 102.931 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER 48.41 56.96 6.73 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.533 1.159 . . . . 63.52 110.384 -177.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 60.47 13.09 3.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.359 2.264 . . . . 75.34 114.999 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -118.35 120.0 36.31 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.259 1.023 . . . . 74.01 111.469 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -71.63 115.7 11.12 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.872 -1.529 . . . . 72.32 106.872 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.335 16.4 pt -101.39 170.69 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.358 0.526 . . . . 54.43 110.201 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -120.89 151.83 39.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.482 1.113 . . . . 72.04 109.704 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.3 t -137.62 135.19 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.579 1.152 . . . . 72.01 108.45 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.35 152.97 32.73 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.427 1.091 . . . . 73.23 110.574 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 143.62 38.49 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.252 1.021 . . . . 72.25 111.005 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 p -141.2 145.83 36.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.917 1.287 . . . . 63.21 110.218 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.8 t 53.27 86.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 127.437 2.295 . . . . 74.32 112.426 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.46 -10.16 1.94 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-O 118.577 -1.124 . . . . 75.51 113.413 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 N-CA-C 108.732 -1.747 . . . . 72.42 108.732 179.653 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.713 0 N-CA-C 111.096 -0.802 . . . . 72.12 111.096 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.35 40.49 0.28 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.998 1.319 . . . . 74.04 112.799 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -155.71 148.58 24.27 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 120.385 -1.447 . . . . 72.32 110.152 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -115.77 165.04 13.5 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 128.042 2.537 . . . . 75.33 104.391 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.5 mt -134.89 135.75 52.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.534 -0.757 . . . . 73.31 109.091 -177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.9 t -96.98 145.34 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 104.992 -2.225 . . . . 75.32 104.992 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -113.62 131.73 56.02 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 104.904 -2.258 . . . . 75.11 104.904 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.88 126.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.091 -1.818 . . . . 64.03 106.091 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.22 177.63 18.36 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.052 0.842 . . . . 73.43 112.419 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.0 17.18 2.22 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.58 2.752 . . . . 64.12 110.671 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.7 mp -58.31 144.32 77.82 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 124.91 1.284 . . . . 74.22 111.688 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.19 160.76 43.4 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.362 2.708 . . . . 71.43 112.406 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -67.06 -37.5 84.13 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.422 -0.955 . . . . 75.35 108.422 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.8 13.59 1.64 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.72 1.007 . . . . 72.11 113.72 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.589 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 6.4 tp -63.98 134.78 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 120.451 -1.405 . . . . 70.34 110.452 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . 0.254 1.3 p -128.63 150.05 50.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.456 1.902 . . . . 71.5 107.124 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.37 64.49 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.382 -0.824 . . . . 74.53 112.638 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 p -64.18 -36.54 77.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.462 -0.94 . . . . 75.23 108.462 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -70.35 -43.44 70.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.979 0.912 . . . . 73.24 108.595 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.99 -47.44 84.8 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.232 -0.655 . . . . 75.41 109.232 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -60.03 -38.55 83.03 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.863 0.865 . . . . 74.13 108.797 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -68.85 -41.9 77.85 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.814 1.188 . . . . 72.23 111.076 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -69.99 -35.86 74.72 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.565 -0.709 . . . . 73.35 112.561 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -100.87 6.44 43.72 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.668 0.787 . . . . 74.0 112.405 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -54.27 -43.85 71.37 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.054 1.342 . . . . 73.42 110.747 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -60.79 -32.03 71.38 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.369 1.068 . . . . 73.31 112.123 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 p -94.24 -22.45 18.4 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.686 1.194 . . . . 72.42 111.378 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t 54.4 79.95 0.32 Allowed Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 129.537 3.135 . . . . 65.33 112.396 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.89 166.24 18.92 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.677 2.918 . . . . 73.51 111.484 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -96.65 -38.55 9.89 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.116 0.966 . . . . 74.43 109.429 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -131.82 151.52 51.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.056 1.342 . . . . 65.22 108.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -139.8 105.29 2.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 106.473 -1.676 . . . . 73.23 106.473 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.57 104.29 9.26 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.46 -1.311 . . . . 74.23 107.46 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -87.01 125.24 33.97 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.63 1.172 . . . . 74.32 108.575 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.17 79.4 1.27 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.16 1.784 . . . . 73.3 107.078 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.01 54.77 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.104 0.962 . . . . 73.44 111.746 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.73 -34.98 29.14 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 126.688 1.995 . . . . 63.32 111.918 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -131.48 14.95 4.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.585 1.154 . . . . 74.52 111.298 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.5 50.23 66.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 124.265 0.936 . . . . 63.41 111.095 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 pt -138.21 170.95 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.235 1.414 . . . . 75.23 109.492 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.74 164.94 34.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.579 1.152 . . . . 61.25 109.094 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -128.69 127.69 42.62 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 105.505 -2.035 . . . . 60.15 105.505 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mp -130.07 106.45 8.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.743 -1.577 . . . . 74.02 106.743 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -96.16 150.14 20.85 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.581 -1.266 . . . . 75.34 107.581 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -136.27 135.28 38.85 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.496 -1.298 . . . . 72.43 107.496 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -79.46 109.61 14.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.323 0.965 . . . . 72.32 110.986 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.17 -24.78 60.6 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.609 1.564 . . . . 73.34 113.668 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.13 -25.93 58.8 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.713 -0.847 . . . . 74.43 108.713 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -60.64 -27.79 68.06 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.913 0.885 . . . . 72.35 111.051 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -161.35 88.48 0.73 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.842 0.746 . . . . 71.43 111.007 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -59.64 -25.41 64.66 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.162 -0.961 . . . . 71.14 112.831 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.0 p -96.95 -12.24 23.62 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.136 0.88 . . . . 72.31 113.181 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.99 -12.24 7.15 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-O 117.753 -1.582 . . . . 60.3 115.5 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 tp -58.0 -37.27 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 120.727 2.263 . . . . 74.33 110.773 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -58.69 -58.55 8.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.672 -1.233 . . . . 71.14 107.672 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -43.19 68.45 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.874 0.761 . . . . 74.25 111.777 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -57.3 -43.8 83.55 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.836 -0.801 . . . . 74.23 108.836 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.2 mtm -64.35 -43.27 95.1 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.985 -0.746 . . . . 75.42 108.985 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.44 -47.58 72.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.142 1.777 . . . . 62.24 111.495 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.11 -37.09 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.263 1.425 . . . . 71.32 107.959 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.06 -37.83 66.67 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.332 0.969 . . . . 75.43 109.44 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.6 mt -67.59 -28.58 67.89 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.625 0.77 . . . . 70.14 110.914 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.58 -8.53 27.6 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.405 0.682 . . . . 74.41 110.978 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -86.42 3.82 42.15 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.874 0.761 . . . . 64.32 111.203 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -66.97 131.1 45.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 119.688 -1.882 . . . . 75.54 107.845 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.09 8.68 58.88 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 117.976 -1.458 . . . . 74.44 114.579 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 p -70.39 146.82 50.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.883 2.342 . . . . 73.15 108.059 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.0 mt -89.9 108.0 19.45 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.743 -2.317 . . . . 73.0 104.743 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.9 tp -110.04 121.81 46.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.912 -1.885 . . . . 74.21 105.912 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 13.9 mtpp 53.92 38.42 28.73 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.813 0.845 . . . . 74.23 111.296 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 62.61 33.21 15.93 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.225 1.41 . . . . 73.52 112.462 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -140.79 117.87 11.22 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.925 1.69 . . . . 75.22 107.949 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -73.95 148.37 42.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.835 -1.543 . . . . 75.24 106.835 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.0 pt -133.66 169.2 22.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 124.876 1.27 . . . . 73.41 111.236 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -120.86 152.34 38.54 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.077 1.351 . . . . 74.3 111.11 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -135.05 136.5 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.528 1.131 . . . . 75.12 108.507 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -150.84 162.8 40.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.614 1.966 . . . . 73.44 108.521 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.73 152.22 18.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.019 1.328 . . . . 72.52 111.589 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.9 p -142.97 161.84 37.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.208 1.403 . . . . 75.33 108.671 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 t 46.01 91.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 128.391 2.676 . . . . 72.21 113.153 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.07 89.91 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.637 -2.185 . . . . 74.4 107.637 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 117.141 -1.921 . . . . 64.33 110.873 179.377 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.364 0 N-CA-C 107.354 -2.299 . . . . 62.34 107.354 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -132.81 44.27 2.88 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.078 1.351 . . . . 72.13 108.314 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.7 ptt85 -147.0 164.22 33.7 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.697 1.199 . . . . 74.11 109.539 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -133.39 165.56 24.55 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.606 2.362 . . . . 75.52 105.877 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.53 136.85 57.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.734 0.778 . . . . 72.51 109.819 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -103.21 118.87 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 104.558 -2.386 . . . . 63.43 104.558 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -90.62 133.15 35.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.222 -1.77 . . . . 75.33 106.222 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 t -138.85 130.93 37.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 118.144 -0.931 . . . . 50.11 108.509 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.81 -179.82 18.57 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 120.022 1.283 . . . . 73.44 112.019 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.48 25.65 2.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.13 2.172 . . . . 71.03 111.598 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.26 149.08 98.19 Favored Pre-proline 0 C--O 1.237 0.398 0 O-C-N 120.877 -1.14 . . . . 74.55 112.474 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.63 168.62 16.17 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.571 3.514 . . . . 75.54 111.612 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -70.31 -46.34 64.43 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.476 -0.935 . . . . 74.12 108.476 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.61 5.03 2.04 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.778 1.631 . . . . 74.1 114.163 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 tp -57.01 130.43 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 121.08 -1.012 . . . . 74.2 109.064 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.69 154.95 45.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.406 1.483 . . . . 71.22 107.788 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.17 -30.28 66.27 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 118.985 -0.531 . . . . 74.3 109.902 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -58.55 -43.96 88.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 118.465 0.575 . . . . 73.43 109.942 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -65.47 -43.73 89.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.169 0.988 . . . . 74.21 109.68 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.8 mt -67.43 -44.69 78.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.911 0.884 . . . . 73.31 111.297 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -56.8 -48.38 78.07 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 107.174 -1.417 . . . . 63.13 107.174 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.93 -40.87 95.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.539 1.136 . . . . 75.44 113.327 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.55 -22.24 57.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 114.377 1.251 . . . . 74.13 114.377 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -108.31 2.86 22.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.821 0.737 . . . . 75.21 111.895 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -52.18 -33.3 40.03 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.464 2.306 . . . . 73.03 113.731 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -82.25 -38.24 24.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.833 0.742 . . . . 64.35 110.046 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -22.6 64.67 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.634 1.173 . . . . 72.33 110.217 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m 53.78 67.27 3.71 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.543 1.137 . . . . 70.24 113.446 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.71 173.38 8.08 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.768 2.979 . . . . 54.42 109.638 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.7 -43.54 4.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.8 -1.185 . . . . 63.13 107.8 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -122.19 154.18 37.81 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.608 1.563 . . . . 74.31 109.648 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -146.7 122.9 3.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.899 -1.889 . . . . 75.34 105.899 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.34 102.95 4.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.441 1.497 . . . . 75.34 109.452 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -80.22 126.65 31.39 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.148 -1.797 . . . . 74.31 106.148 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -118.53 87.44 2.73 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.262 1.425 . . . . 74.42 111.146 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.34 -21.2 61.78 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.996 0.918 . . . . 63.43 111.87 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -54.61 -32.55 58.96 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.267 1.427 . . . . 72.25 111.576 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.3 mmtm -132.85 2.43 3.69 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 114.341 1.237 . . . . 74.01 114.341 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.47 40.38 54.55 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 120.39 1.45 . . . . 74.51 110.106 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 pt -129.53 170.12 19.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.616 1.966 . . . . 75.25 110.625 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.85 120.46 4.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.61 1.964 . . . . 73.15 108.859 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -99.14 150.95 21.52 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 118.615 0.643 . . . . 74.3 109.808 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.9 131.07 24.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.164 -1.051 . . . . 74.31 108.164 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -102.04 149.88 23.8 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 104.648 -2.353 . . . . 62.05 104.648 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -135.81 109.34 7.95 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.119 0.968 . . . . 71.41 108.5 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -68.39 110.01 3.92 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.816 1.246 . . . . 73.33 110.718 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.09 -15.23 57.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.569 2.347 . . . . 73.22 112.943 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.56 -39.3 32.12 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.393 -1.706 . . . . 74.24 106.393 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -61.73 -46.07 91.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.401 -0.963 . . . . 72.32 108.401 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.34 73.84 0.87 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.026 0.93 . . . . 62.01 109.556 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -48.21 -34.19 9.75 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.092 1.145 . . . . 63.43 114.092 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 p -121.81 -19.12 6.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 124.05 0.844 . . . . 75.01 111.686 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.08 -16.73 76.05 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.125 -0.984 . . . . 63.54 112.006 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 tp -50.75 -40.22 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.99 1.316 . . . . 70.13 110.914 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -57.51 -61.56 2.41 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.126 1.37 . . . . 64.11 108.439 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -50.98 -50.94 57.33 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.577 1.151 . . . . 73.41 110.095 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -52.85 -52.01 58.81 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.293 0.637 . . . . 70.31 110.776 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 36.4 mtm -66.79 -35.56 80.37 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 123.103 0.561 . . . . 74.4 111.358 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -46.98 87.7 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.863 1.265 . . . . 71.53 109.454 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.7 mt -62.87 -36.35 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.581 -0.896 . . . . 71.42 108.581 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.4 -43.06 70.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.94 -0.763 . . . . 72.12 108.94 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 mt -63.9 -33.15 75.05 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.663 0.785 . . . . 72.41 111.031 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.78 -13.14 41.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.298 0.851 . . . . 74.55 113.298 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -86.53 3.4 44.35 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.896 0.771 . . . . 74.23 111.547 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -59.74 113.98 2.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.931 -1.106 . . . . 72.53 109.414 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.06 12.34 55.25 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 118.371 -1.238 . . . . 74.44 115.385 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.4 p -69.62 149.08 48.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.174 1.987 . . . . 72.21 109.62 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.9 mt -96.43 107.18 19.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.062 -1.829 . . . . 64.32 106.062 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.423 ' CD2' ' HZ2' ' A' ' 70' ' ' LYS . 3.1 mt -109.92 122.66 48.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.189 -2.152 . . . . 73.21 105.189 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.423 ' HZ2' ' CD2' ' A' ' 69' ' ' LEU . 4.5 mtmm 46.43 40.3 7.79 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.328 1.051 . . . . 72.32 110.954 -178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 67.74 20.38 9.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.627 2.371 . . . . 74.24 114.248 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -120.22 125.96 49.44 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.092 1.357 . . . . 70.4 108.354 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -82.57 112.99 19.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.838 -0.801 . . . . 73.4 108.838 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.0 pp -87.46 171.13 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 124.429 1.092 . . . . 74.34 110.906 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.95 151.27 51.83 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.228 1.411 . . . . 61.11 109.106 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.3 t -134.1 144.24 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.231 1.413 . . . . 63.44 108.31 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -153.54 160.76 42.58 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.467 1.907 . . . . 75.11 108.864 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.34 151.84 22.33 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 120.99 -1.068 . . . . 71.15 108.699 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 p -144.48 140.22 28.77 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.708 -0.849 . . . . 72.24 108.708 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.5 t 50.07 85.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 125.893 1.677 . . . . 74.44 111.826 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.37 79.85 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.887 -0.673 . . . . 62.2 112.721 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 N-CA-C 104.374 -3.49 . . . . 73.15 104.374 178.016 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.894 0 N-CA-C 111.257 -0.737 . . . . 72.31 111.257 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -60.35 5.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.251 1.945 . . . . 74.22 116.251 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.424 HH11 ' CD ' ' A' ' 44' ' ' GLU . 8.9 ttm180 -129.9 115.75 17.64 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 121.132 1.787 . . . . 75.25 106.714 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -99.85 164.91 11.82 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.107 0.963 . . . . 72.33 108.546 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.3 mt -134.87 149.01 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.933 1.293 . . . . 74.41 110.965 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.2 t -118.51 134.3 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.802 2.041 . . . . 75.43 105.851 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -100.62 142.21 32.4 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 126.15 1.78 . . . . 74.43 108.826 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.41 133.53 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.21 -1.774 . . . . 74.11 106.21 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -132.57 -179.7 16.5 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 120.385 1.448 . . . . 55.5 111.123 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.88 14.48 9.84 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.526 1.931 . . . . 71.41 112.621 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.35 148.05 9.37 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 124.737 1.215 . . . . 73.45 112.958 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.78 154.34 50.27 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.649 2.899 . . . . 74.22 110.341 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -70.36 -37.56 74.62 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.881 -0.512 . . . . 75.2 109.917 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.59 25.3 3.11 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.336 1.054 . . . . 61.33 111.855 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.414 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 8.4 tp -53.84 139.92 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.832 1.253 . . . . 75.11 110.537 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -124.78 148.04 48.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.611 1.164 . . . . 73.44 108.423 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.29 -29.84 70.12 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 118.852 -0.594 . . . . 64.44 111.097 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.66 -37.01 76.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 118.764 0.711 . . . . 74.3 109.708 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -69.17 -44.67 71.76 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.727 -0.842 . . . . 74.42 108.727 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 mt -60.49 -54.71 42.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.342 0.657 . . . . 75.22 110.786 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -59.87 -41.42 91.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.373 -0.602 . . . . 74.12 109.373 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -67.94 -40.53 83.29 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.855 0.687 . . . . 64.21 112.855 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -22.68 65.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 120.047 1.294 . . . . 73.33 113.071 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -112.29 6.07 18.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.056 0.942 . . . . 75.52 111.513 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -41.7 63.04 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.25 1.42 . . . . 74.54 112.264 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -58.17 -54.32 48.31 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.972 -0.751 . . . . 75.44 108.972 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.09 -22.06 66.39 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.653 1.181 . . . . 64.42 112.627 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 t 50.41 78.26 0.41 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.195 2.198 . . . . 74.54 112.418 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.55 168.14 20.66 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.256 2.637 . . . . 72.02 110.577 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -94.68 -31.8 13.65 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.488 1.115 . . . . 72.32 109.961 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.04 161.0 41.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.859 0.863 . . . . 65.13 109.807 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.68 107.13 2.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 104.295 -2.483 . . . . 73.25 104.295 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.5 ttp180 -117.98 103.96 10.43 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.577 -1.268 . . . . 75.53 107.577 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.57 124.78 36.85 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.49 1.516 . . . . 75.41 110.51 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.56 80.12 1.49 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.602 1.961 . . . . 74.23 108.024 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.83 -17.37 56.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.107 0.963 . . . . 73.41 111.216 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.429 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 1.4 m-20 -51.4 -32.8 27.63 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.647 1.979 . . . . 65.14 109.884 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.433 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 5.3 mmpt? -126.73 -9.69 6.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.378 1.871 . . . . 74.22 111.351 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.42 36.77 33.2 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.661 -1.376 . . . . 75.13 109.661 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.416 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 36.0 pt -124.47 168.42 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.173 1.389 . . . . 73.4 108.417 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.67 166.3 33.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.569 1.148 . . . . 72.34 109.442 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -135.77 140.82 44.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.562 1.545 . . . . 74.2 108.083 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mp -134.49 123.62 24.25 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.016 -1.475 . . . . 74.13 107.016 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.424 ' CD ' HH11 ' A' ' 3' ' ' ARG . 4.5 mt-10 -98.64 156.73 16.67 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.614 -0.513 . . . . 73.34 109.614 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -146.65 119.63 8.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.201 -1.407 . . . . 74.5 107.201 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -83.72 119.14 24.43 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.765 -0.458 . . . . 73.12 109.765 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.35 61.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.991 1.716 . . . . 54.12 111.219 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -70.4 -23.77 62.82 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.86 -1.163 . . . . 73.45 107.86 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -62.18 -32.37 72.99 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-O 118.362 -0.828 . . . . 71.15 110.368 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -168.02 101.52 0.46 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.461 1.504 . . . . 72.32 108.078 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -52.76 -22.62 5.49 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 116.301 1.963 . . . . 74.43 116.301 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p -121.43 -19.36 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 120.115 1.325 . . . . 71.33 110.872 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.9 -30.62 51.33 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-O 118.592 -1.116 . . . . 64.54 110.705 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.1 tp -52.58 -37.65 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.24 1.416 . . . . 74.14 110.061 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.01 -58.05 9.52 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.618 1.167 . . . . 74.44 107.934 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -54.79 -41.29 70.39 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.258 0.623 . . . . 72.42 110.242 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.6 mtt85 -57.95 -50.23 74.09 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-O 118.421 -0.8 . . . . 74.14 110.233 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 10.8 mtm -59.85 -45.49 92.27 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.195 0.452 . . . . 74.03 110.451 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.4 -54.57 45.13 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 122.86 0.464 . . . . 72.24 110.666 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.8 mt -58.1 -36.94 59.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 125.194 1.398 . . . . 73.35 109.596 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.11 -43.97 73.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.733 -0.469 . . . . 65.14 109.733 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.68 -35.66 81.75 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.347 0.659 . . . . 74.4 110.337 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.8 mt -62.47 -2.57 1.1 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.949 1.7 . . . . 72.3 113.646 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -94.45 3.73 54.77 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.675 1.19 . . . . 71.21 110.314 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -65.85 135.08 54.34 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.153 1.781 . . . . 74.21 109.686 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.01 15.53 67.36 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.706 1.622 . . . . 74.25 113.312 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -78.59 155.99 29.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.883 1.342 . . . . 61.42 108.139 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.32 108.0 20.15 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.356 -0.979 . . . . 73.5 108.356 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -112.32 115.59 29.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.631 -1.618 . . . . 74.02 106.631 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 3.8 mtpp 50.2 53.45 12.84 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.027 0.918 . . . . 75.21 111.081 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 55.43 20.44 3.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.303 2.241 . . . . 74.53 114.523 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -122.8 122.77 39.49 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 126.079 1.751 . . . . 63.44 107.837 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -83.14 104.86 13.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.036 -1.098 . . . . 73.42 108.036 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 pt -87.92 169.3 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.234 -0.894 . . . . 63.45 111.289 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -123.87 154.18 40.03 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.435 1.494 . . . . 74.35 110.222 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.2 142.15 42.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.936 -1.505 . . . . 73.13 106.936 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.67 174.78 14.05 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.472 1.909 . . . . 74.3 110.517 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -90.42 149.2 22.35 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.797 1.239 . . . . 75.11 112.422 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p -150.93 150.01 30.31 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.505 -1.665 . . . . 73.24 106.505 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.7 t 64.53 -67.65 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.535 1.934 . . . . 75.31 113.09 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.03 -16.83 73.13 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 127.011 2.243 . . . . 62.24 115.845 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.919 0 N-CA-C 105.906 -2.877 . . . . 64.51 105.906 179.888 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.383 0 N-CA-C 109.435 -1.466 . . . . 71.21 109.435 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -67.55 -3.14 7.9 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 115.898 1.814 . . . . 72.53 115.898 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -120.6 106.24 11.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.964 0.802 . . . . 73.34 111.889 -177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -99.05 159.33 15.04 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 127.738 2.415 . . . . 73.15 110.055 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.17 149.22 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.604 1.162 . . . . 72.14 110.953 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.8 t -116.07 128.8 73.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.752 -1.573 . . . . 73.3 106.752 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -88.05 131.62 34.59 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.661 1.584 . . . . 73.2 106.886 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.2 t -138.58 128.69 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.31 -1.737 . . . . 75.53 106.31 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.08 -175.15 13.85 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 119.212 0.914 . . . . 75.41 111.871 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.49 14.66 8.35 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.97 1.708 . . . . 74.11 111.157 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.85 150.81 75.76 Favored Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 125.283 1.433 . . . . 74.52 111.551 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.74 157.63 60.9 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.035 2.49 . . . . 64.24 109.975 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -69.3 -36.15 76.73 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.265 -0.897 . . . . 64.12 111.015 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -88.26 15.06 8.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.884 0.874 . . . . 73.3 112.955 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.1 tp -50.46 140.92 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.779 1.231 . . . . 74.31 111.617 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 p -128.47 147.5 50.67 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.122 -0.695 . . . . 70.02 109.122 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.68 -27.21 66.2 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 118.481 -0.771 . . . . 75.0 112.064 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.78 -36.54 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.02 -0.733 . . . . 64.0 109.02 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -73.41 -42.53 61.96 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 123.82 0.848 . . . . 72.5 108.857 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.9 mt -62.09 -49.41 76.05 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.484 -0.561 . . . . 70.25 109.484 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -58.46 -46.58 86.3 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.901 -1.148 . . . . 71.24 107.901 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -57.44 -46.13 83.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 114.003 1.112 . . . . 75.1 114.003 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -65.95 -56.45 11.63 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.08 1.309 . . . . 64.33 110.405 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -73.25 4.27 4.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.424 1.268 . . . . 73.21 114.424 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -53.89 -31.23 49.2 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 125.364 1.466 . . . . 74.33 113.353 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -8.27 56.61 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.298 1.039 . . . . 71.52 112.48 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 p -112.08 -9.62 13.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.333 1.853 . . . . 70.21 110.858 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.4 m 39.5 78.2 0.38 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.912 2.085 . . . . 73.34 115.762 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.37 164.14 29.51 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.991 2.461 . . . . 71.13 109.962 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -90.01 -41.15 11.88 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.018 0.927 . . . . 71.11 108.999 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -144.32 155.88 44.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.316 0.646 . . . . 74.52 109.688 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.35 123.96 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 127.044 2.138 . . . . 65.4 108.939 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.09 104.69 6.03 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.384 2.273 . . . . 75.45 107.233 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.13 121.79 32.51 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.831 -1.174 . . . . 72.42 107.831 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -116.96 75.07 0.94 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.901 -1.518 . . . . 74.42 106.901 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -26.68 27.03 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.186 1.394 . . . . 64.41 112.248 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -51.68 -25.79 7.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.289 2.236 . . . . 75.41 113.315 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -133.07 10.39 4.19 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.907 1.683 . . . . 74.41 110.269 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.85 44.04 96.24 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.043 1.306 . . . . 73.22 110.012 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.5 pt -132.77 169.77 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 C-N-CA 125.067 1.347 . . . . 72.42 111.011 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.06 166.0 29.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.245 1.818 . . . . 62.02 108.829 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.1 116.8 14.96 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.608 -1.627 . . . . 74.23 106.608 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -113.92 115.52 27.81 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.77 -1.567 . . . . 75.41 106.77 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -88.48 152.83 21.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.11 -1.441 . . . . 71.43 107.11 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -145.58 133.27 21.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.342 1.457 . . . . 74.0 107.173 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -101.89 108.33 19.77 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.066 1.346 . . . . 62.12 112.234 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.57 -23.26 65.39 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.083 1.353 . . . . 63.21 112.21 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -75.39 -25.48 57.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.014 -0.736 . . . . 64.31 109.014 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -66.59 -34.51 78.04 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.928 0.891 . . . . 75.23 110.402 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -156.72 91.26 1.21 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.921 0.782 . . . . 74.15 111.269 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -48.65 -34.26 11.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.402 1.881 . . . . 75.12 115.787 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.94 -16.49 14.29 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 113.344 0.868 . . . . 75.45 113.344 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.31 -19.07 29.09 Favored Glycine 0 C--O 1.225 -0.461 0 CA-C-O 117.707 -1.607 . . . . 74.11 112.927 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 tp -56.04 -35.57 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 120.187 1.993 . . . . 74.42 108.758 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -62.52 -60.81 3.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.363 1.865 . . . . 73.14 108.263 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.0 mmt-85 -54.44 -39.01 66.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.144 0.977 . . . . 71.42 110.344 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -62.94 -47.62 82.43 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.207 -1.034 . . . . 74.45 108.207 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.8 mtm -63.27 -41.82 99.06 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 123.839 0.856 . . . . 75.3 110.226 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -56.81 -50.53 72.08 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.601 1.16 . . . . 72.54 109.051 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.36 -30.86 50.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.273 1.429 . . . . 75.42 110.88 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 -44.23 52.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.477 -0.935 . . . . 74.42 108.477 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mt -63.59 -29.01 70.32 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.376 1.071 . . . . 75.21 112.206 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.79 -2.82 22.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 118.755 -0.64 . . . . 72.11 112.018 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -84.79 -5.95 59.34 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.425 1.011 . . . . 72.54 109.987 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -66.19 112.53 3.98 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.724 1.147 . . . . 71.42 108.671 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.23 -8.19 38.07 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.626 1.108 . . . . 73.42 113.049 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.1 p -65.72 148.98 50.88 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 119.234 1.517 . . . . 75.44 108.678 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.2 mt -98.51 108.07 20.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.58 -2.378 . . . . 71.02 104.58 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.0 tp -102.55 111.11 23.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.291 -1.744 . . . . 75.34 106.291 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt 48.89 51.34 16.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.451 1.1 . . . . 73.42 111.163 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.274 9.6 mt-10 57.97 38.7 26.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 128.031 2.532 . . . . 74.34 114.159 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -137.58 118.15 13.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 126.285 1.834 . . . . 74.03 106.59 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -78.46 105.23 9.58 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.772 -1.195 . . . . 75.24 107.772 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.6 pt -79.52 172.4 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 125.149 1.379 . . . . 75.43 113.262 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.42 149.94 44.41 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.528 1.931 . . . . 73.22 106.61 177.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.8 t -139.91 120.98 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 106.308 -1.738 . . . . 73.1 106.308 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.01 175.69 9.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.834 1.254 . . . . 72.53 110.608 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.53 152.22 30.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.442 1.497 . . . . 74.44 113.396 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.63 129.45 15.24 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.24 -1.393 . . . . 75.12 107.24 177.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.5 ' CG1' ' H ' ' A' ' 81' ' ' GLY . 16.3 t 57.87 -164.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.924 0.889 . . . . 75.11 109.971 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.5 ' H ' ' CG1' ' A' ' 80' ' ' VAL . . . 102.64 83.9 1.76 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.97 1.271 . . . . 62.01 110.659 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.3 0 C-N-CA 127.958 2.694 . . . . 74.33 106.604 179.485 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.789 0 N-CA-C 109.787 -1.325 . . . . 73.41 109.787 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -100.85 -12.28 19.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.488 1.644 . . . . 53.03 114.985 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.42 112.58 18.72 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.987 -1.116 . . . . 75.23 107.987 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -103.18 160.71 14.41 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.214 1.805 . . . . 74.32 108.558 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.1 mp -134.37 149.83 30.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.924 1.69 . . . . 72.04 107.63 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.9 t -119.18 124.21 72.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 105.238 -2.134 . . . . 72.44 105.238 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -82.53 131.8 35.21 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.543 -2.021 . . . . 72.44 105.543 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.2 t -136.36 122.53 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.546 -2.02 . . . . 73.44 105.546 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.81 180.0 17.21 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 120.066 1.303 . . . . 73.54 113.485 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.48 19.62 5.11 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.987 2.115 . . . . 64.4 111.331 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.2 mp -62.63 148.13 91.52 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.152 0.981 . . . . 55.14 110.951 -179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.56 150.91 80.17 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.677 2.918 . . . . 71.02 110.553 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -30.15 71.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.618 -0.706 . . . . 74.45 111.3 178.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.98 11.97 18.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.37 1.248 . . . . 74.24 114.37 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.438 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 7.8 tp -54.46 147.93 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.922 1.289 . . . . 74.33 110.42 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -128.21 157.0 42.05 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.428 0.691 . . . . 62.41 110.822 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.12 -32.19 73.66 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.977 -0.452 . . . . 62.3 109.802 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 p -63.39 -44.51 98.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.457 -0.572 . . . . 73.31 109.457 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.58 ' CD ' ' HZ2' ' A' ' 70' ' ' LYS . 69.8 mt-10 -71.05 -36.08 72.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.196 -0.43 . . . . 72.21 110.061 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.0 mt -63.4 -46.28 87.13 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.421 -0.955 . . . . 74.34 108.421 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -58.33 -49.99 75.22 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.883 -1.155 . . . . 75.11 107.883 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -55.45 -44.16 76.13 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.529 0.937 . . . . 75.12 113.529 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -30.25 70.31 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 114.342 1.238 . . . . 73.0 114.342 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.07 6.23 19.11 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.61 0.764 . . . . 74.22 112.662 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -54.44 -43.32 71.5 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.412 1.485 . . . . 64.21 110.637 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -61.21 -35.3 76.83 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.561 0.744 . . . . 64.2 111.618 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.92 -17.36 38.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.735 1.614 . . . . 73.02 111.417 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.43 72.95 0.98 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 126.728 2.011 . . . . 74.34 116.239 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.39 161.71 43.68 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.037 2.492 . . . . 75.44 110.187 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.09 -46.56 8.4 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.031 1.732 . . . . 63.13 108.939 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -131.72 156.32 46.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.25 -0.886 . . . . 73.32 112.383 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.9 mt -146.77 123.9 3.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.416 -1.328 . . . . 75.42 107.416 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.72 104.91 5.44 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 128.28 2.632 . . . . 72.53 106.794 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.12 112.25 24.14 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.33 1.052 . . . . 75.03 110.25 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -97.79 82.78 3.08 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.092 -1.818 . . . . 75.43 106.092 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.04 -29.71 58.03 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.669 0.787 . . . . 74.42 111.563 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.18 -32.3 22.98 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.483 2.313 . . . . 74.15 112.6 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -122.15 -5.13 8.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.372 1.469 . . . . 74.25 110.2 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.09 47.43 85.36 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 125.674 1.607 . . . . 61.22 109.488 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.2 pt -135.57 162.4 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.152 1.381 . . . . 74.23 108.869 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.96 166.22 24.59 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.926 1.29 . . . . 74.31 108.369 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -133.47 104.7 6.53 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.627 -1.62 . . . . 73.4 106.627 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.27 113.16 26.58 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.429 -1.323 . . . . 74.54 107.429 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.32 153.6 19.81 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.33 1.452 . . . . 75.15 108.703 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -147.75 136.24 21.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.895 1.278 . . . . 70.4 108.224 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -101.48 111.51 23.76 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.958 1.303 . . . . 75.1 111.919 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.64 -21.47 55.43 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.073 2.149 . . . . 63.53 110.396 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.64 -30.41 71.35 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.989 -1.486 . . . . 41.5 106.989 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -62.06 -33.59 74.68 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 117.994 -1.003 . . . . 73.25 110.765 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -157.24 108.41 2.33 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 114.642 1.349 . . . . 53.51 114.642 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -68.05 -19.31 64.87 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 117.182 -1.389 . . . . 74.15 112.999 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.359 43.5 p -122.53 14.73 10.29 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.795 1.634 . . . . 74.35 114.535 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -131.03 -19.89 1.21 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.346 1.45 . . . . 60.55 115.167 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.8 -30.41 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 120.484 2.142 . . . . 72.14 109.514 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -64.14 -55.97 18.08 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 126.142 1.777 . . . . 73.31 110.086 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -58.55 -27.36 64.5 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.428 1.491 . . . . 71.54 110.719 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mtt85 -76.33 -45.83 30.41 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.239 -1.023 . . . . 71.33 108.239 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 8.2 mtm -57.57 -41.67 81.54 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.959 0.904 . . . . 73.1 108.904 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -55.17 -49.08 72.77 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.322 1.449 . . . . 74.14 110.391 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.7 mt -64.66 -41.55 92.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 124.271 1.028 . . . . 73.32 109.439 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.36 93.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.69 -0.856 . . . . 64.43 108.69 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.3 mt -63.83 -32.52 74.06 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.188 0.995 . . . . 73.23 110.51 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.32 -10.78 26.36 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.175 -0.917 . . . . 75.0 110.808 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -85.91 -0.78 56.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.031 1.287 . . . . 70.31 110.755 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.2 112.38 3.01 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.682 -1.261 . . . . 73.32 107.767 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.56 1.75 57.68 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 117.421 -1.766 . . . . 70.55 113.261 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.256 51.3 p -66.02 142.83 57.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.988 2.394 . . . . 74.23 110.33 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.48 116.65 29.03 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.593 1.157 . . . . 74.4 108.172 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 mt -122.53 120.4 33.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 105.949 -1.871 . . . . 71.22 105.949 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.58 ' HZ2' ' CD ' ' A' ' 19' ' ' GLU . 10.7 mtmm 44.3 47.53 7.88 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.749 1.62 . . . . 75.43 110.076 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 59.39 33.71 22.49 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.225 1.81 . . . . 73.23 114.712 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -130.18 117.56 20.09 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 104.742 -2.318 . . . . 75.52 104.742 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -78.58 107.96 11.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.97 -1.122 . . . . 74.14 107.97 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -78.99 170.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 124.501 1.12 . . . . 62.21 111.06 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.26 155.62 47.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.001 1.72 . . . . 74.41 109.344 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.6 t -139.23 133.11 39.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 O-C-N 124.003 0.815 . . . . 64.41 110.224 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -143.9 175.43 10.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.013 1.325 . . . . 64.52 108.621 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.89 150.58 21.16 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.828 0.851 . . . . 73.34 109.168 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.9 t -148.69 82.51 1.46 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.99 -1.115 . . . . 73.42 107.99 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -167.37 -62.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 123.83 0.852 . . . . 73.22 109.416 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.33 -32.42 75.75 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.528 -0.629 . . . . 64.24 111.528 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 N-CA-C 106.312 -2.715 . . . . 75.11 106.312 -179.677 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.3 ptt85 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 120.722 0.296 . . . . 54.42 110.669 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -126.36 162.91 24.43 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.956 1.702 . . . . 73.13 106.838 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.461 ' HB ' HG23 ' A' ' 79' ' ' THR . 2.3 mp -129.15 149.67 33.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.11 0.964 . . . . 74.14 108.577 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.2 t -109.79 124.69 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.249 1.42 . . . . 73.21 107.922 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -91.2 100.28 13.13 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.605 -1.998 . . . . 71.14 105.605 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.1 t -104.75 132.04 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.935 -1.876 . . . . 32.53 105.935 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.77 179.3 27.6 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 121.352 1.887 . . . . 54.54 113.758 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.72 14.01 0.99 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.291 2.637 . . . . 52.33 111.943 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 mp -55.7 157.65 7.35 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.897 1.679 . . . . 74.35 115.059 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.69 153.0 59.55 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.289 3.326 . . . . 72.25 110.544 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -34.32 75.3 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.216 0.606 . . . . 74.14 111.685 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -90.39 11.12 22.49 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.714 1.375 . . . . 61.24 114.714 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.3 tp -45.44 140.39 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 114.603 1.334 . . . . 74.43 114.603 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.38 147.6 46.92 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.149 1.38 . . . . 44.14 108.744 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -29.18 69.04 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.493 0.717 . . . . 74.31 111.105 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.16 -43.33 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.194 0.998 . . . . 61.14 109.17 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.09 -18.89 61.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.954 1.301 . . . . 71.22 111.744 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.9 mt -86.25 -44.24 12.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 120.573 -1.329 . . . . 41.43 109.524 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -62.17 -45.64 92.53 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.01 0.924 . . . . 73.43 110.955 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -65.35 -27.26 68.45 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 114.171 1.174 . . . . 65.22 114.171 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -74.49 -60.92 2.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.544 1.138 . . . . 75.34 109.587 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -80.94 3.65 22.15 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 114.675 1.361 . . . . 61.14 114.675 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -48.53 -51.68 26.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.795 1.638 . . . . 63.32 110.595 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -60.54 -44.42 96.12 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.774 0.83 . . . . 61.23 111.857 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 p -70.57 -16.41 62.86 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.145 -0.972 . . . . 13.11 112.981 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m 49.78 71.42 1.58 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.792 2.037 . . . . 53.23 116.064 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.29 165.72 23.67 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.944 2.429 . . . . 63.51 110.312 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -99.15 -47.41 5.22 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.812 1.645 . . . . 53.23 108.134 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.62 149.19 40.11 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.212 1.005 . . . . 73.52 109.872 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -146.7 112.31 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.651 1.58 . . . . 64.23 107.08 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -140.27 104.08 4.72 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.653 1.581 . . . . 74.41 110.13 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -89.87 127.78 36.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.132 1.773 . . . . 62.44 110.589 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -118.95 85.58 2.39 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.22 1.808 . . . . 75.41 108.109 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.64 -22.04 43.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.338 0.655 . . . . 52.42 112.544 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -51.5 -28.21 12.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.664 2.386 . . . . 53.03 112.346 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -133.44 8.43 3.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.697 1.999 . . . . 75.23 110.448 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.01 36.24 72.9 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.787 -1.007 . . . . 73.12 111.877 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.5 170.36 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 126.441 1.896 . . . . 73.33 108.575 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.06 170.89 19.35 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.534 -1.284 . . . . 54.42 107.534 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -128.23 135.83 50.22 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.429 -2.063 . . . . 73.34 105.429 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.96 107.82 6.3 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 106.812 -1.551 . . . . 73.31 106.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -88.36 154.3 20.5 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.442 -1.688 . . . . 52.23 106.442 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -139.93 116.2 10.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.763 1.225 . . . . 65.14 107.817 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -70.22 108.93 4.38 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.624 0.726 . . . . 60.11 111.55 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.43 69.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.387 1.075 . . . . 51.11 110.016 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.14 -21.05 65.85 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.649 0.779 . . . . 61.53 111.76 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -37.91 87.07 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.542 -0.91 . . . . 74.52 108.542 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -158.44 102.69 1.75 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 119.385 0.993 . . . . 71.42 111.327 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -52.74 -33.94 50.51 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.814 0.846 . . . . 64.52 112.769 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 12.9 18.8 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.736 1.013 . . . . 72.43 113.736 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.23 -24.91 3.38 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.849 1.214 . . . . 72.24 112.076 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tp -55.56 -33.4 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 118.442 1.121 . . . . 64.14 110.643 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -61.28 2.54 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.513 1.125 . . . . 52.34 109.545 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -60.54 -36.62 78.87 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 118.791 -0.623 . . . . 61.12 111.515 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -59.2 -42.97 92.19 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.713 -0.847 . . . . 74.33 108.713 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.2 mtm -67.76 -45.5 74.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.469 -1.253 . . . . 73.15 108.801 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -52.27 -51.47 58.26 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.103 1.319 . . . . 60.33 110.001 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.3 mt -59.09 -38.62 75.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 125.32 1.448 . . . . 72.22 110.449 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.36 -42.39 62.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.455 0.571 . . . . 72.41 109.623 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 mt -65.53 -30.3 71.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.791 1.636 . . . . 63.41 111.498 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 mt -65.9 -12.95 58.51 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.996 -0.526 . . . . 74.33 110.527 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -86.7 6.15 32.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.003 0.921 . . . . 71.31 110.823 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -73.76 115.36 13.09 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.39 -2.078 . . . . 72.41 105.39 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.04 5.71 70.26 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 125.053 1.311 . . . . 54.31 111.909 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 p -75.53 162.96 27.86 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 119.949 1.875 . . . . 72.25 107.203 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 mt -95.25 139.42 31.6 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 126.919 2.087 . . . . 62.44 108.048 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -145.74 122.85 11.46 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.668 1.987 . . . . 63.21 107.713 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt 42.06 46.95 3.79 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.779 1.232 . . . . 74.13 113.02 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.315 98.5 mt-10 66.0 23.71 11.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.814 2.045 . . . . 75.42 116.406 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -125.26 152.46 44.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.393 -2.077 . . . . 74.14 105.393 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -103.56 135.7 44.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 102.372 -3.195 . . . . 53.54 102.372 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.5 pt -122.63 161.28 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 119.0 0.818 . . . . 75.32 112.929 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -107.17 156.93 18.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.851 1.26 . . . . 72.43 111.244 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -147.49 118.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 125.512 1.525 . . . . 61.11 107.908 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -141.75 174.92 10.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.593 1.157 . . . . 75.44 110.506 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -84.05 151.9 24.7 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.29 1.036 . . . . 55.11 111.045 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.461 HG23 ' HB ' ' A' ' 5' ' ' ILE . 1.8 t . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 105.951 -1.87 . . . . 51.43 105.951 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 . . . . . 0 CA--C 1.511 -0.521 0 CA-C-O 120.022 -0.037 . . . . 72.04 110.947 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -95.25 163.43 13.27 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.119 1.368 . . . . 75.13 107.49 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -135.16 138.12 49.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 107.392 -1.336 . . . . 74.04 107.392 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.2 t -96.28 146.63 6.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 104.671 -2.344 . . . . 72.42 104.671 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.05 103.62 12.88 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.404 -2.072 . . . . 71.04 105.404 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 11' ' ' LEU . 49.6 t -110.78 121.58 63.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.508 -1.664 . . . . 70.1 106.508 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -142.39 178.35 20.99 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 119.993 1.27 . . . . 74.21 113.043 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.72 21.93 5.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.087 2.155 . . . . 54.51 112.297 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 8' ' ' VAL . 8.5 mp -64.15 150.02 93.07 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.325 1.45 . . . . 73.21 112.854 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.12 149.75 76.76 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.908 2.405 . . . . 70.14 110.171 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -59.8 -35.59 75.0 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.112 0.565 . . . . 74.23 110.142 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.83 14.14 10.99 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.5 1.296 . . . . 62.42 114.5 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.506 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 10.1 tp -47.08 142.88 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 124.372 1.069 . . . . 73.21 111.609 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 p -124.37 148.75 47.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.385 1.074 . . . . 75.23 108.33 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -32.77 72.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.683 -0.675 . . . . 73.24 110.074 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.12 -41.47 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-N 118.831 0.741 . . . . 65.23 109.829 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.36 -42.23 79.5 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.543 -0.54 . . . . 51.23 109.543 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 mt -65.96 -40.44 91.31 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.698 0.399 . . . . 62.45 111.605 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -46.63 77.46 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.516 -1.29 . . . . 75.35 107.516 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -61.11 -48.49 81.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 114.083 1.142 . . . . 74.23 114.083 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -28.44 68.61 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.488 0.921 . . . . 73.05 113.488 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -112.52 9.18 19.51 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 112.92 0.711 . . . . 63.34 112.92 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -55.34 -34.32 64.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.683 -1.26 . . . . 74.42 112.349 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.92 -34.6 44.44 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.324 0.511 . . . . 73.34 110.602 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -27.95 62.86 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.12 -0.696 . . . . 72.3 109.12 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.4 m 58.55 66.24 2.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 127.054 2.141 . . . . 52.51 114.792 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -63.53 164.96 19.13 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.731 2.954 . . . . 62.23 111.854 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -91.1 -40.74 11.43 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.115 1.766 . . . . 63.11 109.291 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -137.23 164.39 28.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.35 0.66 . . . . 74.42 111.311 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.8 mt -151.46 126.26 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.502 -1.666 . . . . 73.31 106.502 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.58 104.65 4.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.444 1.497 . . . . 74.42 107.172 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.35 125.42 34.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.389 -1.337 . . . . 73.14 107.389 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -112.97 86.41 2.37 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.165 -1.791 . . . . 65.41 106.165 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.14 -29.77 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.39 0.676 . . . . 71.32 111.01 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.7 -24.27 8.31 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.305 2.242 . . . . 71.44 113.096 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -132.73 -0.09 3.52 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.846 1.258 . . . . 72.31 111.836 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.63 41.76 98.98 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.132 -1.187 . . . . 75.31 110.132 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.513 HG22 ' CA ' ' A' ' 9' ' ' GLY . 5.3 pt -137.0 167.48 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.707 1.603 . . . . 73.2 109.149 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.18 166.36 24.91 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.382 1.073 . . . . 62.0 108.498 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -130.77 119.14 21.87 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.201 -2.148 . . . . 74.54 105.201 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.14 108.99 12.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.388 -1.708 . . . . 73.22 106.388 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.51 153.06 24.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.322 1.849 . . . . 74.45 109.533 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -144.58 108.37 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.687 1.195 . . . . 64.23 108.633 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -72.59 115.68 12.15 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.578 0.704 . . . . 73.34 110.227 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.2 -24.26 54.68 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.933 2.093 . . . . 52.14 111.834 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.85 -27.98 50.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.321 -0.371 . . . . 61.25 110.415 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -71.09 -36.97 72.4 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.21 0.604 . . . . 73.41 111.206 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.7 76.18 1.71 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.493 1.117 . . . . 75.51 111.085 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -47.55 66.07 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.512 -1.368 . . . . 72.31 113.684 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.25 5.25 52.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 114.086 1.143 . . . . 74.32 114.086 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.59 -5.76 2.8 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 117.386 -1.785 . . . . 72.43 115.502 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.7 tp -56.29 -42.39 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 121.073 2.436 . . . . 74.33 108.781 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -56.34 23.16 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 107.722 -1.214 . . . . 60.11 107.722 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -50.36 -48.49 55.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.417 1.087 . . . . 75.23 110.739 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -48.65 74.28 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.451 0.7 . . . . 72.35 109.124 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 48.8 mtm -68.84 -32.29 71.87 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 118.662 -0.685 . . . . 63.43 112.207 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.21 -51.53 68.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.134 2.173 . . . . 74.25 110.291 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mt -63.1 -39.6 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.313 1.445 . . . . 73.42 108.189 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.02 -41.63 81.89 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.178 -0.915 . . . . 62.12 109.554 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.2 mt -65.72 -31.24 72.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.33 0.968 . . . . 74.4 111.352 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 mt -66.16 -12.71 57.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.713 -0.661 . . . . 73.44 111.319 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -86.29 6.7 28.51 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 117.974 -1.012 . . . . 75.21 111.321 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -73.04 121.54 20.32 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.354 1.862 . . . . 70.42 108.86 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.96 3.22 58.08 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.828 -0.984 . . . . 73.33 114.377 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.4 p -68.84 151.61 46.37 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 119.35 1.575 . . . . 55.14 108.465 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.8 mt -97.42 110.84 23.32 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.711 -1.589 . . . . 72.23 106.711 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mt -113.59 119.11 36.37 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.843 -1.91 . . . . 75.11 105.843 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 41.9 mttm 45.03 58.31 4.13 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.643 1.577 . . . . 72.53 109.806 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 59.12 14.43 3.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.265 1.826 . . . . 70.41 115.033 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -121.14 122.01 39.08 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 120.479 -1.388 . . . . 44.44 110.545 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.86 123.85 25.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 104.601 -2.37 . . . . 74.31 104.601 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.4 pt -108.67 169.85 3.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 119.276 0.944 . . . . 65.34 112.9 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -112.56 146.03 39.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.691 1.196 . . . . 55.54 108.904 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.5 t -143.59 108.54 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 106.48 -1.674 . . . . 45.35 106.48 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -132.84 171.66 13.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.437 1.495 . . . . 64.41 109.144 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.43 HD13 ' H ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -99.8 152.6 19.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 120.666 -1.271 . . . . 61.32 113.795 -178.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.43 ' H ' HD13 ' A' ' 78' ' ' LEU . 13.0 p . . . . . 0 CA--C 1.539 0.524 0 C-N-CA 124.604 1.161 . . . . 75.32 108.9 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.272 0 N-CA-C 108.881 -0.785 . . . . 74.02 108.881 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -138.9 156.79 46.99 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.713 1.605 . . . . 74.45 106.768 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.2 mt -136.18 146.76 28.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.314 -0.857 . . . . 75.44 109.971 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.0 t -106.33 119.24 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 127.949 2.5 . . . . 63.35 106.522 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -88.59 135.13 33.65 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 104.562 -2.384 . . . . 74.24 104.562 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 HD11 ' A' ' 11' ' ' LEU . 17.9 t -138.77 122.51 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.135 -2.172 . . . . 53.3 105.135 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.436 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -130.0 -176.57 14.48 Favored Glycine 0 N--CA 1.467 0.718 0 CA-C-N 121.127 1.785 . . . . 52.32 111.027 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 m 70.51 17.53 6.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.691 1.596 . . . . 51.42 111.554 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.717 HD11 HG12 ' A' ' 8' ' ' VAL . 9.1 mp -67.29 147.55 98.89 Favored Pre-proline 0 C--O 1.235 0.295 0 O-C-N 120.975 -1.078 . . . . 75.11 109.963 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.82 152.31 77.54 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.511 2.141 . . . . 63.31 110.574 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -62.94 -30.76 71.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.779 -0.823 . . . . 73.12 108.779 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.39 -1.4 33.25 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 127.653 2.381 . . . . 73.15 114.121 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.1 tp -47.75 137.44 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.663 1.185 . . . . 72.51 113.29 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 p -115.43 150.01 37.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.464 1.506 . . . . 40.4 108.173 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.77 69.79 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.021 0.528 . . . . 51.41 110.722 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.51 -37.32 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 109.389 -0.597 . . . . 73.4 109.389 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.23 -43.26 82.43 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.061 -1.088 . . . . 61.24 108.061 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.08 -50.47 71.85 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.93 -0.396 . . . . 75.03 109.93 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -54.34 -50.22 67.92 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.587 1.155 . . . . 73.43 108.573 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -60.0 -41.78 92.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.555 1.142 . . . . 71.2 111.021 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -31.18 71.19 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 114.87 1.433 . . . . 71.21 114.87 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.27 9.72 33.86 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.013 0.525 . . . . 64.2 112.36 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -51.81 -43.73 63.21 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.504 1.522 . . . . 72.22 113.309 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -71.73 -25.83 62.23 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.122 0.569 . . . . 72.21 112.117 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.01 -30.02 20.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.182 0.593 . . . . 71.24 109.976 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 56.59 81.41 0.26 Allowed Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 127.946 2.498 . . . . 73.3 112.508 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -68.95 161.37 46.04 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.252 1.968 . . . . 71.42 110.616 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -91.9 -33.4 14.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.686 1.194 . . . . 74.41 109.535 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -138.39 151.36 47.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.196 0.999 . . . . 62.12 110.691 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.8 mt -143.21 121.75 7.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.972 -0.751 . . . . 71.33 108.972 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.7 128.79 25.44 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.055 -1.832 . . . . 64.24 106.055 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -115.84 116.78 28.61 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.323 1.849 . . . . 70.1 106.965 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -110.8 86.49 2.32 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.799 -1.926 . . . . 70.52 105.799 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.31 -19.08 31.88 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 113.475 0.917 . . . . 73.4 113.475 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.41 -28.19 12.12 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.841 2.056 . . . . 71.13 111.622 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -132.67 3.19 3.81 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.471 1.508 . . . . 74.01 109.506 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.74 54.6 36.56 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 126.871 2.177 . . . . 74.23 110.133 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.436 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.8 pt -137.29 155.51 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.897 1.279 . . . . 73.03 109.634 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.6 155.24 50.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.551 1.541 . . . . 63.33 109.047 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -125.28 118.67 26.49 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.981 -1.859 . . . . 54.02 105.981 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.03 104.81 10.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.379 -1.341 . . . . 55.45 107.379 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -84.46 156.8 21.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.726 0.81 . . . . 73.4 108.938 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -143.01 143.84 32.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.264 -1.754 . . . . 74.55 106.264 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -102.01 110.46 22.43 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.535 -0.913 . . . . 74.23 108.535 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.33 -27.16 64.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.691 1.196 . . . . 73.21 111.141 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.9 -33.34 75.11 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.393 -0.965 . . . . 75.4 108.393 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -61.96 -23.36 66.33 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 116.504 -1.713 . . . . 61.2 113.932 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -166.01 96.95 0.62 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.497 1.499 . . . . 72.22 110.771 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -31.9 38.46 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 117.328 2.344 . . . . 74.5 117.328 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -118.18 -9.85 10.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.603 1.547 . . . . 70.33 113.312 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.99 -17.66 34.33 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.256 -1.302 . . . . 64.32 110.759 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.4 tp -58.63 -38.85 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.954 1.877 . . . . 75.41 107.63 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -55.42 -61.28 2.44 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.182 1.793 . . . . 63.34 107.07 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -51.01 -49.44 60.45 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 121.944 -0.472 . . . . 72.24 111.491 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -54.31 -48.37 71.4 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.174 0.59 . . . . 62.2 110.448 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.7 mtm -65.68 -41.4 92.48 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 119.031 -0.509 . . . . 62.4 110.493 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -47.13 86.52 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.431 1.014 . . . . 73.23 110.266 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 mt -60.0 -39.64 80.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.701 1.2 . . . . 73.23 108.683 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.69 -41.16 72.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.419 -0.586 . . . . 74.34 109.419 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.5 mt -63.88 -34.36 77.76 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.928 0.891 . . . . 73.12 110.988 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.2 mt -63.33 -9.57 12.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.191 0.996 . . . . 73.54 111.729 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -85.87 -2.8 58.61 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.615 1.098 . . . . 63.41 110.186 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -64.21 118.91 9.28 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.092 -1.447 . . . . 74.41 107.092 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.453 ' O ' ' HE2' ' A' ' 73' ' ' LYS . . . 84.85 6.64 85.03 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-O 117.006 -1.997 . . . . 64.11 114.248 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.9 p -78.26 163.18 25.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 121.112 2.456 . . . . 75.34 107.731 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.421 ' HG ' ' HE3' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -101.4 108.21 19.75 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.06 -1.089 . . . . 72.43 108.06 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -113.98 121.42 43.86 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 126.307 1.843 . . . . 63.24 107.434 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt 47.44 44.64 16.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.552 1.141 . . . . 63.43 113.074 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 69.37 18.19 8.0 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.289 2.236 . . . . 64.24 114.604 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -125.93 124.14 40.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.98 0.912 . . . . 72.21 108.557 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 66' ' ' GLY . 1.3 ttmt -75.02 114.81 13.93 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 101.815 -3.402 . . . . 72.31 101.815 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.3 pt -96.11 169.62 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.265 0.839 . . . . 65.52 113.265 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -121.43 148.09 44.88 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.819 1.647 . . . . 64.33 108.685 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.453 HG22 HG13 ' A' ' 8' ' ' VAL . 58.3 t -142.15 138.97 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.457 1.103 . . . . 72.32 109.053 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -159.99 176.26 12.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.772 2.029 . . . . 72.22 109.232 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.65 151.67 22.77 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.901 -1.125 . . . . 74.04 109.905 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 105.22 -2.141 . . . . 74.12 105.22 177.393 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.424 0.154 . . . . 75.1 110.709 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -91.62 165.23 13.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.393 1.477 . . . . 71.0 107.977 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.556 ' HB ' HG23 ' A' ' 79' ' ' THR . 2.2 mt -134.97 148.16 29.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.136 1.374 . . . . 74.52 108.96 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.4 136.69 47.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.764 1.625 . . . . 51.44 107.353 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.4 ' HZ ' HG21 ' A' ' 40' ' ' ILE . 69.0 t80 -106.34 117.08 33.1 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.912 1.285 . . . . 72.44 108.253 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 t -122.02 136.37 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.11 -1.07 . . . . 60.51 108.11 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.576 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -144.2 169.7 26.22 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 119.858 1.208 . . . . 71.32 111.477 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 74' ' ' ILE . 7.2 t 82.9 17.09 0.31 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 128.441 2.696 . . . . 74.32 109.766 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mp -53.62 152.09 9.92 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 124.61 1.164 . . . . 71.43 112.591 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -52.54 148.66 26.33 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.958 2.439 . . . . 51.14 111.106 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -59.9 -31.73 70.08 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.785 -0.572 . . . . 74.23 111.083 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -113.63 33.41 5.18 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.123 1.369 . . . . 54.12 111.747 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.68 143.08 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.97 -1.122 . . . . 51.44 107.97 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.36 147.66 46.0 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.426 -0.953 . . . . 73.34 108.426 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.18 68.73 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 117.961 -1.019 . . . . 54.52 111.179 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -62.96 -35.49 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 119.793 1.179 . . . . 71.12 109.509 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -66.46 -48.19 70.71 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.678 -0.86 . . . . 72.44 108.678 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.4 mt -59.91 -52.15 66.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.638 0.775 . . . . 74.43 109.01 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -57.72 -36.48 72.07 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.438 1.495 . . . . 73.03 109.796 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -75.95 -46.24 30.8 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.234 1.414 . . . . 74.32 112.849 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -35.91 81.91 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.632 0.773 . . . . 73.33 111.978 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -97.84 0.28 46.43 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.282 0.845 . . . . 75.35 113.282 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -50.99 -40.97 59.32 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.859 1.664 . . . . 73.45 112.567 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -66.79 -49.33 66.2 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.238 -0.653 . . . . 63.13 109.238 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 p -66.38 -17.15 64.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.789 1.236 . . . . 70.22 112.852 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.8 t 47.55 77.14 0.48 Allowed Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.658 1.583 . . . . 54.12 113.711 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.54 163.76 33.65 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.44 2.76 . . . . 71.41 110.652 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.6 -41.66 17.6 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.73 1.212 . . . . 72.32 108.426 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.33 162.12 40.7 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.641 1.176 . . . . 71.43 108.079 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.3 mt -135.52 128.5 47.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 126.182 1.793 . . . . 73.21 107.793 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -141.12 104.4 4.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.744 1.218 . . . . 55.03 109.359 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.29 125.28 37.81 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.937 -1.505 . . . . 72.42 106.937 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -118.82 91.53 3.58 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.349 1.059 . . . . 74.04 108.854 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.11 -20.94 64.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.203 1.001 . . . . 71.31 110.551 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.07 -32.34 21.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.949 2.1 . . . . 62.25 110.084 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -131.98 3.6 4.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.951 1.7 . . . . 74.05 111.966 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.29 34.8 90.94 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 119.66 1.118 . . . . 54.13 111.929 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.576 HG22 ' CA ' ' A' ' 9' ' ' GLY . 1.7 pp -124.87 171.3 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.289 1.435 . . . . 73.13 110.249 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.12 163.89 33.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.848 0.859 . . . . 72.12 111.031 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -130.49 135.49 48.01 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.398 1.479 . . . . 72.53 107.866 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -142.28 111.63 6.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.124 -1.435 . . . . 70.22 107.124 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.2 159.48 21.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.149 -1.056 . . . . 62.55 108.149 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -144.43 104.47 4.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.047 1.339 . . . . 70.53 107.426 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.69 110.0 5.96 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.644 1.178 . . . . 71.53 112.228 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.71 72.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.506 0.928 . . . . 71.44 113.506 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -75.11 -24.29 58.05 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.21 0.914 . . . . 75.24 111.954 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -61.38 -30.72 70.72 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.498 -0.751 . . . . 61.31 110.302 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -157.0 84.02 0.94 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.976 -0.75 . . . . 73.04 108.976 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -52.47 -38.51 59.51 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.553 0.575 . . . . 73.02 112.553 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.0 -4.77 57.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 113.983 1.105 . . . . 74.22 113.983 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.1 -14.32 4.62 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.148 -1.362 . . . . 62.43 115.024 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.5 tp -51.72 -43.69 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 120.21 2.005 . . . . 72.35 110.886 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -57.05 -51.3 69.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.9 -1.148 . . . . 75.42 107.9 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -57.06 -48.86 77.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.206 1.002 . . . . 73.54 109.318 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.7 mtt85 -52.07 -51.97 54.24 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.656 0.662 . . . . 55.21 109.872 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 21.4 mtm -62.94 -39.61 95.14 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 119.096 -0.478 . . . . 74.14 110.771 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -49.96 75.42 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.297 1.039 . . . . 73.33 110.24 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.37 -39.36 78.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.597 1.159 . . . . 62.55 108.504 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.49 -40.38 70.26 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.324 0.511 . . . . 71.15 110.353 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.11 -38.82 92.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.338 1.055 . . . . 74.23 110.375 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.98 -2.44 1.23 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.719 1.608 . . . . 75.01 113.853 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -92.32 1.17 57.39 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.939 0.79 . . . . 52.21 110.852 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.62 115.3 4.59 Favored 'General case' 0 C--N 1.338 0.078 0 O-C-N 120.279 -1.513 . . . . 63.44 111.054 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.2 4.6 74.14 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 118.291 -1.283 . . . . 54.41 111.955 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.6 p -68.27 157.95 34.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.216 1.508 . . . . 74.14 109.65 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 mt -102.71 111.4 23.69 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.243 -1.392 . . . . 72.35 107.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -116.25 116.17 27.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.31 -1.367 . . . . 61.23 107.31 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt 49.88 53.44 12.79 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.793 1.237 . . . . 74.41 111.68 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 57.62 30.58 19.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.257 1.823 . . . . 74.21 113.838 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.21 118.02 13.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.313 1.445 . . . . 72.01 108.44 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -76.03 140.39 41.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.116 -1.809 . . . . 52.04 106.116 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 11.8 pt -126.63 170.08 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.438 1.086 . . . . 71.04 112.866 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.44 157.13 37.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.195 1.398 . . . . 73.1 110.699 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.0 t -136.87 148.55 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 125.275 1.43 . . . . 71.25 108.938 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.0 174.59 10.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.979 2.512 . . . . 74.45 109.175 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.22 152.0 20.07 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.433 1.093 . . . . 74.25 109.959 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.556 HG23 ' HB ' ' A' ' 5' ' ' ILE . 5.5 t . . . . . 0 C--N 1.332 -0.193 0 N-CA-C 107.72 -1.215 . . . . 53.23 107.72 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 107.935 -1.135 . . . . 63.12 107.935 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -95.04 162.86 13.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.721 -1.585 . . . . 54.22 106.721 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 mt -134.23 149.01 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.534 0.683 . . . . 65.32 109.715 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.9 t -121.06 115.06 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 105.949 -1.871 . . . . 53.22 105.949 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -84.61 139.03 32.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.54 -2.393 . . . . 75.32 104.54 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.444 HG12 HD11 ' A' ' 11' ' ' LEU . 2.5 t -131.74 136.57 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.746 -1.946 . . . . 52.31 105.746 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -141.83 -178.4 17.92 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 119.718 1.145 . . . . 54.13 110.596 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.44 13.06 9.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.14 1.776 . . . . 33.33 112.628 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.444 HD11 HG12 ' A' ' 8' ' ' VAL . 10.4 mp -54.8 148.61 26.27 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.565 1.546 . . . . 73.41 112.603 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.44 150.71 87.77 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.893 2.395 . . . . 75.02 110.365 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -53.58 -45.75 70.08 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.135 0.974 . . . . 71.21 110.718 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.02 18.53 5.72 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.248 1.573 . . . . 74.2 115.248 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.483 HG21 HD21 ' A' ' 34' ' ' LEU . 6.5 tp -44.98 137.21 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 119.902 1.228 . . . . 74.01 111.968 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 p -115.96 150.52 37.03 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.293 1.437 . . . . 75.21 109.236 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.71 -29.63 70.83 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-O 119.13 -0.462 . . . . 61.42 110.647 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.48 -38.35 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 118.443 0.565 . . . . 73.55 109.581 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.42 -38.14 84.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.088 0.858 . . . . 73.2 109.125 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.77 -54.46 31.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.107 -0.701 . . . . 70.24 109.107 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -54.81 -46.56 74.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.123 0.969 . . . . 74.11 109.097 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -62.77 -41.22 99.15 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 114.378 1.251 . . . . 75.33 114.378 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -46.56 69.84 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.056 -1.028 . . . . 64.34 110.493 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -86.09 3.06 44.21 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.057 1.132 . . . . 71.25 114.057 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -53.43 -40.63 65.32 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.538 -1.351 . . . . 71.5 110.69 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -70.59 -31.38 68.35 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.926 1.69 . . . . 74.24 112.174 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 p -89.49 -11.21 43.61 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 117.913 -1.042 . . . . 65.44 112.459 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m 48.58 70.44 2.08 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 115.445 1.646 . . . . 72.4 115.445 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.94 161.4 46.1 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.961 2.441 . . . . 63.03 111.682 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -91.55 -39.5 11.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.05 1.74 . . . . 65.21 107.649 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -135.35 158.19 44.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.698 1.199 . . . . 70.24 110.748 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.6 mt -145.79 126.3 6.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.341 -1.726 . . . . 45.21 106.341 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -140.27 105.93 5.13 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.985 1.314 . . . . 74.42 109.833 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 15' ' ' ILE . 1.6 tm? -92.76 121.16 33.87 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.313 1.045 . . . . 74.22 110.241 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -118.88 81.7 1.74 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.941 -1.133 . . . . 74.11 107.941 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.63 -21.63 60.72 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.217 1.007 . . . . 64.45 111.096 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.74 -20.21 7.93 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.953 1.701 . . . . 64.14 112.346 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -132.37 -4.1 3.4 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.702 1.601 . . . . 75.41 109.447 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.32 41.77 51.69 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.207 -1.557 . . . . 54.45 109.207 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.453 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 40.5 pt -132.86 171.82 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 124.537 1.135 . . . . 61.33 110.678 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.87 165.6 34.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.739 1.615 . . . . 65.31 109.187 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -135.22 142.3 45.99 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.552 1.941 . . . . 65.13 106.219 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -142.9 114.08 7.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.28 -1.378 . . . . 74.41 107.28 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.3 155.98 19.02 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.551 -1.648 . . . . 72.12 106.551 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -145.1 114.02 6.89 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.275 1.83 . . . . 64.1 109.187 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -72.01 112.77 8.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.776 1.028 . . . . 71.35 113.776 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.95 -16.26 61.54 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.427 1.491 . . . . 70.13 112.789 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.62 -22.51 27.94 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.058 0.845 . . . . 75.34 109.57 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -61.62 -43.93 97.94 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 120.952 -1.092 . . . . 64.54 109.697 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -145.44 89.21 1.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.512 0.596 . . . . 72.21 110.755 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -37.57 48.92 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 114.358 1.244 . . . . 75.32 114.358 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.8 p -97.15 -19.85 18.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.221 1.373 . . . . 72.24 112.381 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.49 -16.29 43.56 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 117.65 -1.639 . . . . 52.21 114.911 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.42 -37.3 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.799 2.3 . . . . 71.04 109.366 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -60.84 -60.93 3.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.632 -1.247 . . . . 73.14 107.632 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -50.79 -44.22 58.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 118.614 -0.708 . . . . 74.52 110.628 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -56.42 -49.98 72.98 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.939 -0.763 . . . . 65.05 108.939 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.2 mtm -58.68 -47.71 83.57 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 124.204 1.002 . . . . 73.23 109.447 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -53.76 50.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.997 1.719 . . . . 74.45 111.837 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.6 mt -61.27 -37.01 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.804 1.242 . . . . 75.41 108.937 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.36 -41.44 63.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.434 -0.58 . . . . 71.52 109.434 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.39 -34.95 78.85 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.915 1.286 . . . . 75.12 111.241 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.8 mt -65.81 -9.77 31.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.044 0.938 . . . . 74.4 111.889 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -85.76 -1.68 57.46 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.128 0.876 . . . . 65.41 110.418 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -62.76 111.9 2.3 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.883 1.674 . . . . 60.34 109.673 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.74 7.25 53.68 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.619 1.104 . . . . 64.41 112.945 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.1 p -66.08 146.85 54.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.528 1.664 . . . . 51.53 109.121 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.6 mt -93.08 121.21 34.19 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.547 -2.39 . . . . 55.54 104.547 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.8 120.05 28.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.996 1.318 . . . . 73.23 108.152 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt 48.39 40.48 14.79 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.22 1.408 . . . . 63.03 112.561 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 70.48 29.35 3.47 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 128.519 2.728 . . . . 62.33 113.913 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -136.15 120.71 18.26 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 126.551 1.94 . . . . 70.31 108.772 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -73.61 138.33 44.8 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 105.636 -1.987 . . . . 75.05 105.636 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 pt -119.5 170.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 124.636 1.174 . . . . 65.4 110.695 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -123.66 158.74 30.86 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.247 1.419 . . . . 72.13 111.23 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.96 132.89 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.09 1.756 . . . . 74.34 108.862 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -148.24 160.53 42.86 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.616 1.566 . . . . 73.25 108.565 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -86.28 148.13 25.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.848 1.259 . . . . 71.31 109.784 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.602 0 C-N-CA 125.991 1.717 . . . . 54.23 107.261 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 . . . . . 0 N--CA 1.466 0.369 0 N-CA-C 109.384 -0.598 . . . . 73.33 109.384 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -119.03 161.38 20.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 105.81 -1.922 . . . . 52.33 105.81 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -134.68 139.41 47.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.178 1.391 . . . . 75.44 110.261 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.75 141.56 27.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 106.971 -1.492 . . . . 71.1 106.971 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -103.79 133.19 49.2 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.31 -2.107 . . . . 71.31 105.31 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.426 HG12 HD11 ' A' ' 11' ' ' LEU . 93.2 t -136.79 130.6 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.731 -1.952 . . . . 72.34 105.731 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.95 179.92 21.74 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 121.348 1.885 . . . . 54.24 115.041 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.82 17.15 2.32 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.162 2.585 . . . . 52.52 111.399 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.426 HD11 HG12 ' A' ' 8' ' ' VAL . 7.4 mp -66.76 146.23 99.05 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 125.023 1.329 . . . . 72.43 112.765 -177.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -67.07 167.76 19.13 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.681 2.921 . . . . 75.13 112.119 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -75.0 -34.64 61.97 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.297 -1.001 . . . . 73.33 108.297 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.6 11.62 3.65 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.149 1.38 . . . . 61.11 112.172 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.441 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 8.7 tp -54.77 143.61 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 120.679 -1.263 . . . . 71.21 109.31 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 p -128.11 148.25 50.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.445 1.098 . . . . 71.42 110.074 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.95 -29.63 70.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.209 -0.9 . . . . 41.54 110.652 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.65 -38.21 81.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 119.069 0.85 . . . . 75.2 109.782 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HB3' HD11 ' A' ' 69' ' ' LEU . 4.1 mm-40 -71.48 -43.11 67.19 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.022 -0.732 . . . . 75.43 109.022 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.51 -49.64 75.91 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.34 1.056 . . . . 64.43 111.253 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -59.39 -42.14 91.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.629 0.772 . . . . 74.42 109.178 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -68.79 -40.88 79.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.385 1.474 . . . . 74.14 113.535 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -41.28 91.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 118.739 0.699 . . . . 71.32 111.978 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -99.75 4.74 45.56 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.82 1.044 . . . . 70.24 113.82 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -51.19 -47.54 62.18 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.067 1.347 . . . . 64.5 109.896 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.06 -39.9 79.64 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.633 0.773 . . . . 74.32 111.838 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 p -81.87 -10.76 59.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.732 1.213 . . . . 71.32 112.794 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.64 65.95 6.38 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 114.965 1.468 . . . . 74.24 114.965 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -64.91 151.86 84.32 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.751 2.301 . . . . 61.34 108.897 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.68 -48.49 8.24 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.077 -1.083 . . . . 63.3 108.077 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.5 153.88 41.38 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.258 -1.016 . . . . 72.0 108.258 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.3 mt -145.92 119.83 2.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.425 -1.694 . . . . 71.21 106.425 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.43 108.22 10.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.733 -1.58 . . . . 74.34 106.733 178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -93.59 125.93 38.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.746 -1.576 . . . . 65.5 106.746 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -118.24 89.69 3.18 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.426 -2.064 . . . . 74.11 105.426 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.15 -16.41 52.56 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.148 -0.453 . . . . 32.44 111.417 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -50.48 -40.08 50.0 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.246 2.219 . . . . 75.23 111.034 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -126.84 6.56 6.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.853 1.661 . . . . 64.35 110.174 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.12 42.63 99.73 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.313 -1.115 . . . . 54.52 110.313 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.7 162.31 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.856 1.263 . . . . 70.24 109.37 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.75 152.23 40.06 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.126 0.971 . . . . 64.3 109.527 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -120.31 135.25 55.08 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 103.958 -2.608 . . . . 74.13 103.958 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.53 122.99 25.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.158 -1.793 . . . . 50.33 106.158 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -96.6 150.71 20.35 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.188 -1.412 . . . . 71.51 107.188 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -142.13 110.68 6.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.388 -1.338 . . . . 75.12 107.388 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -76.25 118.19 18.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.645 0.778 . . . . 62.42 109.302 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.76 -18.88 50.03 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 128.025 2.53 . . . . 75.54 112.344 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.5 -30.33 52.94 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.479 -1.674 . . . . 73.05 106.479 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -61.73 -37.5 84.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.696 1.198 . . . . 62.32 112.348 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -147.94 97.92 2.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.297 0.953 . . . . 63.12 108.876 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -51.46 -31.52 23.59 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 115.894 -2.003 . . . . 63.11 116.315 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.79 -20.59 8.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 121.021 1.737 . . . . 64.32 111.287 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.42 -30.7 66.54 Favored Glycine 0 C--N 1.338 0.66 0 O-C-N 121.015 -1.053 . . . . 71.33 110.835 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.7 tp -49.76 -41.95 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.388 1.094 . . . . 43.03 112.055 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -68.23 -61.34 1.89 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.222 0.609 . . . . 74.52 110.342 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -56.15 -30.84 62.74 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.93 -0.481 . . . . 75.32 111.331 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.3 mtt85 -68.44 -41.16 80.7 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.01 -1.056 . . . . 74.32 108.741 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.0 mtm -64.55 -44.09 91.9 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 107.163 -1.421 . . . . 72.53 107.163 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -56.5 -48.24 77.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.948 0.899 . . . . 34.31 109.048 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.58 -41.38 87.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.137 0.975 . . . . 65.42 109.848 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.27 84.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.448 -0.575 . . . . 73.14 109.448 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.28 -32.55 74.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.828 0.851 . . . . 70.21 110.245 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.3 mt -65.28 -13.04 57.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 118.795 -0.621 . . . . 71.24 110.951 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -86.49 3.93 41.97 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.932 0.787 . . . . 53.2 110.262 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -69.53 112.71 6.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.083 -1.636 . . . . 74.41 107.842 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.65 -3.93 85.05 Favored Glycine 0 C--O 1.225 -0.447 0 CA-C-O 116.436 -2.313 . . . . 75.4 111.893 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -64.87 137.73 57.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 121.44 2.62 . . . . 63.34 107.138 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.49 126.28 30.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.027 -1.842 . . . . 75.34 106.027 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 19' ' ' GLU . 49.7 tp -129.82 122.9 29.65 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 105.364 -2.088 . . . . 74.12 105.364 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 6.0 mtpm? 51.37 44.85 28.69 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.768 1.627 . . . . 74.23 111.359 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 57.83 33.89 23.74 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 127.644 2.378 . . . . 72.01 113.193 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -134.46 128.54 33.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 126.039 1.736 . . . . 73.34 108.137 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -78.52 112.15 15.29 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 103.534 -2.765 . . . . 74.44 103.534 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.8 pt -104.56 169.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 118.137 0.426 . . . . 74.14 110.359 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -121.64 158.7 28.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.286 1.034 . . . . 60.04 111.236 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -146.21 143.63 21.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.846 1.258 . . . . 64.12 108.048 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -162.07 161.13 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.647 1.579 . . . . 72.22 108.863 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.67 152.18 22.78 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.916 1.286 . . . . 73.3 109.109 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.33 -0.261 0 C-N-CA 124.797 1.239 . . . . 72.43 108.603 179.531 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.602 0.239 . . . . 75.52 110.74 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -130.21 158.8 38.75 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 129.786 3.234 . . . . 73.13 105.196 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.4 mt -130.36 149.32 33.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.832 0.825 . . . . 42.44 109.338 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 t -108.9 127.14 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 125.798 1.639 . . . . 71.23 107.421 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -91.45 128.32 37.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.537 -2.394 . . . . 61.25 104.537 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.84 129.55 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.462 -1.681 . . . . 75.34 106.462 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.72 -175.72 14.44 Favored Glycine 0 N--CA 1.468 0.814 0 CA-C-N 120.317 1.417 . . . . 32.01 113.09 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 72.21 14.45 5.56 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.217 2.207 . . . . 74.24 111.543 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.26 149.59 82.3 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 125.232 1.413 . . . . 72.42 112.334 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.98 165.15 31.05 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.282 2.655 . . . . 72.45 110.036 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.19 -31.52 58.51 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.219 1.008 . . . . 75.21 109.494 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -85.35 10.89 11.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.303 1.441 . . . . 75.41 113.467 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.551 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 8.6 tp -57.61 138.97 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.488 1.115 . . . . 71.3 111.69 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 p -128.32 153.4 47.05 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.184 0.994 . . . . 74.3 109.738 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.36 -33.31 65.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.446 1.898 . . . . 71.34 111.366 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.8 p -66.14 -37.7 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 119.126 -0.464 . . . . 54.03 110.113 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.79 -43.39 72.22 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.392 -0.966 . . . . 73.24 108.392 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -60.36 -55.63 31.24 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 125.276 1.43 . . . . 73.33 110.069 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -57.63 -45.06 85.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.037 -0.727 . . . . 74.02 109.037 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -60.34 -44.1 95.83 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 65.11 112.813 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -47.98 74.89 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 119.419 1.009 . . . . 74.41 110.825 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -83.01 1.02 42.09 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 115.362 1.615 . . . . 74.53 115.362 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -51.26 -41.57 60.49 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.223 1.409 . . . . 71.43 113.382 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -32.75 74.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.885 0.874 . . . . 75.32 110.666 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 88.1 p -87.16 -28.76 22.25 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.255 1.206 . . . . 64.43 114.255 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.4 t 62.81 75.21 0.42 Allowed Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.53 1.932 . . . . 65.14 112.358 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -67.33 159.97 49.86 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.934 3.09 . . . . 63.02 110.719 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -85.63 -46.47 10.74 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.871 1.668 . . . . 72.14 108.009 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.56 157.21 44.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.902 -0.59 . . . . 73.04 109.598 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.6 mt -137.93 128.46 36.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 125.028 1.331 . . . . 65.12 108.875 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 103.39 5.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.35 -1.352 . . . . 72.41 107.35 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -88.62 111.73 22.25 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.95 -1.5 . . . . 60.45 106.95 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -105.28 80.22 1.57 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.079 -1.452 . . . . 72.24 107.079 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.66 -27.97 43.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.977 0.911 . . . . 74.31 111.246 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -51.09 -27.9 9.32 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 127.515 2.326 . . . . 70.3 113.904 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -132.65 9.96 4.31 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.888 1.275 . . . . 74.53 111.093 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.14 42.7 99.87 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.795 1.188 . . . . 64.14 110.619 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.54 166.05 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 C-N-CA 124.816 1.246 . . . . 73.24 111.482 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.31 148.77 36.84 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.328 2.251 . . . . 53.2 108.239 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -124.16 129.39 50.74 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.961 -1.866 . . . . 75.34 105.961 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.11 114.13 15.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.209 -1.034 . . . . 64.23 108.209 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -92.66 155.04 17.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.745 -1.946 . . . . 62.12 105.745 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -140.02 137.22 34.46 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.629 -1.619 . . . . 74.34 106.629 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -81.7 110.19 16.81 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.944 1.247 . . . . 73.33 109.444 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.59 -16.99 62.9 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.631 1.172 . . . . 60.34 112.273 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.69 -18.38 29.66 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.997 0.817 . . . . 73.32 110.777 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -60.98 -35.61 77.24 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.157 0.889 . . . . 70.41 110.357 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -150.14 86.71 1.43 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.922 -1.881 . . . . 73.43 105.922 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -49.75 -37.36 29.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.471 1.108 . . . . 70.43 112.226 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 -3.1 39.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.257 1.423 . . . . 72.02 113.578 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.06 -19.75 5.84 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 124.923 1.249 . . . . 53.24 114.788 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 tp -52.83 -36.99 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.42 1.61 . . . . 62.43 111.461 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -56.42 -54.84 40.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.846 1.259 . . . . 63.32 108.398 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -47.03 79.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.34 1.056 . . . . 72.52 109.793 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -54.74 -46.59 74.3 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 118.727 -0.654 . . . . 75.01 109.273 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 2.7 mtm -61.33 -50.88 71.16 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 108.173 -1.047 . . . . 72.1 108.173 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.04 -52.52 8.87 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.796 2.038 . . . . 74.14 111.836 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.0 mt -59.08 -41.9 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.199 1.4 . . . . 71.32 110.091 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.32 -36.82 61.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.159 0.984 . . . . 71.13 111.058 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -66.96 -36.08 81.41 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.642 1.11 . . . . 74.31 109.586 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.68 -12.73 11.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.568 1.147 . . . . 55.11 111.512 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -84.61 5.02 29.59 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.871 0.759 . . . . 52.24 110.278 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -69.07 113.92 6.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.285 -1.746 . . . . 72.23 106.285 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.28 6.23 61.56 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.282 -1.288 . . . . 70.42 113.458 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.5 p -68.07 143.56 55.44 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 120.482 2.141 . . . . 74.51 108.607 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 73' ' ' LYS . 15.2 mt -88.71 107.6 19.03 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 103.174 -2.899 . . . . 61.13 103.174 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.9 tp -113.0 117.5 32.21 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.715 -1.587 . . . . 62.32 106.715 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 14.3 mtpp 47.05 56.1 7.22 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.883 0.873 . . . . 65.04 111.891 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 60.95 23.38 13.5 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.856 1.662 . . . . 72.41 114.789 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -132.41 126.67 33.67 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 124.685 1.194 . . . . 73.31 108.757 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.422 ' HA ' HD23 ' A' ' 68' ' ' LEU . 4.6 ttpm? -80.1 114.3 18.9 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 104.067 -2.568 . . . . 75.55 104.067 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.2 pt -94.96 169.24 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 118.436 0.562 . . . . 65.04 109.984 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -122.99 158.59 30.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.01 1.324 . . . . 72.34 110.861 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.0 t -142.52 126.44 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 126.009 1.723 . . . . 72.23 108.797 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -139.03 174.47 10.48 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.475 1.51 . . . . 74.32 108.156 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.46 151.78 18.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.152 -0.967 . . . . 74.51 110.124 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 107.249 -1.389 . . . . 63.02 107.249 178.203 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.414 HH11 ' HB3' ' A' ' 44' ' ' GLU . 9.8 tpp180 . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 108.384 -0.969 . . . . 73.31 108.384 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -128.55 157.71 40.46 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.778 1.631 . . . . 65.54 107.233 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -134.91 146.01 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.361 1.065 . . . . 64.25 110.02 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.8 126.44 57.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.62 -1.993 . . . . 71.32 105.62 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -96.58 105.14 17.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.594 -1.632 . . . . 74.23 106.594 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -113.66 139.35 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 120.027 1.285 . . . . 62.11 108.675 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -149.06 178.31 26.7 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 119.928 1.24 . . . . 62.44 112.663 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 84.99 6.3 0.5 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.405 3.082 . . . . 74.21 111.833 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp -46.24 148.67 1.49 Allowed Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 127.339 2.256 . . . . 73.03 115.392 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.86 175.28 7.55 Favored 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.98 4.453 . . . . 54.32 113.379 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mmt-85 -78.47 -45.44 22.08 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 107.898 -1.149 . . . . 54.25 107.898 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -84.25 22.02 1.3 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.031 1.733 . . . . 61.3 112.889 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.7 tp -61.93 142.25 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.628 -1.249 . . . . 63.03 107.628 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.99 150.01 50.58 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.376 -0.972 . . . . 64.04 108.376 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -32.39 70.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.848 -0.797 . . . . 75.42 108.848 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.01 -49.08 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.138 1.375 . . . . 74.25 109.868 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.46 -34.75 74.84 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.01 -0.676 . . . . 73.42 109.215 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.12 -49.85 72.77 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.943 0.792 . . . . 72.12 109.436 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -59.92 -37.78 80.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.828 -0.606 . . . . 72.23 110.501 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -69.59 -50.82 40.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.394 0.677 . . . . 44.34 110.764 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -24.11 67.7 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 120.971 -1.081 . . . . 74.24 112.213 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -108.54 8.79 27.39 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.88 1.218 . . . . 70.35 111.712 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -61.27 -26.72 67.96 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 120.107 -1.62 . . . . 65.24 114.062 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -30.1 23.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.639 1.109 . . . . 65.53 108.767 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -31.2 58.73 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.407 -0.96 . . . . 63.51 108.407 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m 60.69 72.35 0.73 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 126.674 1.99 . . . . 73.53 113.134 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.14 158.1 58.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.741 2.961 . . . . 65.44 110.465 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -78.96 -45.74 19.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.857 -1.534 . . . . 73.15 106.857 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -156.77 139.71 15.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.477 1.511 . . . . 63.41 108.48 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.14 142.19 22.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.384 -1.71 . . . . 74.54 106.384 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -135.09 103.8 5.69 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.581 -1.637 . . . . 73.33 106.581 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -86.7 121.44 29.22 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.463 -1.31 . . . . 61.24 107.463 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -108.85 82.35 1.59 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.542 -1.651 . . . . 73.32 106.542 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.56 -23.22 62.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.216 0.606 . . . . 62.44 111.347 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.95 -26.93 66.37 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.56 1.544 . . . . 74.12 111.981 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -133.17 6.6 3.89 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.693 1.197 . . . . 70.03 112.591 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.32 47.41 91.03 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 119.063 0.847 . . . . 62.03 111.287 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.469 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 2.3 pt -134.73 159.78 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.196 1.398 . . . . 73.25 108.727 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.68 135.06 21.88 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.58 1.152 . . . . 54.12 108.347 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -108.17 139.33 43.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.573 -2.01 . . . . 74.13 105.573 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.32 116.03 15.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 105.406 -2.072 . . . . 64.45 105.406 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.414 ' HB3' HH11 ' A' ' 3' ' ' ARG . 35.8 mt-10 -88.05 149.98 23.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.918 0.887 . . . . 53.32 109.711 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -140.98 123.31 15.79 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.188 1.795 . . . . 60.11 107.654 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -90.82 112.4 24.19 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.111 0.964 . . . . 72.21 110.882 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.42 -22.58 62.71 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.107 1.363 . . . . 45.25 111.74 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.93 -37.04 64.71 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.941 -1.133 . . . . 51.32 107.941 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -69.17 -38.25 78.61 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 118.687 -0.673 . . . . 73.23 109.657 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.0 75.86 1.4 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.823 0.738 . . . . 63.23 111.564 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -54.15 -39.61 66.68 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 118.837 -0.601 . . . . 74.44 111.979 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.9 p -104.26 -1.26 27.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.872 1.269 . . . . 75.23 113.449 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.43 -13.88 7.91 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-O 117.958 -1.468 . . . . 63.2 114.813 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.3 tp -51.4 -50.37 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 120.171 1.986 . . . . 72.35 112.218 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -53.33 57.02 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.331 -0.989 . . . . 62.34 108.331 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -50.59 -48.65 57.69 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.133 0.573 . . . . 73.13 111.068 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -57.01 -49.63 75.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.549 1.14 . . . . 55.03 108.719 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 43.2 mtm -64.08 -36.53 84.32 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.405 0.682 . . . . 70.31 111.345 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -55.35 -51.07 67.98 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.704 2.002 . . . . 43.4 111.65 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.47 -26.56 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.568 1.547 . . . . 65.13 109.368 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.89 -39.58 19.67 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.973 0.909 . . . . 70.51 108.927 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.31 -44.67 95.23 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.032 1.733 . . . . 72.01 110.221 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.3 mt -58.41 -6.82 0.74 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.485 1.914 . . . . 74.22 113.938 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -89.4 -3.7 58.32 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.29 0.95 . . . . 72.34 111.331 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -59.23 112.66 1.8 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.797 1.239 . . . . 72.1 108.85 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' CA ' ' HE2' ' A' ' 73' ' ' LYS . . . 91.28 3.52 69.51 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.934 -1.481 . . . . 72.34 115.009 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 p -70.6 160.77 31.91 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.618 1.709 . . . . 62.33 109.124 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 mt -109.49 108.85 19.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.307 1.443 . . . . 75.14 109.536 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.78 132.83 55.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.858 -2.275 . . . . 73.52 104.858 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.7 mttm 46.09 45.8 12.6 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.282 1.039 . . . . 75.33 111.655 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 64.32 0.12 0.99 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.685 2.794 . . . . 71.12 115.855 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -109.89 140.2 44.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.63 1.104 . . . . 73.31 109.645 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.461 ' HE2' ' CA ' ' A' ' 66' ' ' GLY . 15.8 tttm -78.95 156.16 28.64 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.47 -0.937 . . . . 73.43 108.47 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 pt -129.58 170.08 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.884 1.274 . . . . 65.02 111.003 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.25 147.98 52.03 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.156 1.783 . . . . 63.23 106.457 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.6 t -139.12 136.31 42.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 124.802 1.241 . . . . 34.42 108.333 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -147.18 171.98 14.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.149 1.78 . . . . 62.13 108.049 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.14 152.79 20.45 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.373 1.469 . . . . 64.22 108.831 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 106.886 -1.524 . . . . 72.42 106.886 176.662 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 ptt-85 . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 108.934 -0.765 . . . . 74.11 108.934 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -123.14 160.42 26.5 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 105.179 -2.156 . . . . 75.13 105.179 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -134.68 129.64 52.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.463 1.505 . . . . 75.21 110.873 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.5 t -102.79 128.42 55.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 105.349 -2.093 . . . . 51.41 105.349 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -96.81 141.49 29.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.184 -1.784 . . . . 74.24 106.184 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.415 HG12 HD11 ' A' ' 11' ' ' LEU . 2.6 t -138.45 133.35 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.944 -1.873 . . . . 74.14 105.944 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.414 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -140.84 177.96 20.46 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 120.888 1.676 . . . . 64.42 111.791 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.423 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 0.5 OUTLIER 73.78 16.47 3.78 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.047 2.539 . . . . 42.53 111.116 -178.156 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.415 HD11 HG12 ' A' ' 8' ' ' VAL . 9.5 mp -62.54 147.63 92.07 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.445 1.498 . . . . 64.33 113.648 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -66.67 164.96 27.11 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.301 2.668 . . . . 74.23 111.329 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -76.38 -29.53 57.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 122.976 0.51 . . . . 71.24 110.742 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.09 13.51 11.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.175 0.99 . . . . 73.44 112.984 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.569 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.6 tp -59.02 138.87 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.234 1.014 . . . . 62.34 111.328 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 p -128.3 158.39 38.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.744 1.618 . . . . 74.44 109.909 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.1 -29.58 69.37 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.101 0.56 . . . . 63.15 110.348 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.21 -34.04 67.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.305 0.642 . . . . 75.43 110.228 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -73.66 -47.94 36.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.038 -1.468 . . . . 74.11 107.038 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -56.06 -46.41 78.95 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.302 1.441 . . . . 75.02 110.652 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -61.6 -36.61 81.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.521 -0.752 . . . . 74.53 110.214 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.14 -30.99 60.94 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.757 0.708 . . . . 73.41 110.877 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -68.36 -50.19 54.87 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.182 -0.949 . . . . 71.44 110.015 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -91.74 10.87 26.58 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.222 1.009 . . . . 75.1 112.825 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -35.76 63.82 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 120.681 -1.262 . . . . 75.42 110.793 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -82.6 -9.15 59.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.1 0.96 . . . . 75.13 113.533 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.17 -10.79 14.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.671 1.188 . . . . 70.11 111.586 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 t 47.24 61.78 13.03 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.58 2.352 . . . . 73.21 114.893 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.36 161.0 15.02 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.399 2.733 . . . . 73.15 111.561 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -38.86 10.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.36 1.064 . . . . 74.32 109.404 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -136.01 153.17 51.45 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.191 0.997 . . . . 71.31 108.358 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.3 mt -139.5 125.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 105.388 -2.078 . . . . 71.44 105.388 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.42 104.5 4.6 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.528 -1.286 . . . . 71.24 107.528 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -88.7 119.47 29.21 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 124.689 1.196 . . . . 64.35 108.331 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -108.69 82.45 1.61 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.026 -1.472 . . . . 72.12 107.026 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.97 -26.88 50.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.778 0.831 . . . . 53.41 111.548 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.08 -28.39 10.41 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 128.285 2.634 . . . . 71.34 112.709 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -132.92 9.16 4.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.782 1.233 . . . . 75.14 110.443 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.16 43.85 96.81 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 119.6 1.091 . . . . 51.14 110.932 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.414 HG22 ' CA ' ' A' ' 9' ' ' GLY . 3.1 pt -134.85 166.2 29.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.102 1.361 . . . . 65.21 111.247 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.49 154.37 43.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.076 1.351 . . . . 72.53 109.489 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.48 123.26 39.74 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.107 1.363 . . . . 75.04 107.387 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.5 114.77 21.71 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.321 -0.992 . . . . 75.2 108.321 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -91.21 151.07 21.09 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.919 -1.141 . . . . 74.23 107.919 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -136.74 134.26 36.93 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.672 1.589 . . . . 70.02 107.304 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.27 112.54 24.35 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.86 1.664 . . . . 74.02 111.319 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.38 -27.41 68.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.086 1.354 . . . . 55.12 111.32 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.52 -32.99 68.79 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.423 -0.322 . . . . 71.04 110.393 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -62.94 -22.82 67.06 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.79 0.723 . . . . 72.44 112.928 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -158.82 99.43 1.55 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.192 -1.41 . . . . 73.52 107.192 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -54.02 50.03 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.512 0.725 . . . . 74.11 112.463 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.84 -19.6 23.23 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.309 1.044 . . . . 72.25 110.976 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.53 -22.3 62.57 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-O 117.228 -1.873 . . . . 62.51 113.589 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.77 -40.8 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 120.532 2.166 . . . . 74.32 110.106 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.53 -58.5 6.94 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.657 -1.238 . . . . 64.55 107.657 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.1 -48.37 76.29 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.812 0.845 . . . . 63.33 111.095 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.18 -41.05 68.1 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.128 -0.693 . . . . 74.32 109.128 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 6.4 mtm -71.88 -44.45 63.73 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.332 1.053 . . . . 75.42 110.681 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -48.88 72.0 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.831 1.652 . . . . 75.54 110.575 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.74 -39.77 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.691 1.597 . . . . 74.32 108.802 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.72 75.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.876 -0.583 . . . . 31.35 109.573 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.43 -31.58 72.75 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.965 0.802 . . . . 73.13 110.493 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.4 mt -68.95 -5.13 19.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.649 -0.657 . . . . 63.13 112.092 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -89.65 -0.64 57.66 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.058 0.845 . . . . 62.34 110.453 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -66.02 113.09 4.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.026 1.73 . . . . 73.31 110.991 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.2 2.99 67.92 Favored Glycine 0 N--CA 1.459 0.233 0 CA-C-O 117.942 -1.477 . . . . 64.14 114.173 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -66.93 133.77 50.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.59 1.695 . . . . 61.01 108.369 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 73' ' ' LYS . 29.6 mt -76.21 108.21 8.98 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 105.743 -1.947 . . . . 71.32 105.743 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.6 tp -115.88 119.6 36.5 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.675 -1.602 . . . . 70.32 106.675 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 17.3 mtpp 49.21 50.44 17.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.741 1.616 . . . . 63.4 112.368 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 64.28 24.99 13.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.172 2.189 . . . . 70.22 113.576 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 10' ' ' SER . 15.0 mmmt -131.77 124.44 29.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.62 1.168 . . . . 74.25 110.647 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' HD23 ' A' ' 68' ' ' LEU . 6.5 tptm -79.83 105.77 11.36 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 101.7 -3.444 . . . . 73.2 101.7 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.3 pt -95.63 169.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 124.006 0.922 . . . . 75.34 108.685 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -127.17 158.97 35.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.796 1.238 . . . . 75.23 111.52 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.0 t -137.06 139.22 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 126.526 1.931 . . . . 73.53 107.191 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -149.67 162.74 39.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.674 1.189 . . . . 55.15 108.127 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 147.55 25.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.469 1.108 . . . . 65.2 109.291 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 117.912 -1.042 . . . . 65.24 108.748 178.883 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.295 0 N-CA-C 112.018 0.377 . . . . 71.54 112.018 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -100.16 157.31 16.67 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 128.21 2.604 . . . . 74.41 107.125 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mt -135.41 149.19 28.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 124.696 1.198 . . . . 74.14 108.082 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.1 t -116.65 127.49 74.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 105.768 -1.938 . . . . 73.24 105.768 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -94.75 139.32 31.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.374 -1.713 . . . . 72.43 106.374 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 t -139.26 132.49 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.327 -1.731 . . . . 61.23 106.327 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.62 -178.19 17.55 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 120.095 1.316 . . . . 52.4 111.63 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.03 10.68 4.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.599 2.36 . . . . 65.51 111.344 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mp -54.27 144.94 38.48 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 125.487 1.515 . . . . 55.03 112.695 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -67.65 157.76 60.28 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.352 2.035 . . . . 74.42 110.26 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -65.57 -43.23 90.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.91 -1.145 . . . . 73.53 107.91 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.64 13.34 0.64 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.352 2.261 . . . . 63.45 112.857 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.506 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 10.3 tp -57.56 144.82 9.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 O-C-N 120.878 -1.139 . . . . 74.45 108.984 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.56 147.5 50.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.45 -1.315 . . . . 72.42 107.45 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.88 71.46 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.253 -0.647 . . . . 35.14 109.253 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.14 -44.28 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 124.048 0.939 . . . . 73.12 110.496 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.99 -38.56 76.06 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.494 -0.558 . . . . 74.54 109.494 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.15 -47.09 86.11 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.876 -0.416 . . . . 73.03 109.876 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -60.88 -47.41 86.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.701 -0.852 . . . . 60.24 108.701 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -58.45 -35.89 72.83 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 115.247 1.573 . . . . 64.05 115.247 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -76.17 -51.84 11.32 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.528 -0.733 . . . . 61.51 110.62 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -81.17 7.32 11.44 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.906 1.076 . . . . 73.53 113.906 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -57.0 -27.12 61.31 Favored 'General case' 0 CA--C 1.527 0.094 0 O-C-N 120.586 -1.321 . . . . 72.45 113.602 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -87.27 -16.65 34.57 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.379 0.672 . . . . 74.33 112.038 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.5 -13.98 18.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.132 0.973 . . . . 73.25 111.701 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m 49.15 73.53 0.98 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 125.921 1.688 . . . . 75.34 114.569 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.83 158.32 54.39 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.919 1.746 . . . . 74.43 110.543 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -89.39 -41.57 12.03 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.784 0.834 . . . . 75.42 109.029 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -137.31 153.56 50.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.711 1.204 . . . . 51.02 109.814 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.3 mt -143.77 121.05 5.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.358 1.463 . . . . 43.25 108.215 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 104.24 6.67 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 125.519 1.528 . . . . 73.11 108.096 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.39 116.11 28.08 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.084 1.354 . . . . 74.23 107.931 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 46.5 mtt-85 -109.46 85.5 2.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.96 -1.496 . . . . 74.3 106.96 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.14 -22.5 60.99 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.706 -0.679 . . . . 71.43 111.508 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -51.58 -29.59 17.86 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.709 2.404 . . . . 73.21 112.286 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -132.88 9.78 4.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.202 1.401 . . . . 53.22 110.335 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.93 48.28 86.83 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.506 -1.037 . . . . 42.45 110.506 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.3 pt -136.76 167.39 23.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.368 1.467 . . . . 63.23 110.718 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.18 155.69 38.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.563 1.145 . . . . 50.23 109.569 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -125.68 125.73 43.53 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.038 1.335 . . . . 73.42 108.185 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.57 112.06 18.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.156 -1.053 . . . . 62.15 108.156 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -91.25 156.07 18.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.847 -1.538 . . . . 72.11 106.847 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -144.09 148.65 35.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.2 -1.408 . . . . 74.41 107.2 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -101.58 111.05 23.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.244 0.929 . . . . 73.43 110.897 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.08 -24.25 62.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.556 0.742 . . . . 44.52 111.242 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.35 -28.4 62.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.008 0.822 . . . . 72.04 110.46 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -64.21 -29.09 70.21 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 124.66 1.184 . . . . 74.24 112.251 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -158.45 86.13 0.86 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.12 -1.067 . . . . 75.32 108.12 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -48.35 -36.34 14.28 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.75 1.759 . . . . 72.44 115.75 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.62 -17.21 14.31 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.627 1.103 . . . . 61.31 111.896 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.1 -26.7 43.4 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 118.196 -1.335 . . . . 74.02 111.71 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.31 -39.9 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.217 1.509 . . . . 72.25 110.689 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -58.14 9.71 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.099 -1.074 . . . . 61.11 108.099 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -57.32 -40.17 77.36 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.034 -1.041 . . . . 75.32 111.253 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -58.53 -41.06 84.65 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.101 -1.074 . . . . 74.13 108.101 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 9.0 mtm -66.85 -50.15 63.45 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 117.972 -1.014 . . . . 50.15 108.292 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -51.62 -48.87 63.11 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.54 1.136 . . . . 63.51 110.169 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.12 -31.2 49.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.665 1.586 . . . . 71.34 111.148 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.62 -38.48 21.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.931 0.787 . . . . 44.04 109.2 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.4 mt -67.17 -31.06 71.23 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.338 1.055 . . . . 64.22 110.268 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.81 -12.76 38.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.938 0.895 . . . . 75.54 110.559 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -89.79 4.21 50.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.805 1.242 . . . . 63.34 111.436 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -68.16 120.56 14.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.608 -1.997 . . . . 73.24 105.608 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.39 9.01 63.68 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.028 -1.429 . . . . 60.35 113.245 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 p -68.04 144.17 55.22 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 120.065 1.933 . . . . 71.41 109.912 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.8 mt -93.19 107.4 19.21 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 102.187 -3.264 . . . . 63.34 102.187 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.19 113.93 27.01 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 104.64 -2.355 . . . . 62.52 104.64 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER 51.76 49.34 21.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.922 0.889 . . . . 73.0 109.325 -178.34 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 60.51 32.22 20.44 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 127.442 2.297 . . . . 73.14 114.083 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -130.72 118.04 20.31 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.898 0.879 . . . . 74.24 110.195 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -70.06 100.88 1.7 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.822 1.249 . . . . 72.42 108.136 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.1 pt -92.78 165.87 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.277 -0.889 . . . . 63.02 109.517 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.83 156.39 39.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.541 1.136 . . . . 65.32 111.334 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.21 149.22 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.453 1.501 . . . . 52.35 110.631 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -164.33 173.63 12.02 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.939 1.296 . . . . 71.32 111.138 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.63 147.72 23.11 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.294 1.437 . . . . 73.02 109.733 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.252 0 C-N-CA 123.137 0.575 . . . . 74.21 110.523 -179.57 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.44 0 CA-C-O 121.396 0.617 . . . . 75.42 112.169 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -97.74 152.71 18.85 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 128.577 2.751 . . . . 74.03 109.124 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 79' ' ' THR . 3.0 mp -135.1 147.06 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.748 1.619 . . . . 70.32 109.404 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.2 t -113.37 131.08 66.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.297 -1.742 . . . . 71.15 106.297 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -91.48 108.98 20.27 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.422 1.889 . . . . 70.11 106.428 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 11' ' ' LEU . 11.6 t -115.83 126.47 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.01 -2.218 . . . . 63.5 105.01 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.26 -179.88 16.88 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 120.214 1.37 . . . . 53.11 112.461 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.84 19.44 5.83 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.03 1.732 . . . . 61.53 111.626 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 8' ' ' VAL . 10.1 mp -60.91 147.91 84.53 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.918 0.887 . . . . 64.45 110.681 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.76 156.98 58.61 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.907 3.071 . . . . 72.12 114.526 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.47 -27.74 68.79 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.642 1.177 . . . . 65.22 112.118 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.65 20.54 18.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.597 1.159 . . . . 74.53 112.536 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.533 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 9.7 tp -55.27 143.16 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 O-C-N 121.005 -1.059 . . . . 72.0 110.852 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 p -128.76 154.56 46.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.61 1.164 . . . . 72.22 109.736 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.0 -30.48 70.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.315 1.046 . . . . 74.22 109.085 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.95 -48.68 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.714 1.206 . . . . 73.42 109.424 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.46 ' HG3' ' HE2' ' A' ' 70' ' ' LYS . 4.1 mm-40 -69.59 -29.3 66.81 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.518 0.727 . . . . 73.4 110.54 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -68.97 -51.27 41.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.06 -1.089 . . . . 74.21 108.06 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -58.75 -45.56 89.43 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 107.946 -1.131 . . . . 73.2 107.946 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -56.08 -48.0 76.92 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.517 1.527 . . . . 72.43 113.629 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -56.34 15.66 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 122.292 1.044 . . . . 74.43 111.454 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -79.68 8.55 6.4 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.481 1.512 . . . . 75.34 114.414 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -56.04 -39.78 72.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.94 -1.1 . . . . 65.31 110.412 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.21 -15.51 57.94 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.982 0.734 . . . . 72.44 112.982 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 p -102.16 -1.49 31.29 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.9 -1.125 . . . . 73.23 111.197 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.0 t 37.32 79.78 0.3 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 127.552 2.341 . . . . 71.15 115.066 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.08 156.57 55.65 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.595 1.53 . . . . 64.04 109.616 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.47 -49.2 8.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.799 -1.556 . . . . 74.43 106.799 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -136.71 154.37 50.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.174 0.99 . . . . 72.53 110.007 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -136.09 133.04 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.372 1.869 . . . . 74.33 109.577 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -142.37 107.95 5.08 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 127.189 2.196 . . . . 63.34 109.5 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -96.41 122.43 39.29 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.649 -1.241 . . . . 63.13 107.649 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -110.29 86.01 2.22 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.948 1.699 . . . . 75.32 106.722 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.65 -32.66 63.39 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.966 0.906 . . . . 71.43 112.333 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -56.78 -19.01 14.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.355 1.462 . . . . 54.34 113.232 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -132.16 -1.31 3.65 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.146 1.378 . . . . 71.44 110.569 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.69 38.79 96.48 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.578 1.085 . . . . 72.11 110.934 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -127.8 163.45 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.19 1.396 . . . . 72.11 109.88 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.61 155.32 47.51 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.04 1.336 . . . . 71.51 109.332 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.76 104.36 9.25 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.18 -1.785 . . . . 71.13 106.18 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.22 111.65 24.14 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 105.158 -2.164 . . . . 51.3 105.158 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.62 157.91 17.23 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.62 0.768 . . . . 75.2 109.494 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -146.19 133.41 20.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.6 1.56 . . . . 72.13 107.304 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -101.73 122.63 44.28 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 105.013 -2.217 . . . . 62.14 105.013 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.63 -23.48 62.55 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.611 1.564 . . . . 63.21 111.261 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -83.65 -18.71 37.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.964 0.506 . . . . 65.55 109.912 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -69.0 -19.11 64.13 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.3 -0.857 . . . . 73.41 111.372 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -168.42 85.04 0.18 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.86 1.664 . . . . 72.21 106.621 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -32.73 6.5 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.821 1.648 . . . . 74.45 113.666 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.3 p -107.57 -20.23 13.3 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.187 0.903 . . . . 64.34 112.806 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.38 -18.03 53.78 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-O 117.677 -1.624 . . . . 61.31 114.494 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.1 tp -50.93 -36.7 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 119.645 1.723 . . . . 61.32 109.13 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -61.26 -61.72 2.35 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.982 2.513 . . . . 74.0 110.653 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.87 -35.45 76.63 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.213 -0.929 . . . . 75.41 109.724 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -60.81 -49.22 78.35 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 108.074 -1.084 . . . . 75.12 108.074 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.4 mtt -57.67 -50.54 72.85 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 124.647 1.179 . . . . 54.44 109.888 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -56.99 -44.62 82.92 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.272 1.029 . . . . 74.2 111.773 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.5 mt -69.85 -34.5 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 108.951 -0.759 . . . . 73.11 108.951 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.82 79.76 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.508 -1.293 . . . . 61.13 107.508 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.4 mt -58.65 -32.24 68.9 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.321 1.048 . . . . 62.23 111.3 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 46.4 mt -66.74 -9.02 32.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.283 -0.865 . . . . 72.12 112.258 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -86.16 -2.48 58.4 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.276 1.398 . . . . 72.24 111.49 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 112.23 2.78 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.788 1.235 . . . . 75.3 108.036 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.11 10.27 59.86 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.404 1.002 . . . . 64.4 114.284 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.3 p -75.1 143.23 43.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.573 1.687 . . . . 65.03 109.591 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.14 108.97 19.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 106.861 -1.533 . . . . 75.04 106.861 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mt -110.38 119.72 40.12 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 105.337 -2.097 . . . . 71.24 105.337 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 33.1 mttt 45.95 49.59 11.87 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.011 0.91 . . . . 74.11 110.528 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 63.29 16.45 9.47 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.92 2.088 . . . . 70.11 116.348 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -119.79 126.77 51.82 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.123 1.369 . . . . 72.31 108.185 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -79.18 106.93 11.57 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.354 -0.239 . . . . 73.31 110.354 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.42 169.89 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 123.543 0.737 . . . . 70.34 111.7 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -128.25 158.75 37.3 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.883 2.073 . . . . 64.12 108.878 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.0 t -142.79 127.41 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.676 1.19 . . . . 64.33 108.784 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -144.0 173.29 11.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.779 1.232 . . . . 74.24 109.361 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.85 151.86 21.55 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.221 1.009 . . . . 75.21 110.308 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.438 HG23 ' HB ' ' A' ' 5' ' ' ILE . 6.9 t . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 106.986 -1.487 . . . . 71.14 106.986 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 . . . . . 0 CA--C 1.512 -0.491 0 N-CA-C 108.584 -0.895 . . . . 71.2 108.584 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -130.77 165.53 22.75 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.081 -1.822 . . . . 63.02 106.081 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.3 mt -130.56 146.41 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 109.001 -0.74 . . . . 72.22 109.001 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.3 131.93 63.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.144 -1.428 . . . . 65.43 107.144 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -89.93 115.41 27.22 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 105.421 -2.066 . . . . 74.25 105.421 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -124.46 128.67 73.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.425 -2.065 . . . . 63.41 105.425 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.406 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -140.3 -179.93 18.45 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 119.233 0.924 . . . . 71.54 111.62 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.418 ' HB3' ' HA ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER 71.83 18.61 5.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.281 1.832 . . . . 73.31 111.097 -178.665 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.59 153.21 62.99 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 124.663 1.185 . . . . 62.52 113.042 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HG3' ' HB2' ' A' ' 70' ' ' LYS . 10.8 Cg_endo -64.33 167.88 13.85 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.127 2.551 . . . . 45.1 111.64 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -75.34 -41.66 56.17 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 121.716 -0.615 . . . . 72.04 109.938 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.56 19.77 4.37 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.591 0.96 . . . . 64.31 113.591 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.536 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.7 tp -53.47 140.73 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 121.289 -0.882 . . . . 64.25 109.547 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -127.81 150.58 49.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.643 1.177 . . . . 72.25 109.106 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.4 -28.46 69.8 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.579 -0.7 . . . . 71.02 111.069 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -43.1 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.793 -0.818 . . . . 75.21 108.793 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -63.96 -45.27 89.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.682 0.793 . . . . 73.22 109.21 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.89 -48.81 80.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.065 -0.493 . . . . 75.22 110.113 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -61.28 -36.63 80.58 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 118.894 0.77 . . . . 61.34 109.784 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.52 -40.02 77.2 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.813 0.733 . . . . 73.41 111.843 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.532 ' ND1' HD21 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.81 -37.99 70.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.109 0.868 . . . . 65.34 111.316 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -94.61 6.2 49.55 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.459 -0.776 . . . . 74.24 112.264 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -54.84 -39.34 68.47 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.958 1.303 . . . . 74.3 112.531 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -71.17 -35.85 71.79 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.379 -0.825 . . . . 64.23 110.639 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -74.69 -24.14 58.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.636 0.774 . . . . 72.32 112.859 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.9 m 63.74 69.54 0.77 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 116.284 1.957 . . . . 73.51 116.284 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.51 159.6 52.97 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.813 2.342 . . . . 71.31 109.896 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.28 -53.99 5.11 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.91 -1.885 . . . . 74.31 105.91 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -143.92 161.53 38.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.424 1.49 . . . . 71.31 109.406 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.12 140.5 42.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 126.039 1.736 . . . . 53.0 107.151 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -133.16 103.93 6.25 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 107.352 -1.351 . . . . 73.24 107.352 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -87.71 112.57 22.52 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.882 0.873 . . . . 72.11 109.157 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -101.24 87.43 3.23 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.557 -1.646 . . . . 72.35 106.557 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.6 -28.8 61.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.634 1.174 . . . . 73.25 112.687 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -52.61 -38.89 61.01 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.967 2.107 . . . . 71.21 114.064 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -118.88 -6.45 10.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 118.219 -0.896 . . . . 74.41 111.956 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.67 48.25 29.67 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.728 -1.749 . . . . 62.11 108.728 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.406 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.5 pt -137.24 156.13 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 126.233 1.813 . . . . 73.22 108.034 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.4 126.97 12.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.964 -0.754 . . . . 62.3 108.964 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -90.11 135.99 33.32 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.49 -1.3 . . . . 74.45 107.49 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.91 123.99 39.82 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.171 -1.788 . . . . 62.31 106.171 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -95.26 143.44 26.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.312 1.445 . . . . 73.42 108.214 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -135.77 106.85 6.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.052 -1.462 . . . . 73.4 107.052 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.68 116.55 8.51 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.979 0.911 . . . . 35.25 110.538 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.01 -31.23 61.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.608 1.963 . . . . 64.2 112.164 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.02 -22.34 63.11 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.098 0.559 . . . . 65.54 109.845 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -60.7 -35.92 77.52 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 108.964 -0.754 . . . . 74.33 108.964 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -162.22 96.29 0.97 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.042 -0.725 . . . . 62.0 109.042 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -55.55 -29.83 59.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 117.81 -1.09 . . . . 74.35 113.068 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.253 29.9 p -110.74 7.5 22.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.947 0.794 . . . . 74.51 112.738 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.41 -20.71 4.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.484 1.516 . . . . 70.4 112.27 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.3 tp -54.55 -39.93 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 125.048 1.339 . . . . 64.32 111.853 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -58.05 9.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.227 -0.657 . . . . 64.33 109.227 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -57.54 -32.61 67.26 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.52 -0.738 . . . . 72.23 111.551 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -64.42 -51.18 64.49 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.179 -1.415 . . . . 73.04 107.179 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.6 mtm -66.27 -30.59 71.05 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.753 0.821 . . . . 63.02 112.429 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.02 -39.73 90.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.691 1.132 . . . . 73.1 108.884 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.6 mt -66.03 -39.16 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.784 -1.191 . . . . 74.23 107.784 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.38 95.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.368 -0.975 . . . . 74.04 108.368 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.1 mt -63.13 -31.08 72.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.304 0.502 . . . . 65.14 111.264 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.56 -6.95 8.58 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.725 1.009 . . . . 72.21 113.725 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -93.45 -0.56 56.39 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.732 0.697 . . . . 75.11 111.029 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.65 112.78 2.14 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.718 1.607 . . . . 71.01 109.833 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.69 5.55 61.35 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.481 -1.177 . . . . 61.13 113.657 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.3 p -66.79 147.69 52.92 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.988 1.894 . . . . 71.31 109.486 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.41 107.92 19.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.498 -2.038 . . . . 64.35 105.498 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.532 HD21 ' ND1' ' A' ' 23' ' ' HIS . 6.2 mt -107.19 126.07 51.92 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 105.331 -2.1 . . . . 74.32 105.331 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 18.6 mttt 42.1 49.84 4.3 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.486 1.039 . . . . 72.2 111.345 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 64.04 21.85 12.73 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.356 2.263 . . . . 74.23 115.235 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -124.87 126.37 45.45 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.313 -1.492 . . . . 62.35 110.986 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 tptt -74.75 109.46 8.24 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.567 -1.642 . . . . 50.25 106.567 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 1.9 pp -92.8 170.02 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.009 0.924 . . . . 64.4 111.103 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -127.57 158.13 38.3 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.881 1.272 . . . . 71.41 109.674 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.4 t -141.52 132.38 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.476 -1.675 . . . . 72.32 106.476 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -146.76 163.02 37.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.827 1.251 . . . . 72.41 109.021 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.52 152.17 28.81 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.265 1.026 . . . . 74.13 109.638 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 C-N-CA 124.065 0.946 . . . . 71.52 109.331 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.1 ptt85 . . . . . 0 CA--C 1.512 -0.492 0 CA-C-O 120.562 0.22 . . . . 64.24 110.932 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -113.55 163.15 15.3 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 104.775 -2.305 . . . . 73.34 104.775 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mt -132.24 149.26 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.618 -1.252 . . . . 62.15 107.618 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.8 t -120.01 124.03 71.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.365 -1.717 . . . . 73.12 106.365 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -88.3 136.29 33.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.837 -1.912 . . . . 73.33 105.837 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 11' ' ' LEU . 11.0 t -136.7 129.14 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.244 -2.132 . . . . 63.21 105.244 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.74 -177.97 15.63 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 120.18 1.354 . . . . 74.25 113.374 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.93 14.37 5.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.495 2.318 . . . . 45.02 110.11 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.46 HD11 HG12 ' A' ' 8' ' ' VAL . 10.7 mp -58.39 142.03 82.37 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.746 1.219 . . . . 70.15 111.802 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.28 156.98 60.19 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.11 2.54 . . . . 62.12 111.071 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -68.3 -35.01 77.19 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.498 -0.751 . . . . 74.34 109.172 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.34 8.98 5.17 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.712 1.605 . . . . 74.03 113.392 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.435 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 9.6 tp -51.13 145.71 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.952 1.301 . . . . 71.43 112.678 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.59 150.41 50.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.511 1.124 . . . . 74.53 110.221 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.0 72.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.64 1.176 . . . . 74.12 109.969 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 t -61.41 -41.26 89.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.647 0.779 . . . . 64.23 110.874 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -70.89 -39.03 73.05 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.97 -0.752 . . . . 74.14 108.97 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.33 -51.5 65.72 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.232 1.013 . . . . 74.43 110.674 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -61.19 -42.78 99.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.063 0.945 . . . . 42.35 109.267 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -64.5 -52.28 58.63 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.334 1.054 . . . . 44.25 113.023 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -48.97 78.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.911 0.778 . . . . 75.44 111.749 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -85.81 1.84 48.07 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 113.857 1.058 . . . . 73.04 113.857 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -47.12 70.24 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 120.083 1.31 . . . . 73.34 111.477 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -60.68 -34.11 73.84 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.133 0.424 . . . . 65.25 111.696 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 p -83.86 -10.48 57.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.883 0.873 . . . . 64.01 111.597 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 m 42.78 68.78 2.61 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 127.057 2.143 . . . . 60.14 113.953 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -64.07 158.39 48.13 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.866 2.377 . . . . 75.51 109.527 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.94 -36.81 13.9 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.032 0.933 . . . . 71.52 108.862 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -127.67 155.74 43.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.901 0.881 . . . . 44.22 111.087 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 75.4 mt -144.74 115.5 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.797 -1.557 . . . . 74.15 106.797 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 104.64 5.57 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.475 1.51 . . . . 75.14 108.407 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.04 119.94 30.82 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.705 1.202 . . . . 73.05 108.285 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 -109.65 84.19 1.88 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.469 -1.678 . . . . 75.02 106.469 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.29 -29.27 65.71 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.343 -0.836 . . . . 34.24 111.369 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -54.31 -26.99 32.57 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.834 1.05 . . . . 62.02 113.834 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.3 mmtt -127.38 9.04 6.59 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.886 0.875 . . . . 65.45 111.262 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.98 48.22 80.99 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.982 -1.247 . . . . 63.14 109.982 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.38 171.29 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 C-N-CA 124.821 1.248 . . . . 71.01 109.675 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.17 168.77 20.82 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.813 1.245 . . . . 52.14 108.46 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -134.82 137.08 43.0 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 104.974 -2.232 . . . . 74.51 104.974 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -137.19 116.29 12.49 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 105.984 -1.858 . . . . 74.13 105.984 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.05 151.33 19.59 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.691 -1.596 . . . . 53.41 106.691 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -141.43 111.83 6.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.069 -1.826 . . . . 70.33 106.069 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.38 122.17 28.56 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.831 0.852 . . . . 65.23 111.183 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.27 93.91 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.496 1.118 . . . . 63.03 111.95 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.25 -28.9 70.03 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.961 -0.755 . . . . 72.31 108.961 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.71 -23.77 66.35 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 117.448 -1.263 . . . . 54.45 112.113 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -163.81 90.4 0.61 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.715 1.606 . . . . 55.11 107.837 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 -56.39 -16.39 5.63 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.513 1.525 . . . . 74.41 115.086 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 m -122.7 -19.44 6.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 120.038 1.29 . . . . 52.32 112.413 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.51 -14.62 43.51 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 117.245 -1.864 . . . . 55.32 114.883 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -50.17 -44.51 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 120.491 2.146 . . . . 73.43 111.572 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -62.39 -58.16 8.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.961 0.904 . . . . 72.04 110.472 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -59.2 -31.2 68.81 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.516 -1.365 . . . . 74.31 111.054 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -62.53 -41.11 98.65 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.519 -1.289 . . . . 64.24 107.519 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 12.1 mtm -65.8 -42.83 90.23 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.158 -1.053 . . . . 54.12 108.158 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -54.13 -49.78 68.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.524 1.056 . . . . 54.03 110.375 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -61.28 -44.85 99.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.299 1.44 . . . . 65.35 109.481 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.83 -42.0 95.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.374 0.534 . . . . 71.45 109.983 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.19 -29.9 69.7 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.132 0.973 . . . . 64.22 111.428 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.19 -13.31 57.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.772 -0.632 . . . . 61.0 109.895 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -85.49 2.17 45.8 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.979 0.809 . . . . 74.21 111.079 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -67.11 112.07 4.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.137 -1.602 . . . . 71.11 108.519 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.47 10.47 53.61 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.646 1.117 . . . . 73.51 113.563 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.9 p -68.77 141.01 55.33 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.773 1.786 . . . . 62.41 110.214 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.5 mt -87.41 110.68 20.44 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 101.938 -3.356 . . . . 70.15 101.938 176.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -115.41 121.49 42.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.587 1.555 . . . . 71.41 108.422 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 5.9 mtpm? 50.17 44.57 26.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.011 0.924 . . . . 74.54 112.761 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 67.67 24.27 8.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.106 2.162 . . . . 74.44 112.315 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -140.19 126.61 20.12 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.638 1.575 . . . . 55.21 110.302 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -75.17 143.54 43.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.475 -1.676 . . . . 75.51 106.475 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.6 pt -128.47 162.64 34.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.002 0.921 . . . . 64.45 109.492 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -120.43 159.02 25.97 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 125.368 1.467 . . . . 75.32 111.694 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.6 t -136.0 148.06 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 107.896 -1.15 . . . . 65.54 107.896 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -161.71 161.56 29.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.868 1.667 . . . . 74.3 108.771 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.5 152.22 23.35 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.626 1.17 . . . . 63.34 113.214 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 125.302 1.441 . . . . 62.23 108.34 179.32 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 106.35 -1.722 . . . . 72.54 106.35 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -127.92 162.9 25.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.508 -1.293 . . . . 75.54 107.508 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 79' ' ' THR . 5.0 mt -135.17 144.09 35.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.874 -1.898 . . . . 53.54 105.874 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.3 t -118.99 128.82 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 126.391 1.876 . . . . 41.21 106.127 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 40' ' ' ILE . 53.7 t80 -101.21 139.14 37.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.25 -2.129 . . . . 75.12 105.25 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.56 127.76 31.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 104.014 -2.587 . . . . 74.34 104.014 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.511 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -132.38 179.54 17.14 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 120.078 1.308 . . . . 55.44 112.634 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.17 17.77 3.97 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.194 2.198 . . . . 54.12 110.302 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 mp -55.03 148.63 27.87 Favored Pre-proline 0 C--O 1.239 0.524 0 C-N-CA 124.929 1.292 . . . . 73.1 111.95 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.28 153.61 75.69 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.956 3.104 . . . . 75.32 112.239 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -65.38 -34.03 77.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 118.508 -0.758 . . . . 74.04 109.492 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -92.65 21.06 5.76 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.641 1.176 . . . . 75.31 112.646 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.557 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 10.3 tp -52.36 138.92 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 121.256 -0.903 . . . . 52.24 109.951 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 p -125.38 150.77 46.91 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.48 -0.933 . . . . 73.54 108.48 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.01 -26.24 68.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 118.299 -0.858 . . . . 65.32 110.133 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.6 p -65.09 -41.17 91.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 119.697 1.135 . . . . 72.11 108.682 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.553 ' HG3' ' HE2' ' A' ' 70' ' ' LYS . 15.8 mm-40 -68.11 -45.27 74.14 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.346 -0.983 . . . . 73.22 108.346 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.1 mt -59.71 -47.65 84.79 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.494 0.588 . . . . 74.11 111.086 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -61.0 -38.01 84.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.56 0.744 . . . . 72.14 109.987 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -74.44 -54.35 7.76 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.364 1.066 . . . . 71.13 113.796 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -34.6 70.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.681 0.993 . . . . 64.43 113.681 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -97.4 3.71 50.88 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.806 0.842 . . . . 70.11 112.58 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -60.72 -28.96 69.06 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.845 -1.159 . . . . 70.0 109.918 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -73.67 -17.57 61.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.093 0.957 . . . . 72.34 111.058 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 p -113.84 -5.84 13.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.439 1.895 . . . . 53.13 113.581 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.8 t 41.68 77.33 0.44 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 126.503 1.921 . . . . 75.05 114.973 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.57 165.99 30.08 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 121.931 1.754 . . . . 72.42 109.988 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -91.2 -32.89 15.61 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 120.742 -1.224 . . . . 72.24 109.501 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -143.54 153.26 42.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.169 1.388 . . . . 71.23 108.187 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.4 mt -133.73 105.12 6.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.788 -1.56 . . . . 71.44 106.788 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.1 ttt-85 -122.62 103.94 9.01 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.875 -0.787 . . . . 75.41 108.875 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -83.15 127.38 33.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.107 -1.812 . . . . 73.32 106.107 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 85.54 2.37 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.582 -2.007 . . . . 75.21 105.582 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.53 -27.55 49.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.918 0.887 . . . . 72.33 113.003 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -52.05 -30.09 24.12 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.68 1.992 . . . . 71.01 114.314 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -132.23 11.96 4.61 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.043 1.337 . . . . 54.15 111.418 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.77 52.45 50.68 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.345 -1.502 . . . . 25.11 109.345 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.511 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.8 pt -139.84 168.07 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.613 1.165 . . . . 65.11 110.594 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.99 154.29 41.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.649 1.179 . . . . 62.21 108.014 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -124.45 123.32 39.88 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.118 -1.808 . . . . 62.2 106.118 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mp -117.77 113.81 22.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.861 -1.533 . . . . 75.2 106.861 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -85.18 152.81 23.08 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.335 -1.357 . . . . 61.22 107.335 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -141.1 136.86 32.37 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.446 1.098 . . . . 74.24 108.709 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -97.98 108.51 21.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.394 1.478 . . . . 75.23 112.616 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.4 -22.6 51.34 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.483 0.713 . . . . 64.22 112.543 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.93 -37.09 35.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 112.096 0.406 . . . . 74.33 112.096 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -68.87 -55.47 10.99 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.186 1.394 . . . . 73.01 111.036 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.57 71.91 0.81 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 122.011 0.91 . . . . 60.41 110.281 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -48.85 -38.49 22.55 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.685 1.194 . . . . 70.31 112.718 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.8 p -104.99 8.0 34.29 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.761 1.022 . . . . 74.44 113.761 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.94 -23.14 2.54 Favored Glycine 0 C--O 1.221 -0.676 0 CA-C-O 118.038 -1.423 . . . . 61.25 113.604 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.1 tp -49.36 -49.57 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 120.244 2.022 . . . . 73.2 113.127 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -64.07 -55.46 22.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.841 -0.8 . . . . 75.45 108.841 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -49.49 -53.2 24.5 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.171 0.896 . . . . 55.25 109.417 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -51.91 -54.86 24.51 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.14 1.776 . . . . 74.31 110.337 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 44.0 mtm -66.32 -28.32 68.59 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 118.908 0.776 . . . . 72.34 111.218 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -65.06 -47.51 77.05 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 120.074 -1.641 . . . . 73.31 109.798 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.5 mt -65.29 -31.65 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.284 1.833 . . . . 72.21 108.063 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.23 -41.13 58.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.674 -0.862 . . . . 65.13 108.674 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -60.61 -37.06 80.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.479 0.712 . . . . 73.23 110.311 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.6 mt -64.42 -6.08 6.52 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.236 1.414 . . . . 72.22 113.616 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -92.39 6.23 47.71 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.491 1.041 . . . . 73.53 111.234 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -72.25 114.89 10.86 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.727 1.211 . . . . 74.34 108.546 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.48 5.09 61.98 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-O 118.005 -1.442 . . . . 21.52 114.445 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.9 p -72.01 154.01 41.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.997 1.899 . . . . 71.03 109.422 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 mt -100.49 107.54 19.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.588 -1.634 . . . . 64.13 106.588 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.67 121.92 44.86 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.622 -2.362 . . . . 74.22 104.622 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 18.8 mttm 48.1 47.33 19.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.822 0.849 . . . . 61.03 110.971 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 58.0 26.97 14.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.846 1.658 . . . . 62.14 114.186 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -126.47 122.31 34.88 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.728 -1.212 . . . . 74.32 107.728 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -81.62 102.55 10.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.298 -1.371 . . . . 64.14 107.298 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.6 pt -85.54 169.64 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 124.282 1.033 . . . . 73.21 110.898 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.62 155.27 45.23 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 125.888 1.675 . . . . 73.53 109.467 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.62 148.91 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.339 1.055 . . . . 54.11 108.479 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.8 172.14 13.34 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.571 1.949 . . . . 64.42 109.368 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.55 153.42 18.18 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.067 1.747 . . . . 55.1 107.366 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.443 HG23 ' HB ' ' A' ' 5' ' ' ILE . 9.2 t . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 108.947 -0.76 . . . . 64.54 108.947 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 109.889 -0.412 . . . . 72.41 109.889 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -133.19 165.62 24.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.105 1.362 . . . . 74.41 108.583 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mt -134.45 148.64 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.024 -0.732 . . . . 74.24 109.024 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.33 126.64 74.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 105.942 -1.873 . . . . 73.22 105.942 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -91.04 137.73 32.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.522 1.529 . . . . 63.4 107.688 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 11' ' ' LEU . 11.9 t -138.73 126.09 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.729 -1.582 . . . . 74.42 106.729 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.412 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -136.9 176.76 20.23 Favored Glycine 0 N--CA 1.468 0.774 0 CA-C-N 120.347 1.431 . . . . 32.25 111.628 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.25 19.02 0.77 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.48 2.312 . . . . 75.11 109.585 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.481 HD11 HG12 ' A' ' 8' ' ' VAL . 9.9 mp -63.76 143.25 98.08 Favored Pre-proline 0 C--O 1.235 0.315 0 O-C-N 120.9 -1.125 . . . . 52.03 112.884 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.3 160.74 43.78 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.62 2.88 . . . . 53.34 111.604 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -44.06 93.46 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.784 -0.821 . . . . 74.23 108.784 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.72 9.46 1.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.522 1.929 . . . . 62.31 114.095 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.538 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.5 tp -58.62 139.45 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 O-C-N 120.725 -1.234 . . . . 61.52 109.822 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 150.52 50.11 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.818 0.847 . . . . 64.21 109.75 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.84 -30.73 70.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.076 0.95 . . . . 75.42 110.404 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.67 -43.27 96.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.549 1.14 . . . . 70.3 109.487 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.08 -42.12 85.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.96 -1.126 . . . . 64.41 107.96 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.67 -53.47 55.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.988 1.315 . . . . 74.23 110.454 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -46.9 83.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.688 -1.226 . . . . 72.44 107.688 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -62.58 -42.85 99.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.918 1.081 . . . . 64.12 113.918 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.99 -47.68 67.86 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 120.993 -1.067 . . . . 72.22 110.66 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.33 6.05 28.04 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.25 1.204 . . . . 74.31 114.25 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -51.48 -41.13 60.7 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 125.067 1.347 . . . . 61.3 113.715 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -72.57 -21.93 61.07 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.404 0.547 . . . . 72.41 112.247 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.66 -17.89 22.76 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.218 1.407 . . . . 72.51 110.843 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 m 49.17 74.15 0.87 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.094 1.758 . . . . 61.33 114.412 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HG2' HD11 ' A' ' 32' ' ' ILE . 74.4 Cg_endo -65.87 153.15 79.34 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.116 1.877 . . . . 74.35 109.111 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -91.62 -39.8 11.67 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.996 -1.112 . . . . 65.4 107.996 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -123.46 146.35 48.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.548 1.139 . . . . 65.12 108.867 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.445 HD11 ' HG2' ' A' ' 29' ' ' PRO . 57.3 mt -141.38 107.02 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.982 -1.118 . . . . 74.23 107.982 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.43 104.74 8.07 Favored 'General case' 0 N--CA 1.46 0.055 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.53 118.66 30.78 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.776 2.03 . . . . 74.02 108.191 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.68 87.84 2.73 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.631 1.572 . . . . 75.22 108.432 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.32 -16.89 63.04 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.696 -0.628 . . . . 73.23 109.88 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -51.62 -26.74 9.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.937 2.495 . . . . 74.04 110.797 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -133.23 -1.6 3.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.798 2.439 . . . . 65.33 111.128 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.83 50.75 45.36 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.263 1.411 . . . . 64.32 110.134 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.412 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.3 pt -140.8 167.94 17.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 125.988 1.715 . . . . 63.34 110.827 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.83 149.81 33.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.247 1.819 . . . . 74.0 109.227 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.35 132.98 55.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.691 -1.596 . . . . 71.22 106.691 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.17 110.12 12.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.183 -1.784 . . . . 62.02 106.183 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -96.86 148.49 22.88 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.755 -1.202 . . . . 53.43 107.755 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -143.5 120.97 11.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.401 1.08 . . . . 75.02 109.358 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.38 121.13 22.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.479 0.712 . . . . 70.21 110.541 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.1 -38.76 63.75 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.943 1.697 . . . . 74.22 112.209 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.38 -29.62 70.89 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.594 -0.521 . . . . 71.5 109.594 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -61.7 -19.27 62.19 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.393 1.077 . . . . 74.3 112.489 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.03 90.33 0.44 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.105 1.321 . . . . 70.52 109.619 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -48.85 -38.71 23.15 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 116.125 1.898 . . . . 75.11 116.125 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -114.59 -0.95 13.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 123.337 0.398 . . . . 74.2 111.371 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.04 -28.68 8.05 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.474 1.035 . . . . 71.41 111.438 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.2 tp -54.13 -37.76 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.906 1.353 . . . . 72.33 110.648 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -56.75 18.04 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.148 -0.686 . . . . 74.14 109.148 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -42.78 66.82 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.715 1.206 . . . . 70.42 110.325 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -57.35 -46.73 83.02 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.001 -1.111 . . . . 55.23 108.001 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.3 mtm -66.88 -44.58 80.52 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 117.938 -1.029 . . . . 53.32 110.769 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -52.42 -49.85 63.69 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.315 1.416 . . . . 54.11 110.217 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.92 -43.51 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.722 1.209 . . . . 74.1 109.16 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.14 96.76 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.783 0.719 . . . . 73.34 109.968 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.39 -26.35 68.42 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.007 1.323 . . . . 60.02 111.571 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.56 -8.2 54.97 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.458 -0.776 . . . . 72.41 109.946 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -88.84 9.02 26.21 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.178 -0.915 . . . . 75.32 111.803 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -76.86 118.03 19.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.694 1.588 . . . . 72.42 106.735 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.62 3.02 64.81 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.508 -1.162 . . . . 64.22 115.094 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.1 p -67.97 144.89 54.99 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 120.018 1.909 . . . . 73.4 107.766 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.8 mt -92.87 107.66 19.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 103.936 -2.616 . . . . 74.41 103.936 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.07 115.39 30.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 102.931 -2.988 . . . . 74.23 102.931 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER 48.41 56.96 6.73 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.533 1.159 . . . . 62.22 110.384 -177.727 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 60.47 13.09 3.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.359 2.264 . . . . 75.34 114.999 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -118.35 120.0 36.31 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.259 1.023 . . . . 74.01 111.469 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -71.63 115.7 11.12 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.872 -1.529 . . . . 50.12 106.872 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.335 16.4 pt -101.39 170.69 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.358 0.526 . . . . 54.43 110.201 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -120.89 151.83 39.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.482 1.113 . . . . 72.04 109.704 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.3 t -137.62 135.19 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.579 1.152 . . . . 65.22 108.45 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.35 152.97 32.73 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.427 1.091 . . . . 71.22 110.574 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 143.62 38.49 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.252 1.021 . . . . 72.25 111.005 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 124.917 1.287 . . . . 61.52 110.218 179.551 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 . . . . . 0 CA--C 1.513 -0.464 0 N-CA-C 110.152 -0.314 . . . . 70.34 110.152 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -115.77 165.04 13.5 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 128.042 2.537 . . . . 75.33 104.391 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.5 mt -134.89 135.75 52.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.534 -0.757 . . . . 73.31 109.091 -177.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.9 t -96.98 145.34 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 104.992 -2.225 . . . . 61.31 104.992 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -113.62 131.73 56.02 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 104.904 -2.258 . . . . 75.11 104.904 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.47 HG12 HD11 ' A' ' 11' ' ' LEU . 21.6 t -135.88 126.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.091 -1.818 . . . . 41.22 106.091 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.22 177.63 18.36 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.052 0.842 . . . . 73.43 112.419 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.0 17.18 2.22 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.58 2.752 . . . . 52.52 110.671 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.47 HD11 HG12 ' A' ' 8' ' ' VAL . 9.7 mp -58.31 144.32 77.82 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 124.91 1.284 . . . . 70.23 111.688 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.19 160.76 43.4 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.362 2.708 . . . . 71.43 112.406 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -67.06 -37.5 84.13 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.422 -0.955 . . . . 75.35 108.422 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.8 13.59 1.64 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.72 1.007 . . . . 43.02 113.72 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.61 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 6.4 tp -63.98 134.78 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 120.451 -1.405 . . . . 70.34 110.452 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . 0.254 1.3 p -128.63 150.05 50.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.456 1.902 . . . . 71.2 107.124 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.37 64.49 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.382 -0.824 . . . . 44.23 112.638 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 p -64.18 -36.54 77.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.462 -0.94 . . . . 75.23 108.462 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -70.35 -43.44 70.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.979 0.912 . . . . 73.24 108.595 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.99 -47.44 84.8 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.232 -0.655 . . . . 74.52 109.232 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -60.03 -38.55 83.03 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.863 0.865 . . . . 74.13 108.797 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -68.85 -41.9 77.85 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.814 1.188 . . . . 65.21 111.076 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -69.99 -35.86 74.72 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.565 -0.709 . . . . 71.53 112.561 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -100.87 6.44 43.72 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.668 0.787 . . . . 74.0 112.405 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -54.27 -43.85 71.37 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.054 1.342 . . . . 73.41 110.747 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -60.79 -32.03 71.38 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.369 1.068 . . . . 73.31 112.123 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 p -94.24 -22.45 18.4 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.686 1.194 . . . . 72.21 111.378 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t 54.4 79.95 0.32 Allowed Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 129.537 3.135 . . . . 65.33 112.396 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.89 166.24 18.92 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.677 2.918 . . . . 64.22 111.484 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -96.65 -38.55 9.89 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.116 0.966 . . . . 72.13 109.429 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -131.82 151.52 51.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.056 1.342 . . . . 54.05 108.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -139.8 105.29 2.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 106.473 -1.676 . . . . 73.23 106.473 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -122.57 104.29 9.26 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.46 -1.311 . . . . 54.24 107.46 178.141 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 15' ' ' ILE . 1.5 tm? -87.01 125.24 33.97 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.63 1.172 . . . . 74.32 108.575 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.17 79.4 1.27 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.16 1.784 . . . . 73.3 107.078 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.01 54.77 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.104 0.962 . . . . 73.22 111.746 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.73 -34.98 29.14 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 126.688 1.995 . . . . 63.32 111.918 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -131.48 14.95 4.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.585 1.154 . . . . 63.11 111.298 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.5 50.23 66.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 124.265 0.936 . . . . 53.33 111.095 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 pt -138.21 170.95 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.235 1.414 . . . . 75.23 109.492 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.74 164.94 34.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.579 1.152 . . . . 61.11 109.094 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -128.69 127.69 42.62 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 105.505 -2.035 . . . . 60.15 105.505 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mp -130.07 106.45 8.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.743 -1.577 . . . . 74.02 106.743 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -96.16 150.14 20.85 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.581 -1.266 . . . . 75.34 107.581 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -136.27 135.28 38.85 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.496 -1.298 . . . . 72.43 107.496 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -79.46 109.61 14.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.323 0.965 . . . . 72.32 110.986 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.17 -24.78 60.6 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.609 1.564 . . . . 73.34 113.668 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.13 -25.93 58.8 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.713 -0.847 . . . . 74.43 108.713 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -60.64 -27.79 68.06 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.913 0.885 . . . . 72.35 111.051 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -161.35 88.48 0.73 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.842 0.746 . . . . 71.43 111.007 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -59.64 -25.41 64.66 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.162 -0.961 . . . . 62.22 112.831 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.0 p -96.95 -12.24 23.62 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.136 0.88 . . . . 63.52 113.181 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.99 -12.24 7.15 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-O 117.753 -1.582 . . . . 60.3 115.5 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 tp -58.0 -37.27 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 120.727 2.263 . . . . 74.33 110.773 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -58.69 -58.55 8.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.672 -1.233 . . . . 53.4 107.672 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -43.19 68.45 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.874 0.761 . . . . 71.22 111.777 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -57.3 -43.8 83.55 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.836 -0.801 . . . . 74.23 108.836 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.2 mtm -64.35 -43.27 95.1 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.985 -0.746 . . . . 75.25 108.985 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.44 -47.58 72.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.142 1.777 . . . . 62.24 111.495 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.11 -37.09 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.263 1.425 . . . . 43.34 107.959 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.06 -37.83 66.67 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.332 0.969 . . . . 75.43 109.44 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 78' ' ' LEU . 32.6 mt -67.59 -28.58 67.89 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.625 0.77 . . . . 60.34 110.914 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.58 -8.53 27.6 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.405 0.682 . . . . 73.14 110.978 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -86.42 3.82 42.15 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.874 0.761 . . . . 60.54 111.203 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -66.97 131.1 45.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 119.688 -1.882 . . . . 75.54 107.845 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.09 8.68 58.88 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 117.976 -1.458 . . . . 74.44 114.579 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 p -70.39 146.82 50.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.883 2.342 . . . . 73.15 108.059 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.0 mt -89.9 108.0 19.45 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.743 -2.317 . . . . 61.05 104.743 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.9 tp -110.04 121.81 46.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.912 -1.885 . . . . 70.03 105.912 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 13.9 mtpp 53.92 38.42 28.73 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.813 0.845 . . . . 62.34 111.296 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 62.61 33.21 15.93 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.225 1.41 . . . . 73.14 112.462 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -140.79 117.87 11.22 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.925 1.69 . . . . 75.22 107.949 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -73.95 148.37 42.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.835 -1.543 . . . . 65.4 106.835 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.0 pt -133.66 169.2 22.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 124.876 1.27 . . . . 61.23 111.236 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -120.86 152.34 38.54 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.077 1.351 . . . . 74.3 111.11 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -135.05 136.5 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.528 1.131 . . . . 75.12 108.507 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -150.84 162.8 40.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.614 1.966 . . . . 73.44 108.521 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -96.73 152.22 18.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.019 1.328 . . . . 72.34 111.589 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.9 p . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 125.208 1.403 . . . . 75.33 108.671 178.687 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.7 ptt85 . . . . . 0 CA--C 1.527 0.092 0 N-CA-C 109.539 -0.541 . . . . 71.31 109.539 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -133.39 165.56 24.55 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.606 2.362 . . . . 75.03 105.877 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.53 136.85 57.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.734 0.778 . . . . 70.31 109.819 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -103.21 118.87 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 104.558 -2.386 . . . . 63.14 104.558 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -90.62 133.15 35.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.222 -1.77 . . . . 75.33 106.222 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 t -138.85 130.93 37.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 118.144 -0.931 . . . . 45.01 108.509 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.81 -179.82 18.57 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 120.022 1.283 . . . . 73.44 112.019 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.48 25.65 2.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.13 2.172 . . . . 71.03 111.598 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.26 149.08 98.19 Favored Pre-proline 0 C--O 1.237 0.398 0 O-C-N 120.877 -1.14 . . . . 74.55 112.474 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.63 168.62 16.17 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.571 3.514 . . . . 70.1 111.612 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -70.31 -46.34 64.43 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.476 -0.935 . . . . 74.02 108.476 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.61 5.03 2.04 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.778 1.631 . . . . 73.12 114.163 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 tp -57.01 130.43 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 121.08 -1.012 . . . . 74.2 109.064 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.69 154.95 45.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.406 1.483 . . . . 71.22 107.788 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.17 -30.28 66.27 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 118.985 -0.531 . . . . 74.3 109.902 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -58.55 -43.96 88.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 118.465 0.575 . . . . 72.03 109.942 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -65.47 -43.73 89.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.169 0.988 . . . . 74.21 109.68 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.8 mt -67.43 -44.69 78.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.911 0.884 . . . . 73.31 111.297 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -56.8 -48.38 78.07 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 107.174 -1.417 . . . . 54.51 107.174 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.93 -40.87 95.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.539 1.136 . . . . 64.15 113.327 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.55 -22.24 57.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 114.377 1.251 . . . . 74.13 114.377 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -108.31 2.86 22.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.821 0.737 . . . . 75.21 111.895 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -52.18 -33.3 40.03 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.464 2.306 . . . . 64.43 113.731 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -82.25 -38.24 24.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.833 0.742 . . . . 64.35 110.046 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -22.6 64.67 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.634 1.173 . . . . 54.3 110.217 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m 53.78 67.27 3.71 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.543 1.137 . . . . 52.2 113.446 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.71 173.38 8.08 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.768 2.979 . . . . 53.2 109.638 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.7 -43.54 4.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.8 -1.185 . . . . 63.13 107.8 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HB3' ' H ' ' A' ' 44' ' ' GLU . 7.0 tp-100 -122.19 154.18 37.81 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.608 1.563 . . . . 71.34 109.648 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -146.7 122.9 3.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.899 -1.889 . . . . 75.34 105.899 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.34 102.95 4.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.441 1.497 . . . . 75.34 109.452 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -80.22 126.65 31.39 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.148 -1.797 . . . . 74.31 106.148 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -118.53 87.44 2.73 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.262 1.425 . . . . 74.33 111.146 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.34 -21.2 61.78 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.996 0.918 . . . . 63.43 111.87 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -54.61 -32.55 58.96 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.267 1.427 . . . . 72.25 111.576 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.3 mmtm -132.85 2.43 3.69 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 114.341 1.237 . . . . 74.01 114.341 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.47 40.38 54.55 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 120.39 1.45 . . . . 44.52 110.106 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 pt -129.53 170.12 19.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.616 1.966 . . . . 75.25 110.625 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.85 120.46 4.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.61 1.964 . . . . 73.15 108.859 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -99.14 150.95 21.52 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 118.615 0.643 . . . . 74.3 109.808 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.9 131.07 24.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.164 -1.051 . . . . 74.31 108.164 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.474 ' H ' ' HB3' ' A' ' 31' ' ' GLN . 59.0 mt-10 -102.04 149.88 23.8 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 104.648 -2.353 . . . . 54.13 104.648 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -135.81 109.34 7.95 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.119 0.968 . . . . 70.33 108.5 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -68.39 110.01 3.92 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.816 1.246 . . . . 73.33 110.718 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.09 -15.23 57.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.569 2.347 . . . . 64.24 112.943 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.56 -39.3 32.12 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.393 -1.706 . . . . 74.24 106.393 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -61.73 -46.07 91.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.401 -0.963 . . . . 61.55 108.401 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.34 73.84 0.87 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.026 0.93 . . . . 62.01 109.556 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -48.21 -34.19 9.75 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.092 1.145 . . . . 63.43 114.092 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 p -121.81 -19.12 6.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 124.05 0.844 . . . . 75.01 111.686 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.08 -16.73 76.05 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.125 -0.984 . . . . 63.54 112.006 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 tp -50.75 -40.22 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.99 1.316 . . . . 63.53 110.914 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -57.51 -61.56 2.41 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.126 1.37 . . . . 63.04 108.439 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -50.98 -50.94 57.33 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.577 1.151 . . . . 62.22 110.095 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -52.85 -52.01 58.81 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.293 0.637 . . . . 70.31 110.776 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 36.4 mtm -66.79 -35.56 80.37 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 123.103 0.561 . . . . 61.51 111.358 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -46.98 87.7 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.863 1.265 . . . . 61.45 109.454 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.7 mt -62.87 -36.35 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.581 -0.896 . . . . 71.42 108.581 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.4 -43.06 70.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.94 -0.763 . . . . 72.12 108.94 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 mt -63.9 -33.15 75.05 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.663 0.785 . . . . 72.31 111.031 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.78 -13.14 41.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.298 0.851 . . . . 73.03 113.298 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -86.53 3.4 44.35 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.896 0.771 . . . . 65.14 111.547 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -59.74 113.98 2.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.931 -1.106 . . . . 72.34 109.414 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.06 12.34 55.25 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 118.371 -1.238 . . . . 71.41 115.385 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.4 p -69.62 149.08 48.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.174 1.987 . . . . 72.11 109.62 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.9 mt -96.43 107.18 19.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.062 -1.829 . . . . 64.32 106.062 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mt -109.92 122.66 48.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.189 -2.152 . . . . 52.24 105.189 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 mtmm 46.43 40.3 7.79 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.328 1.051 . . . . 64.43 110.954 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 67.74 20.38 9.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.627 2.371 . . . . 64.11 114.248 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -120.22 125.96 49.44 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.092 1.357 . . . . 70.4 108.354 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -82.57 112.99 19.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.838 -0.801 . . . . 72.44 108.838 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.0 pp -87.46 171.13 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 124.429 1.092 . . . . 73.12 110.906 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.95 151.27 51.83 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.228 1.411 . . . . 52.32 109.106 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.3 t -134.1 144.24 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.231 1.413 . . . . 63.44 108.31 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -153.54 160.76 42.58 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.467 1.907 . . . . 75.11 108.864 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.34 151.84 22.33 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 120.99 -1.068 . . . . 71.15 108.699 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 108.708 -0.849 . . . . 72.24 108.708 178.861 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 . . . . . 0 CA--C 1.506 -0.748 0 N-CA-C 106.714 -1.587 . . . . 73.41 106.714 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -99.85 164.91 11.82 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.107 0.963 . . . . 72.33 108.546 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.3 mt -134.87 149.01 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.933 1.293 . . . . 72.11 110.965 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.2 t -118.51 134.3 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.802 2.041 . . . . 74.15 105.851 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -100.62 142.21 32.4 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 126.15 1.78 . . . . 74.43 108.826 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.41 133.53 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.21 -1.774 . . . . 73.11 106.21 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -132.57 -179.7 16.5 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 120.385 1.448 . . . . 44.2 111.123 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.88 14.48 9.84 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.526 1.931 . . . . 71.03 112.621 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.35 148.05 9.37 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 124.737 1.215 . . . . 73.45 112.958 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.78 154.34 50.27 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.649 2.899 . . . . 74.22 110.341 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -70.36 -37.56 74.62 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.881 -0.512 . . . . 75.2 109.917 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.59 25.3 3.11 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.336 1.054 . . . . 45.35 111.855 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 8.4 tp -53.84 139.92 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.832 1.253 . . . . 75.11 110.537 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -124.78 148.04 48.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.611 1.164 . . . . 73.44 108.423 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.29 -29.84 70.12 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 118.852 -0.594 . . . . 55.15 111.097 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.66 -37.01 76.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 118.764 0.711 . . . . 61.24 109.708 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -69.17 -44.67 71.76 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.727 -0.842 . . . . 74.42 108.727 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 mt -60.49 -54.71 42.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.342 0.657 . . . . 75.22 110.786 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -59.87 -41.42 91.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.373 -0.602 . . . . 73.21 109.373 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -67.94 -40.53 83.29 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.855 0.687 . . . . 64.21 112.855 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -22.68 65.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 120.047 1.294 . . . . 70.03 113.071 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -112.29 6.07 18.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.056 0.942 . . . . 72.23 111.513 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -41.7 63.04 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.25 1.42 . . . . 74.54 112.264 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -58.17 -54.32 48.31 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.972 -0.751 . . . . 72.22 108.972 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.09 -22.06 66.39 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.653 1.181 . . . . 64.42 112.627 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 t 50.41 78.26 0.41 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.195 2.198 . . . . 63.41 112.418 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.55 168.14 20.66 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.256 2.637 . . . . 72.02 110.577 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -94.68 -31.8 13.65 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.488 1.115 . . . . 65.43 109.961 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.04 161.0 41.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.859 0.863 . . . . 61.23 109.807 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.68 107.13 2.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 104.295 -2.483 . . . . 73.25 104.295 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.5 ttp180 -117.98 103.96 10.43 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.577 -1.268 . . . . 75.53 107.577 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.57 124.78 36.85 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.49 1.516 . . . . 75.41 110.51 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.56 80.12 1.49 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.602 1.961 . . . . 74.23 108.024 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.83 -17.37 56.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.107 0.963 . . . . 72.22 111.216 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.438 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 1.4 m-20 -51.4 -32.8 27.63 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.647 1.979 . . . . 65.14 109.884 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 5.3 mmpt? -126.73 -9.69 6.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.378 1.871 . . . . 64.42 111.351 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.42 36.77 33.2 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.661 -1.376 . . . . 75.13 109.661 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.425 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 36.0 pt -124.47 168.42 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.173 1.389 . . . . 64.32 108.417 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.67 166.3 33.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.569 1.148 . . . . 72.34 109.442 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -135.77 140.82 44.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.562 1.545 . . . . 73.02 108.083 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mp -134.49 123.62 24.25 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.016 -1.475 . . . . 65.12 107.016 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -98.64 156.73 16.67 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.614 -0.513 . . . . 72.23 109.614 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -146.65 119.63 8.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.201 -1.407 . . . . 74.5 107.201 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -83.72 119.14 24.43 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.765 -0.458 . . . . 44.43 109.765 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.35 61.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.991 1.716 . . . . 54.12 111.219 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -70.4 -23.77 62.82 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.86 -1.163 . . . . 73.45 107.86 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -62.18 -32.37 72.99 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-O 118.362 -0.828 . . . . 51.14 110.368 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -168.02 101.52 0.46 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.461 1.504 . . . . 72.32 108.078 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -52.76 -22.62 5.49 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 116.301 1.963 . . . . 74.43 116.301 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p -121.43 -19.36 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 120.115 1.325 . . . . 71.33 110.872 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.9 -30.62 51.33 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-O 118.592 -1.116 . . . . 32.14 110.705 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.1 tp -52.58 -37.65 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.24 1.416 . . . . 72.54 110.061 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.01 -58.05 9.52 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.618 1.167 . . . . 74.44 107.934 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -54.79 -41.29 70.39 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.258 0.623 . . . . 72.42 110.242 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.6 mtt85 -57.95 -50.23 74.09 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-O 118.421 -0.8 . . . . 74.14 110.233 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 10.8 mtm -59.85 -45.49 92.27 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.195 0.452 . . . . 74.03 110.451 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.4 -54.57 45.13 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 122.86 0.464 . . . . 72.24 110.666 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.8 mt -58.1 -36.94 59.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 125.194 1.398 . . . . 73.35 109.596 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.11 -43.97 73.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.733 -0.469 . . . . 63.13 109.733 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.68 -35.66 81.75 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.347 0.659 . . . . 74.33 110.337 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.8 mt -62.47 -2.57 1.1 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.949 1.7 . . . . 71.44 113.646 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -94.45 3.73 54.77 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.675 1.19 . . . . 71.21 110.314 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -65.85 135.08 54.34 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.153 1.781 . . . . 74.21 109.686 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.01 15.53 67.36 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.706 1.622 . . . . 72.12 113.312 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -78.59 155.99 29.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.883 1.342 . . . . 32.34 108.139 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.32 108.0 20.15 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.356 -0.979 . . . . 64.1 108.356 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -112.32 115.59 29.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.631 -1.618 . . . . 73.1 106.631 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 3.8 mtpp 50.2 53.45 12.84 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.027 0.918 . . . . 75.21 111.081 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 55.43 20.44 3.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.303 2.241 . . . . 74.53 114.523 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -122.8 122.77 39.49 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 126.079 1.751 . . . . 63.44 107.837 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -83.14 104.86 13.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.036 -1.098 . . . . 73.42 108.036 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 pt -87.92 169.3 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.234 -0.894 . . . . 45.43 111.289 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -123.87 154.18 40.03 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.435 1.494 . . . . 74.35 110.222 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.2 142.15 42.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.936 -1.505 . . . . 65.43 106.936 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.67 174.78 14.05 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.472 1.909 . . . . 63.1 110.517 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -90.42 149.2 22.35 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.797 1.239 . . . . 75.11 112.422 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--N 1.329 -0.317 0 N-CA-C 106.505 -1.665 . . . . 72.21 106.505 177.004 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? . . . . . 0 C--O 1.237 0.415 0 CA-C-O 121.101 0.477 . . . . 64.02 111.889 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -99.05 159.33 15.04 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 127.738 2.415 . . . . 73.15 110.055 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.17 149.22 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.604 1.162 . . . . 70.11 110.953 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.8 t -116.07 128.8 73.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.752 -1.573 . . . . 73.3 106.752 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -88.05 131.62 34.59 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.661 1.584 . . . . 73.2 106.886 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.403 HG12 HD11 ' A' ' 11' ' ' LEU . 5.2 t -138.58 128.69 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.31 -1.737 . . . . 74.42 106.31 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.08 -175.15 13.85 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 119.212 0.914 . . . . 54.25 111.871 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.49 14.66 8.35 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.97 1.708 . . . . 74.11 111.157 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.403 HD11 HG12 ' A' ' 8' ' ' VAL . 11.0 mp -60.85 150.81 75.76 Favored Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 125.283 1.433 . . . . 73.44 111.551 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.74 157.63 60.9 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.035 2.49 . . . . 64.24 109.975 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -69.3 -36.15 76.73 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.265 -0.897 . . . . 60.34 111.015 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -88.26 15.06 8.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.884 0.874 . . . . 73.3 112.955 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.1 tp -50.46 140.92 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.779 1.231 . . . . 71.41 111.617 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 p -128.47 147.5 50.67 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.122 -0.695 . . . . 70.02 109.122 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.68 -27.21 66.2 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 118.481 -0.771 . . . . 73.21 112.064 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.78 -36.54 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.02 -0.733 . . . . 54.11 109.02 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -73.41 -42.53 61.96 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 123.82 0.848 . . . . 71.23 108.857 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.9 mt -62.09 -49.41 76.05 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.484 -0.561 . . . . 65.1 109.484 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -58.46 -46.58 86.3 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.901 -1.148 . . . . 60.24 107.901 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -57.44 -46.13 83.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 114.003 1.112 . . . . 74.41 114.003 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -65.95 -56.45 11.63 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.08 1.309 . . . . 64.33 110.405 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -73.25 4.27 4.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.424 1.268 . . . . 73.21 114.424 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -53.89 -31.23 49.2 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 125.364 1.466 . . . . 64.51 113.353 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -8.27 56.61 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.298 1.039 . . . . 71.52 112.48 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 p -112.08 -9.62 13.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.333 1.853 . . . . 63.02 110.858 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.4 m 39.5 78.2 0.38 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.912 2.085 . . . . 55.33 115.762 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.37 164.14 29.51 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.991 2.461 . . . . 71.13 109.962 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -90.01 -41.15 11.88 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.018 0.927 . . . . 71.11 108.999 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -144.32 155.88 44.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.316 0.646 . . . . 70.22 109.688 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.35 123.96 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 127.044 2.138 . . . . 62.12 108.939 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.09 104.69 6.03 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.384 2.273 . . . . 75.45 107.233 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.13 121.79 32.51 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.831 -1.174 . . . . 72.42 107.831 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -116.96 75.07 0.94 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.901 -1.518 . . . . 74.42 106.901 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -26.68 27.03 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.186 1.394 . . . . 64.41 112.248 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -51.68 -25.79 7.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.289 2.236 . . . . 54.2 113.315 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -133.07 10.39 4.19 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.907 1.683 . . . . 74.41 110.269 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.85 44.04 96.24 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.043 1.306 . . . . 42.54 110.012 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.5 pt -132.77 169.77 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 C-N-CA 125.067 1.347 . . . . 72.42 111.011 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.06 166.0 29.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.245 1.818 . . . . 62.02 108.829 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.1 116.8 14.96 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.608 -1.627 . . . . 74.23 106.608 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -113.92 115.52 27.81 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.77 -1.567 . . . . 73.23 106.77 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -88.48 152.83 21.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.11 -1.441 . . . . 65.14 107.11 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -145.58 133.27 21.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.342 1.457 . . . . 74.0 107.173 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -101.89 108.33 19.77 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.066 1.346 . . . . 62.12 112.234 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.57 -23.26 65.39 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.083 1.353 . . . . 63.21 112.21 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -75.39 -25.48 57.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.014 -0.736 . . . . 64.31 109.014 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -66.59 -34.51 78.04 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.928 0.891 . . . . 74.14 110.402 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -156.72 91.26 1.21 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.921 0.782 . . . . 74.15 111.269 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -48.65 -34.26 11.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.402 1.881 . . . . 75.12 115.787 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.94 -16.49 14.29 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 113.344 0.868 . . . . 75.45 113.344 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.31 -19.07 29.09 Favored Glycine 0 C--O 1.225 -0.461 0 CA-C-O 117.707 -1.607 . . . . 74.11 112.927 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 tp -56.04 -35.57 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 120.187 1.993 . . . . 64.43 108.758 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -62.52 -60.81 3.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.363 1.865 . . . . 63.21 108.263 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.0 mmt-85 -54.44 -39.01 66.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.144 0.977 . . . . 71.42 110.344 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -62.94 -47.62 82.43 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.207 -1.034 . . . . 74.01 108.207 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.8 mtm -63.27 -41.82 99.06 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 123.839 0.856 . . . . 70.22 110.226 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -56.81 -50.53 72.08 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.601 1.16 . . . . 72.54 109.051 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.36 -30.86 50.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.273 1.429 . . . . 71.11 110.88 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 -44.23 52.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.477 -0.935 . . . . 53.14 108.477 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mt -63.59 -29.01 70.32 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.376 1.071 . . . . 74.44 112.206 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.79 -2.82 22.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 118.755 -0.64 . . . . 71.34 112.018 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -84.79 -5.95 59.34 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.425 1.011 . . . . 71.01 109.987 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -66.19 112.53 3.98 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.724 1.147 . . . . 71.22 108.671 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.23 -8.19 38.07 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.626 1.108 . . . . 73.42 113.049 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.1 p -65.72 148.98 50.88 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 119.234 1.517 . . . . 75.44 108.678 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.2 mt -98.51 108.07 20.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.58 -2.378 . . . . 64.24 104.58 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.0 tp -102.55 111.11 23.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.291 -1.744 . . . . 75.34 106.291 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt 48.89 51.34 16.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.451 1.1 . . . . 63.03 111.163 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.274 9.6 mt-10 57.97 38.7 26.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 128.031 2.532 . . . . 51.31 114.159 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -137.58 118.15 13.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 126.285 1.834 . . . . 71.51 106.59 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -78.46 105.23 9.58 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.772 -1.195 . . . . 75.24 107.772 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.6 pt -79.52 172.4 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 125.149 1.379 . . . . 75.3 113.262 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -123.42 149.94 44.41 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.528 1.931 . . . . 73.22 106.61 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.8 t -139.91 120.98 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 106.308 -1.738 . . . . 60.41 106.308 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.01 175.69 9.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.834 1.254 . . . . 72.53 110.608 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.53 152.22 30.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.442 1.497 . . . . 74.44 113.396 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.505 0 N-CA-C 107.24 -1.393 . . . . 75.12 107.24 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.501 0 N-CA-C 107.987 -1.116 . . . . 70.52 107.987 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -103.18 160.71 14.41 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.214 1.805 . . . . 52.34 108.558 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.485 ' HB ' HG23 ' A' ' 79' ' ' THR . 2.1 mp -134.37 149.83 30.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.924 1.69 . . . . 54.22 107.63 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.9 t -119.18 124.21 72.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 105.238 -2.134 . . . . 61.24 105.238 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -82.53 131.8 35.21 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.543 -2.021 . . . . 70.41 105.543 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 11' ' ' LEU . 15.2 t -136.36 122.53 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.546 -2.02 . . . . 73.44 105.546 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.423 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -135.81 180.0 17.21 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 120.066 1.303 . . . . 73.54 113.485 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.48 19.62 5.11 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.987 2.115 . . . . 64.4 111.331 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.607 HD11 HG12 ' A' ' 8' ' ' VAL . 10.2 mp -62.63 148.13 91.52 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.152 0.981 . . . . 55.14 110.951 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.56 150.91 80.17 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.677 2.918 . . . . 70.12 110.553 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -30.15 71.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.618 -0.706 . . . . 73.31 111.3 178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.98 11.97 18.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.37 1.248 . . . . 74.24 114.37 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.429 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 7.8 tp -54.46 147.93 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.922 1.289 . . . . 74.33 110.42 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -128.21 157.0 42.05 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.428 0.691 . . . . 43.13 110.822 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.12 -32.19 73.66 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.977 -0.452 . . . . 62.3 109.802 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 p -63.39 -44.51 98.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.457 -0.572 . . . . 64.14 109.457 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -71.05 -36.08 72.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.196 -0.43 . . . . 72.21 110.061 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 20' ' ' LEU . 19.0 mt -63.4 -46.28 87.13 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.421 -0.955 . . . . 63.13 108.421 178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -58.33 -49.99 75.22 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.883 -1.155 . . . . 54.0 107.883 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -55.45 -44.16 76.13 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.529 0.937 . . . . 75.12 113.529 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -30.25 70.31 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 114.342 1.238 . . . . 71.55 114.342 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.07 6.23 19.11 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.61 0.764 . . . . 74.22 112.662 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -54.44 -43.32 71.5 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.412 1.485 . . . . 61.31 110.637 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -61.21 -35.3 76.83 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.561 0.744 . . . . 63.05 111.618 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.92 -17.36 38.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.735 1.614 . . . . 61.42 111.417 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.433 ' HB2' ' HE ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER 54.43 72.95 0.98 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 126.728 2.011 . . . . 74.34 116.239 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.39 161.71 43.68 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.037 2.492 . . . . 73.04 110.187 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.09 -46.56 8.4 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.031 1.732 . . . . 63.13 108.939 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -131.72 156.32 46.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.25 -0.886 . . . . 73.32 112.383 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.9 mt -146.77 123.9 3.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.416 -1.328 . . . . 73.13 107.416 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.72 104.91 5.44 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 128.28 2.632 . . . . 72.53 106.794 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.12 112.25 24.14 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.33 1.052 . . . . 71.12 110.25 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -97.79 82.78 3.08 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.092 -1.818 . . . . 71.24 106.092 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.04 -29.71 58.03 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.669 0.787 . . . . 73.25 111.563 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.18 -32.3 22.98 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.483 2.313 . . . . 74.15 112.6 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -122.15 -5.13 8.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.372 1.469 . . . . 61.52 110.2 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.09 47.43 85.36 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 125.674 1.607 . . . . 61.22 109.488 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.423 HG22 ' CA ' ' A' ' 9' ' ' GLY . 3.2 pt -135.57 162.4 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.152 1.381 . . . . 71.25 108.869 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.96 166.22 24.59 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.926 1.29 . . . . 73.44 108.369 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -133.47 104.7 6.53 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.627 -1.62 . . . . 65.53 106.627 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.27 113.16 26.58 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.429 -1.323 . . . . 74.42 107.429 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.32 153.6 19.81 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.33 1.452 . . . . 70.1 108.703 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -147.75 136.24 21.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.895 1.278 . . . . 70.4 108.224 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -101.48 111.51 23.76 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.958 1.303 . . . . 75.1 111.919 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.64 -21.47 55.43 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.073 2.149 . . . . 52.12 110.396 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.64 -30.41 71.35 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.989 -1.486 . . . . 41.33 106.989 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -62.06 -33.59 74.68 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 117.994 -1.003 . . . . 73.25 110.765 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -157.24 108.41 2.33 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 114.642 1.349 . . . . 53.12 114.642 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -68.05 -19.31 64.87 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 117.182 -1.389 . . . . 74.15 112.999 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.359 43.5 p -122.53 14.73 10.29 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.795 1.634 . . . . 74.35 114.535 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -131.03 -19.89 1.21 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.346 1.45 . . . . 53.14 115.167 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.8 -30.41 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 120.484 2.142 . . . . 71.33 109.514 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -64.14 -55.97 18.08 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 126.142 1.777 . . . . 70.43 110.086 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -58.55 -27.36 64.5 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.428 1.491 . . . . 71.54 110.719 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.433 ' HE ' ' HB2' ' A' ' 28' ' ' SER . 28.4 mtt85 -76.33 -45.83 30.41 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.239 -1.023 . . . . 71.24 108.239 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 8.2 mtm -57.57 -41.67 81.54 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.959 0.904 . . . . 64.54 108.904 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -55.17 -49.08 72.77 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.322 1.449 . . . . 74.14 110.391 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.7 mt -64.66 -41.55 92.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 124.271 1.028 . . . . 73.32 109.439 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.36 93.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.69 -0.856 . . . . 54.3 108.69 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.3 mt -63.83 -32.52 74.06 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.188 0.995 . . . . 73.23 110.51 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.32 -10.78 26.36 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.175 -0.917 . . . . 75.0 110.808 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -85.91 -0.78 56.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.031 1.287 . . . . 63.43 110.755 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.2 112.38 3.01 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.682 -1.261 . . . . 73.32 107.767 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.56 1.75 57.68 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 117.421 -1.766 . . . . 70.55 113.261 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.256 51.3 p -66.02 142.83 57.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.988 2.394 . . . . 70.14 110.33 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.48 116.65 29.03 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.593 1.157 . . . . 74.4 108.172 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 mt -122.53 120.4 33.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 105.949 -1.871 . . . . 71.22 105.949 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 10.7 mtmm 44.3 47.53 7.88 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.749 1.62 . . . . 72.45 110.076 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 59.39 33.71 22.49 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.225 1.81 . . . . 62.14 114.712 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -130.18 117.56 20.09 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 104.742 -2.318 . . . . 75.52 104.742 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -78.58 107.96 11.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.97 -1.122 . . . . 61.44 107.97 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -78.99 170.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 124.501 1.12 . . . . 51.43 111.06 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.26 155.62 47.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.001 1.72 . . . . 74.41 109.344 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.6 t -139.23 133.11 39.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 O-C-N 124.003 0.815 . . . . 64.41 110.224 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -143.9 175.43 10.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.013 1.325 . . . . 64.52 108.621 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.89 150.58 21.16 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.828 0.851 . . . . 53.0 109.168 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.485 HG23 ' HB ' ' A' ' 5' ' ' ILE . 5.9 t . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.99 -1.115 . . . . 71.42 107.99 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.738 0 N-CA-C 110.306 -1.118 . . . . 54.05 110.306 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.72 40.76 0.11 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.029 1.731 . . . . 71.45 112.624 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.3 ptt85 -153.55 157.34 39.6 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 120.285 -1.509 . . . . 54.42 110.669 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -126.36 162.91 24.43 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.956 1.702 . . . . 73.13 106.838 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.461 ' HB ' HG23 ' A' ' 79' ' ' THR . 2.3 mp -129.15 149.67 33.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.11 0.964 . . . . 74.14 108.577 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.2 t -109.79 124.69 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.249 1.42 . . . . 73.21 107.922 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -91.2 100.28 13.13 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.605 -1.998 . . . . 71.14 105.605 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.1 t -104.75 132.04 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.935 -1.876 . . . . 32.53 105.935 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.77 179.3 27.6 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 121.352 1.887 . . . . 54.54 113.758 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.72 14.01 0.99 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.291 2.637 . . . . 52.33 111.943 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 mp -55.7 157.65 7.35 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.897 1.679 . . . . 74.35 115.059 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.69 153.0 59.55 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.289 3.326 . . . . 72.25 110.544 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -34.32 75.3 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.216 0.606 . . . . 74.14 111.685 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -90.39 11.12 22.49 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.714 1.375 . . . . 61.24 114.714 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.3 tp -45.44 140.39 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 114.603 1.334 . . . . 74.43 114.603 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.38 147.6 46.92 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.149 1.38 . . . . 44.14 108.744 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -29.18 69.04 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.493 0.717 . . . . 74.31 111.105 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.16 -43.33 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.194 0.998 . . . . 61.14 109.17 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.09 -18.89 61.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.954 1.301 . . . . 71.22 111.744 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.9 mt -86.25 -44.24 12.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 120.573 -1.329 . . . . 41.43 109.524 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -62.17 -45.64 92.53 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.01 0.924 . . . . 73.43 110.955 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -65.35 -27.26 68.45 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 114.171 1.174 . . . . 65.22 114.171 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -74.49 -60.92 2.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.544 1.138 . . . . 75.34 109.587 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -80.94 3.65 22.15 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 114.675 1.361 . . . . 61.14 114.675 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -48.53 -51.68 26.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.795 1.638 . . . . 63.32 110.595 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -60.54 -44.42 96.12 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.774 0.83 . . . . 61.23 111.857 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 p -70.57 -16.41 62.86 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.145 -0.972 . . . . 13.11 112.981 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m 49.78 71.42 1.58 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.792 2.037 . . . . 53.23 116.064 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.29 165.72 23.67 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.944 2.429 . . . . 63.51 110.312 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -99.15 -47.41 5.22 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.812 1.645 . . . . 53.23 108.134 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.62 149.19 40.11 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.212 1.005 . . . . 73.52 109.872 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -146.7 112.31 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.651 1.58 . . . . 64.23 107.08 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -140.27 104.08 4.72 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.653 1.581 . . . . 74.41 110.13 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -89.87 127.78 36.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.132 1.773 . . . . 62.44 110.589 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -118.95 85.58 2.39 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.22 1.808 . . . . 75.41 108.109 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.64 -22.04 43.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.338 0.655 . . . . 52.42 112.544 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -51.5 -28.21 12.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.664 2.386 . . . . 53.03 112.346 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -133.44 8.43 3.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.697 1.999 . . . . 75.23 110.448 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.01 36.24 72.9 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.787 -1.007 . . . . 73.12 111.877 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.5 170.36 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 126.441 1.896 . . . . 73.33 108.575 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.06 170.89 19.35 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.534 -1.284 . . . . 54.42 107.534 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -128.23 135.83 50.22 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.429 -2.063 . . . . 73.34 105.429 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.96 107.82 6.3 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 106.812 -1.551 . . . . 73.31 106.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -88.36 154.3 20.5 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.442 -1.688 . . . . 52.23 106.442 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -139.93 116.2 10.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.763 1.225 . . . . 65.14 107.817 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -70.22 108.93 4.38 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.624 0.726 . . . . 60.11 111.55 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.43 69.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.387 1.075 . . . . 51.11 110.016 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.14 -21.05 65.85 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.649 0.779 . . . . 61.53 111.76 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -37.91 87.07 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.542 -0.91 . . . . 74.52 108.542 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -158.44 102.69 1.75 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 119.385 0.993 . . . . 71.42 111.327 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -52.74 -33.94 50.51 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.814 0.846 . . . . 64.52 112.769 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 12.9 18.8 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.736 1.013 . . . . 72.43 113.736 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.23 -24.91 3.38 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.849 1.214 . . . . 72.24 112.076 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tp -55.56 -33.4 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 118.442 1.121 . . . . 64.14 110.643 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -61.28 2.54 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.513 1.125 . . . . 52.34 109.545 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -60.54 -36.62 78.87 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 118.791 -0.623 . . . . 61.12 111.515 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -59.2 -42.97 92.19 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.713 -0.847 . . . . 74.33 108.713 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.2 mtm -67.76 -45.5 74.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.469 -1.253 . . . . 73.15 108.801 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -52.27 -51.47 58.26 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.103 1.319 . . . . 60.33 110.001 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.3 mt -59.09 -38.62 75.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 125.32 1.448 . . . . 72.22 110.449 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.36 -42.39 62.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.455 0.571 . . . . 72.41 109.623 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 mt -65.53 -30.3 71.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.791 1.636 . . . . 63.41 111.498 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 mt -65.9 -12.95 58.51 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.996 -0.526 . . . . 74.33 110.527 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -86.7 6.15 32.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.003 0.921 . . . . 71.31 110.823 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -73.76 115.36 13.09 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.39 -2.078 . . . . 72.41 105.39 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.04 5.71 70.26 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 125.053 1.311 . . . . 54.31 111.909 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 p -75.53 162.96 27.86 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 119.949 1.875 . . . . 72.25 107.203 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 mt -95.25 139.42 31.6 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 126.919 2.087 . . . . 62.44 108.048 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -145.74 122.85 11.46 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.668 1.987 . . . . 63.21 107.713 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt 42.06 46.95 3.79 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.779 1.232 . . . . 74.13 113.02 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.315 98.5 mt-10 66.0 23.71 11.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.814 2.045 . . . . 75.42 116.406 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -125.26 152.46 44.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.393 -2.077 . . . . 74.14 105.393 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -103.56 135.7 44.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 102.372 -3.195 . . . . 53.54 102.372 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.5 pt -122.63 161.28 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 119.0 0.818 . . . . 75.32 112.929 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -107.17 156.93 18.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.851 1.26 . . . . 72.43 111.244 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -147.49 118.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 125.512 1.525 . . . . 61.11 107.908 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -141.75 174.92 10.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.593 1.157 . . . . 75.44 110.506 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -84.05 151.9 24.7 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.29 1.036 . . . . 55.11 111.045 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.461 HG23 ' HB ' ' A' ' 5' ' ' ILE . 1.8 t -154.53 117.23 4.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.951 -1.87 . . . . 51.43 105.951 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 p 160.6 -65.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 129.242 3.017 . . . . 51.03 105.691 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.18 70.57 1.05 Allowed Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 108.492 -1.843 . . . . 71.22 108.492 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.427 0 N-CA-C 106.314 -2.714 . . . . 75.35 106.314 -178.28 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.939 0 N-CA-C 109.906 -1.278 . . . . 75.24 109.906 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -76.47 5.86 6.63 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 114.561 1.319 . . . . 51.44 114.561 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -144.76 117.95 8.94 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.282 1.856 . . . . 72.04 110.947 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -95.25 163.43 13.27 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.119 1.368 . . . . 75.13 107.49 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -135.16 138.12 49.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 107.392 -1.336 . . . . 74.04 107.392 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.2 t -96.28 146.63 6.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 104.671 -2.344 . . . . 72.42 104.671 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.05 103.62 12.88 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.404 -2.072 . . . . 71.04 105.404 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 11' ' ' LEU . 49.6 t -110.78 121.58 63.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.508 -1.664 . . . . 70.1 106.508 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -142.39 178.35 20.99 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 119.993 1.27 . . . . 74.21 113.043 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.72 21.93 5.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.087 2.155 . . . . 54.51 112.297 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 8' ' ' VAL . 8.5 mp -64.15 150.02 93.07 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.325 1.45 . . . . 73.21 112.854 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.12 149.75 76.76 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.908 2.405 . . . . 70.14 110.171 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -59.8 -35.59 75.0 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.112 0.565 . . . . 74.23 110.142 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.83 14.14 10.99 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.5 1.296 . . . . 62.42 114.5 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.506 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 10.1 tp -47.08 142.88 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 124.372 1.069 . . . . 73.21 111.609 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 p -124.37 148.75 47.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.385 1.074 . . . . 75.23 108.33 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -32.77 72.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.683 -0.675 . . . . 73.24 110.074 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.12 -41.47 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-N 118.831 0.741 . . . . 65.23 109.829 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.36 -42.23 79.5 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.543 -0.54 . . . . 51.23 109.543 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 mt -65.96 -40.44 91.31 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.698 0.399 . . . . 62.45 111.605 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -46.63 77.46 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.516 -1.29 . . . . 75.35 107.516 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -61.11 -48.49 81.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 114.083 1.142 . . . . 74.23 114.083 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -28.44 68.61 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.488 0.921 . . . . 73.05 113.488 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -112.52 9.18 19.51 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 112.92 0.711 . . . . 63.34 112.92 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -55.34 -34.32 64.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.683 -1.26 . . . . 74.42 112.349 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.92 -34.6 44.44 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.324 0.511 . . . . 73.34 110.602 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -27.95 62.86 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.12 -0.696 . . . . 72.3 109.12 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.4 m 58.55 66.24 2.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 127.054 2.141 . . . . 52.51 114.792 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -63.53 164.96 19.13 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.731 2.954 . . . . 62.23 111.854 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -91.1 -40.74 11.43 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.115 1.766 . . . . 63.11 109.291 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -137.23 164.39 28.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.35 0.66 . . . . 74.42 111.311 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.8 mt -151.46 126.26 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.502 -1.666 . . . . 73.31 106.502 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.58 104.65 4.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.444 1.497 . . . . 74.42 107.172 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.35 125.42 34.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.389 -1.337 . . . . 73.14 107.389 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -112.97 86.41 2.37 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.165 -1.791 . . . . 65.41 106.165 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.14 -29.77 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.39 0.676 . . . . 71.32 111.01 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.7 -24.27 8.31 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.305 2.242 . . . . 71.44 113.096 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -132.73 -0.09 3.52 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.846 1.258 . . . . 72.31 111.836 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.63 41.76 98.98 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.132 -1.187 . . . . 75.31 110.132 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.513 HG22 ' CA ' ' A' ' 9' ' ' GLY . 5.3 pt -137.0 167.48 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.707 1.603 . . . . 73.2 109.149 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.18 166.36 24.91 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.382 1.073 . . . . 62.0 108.498 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -130.77 119.14 21.87 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.201 -2.148 . . . . 74.54 105.201 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.14 108.99 12.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.388 -1.708 . . . . 73.22 106.388 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.51 153.06 24.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.322 1.849 . . . . 74.45 109.533 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -144.58 108.37 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.687 1.195 . . . . 64.23 108.633 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -72.59 115.68 12.15 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.578 0.704 . . . . 73.34 110.227 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.2 -24.26 54.68 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.933 2.093 . . . . 52.14 111.834 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.85 -27.98 50.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.321 -0.371 . . . . 61.25 110.415 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -71.09 -36.97 72.4 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.21 0.604 . . . . 73.41 111.206 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.7 76.18 1.71 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.493 1.117 . . . . 75.51 111.085 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -47.55 66.07 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.512 -1.368 . . . . 72.31 113.684 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.25 5.25 52.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 114.086 1.143 . . . . 74.32 114.086 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.59 -5.76 2.8 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 117.386 -1.785 . . . . 72.43 115.502 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.7 tp -56.29 -42.39 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 121.073 2.436 . . . . 74.33 108.781 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -56.34 23.16 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 107.722 -1.214 . . . . 60.11 107.722 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -50.36 -48.49 55.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.417 1.087 . . . . 75.23 110.739 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -48.65 74.28 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.451 0.7 . . . . 72.35 109.124 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 48.8 mtm -68.84 -32.29 71.87 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 118.662 -0.685 . . . . 63.43 112.207 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.21 -51.53 68.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.134 2.173 . . . . 74.25 110.291 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mt -63.1 -39.6 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.313 1.445 . . . . 73.42 108.189 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.02 -41.63 81.89 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.178 -0.915 . . . . 62.12 109.554 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.2 mt -65.72 -31.24 72.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.33 0.968 . . . . 74.4 111.352 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 mt -66.16 -12.71 57.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.713 -0.661 . . . . 73.44 111.319 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -86.29 6.7 28.51 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 117.974 -1.012 . . . . 75.21 111.321 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -73.04 121.54 20.32 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.354 1.862 . . . . 70.42 108.86 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.96 3.22 58.08 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.828 -0.984 . . . . 73.33 114.377 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.4 p -68.84 151.61 46.37 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 119.35 1.575 . . . . 55.14 108.465 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.8 mt -97.42 110.84 23.32 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.711 -1.589 . . . . 72.23 106.711 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mt -113.59 119.11 36.37 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.843 -1.91 . . . . 75.11 105.843 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 41.9 mttm 45.03 58.31 4.13 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.643 1.577 . . . . 72.53 109.806 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 59.12 14.43 3.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.265 1.826 . . . . 70.41 115.033 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -121.14 122.01 39.08 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 120.479 -1.388 . . . . 44.44 110.545 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.86 123.85 25.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 104.601 -2.37 . . . . 74.31 104.601 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.4 pt -108.67 169.85 3.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 119.276 0.944 . . . . 65.34 112.9 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -112.56 146.03 39.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.691 1.196 . . . . 55.54 108.904 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.5 t -143.59 108.54 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 106.48 -1.674 . . . . 45.35 106.48 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -132.84 171.66 13.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.437 1.495 . . . . 64.41 109.144 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.43 HD13 ' H ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -99.8 152.6 19.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 120.666 -1.271 . . . . 61.32 113.795 -178.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.43 ' H ' HD13 ' A' ' 78' ' ' LEU . 13.0 p -141.52 155.93 45.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.604 1.161 . . . . 75.32 108.9 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t 57.52 86.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.817 2.447 . . . . 51.42 114.06 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.85 -9.63 2.06 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.048 -0.862 . . . . 75.15 114.291 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 117.604 -1.665 . . . . 65.3 109.364 179.768 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.563 0 N-CA-C 111.234 -0.746 . . . . 64.51 111.234 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -108.28 8.11 27.62 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.243 1.201 . . . . 72.22 114.243 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 137.87 52.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.734 1.152 . . . . 74.02 108.881 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -138.9 156.79 46.99 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.713 1.605 . . . . 74.45 106.768 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.2 mt -136.18 146.76 28.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.314 -0.857 . . . . 75.44 109.971 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.0 t -106.33 119.24 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 127.949 2.5 . . . . 63.35 106.522 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -88.59 135.13 33.65 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 104.562 -2.384 . . . . 74.24 104.562 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 HD11 ' A' ' 11' ' ' LEU . 17.9 t -138.77 122.51 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.135 -2.172 . . . . 53.3 105.135 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.436 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -130.0 -176.57 14.48 Favored Glycine 0 N--CA 1.467 0.718 0 CA-C-N 121.127 1.785 . . . . 52.32 111.027 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 m 70.51 17.53 6.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.691 1.596 . . . . 51.42 111.554 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.717 HD11 HG12 ' A' ' 8' ' ' VAL . 9.1 mp -67.29 147.55 98.89 Favored Pre-proline 0 C--O 1.235 0.295 0 O-C-N 120.975 -1.078 . . . . 75.11 109.963 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.82 152.31 77.54 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.511 2.141 . . . . 63.31 110.574 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -62.94 -30.76 71.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.779 -0.823 . . . . 73.12 108.779 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.39 -1.4 33.25 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 127.653 2.381 . . . . 73.15 114.121 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.1 tp -47.75 137.44 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.663 1.185 . . . . 72.51 113.29 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 p -115.43 150.01 37.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.464 1.506 . . . . 40.4 108.173 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.77 69.79 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.021 0.528 . . . . 51.41 110.722 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.51 -37.32 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 109.389 -0.597 . . . . 73.4 109.389 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.23 -43.26 82.43 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.061 -1.088 . . . . 61.24 108.061 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.08 -50.47 71.85 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.93 -0.396 . . . . 75.03 109.93 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -54.34 -50.22 67.92 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.587 1.155 . . . . 73.43 108.573 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -60.0 -41.78 92.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.555 1.142 . . . . 71.2 111.021 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -31.18 71.19 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 114.87 1.433 . . . . 71.21 114.87 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.27 9.72 33.86 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.013 0.525 . . . . 64.2 112.36 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -51.81 -43.73 63.21 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.504 1.522 . . . . 72.22 113.309 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -71.73 -25.83 62.23 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.122 0.569 . . . . 72.21 112.117 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.01 -30.02 20.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.182 0.593 . . . . 71.24 109.976 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 56.59 81.41 0.26 Allowed Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 127.946 2.498 . . . . 73.3 112.508 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -68.95 161.37 46.04 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.252 1.968 . . . . 71.42 110.616 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -91.9 -33.4 14.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.686 1.194 . . . . 74.41 109.535 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -138.39 151.36 47.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.196 0.999 . . . . 62.12 110.691 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.8 mt -143.21 121.75 7.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.972 -0.751 . . . . 71.33 108.972 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.7 128.79 25.44 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.055 -1.832 . . . . 64.24 106.055 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -115.84 116.78 28.61 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.323 1.849 . . . . 70.1 106.965 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -110.8 86.49 2.32 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.799 -1.926 . . . . 70.52 105.799 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.31 -19.08 31.88 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 113.475 0.917 . . . . 73.4 113.475 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.41 -28.19 12.12 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.841 2.056 . . . . 71.13 111.622 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -132.67 3.19 3.81 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.471 1.508 . . . . 74.01 109.506 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.74 54.6 36.56 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 126.871 2.177 . . . . 74.23 110.133 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.436 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.8 pt -137.29 155.51 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.897 1.279 . . . . 73.03 109.634 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.6 155.24 50.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.551 1.541 . . . . 63.33 109.047 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -125.28 118.67 26.49 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.981 -1.859 . . . . 54.02 105.981 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.03 104.81 10.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.379 -1.341 . . . . 55.45 107.379 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -84.46 156.8 21.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.726 0.81 . . . . 73.4 108.938 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -143.01 143.84 32.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.264 -1.754 . . . . 74.55 106.264 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -102.01 110.46 22.43 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.535 -0.913 . . . . 74.23 108.535 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.33 -27.16 64.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.691 1.196 . . . . 73.21 111.141 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.9 -33.34 75.11 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.393 -0.965 . . . . 75.4 108.393 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -61.96 -23.36 66.33 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 116.504 -1.713 . . . . 61.2 113.932 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -166.01 96.95 0.62 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.497 1.499 . . . . 72.22 110.771 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -31.9 38.46 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 117.328 2.344 . . . . 74.5 117.328 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -118.18 -9.85 10.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.603 1.547 . . . . 70.33 113.312 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.99 -17.66 34.33 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.256 -1.302 . . . . 64.32 110.759 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.4 tp -58.63 -38.85 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.954 1.877 . . . . 75.41 107.63 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -55.42 -61.28 2.44 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.182 1.793 . . . . 63.34 107.07 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -51.01 -49.44 60.45 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 121.944 -0.472 . . . . 72.24 111.491 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -54.31 -48.37 71.4 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.174 0.59 . . . . 62.2 110.448 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.7 mtm -65.68 -41.4 92.48 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 119.031 -0.509 . . . . 62.4 110.493 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -47.13 86.52 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.431 1.014 . . . . 73.23 110.266 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 mt -60.0 -39.64 80.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.701 1.2 . . . . 73.23 108.683 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.69 -41.16 72.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.419 -0.586 . . . . 74.34 109.419 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.5 mt -63.88 -34.36 77.76 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.928 0.891 . . . . 73.12 110.988 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.2 mt -63.33 -9.57 12.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.191 0.996 . . . . 73.54 111.729 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -85.87 -2.8 58.61 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.615 1.098 . . . . 63.41 110.186 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -64.21 118.91 9.28 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.092 -1.447 . . . . 74.41 107.092 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' O ' ' HE2' ' A' ' 73' ' ' LYS . . . 84.85 6.64 85.03 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-O 117.006 -1.997 . . . . 64.11 114.248 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.9 p -78.26 163.18 25.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 121.112 2.456 . . . . 75.34 107.731 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.421 ' HG ' ' HE3' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -101.4 108.21 19.75 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.06 -1.089 . . . . 72.43 108.06 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -113.98 121.42 43.86 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 126.307 1.843 . . . . 63.24 107.434 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt 47.44 44.64 16.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.552 1.141 . . . . 63.43 113.074 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 69.37 18.19 8.0 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.289 2.236 . . . . 64.24 114.604 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -125.93 124.14 40.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.98 0.912 . . . . 72.21 108.557 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 66' ' ' GLY . 1.3 ttmt -75.02 114.81 13.93 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 101.815 -3.402 . . . . 72.31 101.815 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.3 pt -96.11 169.62 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.265 0.839 . . . . 65.52 113.265 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -121.43 148.09 44.88 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.819 1.647 . . . . 64.33 108.685 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.453 HG22 HG13 ' A' ' 8' ' ' VAL . 58.3 t -142.15 138.97 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.457 1.103 . . . . 72.32 109.053 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -159.99 176.26 12.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.772 2.029 . . . . 72.22 109.232 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.65 151.67 22.77 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.901 -1.125 . . . . 74.04 109.905 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.9 t -140.84 81.3 1.79 Allowed 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 105.22 -2.141 . . . . 74.12 105.22 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 p -174.54 164.38 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.655 -2.35 . . . . 73.32 104.655 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.21 156.54 27.8 Favored Glycine 0 N--CA 1.45 -0.43 0 O-C-N 121.008 -1.057 . . . . 62.03 111.32 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.215 0 C-N-CA 125.518 1.532 . . . . 72.0 110.201 179.819 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.729 0 N-CA-C 111.11 -0.796 . . . . 71.3 111.11 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.512 HD22 ' HB3' ' A' ' 47' ' ' ALA . 7.3 p-10 -71.75 -4.96 30.63 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.644 1.178 . . . . 73.42 113.206 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.28 128.89 35.16 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.474 -0.766 . . . . 75.1 110.709 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -91.62 165.23 13.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.393 1.477 . . . . 71.0 107.977 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.556 ' HB ' HG23 ' A' ' 79' ' ' THR . 2.2 mt -134.97 148.16 29.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.136 1.374 . . . . 74.52 108.96 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.4 136.69 47.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.764 1.625 . . . . 51.44 107.353 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.4 ' HZ ' HG21 ' A' ' 40' ' ' ILE . 69.0 t80 -106.34 117.08 33.1 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.912 1.285 . . . . 72.44 108.253 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 t -122.02 136.37 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.11 -1.07 . . . . 60.51 108.11 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.576 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -144.2 169.7 26.22 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 119.858 1.208 . . . . 71.32 111.477 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 74' ' ' ILE . 7.2 t 82.9 17.09 0.31 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 128.441 2.696 . . . . 74.32 109.766 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mp -53.62 152.09 9.92 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 124.61 1.164 . . . . 71.43 112.591 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -52.54 148.66 26.33 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.958 2.439 . . . . 51.14 111.106 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -59.9 -31.73 70.08 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.785 -0.572 . . . . 74.23 111.083 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -113.63 33.41 5.18 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.123 1.369 . . . . 54.12 111.747 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.68 143.08 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.97 -1.122 . . . . 51.44 107.97 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.36 147.66 46.0 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.426 -0.953 . . . . 73.34 108.426 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.18 68.73 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 117.961 -1.019 . . . . 54.52 111.179 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -62.96 -35.49 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 119.793 1.179 . . . . 71.12 109.509 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -66.46 -48.19 70.71 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.678 -0.86 . . . . 72.44 108.678 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.4 mt -59.91 -52.15 66.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.638 0.775 . . . . 74.43 109.01 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -57.72 -36.48 72.07 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.438 1.495 . . . . 73.03 109.796 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -75.95 -46.24 30.8 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.234 1.414 . . . . 74.32 112.849 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -35.91 81.91 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.632 0.773 . . . . 73.33 111.978 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -97.84 0.28 46.43 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.282 0.845 . . . . 75.35 113.282 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -50.99 -40.97 59.32 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.859 1.664 . . . . 73.45 112.567 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -66.79 -49.33 66.2 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.238 -0.653 . . . . 63.13 109.238 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 p -66.38 -17.15 64.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.789 1.236 . . . . 70.22 112.852 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.8 t 47.55 77.14 0.48 Allowed Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.658 1.583 . . . . 54.12 113.711 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.54 163.76 33.65 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.44 2.76 . . . . 71.41 110.652 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.6 -41.66 17.6 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.73 1.212 . . . . 72.32 108.426 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.33 162.12 40.7 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.641 1.176 . . . . 71.43 108.079 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.3 mt -135.52 128.5 47.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 126.182 1.793 . . . . 73.21 107.793 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -141.12 104.4 4.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.744 1.218 . . . . 55.03 109.359 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.29 125.28 37.81 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.937 -1.505 . . . . 72.42 106.937 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -118.82 91.53 3.58 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.349 1.059 . . . . 74.04 108.854 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.11 -20.94 64.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.203 1.001 . . . . 71.31 110.551 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.07 -32.34 21.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.949 2.1 . . . . 62.25 110.084 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -131.98 3.6 4.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.951 1.7 . . . . 74.05 111.966 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.29 34.8 90.94 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 119.66 1.118 . . . . 54.13 111.929 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.576 HG22 ' CA ' ' A' ' 9' ' ' GLY . 1.7 pp -124.87 171.3 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.289 1.435 . . . . 73.13 110.249 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.12 163.89 33.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.848 0.859 . . . . 72.12 111.031 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -130.49 135.49 48.01 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.398 1.479 . . . . 72.53 107.866 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -142.28 111.63 6.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.124 -1.435 . . . . 70.22 107.124 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.2 159.48 21.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.149 -1.056 . . . . 62.55 108.149 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -144.43 104.47 4.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.047 1.339 . . . . 70.53 107.426 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.69 110.0 5.96 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.644 1.178 . . . . 71.53 112.228 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.512 ' HB3' HD22 ' A' ' 2' ' ' ASN . . . -63.01 -31.71 72.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.506 0.928 . . . . 71.44 113.506 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -75.11 -24.29 58.05 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.21 0.914 . . . . 75.24 111.954 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -61.38 -30.72 70.72 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.498 -0.751 . . . . 61.31 110.302 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -157.0 84.02 0.94 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.976 -0.75 . . . . 73.04 108.976 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -52.47 -38.51 59.51 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.553 0.575 . . . . 73.02 112.553 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.0 -4.77 57.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 113.983 1.105 . . . . 74.22 113.983 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.1 -14.32 4.62 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.148 -1.362 . . . . 62.43 115.024 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.5 tp -51.72 -43.69 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 120.21 2.005 . . . . 72.35 110.886 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -57.05 -51.3 69.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.9 -1.148 . . . . 75.42 107.9 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -57.06 -48.86 77.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.206 1.002 . . . . 73.54 109.318 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.7 mtt85 -52.07 -51.97 54.24 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.656 0.662 . . . . 55.21 109.872 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 21.4 mtm -62.94 -39.61 95.14 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 119.096 -0.478 . . . . 74.14 110.771 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -49.96 75.42 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.297 1.039 . . . . 73.33 110.24 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.37 -39.36 78.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.597 1.159 . . . . 62.55 108.504 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.49 -40.38 70.26 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.324 0.511 . . . . 71.15 110.353 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.11 -38.82 92.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.338 1.055 . . . . 74.23 110.375 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.98 -2.44 1.23 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.719 1.608 . . . . 75.01 113.853 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -92.32 1.17 57.39 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.939 0.79 . . . . 52.21 110.852 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.62 115.3 4.59 Favored 'General case' 0 C--N 1.338 0.078 0 O-C-N 120.279 -1.513 . . . . 63.44 111.054 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.2 4.6 74.14 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 118.291 -1.283 . . . . 54.41 111.955 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.6 p -68.27 157.95 34.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.216 1.508 . . . . 74.14 109.65 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 mt -102.71 111.4 23.69 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.243 -1.392 . . . . 72.35 107.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -116.25 116.17 27.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.31 -1.367 . . . . 61.23 107.31 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt 49.88 53.44 12.79 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.793 1.237 . . . . 74.41 111.68 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 57.62 30.58 19.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.257 1.823 . . . . 74.21 113.838 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.21 118.02 13.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.313 1.445 . . . . 72.01 108.44 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -76.03 140.39 41.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.116 -1.809 . . . . 52.04 106.116 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 11.8 pt -126.63 170.08 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.438 1.086 . . . . 71.04 112.866 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.44 157.13 37.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.195 1.398 . . . . 73.1 110.699 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.0 t -136.87 148.55 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 125.275 1.43 . . . . 71.25 108.938 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.0 174.59 10.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.979 2.512 . . . . 74.45 109.175 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.22 152.0 20.07 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.433 1.093 . . . . 74.25 109.959 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.556 HG23 ' HB ' ' A' ' 5' ' ' ILE . 5.5 t -140.13 82.44 1.86 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.72 -1.215 . . . . 53.23 107.72 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.0 p -166.82 -39.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 123.499 0.72 . . . . 74.54 109.446 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.74 -52.64 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 CA-C-O 118.87 -0.961 . . . . 73.24 111.448 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 N-CA-C 106.513 -2.635 . . . . 44.33 106.513 -179.596 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.349 0 N-CA-C 111.371 -0.691 . . . . 62.51 111.371 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -151.54 45.31 0.79 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.731 1.613 . . . . 73.22 108.567 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 -134.73 131.83 38.09 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.935 -1.135 . . . . 63.12 107.935 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -95.04 162.86 13.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.721 -1.585 . . . . 54.22 106.721 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.487 HD12 ' HB ' ' A' ' 80' ' ' VAL . 22.0 mt -134.23 149.01 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.534 0.683 . . . . 65.32 109.715 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.9 t -121.06 115.06 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 105.949 -1.871 . . . . 53.22 105.949 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -84.61 139.03 32.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.54 -2.393 . . . . 75.32 104.54 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.444 HG12 HD11 ' A' ' 11' ' ' LEU . 2.5 t -131.74 136.57 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.746 -1.946 . . . . 52.31 105.746 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -141.83 -178.4 17.92 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 119.718 1.145 . . . . 54.13 110.596 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.44 13.06 9.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.14 1.776 . . . . 33.33 112.628 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.444 HD11 HG12 ' A' ' 8' ' ' VAL . 10.4 mp -54.8 148.61 26.27 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.565 1.546 . . . . 73.41 112.603 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.44 150.71 87.77 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.893 2.395 . . . . 75.02 110.365 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -53.58 -45.75 70.08 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.135 0.974 . . . . 71.21 110.718 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.02 18.53 5.72 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.248 1.573 . . . . 74.2 115.248 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.483 HG21 HD21 ' A' ' 34' ' ' LEU . 6.5 tp -44.98 137.21 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 119.902 1.228 . . . . 74.01 111.968 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 p -115.96 150.52 37.03 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.293 1.437 . . . . 75.21 109.236 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.71 -29.63 70.83 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-O 119.13 -0.462 . . . . 61.42 110.647 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.48 -38.35 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 118.443 0.565 . . . . 73.55 109.581 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.42 -38.14 84.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.088 0.858 . . . . 73.2 109.125 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.77 -54.46 31.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.107 -0.701 . . . . 70.24 109.107 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -54.81 -46.56 74.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.123 0.969 . . . . 74.11 109.097 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -62.77 -41.22 99.15 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 114.378 1.251 . . . . 75.33 114.378 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -46.56 69.84 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.056 -1.028 . . . . 64.34 110.493 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -86.09 3.06 44.21 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.057 1.132 . . . . 71.25 114.057 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -53.43 -40.63 65.32 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.538 -1.351 . . . . 71.5 110.69 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -70.59 -31.38 68.35 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.926 1.69 . . . . 74.24 112.174 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 p -89.49 -11.21 43.61 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 117.913 -1.042 . . . . 65.44 112.459 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m 48.58 70.44 2.08 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 115.445 1.646 . . . . 72.4 115.445 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.94 161.4 46.1 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.961 2.441 . . . . 63.03 111.682 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -91.55 -39.5 11.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.05 1.74 . . . . 65.21 107.649 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -135.35 158.19 44.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.698 1.199 . . . . 70.24 110.748 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.6 mt -145.79 126.3 6.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.341 -1.726 . . . . 45.21 106.341 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -140.27 105.93 5.13 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.985 1.314 . . . . 74.42 109.833 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 15' ' ' ILE . 1.6 tm? -92.76 121.16 33.87 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.313 1.045 . . . . 74.22 110.241 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -118.88 81.7 1.74 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.941 -1.133 . . . . 74.11 107.941 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.63 -21.63 60.72 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.217 1.007 . . . . 64.45 111.096 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.74 -20.21 7.93 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.953 1.701 . . . . 64.14 112.346 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -132.37 -4.1 3.4 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.702 1.601 . . . . 75.41 109.447 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.32 41.77 51.69 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.207 -1.557 . . . . 54.45 109.207 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.453 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 40.5 pt -132.86 171.82 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 124.537 1.135 . . . . 61.33 110.678 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.87 165.6 34.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.739 1.615 . . . . 65.31 109.187 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -135.22 142.3 45.99 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.552 1.941 . . . . 65.13 106.219 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -142.9 114.08 7.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.28 -1.378 . . . . 74.41 107.28 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.3 155.98 19.02 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.551 -1.648 . . . . 72.12 106.551 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -145.1 114.02 6.89 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.275 1.83 . . . . 64.1 109.187 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -72.01 112.77 8.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.776 1.028 . . . . 71.35 113.776 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.95 -16.26 61.54 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.427 1.491 . . . . 70.13 112.789 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.62 -22.51 27.94 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.058 0.845 . . . . 75.34 109.57 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -61.62 -43.93 97.94 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 120.952 -1.092 . . . . 64.54 109.697 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -145.44 89.21 1.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.512 0.596 . . . . 72.21 110.755 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -37.57 48.92 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 114.358 1.244 . . . . 75.32 114.358 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.8 p -97.15 -19.85 18.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.221 1.373 . . . . 72.24 112.381 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.49 -16.29 43.56 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 117.65 -1.639 . . . . 52.21 114.911 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.42 -37.3 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.799 2.3 . . . . 71.04 109.366 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -60.84 -60.93 3.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.632 -1.247 . . . . 73.14 107.632 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -50.79 -44.22 58.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 118.614 -0.708 . . . . 74.52 110.628 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -56.42 -49.98 72.98 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.939 -0.763 . . . . 65.05 108.939 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.2 mtm -58.68 -47.71 83.57 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 124.204 1.002 . . . . 73.23 109.447 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -53.76 50.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.997 1.719 . . . . 74.45 111.837 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.6 mt -61.27 -37.01 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.804 1.242 . . . . 75.41 108.937 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.36 -41.44 63.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.434 -0.58 . . . . 71.52 109.434 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.39 -34.95 78.85 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.915 1.286 . . . . 75.12 111.241 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.8 mt -65.81 -9.77 31.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.044 0.938 . . . . 74.4 111.889 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -85.76 -1.68 57.46 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.128 0.876 . . . . 65.41 110.418 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -62.76 111.9 2.3 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.883 1.674 . . . . 60.34 109.673 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.74 7.25 53.68 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.619 1.104 . . . . 64.41 112.945 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.1 p -66.08 146.85 54.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.528 1.664 . . . . 51.53 109.121 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.6 mt -93.08 121.21 34.19 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.547 -2.39 . . . . 55.54 104.547 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.8 120.05 28.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.996 1.318 . . . . 73.23 108.152 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt 48.39 40.48 14.79 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.22 1.408 . . . . 63.03 112.561 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 70.48 29.35 3.47 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 128.519 2.728 . . . . 62.33 113.913 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -136.15 120.71 18.26 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 126.551 1.94 . . . . 70.31 108.772 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -73.61 138.33 44.8 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 105.636 -1.987 . . . . 75.05 105.636 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 pt -119.5 170.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 124.636 1.174 . . . . 65.4 110.695 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -123.66 158.74 30.86 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.247 1.419 . . . . 72.13 111.23 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.96 132.89 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.09 1.756 . . . . 74.34 108.862 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -148.24 160.53 42.86 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.616 1.566 . . . . 73.25 108.565 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -86.28 148.13 25.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.848 1.259 . . . . 71.31 109.784 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.77 155.86 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.991 1.717 . . . . 54.23 107.261 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.487 ' HB ' HD12 ' A' ' 5' ' ' ILE . 42.2 t 38.94 77.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.798 1.639 . . . . 64.51 110.745 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.71 88.42 0.07 OUTLIER Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 118.562 -1.78 . . . . 71.1 108.798 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 N-CA-C 104.31 -3.516 . . . . 75.11 104.31 -179.608 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.346 0 N-CA-C 109.966 -1.254 . . . . 44.43 109.966 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -107.85 24.2 13.3 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.851 1.26 . . . . 63.24 112.722 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -125.13 155.89 39.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.759 1.618 . . . . 73.33 109.384 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -119.03 161.38 20.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 105.81 -1.922 . . . . 52.33 105.81 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -134.68 139.41 47.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.178 1.391 . . . . 75.44 110.261 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.75 141.56 27.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 106.971 -1.492 . . . . 71.1 106.971 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -103.79 133.19 49.2 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.31 -2.107 . . . . 71.31 105.31 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG12 HD11 ' A' ' 11' ' ' LEU . 93.2 t -136.79 130.6 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.731 -1.952 . . . . 72.34 105.731 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.95 179.92 21.74 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 121.348 1.885 . . . . 54.24 115.041 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.82 17.15 2.32 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.162 2.585 . . . . 52.52 111.399 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.426 HD11 HG12 ' A' ' 8' ' ' VAL . 7.4 mp -66.76 146.23 99.05 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 125.023 1.329 . . . . 72.43 112.765 -177.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -67.07 167.76 19.13 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.681 2.921 . . . . 75.13 112.119 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -75.0 -34.64 61.97 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.297 -1.001 . . . . 73.33 108.297 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.6 11.62 3.65 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.149 1.38 . . . . 61.11 112.172 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.441 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 8.7 tp -54.77 143.61 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 120.679 -1.263 . . . . 71.21 109.31 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 p -128.11 148.25 50.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.445 1.098 . . . . 71.42 110.074 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.95 -29.63 70.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.209 -0.9 . . . . 41.54 110.652 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.65 -38.21 81.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 119.069 0.85 . . . . 75.2 109.782 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HB3' HD11 ' A' ' 69' ' ' LEU . 4.1 mm-40 -71.48 -43.11 67.19 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.022 -0.732 . . . . 75.43 109.022 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.51 -49.64 75.91 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.34 1.056 . . . . 64.43 111.253 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -59.39 -42.14 91.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.629 0.772 . . . . 74.42 109.178 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -68.79 -40.88 79.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.385 1.474 . . . . 74.14 113.535 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -41.28 91.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 118.739 0.699 . . . . 71.32 111.978 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -99.75 4.74 45.56 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.82 1.044 . . . . 70.24 113.82 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -51.19 -47.54 62.18 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.067 1.347 . . . . 64.5 109.896 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.06 -39.9 79.64 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.633 0.773 . . . . 74.32 111.838 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 p -81.87 -10.76 59.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.732 1.213 . . . . 71.32 112.794 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.64 65.95 6.38 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 114.965 1.468 . . . . 74.24 114.965 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -64.91 151.86 84.32 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.751 2.301 . . . . 61.34 108.897 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.68 -48.49 8.24 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.077 -1.083 . . . . 63.3 108.077 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.5 153.88 41.38 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.258 -1.016 . . . . 72.0 108.258 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 65.3 mt -145.92 119.83 2.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.425 -1.694 . . . . 71.21 106.425 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.43 108.22 10.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.733 -1.58 . . . . 74.34 106.733 178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -93.59 125.93 38.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.746 -1.576 . . . . 65.5 106.746 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -118.24 89.69 3.18 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.426 -2.064 . . . . 74.11 105.426 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.15 -16.41 52.56 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.148 -0.453 . . . . 32.44 111.417 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -50.48 -40.08 50.0 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.246 2.219 . . . . 75.23 111.034 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -126.84 6.56 6.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.853 1.661 . . . . 64.35 110.174 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.12 42.63 99.73 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.313 -1.115 . . . . 54.52 110.313 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.7 162.31 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.856 1.263 . . . . 70.24 109.37 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.75 152.23 40.06 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.126 0.971 . . . . 64.3 109.527 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -120.31 135.25 55.08 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 103.958 -2.608 . . . . 74.13 103.958 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.53 122.99 25.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.158 -1.793 . . . . 50.33 106.158 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -96.6 150.71 20.35 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.188 -1.412 . . . . 71.51 107.188 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -142.13 110.68 6.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.388 -1.338 . . . . 75.12 107.388 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -76.25 118.19 18.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.645 0.778 . . . . 62.42 109.302 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.76 -18.88 50.03 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 128.025 2.53 . . . . 75.54 112.344 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.5 -30.33 52.94 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.479 -1.674 . . . . 73.05 106.479 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -61.73 -37.5 84.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.696 1.198 . . . . 62.32 112.348 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -147.94 97.92 2.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.297 0.953 . . . . 63.12 108.876 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -51.46 -31.52 23.59 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 115.894 -2.003 . . . . 63.11 116.315 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.79 -20.59 8.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 121.021 1.737 . . . . 64.32 111.287 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.42 -30.7 66.54 Favored Glycine 0 C--N 1.338 0.66 0 O-C-N 121.015 -1.053 . . . . 71.33 110.835 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.7 tp -49.76 -41.95 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.388 1.094 . . . . 43.03 112.055 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -68.23 -61.34 1.89 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.222 0.609 . . . . 74.52 110.342 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -56.15 -30.84 62.74 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.93 -0.481 . . . . 75.32 111.331 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.3 mtt85 -68.44 -41.16 80.7 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.01 -1.056 . . . . 74.32 108.741 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.0 mtm -64.55 -44.09 91.9 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 107.163 -1.421 . . . . 72.53 107.163 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -56.5 -48.24 77.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.948 0.899 . . . . 34.31 109.048 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.58 -41.38 87.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.137 0.975 . . . . 65.42 109.848 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.27 84.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.448 -0.575 . . . . 73.14 109.448 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.28 -32.55 74.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.828 0.851 . . . . 70.21 110.245 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.3 mt -65.28 -13.04 57.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 118.795 -0.621 . . . . 71.24 110.951 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -86.49 3.93 41.97 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.932 0.787 . . . . 53.2 110.262 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -69.53 112.71 6.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.083 -1.636 . . . . 74.41 107.842 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.65 -3.93 85.05 Favored Glycine 0 C--O 1.225 -0.447 0 CA-C-O 116.436 -2.313 . . . . 75.4 111.893 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -64.87 137.73 57.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 121.44 2.62 . . . . 63.34 107.138 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.49 126.28 30.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.027 -1.842 . . . . 75.34 106.027 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 19' ' ' GLU . 49.7 tp -129.82 122.9 29.65 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 105.364 -2.088 . . . . 74.12 105.364 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 6.0 mtpm? 51.37 44.85 28.69 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.768 1.627 . . . . 74.23 111.359 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 57.83 33.89 23.74 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 127.644 2.378 . . . . 72.01 113.193 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -134.46 128.54 33.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 126.039 1.736 . . . . 73.34 108.137 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -78.52 112.15 15.29 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 103.534 -2.765 . . . . 74.44 103.534 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.8 pt -104.56 169.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 118.137 0.426 . . . . 74.14 110.359 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -121.64 158.7 28.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.286 1.034 . . . . 60.04 111.236 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -146.21 143.63 21.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.846 1.258 . . . . 64.12 108.048 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -162.07 161.13 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.647 1.579 . . . . 72.22 108.863 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.67 152.18 22.78 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.916 1.286 . . . . 73.3 109.109 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 p -150.14 144.15 25.51 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.797 1.239 . . . . 72.43 108.603 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.8 t 59.49 79.13 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.254 1.422 . . . . 63.5 112.272 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.32 24.94 0.07 OUTLIER Glycine 0 CA--C 1.523 0.592 0 O-C-N 120.805 -1.184 . . . . 54.45 112.61 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 N-CA-C 108.106 -1.998 . . . . 64.34 108.106 179.921 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.842 0 N-CA-C 111.173 -0.771 . . . . 53.24 111.173 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.04 51.9 0.84 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.55 1.175 . . . . 74.31 111.548 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -155.8 159.06 39.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 120.967 -1.083 . . . . 75.52 110.74 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -130.21 158.8 38.75 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 129.786 3.234 . . . . 73.13 105.196 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.432 HD12 HG21 ' A' ' 80' ' ' VAL . 21.4 mt -130.36 149.32 33.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.832 0.825 . . . . 42.44 109.338 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 t -108.9 127.14 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 125.798 1.639 . . . . 71.23 107.421 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -91.45 128.32 37.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.537 -2.394 . . . . 61.25 104.537 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.84 129.55 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.462 -1.681 . . . . 75.34 106.462 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.72 -175.72 14.44 Favored Glycine 0 N--CA 1.468 0.814 0 CA-C-N 120.317 1.417 . . . . 32.01 113.09 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 72.21 14.45 5.56 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.217 2.207 . . . . 74.24 111.543 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.26 149.59 82.3 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 125.232 1.413 . . . . 72.42 112.334 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.98 165.15 31.05 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.282 2.655 . . . . 72.45 110.036 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.19 -31.52 58.51 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.219 1.008 . . . . 75.21 109.494 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -85.35 10.89 11.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.303 1.441 . . . . 75.41 113.467 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.551 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 8.6 tp -57.61 138.97 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.488 1.115 . . . . 71.3 111.69 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 p -128.32 153.4 47.05 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.184 0.994 . . . . 74.3 109.738 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.36 -33.31 65.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.446 1.898 . . . . 71.34 111.366 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.8 p -66.14 -37.7 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 119.126 -0.464 . . . . 54.03 110.113 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.79 -43.39 72.22 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.392 -0.966 . . . . 73.24 108.392 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -60.36 -55.63 31.24 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 125.276 1.43 . . . . 73.33 110.069 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -57.63 -45.06 85.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.037 -0.727 . . . . 74.02 109.037 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -60.34 -44.1 95.83 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 65.11 112.813 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -47.98 74.89 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 119.419 1.009 . . . . 74.41 110.825 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -83.01 1.02 42.09 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 115.362 1.615 . . . . 74.53 115.362 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -51.26 -41.57 60.49 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.223 1.409 . . . . 71.43 113.382 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -32.75 74.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.885 0.874 . . . . 75.32 110.666 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 88.1 p -87.16 -28.76 22.25 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.255 1.206 . . . . 64.43 114.255 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.4 t 62.81 75.21 0.42 Allowed Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.53 1.932 . . . . 65.14 112.358 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -67.33 159.97 49.86 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.934 3.09 . . . . 63.02 110.719 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -85.63 -46.47 10.74 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.871 1.668 . . . . 72.14 108.009 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.56 157.21 44.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.902 -0.59 . . . . 73.04 109.598 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.6 mt -137.93 128.46 36.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 125.028 1.331 . . . . 65.12 108.875 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 103.39 5.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.35 -1.352 . . . . 72.41 107.35 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -88.62 111.73 22.25 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.95 -1.5 . . . . 60.45 106.95 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -105.28 80.22 1.57 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.079 -1.452 . . . . 72.24 107.079 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.66 -27.97 43.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.977 0.911 . . . . 74.31 111.246 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -51.09 -27.9 9.32 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 127.515 2.326 . . . . 70.3 113.904 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -132.65 9.96 4.31 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.888 1.275 . . . . 74.53 111.093 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.14 42.7 99.87 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.795 1.188 . . . . 64.14 110.619 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.54 166.05 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 C-N-CA 124.816 1.246 . . . . 73.24 111.482 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.31 148.77 36.84 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.328 2.251 . . . . 53.2 108.239 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -124.16 129.39 50.74 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.961 -1.866 . . . . 75.34 105.961 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.11 114.13 15.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.209 -1.034 . . . . 64.23 108.209 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -92.66 155.04 17.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.745 -1.946 . . . . 62.12 105.745 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -140.02 137.22 34.46 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.629 -1.619 . . . . 74.34 106.629 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -81.7 110.19 16.81 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.944 1.247 . . . . 73.33 109.444 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.59 -16.99 62.9 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.631 1.172 . . . . 60.34 112.273 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.69 -18.38 29.66 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.997 0.817 . . . . 73.32 110.777 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -60.98 -35.61 77.24 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.157 0.889 . . . . 70.41 110.357 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -150.14 86.71 1.43 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.922 -1.881 . . . . 73.43 105.922 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -49.75 -37.36 29.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.471 1.108 . . . . 70.43 112.226 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 -3.1 39.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.257 1.423 . . . . 72.02 113.578 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.06 -19.75 5.84 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 124.923 1.249 . . . . 53.24 114.788 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 tp -52.83 -36.99 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.42 1.61 . . . . 62.43 111.461 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -56.42 -54.84 40.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.846 1.259 . . . . 63.32 108.398 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -47.03 79.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.34 1.056 . . . . 72.52 109.793 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -54.74 -46.59 74.3 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 118.727 -0.654 . . . . 75.01 109.273 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 2.7 mtm -61.33 -50.88 71.16 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 108.173 -1.047 . . . . 72.1 108.173 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.04 -52.52 8.87 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.796 2.038 . . . . 74.14 111.836 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.0 mt -59.08 -41.9 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.199 1.4 . . . . 71.32 110.091 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.32 -36.82 61.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.159 0.984 . . . . 71.13 111.058 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -66.96 -36.08 81.41 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.642 1.11 . . . . 74.31 109.586 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.68 -12.73 11.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.568 1.147 . . . . 55.11 111.512 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -84.61 5.02 29.59 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.871 0.759 . . . . 52.24 110.278 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -69.07 113.92 6.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.285 -1.746 . . . . 72.23 106.285 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.28 6.23 61.56 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.282 -1.288 . . . . 70.42 113.458 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.5 p -68.07 143.56 55.44 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 120.482 2.141 . . . . 74.51 108.607 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 73' ' ' LYS . 15.2 mt -88.71 107.6 19.03 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 103.174 -2.899 . . . . 61.13 103.174 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.9 tp -113.0 117.5 32.21 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.715 -1.587 . . . . 62.32 106.715 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 14.3 mtpp 47.05 56.1 7.22 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.883 0.873 . . . . 65.04 111.891 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 60.95 23.38 13.5 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.856 1.662 . . . . 72.41 114.789 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -132.41 126.67 33.67 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 124.685 1.194 . . . . 73.31 108.757 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.422 ' HA ' HD23 ' A' ' 68' ' ' LEU . 4.6 ttpm? -80.1 114.3 18.9 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 104.067 -2.568 . . . . 75.55 104.067 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.2 pt -94.96 169.24 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 118.436 0.562 . . . . 65.04 109.984 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -122.99 158.59 30.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.01 1.324 . . . . 72.34 110.861 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.0 t -142.52 126.44 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 126.009 1.723 . . . . 72.23 108.797 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -139.03 174.47 10.48 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.475 1.51 . . . . 74.32 108.156 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.46 151.78 18.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.152 -0.967 . . . . 74.51 110.124 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 t -152.64 132.17 13.01 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.249 -1.389 . . . . 63.02 107.249 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.432 HG21 HD12 ' A' ' 5' ' ' ILE . 3.0 t 68.15 113.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.681 1.592 . . . . 75.02 112.715 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.79 6.47 40.4 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.564 1.078 . . . . 51.23 113.746 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 N-CA-C 104.397 -3.481 . . . . 41.2 104.397 179.196 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 N-CA-C 110.998 -0.841 . . . . 73.33 110.998 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -76.35 16.68 0.44 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.556 1.317 . . . . 62.34 114.556 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.414 HH11 ' HB3' ' A' ' 44' ' ' GLU . 9.8 tpp180 -138.28 138.43 38.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 121.116 1.78 . . . . 73.31 108.384 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -128.55 157.71 40.46 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.778 1.631 . . . . 65.54 107.233 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -134.91 146.01 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.361 1.065 . . . . 64.25 110.02 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.8 126.44 57.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.62 -1.993 . . . . 71.32 105.62 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -96.58 105.14 17.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.594 -1.632 . . . . 74.23 106.594 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -113.66 139.35 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 120.027 1.285 . . . . 62.11 108.675 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -149.06 178.31 26.7 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 119.928 1.24 . . . . 62.44 112.663 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 84.99 6.3 0.5 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.405 3.082 . . . . 74.21 111.833 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp -46.24 148.67 1.49 Allowed Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 127.339 2.256 . . . . 73.03 115.392 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.86 175.28 7.55 Favored 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.98 4.453 . . . . 54.32 113.379 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mmt-85 -78.47 -45.44 22.08 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 107.898 -1.149 . . . . 54.25 107.898 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -84.25 22.02 1.3 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.031 1.733 . . . . 61.3 112.889 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.7 tp -61.93 142.25 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.628 -1.249 . . . . 63.03 107.628 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.99 150.01 50.58 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.376 -0.972 . . . . 64.04 108.376 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -32.39 70.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.848 -0.797 . . . . 75.42 108.848 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.01 -49.08 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.138 1.375 . . . . 74.25 109.868 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.46 -34.75 74.84 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.01 -0.676 . . . . 73.42 109.215 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.12 -49.85 72.77 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.943 0.792 . . . . 72.12 109.436 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -59.92 -37.78 80.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.828 -0.606 . . . . 72.23 110.501 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -69.59 -50.82 40.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.394 0.677 . . . . 44.34 110.764 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -24.11 67.7 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 120.971 -1.081 . . . . 74.24 112.213 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -108.54 8.79 27.39 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.88 1.218 . . . . 70.35 111.712 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -61.27 -26.72 67.96 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 120.107 -1.62 . . . . 65.24 114.062 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -30.1 23.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.639 1.109 . . . . 65.53 108.767 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -31.2 58.73 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.407 -0.96 . . . . 63.51 108.407 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m 60.69 72.35 0.73 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 126.674 1.99 . . . . 73.53 113.134 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.14 158.1 58.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.741 2.961 . . . . 65.44 110.465 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -78.96 -45.74 19.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.857 -1.534 . . . . 73.15 106.857 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -156.77 139.71 15.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.477 1.511 . . . . 63.41 108.48 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.14 142.19 22.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.384 -1.71 . . . . 74.54 106.384 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -135.09 103.8 5.69 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.581 -1.637 . . . . 73.33 106.581 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -86.7 121.44 29.22 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.463 -1.31 . . . . 61.24 107.463 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -108.85 82.35 1.59 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.542 -1.651 . . . . 73.32 106.542 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.56 -23.22 62.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.216 0.606 . . . . 62.44 111.347 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.95 -26.93 66.37 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.56 1.544 . . . . 74.12 111.981 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -133.17 6.6 3.89 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.693 1.197 . . . . 70.03 112.591 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.32 47.41 91.03 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 119.063 0.847 . . . . 62.03 111.287 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.469 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 2.3 pt -134.73 159.78 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.196 1.398 . . . . 73.25 108.727 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.68 135.06 21.88 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.58 1.152 . . . . 54.12 108.347 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -108.17 139.33 43.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.573 -2.01 . . . . 74.13 105.573 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.32 116.03 15.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 105.406 -2.072 . . . . 64.45 105.406 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.414 ' HB3' HH11 ' A' ' 3' ' ' ARG . 35.8 mt-10 -88.05 149.98 23.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.918 0.887 . . . . 53.32 109.711 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -140.98 123.31 15.79 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.188 1.795 . . . . 60.11 107.654 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -90.82 112.4 24.19 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.111 0.964 . . . . 72.21 110.882 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.42 -22.58 62.71 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.107 1.363 . . . . 45.25 111.74 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.93 -37.04 64.71 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.941 -1.133 . . . . 51.32 107.941 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -69.17 -38.25 78.61 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 118.687 -0.673 . . . . 73.23 109.657 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.0 75.86 1.4 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.823 0.738 . . . . 63.23 111.564 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -54.15 -39.61 66.68 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 118.837 -0.601 . . . . 74.44 111.979 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.9 p -104.26 -1.26 27.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.872 1.269 . . . . 75.23 113.449 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.43 -13.88 7.91 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-O 117.958 -1.468 . . . . 63.2 114.813 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.3 tp -51.4 -50.37 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 120.171 1.986 . . . . 72.35 112.218 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -53.33 57.02 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.331 -0.989 . . . . 62.34 108.331 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -50.59 -48.65 57.69 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.133 0.573 . . . . 73.13 111.068 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -57.01 -49.63 75.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.549 1.14 . . . . 55.03 108.719 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 43.2 mtm -64.08 -36.53 84.32 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.405 0.682 . . . . 70.31 111.345 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -55.35 -51.07 67.98 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.704 2.002 . . . . 43.4 111.65 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.47 -26.56 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.568 1.547 . . . . 65.13 109.368 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.89 -39.58 19.67 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.973 0.909 . . . . 70.51 108.927 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.31 -44.67 95.23 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.032 1.733 . . . . 72.01 110.221 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.3 mt -58.41 -6.82 0.74 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.485 1.914 . . . . 74.22 113.938 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -89.4 -3.7 58.32 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.29 0.95 . . . . 72.34 111.331 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -59.23 112.66 1.8 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.797 1.239 . . . . 72.1 108.85 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' CA ' ' HE2' ' A' ' 73' ' ' LYS . . . 91.28 3.52 69.51 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.934 -1.481 . . . . 72.34 115.009 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 p -70.6 160.77 31.91 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.618 1.709 . . . . 62.33 109.124 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 mt -109.49 108.85 19.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.307 1.443 . . . . 75.14 109.536 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.78 132.83 55.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.858 -2.275 . . . . 73.52 104.858 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.7 mttm 46.09 45.8 12.6 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.282 1.039 . . . . 75.33 111.655 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 64.32 0.12 0.99 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.685 2.794 . . . . 71.12 115.855 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -109.89 140.2 44.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.63 1.104 . . . . 73.31 109.645 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' HE2' ' CA ' ' A' ' 66' ' ' GLY . 15.8 tttm -78.95 156.16 28.64 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.47 -0.937 . . . . 73.43 108.47 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 pt -129.58 170.08 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.884 1.274 . . . . 65.02 111.003 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.25 147.98 52.03 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.156 1.783 . . . . 63.23 106.457 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.6 t -139.12 136.31 42.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 124.802 1.241 . . . . 34.42 108.333 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -147.18 171.98 14.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.149 1.78 . . . . 62.13 108.049 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.14 152.79 20.45 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.373 1.469 . . . . 64.22 108.831 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 t -156.05 147.69 22.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.886 -1.524 . . . . 72.42 106.886 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.5 t 48.93 90.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.558 1.543 . . . . 54.43 113.664 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.65 -13.69 13.22 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-O 118.762 -1.021 . . . . 73.24 112.802 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 N-CA-C 104.863 -3.295 . . . . 65.43 104.863 178.334 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.952 0 N-CA-C 110.709 -0.956 . . . . 73.33 110.709 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.86 46.41 2.62 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.873 1.269 . . . . 73.54 108.987 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 ptt-85 -139.23 156.78 46.84 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.934 -0.765 . . . . 74.11 108.934 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -123.14 160.42 26.5 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 105.179 -2.156 . . . . 75.13 105.179 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -134.68 129.64 52.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.463 1.505 . . . . 75.21 110.873 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.5 t -102.79 128.42 55.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 105.349 -2.093 . . . . 51.41 105.349 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -96.81 141.49 29.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.184 -1.784 . . . . 74.24 106.184 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.415 HG12 HD11 ' A' ' 11' ' ' LEU . 2.6 t -138.45 133.35 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.944 -1.873 . . . . 74.14 105.944 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.414 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -140.84 177.96 20.46 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 120.888 1.676 . . . . 64.42 111.791 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.423 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 0.5 OUTLIER 73.78 16.47 3.78 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.047 2.539 . . . . 42.53 111.116 -178.156 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.415 HD11 HG12 ' A' ' 8' ' ' VAL . 9.5 mp -62.54 147.63 92.07 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.445 1.498 . . . . 64.33 113.648 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -66.67 164.96 27.11 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.301 2.668 . . . . 74.23 111.329 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -76.38 -29.53 57.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 122.976 0.51 . . . . 71.24 110.742 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.09 13.51 11.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.175 0.99 . . . . 73.44 112.984 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.569 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.6 tp -59.02 138.87 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.234 1.014 . . . . 62.34 111.328 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 p -128.3 158.39 38.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.744 1.618 . . . . 74.44 109.909 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.1 -29.58 69.37 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.101 0.56 . . . . 63.15 110.348 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.21 -34.04 67.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.305 0.642 . . . . 75.43 110.228 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -73.66 -47.94 36.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.038 -1.468 . . . . 74.11 107.038 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -56.06 -46.41 78.95 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.302 1.441 . . . . 75.02 110.652 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -61.6 -36.61 81.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.521 -0.752 . . . . 74.53 110.214 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.14 -30.99 60.94 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.757 0.708 . . . . 73.41 110.877 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -68.36 -50.19 54.87 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.182 -0.949 . . . . 71.44 110.015 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -91.74 10.87 26.58 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.222 1.009 . . . . 75.1 112.825 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -35.76 63.82 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 120.681 -1.262 . . . . 75.42 110.793 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -82.6 -9.15 59.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.1 0.96 . . . . 75.13 113.533 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.17 -10.79 14.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.671 1.188 . . . . 70.11 111.586 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 t 47.24 61.78 13.03 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.58 2.352 . . . . 73.21 114.893 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.36 161.0 15.02 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.399 2.733 . . . . 73.15 111.561 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -38.86 10.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.36 1.064 . . . . 74.32 109.404 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -136.01 153.17 51.45 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.191 0.997 . . . . 71.31 108.358 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.3 mt -139.5 125.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 105.388 -2.078 . . . . 71.44 105.388 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.42 104.5 4.6 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.528 -1.286 . . . . 71.24 107.528 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -88.7 119.47 29.21 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 124.689 1.196 . . . . 64.35 108.331 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -108.69 82.45 1.61 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.026 -1.472 . . . . 72.12 107.026 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.97 -26.88 50.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.778 0.831 . . . . 53.41 111.548 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.08 -28.39 10.41 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 128.285 2.634 . . . . 71.34 112.709 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -132.92 9.16 4.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.782 1.233 . . . . 75.14 110.443 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.16 43.85 96.81 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 119.6 1.091 . . . . 51.14 110.932 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.414 HG22 ' CA ' ' A' ' 9' ' ' GLY . 3.1 pt -134.85 166.2 29.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.102 1.361 . . . . 65.21 111.247 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.49 154.37 43.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.076 1.351 . . . . 72.53 109.489 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.48 123.26 39.74 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.107 1.363 . . . . 75.04 107.387 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.5 114.77 21.71 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.321 -0.992 . . . . 75.2 108.321 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -91.21 151.07 21.09 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.919 -1.141 . . . . 74.23 107.919 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -136.74 134.26 36.93 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.672 1.589 . . . . 70.02 107.304 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.27 112.54 24.35 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.86 1.664 . . . . 74.02 111.319 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.38 -27.41 68.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.086 1.354 . . . . 55.12 111.32 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.52 -32.99 68.79 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.423 -0.322 . . . . 71.04 110.393 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -62.94 -22.82 67.06 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.79 0.723 . . . . 72.44 112.928 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -158.82 99.43 1.55 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.192 -1.41 . . . . 73.52 107.192 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -54.02 50.03 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.512 0.725 . . . . 74.11 112.463 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.84 -19.6 23.23 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.309 1.044 . . . . 72.25 110.976 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.53 -22.3 62.57 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-O 117.228 -1.873 . . . . 62.51 113.589 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.77 -40.8 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 120.532 2.166 . . . . 74.32 110.106 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.53 -58.5 6.94 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.657 -1.238 . . . . 64.55 107.657 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.1 -48.37 76.29 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.812 0.845 . . . . 63.33 111.095 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.18 -41.05 68.1 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.128 -0.693 . . . . 74.32 109.128 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 6.4 mtm -71.88 -44.45 63.73 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.332 1.053 . . . . 75.42 110.681 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -48.88 72.0 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.831 1.652 . . . . 75.54 110.575 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.74 -39.77 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.691 1.597 . . . . 74.32 108.802 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.72 75.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.876 -0.583 . . . . 31.35 109.573 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.43 -31.58 72.75 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.965 0.802 . . . . 73.13 110.493 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.4 mt -68.95 -5.13 19.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.649 -0.657 . . . . 63.13 112.092 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -89.65 -0.64 57.66 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.058 0.845 . . . . 62.34 110.453 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -66.02 113.09 4.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.026 1.73 . . . . 73.31 110.991 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.2 2.99 67.92 Favored Glycine 0 N--CA 1.459 0.233 0 CA-C-O 117.942 -1.477 . . . . 64.14 114.173 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -66.93 133.77 50.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.59 1.695 . . . . 61.01 108.369 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 73' ' ' LYS . 29.6 mt -76.21 108.21 8.98 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 105.743 -1.947 . . . . 71.32 105.743 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.6 tp -115.88 119.6 36.5 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.675 -1.602 . . . . 70.32 106.675 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 17.3 mtpp 49.21 50.44 17.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.741 1.616 . . . . 63.4 112.368 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 64.28 24.99 13.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.172 2.189 . . . . 70.22 113.576 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 10' ' ' SER . 15.0 mmmt -131.77 124.44 29.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.62 1.168 . . . . 74.25 110.647 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' HD23 ' A' ' 68' ' ' LEU . 6.5 tptm -79.83 105.77 11.36 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 101.7 -3.444 . . . . 73.2 101.7 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.3 pt -95.63 169.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 124.006 0.922 . . . . 75.34 108.685 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -127.17 158.97 35.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.796 1.238 . . . . 75.23 111.52 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.0 t -137.06 139.22 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 126.526 1.931 . . . . 73.53 107.191 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -149.67 162.74 39.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.674 1.189 . . . . 55.15 108.127 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 147.55 25.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.469 1.108 . . . . 65.2 109.291 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 p -148.46 130.36 15.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 117.912 -1.042 . . . . 65.24 108.748 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.8 t 70.53 160.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 126.124 1.77 . . . . 72.12 110.786 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.28 62.54 0.01 OUTLIER Glycine 0 C--O 1.237 0.282 0 N-CA-C 107.557 -2.217 . . . . 65.42 107.557 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 N-CA-C 105.359 -3.096 . . . . 63.43 105.359 -179.224 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 109.002 -1.639 . . . . 52.52 109.002 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -67.06 1.26 2.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.18 1.49 . . . . 73.22 114.978 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.63 107.82 7.7 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.578 1.081 . . . . 71.54 112.018 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -100.16 157.31 16.67 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 128.21 2.604 . . . . 74.41 107.125 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mt -135.41 149.19 28.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 124.696 1.198 . . . . 74.14 108.082 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.1 t -116.65 127.49 74.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 105.768 -1.938 . . . . 73.24 105.768 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -94.75 139.32 31.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.374 -1.713 . . . . 72.43 106.374 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 t -139.26 132.49 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.327 -1.731 . . . . 61.23 106.327 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.62 -178.19 17.55 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 120.095 1.316 . . . . 52.4 111.63 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.03 10.68 4.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.599 2.36 . . . . 65.51 111.344 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mp -54.27 144.94 38.48 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 125.487 1.515 . . . . 55.03 112.695 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -67.65 157.76 60.28 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.352 2.035 . . . . 74.42 110.26 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -65.57 -43.23 90.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.91 -1.145 . . . . 73.53 107.91 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.64 13.34 0.64 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.352 2.261 . . . . 63.45 112.857 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.506 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 10.3 tp -57.56 144.82 9.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 O-C-N 120.878 -1.139 . . . . 74.45 108.984 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.56 147.5 50.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.45 -1.315 . . . . 72.42 107.45 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.88 71.46 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.253 -0.647 . . . . 35.14 109.253 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.14 -44.28 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 124.048 0.939 . . . . 73.12 110.496 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.99 -38.56 76.06 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.494 -0.558 . . . . 74.54 109.494 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.15 -47.09 86.11 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.876 -0.416 . . . . 73.03 109.876 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -60.88 -47.41 86.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.701 -0.852 . . . . 60.24 108.701 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -58.45 -35.89 72.83 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 115.247 1.573 . . . . 64.05 115.247 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -76.17 -51.84 11.32 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.528 -0.733 . . . . 61.51 110.62 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -81.17 7.32 11.44 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.906 1.076 . . . . 73.53 113.906 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -57.0 -27.12 61.31 Favored 'General case' 0 CA--C 1.527 0.094 0 O-C-N 120.586 -1.321 . . . . 72.45 113.602 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -87.27 -16.65 34.57 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.379 0.672 . . . . 74.33 112.038 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.5 -13.98 18.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.132 0.973 . . . . 73.25 111.701 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m 49.15 73.53 0.98 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 125.921 1.688 . . . . 75.34 114.569 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.83 158.32 54.39 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.919 1.746 . . . . 74.43 110.543 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -89.39 -41.57 12.03 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.784 0.834 . . . . 75.42 109.029 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -137.31 153.56 50.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.711 1.204 . . . . 51.02 109.814 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.3 mt -143.77 121.05 5.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.358 1.463 . . . . 43.25 108.215 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 104.24 6.67 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 125.519 1.528 . . . . 73.11 108.096 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.39 116.11 28.08 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.084 1.354 . . . . 74.23 107.931 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 46.5 mtt-85 -109.46 85.5 2.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.96 -1.496 . . . . 74.3 106.96 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.14 -22.5 60.99 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.706 -0.679 . . . . 71.43 111.508 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -51.58 -29.59 17.86 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.709 2.404 . . . . 73.21 112.286 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -132.88 9.78 4.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.202 1.401 . . . . 53.22 110.335 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.93 48.28 86.83 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.506 -1.037 . . . . 42.45 110.506 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.3 pt -136.76 167.39 23.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.368 1.467 . . . . 63.23 110.718 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.18 155.69 38.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.563 1.145 . . . . 50.23 109.569 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -125.68 125.73 43.53 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.038 1.335 . . . . 73.42 108.185 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.57 112.06 18.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.156 -1.053 . . . . 62.15 108.156 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -91.25 156.07 18.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.847 -1.538 . . . . 72.11 106.847 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -144.09 148.65 35.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.2 -1.408 . . . . 74.41 107.2 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -101.58 111.05 23.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.244 0.929 . . . . 73.43 110.897 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.08 -24.25 62.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.556 0.742 . . . . 44.52 111.242 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.35 -28.4 62.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.008 0.822 . . . . 72.04 110.46 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -64.21 -29.09 70.21 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 124.66 1.184 . . . . 74.24 112.251 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -158.45 86.13 0.86 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.12 -1.067 . . . . 75.32 108.12 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -48.35 -36.34 14.28 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.75 1.759 . . . . 72.44 115.75 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.62 -17.21 14.31 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.627 1.103 . . . . 61.31 111.896 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.1 -26.7 43.4 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 118.196 -1.335 . . . . 74.02 111.71 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.31 -39.9 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.217 1.509 . . . . 72.25 110.689 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.68 -58.14 9.71 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.099 -1.074 . . . . 61.11 108.099 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -57.32 -40.17 77.36 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.034 -1.041 . . . . 75.32 111.253 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -58.53 -41.06 84.65 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.101 -1.074 . . . . 74.13 108.101 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 9.0 mtm -66.85 -50.15 63.45 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 117.972 -1.014 . . . . 50.15 108.292 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -51.62 -48.87 63.11 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.54 1.136 . . . . 63.51 110.169 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.12 -31.2 49.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.665 1.586 . . . . 71.34 111.148 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.62 -38.48 21.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.931 0.787 . . . . 44.04 109.2 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.4 mt -67.17 -31.06 71.23 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.338 1.055 . . . . 64.22 110.268 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.81 -12.76 38.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.938 0.895 . . . . 75.54 110.559 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -89.79 4.21 50.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.805 1.242 . . . . 63.34 111.436 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -68.16 120.56 14.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.608 -1.997 . . . . 73.24 105.608 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.39 9.01 63.68 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.028 -1.429 . . . . 60.35 113.245 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 p -68.04 144.17 55.22 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 120.065 1.933 . . . . 71.41 109.912 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.8 mt -93.19 107.4 19.21 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 102.187 -3.264 . . . . 63.34 102.187 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.19 113.93 27.01 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 104.64 -2.355 . . . . 62.52 104.64 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER 51.76 49.34 21.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.922 0.889 . . . . 73.0 109.325 -178.34 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 60.51 32.22 20.44 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 127.442 2.297 . . . . 73.14 114.083 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -130.72 118.04 20.31 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.898 0.879 . . . . 74.24 110.195 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -70.06 100.88 1.7 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.822 1.249 . . . . 72.42 108.136 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.1 pt -92.78 165.87 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.277 -0.889 . . . . 63.02 109.517 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.83 156.39 39.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.541 1.136 . . . . 65.32 111.334 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.21 149.22 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.453 1.501 . . . . 52.35 110.631 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -164.33 173.63 12.02 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.939 1.296 . . . . 71.32 111.138 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.63 147.72 23.11 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.294 1.437 . . . . 73.02 109.733 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t -147.77 82.83 1.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.137 0.575 . . . . 74.21 110.523 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -157.34 164.55 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.844 -1.539 . . . . 64.41 106.844 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.73 101.28 0.21 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-N 119.424 1.011 . . . . 62.55 112.384 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.816 0 N-CA-C 110.147 -1.181 . . . . 70.13 110.147 178.792 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 N-CA-C 109.987 -1.245 . . . . 64.53 109.987 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -70.12 -9.02 54.19 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.153 1.538 . . . . 64.43 115.153 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.43 104.54 10.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 75.42 112.169 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -97.74 152.71 18.85 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 128.577 2.751 . . . . 74.03 109.124 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 79' ' ' THR . 3.0 mp -135.1 147.06 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.748 1.619 . . . . 70.32 109.404 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.2 t -113.37 131.08 66.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.297 -1.742 . . . . 71.15 106.297 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -91.48 108.98 20.27 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.422 1.889 . . . . 70.11 106.428 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 11' ' ' LEU . 11.6 t -115.83 126.47 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.01 -2.218 . . . . 63.5 105.01 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.26 -179.88 16.88 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 120.214 1.37 . . . . 53.11 112.461 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.84 19.44 5.83 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.03 1.732 . . . . 61.53 111.626 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 8' ' ' VAL . 10.1 mp -60.91 147.91 84.53 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.918 0.887 . . . . 64.45 110.681 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.76 156.98 58.61 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.907 3.071 . . . . 72.12 114.526 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.47 -27.74 68.79 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.642 1.177 . . . . 65.22 112.118 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.65 20.54 18.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.597 1.159 . . . . 74.53 112.536 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.533 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 9.7 tp -55.27 143.16 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 O-C-N 121.005 -1.059 . . . . 72.0 110.852 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 p -128.76 154.56 46.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.61 1.164 . . . . 72.22 109.736 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.0 -30.48 70.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.315 1.046 . . . . 74.22 109.085 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.95 -48.68 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.714 1.206 . . . . 73.42 109.424 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' HG3' ' HE2' ' A' ' 70' ' ' LYS . 4.1 mm-40 -69.59 -29.3 66.81 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.518 0.727 . . . . 73.4 110.54 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -68.97 -51.27 41.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.06 -1.089 . . . . 74.21 108.06 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -58.75 -45.56 89.43 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 107.946 -1.131 . . . . 73.2 107.946 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -56.08 -48.0 76.92 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.517 1.527 . . . . 72.43 113.629 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -56.34 15.66 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 122.292 1.044 . . . . 74.43 111.454 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -79.68 8.55 6.4 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.481 1.512 . . . . 75.34 114.414 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -56.04 -39.78 72.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.94 -1.1 . . . . 65.31 110.412 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.21 -15.51 57.94 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.982 0.734 . . . . 72.44 112.982 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 p -102.16 -1.49 31.29 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.9 -1.125 . . . . 73.23 111.197 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.0 t 37.32 79.78 0.3 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 127.552 2.341 . . . . 71.15 115.066 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.08 156.57 55.65 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.595 1.53 . . . . 64.04 109.616 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.47 -49.2 8.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.799 -1.556 . . . . 74.43 106.799 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -136.71 154.37 50.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.174 0.99 . . . . 72.53 110.007 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -136.09 133.04 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.372 1.869 . . . . 74.33 109.577 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -142.37 107.95 5.08 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 127.189 2.196 . . . . 63.34 109.5 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -96.41 122.43 39.29 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.649 -1.241 . . . . 63.13 107.649 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -110.29 86.01 2.22 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.948 1.699 . . . . 75.32 106.722 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.65 -32.66 63.39 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.966 0.906 . . . . 71.43 112.333 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -56.78 -19.01 14.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.355 1.462 . . . . 54.34 113.232 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -132.16 -1.31 3.65 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.146 1.378 . . . . 71.44 110.569 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.69 38.79 96.48 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.578 1.085 . . . . 72.11 110.934 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -127.8 163.45 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.19 1.396 . . . . 72.11 109.88 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.61 155.32 47.51 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.04 1.336 . . . . 71.51 109.332 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.76 104.36 9.25 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.18 -1.785 . . . . 71.13 106.18 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.22 111.65 24.14 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 105.158 -2.164 . . . . 51.3 105.158 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.62 157.91 17.23 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.62 0.768 . . . . 75.2 109.494 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -146.19 133.41 20.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.6 1.56 . . . . 72.13 107.304 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -101.73 122.63 44.28 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 105.013 -2.217 . . . . 62.14 105.013 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.63 -23.48 62.55 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.611 1.564 . . . . 63.21 111.261 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -83.65 -18.71 37.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.964 0.506 . . . . 65.55 109.912 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -69.0 -19.11 64.13 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.3 -0.857 . . . . 73.41 111.372 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -168.42 85.04 0.18 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.86 1.664 . . . . 72.21 106.621 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -32.73 6.5 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.821 1.648 . . . . 74.45 113.666 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.3 p -107.57 -20.23 13.3 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.187 0.903 . . . . 64.34 112.806 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.38 -18.03 53.78 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-O 117.677 -1.624 . . . . 61.31 114.494 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.1 tp -50.93 -36.7 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 119.645 1.723 . . . . 61.32 109.13 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -61.26 -61.72 2.35 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.982 2.513 . . . . 74.0 110.653 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.87 -35.45 76.63 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.213 -0.929 . . . . 75.41 109.724 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -60.81 -49.22 78.35 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 108.074 -1.084 . . . . 75.12 108.074 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.4 mtt -57.67 -50.54 72.85 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 124.647 1.179 . . . . 54.44 109.888 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -56.99 -44.62 82.92 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.272 1.029 . . . . 74.2 111.773 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.5 mt -69.85 -34.5 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 108.951 -0.759 . . . . 73.11 108.951 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.82 79.76 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.508 -1.293 . . . . 61.13 107.508 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.4 mt -58.65 -32.24 68.9 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.321 1.048 . . . . 62.23 111.3 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 46.4 mt -66.74 -9.02 32.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.283 -0.865 . . . . 72.12 112.258 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -86.16 -2.48 58.4 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.276 1.398 . . . . 72.24 111.49 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 112.23 2.78 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.788 1.235 . . . . 75.3 108.036 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.11 10.27 59.86 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.404 1.002 . . . . 64.4 114.284 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.3 p -75.1 143.23 43.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.573 1.687 . . . . 65.03 109.591 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.14 108.97 19.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 106.861 -1.533 . . . . 75.04 106.861 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mt -110.38 119.72 40.12 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 105.337 -2.097 . . . . 71.24 105.337 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 33.1 mttt 45.95 49.59 11.87 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.011 0.91 . . . . 74.11 110.528 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 63.29 16.45 9.47 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.92 2.088 . . . . 70.11 116.348 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -119.79 126.77 51.82 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.123 1.369 . . . . 72.31 108.185 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -79.18 106.93 11.57 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.354 -0.239 . . . . 73.31 110.354 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.42 169.89 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 123.543 0.737 . . . . 70.34 111.7 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -128.25 158.75 37.3 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.883 2.073 . . . . 64.12 108.878 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.0 t -142.79 127.41 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.676 1.19 . . . . 64.33 108.784 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -144.0 173.29 11.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.779 1.232 . . . . 74.24 109.361 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.85 151.86 21.55 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.221 1.009 . . . . 75.21 110.308 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.438 HG23 ' HB ' ' A' ' 5' ' ' ILE . 6.9 t -153.54 82.42 1.17 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 106.986 -1.487 . . . . 71.14 106.986 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.5 p -167.98 171.05 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.273 -1.38 . . . . 71.51 107.273 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.27 -111.17 0.38 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 109.425 -1.47 . . . . 75.14 109.425 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 N-CA-C 108.209 -1.956 . . . . 75.24 108.209 -179.856 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.673 0 N-CA-C 111.82 -0.512 . . . . 72.53 111.82 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -130.82 48.87 2.37 Favored 'General case' 0 N--CA 1.46 0.054 0 C-N-CA 125.19 1.396 . . . . 72.04 113.193 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -151.55 167.58 27.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 120.828 -1.17 . . . . 71.2 108.584 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -130.77 165.53 22.75 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.081 -1.822 . . . . 63.02 106.081 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.3 mt -130.56 146.41 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 109.001 -0.74 . . . . 72.22 109.001 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.3 131.93 63.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.144 -1.428 . . . . 65.43 107.144 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -89.93 115.41 27.22 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 105.421 -2.066 . . . . 74.25 105.421 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -124.46 128.67 73.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.425 -2.065 . . . . 63.41 105.425 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.406 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -140.3 -179.93 18.45 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 119.233 0.924 . . . . 71.54 111.62 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.418 ' HB3' ' HA ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER 71.83 18.61 5.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.281 1.832 . . . . 73.31 111.097 -178.665 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.59 153.21 62.99 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 124.663 1.185 . . . . 62.52 113.042 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HG3' ' HB2' ' A' ' 70' ' ' LYS . 10.8 Cg_endo -64.33 167.88 13.85 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.127 2.551 . . . . 45.1 111.64 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -75.34 -41.66 56.17 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 121.716 -0.615 . . . . 72.04 109.938 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.56 19.77 4.37 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.591 0.96 . . . . 64.31 113.591 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.536 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.7 tp -53.47 140.73 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 121.289 -0.882 . . . . 64.25 109.547 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -127.81 150.58 49.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.643 1.177 . . . . 72.25 109.106 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.4 -28.46 69.8 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.579 -0.7 . . . . 71.02 111.069 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -43.1 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.793 -0.818 . . . . 75.21 108.793 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -63.96 -45.27 89.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.682 0.793 . . . . 73.22 109.21 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.89 -48.81 80.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.065 -0.493 . . . . 75.22 110.113 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -61.28 -36.63 80.58 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 118.894 0.77 . . . . 61.34 109.784 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.52 -40.02 77.2 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.813 0.733 . . . . 73.41 111.843 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.532 ' ND1' HD21 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.81 -37.99 70.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.109 0.868 . . . . 65.34 111.316 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -94.61 6.2 49.55 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.459 -0.776 . . . . 74.24 112.264 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -54.84 -39.34 68.47 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.958 1.303 . . . . 74.3 112.531 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -71.17 -35.85 71.79 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.379 -0.825 . . . . 64.23 110.639 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -74.69 -24.14 58.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.636 0.774 . . . . 72.32 112.859 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.9 m 63.74 69.54 0.77 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 116.284 1.957 . . . . 73.51 116.284 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.51 159.6 52.97 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.813 2.342 . . . . 71.31 109.896 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.28 -53.99 5.11 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.91 -1.885 . . . . 74.31 105.91 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -143.92 161.53 38.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.424 1.49 . . . . 71.31 109.406 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.12 140.5 42.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 126.039 1.736 . . . . 53.0 107.151 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -133.16 103.93 6.25 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 107.352 -1.351 . . . . 73.24 107.352 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -87.71 112.57 22.52 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.882 0.873 . . . . 72.11 109.157 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -101.24 87.43 3.23 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.557 -1.646 . . . . 72.35 106.557 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.6 -28.8 61.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.634 1.174 . . . . 73.25 112.687 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -52.61 -38.89 61.01 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.967 2.107 . . . . 71.21 114.064 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -118.88 -6.45 10.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 118.219 -0.896 . . . . 74.41 111.956 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.67 48.25 29.67 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.728 -1.749 . . . . 62.11 108.728 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.406 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.5 pt -137.24 156.13 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 126.233 1.813 . . . . 73.22 108.034 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.4 126.97 12.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.964 -0.754 . . . . 62.3 108.964 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -90.11 135.99 33.32 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.49 -1.3 . . . . 74.45 107.49 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.91 123.99 39.82 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.171 -1.788 . . . . 62.31 106.171 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -95.26 143.44 26.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.312 1.445 . . . . 73.42 108.214 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -135.77 106.85 6.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.052 -1.462 . . . . 73.4 107.052 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.68 116.55 8.51 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.979 0.911 . . . . 35.25 110.538 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.01 -31.23 61.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.608 1.963 . . . . 64.2 112.164 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.02 -22.34 63.11 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.098 0.559 . . . . 65.54 109.845 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -60.7 -35.92 77.52 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 108.964 -0.754 . . . . 74.33 108.964 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -162.22 96.29 0.97 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.042 -0.725 . . . . 62.0 109.042 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -55.55 -29.83 59.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 117.81 -1.09 . . . . 74.35 113.068 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.253 29.9 p -110.74 7.5 22.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.947 0.794 . . . . 74.51 112.738 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.41 -20.71 4.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.484 1.516 . . . . 70.4 112.27 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.3 tp -54.55 -39.93 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 125.048 1.339 . . . . 64.32 111.853 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -58.05 9.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.227 -0.657 . . . . 64.33 109.227 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -57.54 -32.61 67.26 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.52 -0.738 . . . . 72.23 111.551 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -64.42 -51.18 64.49 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.179 -1.415 . . . . 73.04 107.179 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.6 mtm -66.27 -30.59 71.05 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.753 0.821 . . . . 63.02 112.429 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.02 -39.73 90.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.691 1.132 . . . . 73.1 108.884 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.6 mt -66.03 -39.16 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.784 -1.191 . . . . 74.23 107.784 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.38 95.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.368 -0.975 . . . . 74.04 108.368 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.1 mt -63.13 -31.08 72.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.304 0.502 . . . . 65.14 111.264 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.56 -6.95 8.58 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.725 1.009 . . . . 72.21 113.725 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -93.45 -0.56 56.39 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.732 0.697 . . . . 75.11 111.029 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.65 112.78 2.14 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.718 1.607 . . . . 71.01 109.833 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.69 5.55 61.35 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.481 -1.177 . . . . 61.13 113.657 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.3 p -66.79 147.69 52.92 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.988 1.894 . . . . 71.31 109.486 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.41 107.92 19.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.498 -2.038 . . . . 64.35 105.498 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.532 HD21 ' ND1' ' A' ' 23' ' ' HIS . 6.2 mt -107.19 126.07 51.92 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 105.331 -2.1 . . . . 74.32 105.331 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 18.6 mttt 42.1 49.84 4.3 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.486 1.039 . . . . 72.2 111.345 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 64.04 21.85 12.73 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.356 2.263 . . . . 74.23 115.235 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -124.87 126.37 45.45 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.313 -1.492 . . . . 62.35 110.986 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 tptt -74.75 109.46 8.24 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.567 -1.642 . . . . 50.25 106.567 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 1.9 pp -92.8 170.02 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.009 0.924 . . . . 64.4 111.103 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -127.57 158.13 38.3 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.881 1.272 . . . . 71.41 109.674 178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.4 t -141.52 132.38 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.476 -1.675 . . . . 72.32 106.476 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -146.76 163.02 37.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.827 1.251 . . . . 72.41 109.021 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.52 152.17 28.81 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.265 1.026 . . . . 74.13 109.638 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.57 143.85 29.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.065 0.946 . . . . 71.52 109.331 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.4 t 68.7 -49.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.3 2.24 . . . . 64.33 113.562 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.98 13.42 60.52 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.001 1.762 . . . . 72.23 113.558 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.829 0 N-CA-C 108.592 -1.803 . . . . 73.33 108.592 178.883 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 112.068 -0.413 . . . . 71.25 112.068 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -141.74 37.5 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.78 -1.563 . . . . 55.02 106.78 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.1 ptt85 -113.77 148.94 35.63 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.066 -1.021 . . . . 64.24 110.932 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -113.55 163.15 15.3 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 104.775 -2.305 . . . . 73.34 104.775 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mt -132.24 149.26 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.618 -1.252 . . . . 62.15 107.618 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.8 t -120.01 124.03 71.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.365 -1.717 . . . . 73.12 106.365 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -88.3 136.29 33.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.837 -1.912 . . . . 73.33 105.837 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 11' ' ' LEU . 11.0 t -136.7 129.14 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.244 -2.132 . . . . 63.21 105.244 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.74 -177.97 15.63 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 120.18 1.354 . . . . 74.25 113.374 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.93 14.37 5.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.495 2.318 . . . . 45.02 110.11 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.46 HD11 HG12 ' A' ' 8' ' ' VAL . 10.7 mp -58.39 142.03 82.37 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.746 1.219 . . . . 70.15 111.802 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.28 156.98 60.19 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.11 2.54 . . . . 62.12 111.071 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -68.3 -35.01 77.19 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.498 -0.751 . . . . 74.34 109.172 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.34 8.98 5.17 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.712 1.605 . . . . 74.03 113.392 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.435 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 9.6 tp -51.13 145.71 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.952 1.301 . . . . 71.43 112.678 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.59 150.41 50.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.511 1.124 . . . . 74.53 110.221 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.0 72.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.64 1.176 . . . . 74.12 109.969 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 t -61.41 -41.26 89.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.647 0.779 . . . . 64.23 110.874 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -70.89 -39.03 73.05 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.97 -0.752 . . . . 74.14 108.97 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.33 -51.5 65.72 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.232 1.013 . . . . 74.43 110.674 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -61.19 -42.78 99.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.063 0.945 . . . . 42.35 109.267 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -64.5 -52.28 58.63 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.334 1.054 . . . . 44.25 113.023 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -48.97 78.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.911 0.778 . . . . 75.44 111.749 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -85.81 1.84 48.07 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 113.857 1.058 . . . . 73.04 113.857 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -47.12 70.24 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 120.083 1.31 . . . . 73.34 111.477 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -60.68 -34.11 73.84 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.133 0.424 . . . . 65.25 111.696 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 p -83.86 -10.48 57.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.883 0.873 . . . . 64.01 111.597 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 m 42.78 68.78 2.61 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 127.057 2.143 . . . . 60.14 113.953 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -64.07 158.39 48.13 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.866 2.377 . . . . 75.51 109.527 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.94 -36.81 13.9 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.032 0.933 . . . . 71.52 108.862 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -127.67 155.74 43.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.901 0.881 . . . . 44.22 111.087 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 75.4 mt -144.74 115.5 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.797 -1.557 . . . . 74.15 106.797 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 104.64 5.57 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.475 1.51 . . . . 75.14 108.407 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.04 119.94 30.82 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.705 1.202 . . . . 73.05 108.285 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 -109.65 84.19 1.88 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.469 -1.678 . . . . 75.02 106.469 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.29 -29.27 65.71 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.343 -0.836 . . . . 34.24 111.369 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -54.31 -26.99 32.57 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.834 1.05 . . . . 62.02 113.834 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.3 mmtt -127.38 9.04 6.59 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.886 0.875 . . . . 65.45 111.262 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.98 48.22 80.99 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.982 -1.247 . . . . 63.14 109.982 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.38 171.29 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 C-N-CA 124.821 1.248 . . . . 71.01 109.675 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.17 168.77 20.82 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.813 1.245 . . . . 52.14 108.46 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -134.82 137.08 43.0 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 104.974 -2.232 . . . . 74.51 104.974 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -137.19 116.29 12.49 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 105.984 -1.858 . . . . 74.13 105.984 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.05 151.33 19.59 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.691 -1.596 . . . . 53.41 106.691 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -141.43 111.83 6.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.069 -1.826 . . . . 70.33 106.069 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.38 122.17 28.56 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.831 0.852 . . . . 65.23 111.183 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.27 93.91 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.496 1.118 . . . . 63.03 111.95 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.25 -28.9 70.03 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.961 -0.755 . . . . 72.31 108.961 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.71 -23.77 66.35 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 117.448 -1.263 . . . . 54.45 112.113 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -163.81 90.4 0.61 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.715 1.606 . . . . 55.11 107.837 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 -56.39 -16.39 5.63 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.513 1.525 . . . . 74.41 115.086 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 m -122.7 -19.44 6.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 120.038 1.29 . . . . 52.32 112.413 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.51 -14.62 43.51 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 117.245 -1.864 . . . . 55.32 114.883 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -50.17 -44.51 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 120.491 2.146 . . . . 73.43 111.572 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -62.39 -58.16 8.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.961 0.904 . . . . 72.04 110.472 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -59.2 -31.2 68.81 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.516 -1.365 . . . . 74.31 111.054 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -62.53 -41.11 98.65 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.519 -1.289 . . . . 64.24 107.519 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 12.1 mtm -65.8 -42.83 90.23 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.158 -1.053 . . . . 54.12 108.158 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -54.13 -49.78 68.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.524 1.056 . . . . 54.03 110.375 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -61.28 -44.85 99.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.299 1.44 . . . . 65.35 109.481 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.83 -42.0 95.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.374 0.534 . . . . 71.45 109.983 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.19 -29.9 69.7 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.132 0.973 . . . . 64.22 111.428 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.19 -13.31 57.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.772 -0.632 . . . . 61.0 109.895 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -85.49 2.17 45.8 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.979 0.809 . . . . 74.21 111.079 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -67.11 112.07 4.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.137 -1.602 . . . . 71.11 108.519 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.47 10.47 53.61 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.646 1.117 . . . . 73.51 113.563 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.9 p -68.77 141.01 55.33 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.773 1.786 . . . . 62.41 110.214 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.5 mt -87.41 110.68 20.44 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 101.938 -3.356 . . . . 70.15 101.938 176.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -115.41 121.49 42.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.587 1.555 . . . . 71.41 108.422 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 5.9 mtpm? 50.17 44.57 26.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.011 0.924 . . . . 74.54 112.761 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 67.67 24.27 8.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.106 2.162 . . . . 74.44 112.315 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -140.19 126.61 20.12 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.638 1.575 . . . . 55.21 110.302 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -75.17 143.54 43.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.475 -1.676 . . . . 75.51 106.475 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.6 pt -128.47 162.64 34.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.002 0.921 . . . . 64.45 109.492 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -120.43 159.02 25.97 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 125.368 1.467 . . . . 75.32 111.694 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.6 t -136.0 148.06 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 107.896 -1.15 . . . . 65.54 107.896 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -161.71 161.56 29.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.868 1.667 . . . . 74.3 108.771 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.5 152.22 23.35 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.626 1.17 . . . . 63.34 113.214 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -148.57 129.42 14.28 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.302 1.441 . . . . 62.23 108.34 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.1 t 64.54 95.24 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 126.454 1.902 . . . . 74.14 111.686 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.25 70.78 0.11 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 108.363 -1.895 . . . . 51.23 108.363 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.458 0 N-CA-C 109.037 -1.625 . . . . 73.12 109.037 179.323 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.896 0 CA-C-O 121.741 0.634 . . . . 75.34 111.638 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.86 22.54 7.42 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.501 1.92 . . . . 71.35 108.701 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.34 144.84 49.89 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 106.35 -1.722 . . . . 72.54 106.35 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -127.92 162.9 25.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.508 -1.293 . . . . 75.54 107.508 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 79' ' ' THR . 5.0 mt -135.17 144.09 35.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.874 -1.898 . . . . 53.54 105.874 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.3 t -118.99 128.82 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 126.391 1.876 . . . . 41.21 106.127 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 40' ' ' ILE . 53.7 t80 -101.21 139.14 37.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.25 -2.129 . . . . 75.12 105.25 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.56 127.76 31.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 104.014 -2.587 . . . . 74.34 104.014 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.511 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -132.38 179.54 17.14 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 120.078 1.308 . . . . 55.44 112.634 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.17 17.77 3.97 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.194 2.198 . . . . 54.12 110.302 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 mp -55.03 148.63 27.87 Favored Pre-proline 0 C--O 1.239 0.524 0 C-N-CA 124.929 1.292 . . . . 73.1 111.95 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.28 153.61 75.69 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.956 3.104 . . . . 75.32 112.239 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -65.38 -34.03 77.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 118.508 -0.758 . . . . 74.04 109.492 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -92.65 21.06 5.76 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.641 1.176 . . . . 75.31 112.646 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.557 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 10.3 tp -52.36 138.92 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 121.256 -0.903 . . . . 52.24 109.951 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 p -125.38 150.77 46.91 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.48 -0.933 . . . . 73.54 108.48 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.01 -26.24 68.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 118.299 -0.858 . . . . 65.32 110.133 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.6 p -65.09 -41.17 91.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 119.697 1.135 . . . . 72.11 108.682 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.553 ' HG3' ' HE2' ' A' ' 70' ' ' LYS . 15.8 mm-40 -68.11 -45.27 74.14 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.346 -0.983 . . . . 73.22 108.346 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.1 mt -59.71 -47.65 84.79 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.494 0.588 . . . . 74.11 111.086 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -61.0 -38.01 84.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.56 0.744 . . . . 72.14 109.987 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -74.44 -54.35 7.76 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.364 1.066 . . . . 71.13 113.796 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -34.6 70.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.681 0.993 . . . . 64.43 113.681 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -97.4 3.71 50.88 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.806 0.842 . . . . 70.11 112.58 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -60.72 -28.96 69.06 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.845 -1.159 . . . . 70.0 109.918 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -73.67 -17.57 61.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.093 0.957 . . . . 72.34 111.058 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 p -113.84 -5.84 13.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.439 1.895 . . . . 53.13 113.581 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.8 t 41.68 77.33 0.44 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 126.503 1.921 . . . . 75.05 114.973 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.57 165.99 30.08 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 121.931 1.754 . . . . 72.42 109.988 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -91.2 -32.89 15.61 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 120.742 -1.224 . . . . 72.24 109.501 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -143.54 153.26 42.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.169 1.388 . . . . 71.23 108.187 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.4 mt -133.73 105.12 6.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.788 -1.56 . . . . 71.44 106.788 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.1 ttt-85 -122.62 103.94 9.01 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.875 -0.787 . . . . 75.41 108.875 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -83.15 127.38 33.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.107 -1.812 . . . . 73.32 106.107 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 85.54 2.37 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.582 -2.007 . . . . 75.21 105.582 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.53 -27.55 49.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.918 0.887 . . . . 72.33 113.003 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -52.05 -30.09 24.12 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.68 1.992 . . . . 71.01 114.314 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -132.23 11.96 4.61 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.043 1.337 . . . . 54.15 111.418 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.77 52.45 50.68 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.345 -1.502 . . . . 25.11 109.345 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.511 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.8 pt -139.84 168.07 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.613 1.165 . . . . 65.11 110.594 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.99 154.29 41.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.649 1.179 . . . . 62.21 108.014 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -124.45 123.32 39.88 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.118 -1.808 . . . . 62.2 106.118 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mp -117.77 113.81 22.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.861 -1.533 . . . . 75.2 106.861 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -85.18 152.81 23.08 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.335 -1.357 . . . . 61.22 107.335 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -141.1 136.86 32.37 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.446 1.098 . . . . 74.24 108.709 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -97.98 108.51 21.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.394 1.478 . . . . 75.23 112.616 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.4 -22.6 51.34 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.483 0.713 . . . . 64.22 112.543 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.93 -37.09 35.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 112.096 0.406 . . . . 74.33 112.096 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -68.87 -55.47 10.99 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.186 1.394 . . . . 73.01 111.036 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.57 71.91 0.81 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 122.011 0.91 . . . . 60.41 110.281 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -48.85 -38.49 22.55 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.685 1.194 . . . . 70.31 112.718 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.8 p -104.99 8.0 34.29 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.761 1.022 . . . . 74.44 113.761 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.94 -23.14 2.54 Favored Glycine 0 C--O 1.221 -0.676 0 CA-C-O 118.038 -1.423 . . . . 61.25 113.604 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.1 tp -49.36 -49.57 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 120.244 2.022 . . . . 73.2 113.127 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -64.07 -55.46 22.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.841 -0.8 . . . . 75.45 108.841 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -49.49 -53.2 24.5 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.171 0.896 . . . . 55.25 109.417 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -51.91 -54.86 24.51 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.14 1.776 . . . . 74.31 110.337 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 44.0 mtm -66.32 -28.32 68.59 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 118.908 0.776 . . . . 72.34 111.218 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -65.06 -47.51 77.05 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 120.074 -1.641 . . . . 73.31 109.798 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.5 mt -65.29 -31.65 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.284 1.833 . . . . 72.21 108.063 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.23 -41.13 58.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.674 -0.862 . . . . 65.13 108.674 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -60.61 -37.06 80.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.479 0.712 . . . . 73.23 110.311 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.6 mt -64.42 -6.08 6.52 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.236 1.414 . . . . 72.22 113.616 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -92.39 6.23 47.71 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.491 1.041 . . . . 73.53 111.234 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -72.25 114.89 10.86 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.727 1.211 . . . . 74.34 108.546 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.48 5.09 61.98 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-O 118.005 -1.442 . . . . 21.52 114.445 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.9 p -72.01 154.01 41.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.997 1.899 . . . . 71.03 109.422 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 mt -100.49 107.54 19.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.588 -1.634 . . . . 64.13 106.588 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.67 121.92 44.86 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.622 -2.362 . . . . 74.22 104.622 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 18.8 mttm 48.1 47.33 19.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.822 0.849 . . . . 61.03 110.971 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 58.0 26.97 14.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.846 1.658 . . . . 62.14 114.186 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -126.47 122.31 34.88 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.728 -1.212 . . . . 74.32 107.728 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -81.62 102.55 10.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.298 -1.371 . . . . 64.14 107.298 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.6 pt -85.54 169.64 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 124.282 1.033 . . . . 73.21 110.898 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.62 155.27 45.23 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 125.888 1.675 . . . . 73.53 109.467 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.62 148.91 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.339 1.055 . . . . 54.11 108.479 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.8 172.14 13.34 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.571 1.949 . . . . 64.42 109.368 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.55 153.42 18.18 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.067 1.747 . . . . 55.1 107.366 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.443 HG23 ' HB ' ' A' ' 5' ' ' ILE . 9.2 t -143.27 82.33 1.74 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.947 -0.76 . . . . 64.54 108.947 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 p -167.89 -44.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.444 0.698 . . . . 65.01 111.854 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.46 18.03 0.07 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 114.463 0.545 . . . . 54.34 114.463 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.194 0 C-N-CA 129.209 3.29 . . . . 72.22 106.076 -179.702 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.63 0 N-CA-C 110.29 -1.124 . . . . 65.43 110.29 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.12 52.18 0.8 Allowed 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 124.274 1.03 . . . . 70.13 110.186 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.92 163.75 37.95 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.012 -1.055 . . . . 72.41 109.889 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -133.19 165.62 24.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.105 1.362 . . . . 74.41 108.583 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mt -134.45 148.64 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.024 -0.732 . . . . 74.24 109.024 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.33 126.64 74.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 105.942 -1.873 . . . . 73.22 105.942 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -91.04 137.73 32.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.522 1.529 . . . . 63.4 107.688 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 11' ' ' LEU . 11.9 t -138.73 126.09 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.729 -1.582 . . . . 74.42 106.729 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.412 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -136.9 176.76 20.23 Favored Glycine 0 N--CA 1.468 0.774 0 CA-C-N 120.347 1.431 . . . . 32.25 111.628 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.25 19.02 0.77 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.48 2.312 . . . . 75.11 109.585 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.481 HD11 HG12 ' A' ' 8' ' ' VAL . 9.9 mp -63.76 143.25 98.08 Favored Pre-proline 0 C--O 1.235 0.315 0 O-C-N 120.9 -1.125 . . . . 52.03 112.884 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.3 160.74 43.78 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.62 2.88 . . . . 53.34 111.604 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -44.06 93.46 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.784 -0.821 . . . . 74.23 108.784 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.72 9.46 1.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.522 1.929 . . . . 62.31 114.095 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.538 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.5 tp -58.62 139.45 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 O-C-N 120.725 -1.234 . . . . 61.52 109.822 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 150.52 50.11 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.818 0.847 . . . . 64.21 109.75 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.84 -30.73 70.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.076 0.95 . . . . 75.42 110.404 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.67 -43.27 96.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.549 1.14 . . . . 70.3 109.487 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.08 -42.12 85.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.96 -1.126 . . . . 64.41 107.96 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.67 -53.47 55.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.988 1.315 . . . . 74.23 110.454 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -46.9 83.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.688 -1.226 . . . . 72.44 107.688 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -62.58 -42.85 99.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.918 1.081 . . . . 64.12 113.918 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.99 -47.68 67.86 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 120.993 -1.067 . . . . 72.22 110.66 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.33 6.05 28.04 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.25 1.204 . . . . 74.31 114.25 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -51.48 -41.13 60.7 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 125.067 1.347 . . . . 61.3 113.715 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -72.57 -21.93 61.07 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.404 0.547 . . . . 72.41 112.247 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.66 -17.89 22.76 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.218 1.407 . . . . 72.51 110.843 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 m 49.17 74.15 0.87 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.094 1.758 . . . . 61.33 114.412 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HG2' HD11 ' A' ' 32' ' ' ILE . 74.4 Cg_endo -65.87 153.15 79.34 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.116 1.877 . . . . 74.35 109.111 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -91.62 -39.8 11.67 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.996 -1.112 . . . . 65.4 107.996 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -123.46 146.35 48.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.548 1.139 . . . . 65.12 108.867 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.445 HD11 ' HG2' ' A' ' 29' ' ' PRO . 57.3 mt -141.38 107.02 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.982 -1.118 . . . . 74.23 107.982 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.43 104.74 8.07 Favored 'General case' 0 N--CA 1.46 0.055 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.53 118.66 30.78 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.776 2.03 . . . . 74.02 108.191 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.68 87.84 2.73 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.631 1.572 . . . . 75.22 108.432 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.32 -16.89 63.04 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.696 -0.628 . . . . 73.23 109.88 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -51.62 -26.74 9.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.937 2.495 . . . . 74.04 110.797 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -133.23 -1.6 3.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.798 2.439 . . . . 65.33 111.128 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.83 50.75 45.36 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.263 1.411 . . . . 64.32 110.134 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.412 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.3 pt -140.8 167.94 17.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 125.988 1.715 . . . . 63.34 110.827 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.83 149.81 33.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.247 1.819 . . . . 74.0 109.227 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.35 132.98 55.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.691 -1.596 . . . . 71.22 106.691 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.17 110.12 12.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.183 -1.784 . . . . 62.02 106.183 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -96.86 148.49 22.88 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.755 -1.202 . . . . 53.43 107.755 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -143.5 120.97 11.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.401 1.08 . . . . 75.02 109.358 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.38 121.13 22.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.479 0.712 . . . . 70.21 110.541 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.1 -38.76 63.75 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.943 1.697 . . . . 74.22 112.209 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.38 -29.62 70.89 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.594 -0.521 . . . . 71.5 109.594 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -61.7 -19.27 62.19 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.393 1.077 . . . . 74.3 112.489 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.03 90.33 0.44 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.105 1.321 . . . . 70.52 109.619 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -48.85 -38.71 23.15 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 116.125 1.898 . . . . 75.11 116.125 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -114.59 -0.95 13.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 123.337 0.398 . . . . 74.2 111.371 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.04 -28.68 8.05 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.474 1.035 . . . . 71.41 111.438 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.2 tp -54.13 -37.76 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.906 1.353 . . . . 72.33 110.648 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -56.75 18.04 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.148 -0.686 . . . . 74.14 109.148 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -42.78 66.82 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.715 1.206 . . . . 70.42 110.325 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -57.35 -46.73 83.02 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.001 -1.111 . . . . 55.23 108.001 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.3 mtm -66.88 -44.58 80.52 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 117.938 -1.029 . . . . 53.32 110.769 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -52.42 -49.85 63.69 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.315 1.416 . . . . 54.11 110.217 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 64.4 mt -65.92 -43.51 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.722 1.209 . . . . 74.1 109.16 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.14 96.76 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.783 0.719 . . . . 73.34 109.968 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.39 -26.35 68.42 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.007 1.323 . . . . 60.02 111.571 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.56 -8.2 54.97 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.458 -0.776 . . . . 72.41 109.946 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -88.84 9.02 26.21 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.178 -0.915 . . . . 75.32 111.803 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -76.86 118.03 19.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.694 1.588 . . . . 72.42 106.735 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.62 3.02 64.81 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.508 -1.162 . . . . 64.22 115.094 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.1 p -67.97 144.89 54.99 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 120.018 1.909 . . . . 73.4 107.766 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.8 mt -92.87 107.66 19.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 103.936 -2.616 . . . . 74.41 103.936 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.07 115.39 30.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 102.931 -2.988 . . . . 74.23 102.931 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER 48.41 56.96 6.73 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.533 1.159 . . . . 62.22 110.384 -177.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 60.47 13.09 3.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.359 2.264 . . . . 75.34 114.999 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -118.35 120.0 36.31 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.259 1.023 . . . . 74.01 111.469 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -71.63 115.7 11.12 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.872 -1.529 . . . . 50.12 106.872 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.335 16.4 pt -101.39 170.69 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.358 0.526 . . . . 54.43 110.201 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -120.89 151.83 39.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.482 1.113 . . . . 72.04 109.704 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.3 t -137.62 135.19 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.579 1.152 . . . . 65.22 108.45 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.35 152.97 32.73 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.427 1.091 . . . . 71.22 110.574 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 143.62 38.49 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.252 1.021 . . . . 72.25 111.005 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 p -141.2 145.83 36.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.917 1.287 . . . . 61.52 110.218 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.8 t 53.27 86.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 127.437 2.295 . . . . 74.32 112.426 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.46 -10.16 1.94 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-O 118.577 -1.124 . . . . 75.51 113.413 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 N-CA-C 108.732 -1.747 . . . . 72.42 108.732 179.653 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.713 0 N-CA-C 111.096 -0.802 . . . . 51.11 111.096 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.35 40.49 0.28 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.998 1.319 . . . . 71.05 112.799 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -155.71 148.58 24.27 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 120.385 -1.447 . . . . 70.34 110.152 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -115.77 165.04 13.5 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 128.042 2.537 . . . . 75.33 104.391 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.5 mt -134.89 135.75 52.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.534 -0.757 . . . . 73.31 109.091 -177.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.9 t -96.98 145.34 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 104.992 -2.225 . . . . 61.31 104.992 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -113.62 131.73 56.02 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 104.904 -2.258 . . . . 75.11 104.904 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.47 HG12 HD11 ' A' ' 11' ' ' LEU . 21.6 t -135.88 126.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.091 -1.818 . . . . 41.22 106.091 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.22 177.63 18.36 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.052 0.842 . . . . 73.43 112.419 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.0 17.18 2.22 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.58 2.752 . . . . 52.52 110.671 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.47 HD11 HG12 ' A' ' 8' ' ' VAL . 9.7 mp -58.31 144.32 77.82 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 124.91 1.284 . . . . 70.23 111.688 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.19 160.76 43.4 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.362 2.708 . . . . 71.43 112.406 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -67.06 -37.5 84.13 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.422 -0.955 . . . . 75.35 108.422 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.8 13.59 1.64 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.72 1.007 . . . . 43.02 113.72 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.61 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 6.4 tp -63.98 134.78 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 120.451 -1.405 . . . . 70.34 110.452 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . 0.254 1.3 p -128.63 150.05 50.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.456 1.902 . . . . 71.2 107.124 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.37 64.49 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.382 -0.824 . . . . 44.23 112.638 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 p -64.18 -36.54 77.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.462 -0.94 . . . . 75.23 108.462 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -70.35 -43.44 70.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.979 0.912 . . . . 73.24 108.595 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.99 -47.44 84.8 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.232 -0.655 . . . . 74.52 109.232 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -60.03 -38.55 83.03 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.863 0.865 . . . . 74.13 108.797 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -68.85 -41.9 77.85 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.814 1.188 . . . . 65.21 111.076 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -69.99 -35.86 74.72 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.565 -0.709 . . . . 71.53 112.561 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -100.87 6.44 43.72 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.668 0.787 . . . . 74.0 112.405 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -54.27 -43.85 71.37 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.054 1.342 . . . . 73.41 110.747 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -60.79 -32.03 71.38 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.369 1.068 . . . . 73.31 112.123 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 p -94.24 -22.45 18.4 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.686 1.194 . . . . 72.21 111.378 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t 54.4 79.95 0.32 Allowed Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 129.537 3.135 . . . . 65.33 112.396 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.89 166.24 18.92 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.677 2.918 . . . . 64.22 111.484 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -96.65 -38.55 9.89 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.116 0.966 . . . . 72.13 109.429 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -131.82 151.52 51.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.056 1.342 . . . . 54.05 108.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -139.8 105.29 2.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 106.473 -1.676 . . . . 73.23 106.473 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -122.57 104.29 9.26 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.46 -1.311 . . . . 54.24 107.46 178.141 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 15' ' ' ILE . 1.5 tm? -87.01 125.24 33.97 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.63 1.172 . . . . 74.32 108.575 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.17 79.4 1.27 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.16 1.784 . . . . 73.3 107.078 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.01 54.77 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.104 0.962 . . . . 73.22 111.746 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.73 -34.98 29.14 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 126.688 1.995 . . . . 63.32 111.918 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -131.48 14.95 4.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.585 1.154 . . . . 63.11 111.298 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.5 50.23 66.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 124.265 0.936 . . . . 53.33 111.095 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 pt -138.21 170.95 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.235 1.414 . . . . 75.23 109.492 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.74 164.94 34.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.579 1.152 . . . . 61.11 109.094 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -128.69 127.69 42.62 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 105.505 -2.035 . . . . 60.15 105.505 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mp -130.07 106.45 8.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.743 -1.577 . . . . 74.02 106.743 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -96.16 150.14 20.85 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.581 -1.266 . . . . 75.34 107.581 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -136.27 135.28 38.85 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.496 -1.298 . . . . 72.43 107.496 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -79.46 109.61 14.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.323 0.965 . . . . 72.32 110.986 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.17 -24.78 60.6 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.609 1.564 . . . . 73.34 113.668 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.13 -25.93 58.8 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.713 -0.847 . . . . 74.43 108.713 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -60.64 -27.79 68.06 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.913 0.885 . . . . 72.35 111.051 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -161.35 88.48 0.73 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.842 0.746 . . . . 71.43 111.007 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -59.64 -25.41 64.66 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.162 -0.961 . . . . 62.22 112.831 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.0 p -96.95 -12.24 23.62 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.136 0.88 . . . . 63.52 113.181 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.99 -12.24 7.15 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-O 117.753 -1.582 . . . . 60.3 115.5 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 tp -58.0 -37.27 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 120.727 2.263 . . . . 74.33 110.773 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -58.69 -58.55 8.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.672 -1.233 . . . . 53.4 107.672 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -43.19 68.45 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.874 0.761 . . . . 71.22 111.777 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -57.3 -43.8 83.55 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.836 -0.801 . . . . 74.23 108.836 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.2 mtm -64.35 -43.27 95.1 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.985 -0.746 . . . . 75.25 108.985 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.44 -47.58 72.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.142 1.777 . . . . 62.24 111.495 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.11 -37.09 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.263 1.425 . . . . 43.34 107.959 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.06 -37.83 66.67 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.332 0.969 . . . . 75.43 109.44 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 78' ' ' LEU . 32.6 mt -67.59 -28.58 67.89 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.625 0.77 . . . . 60.34 110.914 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.58 -8.53 27.6 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.405 0.682 . . . . 73.14 110.978 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -86.42 3.82 42.15 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.874 0.761 . . . . 60.54 111.203 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -66.97 131.1 45.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 119.688 -1.882 . . . . 75.54 107.845 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.09 8.68 58.88 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 117.976 -1.458 . . . . 74.44 114.579 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 p -70.39 146.82 50.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.883 2.342 . . . . 73.15 108.059 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.0 mt -89.9 108.0 19.45 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.743 -2.317 . . . . 61.05 104.743 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.9 tp -110.04 121.81 46.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.912 -1.885 . . . . 70.03 105.912 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 13.9 mtpp 53.92 38.42 28.73 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.813 0.845 . . . . 62.34 111.296 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 62.61 33.21 15.93 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.225 1.41 . . . . 73.14 112.462 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -140.79 117.87 11.22 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.925 1.69 . . . . 75.22 107.949 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -73.95 148.37 42.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.835 -1.543 . . . . 65.4 106.835 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.0 pt -133.66 169.2 22.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 124.876 1.27 . . . . 61.23 111.236 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -120.86 152.34 38.54 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.077 1.351 . . . . 74.3 111.11 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -135.05 136.5 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.528 1.131 . . . . 75.12 108.507 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -150.84 162.8 40.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.614 1.966 . . . . 73.44 108.521 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -96.73 152.22 18.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.019 1.328 . . . . 72.34 111.589 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.9 p -142.97 161.84 37.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.208 1.403 . . . . 75.33 108.671 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 t 46.01 91.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 128.391 2.676 . . . . 72.21 113.153 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.07 89.91 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.637 -2.185 . . . . 72.35 107.637 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 117.141 -1.921 . . . . 64.33 110.873 179.377 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.364 0 N-CA-C 107.354 -2.299 . . . . 62.34 107.354 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -132.81 44.27 2.88 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.078 1.351 . . . . 62.32 108.314 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.7 ptt85 -147.0 164.22 33.7 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.697 1.199 . . . . 71.31 109.539 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -133.39 165.56 24.55 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.606 2.362 . . . . 75.03 105.877 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.53 136.85 57.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.734 0.778 . . . . 70.31 109.819 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -103.21 118.87 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 104.558 -2.386 . . . . 63.14 104.558 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -90.62 133.15 35.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.222 -1.77 . . . . 75.33 106.222 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 t -138.85 130.93 37.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 118.144 -0.931 . . . . 45.01 108.509 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.81 -179.82 18.57 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 120.022 1.283 . . . . 73.44 112.019 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.48 25.65 2.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.13 2.172 . . . . 71.03 111.598 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.26 149.08 98.19 Favored Pre-proline 0 C--O 1.237 0.398 0 O-C-N 120.877 -1.14 . . . . 74.55 112.474 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.63 168.62 16.17 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.571 3.514 . . . . 70.1 111.612 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -70.31 -46.34 64.43 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.476 -0.935 . . . . 74.02 108.476 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.61 5.03 2.04 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.778 1.631 . . . . 73.12 114.163 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 tp -57.01 130.43 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 121.08 -1.012 . . . . 74.2 109.064 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.69 154.95 45.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.406 1.483 . . . . 71.22 107.788 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.17 -30.28 66.27 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 118.985 -0.531 . . . . 74.3 109.902 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -58.55 -43.96 88.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 118.465 0.575 . . . . 72.03 109.942 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -65.47 -43.73 89.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.169 0.988 . . . . 74.21 109.68 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.8 mt -67.43 -44.69 78.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.911 0.884 . . . . 73.31 111.297 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -56.8 -48.38 78.07 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 107.174 -1.417 . . . . 54.51 107.174 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.93 -40.87 95.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.539 1.136 . . . . 64.15 113.327 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.55 -22.24 57.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 114.377 1.251 . . . . 74.13 114.377 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -108.31 2.86 22.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.821 0.737 . . . . 75.21 111.895 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -52.18 -33.3 40.03 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.464 2.306 . . . . 64.43 113.731 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -82.25 -38.24 24.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.833 0.742 . . . . 64.35 110.046 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -22.6 64.67 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.634 1.173 . . . . 54.3 110.217 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m 53.78 67.27 3.71 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.543 1.137 . . . . 52.2 113.446 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.71 173.38 8.08 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.768 2.979 . . . . 53.2 109.638 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.7 -43.54 4.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.8 -1.185 . . . . 63.13 107.8 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HB3' ' H ' ' A' ' 44' ' ' GLU . 7.0 tp-100 -122.19 154.18 37.81 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.608 1.563 . . . . 71.34 109.648 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -146.7 122.9 3.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.899 -1.889 . . . . 75.34 105.899 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.34 102.95 4.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.441 1.497 . . . . 75.34 109.452 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -80.22 126.65 31.39 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.148 -1.797 . . . . 74.31 106.148 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -118.53 87.44 2.73 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.262 1.425 . . . . 74.33 111.146 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.34 -21.2 61.78 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.996 0.918 . . . . 63.43 111.87 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -54.61 -32.55 58.96 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.267 1.427 . . . . 72.25 111.576 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.3 mmtm -132.85 2.43 3.69 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 114.341 1.237 . . . . 74.01 114.341 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.47 40.38 54.55 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 120.39 1.45 . . . . 44.52 110.106 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 pt -129.53 170.12 19.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.616 1.966 . . . . 75.25 110.625 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.85 120.46 4.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.61 1.964 . . . . 73.15 108.859 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -99.14 150.95 21.52 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 118.615 0.643 . . . . 74.3 109.808 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.9 131.07 24.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.164 -1.051 . . . . 74.31 108.164 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.474 ' H ' ' HB3' ' A' ' 31' ' ' GLN . 59.0 mt-10 -102.04 149.88 23.8 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 104.648 -2.353 . . . . 54.13 104.648 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -135.81 109.34 7.95 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.119 0.968 . . . . 70.33 108.5 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -68.39 110.01 3.92 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.816 1.246 . . . . 73.33 110.718 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.09 -15.23 57.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.569 2.347 . . . . 64.24 112.943 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.56 -39.3 32.12 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.393 -1.706 . . . . 74.24 106.393 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -61.73 -46.07 91.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.401 -0.963 . . . . 61.55 108.401 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.34 73.84 0.87 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.026 0.93 . . . . 62.01 109.556 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -48.21 -34.19 9.75 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.092 1.145 . . . . 63.43 114.092 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 p -121.81 -19.12 6.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 124.05 0.844 . . . . 75.01 111.686 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.08 -16.73 76.05 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.125 -0.984 . . . . 63.54 112.006 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 tp -50.75 -40.22 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.99 1.316 . . . . 63.53 110.914 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -57.51 -61.56 2.41 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.126 1.37 . . . . 63.04 108.439 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -50.98 -50.94 57.33 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.577 1.151 . . . . 62.22 110.095 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -52.85 -52.01 58.81 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.293 0.637 . . . . 70.31 110.776 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 36.4 mtm -66.79 -35.56 80.37 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 123.103 0.561 . . . . 61.51 111.358 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -46.98 87.7 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.863 1.265 . . . . 61.45 109.454 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.7 mt -62.87 -36.35 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.581 -0.896 . . . . 71.42 108.581 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.4 -43.06 70.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.94 -0.763 . . . . 72.12 108.94 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 mt -63.9 -33.15 75.05 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.663 0.785 . . . . 72.31 111.031 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.78 -13.14 41.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.298 0.851 . . . . 73.03 113.298 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -86.53 3.4 44.35 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.896 0.771 . . . . 65.14 111.547 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -59.74 113.98 2.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.931 -1.106 . . . . 72.34 109.414 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.06 12.34 55.25 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 118.371 -1.238 . . . . 71.41 115.385 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.4 p -69.62 149.08 48.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.174 1.987 . . . . 72.11 109.62 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.9 mt -96.43 107.18 19.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.062 -1.829 . . . . 64.32 106.062 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mt -109.92 122.66 48.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.189 -2.152 . . . . 52.24 105.189 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 mtmm 46.43 40.3 7.79 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.328 1.051 . . . . 64.43 110.954 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 67.74 20.38 9.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.627 2.371 . . . . 64.11 114.248 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -120.22 125.96 49.44 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.092 1.357 . . . . 70.4 108.354 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -82.57 112.99 19.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.838 -0.801 . . . . 72.44 108.838 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.0 pp -87.46 171.13 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 124.429 1.092 . . . . 73.12 110.906 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.95 151.27 51.83 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.228 1.411 . . . . 52.32 109.106 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.3 t -134.1 144.24 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.231 1.413 . . . . 63.44 108.31 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -153.54 160.76 42.58 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.467 1.907 . . . . 75.11 108.864 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.34 151.84 22.33 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 120.99 -1.068 . . . . 71.15 108.699 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 p -144.48 140.22 28.77 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.708 -0.849 . . . . 72.24 108.708 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.5 t 50.07 85.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 125.893 1.677 . . . . 74.44 111.826 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.37 79.85 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.887 -0.673 . . . . 62.2 112.721 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 N-CA-C 104.374 -3.49 . . . . 64.3 104.374 178.016 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.894 0 N-CA-C 111.257 -0.737 . . . . 33.42 111.257 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -60.35 5.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.251 1.945 . . . . 74.22 116.251 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -129.9 115.75 17.64 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 121.132 1.787 . . . . 73.41 106.714 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -99.85 164.91 11.82 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.107 0.963 . . . . 72.33 108.546 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.3 mt -134.87 149.01 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.933 1.293 . . . . 72.11 110.965 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.2 t -118.51 134.3 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.802 2.041 . . . . 74.15 105.851 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -100.62 142.21 32.4 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 126.15 1.78 . . . . 74.43 108.826 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.41 133.53 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.21 -1.774 . . . . 73.11 106.21 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -132.57 -179.7 16.5 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 120.385 1.448 . . . . 44.2 111.123 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.88 14.48 9.84 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.526 1.931 . . . . 71.03 112.621 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.35 148.05 9.37 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 124.737 1.215 . . . . 73.45 112.958 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.78 154.34 50.27 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.649 2.899 . . . . 74.22 110.341 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -70.36 -37.56 74.62 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.881 -0.512 . . . . 75.2 109.917 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.59 25.3 3.11 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.336 1.054 . . . . 45.35 111.855 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 8.4 tp -53.84 139.92 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.832 1.253 . . . . 75.11 110.537 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -124.78 148.04 48.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.611 1.164 . . . . 73.44 108.423 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.29 -29.84 70.12 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 118.852 -0.594 . . . . 55.15 111.097 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.66 -37.01 76.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 118.764 0.711 . . . . 61.24 109.708 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -69.17 -44.67 71.76 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.727 -0.842 . . . . 74.42 108.727 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 mt -60.49 -54.71 42.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.342 0.657 . . . . 75.22 110.786 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -59.87 -41.42 91.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.373 -0.602 . . . . 73.21 109.373 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -67.94 -40.53 83.29 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.855 0.687 . . . . 64.21 112.855 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -22.68 65.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 120.047 1.294 . . . . 70.03 113.071 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -112.29 6.07 18.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.056 0.942 . . . . 72.23 111.513 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -41.7 63.04 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.25 1.42 . . . . 74.54 112.264 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -58.17 -54.32 48.31 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.972 -0.751 . . . . 72.22 108.972 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.09 -22.06 66.39 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.653 1.181 . . . . 64.42 112.627 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 t 50.41 78.26 0.41 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.195 2.198 . . . . 63.41 112.418 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.55 168.14 20.66 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.256 2.637 . . . . 72.02 110.577 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -94.68 -31.8 13.65 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.488 1.115 . . . . 65.43 109.961 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.04 161.0 41.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.859 0.863 . . . . 61.23 109.807 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.68 107.13 2.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 104.295 -2.483 . . . . 73.25 104.295 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.5 ttp180 -117.98 103.96 10.43 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.577 -1.268 . . . . 75.53 107.577 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.57 124.78 36.85 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.49 1.516 . . . . 75.41 110.51 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.56 80.12 1.49 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.602 1.961 . . . . 74.23 108.024 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.83 -17.37 56.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.107 0.963 . . . . 72.22 111.216 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.438 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 1.4 m-20 -51.4 -32.8 27.63 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.647 1.979 . . . . 65.14 109.884 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 5.3 mmpt? -126.73 -9.69 6.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.378 1.871 . . . . 64.42 111.351 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.42 36.77 33.2 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.661 -1.376 . . . . 75.13 109.661 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.425 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 36.0 pt -124.47 168.42 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.173 1.389 . . . . 64.32 108.417 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.67 166.3 33.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.569 1.148 . . . . 72.34 109.442 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -135.77 140.82 44.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.562 1.545 . . . . 73.02 108.083 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mp -134.49 123.62 24.25 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.016 -1.475 . . . . 65.12 107.016 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -98.64 156.73 16.67 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.614 -0.513 . . . . 72.23 109.614 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -146.65 119.63 8.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.201 -1.407 . . . . 74.5 107.201 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -83.72 119.14 24.43 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.765 -0.458 . . . . 44.43 109.765 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.35 61.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.991 1.716 . . . . 54.12 111.219 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -70.4 -23.77 62.82 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.86 -1.163 . . . . 73.45 107.86 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -62.18 -32.37 72.99 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-O 118.362 -0.828 . . . . 51.14 110.368 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -168.02 101.52 0.46 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.461 1.504 . . . . 72.32 108.078 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -52.76 -22.62 5.49 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 116.301 1.963 . . . . 74.43 116.301 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p -121.43 -19.36 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 120.115 1.325 . . . . 71.33 110.872 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.9 -30.62 51.33 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-O 118.592 -1.116 . . . . 32.14 110.705 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.1 tp -52.58 -37.65 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.24 1.416 . . . . 72.54 110.061 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.01 -58.05 9.52 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.618 1.167 . . . . 74.44 107.934 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -54.79 -41.29 70.39 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.258 0.623 . . . . 72.42 110.242 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.6 mtt85 -57.95 -50.23 74.09 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-O 118.421 -0.8 . . . . 74.14 110.233 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 10.8 mtm -59.85 -45.49 92.27 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.195 0.452 . . . . 74.03 110.451 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.4 -54.57 45.13 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 122.86 0.464 . . . . 72.24 110.666 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.8 mt -58.1 -36.94 59.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 125.194 1.398 . . . . 73.35 109.596 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.11 -43.97 73.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.733 -0.469 . . . . 63.13 109.733 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.68 -35.66 81.75 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.347 0.659 . . . . 74.33 110.337 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.8 mt -62.47 -2.57 1.1 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.949 1.7 . . . . 71.44 113.646 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -94.45 3.73 54.77 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.675 1.19 . . . . 71.21 110.314 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -65.85 135.08 54.34 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.153 1.781 . . . . 74.21 109.686 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.01 15.53 67.36 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.706 1.622 . . . . 72.12 113.312 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -78.59 155.99 29.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.883 1.342 . . . . 32.34 108.139 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.32 108.0 20.15 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.356 -0.979 . . . . 64.1 108.356 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -112.32 115.59 29.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.631 -1.618 . . . . 73.1 106.631 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 3.8 mtpp 50.2 53.45 12.84 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.027 0.918 . . . . 75.21 111.081 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 55.43 20.44 3.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.303 2.241 . . . . 74.53 114.523 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -122.8 122.77 39.49 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 126.079 1.751 . . . . 63.44 107.837 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -83.14 104.86 13.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.036 -1.098 . . . . 73.42 108.036 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 pt -87.92 169.3 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.234 -0.894 . . . . 45.43 111.289 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -123.87 154.18 40.03 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.435 1.494 . . . . 74.35 110.222 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.2 142.15 42.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.936 -1.505 . . . . 65.43 106.936 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.67 174.78 14.05 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.472 1.909 . . . . 63.1 110.517 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -90.42 149.2 22.35 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.797 1.239 . . . . 75.11 112.422 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p -150.93 150.01 30.31 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.505 -1.665 . . . . 72.21 106.505 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.7 t 64.53 -67.65 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.535 1.934 . . . . 75.31 113.09 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.03 -16.83 73.13 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 127.011 2.243 . . . . 62.24 115.845 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.919 0 N-CA-C 105.906 -2.877 . . . . 42.44 105.906 179.888 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.383 0 N-CA-C 109.435 -1.466 . . . . 71.21 109.435 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -67.55 -3.14 7.9 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 115.898 1.814 . . . . 72.31 115.898 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -120.6 106.24 11.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.964 0.802 . . . . 64.02 111.889 -177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -99.05 159.33 15.04 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 127.738 2.415 . . . . 73.15 110.055 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.17 149.22 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.604 1.162 . . . . 70.11 110.953 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.8 t -116.07 128.8 73.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.752 -1.573 . . . . 73.3 106.752 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -88.05 131.62 34.59 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.661 1.584 . . . . 73.2 106.886 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.403 HG12 HD11 ' A' ' 11' ' ' LEU . 5.2 t -138.58 128.69 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.31 -1.737 . . . . 74.42 106.31 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.08 -175.15 13.85 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 119.212 0.914 . . . . 54.25 111.871 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.49 14.66 8.35 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.97 1.708 . . . . 74.11 111.157 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.403 HD11 HG12 ' A' ' 8' ' ' VAL . 11.0 mp -60.85 150.81 75.76 Favored Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 125.283 1.433 . . . . 73.44 111.551 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.74 157.63 60.9 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.035 2.49 . . . . 64.24 109.975 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -69.3 -36.15 76.73 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.265 -0.897 . . . . 60.34 111.015 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -88.26 15.06 8.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.884 0.874 . . . . 73.3 112.955 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.1 tp -50.46 140.92 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.779 1.231 . . . . 71.41 111.617 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 p -128.47 147.5 50.67 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.122 -0.695 . . . . 70.02 109.122 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.68 -27.21 66.2 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 118.481 -0.771 . . . . 73.21 112.064 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.78 -36.54 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.02 -0.733 . . . . 54.11 109.02 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -73.41 -42.53 61.96 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 123.82 0.848 . . . . 71.23 108.857 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.9 mt -62.09 -49.41 76.05 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.484 -0.561 . . . . 65.1 109.484 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -58.46 -46.58 86.3 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.901 -1.148 . . . . 60.24 107.901 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -57.44 -46.13 83.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 114.003 1.112 . . . . 74.41 114.003 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -65.95 -56.45 11.63 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.08 1.309 . . . . 64.33 110.405 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -73.25 4.27 4.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.424 1.268 . . . . 73.21 114.424 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -53.89 -31.23 49.2 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 125.364 1.466 . . . . 64.51 113.353 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -8.27 56.61 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.298 1.039 . . . . 71.52 112.48 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 p -112.08 -9.62 13.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.333 1.853 . . . . 63.02 110.858 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.4 m 39.5 78.2 0.38 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.912 2.085 . . . . 55.33 115.762 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.37 164.14 29.51 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.991 2.461 . . . . 71.13 109.962 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -90.01 -41.15 11.88 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.018 0.927 . . . . 71.11 108.999 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -144.32 155.88 44.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.316 0.646 . . . . 70.22 109.688 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.35 123.96 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 127.044 2.138 . . . . 62.12 108.939 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.09 104.69 6.03 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.384 2.273 . . . . 75.45 107.233 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.13 121.79 32.51 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.831 -1.174 . . . . 72.42 107.831 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -116.96 75.07 0.94 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.901 -1.518 . . . . 74.42 106.901 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -26.68 27.03 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.186 1.394 . . . . 64.41 112.248 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -51.68 -25.79 7.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.289 2.236 . . . . 54.2 113.315 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -133.07 10.39 4.19 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.907 1.683 . . . . 74.41 110.269 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.85 44.04 96.24 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.043 1.306 . . . . 42.54 110.012 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.5 pt -132.77 169.77 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 C-N-CA 125.067 1.347 . . . . 72.42 111.011 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.06 166.0 29.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.245 1.818 . . . . 62.02 108.829 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.1 116.8 14.96 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.608 -1.627 . . . . 74.23 106.608 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -113.92 115.52 27.81 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.77 -1.567 . . . . 73.23 106.77 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -88.48 152.83 21.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.11 -1.441 . . . . 65.14 107.11 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -145.58 133.27 21.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.342 1.457 . . . . 74.0 107.173 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -101.89 108.33 19.77 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.066 1.346 . . . . 62.12 112.234 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.57 -23.26 65.39 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.083 1.353 . . . . 63.21 112.21 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -75.39 -25.48 57.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.014 -0.736 . . . . 64.31 109.014 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -66.59 -34.51 78.04 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.928 0.891 . . . . 74.14 110.402 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -156.72 91.26 1.21 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.921 0.782 . . . . 74.15 111.269 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -48.65 -34.26 11.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.402 1.881 . . . . 75.12 115.787 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.94 -16.49 14.29 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 113.344 0.868 . . . . 75.45 113.344 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.31 -19.07 29.09 Favored Glycine 0 C--O 1.225 -0.461 0 CA-C-O 117.707 -1.607 . . . . 74.11 112.927 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 tp -56.04 -35.57 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 120.187 1.993 . . . . 64.43 108.758 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -62.52 -60.81 3.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.363 1.865 . . . . 63.21 108.263 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.0 mmt-85 -54.44 -39.01 66.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.144 0.977 . . . . 71.42 110.344 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -62.94 -47.62 82.43 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.207 -1.034 . . . . 74.01 108.207 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.8 mtm -63.27 -41.82 99.06 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 123.839 0.856 . . . . 70.22 110.226 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -56.81 -50.53 72.08 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.601 1.16 . . . . 72.54 109.051 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.36 -30.86 50.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.273 1.429 . . . . 71.11 110.88 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 -44.23 52.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.477 -0.935 . . . . 53.14 108.477 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mt -63.59 -29.01 70.32 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.376 1.071 . . . . 74.44 112.206 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.79 -2.82 22.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 118.755 -0.64 . . . . 71.34 112.018 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -84.79 -5.95 59.34 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.425 1.011 . . . . 71.01 109.987 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -66.19 112.53 3.98 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.724 1.147 . . . . 71.22 108.671 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.23 -8.19 38.07 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.626 1.108 . . . . 73.42 113.049 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.1 p -65.72 148.98 50.88 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 119.234 1.517 . . . . 75.44 108.678 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.2 mt -98.51 108.07 20.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.58 -2.378 . . . . 64.24 104.58 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.0 tp -102.55 111.11 23.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.291 -1.744 . . . . 75.34 106.291 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt 48.89 51.34 16.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.451 1.1 . . . . 63.03 111.163 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.274 9.6 mt-10 57.97 38.7 26.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 128.031 2.532 . . . . 51.31 114.159 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -137.58 118.15 13.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 126.285 1.834 . . . . 71.51 106.59 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -78.46 105.23 9.58 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.772 -1.195 . . . . 75.24 107.772 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.6 pt -79.52 172.4 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 125.149 1.379 . . . . 75.3 113.262 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -123.42 149.94 44.41 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.528 1.931 . . . . 73.22 106.61 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.8 t -139.91 120.98 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 106.308 -1.738 . . . . 60.41 106.308 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.01 175.69 9.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.834 1.254 . . . . 72.53 110.608 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.53 152.22 30.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.442 1.497 . . . . 74.44 113.396 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.63 129.45 15.24 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.24 -1.393 . . . . 75.12 107.24 177.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 81' ' ' GLY . 16.3 t 57.87 -164.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.924 0.889 . . . . 75.11 109.971 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.8 ' H ' HG12 ' A' ' 80' ' ' VAL . . . 102.64 83.9 1.76 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.97 1.271 . . . . 44.51 110.659 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.3 0 C-N-CA 127.958 2.694 . . . . 74.33 106.604 179.485 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.789 0 N-CA-C 109.787 -1.325 . . . . 73.41 109.787 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -100.85 -12.28 19.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.488 1.644 . . . . 52.41 114.985 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.42 112.58 18.72 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.987 -1.116 . . . . 70.52 107.987 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -103.18 160.71 14.41 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.214 1.805 . . . . 52.34 108.558 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.485 ' HB ' HG23 ' A' ' 79' ' ' THR . 2.1 mp -134.37 149.83 30.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.924 1.69 . . . . 54.22 107.63 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.9 t -119.18 124.21 72.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 105.238 -2.134 . . . . 61.24 105.238 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -82.53 131.8 35.21 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.543 -2.021 . . . . 70.41 105.543 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 11' ' ' LEU . 15.2 t -136.36 122.53 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.546 -2.02 . . . . 73.44 105.546 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -135.81 180.0 17.21 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 120.066 1.303 . . . . 73.54 113.485 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.48 19.62 5.11 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.987 2.115 . . . . 64.4 111.331 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.607 HD11 HG12 ' A' ' 8' ' ' VAL . 10.2 mp -62.63 148.13 91.52 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.152 0.981 . . . . 55.14 110.951 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.56 150.91 80.17 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.677 2.918 . . . . 70.12 110.553 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -30.15 71.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.618 -0.706 . . . . 73.31 111.3 178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.98 11.97 18.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.37 1.248 . . . . 74.24 114.37 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.429 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 7.8 tp -54.46 147.93 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.922 1.289 . . . . 74.33 110.42 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -128.21 157.0 42.05 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.428 0.691 . . . . 43.13 110.822 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.12 -32.19 73.66 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.977 -0.452 . . . . 62.3 109.802 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 p -63.39 -44.51 98.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.457 -0.572 . . . . 64.14 109.457 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -71.05 -36.08 72.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.196 -0.43 . . . . 72.21 110.061 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 20' ' ' LEU . 19.0 mt -63.4 -46.28 87.13 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.421 -0.955 . . . . 63.13 108.421 178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -58.33 -49.99 75.22 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.883 -1.155 . . . . 54.0 107.883 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -55.45 -44.16 76.13 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.529 0.937 . . . . 75.12 113.529 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -30.25 70.31 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 114.342 1.238 . . . . 71.55 114.342 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.07 6.23 19.11 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.61 0.764 . . . . 74.22 112.662 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -54.44 -43.32 71.5 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.412 1.485 . . . . 61.31 110.637 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -61.21 -35.3 76.83 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.561 0.744 . . . . 63.05 111.618 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.92 -17.36 38.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.735 1.614 . . . . 61.42 111.417 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.433 ' HB2' ' HE ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER 54.43 72.95 0.98 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 126.728 2.011 . . . . 74.34 116.239 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.39 161.71 43.68 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.037 2.492 . . . . 73.04 110.187 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.09 -46.56 8.4 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.031 1.732 . . . . 63.13 108.939 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -131.72 156.32 46.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.25 -0.886 . . . . 73.32 112.383 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.9 mt -146.77 123.9 3.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.416 -1.328 . . . . 73.13 107.416 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.72 104.91 5.44 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 128.28 2.632 . . . . 72.53 106.794 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.12 112.25 24.14 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.33 1.052 . . . . 71.12 110.25 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -97.79 82.78 3.08 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.092 -1.818 . . . . 71.24 106.092 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.04 -29.71 58.03 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.669 0.787 . . . . 73.25 111.563 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.18 -32.3 22.98 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.483 2.313 . . . . 74.15 112.6 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -122.15 -5.13 8.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.372 1.469 . . . . 61.52 110.2 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.09 47.43 85.36 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 125.674 1.607 . . . . 61.22 109.488 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.423 HG22 ' CA ' ' A' ' 9' ' ' GLY . 3.2 pt -135.57 162.4 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.152 1.381 . . . . 71.25 108.869 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.96 166.22 24.59 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.926 1.29 . . . . 73.44 108.369 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -133.47 104.7 6.53 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.627 -1.62 . . . . 65.53 106.627 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.27 113.16 26.58 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.429 -1.323 . . . . 74.42 107.429 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.32 153.6 19.81 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.33 1.452 . . . . 70.1 108.703 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -147.75 136.24 21.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.895 1.278 . . . . 70.4 108.224 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -101.48 111.51 23.76 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.958 1.303 . . . . 75.1 111.919 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.64 -21.47 55.43 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.073 2.149 . . . . 52.12 110.396 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.64 -30.41 71.35 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.989 -1.486 . . . . 41.33 106.989 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -62.06 -33.59 74.68 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 117.994 -1.003 . . . . 73.25 110.765 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -157.24 108.41 2.33 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 114.642 1.349 . . . . 53.12 114.642 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -68.05 -19.31 64.87 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 117.182 -1.389 . . . . 74.15 112.999 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.359 43.5 p -122.53 14.73 10.29 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.795 1.634 . . . . 74.35 114.535 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -131.03 -19.89 1.21 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.346 1.45 . . . . 53.14 115.167 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.8 -30.41 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 120.484 2.142 . . . . 71.33 109.514 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -64.14 -55.97 18.08 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 126.142 1.777 . . . . 70.43 110.086 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -58.55 -27.36 64.5 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.428 1.491 . . . . 71.54 110.719 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.433 ' HE ' ' HB2' ' A' ' 28' ' ' SER . 28.4 mtt85 -76.33 -45.83 30.41 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.239 -1.023 . . . . 71.24 108.239 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 8.2 mtm -57.57 -41.67 81.54 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.959 0.904 . . . . 64.54 108.904 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -55.17 -49.08 72.77 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.322 1.449 . . . . 74.14 110.391 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.7 mt -64.66 -41.55 92.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 124.271 1.028 . . . . 73.32 109.439 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.36 93.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.69 -0.856 . . . . 54.3 108.69 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.3 mt -63.83 -32.52 74.06 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.188 0.995 . . . . 73.23 110.51 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.32 -10.78 26.36 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.175 -0.917 . . . . 75.0 110.808 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -85.91 -0.78 56.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.031 1.287 . . . . 63.43 110.755 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.2 112.38 3.01 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.682 -1.261 . . . . 73.32 107.767 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.56 1.75 57.68 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 117.421 -1.766 . . . . 70.55 113.261 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.256 51.3 p -66.02 142.83 57.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.988 2.394 . . . . 70.14 110.33 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.48 116.65 29.03 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.593 1.157 . . . . 74.4 108.172 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 mt -122.53 120.4 33.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 105.949 -1.871 . . . . 71.22 105.949 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 10.7 mtmm 44.3 47.53 7.88 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.749 1.62 . . . . 72.45 110.076 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 59.39 33.71 22.49 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.225 1.81 . . . . 62.14 114.712 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -130.18 117.56 20.09 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 104.742 -2.318 . . . . 75.52 104.742 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -78.58 107.96 11.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.97 -1.122 . . . . 61.44 107.97 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -78.99 170.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 124.501 1.12 . . . . 51.43 111.06 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.26 155.62 47.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.001 1.72 . . . . 74.41 109.344 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.6 t -139.23 133.11 39.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 O-C-N 124.003 0.815 . . . . 64.41 110.224 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -143.9 175.43 10.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.013 1.325 . . . . 64.52 108.621 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.89 150.58 21.16 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.828 0.851 . . . . 53.0 109.168 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.485 HG23 ' HB ' ' A' ' 5' ' ' ILE . 5.9 t -148.69 82.51 1.46 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.99 -1.115 . . . . 71.42 107.99 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -167.37 -62.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 123.83 0.852 . . . . 50.11 109.416 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.33 -32.42 75.75 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.528 -0.629 . . . . 64.24 111.528 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 N-CA-C 106.312 -2.715 . . . . 75.11 106.312 -179.677 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.3 ptt85 . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 120.722 0.296 . . . . 54.42 110.669 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -126.36 162.91 24.43 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.956 1.702 . . . . 73.13 106.838 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.461 ' HB ' HG23 ' A' ' 79' ' ' THR . 2.3 mp -129.15 149.67 33.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.11 0.964 . . . . 74.14 108.577 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.2 t -109.79 124.69 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.249 1.42 . . . . 73.21 107.922 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -91.2 100.28 13.13 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.605 -1.998 . . . . 71.14 105.605 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.1 t -104.75 132.04 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.935 -1.876 . . . . 32.53 105.935 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.77 179.3 27.6 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 121.352 1.887 . . . . 54.54 113.758 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.72 14.01 0.99 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.291 2.637 . . . . 52.33 111.943 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 mp -55.7 157.65 7.35 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.897 1.679 . . . . 74.35 115.059 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.69 153.0 59.55 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.289 3.326 . . . . 72.25 110.544 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -34.32 75.3 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.216 0.606 . . . . 74.14 111.685 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -90.39 11.12 22.49 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.714 1.375 . . . . 61.24 114.714 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.3 tp -45.44 140.39 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 114.603 1.334 . . . . 74.43 114.603 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.38 147.6 46.92 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.149 1.38 . . . . 44.14 108.744 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -29.18 69.04 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.493 0.717 . . . . 74.31 111.105 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.16 -43.33 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.194 0.998 . . . . 61.14 109.17 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.09 -18.89 61.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.954 1.301 . . . . 71.22 111.744 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.9 mt -86.25 -44.24 12.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 120.573 -1.329 . . . . 41.43 109.524 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -62.17 -45.64 92.53 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.01 0.924 . . . . 73.43 110.955 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -65.35 -27.26 68.45 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 114.171 1.174 . . . . 65.22 114.171 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -74.49 -60.92 2.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.544 1.138 . . . . 75.34 109.587 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -80.94 3.65 22.15 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 114.675 1.361 . . . . 61.14 114.675 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -48.53 -51.68 26.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.795 1.638 . . . . 63.32 110.595 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -60.54 -44.42 96.12 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.774 0.83 . . . . 61.23 111.857 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 p -70.57 -16.41 62.86 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.145 -0.972 . . . . 13.11 112.981 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m 49.78 71.42 1.58 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.792 2.037 . . . . 53.23 116.064 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.29 165.72 23.67 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.944 2.429 . . . . 63.51 110.312 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -99.15 -47.41 5.22 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.812 1.645 . . . . 53.23 108.134 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.62 149.19 40.11 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.212 1.005 . . . . 73.52 109.872 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -146.7 112.31 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.651 1.58 . . . . 64.23 107.08 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -140.27 104.08 4.72 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.653 1.581 . . . . 74.41 110.13 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -89.87 127.78 36.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.132 1.773 . . . . 62.44 110.589 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -118.95 85.58 2.39 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.22 1.808 . . . . 75.41 108.109 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.64 -22.04 43.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.338 0.655 . . . . 52.42 112.544 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -51.5 -28.21 12.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.664 2.386 . . . . 53.03 112.346 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -133.44 8.43 3.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.697 1.999 . . . . 75.23 110.448 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.01 36.24 72.9 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.787 -1.007 . . . . 73.12 111.877 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.5 170.36 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 126.441 1.896 . . . . 73.33 108.575 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.06 170.89 19.35 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.534 -1.284 . . . . 54.42 107.534 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -128.23 135.83 50.22 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.429 -2.063 . . . . 73.34 105.429 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.96 107.82 6.3 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 106.812 -1.551 . . . . 73.31 106.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -88.36 154.3 20.5 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.442 -1.688 . . . . 52.23 106.442 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -139.93 116.2 10.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.763 1.225 . . . . 65.14 107.817 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -70.22 108.93 4.38 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.624 0.726 . . . . 60.11 111.55 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.43 69.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.387 1.075 . . . . 51.11 110.016 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.14 -21.05 65.85 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.649 0.779 . . . . 61.53 111.76 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -37.91 87.07 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.542 -0.91 . . . . 74.52 108.542 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -158.44 102.69 1.75 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 119.385 0.993 . . . . 71.42 111.327 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -52.74 -33.94 50.51 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.814 0.846 . . . . 64.52 112.769 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 12.9 18.8 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.736 1.013 . . . . 72.43 113.736 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.23 -24.91 3.38 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.849 1.214 . . . . 72.24 112.076 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tp -55.56 -33.4 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 118.442 1.121 . . . . 64.14 110.643 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -61.28 2.54 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.513 1.125 . . . . 52.34 109.545 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -60.54 -36.62 78.87 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 118.791 -0.623 . . . . 61.12 111.515 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -59.2 -42.97 92.19 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.713 -0.847 . . . . 74.33 108.713 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.2 mtm -67.76 -45.5 74.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.469 -1.253 . . . . 73.15 108.801 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -52.27 -51.47 58.26 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.103 1.319 . . . . 60.33 110.001 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.3 mt -59.09 -38.62 75.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 125.32 1.448 . . . . 72.22 110.449 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.36 -42.39 62.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.455 0.571 . . . . 72.41 109.623 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 mt -65.53 -30.3 71.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.791 1.636 . . . . 63.41 111.498 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 mt -65.9 -12.95 58.51 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.996 -0.526 . . . . 74.33 110.527 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -86.7 6.15 32.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.003 0.921 . . . . 71.31 110.823 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -73.76 115.36 13.09 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.39 -2.078 . . . . 72.41 105.39 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.04 5.71 70.26 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 125.053 1.311 . . . . 54.31 111.909 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 p -75.53 162.96 27.86 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 119.949 1.875 . . . . 72.25 107.203 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 mt -95.25 139.42 31.6 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 126.919 2.087 . . . . 62.44 108.048 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -145.74 122.85 11.46 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.668 1.987 . . . . 63.21 107.713 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt 42.06 46.95 3.79 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.779 1.232 . . . . 74.13 113.02 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.315 98.5 mt-10 66.0 23.71 11.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.814 2.045 . . . . 75.42 116.406 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -125.26 152.46 44.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.393 -2.077 . . . . 74.14 105.393 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -103.56 135.7 44.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 102.372 -3.195 . . . . 53.54 102.372 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.5 pt -122.63 161.28 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 119.0 0.818 . . . . 75.32 112.929 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -107.17 156.93 18.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.851 1.26 . . . . 72.43 111.244 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -147.49 118.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 125.512 1.525 . . . . 61.11 107.908 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -141.75 174.92 10.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.593 1.157 . . . . 75.44 110.506 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -84.05 151.9 24.7 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.29 1.036 . . . . 55.11 111.045 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.461 HG23 ' HB ' ' A' ' 5' ' ' ILE . 1.8 t . . . . . 0 N--CA 1.45 -0.448 0 N-CA-C 105.951 -1.87 . . . . 51.43 105.951 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 . . . . . 0 CA--C 1.511 -0.521 0 CA-C-O 120.022 -0.037 . . . . 72.04 110.947 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -95.25 163.43 13.27 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.119 1.368 . . . . 75.13 107.49 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -135.16 138.12 49.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 107.392 -1.336 . . . . 74.04 107.392 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.2 t -96.28 146.63 6.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 104.671 -2.344 . . . . 72.42 104.671 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.05 103.62 12.88 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.404 -2.072 . . . . 71.04 105.404 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 11' ' ' LEU . 49.6 t -110.78 121.58 63.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.508 -1.664 . . . . 70.1 106.508 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -142.39 178.35 20.99 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 119.993 1.27 . . . . 74.21 113.043 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.72 21.93 5.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.087 2.155 . . . . 54.51 112.297 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 8' ' ' VAL . 8.5 mp -64.15 150.02 93.07 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.325 1.45 . . . . 73.21 112.854 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.12 149.75 76.76 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.908 2.405 . . . . 70.14 110.171 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -59.8 -35.59 75.0 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.112 0.565 . . . . 74.23 110.142 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.83 14.14 10.99 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.5 1.296 . . . . 62.42 114.5 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.506 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 10.1 tp -47.08 142.88 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 124.372 1.069 . . . . 73.21 111.609 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 p -124.37 148.75 47.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.385 1.074 . . . . 75.23 108.33 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -32.77 72.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.683 -0.675 . . . . 73.24 110.074 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.12 -41.47 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-N 118.831 0.741 . . . . 65.23 109.829 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.36 -42.23 79.5 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.543 -0.54 . . . . 51.23 109.543 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 mt -65.96 -40.44 91.31 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.698 0.399 . . . . 62.45 111.605 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -46.63 77.46 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.516 -1.29 . . . . 75.35 107.516 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -61.11 -48.49 81.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 114.083 1.142 . . . . 74.23 114.083 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -28.44 68.61 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.488 0.921 . . . . 73.05 113.488 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -112.52 9.18 19.51 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 112.92 0.711 . . . . 63.34 112.92 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -55.34 -34.32 64.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.683 -1.26 . . . . 74.42 112.349 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.92 -34.6 44.44 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.324 0.511 . . . . 73.34 110.602 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -27.95 62.86 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.12 -0.696 . . . . 72.3 109.12 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.4 m 58.55 66.24 2.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 127.054 2.141 . . . . 52.51 114.792 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -63.53 164.96 19.13 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.731 2.954 . . . . 62.23 111.854 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -91.1 -40.74 11.43 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.115 1.766 . . . . 63.11 109.291 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -137.23 164.39 28.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.35 0.66 . . . . 74.42 111.311 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.8 mt -151.46 126.26 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.502 -1.666 . . . . 73.31 106.502 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.58 104.65 4.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.444 1.497 . . . . 74.42 107.172 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.35 125.42 34.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.389 -1.337 . . . . 73.14 107.389 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -112.97 86.41 2.37 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.165 -1.791 . . . . 65.41 106.165 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.14 -29.77 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.39 0.676 . . . . 71.32 111.01 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.7 -24.27 8.31 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.305 2.242 . . . . 71.44 113.096 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -132.73 -0.09 3.52 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.846 1.258 . . . . 72.31 111.836 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.63 41.76 98.98 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.132 -1.187 . . . . 75.31 110.132 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.513 HG22 ' CA ' ' A' ' 9' ' ' GLY . 5.3 pt -137.0 167.48 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.707 1.603 . . . . 73.2 109.149 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.18 166.36 24.91 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.382 1.073 . . . . 62.0 108.498 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -130.77 119.14 21.87 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.201 -2.148 . . . . 74.54 105.201 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.14 108.99 12.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.388 -1.708 . . . . 73.22 106.388 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.51 153.06 24.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.322 1.849 . . . . 74.45 109.533 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -144.58 108.37 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.687 1.195 . . . . 64.23 108.633 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -72.59 115.68 12.15 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.578 0.704 . . . . 73.34 110.227 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.2 -24.26 54.68 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.933 2.093 . . . . 52.14 111.834 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.85 -27.98 50.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.321 -0.371 . . . . 61.25 110.415 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -71.09 -36.97 72.4 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.21 0.604 . . . . 73.41 111.206 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.7 76.18 1.71 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.493 1.117 . . . . 75.51 111.085 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -47.55 66.07 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.512 -1.368 . . . . 72.31 113.684 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.25 5.25 52.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 114.086 1.143 . . . . 74.32 114.086 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.59 -5.76 2.8 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 117.386 -1.785 . . . . 72.43 115.502 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.7 tp -56.29 -42.39 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 121.073 2.436 . . . . 74.33 108.781 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -56.34 23.16 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 107.722 -1.214 . . . . 60.11 107.722 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -50.36 -48.49 55.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.417 1.087 . . . . 75.23 110.739 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -48.65 74.28 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.451 0.7 . . . . 72.35 109.124 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 48.8 mtm -68.84 -32.29 71.87 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 118.662 -0.685 . . . . 63.43 112.207 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.21 -51.53 68.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.134 2.173 . . . . 74.25 110.291 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mt -63.1 -39.6 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.313 1.445 . . . . 73.42 108.189 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.02 -41.63 81.89 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.178 -0.915 . . . . 62.12 109.554 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.2 mt -65.72 -31.24 72.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.33 0.968 . . . . 74.4 111.352 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 mt -66.16 -12.71 57.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.713 -0.661 . . . . 73.44 111.319 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -86.29 6.7 28.51 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 117.974 -1.012 . . . . 75.21 111.321 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -73.04 121.54 20.32 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.354 1.862 . . . . 70.42 108.86 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.96 3.22 58.08 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.828 -0.984 . . . . 73.33 114.377 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.4 p -68.84 151.61 46.37 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 119.35 1.575 . . . . 55.14 108.465 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.8 mt -97.42 110.84 23.32 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.711 -1.589 . . . . 72.23 106.711 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mt -113.59 119.11 36.37 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.843 -1.91 . . . . 75.11 105.843 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 41.9 mttm 45.03 58.31 4.13 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.643 1.577 . . . . 72.53 109.806 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 59.12 14.43 3.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.265 1.826 . . . . 70.41 115.033 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -121.14 122.01 39.08 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 120.479 -1.388 . . . . 44.44 110.545 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.86 123.85 25.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 104.601 -2.37 . . . . 74.31 104.601 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.4 pt -108.67 169.85 3.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 119.276 0.944 . . . . 65.34 112.9 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -112.56 146.03 39.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.691 1.196 . . . . 55.54 108.904 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.5 t -143.59 108.54 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 106.48 -1.674 . . . . 45.35 106.48 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -132.84 171.66 13.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.437 1.495 . . . . 64.41 109.144 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.43 HD13 ' H ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -99.8 152.6 19.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 120.666 -1.271 . . . . 61.32 113.795 -178.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.43 ' H ' HD13 ' A' ' 78' ' ' LEU . 13.0 p . . . . . 0 CA--C 1.539 0.524 0 C-N-CA 124.604 1.161 . . . . 75.32 108.9 177.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.272 0 N-CA-C 108.881 -0.785 . . . . 74.02 108.881 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -138.9 156.79 46.99 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.713 1.605 . . . . 74.45 106.768 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.2 mt -136.18 146.76 28.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.314 -0.857 . . . . 75.44 109.971 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.0 t -106.33 119.24 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 127.949 2.5 . . . . 63.35 106.522 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -88.59 135.13 33.65 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 104.562 -2.384 . . . . 74.24 104.562 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 HD11 ' A' ' 11' ' ' LEU . 17.9 t -138.77 122.51 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.135 -2.172 . . . . 53.3 105.135 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.436 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -130.0 -176.57 14.48 Favored Glycine 0 N--CA 1.467 0.718 0 CA-C-N 121.127 1.785 . . . . 52.32 111.027 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 m 70.51 17.53 6.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.691 1.596 . . . . 51.42 111.554 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.717 HD11 HG12 ' A' ' 8' ' ' VAL . 9.1 mp -67.29 147.55 98.89 Favored Pre-proline 0 C--O 1.235 0.295 0 O-C-N 120.975 -1.078 . . . . 75.11 109.963 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.82 152.31 77.54 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.511 2.141 . . . . 63.31 110.574 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -62.94 -30.76 71.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.779 -0.823 . . . . 73.12 108.779 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.39 -1.4 33.25 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 127.653 2.381 . . . . 73.15 114.121 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.1 tp -47.75 137.44 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.663 1.185 . . . . 72.51 113.29 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 p -115.43 150.01 37.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.464 1.506 . . . . 40.4 108.173 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.77 69.79 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.021 0.528 . . . . 51.41 110.722 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.51 -37.32 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 109.389 -0.597 . . . . 73.4 109.389 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.23 -43.26 82.43 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.061 -1.088 . . . . 61.24 108.061 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.08 -50.47 71.85 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.93 -0.396 . . . . 75.03 109.93 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -54.34 -50.22 67.92 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.587 1.155 . . . . 73.43 108.573 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -60.0 -41.78 92.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.555 1.142 . . . . 71.2 111.021 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -31.18 71.19 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 114.87 1.433 . . . . 71.21 114.87 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.27 9.72 33.86 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.013 0.525 . . . . 64.2 112.36 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -51.81 -43.73 63.21 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.504 1.522 . . . . 72.22 113.309 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -71.73 -25.83 62.23 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.122 0.569 . . . . 72.21 112.117 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.01 -30.02 20.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.182 0.593 . . . . 71.24 109.976 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 56.59 81.41 0.26 Allowed Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 127.946 2.498 . . . . 73.3 112.508 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -68.95 161.37 46.04 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.252 1.968 . . . . 71.42 110.616 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -91.9 -33.4 14.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.686 1.194 . . . . 74.41 109.535 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -138.39 151.36 47.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.196 0.999 . . . . 62.12 110.691 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.8 mt -143.21 121.75 7.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.972 -0.751 . . . . 71.33 108.972 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.7 128.79 25.44 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.055 -1.832 . . . . 64.24 106.055 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -115.84 116.78 28.61 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.323 1.849 . . . . 70.1 106.965 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -110.8 86.49 2.32 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.799 -1.926 . . . . 70.52 105.799 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.31 -19.08 31.88 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 113.475 0.917 . . . . 73.4 113.475 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.41 -28.19 12.12 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.841 2.056 . . . . 71.13 111.622 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -132.67 3.19 3.81 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.471 1.508 . . . . 74.01 109.506 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.74 54.6 36.56 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 126.871 2.177 . . . . 74.23 110.133 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.436 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.8 pt -137.29 155.51 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.897 1.279 . . . . 73.03 109.634 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.6 155.24 50.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.551 1.541 . . . . 63.33 109.047 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -125.28 118.67 26.49 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.981 -1.859 . . . . 54.02 105.981 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.03 104.81 10.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.379 -1.341 . . . . 55.45 107.379 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -84.46 156.8 21.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.726 0.81 . . . . 73.4 108.938 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -143.01 143.84 32.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.264 -1.754 . . . . 74.55 106.264 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -102.01 110.46 22.43 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.535 -0.913 . . . . 74.23 108.535 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.33 -27.16 64.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.691 1.196 . . . . 73.21 111.141 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.9 -33.34 75.11 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.393 -0.965 . . . . 75.4 108.393 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -61.96 -23.36 66.33 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 116.504 -1.713 . . . . 61.2 113.932 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -166.01 96.95 0.62 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.497 1.499 . . . . 72.22 110.771 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -31.9 38.46 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 117.328 2.344 . . . . 74.5 117.328 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -118.18 -9.85 10.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.603 1.547 . . . . 70.33 113.312 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.99 -17.66 34.33 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.256 -1.302 . . . . 64.32 110.759 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.4 tp -58.63 -38.85 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.954 1.877 . . . . 75.41 107.63 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -55.42 -61.28 2.44 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.182 1.793 . . . . 63.34 107.07 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -51.01 -49.44 60.45 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 121.944 -0.472 . . . . 72.24 111.491 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -54.31 -48.37 71.4 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.174 0.59 . . . . 62.2 110.448 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.7 mtm -65.68 -41.4 92.48 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 119.031 -0.509 . . . . 62.4 110.493 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -47.13 86.52 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.431 1.014 . . . . 73.23 110.266 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 mt -60.0 -39.64 80.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.701 1.2 . . . . 73.23 108.683 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.69 -41.16 72.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.419 -0.586 . . . . 74.34 109.419 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.5 mt -63.88 -34.36 77.76 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.928 0.891 . . . . 73.12 110.988 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.2 mt -63.33 -9.57 12.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.191 0.996 . . . . 73.54 111.729 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -85.87 -2.8 58.61 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.615 1.098 . . . . 63.41 110.186 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -64.21 118.91 9.28 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.092 -1.447 . . . . 74.41 107.092 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.453 ' O ' ' HE2' ' A' ' 73' ' ' LYS . . . 84.85 6.64 85.03 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-O 117.006 -1.997 . . . . 64.11 114.248 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.9 p -78.26 163.18 25.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 121.112 2.456 . . . . 75.34 107.731 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.421 ' HG ' ' HE3' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -101.4 108.21 19.75 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.06 -1.089 . . . . 72.43 108.06 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -113.98 121.42 43.86 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 126.307 1.843 . . . . 63.24 107.434 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt 47.44 44.64 16.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.552 1.141 . . . . 63.43 113.074 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 69.37 18.19 8.0 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.289 2.236 . . . . 64.24 114.604 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -125.93 124.14 40.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.98 0.912 . . . . 72.21 108.557 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 66' ' ' GLY . 1.3 ttmt -75.02 114.81 13.93 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 101.815 -3.402 . . . . 72.31 101.815 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.3 pt -96.11 169.62 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.265 0.839 . . . . 65.52 113.265 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -121.43 148.09 44.88 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.819 1.647 . . . . 64.33 108.685 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.453 HG22 HG13 ' A' ' 8' ' ' VAL . 58.3 t -142.15 138.97 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.457 1.103 . . . . 72.32 109.053 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -159.99 176.26 12.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.772 2.029 . . . . 72.22 109.232 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.65 151.67 22.77 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.901 -1.125 . . . . 74.04 109.905 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 105.22 -2.141 . . . . 74.12 105.22 177.393 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.424 0.154 . . . . 75.1 110.709 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -91.62 165.23 13.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.393 1.477 . . . . 71.0 107.977 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.556 ' HB ' HG23 ' A' ' 79' ' ' THR . 2.2 mt -134.97 148.16 29.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.136 1.374 . . . . 74.52 108.96 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.4 136.69 47.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.764 1.625 . . . . 51.44 107.353 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.4 ' HZ ' HG21 ' A' ' 40' ' ' ILE . 69.0 t80 -106.34 117.08 33.1 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.912 1.285 . . . . 72.44 108.253 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 t -122.02 136.37 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.11 -1.07 . . . . 60.51 108.11 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.576 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -144.2 169.7 26.22 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 119.858 1.208 . . . . 71.32 111.477 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 74' ' ' ILE . 7.2 t 82.9 17.09 0.31 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 128.441 2.696 . . . . 74.32 109.766 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mp -53.62 152.09 9.92 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 124.61 1.164 . . . . 71.43 112.591 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -52.54 148.66 26.33 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.958 2.439 . . . . 51.14 111.106 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -59.9 -31.73 70.08 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.785 -0.572 . . . . 74.23 111.083 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -113.63 33.41 5.18 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.123 1.369 . . . . 54.12 111.747 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.68 143.08 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.97 -1.122 . . . . 51.44 107.97 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.36 147.66 46.0 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.426 -0.953 . . . . 73.34 108.426 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.18 68.73 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 117.961 -1.019 . . . . 54.52 111.179 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -62.96 -35.49 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 119.793 1.179 . . . . 71.12 109.509 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -66.46 -48.19 70.71 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.678 -0.86 . . . . 72.44 108.678 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.4 mt -59.91 -52.15 66.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.638 0.775 . . . . 74.43 109.01 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -57.72 -36.48 72.07 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.438 1.495 . . . . 73.03 109.796 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -75.95 -46.24 30.8 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.234 1.414 . . . . 74.32 112.849 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -35.91 81.91 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.632 0.773 . . . . 73.33 111.978 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -97.84 0.28 46.43 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.282 0.845 . . . . 75.35 113.282 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -50.99 -40.97 59.32 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.859 1.664 . . . . 73.45 112.567 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -66.79 -49.33 66.2 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.238 -0.653 . . . . 63.13 109.238 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 p -66.38 -17.15 64.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.789 1.236 . . . . 70.22 112.852 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.8 t 47.55 77.14 0.48 Allowed Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.658 1.583 . . . . 54.12 113.711 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.54 163.76 33.65 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.44 2.76 . . . . 71.41 110.652 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.6 -41.66 17.6 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.73 1.212 . . . . 72.32 108.426 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.33 162.12 40.7 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.641 1.176 . . . . 71.43 108.079 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.3 mt -135.52 128.5 47.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 126.182 1.793 . . . . 73.21 107.793 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -141.12 104.4 4.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.744 1.218 . . . . 55.03 109.359 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.29 125.28 37.81 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.937 -1.505 . . . . 72.42 106.937 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -118.82 91.53 3.58 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.349 1.059 . . . . 74.04 108.854 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.11 -20.94 64.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.203 1.001 . . . . 71.31 110.551 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.07 -32.34 21.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.949 2.1 . . . . 62.25 110.084 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -131.98 3.6 4.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.951 1.7 . . . . 74.05 111.966 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.29 34.8 90.94 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 119.66 1.118 . . . . 54.13 111.929 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.576 HG22 ' CA ' ' A' ' 9' ' ' GLY . 1.7 pp -124.87 171.3 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.289 1.435 . . . . 73.13 110.249 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.12 163.89 33.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.848 0.859 . . . . 72.12 111.031 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -130.49 135.49 48.01 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.398 1.479 . . . . 72.53 107.866 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -142.28 111.63 6.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.124 -1.435 . . . . 70.22 107.124 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.2 159.48 21.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.149 -1.056 . . . . 62.55 108.149 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -144.43 104.47 4.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.047 1.339 . . . . 70.53 107.426 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.69 110.0 5.96 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.644 1.178 . . . . 71.53 112.228 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.01 -31.71 72.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.506 0.928 . . . . 71.44 113.506 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -75.11 -24.29 58.05 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.21 0.914 . . . . 75.24 111.954 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -61.38 -30.72 70.72 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.498 -0.751 . . . . 61.31 110.302 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -157.0 84.02 0.94 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.976 -0.75 . . . . 73.04 108.976 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -52.47 -38.51 59.51 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.553 0.575 . . . . 73.02 112.553 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.0 -4.77 57.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 113.983 1.105 . . . . 74.22 113.983 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.1 -14.32 4.62 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.148 -1.362 . . . . 62.43 115.024 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.5 tp -51.72 -43.69 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 120.21 2.005 . . . . 72.35 110.886 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -57.05 -51.3 69.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.9 -1.148 . . . . 75.42 107.9 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -57.06 -48.86 77.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.206 1.002 . . . . 73.54 109.318 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.7 mtt85 -52.07 -51.97 54.24 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.656 0.662 . . . . 55.21 109.872 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 21.4 mtm -62.94 -39.61 95.14 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 119.096 -0.478 . . . . 74.14 110.771 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -49.96 75.42 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.297 1.039 . . . . 73.33 110.24 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.37 -39.36 78.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.597 1.159 . . . . 62.55 108.504 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.49 -40.38 70.26 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.324 0.511 . . . . 71.15 110.353 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.11 -38.82 92.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.338 1.055 . . . . 74.23 110.375 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.98 -2.44 1.23 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.719 1.608 . . . . 75.01 113.853 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -92.32 1.17 57.39 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.939 0.79 . . . . 52.21 110.852 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.62 115.3 4.59 Favored 'General case' 0 C--N 1.338 0.078 0 O-C-N 120.279 -1.513 . . . . 63.44 111.054 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.2 4.6 74.14 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 118.291 -1.283 . . . . 54.41 111.955 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.6 p -68.27 157.95 34.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.216 1.508 . . . . 74.14 109.65 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 mt -102.71 111.4 23.69 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.243 -1.392 . . . . 72.35 107.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -116.25 116.17 27.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.31 -1.367 . . . . 61.23 107.31 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt 49.88 53.44 12.79 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.793 1.237 . . . . 74.41 111.68 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 57.62 30.58 19.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.257 1.823 . . . . 74.21 113.838 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.21 118.02 13.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.313 1.445 . . . . 72.01 108.44 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -76.03 140.39 41.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.116 -1.809 . . . . 52.04 106.116 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 11.8 pt -126.63 170.08 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.438 1.086 . . . . 71.04 112.866 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.44 157.13 37.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.195 1.398 . . . . 73.1 110.699 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.0 t -136.87 148.55 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 125.275 1.43 . . . . 71.25 108.938 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.0 174.59 10.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.979 2.512 . . . . 74.45 109.175 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.22 152.0 20.07 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.433 1.093 . . . . 74.25 109.959 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.556 HG23 ' HB ' ' A' ' 5' ' ' ILE . 5.5 t . . . . . 0 C--N 1.332 -0.193 0 N-CA-C 107.72 -1.215 . . . . 53.23 107.72 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 . . . . . 0 CA--C 1.516 -0.346 0 N-CA-C 107.935 -1.135 . . . . 63.12 107.935 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -95.04 162.86 13.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.721 -1.585 . . . . 54.22 106.721 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 mt -134.23 149.01 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.534 0.683 . . . . 65.32 109.715 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.9 t -121.06 115.06 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 105.949 -1.871 . . . . 53.22 105.949 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -84.61 139.03 32.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.54 -2.393 . . . . 75.32 104.54 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.444 HG12 HD11 ' A' ' 11' ' ' LEU . 2.5 t -131.74 136.57 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.746 -1.946 . . . . 52.31 105.746 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -141.83 -178.4 17.92 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 119.718 1.145 . . . . 54.13 110.596 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.44 13.06 9.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.14 1.776 . . . . 33.33 112.628 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.444 HD11 HG12 ' A' ' 8' ' ' VAL . 10.4 mp -54.8 148.61 26.27 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.565 1.546 . . . . 73.41 112.603 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.44 150.71 87.77 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.893 2.395 . . . . 75.02 110.365 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -53.58 -45.75 70.08 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.135 0.974 . . . . 71.21 110.718 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.02 18.53 5.72 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.248 1.573 . . . . 74.2 115.248 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.483 HG21 HD21 ' A' ' 34' ' ' LEU . 6.5 tp -44.98 137.21 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 119.902 1.228 . . . . 74.01 111.968 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 p -115.96 150.52 37.03 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.293 1.437 . . . . 75.21 109.236 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.71 -29.63 70.83 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-O 119.13 -0.462 . . . . 61.42 110.647 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.48 -38.35 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 118.443 0.565 . . . . 73.55 109.581 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.42 -38.14 84.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.088 0.858 . . . . 73.2 109.125 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.77 -54.46 31.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.107 -0.701 . . . . 70.24 109.107 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -54.81 -46.56 74.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.123 0.969 . . . . 74.11 109.097 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -62.77 -41.22 99.15 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 114.378 1.251 . . . . 75.33 114.378 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -46.56 69.84 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.056 -1.028 . . . . 64.34 110.493 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -86.09 3.06 44.21 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.057 1.132 . . . . 71.25 114.057 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -53.43 -40.63 65.32 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.538 -1.351 . . . . 71.5 110.69 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -70.59 -31.38 68.35 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.926 1.69 . . . . 74.24 112.174 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 p -89.49 -11.21 43.61 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 117.913 -1.042 . . . . 65.44 112.459 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m 48.58 70.44 2.08 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 115.445 1.646 . . . . 72.4 115.445 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.94 161.4 46.1 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.961 2.441 . . . . 63.03 111.682 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -91.55 -39.5 11.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.05 1.74 . . . . 65.21 107.649 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -135.35 158.19 44.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.698 1.199 . . . . 70.24 110.748 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.6 mt -145.79 126.3 6.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.341 -1.726 . . . . 45.21 106.341 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -140.27 105.93 5.13 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.985 1.314 . . . . 74.42 109.833 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 15' ' ' ILE . 1.6 tm? -92.76 121.16 33.87 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.313 1.045 . . . . 74.22 110.241 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -118.88 81.7 1.74 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.941 -1.133 . . . . 74.11 107.941 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.63 -21.63 60.72 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.217 1.007 . . . . 64.45 111.096 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.74 -20.21 7.93 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.953 1.701 . . . . 64.14 112.346 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -132.37 -4.1 3.4 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.702 1.601 . . . . 75.41 109.447 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.32 41.77 51.69 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.207 -1.557 . . . . 54.45 109.207 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.453 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 40.5 pt -132.86 171.82 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 124.537 1.135 . . . . 61.33 110.678 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.87 165.6 34.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.739 1.615 . . . . 65.31 109.187 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -135.22 142.3 45.99 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.552 1.941 . . . . 65.13 106.219 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -142.9 114.08 7.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.28 -1.378 . . . . 74.41 107.28 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.3 155.98 19.02 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.551 -1.648 . . . . 72.12 106.551 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -145.1 114.02 6.89 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.275 1.83 . . . . 64.1 109.187 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -72.01 112.77 8.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.776 1.028 . . . . 71.35 113.776 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.95 -16.26 61.54 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.427 1.491 . . . . 70.13 112.789 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.62 -22.51 27.94 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.058 0.845 . . . . 75.34 109.57 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -61.62 -43.93 97.94 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 120.952 -1.092 . . . . 64.54 109.697 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -145.44 89.21 1.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.512 0.596 . . . . 72.21 110.755 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -37.57 48.92 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 114.358 1.244 . . . . 75.32 114.358 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.8 p -97.15 -19.85 18.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.221 1.373 . . . . 72.24 112.381 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.49 -16.29 43.56 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 117.65 -1.639 . . . . 52.21 114.911 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.42 -37.3 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.799 2.3 . . . . 71.04 109.366 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -60.84 -60.93 3.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.632 -1.247 . . . . 73.14 107.632 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -50.79 -44.22 58.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 118.614 -0.708 . . . . 74.52 110.628 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -56.42 -49.98 72.98 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.939 -0.763 . . . . 65.05 108.939 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.2 mtm -58.68 -47.71 83.57 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 124.204 1.002 . . . . 73.23 109.447 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -53.76 50.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.997 1.719 . . . . 74.45 111.837 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.6 mt -61.27 -37.01 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.804 1.242 . . . . 75.41 108.937 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.36 -41.44 63.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.434 -0.58 . . . . 71.52 109.434 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.39 -34.95 78.85 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.915 1.286 . . . . 75.12 111.241 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.8 mt -65.81 -9.77 31.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.044 0.938 . . . . 74.4 111.889 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -85.76 -1.68 57.46 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.128 0.876 . . . . 65.41 110.418 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -62.76 111.9 2.3 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.883 1.674 . . . . 60.34 109.673 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.74 7.25 53.68 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.619 1.104 . . . . 64.41 112.945 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.1 p -66.08 146.85 54.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.528 1.664 . . . . 51.53 109.121 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.6 mt -93.08 121.21 34.19 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.547 -2.39 . . . . 55.54 104.547 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.8 120.05 28.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.996 1.318 . . . . 73.23 108.152 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt 48.39 40.48 14.79 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.22 1.408 . . . . 63.03 112.561 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 70.48 29.35 3.47 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 128.519 2.728 . . . . 62.33 113.913 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -136.15 120.71 18.26 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 126.551 1.94 . . . . 70.31 108.772 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -73.61 138.33 44.8 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 105.636 -1.987 . . . . 75.05 105.636 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 pt -119.5 170.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 124.636 1.174 . . . . 65.4 110.695 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -123.66 158.74 30.86 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.247 1.419 . . . . 72.13 111.23 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.96 132.89 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.09 1.756 . . . . 74.34 108.862 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -148.24 160.53 42.86 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.616 1.566 . . . . 73.25 108.565 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -86.28 148.13 25.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.848 1.259 . . . . 71.31 109.784 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.602 0 C-N-CA 125.991 1.717 . . . . 54.23 107.261 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 . . . . . 0 N--CA 1.466 0.369 0 N-CA-C 109.384 -0.598 . . . . 73.33 109.384 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -119.03 161.38 20.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 105.81 -1.922 . . . . 52.33 105.81 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -134.68 139.41 47.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.178 1.391 . . . . 75.44 110.261 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.75 141.56 27.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 106.971 -1.492 . . . . 71.1 106.971 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -103.79 133.19 49.2 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.31 -2.107 . . . . 71.31 105.31 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.426 HG12 HD11 ' A' ' 11' ' ' LEU . 93.2 t -136.79 130.6 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.731 -1.952 . . . . 72.34 105.731 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.95 179.92 21.74 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 121.348 1.885 . . . . 54.24 115.041 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.82 17.15 2.32 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.162 2.585 . . . . 52.52 111.399 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.426 HD11 HG12 ' A' ' 8' ' ' VAL . 7.4 mp -66.76 146.23 99.05 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 125.023 1.329 . . . . 72.43 112.765 -177.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -67.07 167.76 19.13 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.681 2.921 . . . . 75.13 112.119 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -75.0 -34.64 61.97 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.297 -1.001 . . . . 73.33 108.297 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.6 11.62 3.65 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.149 1.38 . . . . 61.11 112.172 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.441 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 8.7 tp -54.77 143.61 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 120.679 -1.263 . . . . 71.21 109.31 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 p -128.11 148.25 50.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.445 1.098 . . . . 71.42 110.074 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.95 -29.63 70.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.209 -0.9 . . . . 41.54 110.652 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.65 -38.21 81.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 119.069 0.85 . . . . 75.2 109.782 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HB3' HD11 ' A' ' 69' ' ' LEU . 4.1 mm-40 -71.48 -43.11 67.19 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.022 -0.732 . . . . 75.43 109.022 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.51 -49.64 75.91 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.34 1.056 . . . . 64.43 111.253 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -59.39 -42.14 91.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.629 0.772 . . . . 74.42 109.178 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -68.79 -40.88 79.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.385 1.474 . . . . 74.14 113.535 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -41.28 91.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 118.739 0.699 . . . . 71.32 111.978 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -99.75 4.74 45.56 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.82 1.044 . . . . 70.24 113.82 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -51.19 -47.54 62.18 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.067 1.347 . . . . 64.5 109.896 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.06 -39.9 79.64 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.633 0.773 . . . . 74.32 111.838 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 p -81.87 -10.76 59.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.732 1.213 . . . . 71.32 112.794 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.64 65.95 6.38 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 114.965 1.468 . . . . 74.24 114.965 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -64.91 151.86 84.32 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.751 2.301 . . . . 61.34 108.897 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.68 -48.49 8.24 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.077 -1.083 . . . . 63.3 108.077 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' NE2' ' H ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -124.5 153.88 41.38 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.258 -1.016 . . . . 72.0 108.258 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.454 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 65.3 mt -145.92 119.83 2.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.425 -1.694 . . . . 71.21 106.425 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.43 108.22 10.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.733 -1.58 . . . . 74.34 106.733 178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -93.59 125.93 38.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.746 -1.576 . . . . 65.5 106.746 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -118.24 89.69 3.18 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.426 -2.064 . . . . 74.11 105.426 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.15 -16.41 52.56 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.148 -0.453 . . . . 32.44 111.417 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -50.48 -40.08 50.0 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.246 2.219 . . . . 75.23 111.034 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -126.84 6.56 6.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.853 1.661 . . . . 64.35 110.174 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.12 42.63 99.73 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.313 -1.115 . . . . 54.52 110.313 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.7 162.31 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.856 1.263 . . . . 70.24 109.37 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.75 152.23 40.06 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.126 0.971 . . . . 64.3 109.527 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -120.31 135.25 55.08 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 103.958 -2.608 . . . . 74.13 103.958 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.53 122.99 25.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.158 -1.793 . . . . 50.33 106.158 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -96.6 150.71 20.35 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.188 -1.412 . . . . 71.51 107.188 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -142.13 110.68 6.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.388 -1.338 . . . . 75.12 107.388 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -76.25 118.19 18.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.645 0.778 . . . . 62.42 109.302 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.76 -18.88 50.03 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 128.025 2.53 . . . . 75.54 112.344 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.5 -30.33 52.94 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.479 -1.674 . . . . 73.05 106.479 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -61.73 -37.5 84.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.696 1.198 . . . . 62.32 112.348 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -147.94 97.92 2.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.297 0.953 . . . . 63.12 108.876 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -51.46 -31.52 23.59 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 115.894 -2.003 . . . . 63.11 116.315 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.79 -20.59 8.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 121.021 1.737 . . . . 64.32 111.287 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.42 -30.7 66.54 Favored Glycine 0 C--N 1.338 0.66 0 O-C-N 121.015 -1.053 . . . . 71.33 110.835 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.7 tp -49.76 -41.95 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.388 1.094 . . . . 43.03 112.055 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -68.23 -61.34 1.89 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.222 0.609 . . . . 74.52 110.342 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -56.15 -30.84 62.74 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.93 -0.481 . . . . 75.32 111.331 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.3 mtt85 -68.44 -41.16 80.7 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.01 -1.056 . . . . 74.32 108.741 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.0 mtm -64.55 -44.09 91.9 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 107.163 -1.421 . . . . 72.53 107.163 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -56.5 -48.24 77.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.948 0.899 . . . . 34.31 109.048 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.58 -41.38 87.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.137 0.975 . . . . 65.42 109.848 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.27 84.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.448 -0.575 . . . . 73.14 109.448 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.28 -32.55 74.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.828 0.851 . . . . 70.21 110.245 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.3 mt -65.28 -13.04 57.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 118.795 -0.621 . . . . 71.24 110.951 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -86.49 3.93 41.97 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.932 0.787 . . . . 53.2 110.262 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -69.53 112.71 6.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.083 -1.636 . . . . 74.41 107.842 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.65 -3.93 85.05 Favored Glycine 0 C--O 1.225 -0.447 0 CA-C-O 116.436 -2.313 . . . . 75.4 111.893 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -64.87 137.73 57.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 121.44 2.62 . . . . 63.34 107.138 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.49 126.28 30.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.027 -1.842 . . . . 75.34 106.027 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 19' ' ' GLU . 49.7 tp -129.82 122.9 29.65 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 105.364 -2.088 . . . . 74.12 105.364 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 6.0 mtpm? 51.37 44.85 28.69 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.768 1.627 . . . . 74.23 111.359 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 57.83 33.89 23.74 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 127.644 2.378 . . . . 72.01 113.193 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -134.46 128.54 33.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 126.039 1.736 . . . . 73.34 108.137 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -78.52 112.15 15.29 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 103.534 -2.765 . . . . 74.44 103.534 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.8 pt -104.56 169.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 118.137 0.426 . . . . 74.14 110.359 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -121.64 158.7 28.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.286 1.034 . . . . 60.04 111.236 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -146.21 143.63 21.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.846 1.258 . . . . 64.12 108.048 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -162.07 161.13 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.647 1.579 . . . . 72.22 108.863 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.67 152.18 22.78 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.916 1.286 . . . . 73.3 109.109 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.33 -0.261 0 C-N-CA 124.797 1.239 . . . . 72.43 108.603 179.531 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.602 0.239 . . . . 75.52 110.74 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -130.21 158.8 38.75 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 129.786 3.234 . . . . 73.13 105.196 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.4 mt -130.36 149.32 33.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.832 0.825 . . . . 42.44 109.338 -177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 t -108.9 127.14 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 125.798 1.639 . . . . 71.23 107.421 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -91.45 128.32 37.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.537 -2.394 . . . . 61.25 104.537 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.84 129.55 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.462 -1.681 . . . . 75.34 106.462 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.72 -175.72 14.44 Favored Glycine 0 N--CA 1.468 0.814 0 CA-C-N 120.317 1.417 . . . . 32.01 113.09 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 72.21 14.45 5.56 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.217 2.207 . . . . 74.24 111.543 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.26 149.59 82.3 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 125.232 1.413 . . . . 72.42 112.334 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.98 165.15 31.05 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.282 2.655 . . . . 72.45 110.036 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.19 -31.52 58.51 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.219 1.008 . . . . 75.21 109.494 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -85.35 10.89 11.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.303 1.441 . . . . 75.41 113.467 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.551 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 8.6 tp -57.61 138.97 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.488 1.115 . . . . 71.3 111.69 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 p -128.32 153.4 47.05 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.184 0.994 . . . . 74.3 109.738 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.36 -33.31 65.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.446 1.898 . . . . 71.34 111.366 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.8 p -66.14 -37.7 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 119.126 -0.464 . . . . 54.03 110.113 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.79 -43.39 72.22 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.392 -0.966 . . . . 73.24 108.392 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -60.36 -55.63 31.24 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 125.276 1.43 . . . . 73.33 110.069 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -57.63 -45.06 85.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.037 -0.727 . . . . 74.02 109.037 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -60.34 -44.1 95.83 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 65.11 112.813 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -47.98 74.89 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 119.419 1.009 . . . . 74.41 110.825 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -83.01 1.02 42.09 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 115.362 1.615 . . . . 74.53 115.362 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -51.26 -41.57 60.49 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.223 1.409 . . . . 71.43 113.382 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -32.75 74.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.885 0.874 . . . . 75.32 110.666 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 88.1 p -87.16 -28.76 22.25 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.255 1.206 . . . . 64.43 114.255 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.4 t 62.81 75.21 0.42 Allowed Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.53 1.932 . . . . 65.14 112.358 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -67.33 159.97 49.86 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.934 3.09 . . . . 63.02 110.719 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -85.63 -46.47 10.74 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.871 1.668 . . . . 72.14 108.009 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.56 157.21 44.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.902 -0.59 . . . . 73.04 109.598 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.6 mt -137.93 128.46 36.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 125.028 1.331 . . . . 65.12 108.875 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 103.39 5.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.35 -1.352 . . . . 72.41 107.35 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -88.62 111.73 22.25 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.95 -1.5 . . . . 60.45 106.95 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -105.28 80.22 1.57 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.079 -1.452 . . . . 72.24 107.079 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.66 -27.97 43.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.977 0.911 . . . . 74.31 111.246 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -51.09 -27.9 9.32 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 127.515 2.326 . . . . 70.3 113.904 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -132.65 9.96 4.31 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.888 1.275 . . . . 74.53 111.093 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.14 42.7 99.87 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.795 1.188 . . . . 64.14 110.619 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.54 166.05 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 C-N-CA 124.816 1.246 . . . . 73.24 111.482 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.31 148.77 36.84 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.328 2.251 . . . . 53.2 108.239 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -124.16 129.39 50.74 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.961 -1.866 . . . . 75.34 105.961 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.11 114.13 15.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.209 -1.034 . . . . 64.23 108.209 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -92.66 155.04 17.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.745 -1.946 . . . . 62.12 105.745 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -140.02 137.22 34.46 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.629 -1.619 . . . . 74.34 106.629 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -81.7 110.19 16.81 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.944 1.247 . . . . 73.33 109.444 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.59 -16.99 62.9 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.631 1.172 . . . . 60.34 112.273 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.69 -18.38 29.66 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.997 0.817 . . . . 73.32 110.777 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -60.98 -35.61 77.24 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.157 0.889 . . . . 70.41 110.357 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -150.14 86.71 1.43 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.922 -1.881 . . . . 73.43 105.922 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -49.75 -37.36 29.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.471 1.108 . . . . 70.43 112.226 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 -3.1 39.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.257 1.423 . . . . 72.02 113.578 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.06 -19.75 5.84 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 124.923 1.249 . . . . 53.24 114.788 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 tp -52.83 -36.99 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.42 1.61 . . . . 62.43 111.461 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -56.42 -54.84 40.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.846 1.259 . . . . 63.32 108.398 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -47.03 79.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.34 1.056 . . . . 72.52 109.793 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -54.74 -46.59 74.3 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 118.727 -0.654 . . . . 75.01 109.273 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 2.7 mtm -61.33 -50.88 71.16 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 108.173 -1.047 . . . . 72.1 108.173 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.04 -52.52 8.87 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.796 2.038 . . . . 74.14 111.836 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.0 mt -59.08 -41.9 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.199 1.4 . . . . 71.32 110.091 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.32 -36.82 61.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.159 0.984 . . . . 71.13 111.058 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -66.96 -36.08 81.41 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.642 1.11 . . . . 74.31 109.586 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.68 -12.73 11.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.568 1.147 . . . . 55.11 111.512 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -84.61 5.02 29.59 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.871 0.759 . . . . 52.24 110.278 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -69.07 113.92 6.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.285 -1.746 . . . . 72.23 106.285 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.28 6.23 61.56 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.282 -1.288 . . . . 70.42 113.458 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.5 p -68.07 143.56 55.44 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 120.482 2.141 . . . . 74.51 108.607 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 73' ' ' LYS . 15.2 mt -88.71 107.6 19.03 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 103.174 -2.899 . . . . 61.13 103.174 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.9 tp -113.0 117.5 32.21 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.715 -1.587 . . . . 62.32 106.715 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 14.3 mtpp 47.05 56.1 7.22 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.883 0.873 . . . . 65.04 111.891 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 60.95 23.38 13.5 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.856 1.662 . . . . 72.41 114.789 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -132.41 126.67 33.67 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 124.685 1.194 . . . . 73.31 108.757 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.422 ' HA ' HD23 ' A' ' 68' ' ' LEU . 4.6 ttpm? -80.1 114.3 18.9 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 104.067 -2.568 . . . . 75.55 104.067 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.2 pt -94.96 169.24 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 118.436 0.562 . . . . 65.04 109.984 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -122.99 158.59 30.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.01 1.324 . . . . 72.34 110.861 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.0 t -142.52 126.44 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 126.009 1.723 . . . . 72.23 108.797 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -139.03 174.47 10.48 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.475 1.51 . . . . 74.32 108.156 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.46 151.78 18.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.152 -0.967 . . . . 74.51 110.124 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 107.249 -1.389 . . . . 63.02 107.249 178.203 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.414 HH11 ' HB3' ' A' ' 44' ' ' GLU . 9.8 tpp180 . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 108.384 -0.969 . . . . 73.31 108.384 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -128.55 157.71 40.46 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.778 1.631 . . . . 65.54 107.233 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -134.91 146.01 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.361 1.065 . . . . 64.25 110.02 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.8 126.44 57.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.62 -1.993 . . . . 71.32 105.62 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -96.58 105.14 17.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.594 -1.632 . . . . 74.23 106.594 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -113.66 139.35 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 120.027 1.285 . . . . 62.11 108.675 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -149.06 178.31 26.7 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 119.928 1.24 . . . . 62.44 112.663 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 84.99 6.3 0.5 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.405 3.082 . . . . 74.21 111.833 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp -46.24 148.67 1.49 Allowed Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 127.339 2.256 . . . . 73.03 115.392 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.86 175.28 7.55 Favored 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.98 4.453 . . . . 54.32 113.379 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mmt-85 -78.47 -45.44 22.08 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 107.898 -1.149 . . . . 54.25 107.898 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -84.25 22.02 1.3 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.031 1.733 . . . . 61.3 112.889 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.7 tp -61.93 142.25 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.628 -1.249 . . . . 63.03 107.628 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.99 150.01 50.58 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.376 -0.972 . . . . 64.04 108.376 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -32.39 70.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.848 -0.797 . . . . 75.42 108.848 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.01 -49.08 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.138 1.375 . . . . 74.25 109.868 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.46 -34.75 74.84 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.01 -0.676 . . . . 73.42 109.215 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.12 -49.85 72.77 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.943 0.792 . . . . 72.12 109.436 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -59.92 -37.78 80.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.828 -0.606 . . . . 72.23 110.501 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -69.59 -50.82 40.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.394 0.677 . . . . 44.34 110.764 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -24.11 67.7 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 120.971 -1.081 . . . . 74.24 112.213 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -108.54 8.79 27.39 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.88 1.218 . . . . 70.35 111.712 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -61.27 -26.72 67.96 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 120.107 -1.62 . . . . 65.24 114.062 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -30.1 23.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.639 1.109 . . . . 65.53 108.767 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -31.2 58.73 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.407 -0.96 . . . . 63.51 108.407 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m 60.69 72.35 0.73 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 126.674 1.99 . . . . 73.53 113.134 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.14 158.1 58.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.741 2.961 . . . . 65.44 110.465 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -78.96 -45.74 19.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.857 -1.534 . . . . 73.15 106.857 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -156.77 139.71 15.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.477 1.511 . . . . 63.41 108.48 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.14 142.19 22.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.384 -1.71 . . . . 74.54 106.384 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -135.09 103.8 5.69 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.581 -1.637 . . . . 73.33 106.581 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -86.7 121.44 29.22 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.463 -1.31 . . . . 61.24 107.463 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -108.85 82.35 1.59 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.542 -1.651 . . . . 73.32 106.542 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.56 -23.22 62.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.216 0.606 . . . . 62.44 111.347 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.95 -26.93 66.37 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.56 1.544 . . . . 74.12 111.981 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -133.17 6.6 3.89 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.693 1.197 . . . . 70.03 112.591 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.32 47.41 91.03 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 119.063 0.847 . . . . 62.03 111.287 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.469 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 2.3 pt -134.73 159.78 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.196 1.398 . . . . 73.25 108.727 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.68 135.06 21.88 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.58 1.152 . . . . 54.12 108.347 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -108.17 139.33 43.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.573 -2.01 . . . . 74.13 105.573 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.32 116.03 15.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 105.406 -2.072 . . . . 64.45 105.406 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.414 ' HB3' HH11 ' A' ' 3' ' ' ARG . 35.8 mt-10 -88.05 149.98 23.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.918 0.887 . . . . 53.32 109.711 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -140.98 123.31 15.79 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.188 1.795 . . . . 60.11 107.654 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -90.82 112.4 24.19 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.111 0.964 . . . . 72.21 110.882 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.42 -22.58 62.71 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.107 1.363 . . . . 45.25 111.74 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.93 -37.04 64.71 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.941 -1.133 . . . . 51.32 107.941 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -69.17 -38.25 78.61 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 118.687 -0.673 . . . . 73.23 109.657 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.0 75.86 1.4 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.823 0.738 . . . . 63.23 111.564 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -54.15 -39.61 66.68 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 118.837 -0.601 . . . . 74.44 111.979 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.9 p -104.26 -1.26 27.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.872 1.269 . . . . 75.23 113.449 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.43 -13.88 7.91 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-O 117.958 -1.468 . . . . 63.2 114.813 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.3 tp -51.4 -50.37 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 120.171 1.986 . . . . 72.35 112.218 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -53.33 57.02 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.331 -0.989 . . . . 62.34 108.331 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -50.59 -48.65 57.69 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.133 0.573 . . . . 73.13 111.068 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -57.01 -49.63 75.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.549 1.14 . . . . 55.03 108.719 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 43.2 mtm -64.08 -36.53 84.32 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.405 0.682 . . . . 70.31 111.345 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -55.35 -51.07 67.98 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.704 2.002 . . . . 43.4 111.65 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.47 -26.56 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.568 1.547 . . . . 65.13 109.368 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.89 -39.58 19.67 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.973 0.909 . . . . 70.51 108.927 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.31 -44.67 95.23 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.032 1.733 . . . . 72.01 110.221 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.3 mt -58.41 -6.82 0.74 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.485 1.914 . . . . 74.22 113.938 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -89.4 -3.7 58.32 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.29 0.95 . . . . 72.34 111.331 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -59.23 112.66 1.8 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.797 1.239 . . . . 72.1 108.85 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' CA ' ' HE2' ' A' ' 73' ' ' LYS . . . 91.28 3.52 69.51 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.934 -1.481 . . . . 72.34 115.009 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 p -70.6 160.77 31.91 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.618 1.709 . . . . 62.33 109.124 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 mt -109.49 108.85 19.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.307 1.443 . . . . 75.14 109.536 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.78 132.83 55.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.858 -2.275 . . . . 73.52 104.858 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.7 mttm 46.09 45.8 12.6 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.282 1.039 . . . . 75.33 111.655 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 64.32 0.12 0.99 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.685 2.794 . . . . 71.12 115.855 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -109.89 140.2 44.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.63 1.104 . . . . 73.31 109.645 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.461 ' HE2' ' CA ' ' A' ' 66' ' ' GLY . 15.8 tttm -78.95 156.16 28.64 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.47 -0.937 . . . . 73.43 108.47 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 pt -129.58 170.08 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.884 1.274 . . . . 65.02 111.003 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.25 147.98 52.03 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.156 1.783 . . . . 63.23 106.457 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.6 t -139.12 136.31 42.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 124.802 1.241 . . . . 34.42 108.333 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -147.18 171.98 14.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.149 1.78 . . . . 62.13 108.049 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.14 152.79 20.45 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.373 1.469 . . . . 64.22 108.831 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 C--N 1.328 -0.342 0 N-CA-C 106.886 -1.524 . . . . 72.42 106.886 176.662 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 ptt-85 . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 108.934 -0.765 . . . . 74.11 108.934 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -123.14 160.42 26.5 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 105.179 -2.156 . . . . 75.13 105.179 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -134.68 129.64 52.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.463 1.505 . . . . 75.21 110.873 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.5 t -102.79 128.42 55.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 105.349 -2.093 . . . . 51.41 105.349 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -96.81 141.49 29.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.184 -1.784 . . . . 74.24 106.184 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.415 HG12 HD11 ' A' ' 11' ' ' LEU . 2.6 t -138.45 133.35 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.944 -1.873 . . . . 74.14 105.944 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.414 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -140.84 177.96 20.46 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 120.888 1.676 . . . . 64.42 111.791 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.423 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 0.5 OUTLIER 73.78 16.47 3.78 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.047 2.539 . . . . 42.53 111.116 -178.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.415 HD11 HG12 ' A' ' 8' ' ' VAL . 9.5 mp -62.54 147.63 92.07 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.445 1.498 . . . . 64.33 113.648 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -66.67 164.96 27.11 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.301 2.668 . . . . 74.23 111.329 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -76.38 -29.53 57.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 122.976 0.51 . . . . 71.24 110.742 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.09 13.51 11.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.175 0.99 . . . . 73.44 112.984 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.569 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.6 tp -59.02 138.87 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.234 1.014 . . . . 62.34 111.328 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 p -128.3 158.39 38.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.744 1.618 . . . . 74.44 109.909 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.1 -29.58 69.37 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.101 0.56 . . . . 63.15 110.348 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.21 -34.04 67.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.305 0.642 . . . . 75.43 110.228 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -73.66 -47.94 36.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.038 -1.468 . . . . 74.11 107.038 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -56.06 -46.41 78.95 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.302 1.441 . . . . 75.02 110.652 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -61.6 -36.61 81.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.521 -0.752 . . . . 74.53 110.214 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.14 -30.99 60.94 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.757 0.708 . . . . 73.41 110.877 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -68.36 -50.19 54.87 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.182 -0.949 . . . . 71.44 110.015 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -91.74 10.87 26.58 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.222 1.009 . . . . 75.1 112.825 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -35.76 63.82 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 120.681 -1.262 . . . . 75.42 110.793 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -82.6 -9.15 59.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.1 0.96 . . . . 75.13 113.533 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.17 -10.79 14.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.671 1.188 . . . . 70.11 111.586 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 t 47.24 61.78 13.03 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.58 2.352 . . . . 73.21 114.893 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.36 161.0 15.02 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.399 2.733 . . . . 73.15 111.561 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -38.86 10.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.36 1.064 . . . . 74.32 109.404 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -136.01 153.17 51.45 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.191 0.997 . . . . 71.31 108.358 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.3 mt -139.5 125.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 105.388 -2.078 . . . . 71.44 105.388 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.42 104.5 4.6 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.528 -1.286 . . . . 71.24 107.528 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -88.7 119.47 29.21 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 124.689 1.196 . . . . 64.35 108.331 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -108.69 82.45 1.61 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.026 -1.472 . . . . 72.12 107.026 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.97 -26.88 50.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.778 0.831 . . . . 53.41 111.548 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.08 -28.39 10.41 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 128.285 2.634 . . . . 71.34 112.709 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -132.92 9.16 4.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.782 1.233 . . . . 75.14 110.443 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.16 43.85 96.81 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 119.6 1.091 . . . . 51.14 110.932 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.414 HG22 ' CA ' ' A' ' 9' ' ' GLY . 3.1 pt -134.85 166.2 29.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.102 1.361 . . . . 65.21 111.247 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.49 154.37 43.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.076 1.351 . . . . 72.53 109.489 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.48 123.26 39.74 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.107 1.363 . . . . 75.04 107.387 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.5 114.77 21.71 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.321 -0.992 . . . . 75.2 108.321 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -91.21 151.07 21.09 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.919 -1.141 . . . . 74.23 107.919 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -136.74 134.26 36.93 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.672 1.589 . . . . 70.02 107.304 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.27 112.54 24.35 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.86 1.664 . . . . 74.02 111.319 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.38 -27.41 68.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.086 1.354 . . . . 55.12 111.32 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.52 -32.99 68.79 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.423 -0.322 . . . . 71.04 110.393 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -62.94 -22.82 67.06 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.79 0.723 . . . . 72.44 112.928 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -158.82 99.43 1.55 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.192 -1.41 . . . . 73.52 107.192 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -54.02 50.03 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.512 0.725 . . . . 74.11 112.463 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.84 -19.6 23.23 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.309 1.044 . . . . 72.25 110.976 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.53 -22.3 62.57 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-O 117.228 -1.873 . . . . 62.51 113.589 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.77 -40.8 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 120.532 2.166 . . . . 74.32 110.106 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.53 -58.5 6.94 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.657 -1.238 . . . . 64.55 107.657 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.1 -48.37 76.29 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.812 0.845 . . . . 63.33 111.095 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.18 -41.05 68.1 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.128 -0.693 . . . . 74.32 109.128 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 6.4 mtm -71.88 -44.45 63.73 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.332 1.053 . . . . 75.42 110.681 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -48.88 72.0 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.831 1.652 . . . . 75.54 110.575 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.74 -39.77 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.691 1.597 . . . . 74.32 108.802 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.72 75.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.876 -0.583 . . . . 31.35 109.573 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.43 -31.58 72.75 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.965 0.802 . . . . 73.13 110.493 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.4 mt -68.95 -5.13 19.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.649 -0.657 . . . . 63.13 112.092 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -89.65 -0.64 57.66 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.058 0.845 . . . . 62.34 110.453 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -66.02 113.09 4.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.026 1.73 . . . . 73.31 110.991 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.2 2.99 67.92 Favored Glycine 0 N--CA 1.459 0.233 0 CA-C-O 117.942 -1.477 . . . . 64.14 114.173 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -66.93 133.77 50.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.59 1.695 . . . . 61.01 108.369 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 73' ' ' LYS . 29.6 mt -76.21 108.21 8.98 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 105.743 -1.947 . . . . 71.32 105.743 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.6 tp -115.88 119.6 36.5 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.675 -1.602 . . . . 70.32 106.675 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 17.3 mtpp 49.21 50.44 17.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.741 1.616 . . . . 63.4 112.368 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 64.28 24.99 13.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.172 2.189 . . . . 70.22 113.576 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 10' ' ' SER . 15.0 mmmt -131.77 124.44 29.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.62 1.168 . . . . 74.25 110.647 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' HD23 ' A' ' 68' ' ' LEU . 6.5 tptm -79.83 105.77 11.36 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 101.7 -3.444 . . . . 73.2 101.7 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.3 pt -95.63 169.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 124.006 0.922 . . . . 75.34 108.685 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -127.17 158.97 35.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.796 1.238 . . . . 75.23 111.52 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.0 t -137.06 139.22 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 126.526 1.931 . . . . 73.53 107.191 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -149.67 162.74 39.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.674 1.189 . . . . 55.15 108.127 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 147.55 25.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.469 1.108 . . . . 65.2 109.291 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 C--N 1.325 -0.489 0 CA-C-O 117.912 -1.042 . . . . 65.24 108.748 178.883 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.235 0.295 0 N-CA-C 112.018 0.377 . . . . 71.54 112.018 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -100.16 157.31 16.67 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 128.21 2.604 . . . . 74.41 107.125 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mt -135.41 149.19 28.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 124.696 1.198 . . . . 74.14 108.082 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.1 t -116.65 127.49 74.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 105.768 -1.938 . . . . 73.24 105.768 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -94.75 139.32 31.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.374 -1.713 . . . . 72.43 106.374 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 t -139.26 132.49 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.327 -1.731 . . . . 61.23 106.327 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.62 -178.19 17.55 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 120.095 1.316 . . . . 52.4 111.63 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.03 10.68 4.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.599 2.36 . . . . 65.51 111.344 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mp -54.27 144.94 38.48 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 125.487 1.515 . . . . 55.03 112.695 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -67.65 157.76 60.28 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.352 2.035 . . . . 74.42 110.26 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -65.57 -43.23 90.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.91 -1.145 . . . . 73.53 107.91 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.64 13.34 0.64 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.352 2.261 . . . . 63.45 112.857 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.506 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 10.3 tp -57.56 144.82 9.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 O-C-N 120.878 -1.139 . . . . 74.45 108.984 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.56 147.5 50.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.45 -1.315 . . . . 72.42 107.45 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.88 71.46 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.253 -0.647 . . . . 35.14 109.253 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.14 -44.28 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 124.048 0.939 . . . . 73.12 110.496 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.99 -38.56 76.06 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.494 -0.558 . . . . 74.54 109.494 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.15 -47.09 86.11 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.876 -0.416 . . . . 73.03 109.876 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -60.88 -47.41 86.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.701 -0.852 . . . . 60.24 108.701 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -58.45 -35.89 72.83 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 115.247 1.573 . . . . 64.05 115.247 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -76.17 -51.84 11.32 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.528 -0.733 . . . . 61.51 110.62 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -81.17 7.32 11.44 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.906 1.076 . . . . 73.53 113.906 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -57.0 -27.12 61.31 Favored 'General case' 0 CA--C 1.527 0.094 0 O-C-N 120.586 -1.321 . . . . 72.45 113.602 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -87.27 -16.65 34.57 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.379 0.672 . . . . 74.33 112.038 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.5 -13.98 18.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.132 0.973 . . . . 73.25 111.701 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m 49.15 73.53 0.98 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 125.921 1.688 . . . . 75.34 114.569 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.83 158.32 54.39 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.919 1.746 . . . . 74.43 110.543 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -89.39 -41.57 12.03 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.784 0.834 . . . . 75.42 109.029 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -137.31 153.56 50.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.711 1.204 . . . . 51.02 109.814 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.3 mt -143.77 121.05 5.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.358 1.463 . . . . 43.25 108.215 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 104.24 6.67 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 125.519 1.528 . . . . 73.11 108.096 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.39 116.11 28.08 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.084 1.354 . . . . 74.23 107.931 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 46.5 mtt-85 -109.46 85.5 2.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.96 -1.496 . . . . 74.3 106.96 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.14 -22.5 60.99 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.706 -0.679 . . . . 71.43 111.508 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -51.58 -29.59 17.86 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.709 2.404 . . . . 73.21 112.286 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -132.88 9.78 4.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.202 1.401 . . . . 53.22 110.335 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.93 48.28 86.83 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.506 -1.037 . . . . 42.45 110.506 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.3 pt -136.76 167.39 23.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.368 1.467 . . . . 63.23 110.718 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.18 155.69 38.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.563 1.145 . . . . 50.23 109.569 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -125.68 125.73 43.53 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.038 1.335 . . . . 73.42 108.185 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.57 112.06 18.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.156 -1.053 . . . . 62.15 108.156 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -91.25 156.07 18.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.847 -1.538 . . . . 72.11 106.847 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -144.09 148.65 35.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.2 -1.408 . . . . 74.41 107.2 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -101.58 111.05 23.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.244 0.929 . . . . 73.43 110.897 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.08 -24.25 62.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.556 0.742 . . . . 44.52 111.242 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.35 -28.4 62.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.008 0.822 . . . . 72.04 110.46 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -64.21 -29.09 70.21 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 124.66 1.184 . . . . 74.24 112.251 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -158.45 86.13 0.86 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.12 -1.067 . . . . 75.32 108.12 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -48.35 -36.34 14.28 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.75 1.759 . . . . 72.44 115.75 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.62 -17.21 14.31 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.627 1.103 . . . . 61.31 111.896 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.1 -26.7 43.4 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 118.196 -1.335 . . . . 74.02 111.71 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.31 -39.9 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.217 1.509 . . . . 72.25 110.689 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -60.68 -58.14 9.71 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.099 -1.074 . . . . 61.11 108.099 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -57.32 -40.17 77.36 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.034 -1.041 . . . . 75.32 111.253 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -58.53 -41.06 84.65 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.101 -1.074 . . . . 74.13 108.101 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 9.0 mtm -66.85 -50.15 63.45 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 117.972 -1.014 . . . . 50.15 108.292 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -51.62 -48.87 63.11 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.54 1.136 . . . . 63.51 110.169 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.12 -31.2 49.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.665 1.586 . . . . 71.34 111.148 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.62 -38.48 21.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.931 0.787 . . . . 44.04 109.2 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.4 mt -67.17 -31.06 71.23 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.338 1.055 . . . . 64.22 110.268 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.81 -12.76 38.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.938 0.895 . . . . 75.54 110.559 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -89.79 4.21 50.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.805 1.242 . . . . 63.34 111.436 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -68.16 120.56 14.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.608 -1.997 . . . . 73.24 105.608 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.39 9.01 63.68 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.028 -1.429 . . . . 60.35 113.245 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 p -68.04 144.17 55.22 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 120.065 1.933 . . . . 71.41 109.912 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.8 mt -93.19 107.4 19.21 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 102.187 -3.264 . . . . 63.34 102.187 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.19 113.93 27.01 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 104.64 -2.355 . . . . 62.52 104.64 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER 51.76 49.34 21.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.922 0.889 . . . . 73.0 109.325 -178.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 60.51 32.22 20.44 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 127.442 2.297 . . . . 73.14 114.083 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -130.72 118.04 20.31 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.898 0.879 . . . . 74.24 110.195 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -70.06 100.88 1.7 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.822 1.249 . . . . 72.42 108.136 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.1 pt -92.78 165.87 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.277 -0.889 . . . . 63.02 109.517 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.83 156.39 39.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.541 1.136 . . . . 65.32 111.334 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.21 149.22 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.453 1.501 . . . . 52.35 110.631 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -164.33 173.63 12.02 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.939 1.296 . . . . 71.32 111.138 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.63 147.72 23.11 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.294 1.437 . . . . 73.02 109.733 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.33 -0.252 0 C-N-CA 123.137 0.575 . . . . 74.21 110.523 -179.57 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.44 0 CA-C-O 121.396 0.617 . . . . 75.42 112.169 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -97.74 152.71 18.85 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 128.577 2.751 . . . . 74.03 109.124 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 79' ' ' THR . 3.0 mp -135.1 147.06 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.748 1.619 . . . . 70.32 109.404 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.2 t -113.37 131.08 66.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.297 -1.742 . . . . 71.15 106.297 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -91.48 108.98 20.27 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.422 1.889 . . . . 70.11 106.428 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 11' ' ' LEU . 11.6 t -115.83 126.47 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.01 -2.218 . . . . 63.5 105.01 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.26 -179.88 16.88 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 120.214 1.37 . . . . 53.11 112.461 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.84 19.44 5.83 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.03 1.732 . . . . 61.53 111.626 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 8' ' ' VAL . 10.1 mp -60.91 147.91 84.53 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.918 0.887 . . . . 64.45 110.681 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.76 156.98 58.61 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.907 3.071 . . . . 72.12 114.526 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.47 -27.74 68.79 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.642 1.177 . . . . 65.22 112.118 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.65 20.54 18.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.597 1.159 . . . . 74.53 112.536 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.533 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 9.7 tp -55.27 143.16 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 O-C-N 121.005 -1.059 . . . . 72.0 110.852 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 p -128.76 154.56 46.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.61 1.164 . . . . 72.22 109.736 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.0 -30.48 70.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.315 1.046 . . . . 74.22 109.085 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.95 -48.68 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.714 1.206 . . . . 73.42 109.424 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.46 ' HG3' ' HE2' ' A' ' 70' ' ' LYS . 4.1 mm-40 -69.59 -29.3 66.81 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.518 0.727 . . . . 73.4 110.54 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -68.97 -51.27 41.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.06 -1.089 . . . . 74.21 108.06 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -58.75 -45.56 89.43 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 107.946 -1.131 . . . . 73.2 107.946 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -56.08 -48.0 76.92 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.517 1.527 . . . . 72.43 113.629 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -56.34 15.66 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 122.292 1.044 . . . . 74.43 111.454 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -79.68 8.55 6.4 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.481 1.512 . . . . 75.34 114.414 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -56.04 -39.78 72.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.94 -1.1 . . . . 65.31 110.412 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.21 -15.51 57.94 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.982 0.734 . . . . 72.44 112.982 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 p -102.16 -1.49 31.29 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.9 -1.125 . . . . 73.23 111.197 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.0 t 37.32 79.78 0.3 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 127.552 2.341 . . . . 71.15 115.066 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.08 156.57 55.65 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.595 1.53 . . . . 64.04 109.616 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.47 -49.2 8.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.799 -1.556 . . . . 74.43 106.799 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -136.71 154.37 50.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.174 0.99 . . . . 72.53 110.007 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -136.09 133.04 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.372 1.869 . . . . 74.33 109.577 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -142.37 107.95 5.08 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 127.189 2.196 . . . . 63.34 109.5 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -96.41 122.43 39.29 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.649 -1.241 . . . . 63.13 107.649 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -110.29 86.01 2.22 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.948 1.699 . . . . 75.32 106.722 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.65 -32.66 63.39 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.966 0.906 . . . . 71.43 112.333 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -56.78 -19.01 14.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.355 1.462 . . . . 54.34 113.232 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -132.16 -1.31 3.65 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.146 1.378 . . . . 71.44 110.569 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.69 38.79 96.48 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.578 1.085 . . . . 72.11 110.934 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -127.8 163.45 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.19 1.396 . . . . 72.11 109.88 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.61 155.32 47.51 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.04 1.336 . . . . 71.51 109.332 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.76 104.36 9.25 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.18 -1.785 . . . . 71.13 106.18 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.22 111.65 24.14 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 105.158 -2.164 . . . . 51.3 105.158 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.62 157.91 17.23 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.62 0.768 . . . . 75.2 109.494 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -146.19 133.41 20.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.6 1.56 . . . . 72.13 107.304 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -101.73 122.63 44.28 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 105.013 -2.217 . . . . 62.14 105.013 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.63 -23.48 62.55 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.611 1.564 . . . . 63.21 111.261 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -83.65 -18.71 37.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.964 0.506 . . . . 65.55 109.912 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -69.0 -19.11 64.13 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.3 -0.857 . . . . 73.41 111.372 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -168.42 85.04 0.18 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.86 1.664 . . . . 72.21 106.621 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -32.73 6.5 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.821 1.648 . . . . 74.45 113.666 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.3 p -107.57 -20.23 13.3 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.187 0.903 . . . . 64.34 112.806 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.38 -18.03 53.78 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-O 117.677 -1.624 . . . . 61.31 114.494 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.1 tp -50.93 -36.7 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 119.645 1.723 . . . . 61.32 109.13 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -61.26 -61.72 2.35 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.982 2.513 . . . . 74.0 110.653 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.87 -35.45 76.63 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.213 -0.929 . . . . 75.41 109.724 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -60.81 -49.22 78.35 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 108.074 -1.084 . . . . 75.12 108.074 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.4 mtt -57.67 -50.54 72.85 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 124.647 1.179 . . . . 54.44 109.888 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -56.99 -44.62 82.92 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.272 1.029 . . . . 74.2 111.773 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.5 mt -69.85 -34.5 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 108.951 -0.759 . . . . 73.11 108.951 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.82 79.76 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.508 -1.293 . . . . 61.13 107.508 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.4 mt -58.65 -32.24 68.9 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.321 1.048 . . . . 62.23 111.3 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 46.4 mt -66.74 -9.02 32.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.283 -0.865 . . . . 72.12 112.258 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -86.16 -2.48 58.4 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.276 1.398 . . . . 72.24 111.49 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 112.23 2.78 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.788 1.235 . . . . 75.3 108.036 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.11 10.27 59.86 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.404 1.002 . . . . 64.4 114.284 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.3 p -75.1 143.23 43.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.573 1.687 . . . . 65.03 109.591 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.14 108.97 19.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 106.861 -1.533 . . . . 75.04 106.861 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mt -110.38 119.72 40.12 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 105.337 -2.097 . . . . 71.24 105.337 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 33.1 mttt 45.95 49.59 11.87 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.011 0.91 . . . . 74.11 110.528 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 63.29 16.45 9.47 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.92 2.088 . . . . 70.11 116.348 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -119.79 126.77 51.82 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.123 1.369 . . . . 72.31 108.185 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -79.18 106.93 11.57 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.354 -0.239 . . . . 73.31 110.354 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.42 169.89 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 123.543 0.737 . . . . 70.34 111.7 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -128.25 158.75 37.3 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.883 2.073 . . . . 64.12 108.878 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.0 t -142.79 127.41 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.676 1.19 . . . . 64.33 108.784 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -144.0 173.29 11.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.779 1.232 . . . . 74.24 109.361 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.85 151.86 21.55 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.221 1.009 . . . . 75.21 110.308 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.438 HG23 ' HB ' ' A' ' 5' ' ' ILE . 6.9 t . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 106.986 -1.487 . . . . 71.14 106.986 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 . . . . . 0 CA--C 1.512 -0.491 0 N-CA-C 108.584 -0.895 . . . . 71.2 108.584 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -130.77 165.53 22.75 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.081 -1.822 . . . . 63.02 106.081 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.3 mt -130.56 146.41 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 109.001 -0.74 . . . . 72.22 109.001 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.3 131.93 63.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.144 -1.428 . . . . 65.43 107.144 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -89.93 115.41 27.22 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 105.421 -2.066 . . . . 74.25 105.421 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -124.46 128.67 73.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.425 -2.065 . . . . 63.41 105.425 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.406 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -140.3 -179.93 18.45 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 119.233 0.924 . . . . 71.54 111.62 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.418 ' HB3' ' HA ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER 71.83 18.61 5.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.281 1.832 . . . . 73.31 111.097 -178.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.59 153.21 62.99 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 124.663 1.185 . . . . 62.52 113.042 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HG3' ' HB2' ' A' ' 70' ' ' LYS . 10.8 Cg_endo -64.33 167.88 13.85 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.127 2.551 . . . . 45.1 111.64 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -75.34 -41.66 56.17 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 121.716 -0.615 . . . . 72.04 109.938 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.56 19.77 4.37 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.591 0.96 . . . . 64.31 113.591 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.536 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.7 tp -53.47 140.73 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 121.289 -0.882 . . . . 64.25 109.547 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -127.81 150.58 49.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.643 1.177 . . . . 72.25 109.106 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.4 -28.46 69.8 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.579 -0.7 . . . . 71.02 111.069 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -43.1 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.793 -0.818 . . . . 75.21 108.793 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -63.96 -45.27 89.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.682 0.793 . . . . 73.22 109.21 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.89 -48.81 80.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.065 -0.493 . . . . 75.22 110.113 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -61.28 -36.63 80.58 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 118.894 0.77 . . . . 61.34 109.784 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.52 -40.02 77.2 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.813 0.733 . . . . 73.41 111.843 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.532 ' ND1' HD21 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.81 -37.99 70.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.109 0.868 . . . . 65.34 111.316 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -94.61 6.2 49.55 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.459 -0.776 . . . . 74.24 112.264 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -54.84 -39.34 68.47 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.958 1.303 . . . . 74.3 112.531 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -71.17 -35.85 71.79 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.379 -0.825 . . . . 64.23 110.639 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -74.69 -24.14 58.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.636 0.774 . . . . 72.32 112.859 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.9 m 63.74 69.54 0.77 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 116.284 1.957 . . . . 73.51 116.284 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.51 159.6 52.97 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.813 2.342 . . . . 71.31 109.896 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.28 -53.99 5.11 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.91 -1.885 . . . . 74.31 105.91 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -143.92 161.53 38.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.424 1.49 . . . . 71.31 109.406 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.12 140.5 42.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 126.039 1.736 . . . . 53.0 107.151 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -133.16 103.93 6.25 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 107.352 -1.351 . . . . 73.24 107.352 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -87.71 112.57 22.52 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.882 0.873 . . . . 72.11 109.157 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -101.24 87.43 3.23 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.557 -1.646 . . . . 72.35 106.557 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.6 -28.8 61.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.634 1.174 . . . . 73.25 112.687 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -52.61 -38.89 61.01 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.967 2.107 . . . . 71.21 114.064 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -118.88 -6.45 10.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 118.219 -0.896 . . . . 74.41 111.956 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.67 48.25 29.67 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.728 -1.749 . . . . 62.11 108.728 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.406 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.5 pt -137.24 156.13 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 126.233 1.813 . . . . 73.22 108.034 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.4 126.97 12.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.964 -0.754 . . . . 62.3 108.964 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -90.11 135.99 33.32 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.49 -1.3 . . . . 74.45 107.49 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.91 123.99 39.82 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.171 -1.788 . . . . 62.31 106.171 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -95.26 143.44 26.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.312 1.445 . . . . 73.42 108.214 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -135.77 106.85 6.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.052 -1.462 . . . . 73.4 107.052 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.68 116.55 8.51 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.979 0.911 . . . . 35.25 110.538 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.01 -31.23 61.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.608 1.963 . . . . 64.2 112.164 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.02 -22.34 63.11 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.098 0.559 . . . . 65.54 109.845 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -60.7 -35.92 77.52 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 108.964 -0.754 . . . . 74.33 108.964 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -162.22 96.29 0.97 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.042 -0.725 . . . . 62.0 109.042 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -55.55 -29.83 59.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 117.81 -1.09 . . . . 74.35 113.068 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.253 29.9 p -110.74 7.5 22.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.947 0.794 . . . . 74.51 112.738 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.41 -20.71 4.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.484 1.516 . . . . 70.4 112.27 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.3 tp -54.55 -39.93 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 125.048 1.339 . . . . 64.32 111.853 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -58.05 9.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.227 -0.657 . . . . 64.33 109.227 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -57.54 -32.61 67.26 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.52 -0.738 . . . . 72.23 111.551 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -64.42 -51.18 64.49 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.179 -1.415 . . . . 73.04 107.179 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.6 mtm -66.27 -30.59 71.05 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.753 0.821 . . . . 63.02 112.429 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.02 -39.73 90.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.691 1.132 . . . . 73.1 108.884 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.6 mt -66.03 -39.16 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.784 -1.191 . . . . 74.23 107.784 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.38 95.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.368 -0.975 . . . . 74.04 108.368 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.1 mt -63.13 -31.08 72.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.304 0.502 . . . . 65.14 111.264 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.56 -6.95 8.58 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.725 1.009 . . . . 72.21 113.725 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -93.45 -0.56 56.39 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.732 0.697 . . . . 75.11 111.029 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.65 112.78 2.14 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.718 1.607 . . . . 71.01 109.833 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.69 5.55 61.35 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.481 -1.177 . . . . 61.13 113.657 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.3 p -66.79 147.69 52.92 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.988 1.894 . . . . 71.31 109.486 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.41 107.92 19.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.498 -2.038 . . . . 64.35 105.498 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.532 HD21 ' ND1' ' A' ' 23' ' ' HIS . 6.2 mt -107.19 126.07 51.92 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 105.331 -2.1 . . . . 74.32 105.331 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 18.6 mttt 42.1 49.84 4.3 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.486 1.039 . . . . 72.2 111.345 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 64.04 21.85 12.73 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.356 2.263 . . . . 74.23 115.235 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -124.87 126.37 45.45 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.313 -1.492 . . . . 62.35 110.986 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 tptt -74.75 109.46 8.24 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.567 -1.642 . . . . 50.25 106.567 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 1.9 pp -92.8 170.02 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.009 0.924 . . . . 64.4 111.103 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.57 158.13 38.3 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.881 1.272 . . . . 71.41 109.674 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.4 t -141.52 132.38 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.476 -1.675 . . . . 72.32 106.476 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -146.76 163.02 37.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.827 1.251 . . . . 72.41 109.021 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.52 152.17 28.81 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.265 1.026 . . . . 74.13 109.638 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 C-N-CA 124.065 0.946 . . . . 71.52 109.331 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.1 ptt85 . . . . . 0 CA--C 1.512 -0.492 0 CA-C-O 120.562 0.22 . . . . 64.24 110.932 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -113.55 163.15 15.3 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 104.775 -2.305 . . . . 73.34 104.775 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mt -132.24 149.26 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.618 -1.252 . . . . 62.15 107.618 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.8 t -120.01 124.03 71.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.365 -1.717 . . . . 73.12 106.365 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -88.3 136.29 33.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.837 -1.912 . . . . 73.33 105.837 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 11' ' ' LEU . 11.0 t -136.7 129.14 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.244 -2.132 . . . . 63.21 105.244 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.74 -177.97 15.63 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 120.18 1.354 . . . . 74.25 113.374 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.93 14.37 5.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.495 2.318 . . . . 45.02 110.11 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.46 HD11 HG12 ' A' ' 8' ' ' VAL . 10.7 mp -58.39 142.03 82.37 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.746 1.219 . . . . 70.15 111.802 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.28 156.98 60.19 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.11 2.54 . . . . 62.12 111.071 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -68.3 -35.01 77.19 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.498 -0.751 . . . . 74.34 109.172 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.34 8.98 5.17 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.712 1.605 . . . . 74.03 113.392 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.435 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 9.6 tp -51.13 145.71 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.952 1.301 . . . . 71.43 112.678 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.59 150.41 50.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.511 1.124 . . . . 74.53 110.221 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.0 72.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.64 1.176 . . . . 74.12 109.969 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 t -61.41 -41.26 89.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.647 0.779 . . . . 64.23 110.874 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -70.89 -39.03 73.05 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.97 -0.752 . . . . 74.14 108.97 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.33 -51.5 65.72 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.232 1.013 . . . . 74.43 110.674 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -42.78 99.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.063 0.945 . . . . 42.35 109.267 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -64.5 -52.28 58.63 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.334 1.054 . . . . 44.25 113.023 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -48.97 78.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.911 0.778 . . . . 75.44 111.749 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -85.81 1.84 48.07 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 113.857 1.058 . . . . 73.04 113.857 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -47.12 70.24 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 120.083 1.31 . . . . 73.34 111.477 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -60.68 -34.11 73.84 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.133 0.424 . . . . 65.25 111.696 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 p -83.86 -10.48 57.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.883 0.873 . . . . 64.01 111.597 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 m 42.78 68.78 2.61 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 127.057 2.143 . . . . 60.14 113.953 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -64.07 158.39 48.13 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.866 2.377 . . . . 75.51 109.527 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.94 -36.81 13.9 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.032 0.933 . . . . 71.52 108.862 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -127.67 155.74 43.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.901 0.881 . . . . 44.22 111.087 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 75.4 mt -144.74 115.5 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.797 -1.557 . . . . 74.15 106.797 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 104.64 5.57 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.475 1.51 . . . . 75.14 108.407 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.04 119.94 30.82 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.705 1.202 . . . . 73.05 108.285 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 -109.65 84.19 1.88 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.469 -1.678 . . . . 75.02 106.469 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.29 -29.27 65.71 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.343 -0.836 . . . . 34.24 111.369 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -54.31 -26.99 32.57 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.834 1.05 . . . . 62.02 113.834 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.3 mmtt -127.38 9.04 6.59 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.886 0.875 . . . . 65.45 111.262 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.98 48.22 80.99 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.982 -1.247 . . . . 63.14 109.982 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.38 171.29 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 C-N-CA 124.821 1.248 . . . . 71.01 109.675 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.17 168.77 20.82 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.813 1.245 . . . . 52.14 108.46 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -134.82 137.08 43.0 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 104.974 -2.232 . . . . 74.51 104.974 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -137.19 116.29 12.49 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 105.984 -1.858 . . . . 74.13 105.984 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.05 151.33 19.59 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.691 -1.596 . . . . 53.41 106.691 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -141.43 111.83 6.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.069 -1.826 . . . . 70.33 106.069 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.38 122.17 28.56 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.831 0.852 . . . . 65.23 111.183 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.27 93.91 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.496 1.118 . . . . 63.03 111.95 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -62.25 -28.9 70.03 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.961 -0.755 . . . . 72.31 108.961 178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.71 -23.77 66.35 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 117.448 -1.263 . . . . 54.45 112.113 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -163.81 90.4 0.61 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.715 1.606 . . . . 55.11 107.837 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 -56.39 -16.39 5.63 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.513 1.525 . . . . 74.41 115.086 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 m -122.7 -19.44 6.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 120.038 1.29 . . . . 52.32 112.413 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.51 -14.62 43.51 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 117.245 -1.864 . . . . 55.32 114.883 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -50.17 -44.51 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 120.491 2.146 . . . . 73.43 111.572 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -62.39 -58.16 8.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.961 0.904 . . . . 72.04 110.472 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -59.2 -31.2 68.81 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.516 -1.365 . . . . 74.31 111.054 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -62.53 -41.11 98.65 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.519 -1.289 . . . . 64.24 107.519 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 12.1 mtm -65.8 -42.83 90.23 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.158 -1.053 . . . . 54.12 108.158 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -54.13 -49.78 68.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.524 1.056 . . . . 54.03 110.375 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -61.28 -44.85 99.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.299 1.44 . . . . 65.35 109.481 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.83 -42.0 95.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.374 0.534 . . . . 71.45 109.983 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.19 -29.9 69.7 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.132 0.973 . . . . 64.22 111.428 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.19 -13.31 57.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.772 -0.632 . . . . 61.0 109.895 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -85.49 2.17 45.8 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.979 0.809 . . . . 74.21 111.079 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -67.11 112.07 4.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.137 -1.602 . . . . 71.11 108.519 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.47 10.47 53.61 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.646 1.117 . . . . 73.51 113.563 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.9 p -68.77 141.01 55.33 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.773 1.786 . . . . 62.41 110.214 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.5 mt -87.41 110.68 20.44 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 101.938 -3.356 . . . . 70.15 101.938 176.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -115.41 121.49 42.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.587 1.555 . . . . 71.41 108.422 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 5.9 mtpm? 50.17 44.57 26.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.011 0.924 . . . . 74.54 112.761 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 67.67 24.27 8.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.106 2.162 . . . . 74.44 112.315 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -140.19 126.61 20.12 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.638 1.575 . . . . 55.21 110.302 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -75.17 143.54 43.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.475 -1.676 . . . . 75.51 106.475 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.6 pt -128.47 162.64 34.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.002 0.921 . . . . 64.45 109.492 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -120.43 159.02 25.97 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 125.368 1.467 . . . . 75.32 111.694 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.6 t -136.0 148.06 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 107.896 -1.15 . . . . 65.54 107.896 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -161.71 161.56 29.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.868 1.667 . . . . 74.3 108.771 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.5 152.22 23.35 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.626 1.17 . . . . 63.34 113.214 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 125.302 1.441 . . . . 62.23 108.34 179.32 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.861 0 N-CA-C 106.35 -1.722 . . . . 72.54 106.35 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -127.92 162.9 25.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.508 -1.293 . . . . 75.54 107.508 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 79' ' ' THR . 5.0 mt -135.17 144.09 35.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.874 -1.898 . . . . 53.54 105.874 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.3 t -118.99 128.82 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 126.391 1.876 . . . . 41.21 106.127 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 40' ' ' ILE . 53.7 t80 -101.21 139.14 37.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.25 -2.129 . . . . 75.12 105.25 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.56 127.76 31.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 104.014 -2.587 . . . . 74.34 104.014 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.511 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -132.38 179.54 17.14 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 120.078 1.308 . . . . 55.44 112.634 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.17 17.77 3.97 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.194 2.198 . . . . 54.12 110.302 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 mp -55.03 148.63 27.87 Favored Pre-proline 0 C--O 1.239 0.524 0 C-N-CA 124.929 1.292 . . . . 73.1 111.95 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.28 153.61 75.69 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.956 3.104 . . . . 75.32 112.239 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -65.38 -34.03 77.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 118.508 -0.758 . . . . 74.04 109.492 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -92.65 21.06 5.76 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.641 1.176 . . . . 75.31 112.646 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.557 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 10.3 tp -52.36 138.92 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 121.256 -0.903 . . . . 52.24 109.951 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 p -125.38 150.77 46.91 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.48 -0.933 . . . . 73.54 108.48 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.01 -26.24 68.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 118.299 -0.858 . . . . 65.32 110.133 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.6 p -65.09 -41.17 91.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 119.697 1.135 . . . . 72.11 108.682 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.553 ' HG3' ' HE2' ' A' ' 70' ' ' LYS . 15.8 mm-40 -68.11 -45.27 74.14 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.346 -0.983 . . . . 73.22 108.346 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.1 mt -59.71 -47.65 84.79 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.494 0.588 . . . . 74.11 111.086 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -61.0 -38.01 84.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.56 0.744 . . . . 72.14 109.987 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -74.44 -54.35 7.76 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.364 1.066 . . . . 71.13 113.796 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -34.6 70.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.681 0.993 . . . . 64.43 113.681 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -97.4 3.71 50.88 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.806 0.842 . . . . 70.11 112.58 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -60.72 -28.96 69.06 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.845 -1.159 . . . . 70.0 109.918 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -73.67 -17.57 61.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.093 0.957 . . . . 72.34 111.058 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 p -113.84 -5.84 13.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.439 1.895 . . . . 53.13 113.581 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.8 t 41.68 77.33 0.44 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 126.503 1.921 . . . . 75.05 114.973 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.57 165.99 30.08 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 121.931 1.754 . . . . 72.42 109.988 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -91.2 -32.89 15.61 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 120.742 -1.224 . . . . 72.24 109.501 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -143.54 153.26 42.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.169 1.388 . . . . 71.23 108.187 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.4 mt -133.73 105.12 6.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.788 -1.56 . . . . 71.44 106.788 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.1 ttt-85 -122.62 103.94 9.01 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.875 -0.787 . . . . 75.41 108.875 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -83.15 127.38 33.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.107 -1.812 . . . . 73.32 106.107 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 85.54 2.37 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.582 -2.007 . . . . 75.21 105.582 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.53 -27.55 49.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.918 0.887 . . . . 72.33 113.003 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -52.05 -30.09 24.12 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.68 1.992 . . . . 71.01 114.314 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -132.23 11.96 4.61 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.043 1.337 . . . . 54.15 111.418 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.77 52.45 50.68 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.345 -1.502 . . . . 25.11 109.345 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.511 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.8 pt -139.84 168.07 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.613 1.165 . . . . 65.11 110.594 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.99 154.29 41.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.649 1.179 . . . . 62.21 108.014 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -124.45 123.32 39.88 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.118 -1.808 . . . . 62.2 106.118 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mp -117.77 113.81 22.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.861 -1.533 . . . . 75.2 106.861 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -85.18 152.81 23.08 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.335 -1.357 . . . . 61.22 107.335 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -141.1 136.86 32.37 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.446 1.098 . . . . 74.24 108.709 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -97.98 108.51 21.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.394 1.478 . . . . 75.23 112.616 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.4 -22.6 51.34 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.483 0.713 . . . . 64.22 112.543 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.93 -37.09 35.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 112.096 0.406 . . . . 74.33 112.096 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -68.87 -55.47 10.99 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.186 1.394 . . . . 73.01 111.036 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.57 71.91 0.81 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 122.011 0.91 . . . . 60.41 110.281 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -48.85 -38.49 22.55 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.685 1.194 . . . . 70.31 112.718 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.8 p -104.99 8.0 34.29 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.761 1.022 . . . . 74.44 113.761 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.94 -23.14 2.54 Favored Glycine 0 C--O 1.221 -0.676 0 CA-C-O 118.038 -1.423 . . . . 61.25 113.604 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.1 tp -49.36 -49.57 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 120.244 2.022 . . . . 73.2 113.127 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -64.07 -55.46 22.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.841 -0.8 . . . . 75.45 108.841 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -49.49 -53.2 24.5 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.171 0.896 . . . . 55.25 109.417 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -51.91 -54.86 24.51 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.14 1.776 . . . . 74.31 110.337 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 44.0 mtm -66.32 -28.32 68.59 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 118.908 0.776 . . . . 72.34 111.218 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -65.06 -47.51 77.05 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 120.074 -1.641 . . . . 73.31 109.798 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.5 mt -65.29 -31.65 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.284 1.833 . . . . 72.21 108.063 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.23 -41.13 58.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.674 -0.862 . . . . 65.13 108.674 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -60.61 -37.06 80.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.479 0.712 . . . . 73.23 110.311 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.6 mt -64.42 -6.08 6.52 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.236 1.414 . . . . 72.22 113.616 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -92.39 6.23 47.71 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.491 1.041 . . . . 73.53 111.234 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -72.25 114.89 10.86 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.727 1.211 . . . . 74.34 108.546 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.48 5.09 61.98 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-O 118.005 -1.442 . . . . 21.52 114.445 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.9 p -72.01 154.01 41.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.997 1.899 . . . . 71.03 109.422 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 mt -100.49 107.54 19.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.588 -1.634 . . . . 64.13 106.588 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.67 121.92 44.86 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.622 -2.362 . . . . 74.22 104.622 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 18.8 mttm 48.1 47.33 19.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.822 0.849 . . . . 61.03 110.971 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 58.0 26.97 14.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.846 1.658 . . . . 62.14 114.186 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -126.47 122.31 34.88 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.728 -1.212 . . . . 74.32 107.728 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -81.62 102.55 10.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.298 -1.371 . . . . 64.14 107.298 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.6 pt -85.54 169.64 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 124.282 1.033 . . . . 73.21 110.898 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.62 155.27 45.23 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 125.888 1.675 . . . . 73.53 109.467 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.62 148.91 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.339 1.055 . . . . 54.11 108.479 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.8 172.14 13.34 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.571 1.949 . . . . 64.42 109.368 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.55 153.42 18.18 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.067 1.747 . . . . 55.1 107.366 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.443 HG23 ' HB ' ' A' ' 5' ' ' ILE . 9.2 t . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 108.947 -0.76 . . . . 64.54 108.947 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.341 0 N-CA-C 109.889 -0.412 . . . . 72.41 109.889 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -133.19 165.62 24.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.105 1.362 . . . . 74.41 108.583 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mt -134.45 148.64 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.024 -0.732 . . . . 74.24 109.024 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.33 126.64 74.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 105.942 -1.873 . . . . 73.22 105.942 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -91.04 137.73 32.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.522 1.529 . . . . 63.4 107.688 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 11' ' ' LEU . 11.9 t -138.73 126.09 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.729 -1.582 . . . . 74.42 106.729 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.428 ' H ' ' ND2' ' A' ' 75' ' ' ASN . . . -136.9 176.76 20.23 Favored Glycine 0 N--CA 1.468 0.774 0 CA-C-N 120.347 1.431 . . . . 32.25 111.628 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.25 19.02 0.77 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.48 2.312 . . . . 75.11 109.585 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.481 HD11 HG12 ' A' ' 8' ' ' VAL . 9.9 mp -63.76 143.25 98.08 Favored Pre-proline 0 C--O 1.235 0.315 0 O-C-N 120.9 -1.125 . . . . 52.03 112.884 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.3 160.74 43.78 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.62 2.88 . . . . 53.34 111.604 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -44.06 93.46 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.784 -0.821 . . . . 74.23 108.784 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.72 9.46 1.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.522 1.929 . . . . 62.31 114.095 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.538 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.5 tp -58.62 139.45 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 O-C-N 120.725 -1.234 . . . . 61.52 109.822 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 150.52 50.11 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.818 0.847 . . . . 64.21 109.75 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.84 -30.73 70.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.076 0.95 . . . . 75.42 110.404 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.67 -43.27 96.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.549 1.14 . . . . 70.3 109.487 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.08 -42.12 85.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.96 -1.126 . . . . 64.41 107.96 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.67 -53.47 55.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.988 1.315 . . . . 74.23 110.454 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -46.9 83.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.688 -1.226 . . . . 72.44 107.688 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -62.58 -42.85 99.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.918 1.081 . . . . 64.12 113.918 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.99 -47.68 67.86 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 120.993 -1.067 . . . . 72.22 110.66 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.33 6.05 28.04 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.25 1.204 . . . . 74.31 114.25 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -51.48 -41.13 60.7 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 125.067 1.347 . . . . 61.3 113.715 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.458 HD22 HD13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -72.57 -21.93 61.07 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.404 0.547 . . . . 72.41 112.247 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.66 -17.89 22.76 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.218 1.407 . . . . 72.51 110.843 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 m 49.17 74.15 0.87 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.094 1.758 . . . . 61.33 114.412 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HG2' HD11 ' A' ' 32' ' ' ILE . 74.4 Cg_endo -65.87 153.15 79.34 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.116 1.877 . . . . 74.35 109.111 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -91.62 -39.8 11.67 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.996 -1.112 . . . . 65.4 107.996 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -123.46 146.35 48.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.548 1.139 . . . . 65.12 108.867 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.445 HD11 ' HG2' ' A' ' 29' ' ' PRO . 57.3 mt -141.38 107.02 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.982 -1.118 . . . . 74.23 107.982 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.43 104.74 8.07 Favored 'General case' 0 N--CA 1.46 0.055 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.53 118.66 30.78 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.776 2.03 . . . . 74.02 108.191 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.68 87.84 2.73 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.631 1.572 . . . . 75.22 108.432 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.32 -16.89 63.04 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.696 -0.628 . . . . 73.23 109.88 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -51.62 -26.74 9.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.937 2.495 . . . . 74.04 110.797 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -133.23 -1.6 3.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.798 2.439 . . . . 65.33 111.128 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.83 50.75 45.36 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.263 1.411 . . . . 64.32 110.134 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.412 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.3 pt -140.8 167.94 17.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 125.988 1.715 . . . . 63.34 110.827 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.83 149.81 33.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.247 1.819 . . . . 74.0 109.227 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.35 132.98 55.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.691 -1.596 . . . . 71.22 106.691 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.17 110.12 12.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.183 -1.784 . . . . 62.02 106.183 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -96.86 148.49 22.88 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.755 -1.202 . . . . 53.43 107.755 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -143.5 120.97 11.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.401 1.08 . . . . 75.02 109.358 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.38 121.13 22.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.479 0.712 . . . . 70.21 110.541 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.1 -38.76 63.75 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.943 1.697 . . . . 74.22 112.209 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.38 -29.62 70.89 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.594 -0.521 . . . . 71.5 109.594 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -61.7 -19.27 62.19 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.393 1.077 . . . . 74.3 112.489 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.03 90.33 0.44 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.105 1.321 . . . . 70.52 109.619 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -48.85 -38.71 23.15 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 116.125 1.898 . . . . 75.11 116.125 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -114.59 -0.95 13.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 123.337 0.398 . . . . 74.2 111.371 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.04 -28.68 8.05 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.474 1.035 . . . . 71.41 111.438 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.2 tp -54.13 -37.76 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.906 1.353 . . . . 72.33 110.648 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -56.75 18.04 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.148 -0.686 . . . . 74.14 109.148 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -42.78 66.82 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.715 1.206 . . . . 70.42 110.325 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -57.35 -46.73 83.02 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.001 -1.111 . . . . 55.23 108.001 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.3 mtm -66.88 -44.58 80.52 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 117.938 -1.029 . . . . 53.32 110.769 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -52.42 -49.85 63.69 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.315 1.416 . . . . 54.11 110.217 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.458 HD13 HD22 ' A' ' 26' ' ' ASN . 64.4 mt -65.92 -43.51 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.722 1.209 . . . . 74.1 109.16 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.14 96.76 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.783 0.719 . . . . 73.34 109.968 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.39 -26.35 68.42 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.007 1.323 . . . . 60.02 111.571 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.56 -8.2 54.97 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.458 -0.776 . . . . 72.41 109.946 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -88.84 9.02 26.21 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.178 -0.915 . . . . 75.32 111.803 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -76.86 118.03 19.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.694 1.588 . . . . 72.42 106.735 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.62 3.02 64.81 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.508 -1.162 . . . . 64.22 115.094 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.1 p -67.97 144.89 54.99 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 120.018 1.909 . . . . 73.4 107.766 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.8 mt -92.87 107.66 19.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 103.936 -2.616 . . . . 74.41 103.936 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.07 115.39 30.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 102.931 -2.988 . . . . 74.23 102.931 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER 48.41 56.96 6.73 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.533 1.159 . . . . 62.22 110.384 -177.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 60.47 13.09 3.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.359 2.264 . . . . 75.34 114.999 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -118.35 120.0 36.31 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.259 1.023 . . . . 74.01 111.469 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -71.63 115.7 11.12 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.872 -1.529 . . . . 50.12 106.872 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.335 16.4 pt -101.39 170.69 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.358 0.526 . . . . 54.43 110.201 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.428 ' ND2' ' H ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -120.89 151.83 39.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.482 1.113 . . . . 72.04 109.704 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.3 t -137.62 135.19 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.579 1.152 . . . . 65.22 108.45 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.35 152.97 32.73 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.427 1.091 . . . . 71.22 110.574 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 143.62 38.49 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.252 1.021 . . . . 72.25 111.005 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.449 -0.484 0 C-N-CA 124.917 1.287 . . . . 61.52 110.218 179.551 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 . . . . . 0 CA--C 1.513 -0.464 0 N-CA-C 110.152 -0.314 . . . . 70.34 110.152 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -115.77 165.04 13.5 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 128.042 2.537 . . . . 75.33 104.391 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.5 mt -134.89 135.75 52.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.534 -0.757 . . . . 73.31 109.091 -177.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.9 t -96.98 145.34 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 104.992 -2.225 . . . . 61.31 104.992 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -113.62 131.73 56.02 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 104.904 -2.258 . . . . 75.11 104.904 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.47 HG12 HD11 ' A' ' 11' ' ' LEU . 21.6 t -135.88 126.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.091 -1.818 . . . . 41.22 106.091 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.22 177.63 18.36 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.052 0.842 . . . . 73.43 112.419 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.0 17.18 2.22 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.58 2.752 . . . . 52.52 110.671 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.47 HD11 HG12 ' A' ' 8' ' ' VAL . 9.7 mp -58.31 144.32 77.82 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 124.91 1.284 . . . . 70.23 111.688 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.19 160.76 43.4 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.362 2.708 . . . . 71.43 112.406 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -67.06 -37.5 84.13 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.422 -0.955 . . . . 75.35 108.422 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.8 13.59 1.64 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.72 1.007 . . . . 43.02 113.72 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.61 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 6.4 tp -63.98 134.78 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 120.451 -1.405 . . . . 70.34 110.452 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . 0.254 1.3 p -128.63 150.05 50.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.456 1.902 . . . . 71.2 107.124 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.37 64.49 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.382 -0.824 . . . . 44.23 112.638 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 p -64.18 -36.54 77.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.462 -0.94 . . . . 75.23 108.462 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -70.35 -43.44 70.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.979 0.912 . . . . 73.24 108.595 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.99 -47.44 84.8 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.232 -0.655 . . . . 74.52 109.232 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -60.03 -38.55 83.03 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.863 0.865 . . . . 74.13 108.797 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -68.85 -41.9 77.85 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.814 1.188 . . . . 65.21 111.076 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -69.99 -35.86 74.72 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.565 -0.709 . . . . 71.53 112.561 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -100.87 6.44 43.72 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.668 0.787 . . . . 74.0 112.405 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -54.27 -43.85 71.37 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.054 1.342 . . . . 73.41 110.747 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -60.79 -32.03 71.38 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.369 1.068 . . . . 73.31 112.123 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 p -94.24 -22.45 18.4 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.686 1.194 . . . . 72.21 111.378 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t 54.4 79.95 0.32 Allowed Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 129.537 3.135 . . . . 65.33 112.396 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.89 166.24 18.92 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.677 2.918 . . . . 64.22 111.484 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -96.65 -38.55 9.89 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.116 0.966 . . . . 72.13 109.429 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -131.82 151.52 51.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.056 1.342 . . . . 54.05 108.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -139.8 105.29 2.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 106.473 -1.676 . . . . 73.23 106.473 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -122.57 104.29 9.26 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.46 -1.311 . . . . 54.24 107.46 178.141 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 15' ' ' ILE . 1.5 tm? -87.01 125.24 33.97 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.63 1.172 . . . . 74.32 108.575 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.17 79.4 1.27 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.16 1.784 . . . . 73.3 107.078 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.01 54.77 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.104 0.962 . . . . 73.22 111.746 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.73 -34.98 29.14 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 126.688 1.995 . . . . 63.32 111.918 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -131.48 14.95 4.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.585 1.154 . . . . 63.11 111.298 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.5 50.23 66.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 124.265 0.936 . . . . 53.33 111.095 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 pt -138.21 170.95 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.235 1.414 . . . . 75.23 109.492 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.74 164.94 34.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.579 1.152 . . . . 61.11 109.094 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -128.69 127.69 42.62 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 105.505 -2.035 . . . . 60.15 105.505 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mp -130.07 106.45 8.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.743 -1.577 . . . . 74.02 106.743 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -96.16 150.14 20.85 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.581 -1.266 . . . . 75.34 107.581 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -136.27 135.28 38.85 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.496 -1.298 . . . . 72.43 107.496 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -79.46 109.61 14.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.323 0.965 . . . . 72.32 110.986 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.17 -24.78 60.6 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.609 1.564 . . . . 73.34 113.668 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.13 -25.93 58.8 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.713 -0.847 . . . . 74.43 108.713 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -60.64 -27.79 68.06 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.913 0.885 . . . . 72.35 111.051 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -161.35 88.48 0.73 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.842 0.746 . . . . 71.43 111.007 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -59.64 -25.41 64.66 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.162 -0.961 . . . . 62.22 112.831 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.0 p -96.95 -12.24 23.62 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.136 0.88 . . . . 63.52 113.181 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.99 -12.24 7.15 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-O 117.753 -1.582 . . . . 60.3 115.5 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 tp -58.0 -37.27 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 120.727 2.263 . . . . 74.33 110.773 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -58.69 -58.55 8.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.672 -1.233 . . . . 53.4 107.672 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -43.19 68.45 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.874 0.761 . . . . 71.22 111.777 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -57.3 -43.8 83.55 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.836 -0.801 . . . . 74.23 108.836 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.2 mtm -64.35 -43.27 95.1 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.985 -0.746 . . . . 75.25 108.985 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.44 -47.58 72.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.142 1.777 . . . . 62.24 111.495 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.11 -37.09 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.263 1.425 . . . . 43.34 107.959 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.06 -37.83 66.67 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.332 0.969 . . . . 75.43 109.44 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 78' ' ' LEU . 32.6 mt -67.59 -28.58 67.89 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.625 0.77 . . . . 60.34 110.914 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.58 -8.53 27.6 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.405 0.682 . . . . 73.14 110.978 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -86.42 3.82 42.15 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.874 0.761 . . . . 60.54 111.203 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -66.97 131.1 45.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 119.688 -1.882 . . . . 75.54 107.845 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.09 8.68 58.88 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 117.976 -1.458 . . . . 74.44 114.579 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 p -70.39 146.82 50.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.883 2.342 . . . . 73.15 108.059 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.0 mt -89.9 108.0 19.45 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.743 -2.317 . . . . 61.05 104.743 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.9 tp -110.04 121.81 46.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.912 -1.885 . . . . 70.03 105.912 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 13.9 mtpp 53.92 38.42 28.73 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.813 0.845 . . . . 62.34 111.296 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 62.61 33.21 15.93 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.225 1.41 . . . . 73.14 112.462 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -140.79 117.87 11.22 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.925 1.69 . . . . 75.22 107.949 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -73.95 148.37 42.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.835 -1.543 . . . . 65.4 106.835 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.0 pt -133.66 169.2 22.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 124.876 1.27 . . . . 61.23 111.236 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -120.86 152.34 38.54 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.077 1.351 . . . . 74.3 111.11 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -135.05 136.5 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.528 1.131 . . . . 75.12 108.507 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -150.84 162.8 40.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.614 1.966 . . . . 73.44 108.521 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -96.73 152.22 18.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.019 1.328 . . . . 72.34 111.589 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.9 p . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 125.208 1.403 . . . . 75.33 108.671 178.687 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.7 ptt85 . . . . . 0 CA--C 1.527 0.092 0 N-CA-C 109.539 -0.541 . . . . 71.31 109.539 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -133.39 165.56 24.55 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.606 2.362 . . . . 75.03 105.877 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.53 136.85 57.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.734 0.778 . . . . 70.31 109.819 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -103.21 118.87 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 104.558 -2.386 . . . . 63.14 104.558 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -90.62 133.15 35.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.222 -1.77 . . . . 75.33 106.222 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 t -138.85 130.93 37.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 118.144 -0.931 . . . . 45.01 108.509 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.81 -179.82 18.57 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 120.022 1.283 . . . . 73.44 112.019 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.48 25.65 2.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.13 2.172 . . . . 71.03 111.598 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.26 149.08 98.19 Favored Pre-proline 0 C--O 1.237 0.398 0 O-C-N 120.877 -1.14 . . . . 74.55 112.474 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.63 168.62 16.17 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.571 3.514 . . . . 70.1 111.612 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -70.31 -46.34 64.43 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.476 -0.935 . . . . 74.02 108.476 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.61 5.03 2.04 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.778 1.631 . . . . 73.12 114.163 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 tp -57.01 130.43 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 121.08 -1.012 . . . . 74.2 109.064 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.69 154.95 45.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.406 1.483 . . . . 71.22 107.788 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.17 -30.28 66.27 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 118.985 -0.531 . . . . 74.3 109.902 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -58.55 -43.96 88.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 118.465 0.575 . . . . 72.03 109.942 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -65.47 -43.73 89.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.169 0.988 . . . . 74.21 109.68 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.8 mt -67.43 -44.69 78.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.911 0.884 . . . . 73.31 111.297 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -56.8 -48.38 78.07 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 107.174 -1.417 . . . . 54.51 107.174 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.93 -40.87 95.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.539 1.136 . . . . 64.15 113.327 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.55 -22.24 57.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 114.377 1.251 . . . . 74.13 114.377 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -108.31 2.86 22.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.821 0.737 . . . . 75.21 111.895 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -52.18 -33.3 40.03 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.464 2.306 . . . . 64.43 113.731 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -82.25 -38.24 24.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.833 0.742 . . . . 64.35 110.046 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -22.6 64.67 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.634 1.173 . . . . 54.3 110.217 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m 53.78 67.27 3.71 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.543 1.137 . . . . 52.2 113.446 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.71 173.38 8.08 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.768 2.979 . . . . 53.2 109.638 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.7 -43.54 4.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.8 -1.185 . . . . 63.13 107.8 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HB3' ' H ' ' A' ' 44' ' ' GLU . 7.0 tp-100 -122.19 154.18 37.81 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.608 1.563 . . . . 71.34 109.648 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -146.7 122.9 3.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.899 -1.889 . . . . 75.34 105.899 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.34 102.95 4.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.441 1.497 . . . . 75.34 109.452 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -80.22 126.65 31.39 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.148 -1.797 . . . . 74.31 106.148 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -118.53 87.44 2.73 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.262 1.425 . . . . 74.33 111.146 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.34 -21.2 61.78 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.996 0.918 . . . . 63.43 111.87 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -54.61 -32.55 58.96 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.267 1.427 . . . . 72.25 111.576 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.3 mmtm -132.85 2.43 3.69 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 114.341 1.237 . . . . 74.01 114.341 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.47 40.38 54.55 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 120.39 1.45 . . . . 44.52 110.106 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 pt -129.53 170.12 19.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.616 1.966 . . . . 75.25 110.625 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.85 120.46 4.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.61 1.964 . . . . 73.15 108.859 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -99.14 150.95 21.52 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 118.615 0.643 . . . . 74.3 109.808 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.9 131.07 24.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.164 -1.051 . . . . 74.31 108.164 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.474 ' H ' ' HB3' ' A' ' 31' ' ' GLN . 59.0 mt-10 -102.04 149.88 23.8 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 104.648 -2.353 . . . . 54.13 104.648 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -135.81 109.34 7.95 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.119 0.968 . . . . 70.33 108.5 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -68.39 110.01 3.92 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.816 1.246 . . . . 73.33 110.718 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.09 -15.23 57.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.569 2.347 . . . . 64.24 112.943 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.56 -39.3 32.12 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.393 -1.706 . . . . 74.24 106.393 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -61.73 -46.07 91.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.401 -0.963 . . . . 61.55 108.401 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.34 73.84 0.87 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.026 0.93 . . . . 62.01 109.556 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -48.21 -34.19 9.75 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.092 1.145 . . . . 63.43 114.092 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 p -121.81 -19.12 6.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 124.05 0.844 . . . . 75.01 111.686 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.08 -16.73 76.05 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.125 -0.984 . . . . 63.54 112.006 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 tp -50.75 -40.22 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.99 1.316 . . . . 63.53 110.914 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -57.51 -61.56 2.41 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.126 1.37 . . . . 63.04 108.439 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -50.98 -50.94 57.33 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.577 1.151 . . . . 62.22 110.095 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -52.85 -52.01 58.81 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.293 0.637 . . . . 70.31 110.776 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 36.4 mtm -66.79 -35.56 80.37 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 123.103 0.561 . . . . 61.51 111.358 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -46.98 87.7 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.863 1.265 . . . . 61.45 109.454 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.7 mt -62.87 -36.35 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.581 -0.896 . . . . 71.42 108.581 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.4 -43.06 70.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.94 -0.763 . . . . 72.12 108.94 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 mt -63.9 -33.15 75.05 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.663 0.785 . . . . 72.31 111.031 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.78 -13.14 41.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.298 0.851 . . . . 73.03 113.298 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -86.53 3.4 44.35 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.896 0.771 . . . . 65.14 111.547 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -59.74 113.98 2.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.931 -1.106 . . . . 72.34 109.414 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.06 12.34 55.25 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 118.371 -1.238 . . . . 71.41 115.385 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.4 p -69.62 149.08 48.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.174 1.987 . . . . 72.11 109.62 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.9 mt -96.43 107.18 19.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.062 -1.829 . . . . 64.32 106.062 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mt -109.92 122.66 48.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.189 -2.152 . . . . 52.24 105.189 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 mtmm 46.43 40.3 7.79 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.328 1.051 . . . . 64.43 110.954 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 67.74 20.38 9.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.627 2.371 . . . . 64.11 114.248 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -120.22 125.96 49.44 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.092 1.357 . . . . 70.4 108.354 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -82.57 112.99 19.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.838 -0.801 . . . . 72.44 108.838 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.0 pp -87.46 171.13 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 124.429 1.092 . . . . 73.12 110.906 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.95 151.27 51.83 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.228 1.411 . . . . 52.32 109.106 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.3 t -134.1 144.24 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.231 1.413 . . . . 63.44 108.31 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -153.54 160.76 42.58 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.467 1.907 . . . . 75.11 108.864 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.34 151.84 22.33 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 120.99 -1.068 . . . . 71.15 108.699 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 108.708 -0.849 . . . . 72.24 108.708 178.861 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 . . . . . 0 CA--C 1.506 -0.748 0 N-CA-C 106.714 -1.587 . . . . 73.41 106.714 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -99.85 164.91 11.82 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.107 0.963 . . . . 72.33 108.546 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.3 mt -134.87 149.01 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.933 1.293 . . . . 72.11 110.965 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.2 t -118.51 134.3 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.802 2.041 . . . . 74.15 105.851 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -100.62 142.21 32.4 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 126.15 1.78 . . . . 74.43 108.826 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.41 133.53 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.21 -1.774 . . . . 73.11 106.21 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -132.57 -179.7 16.5 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 120.385 1.448 . . . . 44.2 111.123 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.88 14.48 9.84 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.526 1.931 . . . . 71.03 112.621 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.35 148.05 9.37 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 124.737 1.215 . . . . 73.45 112.958 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.78 154.34 50.27 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.649 2.899 . . . . 74.22 110.341 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -70.36 -37.56 74.62 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.881 -0.512 . . . . 75.2 109.917 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.59 25.3 3.11 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.336 1.054 . . . . 45.35 111.855 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 8.4 tp -53.84 139.92 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.832 1.253 . . . . 75.11 110.537 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -124.78 148.04 48.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.611 1.164 . . . . 73.44 108.423 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.29 -29.84 70.12 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 118.852 -0.594 . . . . 55.15 111.097 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.66 -37.01 76.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 118.764 0.711 . . . . 61.24 109.708 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -69.17 -44.67 71.76 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.727 -0.842 . . . . 74.42 108.727 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 mt -60.49 -54.71 42.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.342 0.657 . . . . 75.22 110.786 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -59.87 -41.42 91.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.373 -0.602 . . . . 73.21 109.373 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -67.94 -40.53 83.29 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.855 0.687 . . . . 64.21 112.855 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -22.68 65.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 120.047 1.294 . . . . 70.03 113.071 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -112.29 6.07 18.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.056 0.942 . . . . 72.23 111.513 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -41.7 63.04 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.25 1.42 . . . . 74.54 112.264 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -58.17 -54.32 48.31 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.972 -0.751 . . . . 72.22 108.972 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.09 -22.06 66.39 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.653 1.181 . . . . 64.42 112.627 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 t 50.41 78.26 0.41 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.195 2.198 . . . . 63.41 112.418 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.55 168.14 20.66 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.256 2.637 . . . . 72.02 110.577 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -94.68 -31.8 13.65 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.488 1.115 . . . . 65.43 109.961 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.04 161.0 41.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.859 0.863 . . . . 61.23 109.807 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.68 107.13 2.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 104.295 -2.483 . . . . 73.25 104.295 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.5 ttp180 -117.98 103.96 10.43 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.577 -1.268 . . . . 75.53 107.577 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.57 124.78 36.85 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.49 1.516 . . . . 75.41 110.51 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.56 80.12 1.49 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.602 1.961 . . . . 74.23 108.024 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.83 -17.37 56.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.107 0.963 . . . . 72.22 111.216 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.438 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 1.4 m-20 -51.4 -32.8 27.63 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.647 1.979 . . . . 65.14 109.884 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 5.3 mmpt? -126.73 -9.69 6.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.378 1.871 . . . . 64.42 111.351 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.42 36.77 33.2 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.661 -1.376 . . . . 75.13 109.661 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.425 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 36.0 pt -124.47 168.42 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.173 1.389 . . . . 64.32 108.417 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.67 166.3 33.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.569 1.148 . . . . 72.34 109.442 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -135.77 140.82 44.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.562 1.545 . . . . 73.02 108.083 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mp -134.49 123.62 24.25 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.016 -1.475 . . . . 65.12 107.016 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -98.64 156.73 16.67 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.614 -0.513 . . . . 72.23 109.614 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -146.65 119.63 8.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.201 -1.407 . . . . 74.5 107.201 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -83.72 119.14 24.43 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.765 -0.458 . . . . 44.43 109.765 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.35 61.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.991 1.716 . . . . 54.12 111.219 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -70.4 -23.77 62.82 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.86 -1.163 . . . . 73.45 107.86 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -62.18 -32.37 72.99 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-O 118.362 -0.828 . . . . 51.14 110.368 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -168.02 101.52 0.46 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.461 1.504 . . . . 72.32 108.078 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -52.76 -22.62 5.49 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 116.301 1.963 . . . . 74.43 116.301 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p -121.43 -19.36 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 120.115 1.325 . . . . 71.33 110.872 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.9 -30.62 51.33 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-O 118.592 -1.116 . . . . 32.14 110.705 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.1 tp -52.58 -37.65 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.24 1.416 . . . . 72.54 110.061 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.01 -58.05 9.52 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.618 1.167 . . . . 74.44 107.934 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -54.79 -41.29 70.39 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.258 0.623 . . . . 72.42 110.242 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.6 mtt85 -57.95 -50.23 74.09 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-O 118.421 -0.8 . . . . 74.14 110.233 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 10.8 mtm -59.85 -45.49 92.27 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.195 0.452 . . . . 74.03 110.451 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.4 -54.57 45.13 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 122.86 0.464 . . . . 72.24 110.666 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.8 mt -58.1 -36.94 59.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 125.194 1.398 . . . . 73.35 109.596 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.11 -43.97 73.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.733 -0.469 . . . . 63.13 109.733 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.68 -35.66 81.75 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.347 0.659 . . . . 74.33 110.337 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.8 mt -62.47 -2.57 1.1 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.949 1.7 . . . . 71.44 113.646 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -94.45 3.73 54.77 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.675 1.19 . . . . 71.21 110.314 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -65.85 135.08 54.34 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.153 1.781 . . . . 74.21 109.686 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.01 15.53 67.36 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.706 1.622 . . . . 72.12 113.312 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -78.59 155.99 29.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.883 1.342 . . . . 32.34 108.139 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.32 108.0 20.15 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.356 -0.979 . . . . 64.1 108.356 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -112.32 115.59 29.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.631 -1.618 . . . . 73.1 106.631 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 3.8 mtpp 50.2 53.45 12.84 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.027 0.918 . . . . 75.21 111.081 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 55.43 20.44 3.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.303 2.241 . . . . 74.53 114.523 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -122.8 122.77 39.49 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 126.079 1.751 . . . . 63.44 107.837 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -83.14 104.86 13.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.036 -1.098 . . . . 73.42 108.036 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 pt -87.92 169.3 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.234 -0.894 . . . . 45.43 111.289 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -123.87 154.18 40.03 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.435 1.494 . . . . 74.35 110.222 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.2 142.15 42.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.936 -1.505 . . . . 65.43 106.936 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.67 174.78 14.05 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.472 1.909 . . . . 63.1 110.517 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -90.42 149.2 22.35 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.797 1.239 . . . . 75.11 112.422 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 C--N 1.329 -0.317 0 N-CA-C 106.505 -1.665 . . . . 72.21 106.505 177.004 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? . . . . . 0 C--O 1.237 0.415 0 CA-C-O 121.101 0.477 . . . . 64.02 111.889 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -99.05 159.33 15.04 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 127.738 2.415 . . . . 73.15 110.055 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.17 149.22 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.604 1.162 . . . . 70.11 110.953 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.8 t -116.07 128.8 73.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.752 -1.573 . . . . 73.3 106.752 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -88.05 131.62 34.59 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.661 1.584 . . . . 73.2 106.886 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.403 HG12 HD11 ' A' ' 11' ' ' LEU . 5.2 t -138.58 128.69 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.31 -1.737 . . . . 74.42 106.31 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.08 -175.15 13.85 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 119.212 0.914 . . . . 54.25 111.871 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.49 14.66 8.35 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.97 1.708 . . . . 74.11 111.157 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.403 HD11 HG12 ' A' ' 8' ' ' VAL . 11.0 mp -60.85 150.81 75.76 Favored Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 125.283 1.433 . . . . 73.44 111.551 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.74 157.63 60.9 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.035 2.49 . . . . 64.24 109.975 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -69.3 -36.15 76.73 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.265 -0.897 . . . . 60.34 111.015 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -88.26 15.06 8.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.884 0.874 . . . . 73.3 112.955 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.1 tp -50.46 140.92 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.779 1.231 . . . . 71.41 111.617 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 p -128.47 147.5 50.67 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.122 -0.695 . . . . 70.02 109.122 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.68 -27.21 66.2 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 118.481 -0.771 . . . . 73.21 112.064 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.78 -36.54 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.02 -0.733 . . . . 54.11 109.02 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -73.41 -42.53 61.96 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 123.82 0.848 . . . . 71.23 108.857 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.9 mt -62.09 -49.41 76.05 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.484 -0.561 . . . . 65.1 109.484 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -58.46 -46.58 86.3 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.901 -1.148 . . . . 60.24 107.901 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -57.44 -46.13 83.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 114.003 1.112 . . . . 74.41 114.003 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -65.95 -56.45 11.63 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.08 1.309 . . . . 64.33 110.405 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -73.25 4.27 4.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.424 1.268 . . . . 73.21 114.424 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -53.89 -31.23 49.2 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 125.364 1.466 . . . . 64.51 113.353 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -8.27 56.61 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.298 1.039 . . . . 71.52 112.48 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 p -112.08 -9.62 13.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.333 1.853 . . . . 63.02 110.858 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.4 m 39.5 78.2 0.38 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.912 2.085 . . . . 55.33 115.762 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.37 164.14 29.51 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.991 2.461 . . . . 71.13 109.962 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -90.01 -41.15 11.88 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.018 0.927 . . . . 71.11 108.999 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -144.32 155.88 44.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.316 0.646 . . . . 70.22 109.688 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.35 123.96 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 127.044 2.138 . . . . 62.12 108.939 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.09 104.69 6.03 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.384 2.273 . . . . 75.45 107.233 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.13 121.79 32.51 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.831 -1.174 . . . . 72.42 107.831 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -116.96 75.07 0.94 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.901 -1.518 . . . . 74.42 106.901 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -26.68 27.03 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.186 1.394 . . . . 64.41 112.248 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -51.68 -25.79 7.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.289 2.236 . . . . 54.2 113.315 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -133.07 10.39 4.19 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.907 1.683 . . . . 74.41 110.269 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.85 44.04 96.24 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.043 1.306 . . . . 42.54 110.012 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.5 pt -132.77 169.77 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 C-N-CA 125.067 1.347 . . . . 72.42 111.011 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.06 166.0 29.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.245 1.818 . . . . 62.02 108.829 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.1 116.8 14.96 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.608 -1.627 . . . . 74.23 106.608 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -113.92 115.52 27.81 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.77 -1.567 . . . . 73.23 106.77 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -88.48 152.83 21.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.11 -1.441 . . . . 65.14 107.11 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -145.58 133.27 21.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.342 1.457 . . . . 74.0 107.173 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -101.89 108.33 19.77 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.066 1.346 . . . . 62.12 112.234 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.57 -23.26 65.39 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.083 1.353 . . . . 63.21 112.21 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -75.39 -25.48 57.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.014 -0.736 . . . . 64.31 109.014 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -66.59 -34.51 78.04 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.928 0.891 . . . . 74.14 110.402 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -156.72 91.26 1.21 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.921 0.782 . . . . 74.15 111.269 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -48.65 -34.26 11.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.402 1.881 . . . . 75.12 115.787 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.94 -16.49 14.29 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 113.344 0.868 . . . . 75.45 113.344 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.31 -19.07 29.09 Favored Glycine 0 C--O 1.225 -0.461 0 CA-C-O 117.707 -1.607 . . . . 74.11 112.927 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 tp -56.04 -35.57 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 120.187 1.993 . . . . 64.43 108.758 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -62.52 -60.81 3.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.363 1.865 . . . . 63.21 108.263 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.0 mmt-85 -54.44 -39.01 66.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.144 0.977 . . . . 71.42 110.344 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -62.94 -47.62 82.43 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.207 -1.034 . . . . 74.01 108.207 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.8 mtm -63.27 -41.82 99.06 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 123.839 0.856 . . . . 70.22 110.226 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -56.81 -50.53 72.08 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.601 1.16 . . . . 72.54 109.051 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.36 -30.86 50.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.273 1.429 . . . . 71.11 110.88 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 -44.23 52.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.477 -0.935 . . . . 53.14 108.477 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mt -63.59 -29.01 70.32 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.376 1.071 . . . . 74.44 112.206 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.79 -2.82 22.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 118.755 -0.64 . . . . 71.34 112.018 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -84.79 -5.95 59.34 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.425 1.011 . . . . 71.01 109.987 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -66.19 112.53 3.98 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.724 1.147 . . . . 71.22 108.671 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.23 -8.19 38.07 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.626 1.108 . . . . 73.42 113.049 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.1 p -65.72 148.98 50.88 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 119.234 1.517 . . . . 75.44 108.678 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.2 mt -98.51 108.07 20.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.58 -2.378 . . . . 64.24 104.58 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.0 tp -102.55 111.11 23.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.291 -1.744 . . . . 75.34 106.291 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt 48.89 51.34 16.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.451 1.1 . . . . 63.03 111.163 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.274 9.6 mt-10 57.97 38.7 26.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 128.031 2.532 . . . . 51.31 114.159 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -137.58 118.15 13.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 126.285 1.834 . . . . 71.51 106.59 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -78.46 105.23 9.58 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.772 -1.195 . . . . 75.24 107.772 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.6 pt -79.52 172.4 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 125.149 1.379 . . . . 75.3 113.262 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.42 149.94 44.41 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.528 1.931 . . . . 73.22 106.61 177.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.8 t -139.91 120.98 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 106.308 -1.738 . . . . 60.41 106.308 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.01 175.69 9.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.834 1.254 . . . . 72.53 110.608 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.53 152.22 30.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.442 1.497 . . . . 74.44 113.396 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.505 0 N-CA-C 107.24 -1.393 . . . . 75.12 107.24 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.501 0 N-CA-C 107.987 -1.116 . . . . 70.52 107.987 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -103.18 160.71 14.41 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.214 1.805 . . . . 52.34 108.558 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.485 ' HB ' HG23 ' A' ' 79' ' ' THR . 2.1 mp -134.37 149.83 30.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.924 1.69 . . . . 54.22 107.63 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.9 t -119.18 124.21 72.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 105.238 -2.134 . . . . 61.24 105.238 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -82.53 131.8 35.21 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.543 -2.021 . . . . 70.41 105.543 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 11' ' ' LEU . 15.2 t -136.36 122.53 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.546 -2.02 . . . . 73.44 105.546 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.423 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -135.81 180.0 17.21 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 120.066 1.303 . . . . 73.54 113.485 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.48 19.62 5.11 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.987 2.115 . . . . 64.4 111.331 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.607 HD11 HG12 ' A' ' 8' ' ' VAL . 10.2 mp -62.63 148.13 91.52 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.152 0.981 . . . . 55.14 110.951 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.56 150.91 80.17 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.677 2.918 . . . . 70.12 110.553 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -30.15 71.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.618 -0.706 . . . . 73.31 111.3 178.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.98 11.97 18.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.37 1.248 . . . . 74.24 114.37 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.429 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 7.8 tp -54.46 147.93 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.922 1.289 . . . . 74.33 110.42 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -128.21 157.0 42.05 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.428 0.691 . . . . 43.13 110.822 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.12 -32.19 73.66 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.977 -0.452 . . . . 62.3 109.802 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 p -63.39 -44.51 98.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.457 -0.572 . . . . 64.14 109.457 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -71.05 -36.08 72.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.196 -0.43 . . . . 72.21 110.061 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 20' ' ' LEU . 19.0 mt -63.4 -46.28 87.13 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.421 -0.955 . . . . 63.13 108.421 178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -58.33 -49.99 75.22 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.883 -1.155 . . . . 54.0 107.883 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -55.45 -44.16 76.13 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.529 0.937 . . . . 75.12 113.529 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -30.25 70.31 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 114.342 1.238 . . . . 71.55 114.342 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.07 6.23 19.11 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.61 0.764 . . . . 74.22 112.662 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -54.44 -43.32 71.5 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.412 1.485 . . . . 61.31 110.637 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -61.21 -35.3 76.83 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.561 0.744 . . . . 63.05 111.618 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.92 -17.36 38.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.735 1.614 . . . . 61.42 111.417 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.433 ' HB2' ' HE ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER 54.43 72.95 0.98 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 126.728 2.011 . . . . 74.34 116.239 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.39 161.71 43.68 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.037 2.492 . . . . 73.04 110.187 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.09 -46.56 8.4 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.031 1.732 . . . . 63.13 108.939 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -131.72 156.32 46.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.25 -0.886 . . . . 73.32 112.383 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.9 mt -146.77 123.9 3.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.416 -1.328 . . . . 73.13 107.416 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.72 104.91 5.44 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 128.28 2.632 . . . . 72.53 106.794 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.12 112.25 24.14 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.33 1.052 . . . . 71.12 110.25 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -97.79 82.78 3.08 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.092 -1.818 . . . . 71.24 106.092 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.04 -29.71 58.03 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.669 0.787 . . . . 73.25 111.563 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.18 -32.3 22.98 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.483 2.313 . . . . 74.15 112.6 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -122.15 -5.13 8.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.372 1.469 . . . . 61.52 110.2 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.09 47.43 85.36 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 125.674 1.607 . . . . 61.22 109.488 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.423 HG22 ' CA ' ' A' ' 9' ' ' GLY . 3.2 pt -135.57 162.4 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.152 1.381 . . . . 71.25 108.869 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.96 166.22 24.59 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.926 1.29 . . . . 73.44 108.369 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -133.47 104.7 6.53 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.627 -1.62 . . . . 65.53 106.627 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.27 113.16 26.58 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.429 -1.323 . . . . 74.42 107.429 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.32 153.6 19.81 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.33 1.452 . . . . 70.1 108.703 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -147.75 136.24 21.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.895 1.278 . . . . 70.4 108.224 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -101.48 111.51 23.76 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.958 1.303 . . . . 75.1 111.919 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.64 -21.47 55.43 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.073 2.149 . . . . 52.12 110.396 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.64 -30.41 71.35 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.989 -1.486 . . . . 41.33 106.989 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -62.06 -33.59 74.68 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 117.994 -1.003 . . . . 73.25 110.765 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -157.24 108.41 2.33 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 114.642 1.349 . . . . 53.12 114.642 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -68.05 -19.31 64.87 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 117.182 -1.389 . . . . 74.15 112.999 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.359 43.5 p -122.53 14.73 10.29 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.795 1.634 . . . . 74.35 114.535 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -131.03 -19.89 1.21 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.346 1.45 . . . . 53.14 115.167 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.8 -30.41 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 120.484 2.142 . . . . 71.33 109.514 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -64.14 -55.97 18.08 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 126.142 1.777 . . . . 70.43 110.086 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -58.55 -27.36 64.5 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.428 1.491 . . . . 71.54 110.719 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.433 ' HE ' ' HB2' ' A' ' 28' ' ' SER . 28.4 mtt85 -76.33 -45.83 30.41 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.239 -1.023 . . . . 71.24 108.239 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 8.2 mtm -57.57 -41.67 81.54 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.959 0.904 . . . . 64.54 108.904 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -55.17 -49.08 72.77 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.322 1.449 . . . . 74.14 110.391 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.7 mt -64.66 -41.55 92.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 124.271 1.028 . . . . 73.32 109.439 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.36 93.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.69 -0.856 . . . . 54.3 108.69 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.3 mt -63.83 -32.52 74.06 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.188 0.995 . . . . 73.23 110.51 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.32 -10.78 26.36 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.175 -0.917 . . . . 75.0 110.808 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -85.91 -0.78 56.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.031 1.287 . . . . 63.43 110.755 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.2 112.38 3.01 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.682 -1.261 . . . . 73.32 107.767 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.56 1.75 57.68 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 117.421 -1.766 . . . . 70.55 113.261 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.256 51.3 p -66.02 142.83 57.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.988 2.394 . . . . 70.14 110.33 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.48 116.65 29.03 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.593 1.157 . . . . 74.4 108.172 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 mt -122.53 120.4 33.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 105.949 -1.871 . . . . 71.22 105.949 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 10.7 mtmm 44.3 47.53 7.88 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.749 1.62 . . . . 72.45 110.076 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 59.39 33.71 22.49 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.225 1.81 . . . . 62.14 114.712 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -130.18 117.56 20.09 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 104.742 -2.318 . . . . 75.52 104.742 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -78.58 107.96 11.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.97 -1.122 . . . . 61.44 107.97 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -78.99 170.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 124.501 1.12 . . . . 51.43 111.06 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.26 155.62 47.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.001 1.72 . . . . 74.41 109.344 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.6 t -139.23 133.11 39.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 O-C-N 124.003 0.815 . . . . 64.41 110.224 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -143.9 175.43 10.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.013 1.325 . . . . 64.52 108.621 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.89 150.58 21.16 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.828 0.851 . . . . 53.0 109.168 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.485 HG23 ' HB ' ' A' ' 5' ' ' ILE . 5.9 t . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.99 -1.115 . . . . 71.42 107.99 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.738 0 N-CA-C 110.306 -1.118 . . . . 54.05 110.306 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.72 40.76 0.11 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.029 1.731 . . . . 71.45 112.624 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.3 ptt85 -153.55 157.34 39.6 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 120.285 -1.509 . . . . 54.42 110.669 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -126.36 162.91 24.43 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 125.956 1.702 . . . . 73.13 106.838 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.461 ' HB ' HG23 ' A' ' 79' ' ' THR . 2.3 mp -129.15 149.67 33.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.11 0.964 . . . . 74.14 108.577 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 52.2 t -109.79 124.69 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 125.249 1.42 . . . . 73.21 107.922 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -91.2 100.28 13.13 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 105.605 -1.998 . . . . 71.14 105.605 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.1 t -104.75 132.04 52.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.935 -1.876 . . . . 32.53 105.935 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.77 179.3 27.6 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 121.352 1.887 . . . . 54.54 113.758 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.72 14.01 0.99 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 128.291 2.637 . . . . 52.33 111.943 -179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.6 mp -55.7 157.65 7.35 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.897 1.679 . . . . 74.35 115.059 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -71.69 153.0 59.55 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 124.289 3.326 . . . . 72.25 110.544 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -34.32 75.3 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.216 0.606 . . . . 74.14 111.685 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -90.39 11.12 22.49 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 114.714 1.375 . . . . 61.24 114.714 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.3 tp -45.44 140.39 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 114.603 1.334 . . . . 74.43 114.603 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.38 147.6 46.92 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.149 1.38 . . . . 44.14 108.744 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -29.18 69.04 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.493 0.717 . . . . 74.31 111.105 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.16 -43.33 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.194 0.998 . . . . 61.14 109.17 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -73.09 -18.89 61.26 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.954 1.301 . . . . 71.22 111.744 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.9 mt -86.25 -44.24 12.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 120.573 -1.329 . . . . 41.43 109.524 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -62.17 -45.64 92.53 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.01 0.924 . . . . 73.43 110.955 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -65.35 -27.26 68.45 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 114.171 1.174 . . . . 65.22 114.171 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -74.49 -60.92 2.05 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.544 1.138 . . . . 75.34 109.587 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -80.94 3.65 22.15 Favored 'General case' 0 C--O 1.231 0.096 0 N-CA-C 114.675 1.361 . . . . 61.14 114.675 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -48.53 -51.68 26.29 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.795 1.638 . . . . 63.32 110.595 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -60.54 -44.42 96.12 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.774 0.83 . . . . 61.23 111.857 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 p -70.57 -16.41 62.86 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.145 -0.972 . . . . 13.11 112.981 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.0 m 49.78 71.42 1.58 Allowed Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 126.792 2.037 . . . . 53.23 116.064 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.29 165.72 23.67 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.944 2.429 . . . . 63.51 110.312 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -99.15 -47.41 5.22 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.812 1.645 . . . . 53.23 108.134 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.62 149.19 40.11 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.212 1.005 . . . . 73.52 109.872 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 95.0 mt -146.7 112.31 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.651 1.58 . . . . 64.23 107.08 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -140.27 104.08 4.72 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.653 1.581 . . . . 74.41 110.13 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -89.87 127.78 36.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.132 1.773 . . . . 62.44 110.589 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 -118.95 85.58 2.39 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 126.22 1.808 . . . . 75.41 108.109 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.64 -22.04 43.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.338 0.655 . . . . 52.42 112.544 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -51.5 -28.21 12.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.664 2.386 . . . . 53.03 112.346 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.1 mmtt -133.44 8.43 3.94 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.697 1.999 . . . . 75.23 110.448 177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.01 36.24 72.9 Favored Glycine 0 CA--C 1.524 0.651 0 CA-C-O 118.787 -1.007 . . . . 73.12 111.877 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.5 170.36 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 126.441 1.896 . . . . 73.33 108.575 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.06 170.89 19.35 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 107.534 -1.284 . . . . 54.42 107.534 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -128.23 135.83 50.22 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.429 -2.063 . . . . 73.34 105.429 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.96 107.82 6.3 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 106.812 -1.551 . . . . 73.31 106.812 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -88.36 154.3 20.5 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.442 -1.688 . . . . 52.23 106.442 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -139.93 116.2 10.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.763 1.225 . . . . 65.14 107.817 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -70.22 108.93 4.38 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.624 0.726 . . . . 60.11 111.55 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.43 69.98 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.387 1.075 . . . . 51.11 110.016 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.14 -21.05 65.85 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.649 0.779 . . . . 61.53 111.76 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -37.91 87.07 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.542 -0.91 . . . . 74.52 108.542 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -158.44 102.69 1.75 Allowed 'General case' 0 C--O 1.24 0.574 0 CA-C-N 119.385 0.993 . . . . 71.42 111.327 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -52.74 -33.94 50.51 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.814 0.846 . . . . 64.52 112.769 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.45 12.9 18.8 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.736 1.013 . . . . 72.43 113.736 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.23 -24.91 3.38 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.849 1.214 . . . . 72.24 112.076 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.3 tp -55.56 -33.4 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 118.442 1.121 . . . . 64.14 110.643 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -61.28 2.54 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.513 1.125 . . . . 52.34 109.545 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.3 mmt85 -60.54 -36.62 78.87 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 118.791 -0.623 . . . . 61.12 111.515 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -59.2 -42.97 92.19 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.713 -0.847 . . . . 74.33 108.713 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.2 mtm -67.76 -45.5 74.74 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 117.469 -1.253 . . . . 73.15 108.801 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -52.27 -51.47 58.26 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.103 1.319 . . . . 60.33 110.001 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.3 mt -59.09 -38.62 75.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 125.32 1.448 . . . . 72.22 110.449 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.36 -42.39 62.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.455 0.571 . . . . 72.41 109.623 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.4 mt -65.53 -30.3 71.03 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.791 1.636 . . . . 63.41 111.498 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.8 mt -65.9 -12.95 58.51 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.996 -0.526 . . . . 74.33 110.527 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -86.7 6.15 32.66 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.003 0.921 . . . . 71.31 110.823 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -73.76 115.36 13.09 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 105.39 -2.078 . . . . 72.41 105.39 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.04 5.71 70.26 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 125.053 1.311 . . . . 54.31 111.909 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.8 p -75.53 162.96 27.86 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 119.949 1.875 . . . . 72.25 107.203 178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.1 mt -95.25 139.42 31.6 Favored 'General case' 0 N--CA 1.435 -1.2 0 C-N-CA 126.919 2.087 . . . . 62.44 108.048 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -145.74 122.85 11.46 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.668 1.987 . . . . 63.21 107.713 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.5 mtmt 42.06 46.95 3.79 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.779 1.232 . . . . 74.13 113.02 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.315 98.5 mt-10 66.0 23.71 11.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.814 2.045 . . . . 75.42 116.406 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt -125.26 152.46 44.59 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.393 -2.077 . . . . 74.14 105.393 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -103.56 135.7 44.66 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 102.372 -3.195 . . . . 53.54 102.372 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.5 pt -122.63 161.28 24.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 119.0 0.818 . . . . 75.32 112.929 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -107.17 156.93 18.28 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.851 1.26 . . . . 72.43 111.244 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.9 t -147.49 118.03 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 125.512 1.525 . . . . 61.11 107.908 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -141.75 174.92 10.13 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.593 1.157 . . . . 75.44 110.506 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp -84.05 151.9 24.7 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.29 1.036 . . . . 55.11 111.045 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.461 HG23 ' HB ' ' A' ' 5' ' ' ILE . 1.8 t -154.53 117.23 4.37 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.951 -1.87 . . . . 51.43 105.951 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 p 160.6 -65.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 129.242 3.017 . . . . 51.03 105.691 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.18 70.57 1.05 Allowed Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 108.492 -1.843 . . . . 71.22 108.492 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.427 0 N-CA-C 106.314 -2.714 . . . . 75.35 106.314 -178.28 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.939 0 N-CA-C 109.906 -1.278 . . . . 75.24 109.906 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -76.47 5.86 6.63 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 114.561 1.319 . . . . 51.44 114.561 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -144.76 117.95 8.94 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.282 1.856 . . . . 72.04 110.947 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -95.25 163.43 13.27 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.119 1.368 . . . . 75.13 107.49 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -135.16 138.12 49.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 107.392 -1.336 . . . . 74.04 107.392 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.2 t -96.28 146.63 6.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 104.671 -2.344 . . . . 72.42 104.671 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -108.05 103.62 12.88 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 105.404 -2.072 . . . . 71.04 105.404 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 11' ' ' LEU . 49.6 t -110.78 121.58 63.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.508 -1.664 . . . . 70.1 106.508 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.513 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -142.39 178.35 20.99 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 119.993 1.27 . . . . 74.21 113.043 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 70.72 21.93 5.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.087 2.155 . . . . 54.51 112.297 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 8' ' ' VAL . 8.5 mp -64.15 150.02 93.07 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 125.325 1.45 . . . . 73.21 112.854 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.12 149.75 76.76 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.908 2.405 . . . . 70.14 110.171 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -59.8 -35.59 75.0 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.112 0.565 . . . . 74.23 110.142 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.83 14.14 10.99 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.5 1.296 . . . . 62.42 114.5 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.506 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 10.1 tp -47.08 142.88 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 124.372 1.069 . . . . 73.21 111.609 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 p -124.37 148.75 47.32 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.385 1.074 . . . . 75.23 108.33 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -32.77 72.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.683 -0.675 . . . . 73.24 110.074 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -61.12 -41.47 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-N 118.831 0.741 . . . . 65.23 109.829 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -68.36 -42.23 79.5 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.543 -0.54 . . . . 51.23 109.543 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 35.2 mt -65.96 -40.44 91.31 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.698 0.399 . . . . 62.45 111.605 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -46.63 77.46 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.516 -1.29 . . . . 75.35 107.516 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -61.11 -48.49 81.43 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 114.083 1.142 . . . . 74.23 114.083 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -28.44 68.61 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 113.488 0.921 . . . . 73.05 113.488 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -112.52 9.18 19.51 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 112.92 0.711 . . . . 63.34 112.92 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.4 tttm -55.34 -34.32 64.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.683 -1.26 . . . . 74.42 112.349 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.92 -34.6 44.44 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.324 0.511 . . . . 73.34 110.602 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -27.95 62.86 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.12 -0.696 . . . . 72.3 109.12 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.4 m 58.55 66.24 2.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 127.054 2.141 . . . . 52.51 114.792 178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -63.53 164.96 19.13 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.731 2.954 . . . . 62.23 111.854 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -91.1 -40.74 11.43 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 126.115 1.766 . . . . 63.11 109.291 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -137.23 164.39 28.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.35 0.66 . . . . 74.42 111.311 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.8 mt -151.46 126.26 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 106.502 -1.666 . . . . 73.31 106.502 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.58 104.65 4.78 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.444 1.497 . . . . 74.42 107.172 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.35 125.42 34.23 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.389 -1.337 . . . . 73.14 107.389 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -112.97 86.41 2.37 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.165 -1.791 . . . . 65.41 106.165 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.14 -29.77 61.21 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.39 0.676 . . . . 71.32 111.01 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -52.7 -24.27 8.31 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.305 2.242 . . . . 71.44 113.096 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -132.73 -0.09 3.52 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.846 1.258 . . . . 72.31 111.836 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.63 41.76 98.98 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.132 -1.187 . . . . 75.31 110.132 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.513 HG22 ' CA ' ' A' ' 9' ' ' GLY . 5.3 pt -137.0 167.48 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.707 1.603 . . . . 73.2 109.149 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.18 166.36 24.91 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.382 1.073 . . . . 62.0 108.498 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -130.77 119.14 21.87 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.201 -2.148 . . . . 74.54 105.201 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -124.14 108.99 12.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.388 -1.708 . . . . 73.22 106.388 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.51 153.06 24.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.322 1.849 . . . . 74.45 109.533 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -144.58 108.37 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.687 1.195 . . . . 64.23 108.633 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -72.59 115.68 12.15 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.578 0.704 . . . . 73.34 110.227 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.2 -24.26 54.68 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.933 2.093 . . . . 52.14 111.834 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.85 -27.98 50.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.321 -0.371 . . . . 61.25 110.415 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -71.09 -36.97 72.4 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.21 0.604 . . . . 73.41 111.206 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.7 76.18 1.71 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.493 1.117 . . . . 75.51 111.085 -177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -47.55 66.07 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 120.512 -1.368 . . . . 72.31 113.684 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.25 5.25 52.19 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 114.086 1.143 . . . . 74.32 114.086 -178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -133.59 -5.76 2.8 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-O 117.386 -1.785 . . . . 72.43 115.502 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 3.7 tp -56.29 -42.39 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 121.073 2.436 . . . . 74.33 108.781 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -56.34 23.16 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 107.722 -1.214 . . . . 60.11 107.722 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -50.36 -48.49 55.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 124.417 1.087 . . . . 75.23 110.739 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.5 -48.65 74.28 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.451 0.7 . . . . 72.35 109.124 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 48.8 mtm -68.84 -32.29 71.87 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 118.662 -0.685 . . . . 63.43 112.207 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.21 -51.53 68.95 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.134 2.173 . . . . 74.25 110.291 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.4 mt -63.1 -39.6 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.313 1.445 . . . . 73.42 108.189 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.02 -41.63 81.89 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.178 -0.915 . . . . 62.12 109.554 178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.2 mt -65.72 -31.24 72.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.33 0.968 . . . . 74.4 111.352 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 30.5 mt -66.16 -12.71 57.59 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 118.713 -0.661 . . . . 73.44 111.319 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.9 mm-40 -86.29 6.7 28.51 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-O 117.974 -1.012 . . . . 75.21 111.321 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -73.04 121.54 20.32 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.354 1.862 . . . . 70.42 108.86 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.96 3.22 58.08 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.828 -0.984 . . . . 73.33 114.377 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 76.4 p -68.84 151.61 46.37 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 119.35 1.575 . . . . 55.14 108.465 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.8 mt -97.42 110.84 23.32 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.711 -1.589 . . . . 72.23 106.711 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 mt -113.59 119.11 36.37 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 105.843 -1.91 . . . . 75.11 105.843 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 41.9 mttm 45.03 58.31 4.13 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.643 1.577 . . . . 72.53 109.806 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 59.12 14.43 3.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.265 1.826 . . . . 70.41 115.033 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -121.14 122.01 39.08 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 120.479 -1.388 . . . . 44.44 110.545 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.86 123.85 25.8 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 104.601 -2.37 . . . . 74.31 104.601 178.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.4 pt -108.67 169.85 3.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 119.276 0.944 . . . . 65.34 112.9 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -112.56 146.03 39.26 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.691 1.196 . . . . 55.54 108.904 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.5 t -143.59 108.54 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 106.48 -1.674 . . . . 45.35 106.48 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -132.84 171.66 13.62 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.437 1.495 . . . . 64.41 109.144 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.43 HD13 ' H ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -99.8 152.6 19.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 120.666 -1.271 . . . . 61.32 113.795 -178.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.43 ' H ' HD13 ' A' ' 78' ' ' LEU . 13.0 p -141.52 155.93 45.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.604 1.161 . . . . 75.32 108.9 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.5 t 57.52 86.19 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.817 2.447 . . . . 51.42 114.06 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.85 -9.63 2.06 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.048 -0.862 . . . . 75.15 114.291 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 117.604 -1.665 . . . . 65.3 109.364 179.768 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.563 0 N-CA-C 111.234 -0.746 . . . . 64.51 111.234 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -108.28 8.11 27.62 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 114.243 1.201 . . . . 72.22 114.243 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 137.87 52.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.734 1.152 . . . . 74.02 108.881 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -138.9 156.79 46.99 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.713 1.605 . . . . 74.45 106.768 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.2 mt -136.18 146.76 28.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.314 -0.857 . . . . 75.44 109.971 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.0 t -106.33 119.24 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 127.949 2.5 . . . . 63.35 106.522 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -88.59 135.13 33.65 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 104.562 -2.384 . . . . 74.24 104.562 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 HD11 ' A' ' 11' ' ' LEU . 17.9 t -138.77 122.51 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.135 -2.172 . . . . 53.3 105.135 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.436 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -130.0 -176.57 14.48 Favored Glycine 0 N--CA 1.467 0.718 0 CA-C-N 121.127 1.785 . . . . 52.32 111.027 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.4 m 70.51 17.53 6.77 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.691 1.596 . . . . 51.42 111.554 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.717 HD11 HG12 ' A' ' 8' ' ' VAL . 9.1 mp -67.29 147.55 98.89 Favored Pre-proline 0 C--O 1.235 0.295 0 O-C-N 120.975 -1.078 . . . . 75.11 109.963 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -67.82 152.31 77.54 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.511 2.141 . . . . 63.31 110.574 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -62.94 -30.76 71.81 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.779 -0.823 . . . . 73.12 108.779 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.39 -1.4 33.25 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 127.653 2.381 . . . . 73.15 114.121 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.1 tp -47.75 137.44 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.663 1.185 . . . . 72.51 113.29 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 p -115.43 150.01 37.12 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.464 1.506 . . . . 40.4 108.173 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.82 -29.77 69.79 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.021 0.528 . . . . 51.41 110.722 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 p -67.51 -37.32 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 109.389 -0.597 . . . . 73.4 109.389 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.23 -43.26 82.43 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.061 -1.088 . . . . 61.24 108.061 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.2 mt -62.08 -50.47 71.85 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.93 -0.396 . . . . 75.03 109.93 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -54.34 -50.22 67.92 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 124.587 1.155 . . . . 73.43 108.573 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -60.0 -41.78 92.85 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.555 1.142 . . . . 71.2 111.021 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.44 -31.18 71.19 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 114.87 1.433 . . . . 71.21 114.87 -179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.27 9.72 33.86 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.013 0.525 . . . . 64.2 112.36 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -51.81 -43.73 63.21 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.504 1.522 . . . . 72.22 113.309 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -71.73 -25.83 62.23 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 123.122 0.569 . . . . 72.21 112.117 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.01 -30.02 20.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.182 0.593 . . . . 71.24 109.976 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 56.59 81.41 0.26 Allowed Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 127.946 2.498 . . . . 73.3 112.508 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -68.95 161.37 46.04 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.252 1.968 . . . . 71.42 110.616 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -91.9 -33.4 14.92 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.686 1.194 . . . . 74.41 109.535 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -138.39 151.36 47.42 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.196 0.999 . . . . 62.12 110.691 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.8 mt -143.21 121.75 7.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 108.972 -0.751 . . . . 71.33 108.972 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.7 128.79 25.44 Favored 'General case' 0 CA--C 1.522 -0.114 0 N-CA-C 106.055 -1.832 . . . . 64.24 106.055 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -115.84 116.78 28.61 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.323 1.849 . . . . 70.1 106.965 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -110.8 86.49 2.32 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.799 -1.926 . . . . 70.52 105.799 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.31 -19.08 31.88 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 113.475 0.917 . . . . 73.4 113.475 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -51.41 -28.19 12.12 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.841 2.056 . . . . 71.13 111.622 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -132.67 3.19 3.81 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.471 1.508 . . . . 74.01 109.506 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.74 54.6 36.56 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 126.871 2.177 . . . . 74.23 110.133 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.436 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.8 pt -137.29 155.51 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.897 1.279 . . . . 73.03 109.634 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -134.6 155.24 50.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.551 1.541 . . . . 63.33 109.047 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -125.28 118.67 26.49 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.981 -1.859 . . . . 54.02 105.981 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -121.03 104.81 10.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.379 -1.341 . . . . 55.45 107.379 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -84.46 156.8 21.58 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.726 0.81 . . . . 73.4 108.938 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -143.01 143.84 32.06 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.264 -1.754 . . . . 74.55 106.264 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -102.01 110.46 22.43 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.535 -0.913 . . . . 74.23 108.535 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.33 -27.16 64.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.691 1.196 . . . . 73.21 111.141 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -62.9 -33.34 75.11 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.393 -0.965 . . . . 75.4 108.393 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -61.96 -23.36 66.33 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-O 116.504 -1.713 . . . . 61.2 113.932 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -166.01 96.95 0.62 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 120.497 1.499 . . . . 72.22 110.771 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -31.9 38.46 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 117.328 2.344 . . . . 74.5 117.328 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.7 p -118.18 -9.85 10.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 120.603 1.547 . . . . 70.33 113.312 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.99 -17.66 34.33 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-O 118.256 -1.302 . . . . 64.32 110.759 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.4 tp -58.63 -38.85 73.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 119.954 1.877 . . . . 75.41 107.63 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -55.42 -61.28 2.44 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 126.182 1.793 . . . . 63.34 107.07 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -51.01 -49.44 60.45 Favored 'General case' 0 C--N 1.342 0.268 0 O-C-N 121.944 -0.472 . . . . 72.24 111.491 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -54.31 -48.37 71.4 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.174 0.59 . . . . 62.2 110.448 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.7 mtm -65.68 -41.4 92.48 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 119.031 -0.509 . . . . 62.4 110.493 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -47.13 86.52 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.431 1.014 . . . . 73.23 110.266 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 mt -60.0 -39.64 80.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 C-N-CA 124.701 1.2 . . . . 73.23 108.683 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.69 -41.16 72.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.419 -0.586 . . . . 74.34 109.419 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.5 mt -63.88 -34.36 77.76 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 123.928 0.891 . . . . 73.12 110.988 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 29.2 mt -63.33 -9.57 12.56 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.191 0.996 . . . . 73.54 111.729 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -85.87 -2.8 58.61 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.615 1.098 . . . . 63.41 110.186 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -64.21 118.91 9.28 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.092 -1.447 . . . . 74.41 107.092 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' O ' ' HE2' ' A' ' 73' ' ' LYS . . . 84.85 6.64 85.03 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-O 117.006 -1.997 . . . . 64.11 114.248 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.9 p -78.26 163.18 25.98 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 121.112 2.456 . . . . 75.34 107.731 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.421 ' HG ' ' HE3' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -101.4 108.21 19.75 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.06 -1.089 . . . . 72.43 108.06 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -113.98 121.42 43.86 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 126.307 1.843 . . . . 63.24 107.434 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt 47.44 44.64 16.75 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.552 1.141 . . . . 63.43 113.074 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 69.37 18.19 8.0 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 127.289 2.236 . . . . 64.24 114.604 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -125.93 124.14 40.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.98 0.912 . . . . 72.21 108.557 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 66' ' ' GLY . 1.3 ttmt -75.02 114.81 13.93 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 101.815 -3.402 . . . . 72.31 101.815 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.3 pt -96.11 169.62 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 113.265 0.839 . . . . 65.52 113.265 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -121.43 148.09 44.88 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.819 1.647 . . . . 64.33 108.685 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.453 HG22 HG13 ' A' ' 8' ' ' VAL . 58.3 t -142.15 138.97 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.457 1.103 . . . . 72.32 109.053 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -159.99 176.26 12.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.772 2.029 . . . . 72.22 109.232 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -87.65 151.67 22.77 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.901 -1.125 . . . . 74.04 109.905 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.9 t -140.84 81.3 1.79 Allowed 'General case' 0 C--O 1.224 -0.252 0 N-CA-C 105.22 -2.141 . . . . 74.12 105.22 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 p -174.54 164.38 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.655 -2.35 . . . . 73.32 104.655 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.21 156.54 27.8 Favored Glycine 0 N--CA 1.45 -0.43 0 O-C-N 121.008 -1.057 . . . . 62.03 111.32 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.215 0 C-N-CA 125.518 1.532 . . . . 72.0 110.201 179.819 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.729 0 N-CA-C 111.11 -0.796 . . . . 71.3 111.11 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.512 HD22 ' HB3' ' A' ' 47' ' ' ALA . 7.3 p-10 -71.75 -4.96 30.63 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.644 1.178 . . . . 73.42 113.206 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -87.28 128.89 35.16 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.474 -0.766 . . . . 75.1 110.709 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -91.62 165.23 13.43 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.393 1.477 . . . . 71.0 107.977 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.556 ' HB ' HG23 ' A' ' 79' ' ' THR . 2.2 mt -134.97 148.16 29.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.136 1.374 . . . . 74.52 108.96 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.2 t -112.4 136.69 47.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.764 1.625 . . . . 51.44 107.353 178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.4 ' HZ ' HG21 ' A' ' 40' ' ' ILE . 69.0 t80 -106.34 117.08 33.1 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 124.912 1.285 . . . . 72.44 108.253 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.4 t -122.02 136.37 59.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 108.11 -1.07 . . . . 60.51 108.11 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.576 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -144.2 169.7 26.22 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 119.858 1.208 . . . . 71.32 111.477 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.518 ' HB3' ' HA ' ' A' ' 74' ' ' ILE . 7.2 t 82.9 17.09 0.31 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 128.441 2.696 . . . . 74.32 109.766 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mp -53.62 152.09 9.92 Favored Pre-proline 0 CA--C 1.53 0.203 0 C-N-CA 124.61 1.164 . . . . 71.43 112.591 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -52.54 148.66 26.33 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.958 2.439 . . . . 51.14 111.106 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -59.9 -31.73 70.08 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.785 -0.572 . . . . 74.23 111.083 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -113.63 33.41 5.18 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.123 1.369 . . . . 54.12 111.747 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.68 143.08 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 107.97 -1.122 . . . . 51.44 107.97 178.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -122.36 147.66 46.0 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 108.426 -0.953 . . . . 73.34 108.426 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.91 -28.18 68.73 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 117.961 -1.019 . . . . 54.52 111.179 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.4 p -62.96 -35.49 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 119.793 1.179 . . . . 71.12 109.509 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -66.46 -48.19 70.71 Favored 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 108.678 -0.86 . . . . 72.44 108.678 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.4 mt -59.91 -52.15 66.65 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 123.638 0.775 . . . . 74.43 109.01 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -57.72 -36.48 72.07 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.438 1.495 . . . . 73.03 109.796 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -75.95 -46.24 30.8 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.234 1.414 . . . . 74.32 112.849 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -35.91 81.91 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.632 0.773 . . . . 73.33 111.978 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -97.84 0.28 46.43 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.282 0.845 . . . . 75.35 113.282 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.2 tttt -50.99 -40.97 59.32 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.859 1.664 . . . . 73.45 112.567 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -66.79 -49.33 66.2 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.238 -0.653 . . . . 63.13 109.238 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.5 p -66.38 -17.15 64.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.789 1.236 . . . . 70.22 112.852 179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.8 t 47.55 77.14 0.48 Allowed Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.658 1.583 . . . . 54.12 113.711 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.54 163.76 33.65 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.44 2.76 . . . . 71.41 110.652 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.6 -41.66 17.6 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.73 1.212 . . . . 72.32 108.426 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.33 162.12 40.7 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.641 1.176 . . . . 71.43 108.079 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 62.3 mt -135.52 128.5 47.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 126.182 1.793 . . . . 73.21 107.793 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -141.12 104.4 4.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.744 1.218 . . . . 55.03 109.359 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.29 125.28 37.81 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.937 -1.505 . . . . 72.42 106.937 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -118.82 91.53 3.58 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.349 1.059 . . . . 74.04 108.854 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.11 -20.94 64.58 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.203 1.001 . . . . 71.31 110.551 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.07 -32.34 21.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.949 2.1 . . . . 62.25 110.084 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -131.98 3.6 4.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.951 1.7 . . . . 74.05 111.966 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 63.29 34.8 90.94 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 119.66 1.118 . . . . 54.13 111.929 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.576 HG22 ' CA ' ' A' ' 9' ' ' GLY . 1.7 pp -124.87 171.3 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.289 1.435 . . . . 73.13 110.249 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.12 163.89 33.91 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.848 0.859 . . . . 72.12 111.031 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -130.49 135.49 48.01 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.398 1.479 . . . . 72.53 107.866 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -142.28 111.63 6.55 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.124 -1.435 . . . . 70.22 107.124 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.2 159.48 21.01 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.149 -1.056 . . . . 62.55 108.149 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -144.43 104.47 4.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.047 1.339 . . . . 70.53 107.426 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.69 110.0 5.96 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.644 1.178 . . . . 71.53 112.228 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.512 ' HB3' HD22 ' A' ' 2' ' ' ASN . . . -63.01 -31.71 72.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 113.506 0.928 . . . . 71.44 113.506 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -75.11 -24.29 58.05 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.21 0.914 . . . . 75.24 111.954 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -61.38 -30.72 70.72 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.498 -0.751 . . . . 61.31 110.302 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -157.0 84.02 0.94 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.976 -0.75 . . . . 73.04 108.976 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -52.47 -38.51 59.51 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.553 0.575 . . . . 73.02 112.553 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.0 -4.77 57.24 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 113.983 1.105 . . . . 74.22 113.983 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.1 -14.32 4.62 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.148 -1.362 . . . . 62.43 115.024 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 5.5 tp -51.72 -43.69 34.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 120.21 2.005 . . . . 72.35 110.886 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -57.05 -51.3 69.81 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.9 -1.148 . . . . 75.42 107.9 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -57.06 -48.86 77.53 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.206 1.002 . . . . 73.54 109.318 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 54.7 mtt85 -52.07 -51.97 54.24 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 118.656 0.662 . . . . 55.21 109.872 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 21.4 mtm -62.94 -39.61 95.14 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 119.096 -0.478 . . . . 74.14 110.771 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -49.96 75.42 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.297 1.039 . . . . 73.33 110.24 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.0 mt -59.37 -39.36 78.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 C-N-CA 124.597 1.159 . . . . 62.55 108.504 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.49 -40.38 70.26 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.324 0.511 . . . . 71.15 110.353 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.8 mt -63.11 -38.82 92.68 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.338 1.055 . . . . 74.23 110.375 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 47.1 mt -62.98 -2.44 1.23 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.719 1.608 . . . . 75.01 113.853 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -92.32 1.17 57.39 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.939 0.79 . . . . 52.21 110.852 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -63.62 115.3 4.59 Favored 'General case' 0 C--N 1.338 0.078 0 O-C-N 120.279 -1.513 . . . . 63.44 111.054 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.2 4.6 74.14 Favored Glycine 0 CA--C 1.521 0.457 0 CA-C-O 118.291 -1.283 . . . . 54.41 111.955 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.6 p -68.27 157.95 34.45 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 119.216 1.508 . . . . 74.14 109.65 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 21.5 mt -102.71 111.4 23.69 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 107.243 -1.392 . . . . 72.35 107.243 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -116.25 116.17 27.29 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.31 -1.367 . . . . 61.23 107.31 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt 49.88 53.44 12.79 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.793 1.237 . . . . 74.41 111.68 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 57.62 30.58 19.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.257 1.823 . . . . 74.21 113.838 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.21 118.02 13.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.313 1.445 . . . . 72.01 108.44 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.3 tttm -76.03 140.39 41.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 106.116 -1.809 . . . . 52.04 106.116 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.518 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 11.8 pt -126.63 170.08 17.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.438 1.086 . . . . 71.04 112.866 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.44 157.13 37.67 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 125.195 1.398 . . . . 73.1 110.699 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.0 t -136.87 148.55 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 125.275 1.43 . . . . 71.25 108.938 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -165.0 174.59 10.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 127.979 2.512 . . . . 74.45 109.175 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.22 152.0 20.07 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.433 1.093 . . . . 74.25 109.959 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.556 HG23 ' HB ' ' A' ' 5' ' ' ILE . 5.5 t -140.13 82.44 1.86 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.72 -1.215 . . . . 53.23 107.72 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.0 p -166.82 -39.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 123.499 0.72 . . . . 74.54 109.446 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.74 -52.64 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 CA-C-O 118.87 -0.961 . . . . 73.24 111.448 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.859 0 N-CA-C 106.513 -2.635 . . . . 44.33 106.513 -179.596 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.349 0 N-CA-C 111.371 -0.691 . . . . 62.51 111.371 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -151.54 45.31 0.79 Allowed 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.731 1.613 . . . . 73.22 108.567 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.4 ptt-85 -134.73 131.83 38.09 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 107.935 -1.135 . . . . 63.12 107.935 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -95.04 162.86 13.55 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.721 -1.585 . . . . 54.22 106.721 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.487 HD12 ' HB ' ' A' ' 80' ' ' VAL . 22.0 mt -134.23 149.01 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.534 0.683 . . . . 65.32 109.715 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.9 t -121.06 115.06 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 105.949 -1.871 . . . . 53.22 105.949 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -84.61 139.03 32.36 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.54 -2.393 . . . . 75.32 104.54 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.444 HG12 HD11 ' A' ' 11' ' ' LEU . 2.5 t -131.74 136.57 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.746 -1.946 . . . . 52.31 105.746 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -141.83 -178.4 17.92 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 119.718 1.145 . . . . 54.13 110.596 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.44 13.06 9.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.14 1.776 . . . . 33.33 112.628 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.444 HD11 HG12 ' A' ' 8' ' ' VAL . 10.4 mp -54.8 148.61 26.27 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 125.565 1.546 . . . . 73.41 112.603 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.44 150.71 87.77 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.893 2.395 . . . . 75.02 110.365 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -53.58 -45.75 70.08 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.135 0.974 . . . . 71.21 110.718 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.02 18.53 5.72 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.248 1.573 . . . . 74.2 115.248 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.483 HG21 HD21 ' A' ' 34' ' ' LEU . 6.5 tp -44.98 137.21 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 119.902 1.228 . . . . 74.01 111.968 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 p -115.96 150.52 37.03 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.293 1.437 . . . . 75.21 109.236 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.71 -29.63 70.83 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-O 119.13 -0.462 . . . . 61.42 110.647 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.48 -38.35 82.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 118.443 0.565 . . . . 73.55 109.581 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -67.42 -38.14 84.14 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.088 0.858 . . . . 73.2 109.125 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.6 mt -64.77 -54.46 31.01 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.107 -0.701 . . . . 70.24 109.107 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -54.81 -46.56 74.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.123 0.969 . . . . 74.11 109.097 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -62.77 -41.22 99.15 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 114.378 1.251 . . . . 75.33 114.378 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -46.56 69.84 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.056 -1.028 . . . . 64.34 110.493 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -86.09 3.06 44.21 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 114.057 1.132 . . . . 71.25 114.057 -179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -53.43 -40.63 65.32 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.538 -1.351 . . . . 71.5 110.69 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -70.59 -31.38 68.35 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.926 1.69 . . . . 74.24 112.174 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 p -89.49 -11.21 43.61 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 117.913 -1.042 . . . . 65.44 112.459 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.0 m 48.58 70.44 2.08 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 115.445 1.646 . . . . 72.4 115.445 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.94 161.4 46.1 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.961 2.441 . . . . 63.03 111.682 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -91.55 -39.5 11.88 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.05 1.74 . . . . 65.21 107.649 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tp60 -135.35 158.19 44.99 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.698 1.199 . . . . 70.24 110.748 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 55.6 mt -145.79 126.3 6.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.341 -1.726 . . . . 45.21 106.341 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -140.27 105.93 5.13 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 124.985 1.314 . . . . 74.42 109.833 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 15' ' ' ILE . 1.6 tm? -92.76 121.16 33.87 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.313 1.045 . . . . 74.22 110.241 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -118.88 81.7 1.74 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 107.941 -1.133 . . . . 74.11 107.941 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.63 -21.63 60.72 Favored 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 124.217 1.007 . . . . 64.45 111.096 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.74 -20.21 7.93 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.953 1.701 . . . . 64.14 112.346 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.3 mttt -132.37 -4.1 3.4 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.702 1.601 . . . . 75.41 109.447 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.32 41.77 51.69 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.207 -1.557 . . . . 54.45 109.207 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.453 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 40.5 pt -132.86 171.82 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 124.537 1.135 . . . . 61.33 110.678 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.87 165.6 34.94 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.739 1.615 . . . . 65.31 109.187 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -135.22 142.3 45.99 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.552 1.941 . . . . 65.13 106.219 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -142.9 114.08 7.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.28 -1.378 . . . . 74.41 107.28 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -89.3 155.98 19.02 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 106.551 -1.648 . . . . 72.12 106.551 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -145.1 114.02 6.89 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.275 1.83 . . . . 64.1 109.187 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -72.01 112.77 8.39 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.776 1.028 . . . . 71.35 113.776 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -72.95 -16.26 61.54 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 125.427 1.491 . . . . 70.13 112.789 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.62 -22.51 27.94 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 119.058 0.845 . . . . 75.34 109.57 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -61.62 -43.93 97.94 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 120.952 -1.092 . . . . 64.54 109.697 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -145.44 89.21 1.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.512 0.596 . . . . 72.21 110.755 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.39 -37.57 48.92 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 114.358 1.244 . . . . 75.32 114.358 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.8 p -97.15 -19.85 18.37 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.221 1.373 . . . . 72.24 112.381 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.49 -16.29 43.56 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-O 117.65 -1.639 . . . . 52.21 114.911 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.6 tp -55.42 -37.3 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 120.799 2.3 . . . . 71.04 109.366 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -60.84 -60.93 3.01 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.632 -1.247 . . . . 73.14 107.632 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -50.79 -44.22 58.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 118.614 -0.708 . . . . 74.52 110.628 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -56.42 -49.98 72.98 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.939 -0.763 . . . . 65.05 108.939 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.2 mtm -58.68 -47.71 83.57 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 124.204 1.002 . . . . 73.23 109.447 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.51 -53.76 50.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.997 1.719 . . . . 74.45 111.837 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 44.6 mt -61.27 -37.01 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.804 1.242 . . . . 75.41 108.937 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.36 -41.44 63.41 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.434 -0.58 . . . . 71.52 109.434 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.39 -34.95 78.85 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.915 1.286 . . . . 75.12 111.241 -178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.8 mt -65.81 -9.77 31.66 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.044 0.938 . . . . 74.4 111.889 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -85.76 -1.68 57.46 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 119.128 0.876 . . . . 65.41 110.418 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -62.76 111.9 2.3 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 120.883 1.674 . . . . 60.34 109.673 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.74 7.25 53.68 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.619 1.104 . . . . 64.41 112.945 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.1 p -66.08 146.85 54.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 119.528 1.664 . . . . 51.53 109.121 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.6 mt -93.08 121.21 34.19 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.547 -2.39 . . . . 55.54 104.547 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.8 120.05 28.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.996 1.318 . . . . 73.23 108.152 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt 48.39 40.48 14.79 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.22 1.408 . . . . 63.03 112.561 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 70.48 29.35 3.47 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 128.519 2.728 . . . . 62.33 113.913 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -136.15 120.71 18.26 Favored 'General case' 0 CA--C 1.522 -0.116 0 C-N-CA 126.551 1.94 . . . . 70.31 108.772 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -73.61 138.33 44.8 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 105.636 -1.987 . . . . 75.05 105.636 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 pt -119.5 170.09 9.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 124.636 1.174 . . . . 65.4 110.695 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -123.66 158.74 30.86 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.247 1.419 . . . . 72.13 111.23 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.3 t -143.96 132.89 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 126.09 1.756 . . . . 74.34 108.862 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -148.24 160.53 42.86 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.616 1.566 . . . . 73.25 108.565 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -86.28 148.13 25.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.848 1.259 . . . . 71.31 109.784 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.77 155.86 43.75 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.991 1.717 . . . . 54.23 107.261 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.487 ' HB ' HD12 ' A' ' 5' ' ' ILE . 42.2 t 38.94 77.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.268 0 C-N-CA 125.798 1.639 . . . . 64.51 110.745 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.71 88.42 0.07 OUTLIER Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 118.562 -1.78 . . . . 71.1 108.798 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.932 0 N-CA-C 104.31 -3.516 . . . . 75.11 104.31 -179.608 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.346 0 N-CA-C 109.966 -1.254 . . . . 44.43 109.966 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -107.85 24.2 13.3 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 124.851 1.26 . . . . 63.24 112.722 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.6 ptt85 -125.13 155.89 39.2 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.759 1.618 . . . . 73.33 109.384 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -119.03 161.38 20.34 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 105.81 -1.922 . . . . 52.33 105.81 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.1 mt -134.68 139.41 47.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.178 1.391 . . . . 75.44 110.261 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.75 141.56 27.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 106.971 -1.492 . . . . 71.1 106.971 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -103.79 133.19 49.2 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.31 -2.107 . . . . 71.31 105.31 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG12 HD11 ' A' ' 11' ' ' LEU . 93.2 t -136.79 130.6 46.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 105.731 -1.952 . . . . 72.34 105.731 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -144.95 179.92 21.74 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 121.348 1.885 . . . . 54.24 115.041 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.82 17.15 2.32 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 128.162 2.585 . . . . 52.52 111.399 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.426 HD11 HG12 ' A' ' 8' ' ' VAL . 7.4 mp -66.76 146.23 99.05 Favored Pre-proline 0 C--O 1.238 0.45 0 C-N-CA 125.023 1.329 . . . . 72.43 112.765 -177.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -67.07 167.76 19.13 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.681 2.921 . . . . 75.13 112.119 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.8 mtm-85 -75.0 -34.64 61.97 Favored 'General case' 0 N--CA 1.462 0.139 0 N-CA-C 108.297 -1.001 . . . . 73.33 108.297 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -80.6 11.62 3.65 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.149 1.38 . . . . 61.11 112.172 179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.441 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 8.7 tp -54.77 143.61 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 120.679 -1.263 . . . . 71.21 109.31 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.8 p -128.11 148.25 50.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.445 1.098 . . . . 71.42 110.074 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.95 -29.63 70.37 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 118.209 -0.9 . . . . 41.54 110.652 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.65 -38.21 81.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 119.069 0.85 . . . . 75.2 109.782 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HB3' HD11 ' A' ' 69' ' ' LEU . 4.1 mm-40 -71.48 -43.11 67.19 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.022 -0.732 . . . . 75.43 109.022 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.51 -49.64 75.91 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.34 1.056 . . . . 64.43 111.253 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -59.39 -42.14 91.02 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.629 0.772 . . . . 74.42 109.178 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -68.79 -40.88 79.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.385 1.474 . . . . 74.14 113.535 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -41.28 91.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 118.739 0.699 . . . . 71.32 111.978 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -99.75 4.74 45.56 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.82 1.044 . . . . 70.24 113.82 -179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -51.19 -47.54 62.18 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.067 1.347 . . . . 64.5 109.896 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -58.06 -39.9 79.64 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.633 0.773 . . . . 74.32 111.838 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 p -81.87 -10.76 59.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.732 1.213 . . . . 71.32 112.794 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.64 65.95 6.38 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 114.965 1.468 . . . . 74.24 114.965 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -64.91 151.86 84.32 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.751 2.301 . . . . 61.34 108.897 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -86.68 -48.49 8.24 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.077 -1.083 . . . . 63.3 108.077 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' NE2' ' H ' ' A' ' 32' ' ' ILE . 0.0 OUTLIER -124.5 153.88 41.38 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 108.258 -1.016 . . . . 72.0 108.258 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.454 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 65.3 mt -145.92 119.83 2.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 106.425 -1.694 . . . . 71.21 106.425 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.43 108.22 10.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.733 -1.58 . . . . 74.34 106.733 178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -93.59 125.93 38.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.746 -1.576 . . . . 65.5 106.746 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -118.24 89.69 3.18 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 105.426 -2.064 . . . . 74.11 105.426 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.15 -16.41 52.56 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 119.148 -0.453 . . . . 32.44 111.417 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -50.48 -40.08 50.0 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.246 2.219 . . . . 75.23 111.034 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -126.84 6.56 6.68 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.853 1.661 . . . . 64.35 110.174 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 62.12 42.63 99.73 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 110.313 -1.115 . . . . 54.52 110.313 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.2 pp -127.7 162.31 33.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.856 1.263 . . . . 70.24 109.37 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.75 152.23 40.06 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.126 0.971 . . . . 64.3 109.527 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -120.31 135.25 55.08 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 103.958 -2.608 . . . . 74.13 103.958 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.53 122.99 25.67 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.158 -1.793 . . . . 50.33 106.158 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -96.6 150.71 20.35 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.188 -1.412 . . . . 71.51 107.188 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -142.13 110.68 6.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.388 -1.338 . . . . 75.12 107.388 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -76.25 118.19 18.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.645 0.778 . . . . 62.42 109.302 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.76 -18.88 50.03 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 128.025 2.53 . . . . 75.54 112.344 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.5 -30.33 52.94 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.479 -1.674 . . . . 73.05 106.479 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -61.73 -37.5 84.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.696 1.198 . . . . 62.32 112.348 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -147.94 97.92 2.87 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 119.297 0.953 . . . . 63.12 108.876 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -51.46 -31.52 23.59 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 115.894 -2.003 . . . . 63.11 116.315 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.79 -20.59 8.17 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 121.021 1.737 . . . . 64.32 111.287 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.42 -30.7 66.54 Favored Glycine 0 C--N 1.338 0.66 0 O-C-N 121.015 -1.053 . . . . 71.33 110.835 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.7 tp -49.76 -41.95 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 118.388 1.094 . . . . 43.03 112.055 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -68.23 -61.34 1.89 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.222 0.609 . . . . 74.52 110.342 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.9 mtt85 -56.15 -30.84 62.74 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.93 -0.481 . . . . 75.32 111.331 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.3 mtt85 -68.44 -41.16 80.7 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 121.01 -1.056 . . . . 74.32 108.741 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.0 mtm -64.55 -44.09 91.9 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 107.163 -1.421 . . . . 72.53 107.163 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -56.5 -48.24 77.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.948 0.899 . . . . 34.31 109.048 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 54.2 mt -60.58 -41.38 87.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 124.137 0.975 . . . . 65.42 109.848 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.27 84.3 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.448 -0.575 . . . . 73.14 109.448 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.6 mt -63.28 -32.55 74.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.828 0.851 . . . . 70.21 110.245 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.3 mt -65.28 -13.04 57.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 118.795 -0.621 . . . . 71.24 110.951 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -86.49 3.93 41.97 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 118.932 0.787 . . . . 53.2 110.262 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -69.53 112.71 6.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.083 -1.636 . . . . 74.41 107.842 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.65 -3.93 85.05 Favored Glycine 0 C--O 1.225 -0.447 0 CA-C-O 116.436 -2.313 . . . . 75.4 111.893 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -64.87 137.73 57.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 121.44 2.62 . . . . 63.34 107.138 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 73.9 mt -75.49 126.28 30.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 106.027 -1.842 . . . . 75.34 106.027 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 19' ' ' GLU . 49.7 tp -129.82 122.9 29.65 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 105.364 -2.088 . . . . 74.12 105.364 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 6.0 mtpm? 51.37 44.85 28.69 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.768 1.627 . . . . 74.23 111.359 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 57.83 33.89 23.74 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 127.644 2.378 . . . . 72.01 113.193 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -134.46 128.54 33.67 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 126.039 1.736 . . . . 73.34 108.137 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.5 tptp -78.52 112.15 15.29 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 103.534 -2.765 . . . . 74.44 103.534 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.8 pt -104.56 169.29 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 118.137 0.426 . . . . 74.14 110.359 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -121.64 158.7 28.06 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.286 1.034 . . . . 60.04 111.236 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.0 t -146.21 143.63 21.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 124.846 1.258 . . . . 64.12 108.048 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -162.07 161.13 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.647 1.579 . . . . 72.22 108.863 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.67 152.18 22.78 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.916 1.286 . . . . 73.3 109.109 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.8 p -150.14 144.15 25.51 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.797 1.239 . . . . 72.43 108.603 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.8 t 59.49 79.13 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 125.254 1.422 . . . . 63.5 112.272 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.32 24.94 0.07 OUTLIER Glycine 0 CA--C 1.523 0.592 0 O-C-N 120.805 -1.184 . . . . 54.45 112.61 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 N-CA-C 108.106 -1.998 . . . . 64.34 108.106 179.921 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.842 0 N-CA-C 111.173 -0.771 . . . . 53.24 111.173 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.04 51.9 0.84 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.55 1.175 . . . . 74.31 111.548 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -155.8 159.06 39.09 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 120.967 -1.083 . . . . 75.52 110.74 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -130.21 158.8 38.75 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 129.786 3.234 . . . . 73.13 105.196 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.432 HD12 HG21 ' A' ' 80' ' ' VAL . 21.4 mt -130.36 149.32 33.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.832 0.825 . . . . 42.44 109.338 -177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.0 t -108.9 127.14 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 125.798 1.639 . . . . 71.23 107.421 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -91.45 128.32 37.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 104.537 -2.394 . . . . 61.25 104.537 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.6 t -133.84 129.55 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 106.462 -1.681 . . . . 75.34 106.462 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.72 -175.72 14.44 Favored Glycine 0 N--CA 1.468 0.814 0 CA-C-N 120.317 1.417 . . . . 32.01 113.09 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 72.21 14.45 5.56 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.217 2.207 . . . . 74.24 111.543 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.26 149.59 82.3 Favored Pre-proline 0 C--O 1.24 0.573 0 C-N-CA 125.232 1.413 . . . . 72.42 112.334 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -68.98 165.15 31.05 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.282 2.655 . . . . 72.45 110.036 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.19 -31.52 58.51 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 124.219 1.008 . . . . 75.21 109.494 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -85.35 10.89 11.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.303 1.441 . . . . 75.41 113.467 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.551 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 8.6 tp -57.61 138.97 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.488 1.115 . . . . 71.3 111.69 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 p -128.32 153.4 47.05 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 124.184 0.994 . . . . 74.3 109.738 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.36 -33.31 65.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 126.446 1.898 . . . . 71.34 111.366 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.8 p -66.14 -37.7 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 CA-C-O 119.126 -0.464 . . . . 54.03 110.113 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.79 -43.39 72.22 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.392 -0.966 . . . . 73.24 108.392 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -60.36 -55.63 31.24 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 125.276 1.43 . . . . 73.33 110.069 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -57.63 -45.06 85.9 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.037 -0.727 . . . . 74.02 109.037 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -60.34 -44.1 95.83 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.485 0.714 . . . . 65.11 112.813 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -47.98 74.89 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 119.419 1.009 . . . . 74.41 110.825 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -83.01 1.02 42.09 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 115.362 1.615 . . . . 74.53 115.362 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.2 pttt -51.26 -41.57 60.49 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.223 1.409 . . . . 71.43 113.382 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -32.75 74.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.885 0.874 . . . . 75.32 110.666 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 88.1 p -87.16 -28.76 22.25 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.255 1.206 . . . . 64.43 114.255 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.4 t 62.81 75.21 0.42 Allowed Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.53 1.932 . . . . 65.14 112.358 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -67.33 159.97 49.86 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.934 3.09 . . . . 63.02 110.719 178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -85.63 -46.47 10.74 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.871 1.668 . . . . 72.14 108.009 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -142.56 157.21 44.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.902 -0.59 . . . . 73.04 109.598 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 50.6 mt -137.93 128.46 36.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 125.028 1.331 . . . . 65.12 108.875 -178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 103.39 5.92 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.35 -1.352 . . . . 72.41 107.35 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -88.62 111.73 22.25 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 106.95 -1.5 . . . . 60.45 106.95 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -105.28 80.22 1.57 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.079 -1.452 . . . . 72.24 107.079 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.66 -27.97 43.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.977 0.911 . . . . 74.31 111.246 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -51.09 -27.9 9.32 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 127.515 2.326 . . . . 70.3 113.904 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -132.65 9.96 4.31 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.888 1.275 . . . . 74.53 111.093 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.14 42.7 99.87 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.795 1.188 . . . . 64.14 110.619 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.54 166.05 29.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 C-N-CA 124.816 1.246 . . . . 73.24 111.482 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.31 148.77 36.84 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 127.328 2.251 . . . . 53.2 108.239 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -124.16 129.39 50.74 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 105.961 -1.866 . . . . 75.34 105.961 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.11 114.13 15.36 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 108.209 -1.034 . . . . 64.23 108.209 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -92.66 155.04 17.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.745 -1.946 . . . . 62.12 105.745 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -140.02 137.22 34.46 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 106.629 -1.619 . . . . 74.34 106.629 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -81.7 110.19 16.81 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.944 1.247 . . . . 73.33 109.444 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.59 -16.99 62.9 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.631 1.172 . . . . 60.34 112.273 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.69 -18.38 29.66 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.997 0.817 . . . . 73.32 110.777 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -60.98 -35.61 77.24 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.157 0.889 . . . . 70.41 110.357 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -150.14 86.71 1.43 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.922 -1.881 . . . . 73.43 105.922 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -49.75 -37.36 29.25 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.471 1.108 . . . . 70.43 112.226 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.97 -3.1 39.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.257 1.423 . . . . 72.02 113.578 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.06 -19.75 5.84 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 124.923 1.249 . . . . 53.24 114.788 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.0 tp -52.83 -36.99 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 119.42 1.61 . . . . 62.43 111.461 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -56.42 -54.84 40.96 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.846 1.259 . . . . 63.32 108.398 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.24 -47.03 79.31 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.34 1.056 . . . . 72.52 109.793 178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -54.74 -46.59 74.3 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 118.727 -0.654 . . . . 75.01 109.273 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 2.7 mtm -61.33 -50.88 71.16 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 108.173 -1.047 . . . . 72.1 108.173 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.04 -52.52 8.87 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.796 2.038 . . . . 74.14 111.836 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.0 mt -59.08 -41.9 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 125.199 1.4 . . . . 71.32 110.091 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.32 -36.82 61.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.159 0.984 . . . . 71.13 111.058 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 70.6 mt -66.96 -36.08 81.41 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 119.642 1.11 . . . . 74.31 109.586 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.68 -12.73 11.23 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.568 1.147 . . . . 55.11 111.512 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -84.61 5.02 29.59 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 118.871 0.759 . . . . 52.24 110.278 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -69.07 113.92 6.88 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.285 -1.746 . . . . 72.23 106.285 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.28 6.23 61.56 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.282 -1.288 . . . . 70.42 113.458 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.5 p -68.07 143.56 55.44 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 120.482 2.141 . . . . 74.51 108.607 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 73' ' ' LYS . 15.2 mt -88.71 107.6 19.03 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 103.174 -2.899 . . . . 61.13 103.174 177.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.9 tp -113.0 117.5 32.21 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.715 -1.587 . . . . 62.32 106.715 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 14.3 mtpp 47.05 56.1 7.22 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.883 0.873 . . . . 65.04 111.891 178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 60.95 23.38 13.5 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.856 1.662 . . . . 72.41 114.789 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -132.41 126.67 33.67 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 124.685 1.194 . . . . 73.31 108.757 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.422 ' HA ' HD23 ' A' ' 68' ' ' LEU . 4.6 ttpm? -80.1 114.3 18.9 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 104.067 -2.568 . . . . 75.55 104.067 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.2 pt -94.96 169.24 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 118.436 0.562 . . . . 65.04 109.984 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -122.99 158.59 30.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 125.01 1.324 . . . . 72.34 110.861 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.0 t -142.52 126.44 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 126.009 1.723 . . . . 72.23 108.797 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -139.03 174.47 10.48 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.475 1.51 . . . . 74.32 108.156 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -95.46 151.78 18.99 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.152 -0.967 . . . . 74.51 110.124 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 t -152.64 132.17 13.01 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.249 -1.389 . . . . 63.02 107.249 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.432 HG21 HD12 ' A' ' 5' ' ' ILE . 3.0 t 68.15 113.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 125.681 1.592 . . . . 75.02 112.715 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.79 6.47 40.4 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.564 1.078 . . . . 51.23 113.746 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 N-CA-C 104.397 -3.481 . . . . 41.2 104.397 179.196 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 N-CA-C 110.998 -0.841 . . . . 73.33 110.998 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -76.35 16.68 0.44 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 114.556 1.317 . . . . 62.34 114.556 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.414 HH11 ' HB3' ' A' ' 44' ' ' GLU . 9.8 tpp180 -138.28 138.43 38.41 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 121.116 1.78 . . . . 73.31 108.384 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -128.55 157.71 40.46 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.778 1.631 . . . . 65.54 107.233 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 mt -134.91 146.01 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.361 1.065 . . . . 64.25 110.02 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.6 t -102.8 126.44 57.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.62 -1.993 . . . . 71.32 105.62 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -96.58 105.14 17.19 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.594 -1.632 . . . . 74.23 106.594 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -113.66 139.35 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 120.027 1.285 . . . . 62.11 108.675 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -149.06 178.31 26.7 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 119.928 1.24 . . . . 62.44 112.663 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 84.99 6.3 0.5 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.405 3.082 . . . . 74.21 111.833 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.3 mp -46.24 148.67 1.49 Allowed Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 127.339 2.256 . . . . 73.03 115.392 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.86 175.28 7.55 Favored 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.98 4.453 . . . . 54.32 113.379 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 mmt-85 -78.47 -45.44 22.08 Favored 'General case' 0 C--O 1.226 -0.133 0 N-CA-C 107.898 -1.149 . . . . 54.25 107.898 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -84.25 22.02 1.3 Allowed 'General case' 0 C--O 1.235 0.299 0 C-N-CA 126.031 1.733 . . . . 61.3 112.889 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.7 tp -61.93 142.25 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.628 -1.249 . . . . 63.03 107.628 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.99 150.01 50.58 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.376 -0.972 . . . . 64.04 108.376 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.6 -32.39 70.35 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.848 -0.797 . . . . 75.42 108.848 177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.01 -49.08 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 125.138 1.375 . . . . 74.25 109.868 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.46 -34.75 74.84 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 120.01 -0.676 . . . . 73.42 109.215 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.12 -49.85 72.77 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.943 0.792 . . . . 72.12 109.436 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -59.92 -37.78 80.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.828 -0.606 . . . . 72.23 110.501 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -69.59 -50.82 40.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.394 0.677 . . . . 44.34 110.764 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -24.11 67.7 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 120.971 -1.081 . . . . 74.24 112.213 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -108.54 8.79 27.39 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.88 1.218 . . . . 70.35 111.712 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -61.27 -26.72 67.96 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 120.107 -1.62 . . . . 65.24 114.062 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -85.73 -30.1 23.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.639 1.109 . . . . 65.53 108.767 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -31.2 58.73 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.407 -0.96 . . . . 63.51 108.407 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m 60.69 72.35 0.73 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 126.674 1.99 . . . . 73.53 113.134 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.14 158.1 58.53 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.741 2.961 . . . . 65.44 110.465 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -78.96 -45.74 19.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 106.857 -1.534 . . . . 73.15 106.857 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -156.77 139.71 15.31 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.477 1.511 . . . . 63.41 108.48 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.5 mp -109.14 142.19 22.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.384 -1.71 . . . . 74.54 106.384 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -135.09 103.8 5.69 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.581 -1.637 . . . . 73.33 106.581 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -86.7 121.44 29.22 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.463 -1.31 . . . . 61.24 107.463 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -108.85 82.35 1.59 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.542 -1.651 . . . . 73.32 106.542 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.56 -23.22 62.7 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.216 0.606 . . . . 62.44 111.347 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.95 -26.93 66.37 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.56 1.544 . . . . 74.12 111.981 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.6 mmmt -133.17 6.6 3.89 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.693 1.197 . . . . 70.03 112.591 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.32 47.41 91.03 Favored Glycine 0 CA--C 1.524 0.601 0 CA-C-N 119.063 0.847 . . . . 62.03 111.287 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.469 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 2.3 pt -134.73 159.78 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.196 1.398 . . . . 73.25 108.727 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.68 135.06 21.88 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.58 1.152 . . . . 54.12 108.347 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -108.17 139.33 43.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.573 -2.01 . . . . 74.13 105.573 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mp -133.32 116.03 15.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 105.406 -2.072 . . . . 64.45 105.406 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.414 ' HB3' HH11 ' A' ' 3' ' ' ARG . 35.8 mt-10 -88.05 149.98 23.66 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 123.918 0.887 . . . . 53.32 109.711 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -140.98 123.31 15.79 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.188 1.795 . . . . 60.11 107.654 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -90.82 112.4 24.19 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.111 0.964 . . . . 72.21 110.882 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.42 -22.58 62.71 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.107 1.363 . . . . 45.25 111.74 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.93 -37.04 64.71 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.941 -1.133 . . . . 51.32 107.941 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -69.17 -38.25 78.61 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 118.687 -0.673 . . . . 73.23 109.657 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -124.0 75.86 1.4 Allowed 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.823 0.738 . . . . 63.23 111.564 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -54.15 -39.61 66.68 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 118.837 -0.601 . . . . 74.44 111.979 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 22.9 p -104.26 -1.26 27.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.872 1.269 . . . . 75.23 113.449 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.43 -13.88 7.91 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-O 117.958 -1.468 . . . . 63.2 114.813 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.3 tp -51.4 -50.37 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 120.171 1.986 . . . . 72.35 112.218 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -53.33 57.02 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 108.331 -0.989 . . . . 62.34 108.331 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -50.59 -48.65 57.69 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.133 0.573 . . . . 73.13 111.068 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -57.01 -49.63 75.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.549 1.14 . . . . 55.03 108.719 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 43.2 mtm -64.08 -36.53 84.32 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.405 0.682 . . . . 70.31 111.345 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -55.35 -51.07 67.98 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 126.704 2.002 . . . . 43.4 111.65 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.47 -26.56 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.568 1.547 . . . . 65.13 109.368 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.89 -39.58 19.67 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.973 0.909 . . . . 70.51 108.927 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.31 -44.67 95.23 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.032 1.733 . . . . 72.01 110.221 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.3 mt -58.41 -6.82 0.74 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.485 1.914 . . . . 74.22 113.938 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -89.4 -3.7 58.32 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.29 0.95 . . . . 72.34 111.331 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -59.23 112.66 1.8 Allowed 'General case' 0 C--N 1.339 0.129 0 C-N-CA 124.797 1.239 . . . . 72.1 108.85 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' CA ' ' HE2' ' A' ' 73' ' ' LYS . . . 91.28 3.52 69.51 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 117.934 -1.481 . . . . 72.34 115.009 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 p -70.6 160.77 31.91 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.618 1.709 . . . . 62.33 109.124 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.2 mt -109.49 108.85 19.49 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.307 1.443 . . . . 75.14 109.536 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.78 132.83 55.07 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 104.858 -2.275 . . . . 73.52 104.858 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.7 mttm 46.09 45.8 12.6 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.282 1.039 . . . . 75.33 111.655 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 64.32 0.12 0.99 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 128.685 2.794 . . . . 71.12 115.855 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt -109.89 140.2 44.11 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 119.63 1.104 . . . . 73.31 109.645 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.461 ' HE2' ' CA ' ' A' ' 66' ' ' GLY . 15.8 tttm -78.95 156.16 28.64 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.47 -0.937 . . . . 73.43 108.47 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 pt -129.58 170.08 19.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 C-N-CA 124.884 1.274 . . . . 65.02 111.003 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.25 147.98 52.03 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.156 1.783 . . . . 63.23 106.457 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.6 t -139.12 136.31 42.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.192 0 C-N-CA 124.802 1.241 . . . . 34.42 108.333 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -147.18 171.98 14.52 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.149 1.78 . . . . 62.13 108.049 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.14 152.79 20.45 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.373 1.469 . . . . 64.22 108.831 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 t -156.05 147.69 22.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.886 -1.524 . . . . 72.42 106.886 176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 39.5 t 48.93 90.59 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.558 1.543 . . . . 54.43 113.664 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.65 -13.69 13.22 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-O 118.762 -1.021 . . . . 73.24 112.802 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 N-CA-C 104.863 -3.295 . . . . 65.43 104.863 178.334 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.952 0 N-CA-C 110.709 -0.956 . . . . 73.33 110.709 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.86 46.41 2.62 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.873 1.269 . . . . 73.54 108.987 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.4 ptt-85 -139.23 156.78 46.84 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.934 -0.765 . . . . 74.11 108.934 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -123.14 160.42 26.5 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 105.179 -2.156 . . . . 75.13 105.179 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.4 mt -134.68 129.64 52.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.463 1.505 . . . . 75.21 110.873 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.5 t -102.79 128.42 55.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 105.349 -2.093 . . . . 51.41 105.349 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -96.81 141.49 29.95 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.184 -1.784 . . . . 74.24 106.184 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.415 HG12 HD11 ' A' ' 11' ' ' LEU . 2.6 t -138.45 133.35 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.944 -1.873 . . . . 74.14 105.944 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.414 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -140.84 177.96 20.46 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 120.888 1.676 . . . . 64.42 111.791 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.423 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 0.5 OUTLIER 73.78 16.47 3.78 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.047 2.539 . . . . 42.53 111.116 -178.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.415 HD11 HG12 ' A' ' 8' ' ' VAL . 9.5 mp -62.54 147.63 92.07 Favored Pre-proline 0 C--O 1.237 0.432 0 C-N-CA 125.445 1.498 . . . . 64.33 113.648 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -66.67 164.96 27.11 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.301 2.668 . . . . 74.23 111.329 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -76.38 -29.53 57.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 122.976 0.51 . . . . 71.24 110.742 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.09 13.51 11.06 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.175 0.99 . . . . 73.44 112.984 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.569 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.6 tp -59.02 138.87 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 124.234 1.014 . . . . 62.34 111.328 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 p -128.3 158.39 38.32 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.744 1.618 . . . . 74.44 109.909 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.1 -29.58 69.37 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.101 0.56 . . . . 63.15 110.348 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 p -66.21 -34.04 67.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.305 0.642 . . . . 75.43 110.228 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -73.66 -47.94 36.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.038 -1.468 . . . . 74.11 107.038 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -56.06 -46.41 78.95 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 125.302 1.441 . . . . 75.02 110.652 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -61.6 -36.61 81.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.521 -0.752 . . . . 74.53 110.214 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.14 -30.99 60.94 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 118.757 0.708 . . . . 73.41 110.877 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -68.36 -50.19 54.87 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.182 -0.949 . . . . 71.44 110.015 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -91.74 10.87 26.58 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.222 1.009 . . . . 75.1 112.825 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -35.76 63.82 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 120.681 -1.262 . . . . 75.42 110.793 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -82.6 -9.15 59.51 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.1 0.96 . . . . 75.13 113.533 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.17 -10.79 14.97 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.671 1.188 . . . . 70.11 111.586 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 t 47.24 61.78 13.03 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 127.58 2.352 . . . . 73.21 114.893 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.36 161.0 15.02 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.399 2.733 . . . . 73.15 111.561 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.3 -38.86 10.34 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.36 1.064 . . . . 74.32 109.404 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -136.01 153.17 51.45 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.191 0.997 . . . . 71.31 108.358 178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.3 mt -139.5 125.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 105.388 -2.078 . . . . 71.44 105.388 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.42 104.5 4.6 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.528 -1.286 . . . . 71.24 107.528 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -88.7 119.47 29.21 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 124.689 1.196 . . . . 64.35 108.331 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -108.69 82.45 1.61 Allowed 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.026 -1.472 . . . . 72.12 107.026 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.97 -26.88 50.18 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.778 0.831 . . . . 53.41 111.548 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.08 -28.39 10.41 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 128.285 2.634 . . . . 71.34 112.709 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -132.92 9.16 4.15 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.782 1.233 . . . . 75.14 110.443 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.16 43.85 96.81 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 119.6 1.091 . . . . 51.14 110.932 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.414 HG22 ' CA ' ' A' ' 9' ' ' GLY . 3.1 pt -134.85 166.2 29.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 125.102 1.361 . . . . 65.21 111.247 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.49 154.37 43.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.076 1.351 . . . . 72.53 109.489 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -124.48 123.26 39.74 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.107 1.363 . . . . 75.04 107.387 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.5 114.77 21.71 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.321 -0.992 . . . . 75.2 108.321 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -91.21 151.07 21.09 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 107.919 -1.141 . . . . 74.23 107.919 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -136.74 134.26 36.93 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.672 1.589 . . . . 70.02 107.304 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.27 112.54 24.35 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.86 1.664 . . . . 74.02 111.319 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.38 -27.41 68.55 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.086 1.354 . . . . 55.12 111.32 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.52 -32.99 68.79 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.423 -0.322 . . . . 71.04 110.393 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -62.94 -22.82 67.06 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.79 0.723 . . . . 72.44 112.928 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -158.82 99.43 1.55 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 107.192 -1.41 . . . . 73.52 107.192 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.09 -54.02 50.03 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.512 0.725 . . . . 74.11 112.463 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.84 -19.6 23.23 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.309 1.044 . . . . 72.25 110.976 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.53 -22.3 62.57 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-O 117.228 -1.873 . . . . 62.51 113.589 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.77 -40.8 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 120.532 2.166 . . . . 74.32 110.106 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.53 -58.5 6.94 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.657 -1.238 . . . . 64.55 107.657 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.1 -48.37 76.29 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.812 0.845 . . . . 63.33 111.095 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.18 -41.05 68.1 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.128 -0.693 . . . . 74.32 109.128 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 6.4 mtm -71.88 -44.45 63.73 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 124.332 1.053 . . . . 75.42 110.681 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -48.88 72.0 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.831 1.652 . . . . 75.54 110.575 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 58.5 mt -64.74 -39.77 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 125.691 1.597 . . . . 74.32 108.802 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.19 -38.72 75.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 118.876 -0.583 . . . . 31.35 109.573 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -65.43 -31.58 72.75 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.965 0.802 . . . . 73.13 110.493 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.4 mt -68.95 -5.13 19.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.649 -0.657 . . . . 63.13 112.092 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -89.65 -0.64 57.66 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.058 0.845 . . . . 62.34 110.453 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -66.02 113.09 4.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.026 1.73 . . . . 73.31 110.991 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.2 2.99 67.92 Favored Glycine 0 N--CA 1.459 0.233 0 CA-C-O 117.942 -1.477 . . . . 64.14 114.173 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.7 p -66.93 133.77 50.66 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 119.59 1.695 . . . . 61.01 108.369 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 73' ' ' LYS . 29.6 mt -76.21 108.21 8.98 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 105.743 -1.947 . . . . 71.32 105.743 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.6 tp -115.88 119.6 36.5 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.675 -1.602 . . . . 70.32 106.675 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.569 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 17.3 mtpp 49.21 50.44 17.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.741 1.616 . . . . 63.4 112.368 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 64.28 24.99 13.44 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 127.172 2.189 . . . . 70.22 113.576 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 10' ' ' SER . 15.0 mmmt -131.77 124.44 29.71 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 124.62 1.168 . . . . 74.25 110.647 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.444 ' HA ' HD23 ' A' ' 68' ' ' LEU . 6.5 tptm -79.83 105.77 11.36 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 101.7 -3.444 . . . . 73.2 101.7 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.3 pt -95.63 169.9 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 124.006 0.922 . . . . 75.34 108.685 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -127.17 158.97 35.68 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.796 1.238 . . . . 75.23 111.52 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.0 t -137.06 139.22 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 126.526 1.931 . . . . 73.53 107.191 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -149.67 162.74 39.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.674 1.189 . . . . 55.15 108.127 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.74 147.55 25.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.469 1.108 . . . . 65.2 109.291 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 17.1 p -148.46 130.36 15.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 117.912 -1.042 . . . . 65.24 108.748 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.8 t 70.53 160.4 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 126.124 1.77 . . . . 72.12 110.786 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.28 62.54 0.01 OUTLIER Glycine 0 C--O 1.237 0.282 0 N-CA-C 107.557 -2.217 . . . . 65.42 107.557 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 N-CA-C 105.359 -3.096 . . . . 63.43 105.359 -179.224 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 109.002 -1.639 . . . . 52.52 109.002 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -67.06 1.26 2.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.18 1.49 . . . . 73.22 114.978 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.63 107.82 7.7 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.578 1.081 . . . . 71.54 112.018 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -100.16 157.31 16.67 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 128.21 2.604 . . . . 74.41 107.125 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mt -135.41 149.19 28.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 124.696 1.198 . . . . 74.14 108.082 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.1 t -116.65 127.49 74.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 105.768 -1.938 . . . . 73.24 105.768 178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -94.75 139.32 31.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.374 -1.713 . . . . 72.43 106.374 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.7 t -139.26 132.49 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 106.327 -1.731 . . . . 61.23 106.327 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.62 -178.19 17.55 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 120.095 1.316 . . . . 52.4 111.63 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 74.03 10.68 4.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.599 2.36 . . . . 65.51 111.344 -177.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 mp -54.27 144.94 38.48 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 125.487 1.515 . . . . 55.03 112.695 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -67.65 157.76 60.28 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 122.352 2.035 . . . . 74.42 110.26 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -65.57 -43.23 90.45 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.91 -1.145 . . . . 73.53 107.91 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -74.64 13.34 0.64 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.352 2.261 . . . . 63.45 112.857 -179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.506 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 10.3 tp -57.56 144.82 9.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 O-C-N 120.878 -1.139 . . . . 74.45 108.984 177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.56 147.5 50.71 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.45 -1.315 . . . . 72.42 107.45 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.88 71.46 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.253 -0.647 . . . . 35.14 109.253 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 t -59.14 -44.28 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 124.048 0.939 . . . . 73.12 110.496 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -69.99 -38.56 76.06 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 109.494 -0.558 . . . . 74.54 109.494 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.15 -47.09 86.11 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.876 -0.416 . . . . 73.03 109.876 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -60.88 -47.41 86.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.701 -0.852 . . . . 60.24 108.701 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -58.45 -35.89 72.83 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 115.247 1.573 . . . . 64.05 115.247 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -76.17 -51.84 11.32 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.528 -0.733 . . . . 61.51 110.62 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -81.17 7.32 11.44 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.906 1.076 . . . . 73.53 113.906 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -57.0 -27.12 61.31 Favored 'General case' 0 CA--C 1.527 0.094 0 O-C-N 120.586 -1.321 . . . . 72.45 113.602 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -87.27 -16.65 34.57 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.379 0.672 . . . . 74.33 112.038 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.5 -13.98 18.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.132 0.973 . . . . 73.25 111.701 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.8 m 49.15 73.53 0.98 Allowed Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 125.921 1.688 . . . . 75.34 114.569 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.83 158.32 54.39 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.919 1.746 . . . . 74.43 110.543 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -89.39 -41.57 12.03 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.784 0.834 . . . . 75.42 109.029 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -137.31 153.56 50.25 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.711 1.204 . . . . 51.02 109.814 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 42.3 mt -143.77 121.05 5.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 C-N-CA 125.358 1.463 . . . . 43.25 108.215 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.21 104.24 6.67 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 125.519 1.528 . . . . 73.11 108.096 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.39 116.11 28.08 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.084 1.354 . . . . 74.23 107.931 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 46.5 mtt-85 -109.46 85.5 2.11 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.96 -1.496 . . . . 74.3 106.96 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.14 -22.5 60.99 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.706 -0.679 . . . . 71.43 111.508 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -51.58 -29.59 17.86 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.709 2.404 . . . . 73.21 112.286 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -132.88 9.78 4.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.202 1.401 . . . . 53.22 110.335 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 59.93 48.28 86.83 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.506 -1.037 . . . . 42.45 110.506 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.3 pt -136.76 167.39 23.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 125.368 1.467 . . . . 63.23 110.718 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.18 155.69 38.31 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.563 1.145 . . . . 50.23 109.569 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -125.68 125.73 43.53 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.038 1.335 . . . . 73.42 108.185 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -121.57 112.06 18.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.156 -1.053 . . . . 62.15 108.156 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -91.25 156.07 18.09 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.847 -1.538 . . . . 72.11 106.847 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -144.09 148.65 35.42 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.2 -1.408 . . . . 74.41 107.2 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -101.58 111.05 23.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.244 0.929 . . . . 73.43 110.897 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.08 -24.25 62.28 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.556 0.742 . . . . 44.52 111.242 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -73.35 -28.4 62.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.008 0.822 . . . . 72.04 110.46 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -64.21 -29.09 70.21 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 124.66 1.184 . . . . 74.24 112.251 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -158.45 86.13 0.86 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.12 -1.067 . . . . 75.32 108.12 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -48.35 -36.34 14.28 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.75 1.759 . . . . 72.44 115.75 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.62 -17.21 14.31 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.627 1.103 . . . . 61.31 111.896 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.1 -26.7 43.4 Favored Glycine 0 C--N 1.335 0.52 0 CA-C-O 118.196 -1.335 . . . . 74.02 111.71 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.31 -39.9 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 119.217 1.509 . . . . 72.25 110.689 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -60.68 -58.14 9.71 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.099 -1.074 . . . . 61.11 108.099 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -57.32 -40.17 77.36 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.034 -1.041 . . . . 75.32 111.253 178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -58.53 -41.06 84.65 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.101 -1.074 . . . . 74.13 108.101 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 9.0 mtm -66.85 -50.15 63.45 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-O 117.972 -1.014 . . . . 50.15 108.292 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -51.62 -48.87 63.11 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.54 1.136 . . . . 63.51 110.169 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.12 -31.2 49.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.665 1.586 . . . . 71.34 111.148 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.62 -38.48 21.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 118.931 0.787 . . . . 44.04 109.2 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.4 mt -67.17 -31.06 71.23 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.338 1.055 . . . . 64.22 110.268 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.81 -12.76 38.48 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.938 0.895 . . . . 75.54 110.559 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -89.79 4.21 50.46 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.805 1.242 . . . . 63.34 111.436 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -68.16 120.56 14.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 105.608 -1.997 . . . . 73.24 105.608 177.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.39 9.01 63.68 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.028 -1.429 . . . . 60.35 113.245 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.2 p -68.04 144.17 55.22 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 120.065 1.933 . . . . 71.41 109.912 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.8 mt -93.19 107.4 19.21 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 102.187 -3.264 . . . . 63.34 102.187 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.19 113.93 27.01 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 104.64 -2.355 . . . . 62.52 104.64 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER 51.76 49.34 21.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.922 0.889 . . . . 73.0 109.325 -178.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 60.51 32.22 20.44 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 127.442 2.297 . . . . 73.14 114.083 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -130.72 118.04 20.31 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.898 0.879 . . . . 74.24 110.195 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -70.06 100.88 1.7 Allowed 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.822 1.249 . . . . 72.42 108.136 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.1 pt -92.78 165.87 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 O-C-N 121.277 -0.889 . . . . 63.02 109.517 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.83 156.39 39.64 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.541 1.136 . . . . 65.32 111.334 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.5 t -138.21 149.22 24.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.453 1.501 . . . . 52.35 110.631 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -164.33 173.63 12.02 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.939 1.296 . . . . 71.32 111.138 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.63 147.72 23.11 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.294 1.437 . . . . 73.02 109.733 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t -147.77 82.83 1.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.137 0.575 . . . . 74.21 110.523 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -157.34 164.55 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 106.844 -1.539 . . . . 64.41 106.844 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.73 101.28 0.21 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-N 119.424 1.011 . . . . 62.55 112.384 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.816 0 N-CA-C 110.147 -1.181 . . . . 70.13 110.147 178.792 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.954 0 N-CA-C 109.987 -1.245 . . . . 64.53 109.987 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -70.12 -9.02 54.19 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.153 1.538 . . . . 64.43 115.153 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.43 104.54 10.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 75.42 112.169 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -97.74 152.71 18.85 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 128.577 2.751 . . . . 74.03 109.124 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 79' ' ' THR . 3.0 mp -135.1 147.06 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.748 1.619 . . . . 70.32 109.404 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 85.2 t -113.37 131.08 66.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.297 -1.742 . . . . 71.15 106.297 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -91.48 108.98 20.27 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.422 1.889 . . . . 70.11 106.428 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 11' ' ' LEU . 11.6 t -115.83 126.47 73.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.01 -2.218 . . . . 63.5 105.01 179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.26 -179.88 16.88 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 120.214 1.37 . . . . 53.11 112.461 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 70.84 19.44 5.83 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.03 1.732 . . . . 61.53 111.626 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.482 HD11 HG12 ' A' ' 8' ' ' VAL . 10.1 mp -60.91 147.91 84.53 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.918 0.887 . . . . 64.45 110.681 -179.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -64.76 156.98 58.61 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.907 3.071 . . . . 72.12 114.526 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.47 -27.74 68.79 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.642 1.177 . . . . 65.22 112.118 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.65 20.54 18.7 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.597 1.159 . . . . 74.53 112.536 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.533 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 9.7 tp -55.27 143.16 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 O-C-N 121.005 -1.059 . . . . 72.0 110.852 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 p -128.76 154.56 46.25 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.61 1.164 . . . . 72.22 109.736 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.0 -30.48 70.31 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.315 1.046 . . . . 74.22 109.085 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.1 t -59.95 -48.68 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 124.714 1.206 . . . . 73.42 109.424 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' HG3' ' HE2' ' A' ' 70' ' ' LYS . 4.1 mm-40 -69.59 -29.3 66.81 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.518 0.727 . . . . 73.4 110.54 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.4 mp -68.97 -51.27 41.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.06 -1.089 . . . . 74.21 108.06 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -58.75 -45.56 89.43 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 107.946 -1.131 . . . . 73.2 107.946 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -56.08 -48.0 76.92 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.517 1.527 . . . . 72.43 113.629 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -56.34 15.66 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 122.292 1.044 . . . . 74.43 111.454 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -79.68 8.55 6.4 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.481 1.512 . . . . 75.34 114.414 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -56.04 -39.78 72.51 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.94 -1.1 . . . . 65.31 110.412 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.21 -15.51 57.94 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.982 0.734 . . . . 72.44 112.982 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.6 p -102.16 -1.49 31.29 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 120.9 -1.125 . . . . 73.23 111.197 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.0 t 37.32 79.78 0.3 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 127.552 2.341 . . . . 71.15 115.066 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.08 156.57 55.65 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 121.595 1.53 . . . . 64.04 109.616 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.47 -49.2 8.85 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 106.799 -1.556 . . . . 74.43 106.799 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -136.71 154.37 50.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.174 0.99 . . . . 72.53 110.007 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 70.3 mt -136.09 133.04 50.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.372 1.869 . . . . 74.33 109.577 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 -142.37 107.95 5.08 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 127.189 2.196 . . . . 63.34 109.5 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -96.41 122.43 39.29 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 107.649 -1.241 . . . . 63.13 107.649 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -110.29 86.01 2.22 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 125.948 1.699 . . . . 75.32 106.722 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.65 -32.66 63.39 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.966 0.906 . . . . 71.43 112.333 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -56.78 -19.01 14.78 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.355 1.462 . . . . 54.34 113.232 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -132.16 -1.31 3.65 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.146 1.378 . . . . 71.44 110.569 178.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 61.69 38.79 96.48 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.578 1.085 . . . . 72.11 110.934 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.4 pt -127.8 163.45 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 125.19 1.396 . . . . 72.11 109.88 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.61 155.32 47.51 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.04 1.336 . . . . 71.51 109.332 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.76 104.36 9.25 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 106.18 -1.785 . . . . 71.13 106.18 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.22 111.65 24.14 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 105.158 -2.164 . . . . 51.3 105.158 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -90.62 157.91 17.23 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 123.62 0.768 . . . . 75.2 109.494 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -146.19 133.41 20.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.6 1.56 . . . . 72.13 107.304 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -101.73 122.63 44.28 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 105.013 -2.217 . . . . 62.14 105.013 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.63 -23.48 62.55 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.611 1.564 . . . . 63.21 111.261 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -83.65 -18.71 37.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.964 0.506 . . . . 65.55 109.912 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -69.0 -19.11 64.13 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.3 -0.857 . . . . 73.41 111.372 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -168.42 85.04 0.18 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.86 1.664 . . . . 72.21 106.621 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.85 -32.73 6.5 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.821 1.648 . . . . 74.45 113.666 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.3 p -107.57 -20.23 13.3 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 119.187 0.903 . . . . 64.34 112.806 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.38 -18.03 53.78 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-O 117.677 -1.624 . . . . 61.31 114.494 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.1 tp -50.93 -36.7 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 119.645 1.723 . . . . 61.32 109.13 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -61.26 -61.72 2.35 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.982 2.513 . . . . 74.0 110.653 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -60.87 -35.45 76.63 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.213 -0.929 . . . . 75.41 109.724 179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -60.81 -49.22 78.35 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 108.074 -1.084 . . . . 75.12 108.074 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 4.4 mtt -57.67 -50.54 72.85 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 124.647 1.179 . . . . 54.44 109.888 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -56.99 -44.62 82.92 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.272 1.029 . . . . 74.2 111.773 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.5 mt -69.85 -34.5 60.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 108.951 -0.759 . . . . 73.11 108.951 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.82 79.76 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.508 -1.293 . . . . 61.13 107.508 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 24.4 mt -58.65 -32.24 68.9 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.321 1.048 . . . . 62.23 111.3 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 46.4 mt -66.74 -9.02 32.26 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.283 -0.865 . . . . 72.12 112.258 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -86.16 -2.48 58.4 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.276 1.398 . . . . 72.24 111.49 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 112.23 2.78 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.788 1.235 . . . . 75.3 108.036 179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.11 10.27 59.86 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.404 1.002 . . . . 64.4 114.284 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.3 p -75.1 143.23 43.47 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 119.573 1.687 . . . . 65.03 109.591 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.14 108.97 19.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 106.861 -1.533 . . . . 75.04 106.861 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mt -110.38 119.72 40.12 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 105.337 -2.097 . . . . 71.24 105.337 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 33.1 mttt 45.95 49.59 11.87 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.011 0.91 . . . . 74.11 110.528 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 63.29 16.45 9.47 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.92 2.088 . . . . 70.11 116.348 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.9 mmmt -119.79 126.77 51.82 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.123 1.369 . . . . 72.31 108.185 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -79.18 106.93 11.57 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 110.354 -0.239 . . . . 73.31 110.354 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.2 pt -80.42 169.89 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 123.543 0.737 . . . . 70.34 111.7 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -128.25 158.75 37.3 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.883 2.073 . . . . 64.12 108.878 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 53.0 t -142.79 127.41 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.676 1.19 . . . . 64.33 108.784 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -144.0 173.29 11.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.779 1.232 . . . . 74.24 109.361 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -89.85 151.86 21.55 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.221 1.009 . . . . 75.21 110.308 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.438 HG23 ' HB ' ' A' ' 5' ' ' ILE . 6.9 t -153.54 82.42 1.17 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 106.986 -1.487 . . . . 71.14 106.986 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.5 p -167.98 171.05 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.484 0 N-CA-C 107.273 -1.38 . . . . 71.51 107.273 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -155.27 -111.17 0.38 Allowed Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 109.425 -1.47 . . . . 75.14 109.425 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 N-CA-C 108.209 -1.956 . . . . 75.24 108.209 -179.856 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.673 0 N-CA-C 111.82 -0.512 . . . . 72.53 111.82 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -130.82 48.87 2.37 Favored 'General case' 0 N--CA 1.46 0.054 0 C-N-CA 125.19 1.396 . . . . 72.04 113.193 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.4 ptt-85 -151.55 167.58 27.62 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 120.828 -1.17 . . . . 71.2 108.584 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -130.77 165.53 22.75 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.081 -1.822 . . . . 63.02 106.081 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.3 mt -130.56 146.41 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 109.001 -0.74 . . . . 72.22 109.001 -178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.3 131.93 63.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.144 -1.428 . . . . 65.43 107.144 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -89.93 115.41 27.22 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 105.421 -2.066 . . . . 74.25 105.421 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -124.46 128.67 73.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.425 -2.065 . . . . 63.41 105.425 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.406 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -140.3 -179.93 18.45 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 119.233 0.924 . . . . 71.54 111.62 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.418 ' HB3' ' HA ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER 71.83 18.61 5.07 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.281 1.832 . . . . 73.31 111.097 -178.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.59 153.21 62.99 Favored Pre-proline 0 C--O 1.234 0.289 0 C-N-CA 124.663 1.185 . . . . 62.52 113.042 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.405 ' HG3' ' HB2' ' A' ' 70' ' ' LYS . 10.8 Cg_endo -64.33 167.88 13.85 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.127 2.551 . . . . 45.1 111.64 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.3 mmm-85 -75.34 -41.66 56.17 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 121.716 -0.615 . . . . 72.04 109.938 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.56 19.77 4.37 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.591 0.96 . . . . 64.31 113.591 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.536 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.7 tp -53.47 140.73 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 121.289 -0.882 . . . . 64.25 109.547 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 p -127.81 150.58 49.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.643 1.177 . . . . 72.25 109.106 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.4 -28.46 69.8 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 121.579 -0.7 . . . . 71.02 111.069 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -43.1 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.793 -0.818 . . . . 75.21 108.793 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -63.96 -45.27 89.87 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 123.682 0.793 . . . . 73.22 109.21 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -59.89 -48.81 80.17 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.065 -0.493 . . . . 75.22 110.113 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -61.28 -36.63 80.58 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 118.894 0.77 . . . . 61.34 109.784 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -69.52 -40.02 77.2 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 118.813 0.733 . . . . 73.41 111.843 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.532 ' ND1' HD21 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -71.81 -37.99 70.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.109 0.868 . . . . 65.34 111.316 -179.142 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -94.61 6.2 49.55 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.459 -0.776 . . . . 74.24 112.264 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 tttt -54.84 -39.34 68.47 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.958 1.303 . . . . 74.3 112.531 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -71.17 -35.85 71.79 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.379 -0.825 . . . . 64.23 110.639 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.2 p -74.69 -24.14 58.73 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.636 0.774 . . . . 72.32 112.859 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.9 m 63.74 69.54 0.77 Allowed Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 116.284 1.957 . . . . 73.51 116.284 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.51 159.6 52.97 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.813 2.342 . . . . 71.31 109.896 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -84.28 -53.99 5.11 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 105.91 -1.885 . . . . 74.31 105.91 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -143.92 161.53 38.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.424 1.49 . . . . 71.31 109.406 -178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.12 140.5 42.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 126.039 1.736 . . . . 53.0 107.151 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -133.16 103.93 6.25 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 107.352 -1.351 . . . . 73.24 107.352 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -87.71 112.57 22.52 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.882 0.873 . . . . 72.11 109.157 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 75.1 mmt-85 -101.24 87.43 3.23 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 106.557 -1.646 . . . . 72.35 106.557 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.6 -28.8 61.19 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.634 1.174 . . . . 73.25 112.687 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -52.61 -38.89 61.01 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.967 2.107 . . . . 71.21 114.064 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -118.88 -6.45 10.54 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 118.219 -0.896 . . . . 74.41 111.956 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.67 48.25 29.67 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.728 -1.749 . . . . 62.11 108.728 -179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.406 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.5 pt -137.24 156.13 33.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 126.233 1.813 . . . . 73.22 108.034 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.4 126.97 12.42 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.964 -0.754 . . . . 62.3 108.964 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -90.11 135.99 33.32 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.49 -1.3 . . . . 74.45 107.49 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mp -125.91 123.99 39.82 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.171 -1.788 . . . . 62.31 106.171 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -95.26 143.44 26.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.312 1.445 . . . . 73.42 108.214 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -135.77 106.85 6.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 107.052 -1.462 . . . . 73.4 107.052 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.68 116.55 8.51 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.979 0.911 . . . . 35.25 110.538 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.01 -31.23 61.33 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.608 1.963 . . . . 64.2 112.164 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -70.02 -22.34 63.11 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.098 0.559 . . . . 65.54 109.845 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -60.7 -35.92 77.52 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 108.964 -0.754 . . . . 74.33 108.964 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -162.22 96.29 0.97 Allowed 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.042 -0.725 . . . . 62.0 109.042 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -55.55 -29.83 59.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 117.81 -1.09 . . . . 74.35 113.068 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.253 29.9 p -110.74 7.5 22.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 118.947 0.794 . . . . 74.51 112.738 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.41 -20.71 4.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.484 1.516 . . . . 70.4 112.27 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.3 tp -54.55 -39.93 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 C-N-CA 125.048 1.339 . . . . 64.32 111.853 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -58.05 9.17 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.227 -0.657 . . . . 64.33 109.227 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -57.54 -32.61 67.26 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 121.52 -0.738 . . . . 72.23 111.551 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -64.42 -51.18 64.49 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 107.179 -1.415 . . . . 73.04 107.179 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 16.6 mtm -66.27 -30.59 71.05 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.753 0.821 . . . . 63.02 112.429 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -61.02 -39.73 90.88 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.691 1.132 . . . . 73.1 108.884 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.6 mt -66.03 -39.16 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.784 -1.191 . . . . 74.23 107.784 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.38 95.87 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.368 -0.975 . . . . 74.04 108.368 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.1 mt -63.13 -31.08 72.14 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.304 0.502 . . . . 65.14 111.264 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.56 -6.95 8.58 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.725 1.009 . . . . 72.21 113.725 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -93.45 -0.56 56.39 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 118.732 0.697 . . . . 75.11 111.029 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -60.65 112.78 2.14 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.718 1.607 . . . . 71.01 109.833 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.69 5.55 61.35 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.481 -1.177 . . . . 61.13 113.657 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.3 p -66.79 147.69 52.92 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.988 1.894 . . . . 71.31 109.486 179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.41 107.92 19.67 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.498 -2.038 . . . . 64.35 105.498 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.532 HD21 ' ND1' ' A' ' 23' ' ' HIS . 6.2 mt -107.19 126.07 51.92 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 105.331 -2.1 . . . . 74.32 105.331 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 18.6 mttt 42.1 49.84 4.3 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.486 1.039 . . . . 72.2 111.345 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 64.04 21.85 12.73 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.356 2.263 . . . . 74.23 115.235 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.6 mmmt -124.87 126.37 45.45 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 120.313 -1.492 . . . . 62.35 110.986 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 tptt -74.75 109.46 8.24 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.567 -1.642 . . . . 50.25 106.567 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 10' ' ' SER . 1.9 pp -92.8 170.02 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 124.009 0.924 . . . . 64.4 111.103 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.57 158.13 38.3 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 124.881 1.272 . . . . 71.41 109.674 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.4 t -141.52 132.38 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 106.476 -1.675 . . . . 72.32 106.476 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -146.76 163.02 37.32 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.827 1.251 . . . . 72.41 109.021 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.52 152.17 28.81 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.265 1.026 . . . . 74.13 109.638 178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.57 143.85 29.16 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.065 0.946 . . . . 71.52 109.331 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.4 t 68.7 -49.38 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 127.3 2.24 . . . . 64.33 113.562 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.98 13.42 60.52 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.001 1.762 . . . . 72.23 113.558 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.829 0 N-CA-C 108.592 -1.803 . . . . 73.33 108.592 178.883 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.726 0 N-CA-C 112.068 -0.413 . . . . 71.25 112.068 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.518 ' ND2' ' H ' ' A' ' 48' ' ' ASP . 0.4 OUTLIER -141.74 37.5 1.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.78 -1.563 . . . . 55.02 106.78 178.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.1 ptt85 -113.77 148.94 35.63 Favored 'General case' 0 CA--C 1.512 -0.492 0 O-C-N 121.066 -1.021 . . . . 64.24 110.932 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -113.55 163.15 15.3 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 104.775 -2.305 . . . . 73.34 104.775 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mt -132.24 149.26 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.618 -1.252 . . . . 62.15 107.618 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.8 t -120.01 124.03 71.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 106.365 -1.717 . . . . 73.12 106.365 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -88.3 136.29 33.05 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.837 -1.912 . . . . 73.33 105.837 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG12 HD11 ' A' ' 11' ' ' LEU . 11.0 t -136.7 129.14 44.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.244 -2.132 . . . . 63.21 105.244 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.74 -177.97 15.63 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 120.18 1.354 . . . . 74.25 113.374 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.93 14.37 5.87 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.495 2.318 . . . . 45.02 110.11 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.46 HD11 HG12 ' A' ' 8' ' ' VAL . 10.7 mp -58.39 142.03 82.37 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.746 1.219 . . . . 70.15 111.802 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -65.28 156.98 60.19 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.11 2.54 . . . . 62.12 111.071 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -68.3 -35.01 77.19 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.498 -0.751 . . . . 74.34 109.172 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.34 8.98 5.17 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.712 1.605 . . . . 74.03 113.392 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.435 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 9.6 tp -51.13 145.71 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.952 1.301 . . . . 71.43 112.678 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.59 150.41 50.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.511 1.124 . . . . 74.53 110.221 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.88 -35.0 72.28 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.64 1.176 . . . . 74.12 109.969 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.4 t -61.41 -41.26 89.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 123.647 0.779 . . . . 64.23 110.874 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -70.89 -39.03 73.05 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.97 -0.752 . . . . 74.14 108.97 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp -63.33 -51.5 65.72 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.232 1.013 . . . . 74.43 110.674 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -42.78 99.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.063 0.945 . . . . 42.35 109.267 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -64.5 -52.28 58.63 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 124.334 1.054 . . . . 44.25 113.023 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.3 -48.97 78.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.911 0.778 . . . . 75.44 111.749 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -85.81 1.84 48.07 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 113.857 1.058 . . . . 73.04 113.857 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.53 -47.12 70.24 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 120.083 1.31 . . . . 73.34 111.477 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -60.68 -34.11 73.84 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.133 0.424 . . . . 65.25 111.696 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.8 p -83.86 -10.48 57.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.883 0.873 . . . . 64.01 111.597 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 m 42.78 68.78 2.61 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 127.057 2.143 . . . . 60.14 113.953 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -64.07 158.39 48.13 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.866 2.377 . . . . 75.51 109.527 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.94 -36.81 13.9 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.032 0.933 . . . . 71.52 108.862 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -127.67 155.74 43.45 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 123.901 0.881 . . . . 44.22 111.087 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 75.4 mt -144.74 115.5 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.797 -1.557 . . . . 74.15 106.797 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 104.64 5.57 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 125.475 1.51 . . . . 75.14 108.407 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -90.04 119.94 30.82 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.705 1.202 . . . . 73.05 108.285 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 -109.65 84.19 1.88 Allowed 'General case' 0 C--O 1.238 0.464 0 N-CA-C 106.469 -1.678 . . . . 75.02 106.469 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.29 -29.27 65.71 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 118.343 -0.836 . . . . 34.24 111.369 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -54.31 -26.99 32.57 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.834 1.05 . . . . 62.02 113.834 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.3 mmtt -127.38 9.04 6.59 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.886 0.875 . . . . 65.45 111.262 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.98 48.22 80.99 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 109.982 -1.247 . . . . 63.14 109.982 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.38 171.29 14.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 C-N-CA 124.821 1.248 . . . . 71.01 109.675 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.17 168.77 20.82 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.813 1.245 . . . . 52.14 108.46 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -134.82 137.08 43.0 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 104.974 -2.232 . . . . 74.51 104.974 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -137.19 116.29 12.49 Favored 'General case' 0 CA--C 1.511 -0.521 0 N-CA-C 105.984 -1.858 . . . . 74.13 105.984 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -94.05 151.33 19.59 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.691 -1.596 . . . . 53.41 106.691 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -141.43 111.83 6.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.069 -1.826 . . . . 70.33 106.069 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.38 122.17 28.56 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.831 0.852 . . . . 65.23 111.183 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.27 93.91 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.496 1.118 . . . . 63.03 111.95 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.518 ' H ' ' ND2' ' A' ' 2' ' ' ASN . 5.0 t70 -62.25 -28.9 70.03 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.961 -0.755 . . . . 72.31 108.961 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -61.71 -23.77 66.35 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-O 117.448 -1.263 . . . . 54.45 112.113 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -163.81 90.4 0.61 Allowed 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.715 1.606 . . . . 55.11 107.837 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 -56.39 -16.39 5.63 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.513 1.525 . . . . 74.41 115.086 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 m -122.7 -19.44 6.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 120.038 1.29 . . . . 52.32 112.413 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.51 -14.62 43.51 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-O 117.245 -1.864 . . . . 55.32 114.883 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 6.4 tp -50.17 -44.51 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 120.491 2.146 . . . . 73.43 111.572 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -62.39 -58.16 8.66 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.961 0.904 . . . . 72.04 110.472 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -59.2 -31.2 68.81 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 120.516 -1.365 . . . . 74.31 111.054 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -62.53 -41.11 98.65 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.519 -1.289 . . . . 64.24 107.519 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 12.1 mtm -65.8 -42.83 90.23 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 108.158 -1.053 . . . . 54.12 108.158 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -54.13 -49.78 68.41 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.524 1.056 . . . . 54.03 110.375 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.0 mt -61.28 -44.85 99.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.299 1.44 . . . . 65.35 109.481 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.83 -42.0 95.3 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.374 0.534 . . . . 71.45 109.983 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.19 -29.9 69.7 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.132 0.973 . . . . 64.22 111.428 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.6 mt -65.19 -13.31 57.92 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 118.772 -0.632 . . . . 61.0 109.895 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -85.49 2.17 45.8 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.979 0.809 . . . . 74.21 111.079 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -67.11 112.07 4.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 120.137 -1.602 . . . . 71.11 108.519 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.47 10.47 53.61 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.646 1.117 . . . . 73.51 113.563 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.9 p -68.77 141.01 55.33 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.773 1.786 . . . . 62.41 110.214 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.5 mt -87.41 110.68 20.44 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 101.938 -3.356 . . . . 70.15 101.938 176.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -115.41 121.49 42.92 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 125.587 1.555 . . . . 71.41 108.422 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 5.9 mtpm? 50.17 44.57 26.1 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.011 0.924 . . . . 74.54 112.761 178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 67.67 24.27 8.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.106 2.162 . . . . 74.44 112.315 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -140.19 126.61 20.12 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.638 1.575 . . . . 55.21 110.302 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -75.17 143.54 43.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.475 -1.676 . . . . 75.51 106.475 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.6 pt -128.47 162.64 34.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 124.002 0.921 . . . . 64.45 109.492 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -120.43 159.02 25.97 Favored 'General case' 0 CA--C 1.508 -0.659 0 C-N-CA 125.368 1.467 . . . . 75.32 111.694 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 76.6 t -136.0 148.06 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 107.896 -1.15 . . . . 65.54 107.896 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -161.71 161.56 29.43 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.868 1.667 . . . . 74.3 108.771 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.5 152.22 23.35 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 124.626 1.17 . . . . 63.34 113.214 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.2 p -148.57 129.42 14.28 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.302 1.441 . . . . 62.23 108.34 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 23.1 t 64.54 95.24 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 126.454 1.902 . . . . 74.14 111.686 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.25 70.78 0.11 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 108.363 -1.895 . . . . 51.23 108.363 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.458 0 N-CA-C 109.037 -1.625 . . . . 73.12 109.037 179.323 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.896 0 CA-C-O 121.741 0.634 . . . . 75.34 111.638 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.86 22.54 7.42 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.501 1.92 . . . . 71.35 108.701 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.34 144.84 49.89 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 106.35 -1.722 . . . . 72.54 106.35 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -127.92 162.9 25.65 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.508 -1.293 . . . . 75.54 107.508 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 79' ' ' THR . 5.0 mt -135.17 144.09 35.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 105.874 -1.898 . . . . 53.54 105.874 178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.3 t -118.99 128.82 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 126.391 1.876 . . . . 41.21 106.127 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.42 ' CZ ' HG21 ' A' ' 40' ' ' ILE . 53.7 t80 -101.21 139.14 37.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 105.25 -2.129 . . . . 75.12 105.25 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.1 t -138.56 127.76 31.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 104.014 -2.587 . . . . 74.34 104.014 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.511 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -132.38 179.54 17.14 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 120.078 1.308 . . . . 55.44 112.634 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 73.17 17.77 3.97 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.194 2.198 . . . . 54.12 110.302 -177.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 9.4 mp -55.03 148.63 27.87 Favored Pre-proline 0 C--O 1.239 0.524 0 C-N-CA 124.929 1.292 . . . . 73.1 111.95 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -64.28 153.61 75.69 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.956 3.104 . . . . 75.32 112.239 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -65.38 -34.03 77.35 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 118.508 -0.758 . . . . 74.04 109.492 179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -92.65 21.06 5.76 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.641 1.176 . . . . 75.31 112.646 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.557 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 10.3 tp -52.36 138.92 10.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 121.256 -0.903 . . . . 52.24 109.951 178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 p -125.38 150.77 46.91 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.48 -0.933 . . . . 73.54 108.48 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.01 -26.24 68.2 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 118.299 -0.858 . . . . 65.32 110.133 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.6 p -65.09 -41.17 91.21 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 CA-C-N 119.697 1.135 . . . . 72.11 108.682 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.553 ' HG3' ' HE2' ' A' ' 70' ' ' LYS . 15.8 mm-40 -68.11 -45.27 74.14 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 108.346 -0.983 . . . . 73.22 108.346 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.1 mt -59.71 -47.65 84.79 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.494 0.588 . . . . 74.11 111.086 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -61.0 -38.01 84.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.56 0.744 . . . . 72.14 109.987 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -74.44 -54.35 7.76 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.364 1.066 . . . . 71.13 113.796 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.95 -34.6 70.08 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.681 0.993 . . . . 64.43 113.681 -178.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -97.4 3.71 50.88 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.806 0.842 . . . . 70.11 112.58 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 pttt -60.72 -28.96 69.06 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.845 -1.159 . . . . 70.0 109.918 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -73.67 -17.57 61.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.093 0.957 . . . . 72.34 111.058 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.9 p -113.84 -5.84 13.25 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.439 1.895 . . . . 53.13 113.581 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.8 t 41.68 77.33 0.44 Allowed Pre-proline 0 CA--C 1.543 0.678 0 C-N-CA 126.503 1.921 . . . . 75.05 114.973 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.57 165.99 30.08 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 121.931 1.754 . . . . 72.42 109.988 178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -91.2 -32.89 15.61 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 120.742 -1.224 . . . . 72.24 109.501 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -143.54 153.26 42.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.169 1.388 . . . . 71.23 108.187 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.4 mt -133.73 105.12 6.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.788 -1.56 . . . . 71.44 106.788 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.1 ttt-85 -122.62 103.94 9.01 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.875 -0.787 . . . . 75.41 108.875 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -83.15 127.38 33.55 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.107 -1.812 . . . . 73.32 106.107 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 85.54 2.37 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 105.582 -2.007 . . . . 75.21 105.582 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.53 -27.55 49.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.918 0.887 . . . . 72.33 113.003 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -52.05 -30.09 24.12 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 126.68 1.992 . . . . 71.01 114.314 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -132.23 11.96 4.61 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.043 1.337 . . . . 54.15 111.418 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 56.77 52.45 50.68 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.345 -1.502 . . . . 25.11 109.345 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.511 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.8 pt -139.84 168.07 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 124.613 1.165 . . . . 65.11 110.594 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.99 154.29 41.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.649 1.179 . . . . 62.21 108.014 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -124.45 123.32 39.88 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.118 -1.808 . . . . 62.2 106.118 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.8 mp -117.77 113.81 22.37 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.861 -1.533 . . . . 75.2 106.861 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -85.18 152.81 23.08 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.335 -1.357 . . . . 61.22 107.335 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -141.1 136.86 32.37 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.446 1.098 . . . . 74.24 108.709 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -97.98 108.51 21.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.394 1.478 . . . . 75.23 112.616 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.4 -22.6 51.34 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.483 0.713 . . . . 64.22 112.543 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.93 -37.09 35.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 112.096 0.406 . . . . 74.33 112.096 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -68.87 -55.47 10.99 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 125.186 1.394 . . . . 73.01 111.036 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.57 71.91 0.81 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 122.011 0.91 . . . . 60.41 110.281 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.1 mmt180 -48.85 -38.49 22.55 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.685 1.194 . . . . 70.31 112.718 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.8 p -104.99 8.0 34.29 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 113.761 1.022 . . . . 74.44 113.761 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.94 -23.14 2.54 Favored Glycine 0 C--O 1.221 -0.676 0 CA-C-O 118.038 -1.423 . . . . 61.25 113.604 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.1 tp -49.36 -49.57 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 120.244 2.022 . . . . 73.2 113.127 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -64.07 -55.46 22.0 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.841 -0.8 . . . . 75.45 108.841 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -49.49 -53.2 24.5 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.171 0.896 . . . . 55.25 109.417 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -51.91 -54.86 24.51 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.14 1.776 . . . . 74.31 110.337 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 44.0 mtm -66.32 -28.32 68.59 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 118.908 0.776 . . . . 72.34 111.218 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -65.06 -47.51 77.05 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 120.074 -1.641 . . . . 73.31 109.798 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.5 mt -65.29 -31.65 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 126.284 1.833 . . . . 72.21 108.063 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.23 -41.13 58.22 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.674 -0.862 . . . . 65.13 108.674 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -60.61 -37.06 80.15 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.479 0.712 . . . . 73.23 110.311 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.6 mt -64.42 -6.08 6.52 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.236 1.414 . . . . 72.22 113.616 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -92.39 6.23 47.71 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.491 1.041 . . . . 73.53 111.234 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -72.25 114.89 10.86 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.727 1.211 . . . . 74.34 108.546 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 94.48 5.09 61.98 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-O 118.005 -1.442 . . . . 21.52 114.445 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 44.9 p -72.01 154.01 41.41 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.997 1.899 . . . . 71.03 109.422 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 mt -100.49 107.54 19.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.588 -1.634 . . . . 64.13 106.588 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.67 121.92 44.86 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 104.622 -2.362 . . . . 74.22 104.622 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 18.8 mttm 48.1 47.33 19.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.822 0.849 . . . . 61.03 110.971 -177.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 58.0 26.97 14.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.846 1.658 . . . . 62.14 114.186 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -126.47 122.31 34.88 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.728 -1.212 . . . . 74.32 107.728 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -81.62 102.55 10.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.298 -1.371 . . . . 64.14 107.298 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.6 pt -85.54 169.64 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 124.282 1.033 . . . . 73.21 110.898 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.62 155.27 45.23 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 125.888 1.675 . . . . 73.53 109.467 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.2 t -132.62 148.91 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.339 1.055 . . . . 54.11 108.479 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.8 172.14 13.34 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.571 1.949 . . . . 64.42 109.368 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -97.55 153.42 18.18 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.067 1.747 . . . . 55.1 107.366 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.443 HG23 ' HB ' ' A' ' 5' ' ' ILE . 9.2 t -143.27 82.33 1.74 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.947 -0.76 . . . . 64.54 108.947 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 p -167.89 -44.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 123.444 0.698 . . . . 65.01 111.854 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.46 18.03 0.07 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 114.463 0.545 . . . . 54.34 114.463 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.194 0 C-N-CA 129.209 3.29 . . . . 72.22 106.076 -179.702 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.63 0 N-CA-C 110.29 -1.124 . . . . 65.43 110.29 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.12 52.18 0.8 Allowed 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 124.274 1.03 . . . . 70.13 110.186 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.92 163.75 37.95 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.012 -1.055 . . . . 72.41 109.889 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -133.19 165.62 24.35 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.105 1.362 . . . . 74.41 108.583 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mt -134.45 148.64 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.024 -0.732 . . . . 74.24 109.024 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.33 126.64 74.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 105.942 -1.873 . . . . 73.22 105.942 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -91.04 137.73 32.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.522 1.529 . . . . 63.4 107.688 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.481 HG12 HD11 ' A' ' 11' ' ' LEU . 11.9 t -138.73 126.09 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.729 -1.582 . . . . 74.42 106.729 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.428 ' H ' ' ND2' ' A' ' 75' ' ' ASN . . . -136.9 176.76 20.23 Favored Glycine 0 N--CA 1.468 0.774 0 CA-C-N 120.347 1.431 . . . . 32.25 111.628 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 79.25 19.02 0.77 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.48 2.312 . . . . 75.11 109.585 -178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.481 HD11 HG12 ' A' ' 8' ' ' VAL . 9.9 mp -63.76 143.25 98.08 Favored Pre-proline 0 C--O 1.235 0.315 0 O-C-N 120.9 -1.125 . . . . 52.03 112.884 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.3 160.74 43.78 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.62 2.88 . . . . 53.34 111.604 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -44.06 93.46 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.784 -0.821 . . . . 74.23 108.784 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.72 9.46 1.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.522 1.929 . . . . 62.31 114.095 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.538 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 7.5 tp -58.62 139.45 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 O-C-N 120.725 -1.234 . . . . 61.52 109.822 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.46 150.52 50.11 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.818 0.847 . . . . 64.21 109.75 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.84 -30.73 70.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.076 0.95 . . . . 75.42 110.404 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.67 -43.27 96.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.549 1.14 . . . . 70.3 109.487 179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -67.08 -42.12 85.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.96 -1.126 . . . . 64.41 107.96 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.67 -53.47 55.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.988 1.315 . . . . 74.23 110.454 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -46.9 83.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.688 -1.226 . . . . 72.44 107.688 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -62.58 -42.85 99.81 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.918 1.081 . . . . 64.12 113.918 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.99 -47.68 67.86 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 120.993 -1.067 . . . . 72.22 110.66 -179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -85.33 6.05 28.04 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.25 1.204 . . . . 74.31 114.25 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -51.48 -41.13 60.7 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 125.067 1.347 . . . . 61.3 113.715 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.458 HD22 HD13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -72.57 -21.93 61.07 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.404 0.547 . . . . 72.41 112.247 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.66 -17.89 22.76 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.218 1.407 . . . . 72.51 110.843 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.6 m 49.17 74.15 0.87 Allowed Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.094 1.758 . . . . 61.33 114.412 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HG2' HD11 ' A' ' 32' ' ' ILE . 74.4 Cg_endo -65.87 153.15 79.34 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.116 1.877 . . . . 74.35 109.111 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -91.62 -39.8 11.67 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.996 -1.112 . . . . 65.4 107.996 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -123.46 146.35 48.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 124.548 1.139 . . . . 65.12 108.867 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.445 HD11 ' HG2' ' A' ' 29' ' ' PRO . 57.3 mt -141.38 107.02 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.982 -1.118 . . . . 74.23 107.982 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.43 104.74 8.07 Favored 'General case' 0 N--CA 1.46 0.055 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -91.53 118.66 30.78 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.776 2.03 . . . . 74.02 108.191 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.68 87.84 2.73 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.631 1.572 . . . . 75.22 108.432 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.32 -16.89 63.04 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 121.696 -0.628 . . . . 73.23 109.88 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -51.62 -26.74 9.5 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.937 2.495 . . . . 74.04 110.797 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.9 mttp -133.23 -1.6 3.21 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.798 2.439 . . . . 65.33 111.128 177.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.83 50.75 45.36 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 125.263 1.411 . . . . 64.32 110.134 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.412 HG22 ' CA ' ' A' ' 9' ' ' GLY . 2.3 pt -140.8 167.94 17.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 125.988 1.715 . . . . 63.34 110.827 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.83 149.81 33.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.247 1.819 . . . . 74.0 109.227 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -120.35 132.98 55.52 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.691 -1.596 . . . . 71.22 106.691 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.17 110.12 12.56 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.183 -1.784 . . . . 62.02 106.183 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -96.86 148.49 22.88 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.755 -1.202 . . . . 53.43 107.755 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -143.5 120.97 11.7 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.401 1.08 . . . . 75.02 109.358 -179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -76.38 121.13 22.58 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.479 0.712 . . . . 70.21 110.541 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -74.1 -38.76 63.75 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.943 1.697 . . . . 74.22 112.209 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.38 -29.62 70.89 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.594 -0.521 . . . . 71.5 109.594 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -61.7 -19.27 62.19 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.393 1.077 . . . . 74.3 112.489 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.03 90.33 0.44 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.105 1.321 . . . . 70.52 109.619 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -48.85 -38.71 23.15 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 116.125 1.898 . . . . 75.11 116.125 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -114.59 -0.95 13.49 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 123.337 0.398 . . . . 74.2 111.371 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.04 -28.68 8.05 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.474 1.035 . . . . 71.41 111.438 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.2 tp -54.13 -37.76 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 118.906 1.353 . . . . 72.33 110.648 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -56.75 18.04 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.148 -0.686 . . . . 74.14 109.148 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.25 -42.78 66.82 Favored 'General case' 0 CA--C 1.522 -0.133 0 C-N-CA 124.715 1.206 . . . . 70.42 110.325 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -57.35 -46.73 83.02 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.001 -1.111 . . . . 55.23 108.001 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 17.3 mtm -66.88 -44.58 80.52 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-O 117.938 -1.029 . . . . 53.32 110.769 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -52.42 -49.85 63.69 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 120.315 1.416 . . . . 54.11 110.217 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.458 HD13 HD22 ' A' ' 26' ' ' ASN . 64.4 mt -65.92 -43.51 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.722 1.209 . . . . 74.1 109.16 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.14 96.76 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.783 0.719 . . . . 73.34 109.968 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.39 -26.35 68.42 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.007 1.323 . . . . 60.02 111.571 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 mt -73.56 -8.2 54.97 Favored 'General case' 0 C--O 1.234 0.288 0 O-C-N 121.458 -0.776 . . . . 72.41 109.946 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -88.84 9.02 26.21 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 118.178 -0.915 . . . . 75.32 111.803 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -76.86 118.03 19.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.694 1.588 . . . . 72.42 106.735 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.62 3.02 64.81 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 118.508 -1.162 . . . . 64.22 115.094 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.1 p -67.97 144.89 54.99 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 120.018 1.909 . . . . 73.4 107.766 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.8 mt -92.87 107.66 19.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 103.936 -2.616 . . . . 74.41 103.936 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.07 115.39 30.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 102.931 -2.988 . . . . 74.23 102.931 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 0.5 OUTLIER 48.41 56.96 6.73 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.533 1.159 . . . . 62.22 110.384 -177.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 60.47 13.09 3.88 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 127.359 2.264 . . . . 75.34 114.999 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -118.35 120.0 36.31 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.259 1.023 . . . . 74.01 111.469 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -71.63 115.7 11.12 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.872 -1.529 . . . . 50.12 106.872 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.335 16.4 pt -101.39 170.69 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 118.358 0.526 . . . . 54.43 110.201 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.428 ' ND2' ' H ' ' A' ' 9' ' ' GLY . 0.8 OUTLIER -120.89 151.83 39.19 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 124.482 1.113 . . . . 72.04 109.704 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 86.3 t -137.62 135.19 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.579 1.152 . . . . 65.22 108.45 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -152.35 152.97 32.73 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.427 1.091 . . . . 71.22 110.574 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.41 143.62 38.49 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.252 1.021 . . . . 72.25 111.005 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 21.3 p -141.2 145.83 36.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 124.917 1.287 . . . . 61.52 110.218 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.8 t 53.27 86.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 127.437 2.295 . . . . 74.32 112.426 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.46 -10.16 1.94 Allowed Glycine 0 CA--C 1.522 0.52 0 CA-C-O 118.577 -1.124 . . . . 75.51 113.413 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 N-CA-C 108.732 -1.747 . . . . 72.42 108.732 179.653 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.713 0 N-CA-C 111.096 -0.802 . . . . 51.11 111.096 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.35 40.49 0.28 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.998 1.319 . . . . 71.05 112.799 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 ptt-85 -155.71 148.58 24.27 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 120.385 -1.447 . . . . 70.34 110.152 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -115.77 165.04 13.5 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 128.042 2.537 . . . . 75.33 104.391 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.5 mt -134.89 135.75 52.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.534 -0.757 . . . . 73.31 109.091 -177.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.9 t -96.98 145.34 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 104.992 -2.225 . . . . 61.31 104.992 178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -113.62 131.73 56.02 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 104.904 -2.258 . . . . 75.11 104.904 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.47 HG12 HD11 ' A' ' 11' ' ' LEU . 21.6 t -135.88 126.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.091 -1.818 . . . . 41.22 106.091 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.22 177.63 18.36 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.052 0.842 . . . . 73.43 112.419 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.0 17.18 2.22 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 128.58 2.752 . . . . 52.52 110.671 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.47 HD11 HG12 ' A' ' 8' ' ' VAL . 9.7 mp -58.31 144.32 77.82 Favored Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 124.91 1.284 . . . . 70.23 111.688 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -66.19 160.76 43.4 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.362 2.708 . . . . 71.43 112.406 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -67.06 -37.5 84.13 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.422 -0.955 . . . . 75.35 108.422 177.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.8 13.59 1.64 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.72 1.007 . . . . 43.02 113.72 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.61 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 6.4 tp -63.98 134.78 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 O-C-N 120.451 -1.405 . . . . 70.34 110.452 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . 0.254 1.3 p -128.63 150.05 50.39 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.456 1.902 . . . . 71.2 107.124 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.02 -26.37 64.49 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.382 -0.824 . . . . 44.23 112.638 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 p -64.18 -36.54 77.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.462 -0.94 . . . . 75.23 108.462 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -70.35 -43.44 70.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.979 0.912 . . . . 73.24 108.595 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.99 -47.44 84.8 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 109.232 -0.655 . . . . 74.52 109.232 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -60.03 -38.55 83.03 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.863 0.865 . . . . 74.13 108.797 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -68.85 -41.9 77.85 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.814 1.188 . . . . 65.21 111.076 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -69.99 -35.86 74.72 Favored 'General case' 0 C--O 1.234 0.245 0 O-C-N 121.565 -0.709 . . . . 71.53 112.561 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -100.87 6.44 43.72 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.668 0.787 . . . . 74.0 112.405 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -54.27 -43.85 71.37 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.054 1.342 . . . . 73.41 110.747 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -60.79 -32.03 71.38 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.369 1.068 . . . . 73.31 112.123 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 p -94.24 -22.45 18.4 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.686 1.194 . . . . 72.21 111.378 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t 54.4 79.95 0.32 Allowed Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 129.537 3.135 . . . . 65.33 112.396 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -64.89 166.24 18.92 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.677 2.918 . . . . 64.22 111.484 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -96.65 -38.55 9.89 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.116 0.966 . . . . 72.13 109.429 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -131.82 151.52 51.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.056 1.342 . . . . 54.05 108.9 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 63.9 mt -139.8 105.29 2.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 106.473 -1.676 . . . . 73.23 106.473 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.461 ' HE ' ' HA ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -122.57 104.29 9.26 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 107.46 -1.311 . . . . 54.24 107.46 178.141 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 15' ' ' ILE . 1.5 tm? -87.01 125.24 33.97 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.63 1.172 . . . . 74.32 108.575 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -115.17 79.4 1.27 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.16 1.784 . . . . 73.3 107.078 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.01 54.77 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.104 0.962 . . . . 73.22 111.746 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -50.73 -34.98 29.14 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 126.688 1.995 . . . . 63.32 111.918 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -131.48 14.95 4.99 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.585 1.154 . . . . 63.11 111.298 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 57.5 50.23 66.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 124.265 0.936 . . . . 53.33 111.095 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.9 pt -138.21 170.95 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.235 1.414 . . . . 75.23 109.492 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.74 164.94 34.96 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.579 1.152 . . . . 61.11 109.094 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -128.69 127.69 42.62 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 105.505 -2.035 . . . . 60.15 105.505 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mp -130.07 106.45 8.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.743 -1.577 . . . . 74.02 106.743 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -96.16 150.14 20.85 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.581 -1.266 . . . . 75.34 107.581 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -136.27 135.28 38.85 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.496 -1.298 . . . . 72.43 107.496 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -79.46 109.61 14.0 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.323 0.965 . . . . 72.32 110.986 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.17 -24.78 60.6 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.609 1.564 . . . . 73.34 113.668 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -75.13 -25.93 58.8 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.713 -0.847 . . . . 74.43 108.713 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tttp -60.64 -27.79 68.06 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 123.913 0.885 . . . . 72.35 111.051 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -161.35 88.48 0.73 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.842 0.746 . . . . 71.43 111.007 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -59.64 -25.41 64.66 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 121.162 -0.961 . . . . 62.22 112.831 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.0 p -96.95 -12.24 23.62 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.136 0.88 . . . . 63.52 113.181 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.99 -12.24 7.15 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-O 117.753 -1.582 . . . . 60.3 115.5 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.4 tp -58.0 -37.27 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 120.727 2.263 . . . . 74.33 110.773 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -58.69 -58.55 8.1 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.672 -1.233 . . . . 53.4 107.672 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.61 -43.19 68.45 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.874 0.761 . . . . 71.22 111.777 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.3 mtt85 -57.3 -43.8 83.55 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.836 -0.801 . . . . 74.23 108.836 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.2 mtm -64.35 -43.27 95.1 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.985 -0.746 . . . . 75.25 108.985 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.44 -47.58 72.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.142 1.777 . . . . 62.24 111.495 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.5 mt -65.11 -37.09 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 125.263 1.425 . . . . 43.34 107.959 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -73.06 -37.83 66.67 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.332 0.969 . . . . 75.43 109.44 178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 78' ' ' LEU . 32.6 mt -67.59 -28.58 67.89 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.625 0.77 . . . . 60.34 110.914 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.3 mt -66.58 -8.53 27.6 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.405 0.682 . . . . 73.14 110.978 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -86.42 3.82 42.15 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.874 0.761 . . . . 60.54 111.203 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -66.97 131.1 45.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 119.688 -1.882 . . . . 75.54 107.845 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.09 8.68 58.88 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 117.976 -1.458 . . . . 74.44 114.579 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.7 p -70.39 146.82 50.15 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 120.883 2.342 . . . . 73.15 108.059 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.0 mt -89.9 108.0 19.45 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 104.743 -2.317 . . . . 61.05 104.743 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.9 tp -110.04 121.81 46.13 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.912 -1.885 . . . . 70.03 105.912 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 13.9 mtpp 53.92 38.42 28.73 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.813 0.845 . . . . 62.34 111.296 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 62.61 33.21 15.93 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.225 1.41 . . . . 73.14 112.462 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.1 mmmt -140.79 117.87 11.22 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.925 1.69 . . . . 75.22 107.949 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -73.95 148.37 42.22 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.835 -1.543 . . . . 65.4 106.835 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.0 pt -133.66 169.2 22.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 124.876 1.27 . . . . 61.23 111.236 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -120.86 152.34 38.54 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.077 1.351 . . . . 74.3 111.11 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -135.05 136.5 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 124.528 1.131 . . . . 75.12 108.507 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -150.84 162.8 40.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.614 1.966 . . . . 73.44 108.521 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -96.73 152.22 18.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.019 1.328 . . . . 72.34 111.589 179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 54.9 p -142.97 161.84 37.05 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.208 1.403 . . . . 75.33 108.671 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 t 46.01 91.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 128.391 2.676 . . . . 72.21 113.153 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.07 89.91 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.637 -2.185 . . . . 72.35 107.637 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 CA-C-O 117.141 -1.921 . . . . 64.33 110.873 179.377 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.364 0 N-CA-C 107.354 -2.299 . . . . 62.34 107.354 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -132.81 44.27 2.88 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 125.078 1.351 . . . . 62.32 108.314 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 22.7 ptt85 -147.0 164.22 33.7 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.697 1.199 . . . . 71.31 109.539 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -133.39 165.56 24.55 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.606 2.362 . . . . 75.03 105.877 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 mt -130.53 136.85 57.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.734 0.778 . . . . 70.31 109.819 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -103.21 118.87 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 104.558 -2.386 . . . . 63.14 104.558 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -90.62 133.15 35.31 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 106.222 -1.77 . . . . 75.33 106.222 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.5 t -138.85 130.93 37.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 118.144 -0.931 . . . . 45.01 108.509 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.81 -179.82 18.57 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-N 120.022 1.283 . . . . 73.44 112.019 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.48 25.65 2.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 127.13 2.172 . . . . 71.03 111.598 -178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 mp -66.26 149.08 98.19 Favored Pre-proline 0 C--O 1.237 0.398 0 O-C-N 120.877 -1.14 . . . . 74.55 112.474 -178.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.63 168.62 16.17 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.571 3.514 . . . . 70.1 111.612 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -70.31 -46.34 64.43 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 108.476 -0.935 . . . . 74.02 108.476 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.61 5.03 2.04 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.778 1.631 . . . . 73.12 114.163 -179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.2 tp -57.01 130.43 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 121.08 -1.012 . . . . 74.2 109.064 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.69 154.95 45.79 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.406 1.483 . . . . 71.22 107.788 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.17 -30.28 66.27 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-O 118.985 -0.531 . . . . 74.3 109.902 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.6 t -58.55 -43.96 88.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 118.465 0.575 . . . . 72.03 109.942 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -65.47 -43.73 89.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.169 0.988 . . . . 74.21 109.68 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.8 mt -67.43 -44.69 78.11 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.911 0.884 . . . . 73.31 111.297 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -56.8 -48.38 78.07 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 107.174 -1.417 . . . . 54.51 107.174 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.93 -40.87 95.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.539 1.136 . . . . 64.15 113.327 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.55 -22.24 57.22 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 114.377 1.251 . . . . 74.13 114.377 -179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -108.31 2.86 22.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.821 0.737 . . . . 75.21 111.895 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -52.18 -33.3 40.03 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.464 2.306 . . . . 64.43 113.731 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -82.25 -38.24 24.76 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.833 0.742 . . . . 64.35 110.046 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -22.6 64.67 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.634 1.173 . . . . 54.3 110.217 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m 53.78 67.27 3.71 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 124.543 1.137 . . . . 52.2 113.446 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.71 173.38 8.08 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.768 2.979 . . . . 53.2 109.638 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -105.7 -43.54 4.88 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.8 -1.185 . . . . 63.13 107.8 177.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HB3' ' H ' ' A' ' 44' ' ' GLU . 7.0 tp-100 -122.19 154.18 37.81 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 125.608 1.563 . . . . 71.34 109.648 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 97.3 mt -146.7 122.9 3.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 105.899 -1.889 . . . . 75.34 105.899 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.34 102.95 4.32 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.441 1.497 . . . . 75.34 109.452 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -80.22 126.65 31.39 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.148 -1.797 . . . . 74.31 106.148 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -118.53 87.44 2.73 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.262 1.425 . . . . 74.33 111.146 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.34 -21.2 61.78 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.996 0.918 . . . . 63.43 111.87 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -54.61 -32.55 58.96 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.267 1.427 . . . . 72.25 111.576 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 20.3 mmtm -132.85 2.43 3.69 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 114.341 1.237 . . . . 74.01 114.341 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.47 40.38 54.55 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 120.39 1.45 . . . . 44.52 110.106 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 3.0 pt -129.53 170.12 19.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 126.616 1.966 . . . . 75.25 110.625 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.85 120.46 4.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 126.61 1.964 . . . . 73.15 108.859 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -99.14 150.95 21.52 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 118.615 0.643 . . . . 74.3 109.808 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mp -140.9 131.07 24.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.164 -1.051 . . . . 74.31 108.164 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.474 ' H ' ' HB3' ' A' ' 31' ' ' GLN . 59.0 mt-10 -102.04 149.88 23.8 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 104.648 -2.353 . . . . 54.13 104.648 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -135.81 109.34 7.95 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.119 0.968 . . . . 70.33 108.5 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -68.39 110.01 3.92 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.816 1.246 . . . . 73.33 110.718 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.09 -15.23 57.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 127.569 2.347 . . . . 64.24 112.943 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.56 -39.3 32.12 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 106.393 -1.706 . . . . 74.24 106.393 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.3 tttm -61.73 -46.07 91.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.401 -0.963 . . . . 61.55 108.401 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.34 73.84 0.87 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.026 0.93 . . . . 62.01 109.556 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -48.21 -34.19 9.75 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.092 1.145 . . . . 63.43 114.092 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 p -121.81 -19.12 6.86 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 124.05 0.844 . . . . 75.01 111.686 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.08 -16.73 76.05 Favored Glycine 0 CA--C 1.528 0.893 0 O-C-N 121.125 -0.984 . . . . 63.54 112.006 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 tp -50.75 -40.22 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.99 1.316 . . . . 63.53 110.914 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -57.51 -61.56 2.41 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.126 1.37 . . . . 63.04 108.439 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -50.98 -50.94 57.33 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.577 1.151 . . . . 62.22 110.095 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -52.85 -52.01 58.81 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.293 0.637 . . . . 70.31 110.776 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 36.4 mtm -66.79 -35.56 80.37 Favored 'General case' 0 C--O 1.223 -0.324 0 C-N-CA 123.103 0.561 . . . . 61.51 111.358 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -46.98 87.7 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.863 1.265 . . . . 61.45 109.454 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.7 mt -62.87 -36.35 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.581 -0.896 . . . . 71.42 108.581 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.4 -43.06 70.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.94 -0.763 . . . . 72.12 108.94 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 mt -63.9 -33.15 75.05 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.663 0.785 . . . . 72.31 111.031 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 mt -63.78 -13.14 41.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.298 0.851 . . . . 73.03 113.298 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -86.53 3.4 44.35 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.896 0.771 . . . . 65.14 111.547 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -59.74 113.98 2.53 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 120.931 -1.106 . . . . 72.34 109.414 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.06 12.34 55.25 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-O 118.371 -1.238 . . . . 71.41 115.385 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.4 p -69.62 149.08 48.52 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 120.174 1.987 . . . . 72.11 109.62 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.9 mt -96.43 107.18 19.53 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 106.062 -1.829 . . . . 64.32 106.062 178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mt -109.92 122.66 48.06 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.189 -2.152 . . . . 52.24 105.189 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.5 mtmm 46.43 40.3 7.79 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.328 1.051 . . . . 64.43 110.954 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 67.74 20.38 9.48 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.627 2.371 . . . . 64.11 114.248 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -120.22 125.96 49.44 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 125.092 1.357 . . . . 70.4 108.354 179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -82.57 112.99 19.98 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.838 -0.801 . . . . 72.44 108.838 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.0 pp -87.46 171.13 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 124.429 1.092 . . . . 73.12 110.906 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -131.95 151.27 51.83 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.228 1.411 . . . . 52.32 109.106 178.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.3 t -134.1 144.24 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.231 1.413 . . . . 63.44 108.31 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -153.54 160.76 42.58 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.467 1.907 . . . . 75.11 108.864 177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.34 151.84 22.33 Favored 'General case' 0 CA--C 1.515 -0.377 0 O-C-N 120.99 -1.068 . . . . 71.15 108.699 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 p -144.48 140.22 28.77 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.708 -0.849 . . . . 72.24 108.708 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 88.5 t 50.07 85.58 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 125.893 1.677 . . . . 74.44 111.826 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.37 79.85 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.887 -0.673 . . . . 62.2 112.721 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 N-CA-C 104.374 -3.49 . . . . 64.3 104.374 178.016 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.894 0 N-CA-C 111.257 -0.737 . . . . 33.42 111.257 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -60.35 5.57 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.251 1.945 . . . . 74.22 116.251 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -129.9 115.75 17.64 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 121.132 1.787 . . . . 73.41 106.714 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -99.85 164.91 11.82 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.107 0.963 . . . . 72.33 108.546 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.3 mt -134.87 149.01 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.933 1.293 . . . . 72.11 110.965 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.2 t -118.51 134.3 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.802 2.041 . . . . 74.15 105.851 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -100.62 142.21 32.4 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 126.15 1.78 . . . . 74.43 108.826 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.8 t -138.41 133.53 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.21 -1.774 . . . . 73.11 106.21 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 40' ' ' ILE . . . -132.57 -179.7 16.5 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 120.385 1.448 . . . . 44.2 111.123 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 66.88 14.48 9.84 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.526 1.931 . . . . 71.03 112.621 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.9 mp -51.35 148.05 9.37 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 124.737 1.215 . . . . 73.45 112.958 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.78 154.34 50.27 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.649 2.899 . . . . 74.22 110.341 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -70.36 -37.56 74.62 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 121.881 -0.512 . . . . 75.2 109.917 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.59 25.3 3.11 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.336 1.054 . . . . 45.35 111.855 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HA ' ' HE2' ' A' ' 70' ' ' LYS . 8.4 tp -53.84 139.92 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.832 1.253 . . . . 75.11 110.537 178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -124.78 148.04 48.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.611 1.164 . . . . 73.44 108.423 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.29 -29.84 70.12 Favored 'General case' 0 CA--C 1.527 0.075 0 CA-C-O 118.852 -0.594 . . . . 55.15 111.097 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.3 p -61.66 -37.01 76.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 118.764 0.711 . . . . 61.24 109.708 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -69.17 -44.67 71.76 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.727 -0.842 . . . . 74.42 108.727 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.6 mt -60.49 -54.71 42.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.342 0.657 . . . . 75.22 110.786 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -59.87 -41.42 91.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.373 -0.602 . . . . 73.21 109.373 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -67.94 -40.53 83.29 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.855 0.687 . . . . 64.21 112.855 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -22.68 65.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 120.047 1.294 . . . . 70.03 113.071 -179.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -112.29 6.07 18.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.056 0.942 . . . . 72.23 111.513 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -41.7 63.04 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.25 1.42 . . . . 74.54 112.264 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -58.17 -54.32 48.31 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.972 -0.751 . . . . 72.22 108.972 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.09 -22.06 66.39 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.653 1.181 . . . . 64.42 112.627 179.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 t 50.41 78.26 0.41 Allowed Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 127.195 2.198 . . . . 63.41 112.418 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.55 168.14 20.66 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.256 2.637 . . . . 72.02 110.577 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -94.68 -31.8 13.65 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.488 1.115 . . . . 65.43 109.961 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.04 161.0 41.11 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.859 0.863 . . . . 61.23 109.807 178.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.68 107.13 2.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 104.295 -2.483 . . . . 73.25 104.295 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.5 ttp180 -117.98 103.96 10.43 Favored 'General case' 0 C--N 1.334 -0.103 0 N-CA-C 107.577 -1.268 . . . . 75.53 107.577 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -92.57 124.78 36.85 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.49 1.516 . . . . 75.41 110.51 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.56 80.12 1.49 Allowed 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.602 1.961 . . . . 74.23 108.024 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.83 -17.37 56.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.107 0.963 . . . . 72.22 111.216 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.438 ' O ' ' HE2' ' A' ' 38' ' ' LYS . 1.4 m-20 -51.4 -32.8 27.63 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.647 1.979 . . . . 65.14 109.884 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 5.3 mmpt? -126.73 -9.69 6.14 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.378 1.871 . . . . 64.42 111.351 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.42 36.77 33.2 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 109.661 -1.376 . . . . 75.13 109.661 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.425 ' HA ' ' HA2' ' A' ' 9' ' ' GLY . 36.0 pt -124.47 168.42 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.173 1.389 . . . . 64.32 108.417 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.67 166.3 33.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.569 1.148 . . . . 72.34 109.442 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -135.77 140.82 44.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.562 1.545 . . . . 73.02 108.083 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.2 mp -134.49 123.62 24.25 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.016 -1.475 . . . . 65.12 107.016 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -98.64 156.73 16.67 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.614 -0.513 . . . . 72.23 109.614 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -146.65 119.63 8.76 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.201 -1.407 . . . . 74.5 107.201 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -83.72 119.14 24.43 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.765 -0.458 . . . . 44.43 109.765 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.97 -24.35 61.58 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.991 1.716 . . . . 54.12 111.219 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -70.4 -23.77 62.82 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.86 -1.163 . . . . 73.45 107.86 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -62.18 -32.37 72.99 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-O 118.362 -0.828 . . . . 51.14 110.368 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -168.02 101.52 0.46 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.461 1.504 . . . . 72.32 108.078 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.7 mtt180 -52.76 -22.62 5.49 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 116.301 1.963 . . . . 74.43 116.301 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 p -121.43 -19.36 6.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 120.115 1.325 . . . . 71.33 110.872 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.9 -30.62 51.33 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-O 118.592 -1.116 . . . . 32.14 110.705 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.1 tp -52.58 -37.65 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.24 1.416 . . . . 72.54 110.061 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.01 -58.05 9.52 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.618 1.167 . . . . 74.44 107.934 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -54.79 -41.29 70.39 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.258 0.623 . . . . 72.42 110.242 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.6 mtt85 -57.95 -50.23 74.09 Favored 'General case' 0 N--CA 1.46 0.043 0 CA-C-O 118.421 -0.8 . . . . 74.14 110.233 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 10.8 mtm -59.85 -45.49 92.27 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 118.195 0.452 . . . . 74.03 110.451 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.4 -54.57 45.13 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 122.86 0.464 . . . . 72.24 110.666 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.8 mt -58.1 -36.94 59.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 125.194 1.398 . . . . 73.35 109.596 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.11 -43.97 73.38 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.733 -0.469 . . . . 63.13 109.733 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.68 -35.66 81.75 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.347 0.659 . . . . 74.33 110.337 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 41.8 mt -62.47 -2.57 1.1 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.949 1.7 . . . . 71.44 113.646 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -94.45 3.73 54.77 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.675 1.19 . . . . 71.21 110.314 177.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -65.85 135.08 54.34 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.153 1.781 . . . . 74.21 109.686 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.01 15.53 67.36 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.706 1.622 . . . . 72.12 113.312 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.5 p -78.59 155.99 29.35 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.883 1.342 . . . . 32.34 108.139 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.32 108.0 20.15 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.356 -0.979 . . . . 64.1 108.356 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.1 tp -112.32 115.59 29.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.631 -1.618 . . . . 73.1 106.631 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' A' ' 15' ' ' ILE . 3.8 mtpp 50.2 53.45 12.84 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.027 0.918 . . . . 75.21 111.081 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 55.43 20.44 3.67 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.303 2.241 . . . . 74.53 114.523 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.8 mmmt -122.8 122.77 39.49 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 126.079 1.751 . . . . 63.44 107.837 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 ttpm? -83.14 104.86 13.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.036 -1.098 . . . . 73.42 108.036 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.5 pt -87.92 169.3 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.234 -0.894 . . . . 45.43 111.289 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -123.87 154.18 40.03 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.435 1.494 . . . . 74.35 110.222 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.2 142.15 42.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 106.936 -1.505 . . . . 65.43 106.936 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.67 174.78 14.05 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.472 1.909 . . . . 63.1 110.517 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -90.42 149.2 22.35 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.797 1.239 . . . . 75.11 112.422 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 p -150.93 150.01 30.31 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.505 -1.665 . . . . 72.21 106.505 177.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.7 t 64.53 -67.65 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 126.535 1.934 . . . . 75.31 113.09 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.03 -16.83 73.13 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 127.011 2.243 . . . . 62.24 115.845 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.919 0 N-CA-C 105.906 -2.877 . . . . 42.44 105.906 179.888 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.383 0 N-CA-C 109.435 -1.466 . . . . 71.21 109.435 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -67.55 -3.14 7.9 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 115.898 1.814 . . . . 72.31 115.898 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -120.6 106.24 11.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.964 0.802 . . . . 64.02 111.889 -177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -99.05 159.33 15.04 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 127.738 2.415 . . . . 73.15 110.055 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mt -135.17 149.22 28.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.604 1.162 . . . . 70.11 110.953 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 82.8 t -116.07 128.8 73.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 106.752 -1.573 . . . . 73.3 106.752 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -88.05 131.62 34.59 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.661 1.584 . . . . 73.2 106.886 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.403 HG12 HD11 ' A' ' 11' ' ' LEU . 5.2 t -138.58 128.69 33.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 106.31 -1.737 . . . . 74.42 106.31 178.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.08 -175.15 13.85 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-N 119.212 0.914 . . . . 54.25 111.871 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 69.49 14.66 8.35 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.97 1.708 . . . . 74.11 111.157 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.403 HD11 HG12 ' A' ' 8' ' ' VAL . 11.0 mp -60.85 150.81 75.76 Favored Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 125.283 1.433 . . . . 73.44 111.551 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.74 157.63 60.9 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.035 2.49 . . . . 64.24 109.975 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -69.3 -36.15 76.73 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 121.265 -0.897 . . . . 60.34 111.015 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -88.26 15.06 8.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.884 0.874 . . . . 73.3 112.955 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.1 tp -50.46 140.92 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.779 1.231 . . . . 71.41 111.617 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.6 p -128.47 147.5 50.67 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.122 -0.695 . . . . 70.02 109.122 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.68 -27.21 66.2 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 118.481 -0.771 . . . . 73.21 112.064 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 p -62.78 -36.54 75.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.02 -0.733 . . . . 54.11 109.02 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -73.41 -42.53 61.96 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 123.82 0.848 . . . . 71.23 108.857 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.9 mt -62.09 -49.41 76.05 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.484 -0.561 . . . . 65.1 109.484 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.7 mm-40 -58.46 -46.58 86.3 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 107.901 -1.148 . . . . 60.24 107.901 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -57.44 -46.13 83.93 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 114.003 1.112 . . . . 74.41 114.003 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -65.95 -56.45 11.63 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.08 1.309 . . . . 64.33 110.405 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -73.25 4.27 4.74 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.424 1.268 . . . . 73.21 114.424 -179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -53.89 -31.23 49.2 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 125.364 1.466 . . . . 64.51 113.353 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -8.27 56.61 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.298 1.039 . . . . 71.52 112.48 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.7 p -112.08 -9.62 13.96 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.333 1.853 . . . . 63.02 110.858 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.4 m 39.5 78.2 0.38 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 126.912 2.085 . . . . 55.33 115.762 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.37 164.14 29.51 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.991 2.461 . . . . 71.13 109.962 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -90.01 -41.15 11.88 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.018 0.927 . . . . 71.11 108.999 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -144.32 155.88 44.0 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.316 0.646 . . . . 70.22 109.688 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 96.7 mt -136.35 123.96 33.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 127.044 2.138 . . . . 62.12 108.939 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.09 104.69 6.03 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.384 2.273 . . . . 75.45 107.233 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -90.13 121.79 32.51 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.831 -1.174 . . . . 72.42 107.831 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -116.96 75.07 0.94 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.901 -1.518 . . . . 74.42 106.901 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.97 -26.68 27.03 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.186 1.394 . . . . 64.41 112.248 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -51.68 -25.79 7.93 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.289 2.236 . . . . 54.2 113.315 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -133.07 10.39 4.19 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.907 1.683 . . . . 74.41 110.269 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 58.85 44.04 96.24 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.043 1.306 . . . . 42.54 110.012 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.5 pt -132.77 169.77 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 C-N-CA 125.067 1.347 . . . . 72.42 111.011 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -148.06 166.0 29.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.245 1.818 . . . . 62.02 108.829 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -135.1 116.8 14.96 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 106.608 -1.627 . . . . 74.23 106.608 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -113.92 115.52 27.81 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 106.77 -1.567 . . . . 73.23 106.77 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -88.48 152.83 21.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.11 -1.441 . . . . 65.14 107.11 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -145.58 133.27 21.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.342 1.457 . . . . 74.0 107.173 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -101.89 108.33 19.77 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.066 1.346 . . . . 62.12 112.234 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.57 -23.26 65.39 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.083 1.353 . . . . 63.21 112.21 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -75.39 -25.48 57.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.014 -0.736 . . . . 64.31 109.014 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -66.59 -34.51 78.04 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.928 0.891 . . . . 74.14 110.402 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -156.72 91.26 1.21 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.921 0.782 . . . . 74.15 111.269 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -48.65 -34.26 11.46 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.402 1.881 . . . . 75.12 115.787 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.94 -16.49 14.29 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 113.344 0.868 . . . . 75.45 113.344 -178.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.31 -19.07 29.09 Favored Glycine 0 C--O 1.225 -0.461 0 CA-C-O 117.707 -1.607 . . . . 74.11 112.927 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 7.4 tp -56.04 -35.57 41.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 120.187 1.993 . . . . 64.43 108.758 178.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -62.52 -60.81 3.0 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.363 1.865 . . . . 63.21 108.263 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.0 mmt-85 -54.44 -39.01 66.98 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.144 0.977 . . . . 71.42 110.344 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -62.94 -47.62 82.43 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.207 -1.034 . . . . 74.01 108.207 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.8 mtm -63.27 -41.82 99.06 Favored 'General case' 0 C--O 1.222 -0.372 0 C-N-CA 123.839 0.856 . . . . 70.22 110.226 179.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -56.81 -50.53 72.08 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.601 1.16 . . . . 72.54 109.051 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.36 -30.86 50.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 125.273 1.429 . . . . 71.11 110.88 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 -44.23 52.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.477 -0.935 . . . . 53.14 108.477 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.2 mt -63.59 -29.01 70.32 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.376 1.071 . . . . 74.44 112.206 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.9 mt -72.79 -2.82 22.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 118.755 -0.64 . . . . 71.34 112.018 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -84.79 -5.95 59.34 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.425 1.011 . . . . 71.01 109.987 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 69.6 t60 -66.19 112.53 3.98 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.724 1.147 . . . . 71.22 108.671 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.23 -8.19 38.07 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.626 1.108 . . . . 73.42 113.049 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 71.1 p -65.72 148.98 50.88 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 119.234 1.517 . . . . 75.44 108.678 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.2 mt -98.51 108.07 20.68 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.58 -2.378 . . . . 64.24 104.58 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.0 tp -102.55 111.11 23.28 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.291 -1.744 . . . . 75.34 106.291 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt 48.89 51.34 16.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.451 1.1 . . . . 63.03 111.163 -178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . 0.274 9.6 mt-10 57.97 38.7 26.9 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 128.031 2.532 . . . . 51.31 114.159 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -137.58 118.15 13.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 126.285 1.834 . . . . 71.51 106.59 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -78.46 105.23 9.58 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.772 -1.195 . . . . 75.24 107.772 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.6 pt -79.52 172.4 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 125.149 1.379 . . . . 75.3 113.262 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -123.42 149.94 44.41 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 126.528 1.931 . . . . 73.22 106.61 177.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.8 t -139.91 120.98 14.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 106.308 -1.738 . . . . 60.41 106.308 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -139.01 175.69 9.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.834 1.254 . . . . 72.53 110.608 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.53 152.22 30.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.442 1.497 . . . . 74.44 113.396 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.63 129.45 15.24 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.24 -1.393 . . . . 75.12 107.24 177.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 81' ' ' GLY . 16.3 t 57.87 -164.92 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 123.924 0.889 . . . . 75.11 109.971 179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.8 ' H ' HG12 ' A' ' 80' ' ' VAL . . . 102.64 83.9 1.76 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 124.97 1.271 . . . . 44.51 110.659 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.3 0 C-N-CA 127.958 2.694 . . . . 74.33 106.604 179.485 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.789 0 N-CA-C 109.787 -1.325 . . . . 73.41 109.787 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -100.85 -12.28 19.14 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.488 1.644 . . . . 52.41 114.985 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.42 112.58 18.72 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.987 -1.116 . . . . 70.52 107.987 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -103.18 160.71 14.41 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.214 1.805 . . . . 52.34 108.558 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.485 ' HB ' HG23 ' A' ' 79' ' ' THR . 2.1 mp -134.37 149.83 30.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.924 1.69 . . . . 54.22 107.63 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.9 t -119.18 124.21 72.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 105.238 -2.134 . . . . 61.24 105.238 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -82.53 131.8 35.21 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.543 -2.021 . . . . 70.41 105.543 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 11' ' ' LEU . 15.2 t -136.36 122.53 30.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.546 -2.02 . . . . 73.44 105.546 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' CA ' HG22 ' A' ' 40' ' ' ILE . . . -135.81 180.0 17.21 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 120.066 1.303 . . . . 73.54 113.485 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.48 19.62 5.11 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.987 2.115 . . . . 64.4 111.331 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.607 HD11 HG12 ' A' ' 8' ' ' VAL . 10.2 mp -62.63 148.13 91.52 Favored Pre-proline 0 C--O 1.237 0.436 0 C-N-CA 124.152 0.981 . . . . 55.14 110.951 -179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -67.56 150.91 80.17 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 123.677 2.918 . . . . 70.12 110.553 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.71 -30.15 71.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 118.618 -0.706 . . . . 73.31 111.3 178.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.98 11.97 18.94 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 114.37 1.248 . . . . 74.24 114.37 -179.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.429 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 7.8 tp -54.46 147.93 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.922 1.289 . . . . 74.33 110.42 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.3 p -128.21 157.0 42.05 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.428 0.691 . . . . 43.13 110.822 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.12 -32.19 73.66 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.977 -0.452 . . . . 62.3 109.802 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 p -63.39 -44.51 98.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 109.457 -0.572 . . . . 64.14 109.457 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -71.05 -36.08 72.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 119.196 -0.43 . . . . 72.21 110.061 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 20' ' ' LEU . 19.0 mt -63.4 -46.28 87.13 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 108.421 -0.955 . . . . 63.13 108.421 178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -58.33 -49.99 75.22 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.883 -1.155 . . . . 54.0 107.883 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -55.45 -44.16 76.13 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 113.529 0.937 . . . . 75.12 113.529 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -66.99 -30.25 70.31 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 114.342 1.238 . . . . 71.55 114.342 -179.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.07 6.23 19.11 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.61 0.764 . . . . 74.22 112.662 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp -54.44 -43.32 71.5 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.412 1.485 . . . . 61.31 110.637 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -61.21 -35.3 76.83 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.561 0.744 . . . . 63.05 111.618 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.92 -17.36 38.04 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.735 1.614 . . . . 61.42 111.417 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.433 ' HB2' ' HE ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER 54.43 72.95 0.98 Allowed Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 126.728 2.011 . . . . 74.34 116.239 178.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.39 161.71 43.68 Favored 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 123.037 2.492 . . . . 73.04 110.187 178.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.09 -46.56 8.4 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.031 1.732 . . . . 63.13 108.939 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -131.72 156.32 46.12 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.25 -0.886 . . . . 73.32 112.383 -178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.9 mt -146.77 123.9 3.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.416 -1.328 . . . . 73.13 107.416 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.72 104.91 5.44 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 128.28 2.632 . . . . 72.53 106.794 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -93.12 112.25 24.14 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.33 1.052 . . . . 71.12 110.25 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -97.79 82.78 3.08 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.092 -1.818 . . . . 71.24 106.092 177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.04 -29.71 58.03 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.669 0.787 . . . . 73.25 111.563 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.18 -32.3 22.98 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.483 2.313 . . . . 74.15 112.6 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.6 mmmm -122.15 -5.13 8.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.372 1.469 . . . . 61.52 110.2 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 64.09 47.43 85.36 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 125.674 1.607 . . . . 61.22 109.488 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.423 HG22 ' CA ' ' A' ' 9' ' ' GLY . 3.2 pt -135.57 162.4 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.152 1.381 . . . . 71.25 108.869 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.96 166.22 24.59 Favored 'General case' 0 N--CA 1.439 -1.007 0 C-N-CA 124.926 1.29 . . . . 73.44 108.369 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -133.47 104.7 6.53 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.627 -1.62 . . . . 65.53 106.627 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -105.27 113.16 26.58 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.429 -1.323 . . . . 74.42 107.429 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -91.32 153.6 19.81 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.33 1.452 . . . . 70.1 108.703 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -147.75 136.24 21.65 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.895 1.278 . . . . 70.4 108.224 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -101.48 111.51 23.76 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.958 1.303 . . . . 75.1 111.919 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.64 -21.47 55.43 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.073 2.149 . . . . 52.12 110.396 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -62.64 -30.41 71.35 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 106.989 -1.486 . . . . 41.33 106.989 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -62.06 -33.59 74.68 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 117.994 -1.003 . . . . 73.25 110.765 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -157.24 108.41 2.33 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 114.642 1.349 . . . . 53.12 114.642 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -68.05 -19.31 64.87 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 117.182 -1.389 . . . . 74.15 112.999 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.359 43.5 p -122.53 14.73 10.29 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.795 1.634 . . . . 74.35 114.535 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -131.03 -19.89 1.21 Allowed Glycine 0 CA--C 1.533 1.186 0 C-N-CA 125.346 1.45 . . . . 53.14 115.167 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 9.5 tp -57.8 -30.41 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 120.484 2.142 . . . . 71.33 109.514 178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -64.14 -55.97 18.08 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 126.142 1.777 . . . . 70.43 110.086 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -58.55 -27.36 64.5 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.428 1.491 . . . . 71.54 110.719 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.433 ' HE ' ' HB2' ' A' ' 28' ' ' SER . 28.4 mtt85 -76.33 -45.83 30.41 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.239 -1.023 . . . . 71.24 108.239 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 8.2 mtm -57.57 -41.67 81.54 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 123.959 0.904 . . . . 64.54 108.904 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -55.17 -49.08 72.77 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.322 1.449 . . . . 74.14 110.391 179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.7 mt -64.66 -41.55 92.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 124.271 1.028 . . . . 73.32 109.439 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.3 -45.36 93.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.69 -0.856 . . . . 54.3 108.69 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.3 mt -63.83 -32.52 74.06 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.188 0.995 . . . . 73.23 110.51 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.32 -10.78 26.36 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.175 -0.917 . . . . 75.0 110.808 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 66.4 mm-40 -85.91 -0.78 56.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 120.031 1.287 . . . . 63.43 110.755 178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.2 112.38 3.01 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 120.682 -1.261 . . . . 73.32 107.767 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.56 1.75 57.68 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-O 117.421 -1.766 . . . . 70.55 113.261 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . 0.256 51.3 p -66.02 142.83 57.69 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 120.988 2.394 . . . . 70.14 110.33 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.0 mt -91.48 116.65 29.03 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.593 1.157 . . . . 74.4 108.172 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 mt -122.53 120.4 33.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 105.949 -1.871 . . . . 71.22 105.949 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 15' ' ' ILE . 10.7 mtmm 44.3 47.53 7.88 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.749 1.62 . . . . 72.45 110.076 -178.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 59.39 33.71 22.49 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.225 1.81 . . . . 62.14 114.712 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -130.18 117.56 20.09 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 104.742 -2.318 . . . . 75.52 104.742 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tttm -78.58 107.96 11.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.97 -1.122 . . . . 61.44 107.97 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -78.99 170.29 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 124.501 1.12 . . . . 51.43 111.06 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.26 155.62 47.98 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 126.001 1.72 . . . . 74.41 109.344 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.6 t -139.23 133.11 39.29 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.236 0 O-C-N 124.003 0.815 . . . . 64.41 110.224 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -143.9 175.43 10.02 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.013 1.325 . . . . 64.52 108.621 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.89 150.58 21.16 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.828 0.851 . . . . 53.0 109.168 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.485 HG23 ' HB ' ' A' ' 5' ' ' ILE . 5.9 t -148.69 82.51 1.46 Allowed 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.99 -1.115 . . . . 71.42 107.99 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -167.37 -62.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 123.83 0.852 . . . . 50.11 109.416 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.33 -32.42 75.75 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.528 -0.629 . . . . 64.24 111.528 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 N-CA-C 106.312 -2.715 . . . . 75.11 106.312 -179.677 . . . . . . . . 0 0 . 1 stop_ save_